country,term,count
AL,LACTIC ACIDOSIS,4
AL,MULTI-ORGAN FAILURE,4
AL,ANURIA,1
AL,BLINDNESS,1
AL,BLOOD PRESSURE FLUCTUATION,1
AL,CARDIAC FAILURE,1
AL,CIRCULATORY COLLAPSE,1
AL,COMA,1
AL,GENERAL PHYSICAL HEALTH DETERIORATION,1
AL,OVERDOSE,1
AL,VOMITING,1
DZ,INVESTIGATION,5
DZ,COUGH,3
DZ,NAUSEA,3
DZ,NEPHROLITHIASIS,3
DZ,TRANSAMINASES INCREASED,3
DZ,URINARY TRACT INFECTION,3
DZ,VOMITING,3
DZ,ABDOMINAL DISTENSION,2
DZ,MALAISE,2
DZ,ABDOMINAL PAIN,1
DZ,ABDOMINAL PAIN UPPER,1
DZ,ALTERED STATE OF CONSCIOUSNESS,1
DZ,AMNESIA,1
DZ,BRONCHITIS,1
DZ,CARDIO-RESPIRATORY ARREST,1
DZ,CONDITION AGGRAVATED,1
DZ,DECREASED APPETITE,1
DZ,DIARRHOEA,1
DZ,ENCEPHALOPATHY,1
DZ,HAEMATEMESIS,1
DZ,HEADACHE,1
DZ,LIMB INJURY,1
DZ,MYOCARDIAL ISCHAEMIA,1
DZ,ORTHOSTATIC HYPOTENSION,1
DZ,RETINAL DETACHMENT,1
DZ,RETINAL HAEMORRHAGE,1
DZ,SUPERINFECTION,1
DZ,VISION BLURRED,1
AR,DIABETES MELLITUS,16
AR,WEIGHT DECREASED,15
AR,MALAISE,13
AR,PNEUMONIA,11
AR,BLOOD PRESSURE INCREASED,9
AR,HYPERTENSION,8
AR,PYREXIA,8
AR,BLOOD GLUCOSE INCREASED,7
AR,FALL,7
AR,FATIGUE,7
AR,CHOLELITHIASIS,6
AR,CONDITION AGGRAVATED,6
AR,COUGH,6
AR,DIARRHOEA,6
AR,DYSPNOEA,6
AR,FEELING ABNORMAL,6
AR,HEADACHE,6
AR,ACUTE MYOCARDIAL INFARCTION,5
AR,ARRHYTHMIA,5
AR,CEREBROVASCULAR ACCIDENT,5
AR,DEHYDRATION,5
AR,GAIT DISTURBANCE,5
AR,HYPERGLYCAEMIA,5
AR,MEMORY IMPAIRMENT,5
AR,PAIN,5
AR,VOMITING,5
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
AR,ABDOMINAL DISCOMFORT,4
AR,ARTHRALGIA,4
AR,CARDIO-RESPIRATORY ARREST,4
AR,CHEST DISCOMFORT,4
AR,CORONARY ARTERY OCCLUSION,4
AR,DIZZINESS,4
AR,DRUG INEFFECTIVE,4
AR,HYPOGLYCAEMIA,4
AR,NECK PAIN,4
AR,PAIN IN EXTREMITY,4
AR,PANCREATITIS ACUTE,4
AR,RENAL FAILURE,4
AR,ABASIA,3
AR,ANAEMIA,3
AR,ANGINA PECTORIS,3
AR,ANGINA UNSTABLE,3
AR,ASTHENIA,3
AR,BLOOD PRESSURE SYSTOLIC INCREASED,3
AR,BRONCHITIS,3
AR,CARDIAC FAILURE,3
AR,CEREBRAL ISCHAEMIA,3
AR,CHEST PAIN,3
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
AR,DEPRESSION,3
AR,DIABETIC FOOT,3
AR,DISEASE PROGRESSION,3
AR,GLAUCOMA,3
AR,HYPOAESTHESIA,3
AR,HYPOTENSION,3
AR,INCORRECT DOSE ADMINISTERED,3
AR,INJECTION SITE PAIN,3
AR,LIMB DISCOMFORT,3
AR,LOSS OF CONSCIOUSNESS,3
AR,MATERNAL EXPOSURE DURING PREGNANCY,3
AR,MUSCLE SPASMS,3
AR,NERVOUSNESS,3
AR,OSTEOARTHRITIS,3
AR,PARAESTHESIA,3
AR,PERIPHERAL SWELLING,3
AR,PLEURAL EFFUSION,3
AR,RESTLESSNESS,3
AR,SWELLING,3
AR,WEIGHT INCREASED,3
AR,ABDOMINAL PAIN,2
AR,ABDOMINAL PAIN UPPER,2
AR,ABORTION SPONTANEOUS,2
AR,ANGIOEDEMA,2
AR,ANXIETY,2
AR,ARTHROPATHY,2
AR,BACK PAIN,2
AR,BILE DUCT STONE,2
AR,BLOOD GLUCOSE DECREASED,2
AR,BLOOD PRESSURE DECREASED,2
AR,BONE PAIN,2
AR,BREAST CANCER,2
AR,CHOLECYSTITIS ACUTE,2
AR,CHRONIC KIDNEY DISEASE,2
AR,DEATH,2
AR,DEEP VEIN THROMBOSIS,2
AR,DIABETIC COMA,2
AR,DIABETIC KETOACIDOSIS,2
AR,DYSPHONIA,2
AR,EPISTAXIS,2
AR,ERYSIPELAS,2
AR,ERYTHEMA,2
AR,ERYTHEMA MULTIFORME,2
AR,FACIAL PARALYSIS,2
AR,FOETAL EXPOSURE DURING PREGNANCY,2
AR,GASTRITIS,2
AR,HAEMORRHAGIC STROKE,2
AR,HEPATITIS,2
AR,HEPATITIS CHOLESTATIC,2
AR,HYPERSENSITIVITY,2
AR,HYPERSOMNIA,2
AR,HYPOKALAEMIA,2
AR,HYPOPHAGIA,2
AR,INFARCTION,2
AR,INFECTION,2
AR,INSULIN RESISTANT DIABETES,2
AR,ISCHAEMIC STROKE,2
AR,LOCALISED INFECTION,2
AR,MALIGNANT NEOPLASM PROGRESSION,2
AR,MENTAL DISORDER,2
AR,MYALGIA,2
AR,NASOPHARYNGITIS,2
AR,NEOPLASM PROGRESSION,2
AR,NEPHROLITHIASIS,2
AR,OBESITY,2
AR,PANCREATIC CARCINOMA,2
AR,PITUITARY TUMOUR,2
AR,PLATELET COUNT DECREASED,2
AR,PNEUMONITIS,2
AR,POLLAKIURIA,2
AR,PREGNANCY ON CONTRACEPTIVE,2
AR,PRODUCTIVE COUGH,2
AR,PSORIASIS,2
AR,PSORIATIC ARTHROPATHY,2
AR,PULMONARY EMBOLISM,2
AR,PULMONARY MASS,2
AR,SEIZURE,2
AR,SEPSIS,2
AR,SINUSITIS,2
AR,SKIN ULCER,2
AR,STRESS,2
AR,SYNCOPE,2
AR,THROMBOSIS,2
AR,TREMOR,2
AR,URINARY TRACT INFECTION,2
AR,VIRAL INFECTION,2
AR,VISUAL ACUITY REDUCED,2
AR,VISUAL IMPAIRMENT,2
AR,WEIGHT LOSS POOR,2
AR,WHITE BLOOD CELL COUNT INCREASED,2
AR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
AR,ABDOMINAL DISTENSION,1
AR,ABULIA,1
AR,ACUTE KIDNEY INJURY,1
AR,ACUTE PULMONARY OEDEMA,1
AR,ADENOCARCINOMA,1
AR,ADENOCARCINOMA OF COLON,1
AR,ADENOCARCINOMA PANCREAS,1
AR,ADRENAL GLAND CANCER,1
AR,AGITATION,1
AR,ALOPECIA,1
AR,AMENORRHOEA,1
AR,ANAL ABSCESS,1
AR,ANAL FISSURE,1
AR,ANGER,1
AR,ANGIOPATHY,1
AR,ANKYLOSING SPONDYLITIS,1
AR,AORTIC ANEURYSM,1
AR,APHAGIA,1
AR,ARTHRITIS BACTERIAL,1
AR,ASPHYXIA,1
AR,ATRIOVENTRICULAR BLOCK COMPLETE,1
AR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
AR,BACTERAEMIA,1
AR,BALANCE DISORDER,1
AR,BASAL CELL CARCINOMA,1
AR,BENIGN OVARIAN TUMOUR,1
AR,BENIGN PROSTATIC HYPERPLASIA,1
AR,BILE DUCT STENOSIS,1
AR,BLISTER,1
AR,BLISTER INFECTED,1
AR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AR,BLOOD GLUCOSE ABNORMAL,1
AR,BLOOD PRESSURE DIASTOLIC DECREASED,1
AR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AR,BLOODY DISCHARGE,1
AR,BODY TEMPERATURE INCREASED,1
AR,BONE DISORDER,1
AR,BONE NEOPLASM,1
AR,BRONCHIAL DISORDER,1
AR,BRONCHOPULMONARY DISEASE,1
AR,CARBOHYDRATE INTOLERANCE,1
AR,CARDIAC FAILURE CONGESTIVE,1
AR,CARDIOGENIC SHOCK,1
AR,CARDIOMYOPATHY,1
AR,CAROTID ARTERY OCCLUSION,1
AR,CATARACT,1
AR,CATARRH,1
AR,CELLULITIS,1
AR,CEREBROSPINAL FISTULA,1
AR,CERVICAL CYST,1
AR,CERVIX HAEMORRHAGE UTERINE,1
AR,CHOLECYSTITIS INFECTIVE,1
AR,CHRONIC GASTRITIS,1
AR,COAGULATION TIME PROLONGED,1
AR,COLITIS,1
AR,COLITIS ULCERATIVE,1
AR,COLON NEOPLASM,1
AR,COMA,1
AR,CONCOMITANT DISEASE PROGRESSION,1
AR,CONCUSSION,1
AR,CONFUSIONAL STATE,1
AR,CORNEAL DISORDER,1
AR,CORONARY ARTERY STENOSIS,1
AR,CYST,1
AR,DAYDREAMING,1
AR,DECREASED APPETITE,1
AR,DECREASED IMMUNE RESPONSIVENESS,1
AR,DEMYELINATING POLYNEUROPATHY,1
AR,DEVICE MALFUNCTION,1
AR,DIABETES INSIPIDUS,1
AR,DIABETES MELLITUS INADEQUATE CONTROL,1
AR,DIABETIC COMPLICATION,1
AR,DIABETIC FOOT INFECTION,1
AR,DIABETIC NEUROPATHY,1
AR,DIABETIC RETINOPATHY,1
AR,DIALYSIS,1
AR,DISTURBANCE IN ATTENTION,1
AR,DRUG DOSE OMISSION,1
AR,DRUG INTOLERANCE,1
AR,DRUG PRESCRIBING ERROR,1
AR,DRUG-INDUCED LIVER INJURY,1
AR,DUODENAL ULCER,1
AR,DYSBACTERIOSIS,1
AR,DYSGRAPHIA,1
AR,EPILEPSY,1
AR,EXOSTOSIS,1
AR,EYE HAEMORRHAGE,1
AR,EYE PAIN,1
AR,EYE ULCER,1
AR,FEAR,1
AR,FEAR OF INJECTION,1
AR,FEBRILE NEUTROPENIA,1
AR,FEELING HOT,1
AR,FEMUR FRACTURE,1
AR,FISTULA,1
AR,GANGRENE,1
AR,GASTRIC DISORDER,1
AR,GASTRIC DYSPLASIA,1
AR,GASTRIC HAEMORRHAGE,1
AR,GASTRIC ULCER,1
AR,GASTROENTERITIS,1
AR,GASTROINTESTINAL DISORDER,1
AR,GASTROINTESTINAL INFECTION,1
AR,GENERAL PHYSICAL HEALTH DETERIORATION,1
AR,GENERALISED TONIC-CLONIC SEIZURE,1
AR,GINGIVAL BLEEDING,1
AR,GLOMERULAR FILTRATION RATE DECREASED,1
AR,GRANULOMA,1
AR,GROIN PAIN,1
AR,GUILLAIN-BARRE SYNDROME,1
AR,HAEMATOCHEZIA,1
AR,HAEMORRHOIDS,1
AR,HEART RATE DECREASED,1
AR,HEPATIC CIRRHOSIS,1
AR,HEPATIC ENZYME ABNORMAL,1
AR,HEPATIC ENZYME INCREASED,1
AR,HEPATITIS E,1
AR,HERNIAL EVENTRATION,1
AR,HORMONE LEVEL ABNORMAL,1
AR,HUMERUS FRACTURE,1
AR,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
AR,HYPERHIDROSIS,1
AR,HYPERINSULINISM,1
AR,HYPERKERATOSIS,1
AR,HYPERTENSIVE EMERGENCY,1
AR,HYPONATRAEMIA,1
AR,HYPOTHYROIDISM,1
AR,HYPOVENTILATION,1
AR,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
AR,IMPAIRED HEALING,1
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AR,INCORRECT DOSE ADMINISTERED BY DEVICE,1
AR,INFLAMMATION,1
AR,INFLUENZA,1
AR,INJECTION SITE BRUISING,1
AR,INJECTION SITE URTICARIA,1
AR,INJURY ASSOCIATED WITH DEVICE,1
AR,INTERVERTEBRAL DISC DEGENERATION,1
AR,INTERVERTEBRAL DISC PROTRUSION,1
AR,INTESTINAL HAEMORRHAGE,1
AR,INTESTINAL POLYP,1
AR,IRRITABLE BOWEL SYNDROME,1
AR,ISCHAEMIA,1
AR,JOINT DISLOCATION,1
AR,LARGE FOR DATES BABY,1
AR,LIMB DEFORMITY,1
AR,LIPOMA,1
AR,LIVER DISORDER,1
AR,LOCAL SWELLING,1
AR,LUNG NEOPLASM,1
AR,LUNG NEOPLASM MALIGNANT,1
AR,LYMPHOEDEMA,1
AR,MACULOPATHY,1
AR,MALNUTRITION,1
AR,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
AR,MEDICATION RESIDUE PRESENT,1
AR,MENINGITIS,1
AR,METASTASES TO BONE,1
AR,METASTASES TO CENTRAL NERVOUS SYSTEM,1
AR,METASTASES TO LIVER,1
AR,METASTATIC RENAL CELL CARCINOMA,1
AR,MOBILITY DECREASED,1
AR,MONOPLEGIA,1
AR,MUSCULAR WEAKNESS,1
AR,MUSCULOSKELETAL DISCOMFORT,1
AR,MUSCULOSKELETAL STIFFNESS,1
AR,MYELODYSPLASTIC SYNDROME,1
AR,MYOCARDIAL ISCHAEMIA,1
AR,MYOCLONUS,1
AR,NASAL CONGESTION,1
AR,NASAL INJURY,1
AR,NECROTISING FASCIITIS,1
AR,NEOPLASM,1
AR,NORMAL NEWBORN,1
AR,NOSE DEFORMITY,1
AR,OCULAR DISCOMFORT,1
AR,OEDEMA PERIPHERAL,1
AR,OESOPHAGEAL DISORDER,1
AR,ORAL CANDIDIASIS,1
AR,OSTEOMYELITIS,1
AR,OVERDOSE,1
AR,OVERWEIGHT,1
AR,PANCREATIC CYST,1
AR,PANCREATITIS,1
AR,PANCYTOPENIA,1
AR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AR,PERIPHERAL ARTERY ANGIOPLASTY,1
AR,PERIPHERAL ARTERY OCCLUSION,1
AR,PERIPHERAL VENOUS DISEASE,1
AR,PERITONITIS,1
AR,POLYP,1
AR,POST PROCEDURAL INFECTION,1
AR,PREMATURE BABY,1
AR,PREMATURE SEPARATION OF PLACENTA,1
AR,PRODUCT USE ISSUE,1
AR,PROSTATIC OPERATION,1
AR,PROSTATOMEGALY,1
AR,PRURIGO,1
AR,PRURITUS,1
AR,PULMONARY FUNCTION TEST DECREASED,1
AR,PULMONARY OEDEMA,1
AR,PULSE ABNORMAL,1
AR,PURULENT DISCHARGE,1
AR,PYELONEPHRITIS,1
AR,RASH,1
AR,RASH MACULO-PAPULAR,1
AR,RED BLOOD CELL COUNT INCREASED,1
AR,RENAL DISORDER,1
AR,RENAL IMPAIRMENT,1
AR,RENIN INCREASED,1
AR,RESPIRATORY DISTRESS,1
AR,RESPIRATORY TRACT CONGESTION,1
AR,RETINAL DISORDER,1
AR,RETINAL INJURY,1
AR,ROTATOR CUFF SYNDROME,1
AR,SCAN ABDOMEN ABNORMAL,1
AR,SCAN ABNORMAL,1
AR,SCIATICA,1
AR,SENSORY DISTURBANCE,1
AR,SENSORY LOSS,1
AR,SHOCK,1
AR,SIGHT DISABILITY,1
AR,SKIN DISCOLOURATION,1
AR,SKIN EXFOLIATION,1
AR,SKIN WRINKLING,1
AR,SKULL FRACTURED BASE,1
AR,SLEEP DISORDER,1
AR,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
AR,SNEEZING,1
AR,SOFT TISSUE INFECTION,1
AR,SPEECH DISORDER,1
AR,SPINAL DISORDER,1
AR,STOMATITIS,1
AR,SUDDEN DEATH,1
AR,SUICIDAL IDEATION,1
AR,SUPPRESSED LACTATION,1
AR,SUPRANUCLEAR PALSY,1
AR,SUPRAVENTRICULAR TACHYCARDIA,1
AR,SWELLING FACE,1
AR,SYNOVIAL CYST,1
AR,TACHYCARDIA,1
AR,TENDON RUPTURE,1
AR,TENSION,1
AR,THROAT TIGHTNESS,1
AR,THROMBOCYTOPENIA,1
AR,THYROID DISORDER,1
AR,TIME PERCEPTION ALTERED,1
AR,TOOTH FRACTURE,1
AR,TRANSIENT ISCHAEMIC ATTACK,1
AR,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
AR,TUMOUR HAEMORRHAGE,1
AR,TUMOUR MARKER INCREASED,1
AR,TYPE 1 DIABETES MELLITUS,1
AR,TYPE 2 DIABETES MELLITUS,1
AR,URINARY BLADDER HAEMORRHAGE,1
AR,URINE ANALYSIS ABNORMAL,1
AR,UTERINE LEIOMYOMA,1
AR,VAGINAL HAEMORRHAGE,1
AR,VARICOSE VEIN,1
AR,VASCULAR OCCLUSION,1
AR,WALKING DISABILITY,1
AR,YELLOW SKIN,1
AU,LACTIC ACIDOSIS,129
AU,INTENTIONAL OVERDOSE,89
AU,HYPOTENSION,80
AU,DIABETIC KETOACIDOSIS,67
AU,TACHYCARDIA,65
AU,HYPOGLYCAEMIA,64
AU,VOMITING,60
AU,ACUTE KIDNEY INJURY,56
AU,PYREXIA,55
AU,TOXICITY TO VARIOUS AGENTS,51
AU,NAUSEA,50
AU,ELECTROCARDIOGRAM QT PROLONGED,46
AU,DIARRHOEA,44
AU,CHEST PAIN,42
AU,OVERDOSE,42
AU,BLOOD CREATININE INCREASED,39
AU,MALAISE,38
AU,DYSPNOEA,36
AU,RENAL IMPAIRMENT,34
AU,BLOOD GLUCOSE INCREASED,33
AU,BRADYCARDIA,33
AU,DECREASED APPETITE,32
AU,RENAL FAILURE ACUTE,32
AU,ALANINE AMINOTRANSFERASE INCREASED,31
AU,RENAL FAILURE,31
AU,C-REACTIVE PROTEIN INCREASED,30
AU,HYPERKALAEMIA,28
AU,DIZZINESS,27
AU,DRUG-INDUCED LIVER INJURY,27
AU,DEHYDRATION,26
AU,FATIGUE,26
AU,MYOCARDITIS,26
AU,SINUS TACHYCARDIA,26
AU,ACIDOSIS,24
AU,WHITE BLOOD CELL COUNT INCREASED,23
AU,CONFUSIONAL STATE,22
AU,HYPERLACTACIDAEMIA,22
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,21
AU,LETHARGY,21
AU,WEIGHT INCREASED,21
AU,ATRIAL FIBRILLATION,20
AU,FALL,20
AU,HAEMOGLOBIN DECREASED,20
AU,WEIGHT DECREASED,20
AU,ANAEMIA,19
AU,LOWER RESPIRATORY TRACT INFECTION,19
AU,NEUTROPHIL COUNT INCREASED,19
AU,PANCREATITIS,19
AU,TRICUSPID VALVE INCOMPETENCE,19
AU,ASPARTATE AMINOTRANSFERASE INCREASED,18
AU,COMA,18
AU,COMA SCALE ABNORMAL,18
AU,CONGESTIVE CARDIOMYOPATHY,18
AU,CONSTIPATION,18
AU,DELIRIUM,18
AU,MYOCARDIAL INFARCTION,18
AU,NEUTROPENIA,18
AU,SCHIZOPHRENIA,18
AU,SEPSIS,18
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,17
AU,ENCEPHALOPATHY,17
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,17
AU,HYPERTENSION,17
AU,HYPONATRAEMIA,17
AU,OBSTRUCTIVE AIRWAYS DISORDER,17
AU,TROPONIN INCREASED,17
AU,ABDOMINAL PAIN,16
AU,CARDIAC FAILURE,16
AU,GENERALISED TONIC-CLONIC SEIZURE,16
AU,METABOLIC ACIDOSIS,16
AU,RESPIRATORY FAILURE,16
AU,BEZOAR,15
AU,DEPRESSION,15
AU,MENTAL DISORDER,15
AU,PNEUMONIA,15
AU,MITRAL VALVE INCOMPETENCE,14
AU,SOMNOLENCE,14
AU,URINARY TRACT INFECTION,14
AU,DRUG LEVEL INCREASED,13
AU,HYPOMAGNESAEMIA,13
AU,SEDATION,13
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,12
AU,CARDIAC DISORDER,12
AU,CELLULITIS,12
AU,DISTRIBUTIVE SHOCK,12
AU,MENTAL IMPAIRMENT,12
AU,PERICARDIAL EFFUSION,12
AU,PULMONARY EMBOLISM,12
AU,THROMBOCYTOPENIA,12
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,11
AU,BLOOD CHLORIDE DECREASED,11
AU,BLOOD PRESSURE INCREASED,11
AU,BLOOD SODIUM DECREASED,11
AU,BLOOD TRIGLYCERIDES INCREASED,11
AU,CEREBELLAR SYNDROME,11
AU,CHEST DISCOMFORT,11
AU,COUGH,11
AU,DEATH,11
AU,DELUSION,11
AU,FOETAL EXPOSURE DURING PREGNANCY,11
AU,GLOMERULAR FILTRATION RATE DECREASED,11
AU,INTENTIONAL SELF-INJURY,11
AU,LOSS OF CONSCIOUSNESS,11
AU,MYALGIA,11
AU,NEUTROPHILIA,11
AU,OEDEMA PERIPHERAL,11
AU,OLIGURIA,11
AU,PERICARDITIS,11
AU,BLOOD BILIRUBIN INCREASED,10
AU,CARDIAC ARREST,10
AU,CARDIOMYOPATHY,10
AU,DRUG INEFFECTIVE,10
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,10
AU,MONOCYTE COUNT INCREASED,10
AU,PALPITATIONS,10
AU,PSYCHOTIC DISORDER,10
AU,SUICIDE ATTEMPT,10
AU,AGITATION,9
AU,BACK PAIN,9
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,9
AU,BLOOD LACTIC ACID INCREASED,9
AU,EJECTION FRACTION DECREASED,9
AU,HAEMORRHAGE,9
AU,HEADACHE,9
AU,HEPATOTOXICITY,9
AU,LIVER FUNCTION TEST ABNORMAL,9
AU,OBESITY,9
AU,ORTHOSTATIC HYPOTENSION,9
AU,PAIN IN EXTREMITY,9
AU,PERSONALITY DISORDER,9
AU,PRURITUS,9
AU,ABDOMINAL PAIN UPPER,8
AU,ACUTE MYOCARDIAL INFARCTION,8
AU,ANGIOEDEMA,8
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,8
AU,ANXIETY,8
AU,BLOOD PRESSURE DECREASED,8
AU,COMPLETED SUICIDE,8
AU,DIABETES MELLITUS INADEQUATE CONTROL,8
AU,DRUG DOSE OMISSION,8
AU,DYSPHAGIA,8
AU,DYSPNOEA EXERTIONAL,8
AU,EOSINOPHILIA,8
AU,HEPATIC FAILURE,8
AU,HYPERHIDROSIS,8
AU,INCORRECT DOSE ADMINISTERED,8
AU,LEUKOPENIA,8
AU,MEAN CELL VOLUME DECREASED,8
AU,MOOD ALTERED,8
AU,MUSCULAR WEAKNESS,8
AU,OXYGEN SATURATION DECREASED,8
AU,PAIN,8
AU,PANCYTOPENIA,8
AU,PRODUCT USE ISSUE,8
AU,PULMONARY HYPERTENSION,8
AU,RASH,8
AU,TACHYPNOEA,8
AU,TOXIC ENCEPHALOPATHY,8
AU,WHITE BLOOD CELL COUNT DECREASED,8
AU,ACUTE LUNG INJURY,7
AU,ASTHENIA,7
AU,BLOOD CREATININE DECREASED,7
AU,CARDIAC FAILURE CONGESTIVE,7
AU,CEREBROVASCULAR ACCIDENT,7
AU,CHILLS,7
AU,CREATININE RENAL CLEARANCE DECREASED,7
AU,DISEASE PROGRESSION,7
AU,EXPOSURE DURING PREGNANCY,7
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,7
AU,HAEMATURIA,7
AU,INFECTION,7
AU,MEAN CELL HAEMOGLOBIN DECREASED,7
AU,MYELODYSPLASTIC SYNDROME,7
AU,PHARYNGITIS,7
AU,PLEURAL EFFUSION,7
AU,RECTAL HAEMORRHAGE,7
AU,RIGHT VENTRICULAR DYSFUNCTION,7
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,7
AU,URINE OUTPUT DECREASED,7
AU,ARTHRALGIA,6
AU,ATELECTASIS,6
AU,BLOOD GLUCOSE DECREASED,6
AU,BLOOD LACTATE DEHYDROGENASE DECREASED,6
AU,BLOOD UREA DECREASED,6
AU,BUNDLE BRANCH BLOCK LEFT,6
AU,CONDITION AGGRAVATED,6
AU,DIABETES MELLITUS,6
AU,EXERCISE TOLERANCE DECREASED,6
AU,FLUID OVERLOAD,6
AU,GAIT DISTURBANCE,6
AU,INSOMNIA,6
AU,LEFT VENTRICULAR DYSFUNCTION,6
AU,LEUKOCYTOSIS,6
AU,MYOCARDIAL ISCHAEMIA,6
AU,OEDEMA,6
AU,POISONING DELIBERATE,6
AU,RENAL HAEMORRHAGE,6
AU,SALIVARY HYPERSECRETION,6
AU,SLEEP APNOEA SYNDROME,6
AU,SPEECH DISORDER,6
AU,SYNCOPE,6
AU,TARDIVE DYSKINESIA,6
AU,TRANSAMINASES INCREASED,6
AU,TRANSIENT ISCHAEMIC ATTACK,6
AU,TREMOR,6
AU,WHEEZING,6
AU,ACUTE CORONARY SYNDROME,5
AU,ANGINA PECTORIS,5
AU,ASCITES,5
AU,BILIRUBIN CONJUGATED INCREASED,5
AU,BLOOD ALBUMIN DECREASED,5
AU,BLOOD BICARBONATE DECREASED,5
AU,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,5
AU,BLOOD PH DECREASED,5
AU,BLOOD POTASSIUM INCREASED,5
AU,CARDIAC MURMUR,5
AU,CARDIOGENIC SHOCK,5
AU,CONVULSION,5
AU,DIASTOLIC DYSFUNCTION,5
AU,DRUG EFFECT DECREASED,5
AU,DYSARTHRIA,5
AU,EOSINOPHIL COUNT INCREASED,5
AU,GASTROENTERITIS,5
AU,HAEMATEMESIS,5
AU,HAEMODYNAMIC INSTABILITY,5
AU,HALLUCINATION,5
AU,HEART RATE INCREASED,5
AU,HYPERCHOLESTEROLAEMIA,5
AU,HYPOPHAGIA,5
AU,IMMUNE-MEDIATED NECROTISING MYOPATHY,5
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
AU,INFLUENZA LIKE ILLNESS,5
AU,INTERNATIONAL NORMALISED RATIO INCREASED,5
AU,LEFT ATRIAL DILATATION,5
AU,LYMPHOCYTE COUNT DECREASED,5
AU,MELAENA,5
AU,MENTAL STATUS CHANGES,5
AU,MONOCYTE COUNT DECREASED,5
AU,MYOPATHY,5
AU,PARAESTHESIA,5
AU,PULMONARY VALVE INCOMPETENCE,5
AU,RESPIRATORY TRACT INFECTION,5
AU,SEPTIC SHOCK,5
AU,SMALL INTESTINAL OBSTRUCTION,5
AU,UROSEPSIS,5
AU,VENTRICULAR HYPOKINESIA,5
AU,VIRAL INFECTION,5
AU,ABDOMINAL DISTENSION,4
AU,AGGRESSION,4
AU,AGRANULOCYTOSIS,4
AU,ALTERED STATE OF CONSCIOUSNESS,4
AU,ANION GAP INCREASED,4
AU,ASPIRATION,4
AU,ATAXIA,4
AU,ATRIAL FLUTTER,4
AU,BLOOD IRON DECREASED,4
AU,BLOOD POTASSIUM DECREASED,4
AU,BLOOD UREA NITROGEN/CREATININE RATIO INCREASED,4
AU,CAESAREAN SECTION,4
AU,CARDIO-RESPIRATORY ARREST,4
AU,DEEP VEIN THROMBOSIS,4
AU,DEMENTIA,4
AU,DRUG EFFECT INCOMPLETE,4
AU,DRY MOUTH,4
AU,EOSINOPHIL COUNT DECREASED,4
AU,FEBRILE NEUTROPENIA,4
AU,HAEMATOMA,4
AU,HAEMORRHAGE INTRACRANIAL,4
AU,HALLUCINATION_ AUDITORY,4
AU,HYPOVOLAEMIA,4
AU,HYPOXIA,4
AU,INJECTION SITE HAEMORRHAGE,4
AU,LYMPHOCYTE COUNT INCREASED,4
AU,MOBILITY DECREASED,4
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
AU,NEUROPATHY PERIPHERAL,4
AU,POLYCHROMASIA,4
AU,PREGNANCY,4
AU,PULMONARY OEDEMA,4
AU,RASH MACULO-PAPULAR,4
AU,RED BLOOD CELL COUNT DECREASED,4
AU,RESPIRATORY RATE INCREASED,4
AU,RHABDOMYOLYSIS,4
AU,TACHYCARDIA FOETAL,4
AU,TREATMENT NONCOMPLIANCE,4
AU,TYPE 2 DIABETES MELLITUS,4
AU,VITAMIN B12 DEFICIENCY,4
AU,VITAMIN D DECREASED,4
AU,ABASIA,3
AU,ABDOMINAL TENDERNESS,3
AU,ABNORMAL BEHAVIOUR,3
AU,ABORTION SPONTANEOUS,3
AU,AKATHISIA,3
AU,ANAL INCONTINENCE,3
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,3
AU,AORTIC DILATATION,3
AU,ARTHRITIS,3
AU,ATYPICAL FEMUR FRACTURE,3
AU,AZOTAEMIA,3
AU,BLOOD CALCIUM DECREASED,3
AU,BLOOD CALCIUM INCREASED,3
AU,BLOOD KETONE BODY INCREASED,3
AU,BLOOD MAGNESIUM DECREASED,3
AU,BLOOD PRESSURE SYSTOLIC INCREASED,3
AU,BLOOD TEST ABNORMAL,3
AU,BLOOD UREA NITROGEN/CREATININE RATIO,3
AU,BONE PAIN,3
AU,BRADYCARDIA FOETAL,3
AU,BREAST CANCER,3
AU,BRONCHITIS,3
AU,BUNDLE BRANCH BLOCK RIGHT,3
AU,CALCIPHYLAXIS,3
AU,CARDIOPULMONARY FAILURE,3
AU,CHROMATOPSIA,3
AU,CHROMATURIA,3
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
AU,COLON CANCER,3
AU,CRYING,3
AU,CYCLOTHYMIC DISORDER,3
AU,DELIRIUM FEBRILE,3
AU,DIABETIC ULCER,3
AU,DIPLOPIA,3
AU,DISTURBANCE IN ATTENTION,3
AU,DROOLING,3
AU,DRUG ADMINISTRATION ERROR,3
AU,DUODENAL ULCER,3
AU,DYSPLASIA,3
AU,DYSPROSODY,3
AU,DYSURIA,3
AU,ELECTROCARDIOGRAM ABNORMAL,3
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
AU,ELECTROCARDIOGRAM T WAVE INVERSION,3
AU,EMOTIONAL DISTRESS,3
AU,EPISTAXIS,3
AU,ERYTHEMA,3
AU,ESCHERICHIA URINARY TRACT INFECTION,3
AU,EYE DISORDER,3
AU,FEELING ABNORMAL,3
AU,FEELING COLD,3
AU,FIBROSIS,3
AU,FLANK PAIN,3
AU,FOETAL DEATH,3
AU,FOETAL HYPOKINESIA,3
AU,GASTROINTESTINAL DISORDER,3
AU,GASTROINTESTINAL HAEMORRHAGE,3
AU,GASTROOESOPHAGEAL REFLUX DISEASE,3
AU,GENERAL PHYSICAL HEALTH DETERIORATION,3
AU,GLOBULINS DECREASED,3
AU,HAEMATOCRIT DECREASED,3
AU,HEPATIC FUNCTION ABNORMAL,3
AU,HEPATIC STEATOSIS,3
AU,HEPATITIS,3
AU,HERPES ZOSTER,3
AU,HYPERGLYCAEMIA,3
AU,HYPOKALAEMIA,3
AU,HYPOPERFUSION,3
AU,HYPOPITUITARISM,3
AU,HYPOVOLAEMIC SHOCK,3
AU,INSULIN RESISTANCE,3
AU,IRON DEFICIENCY ANAEMIA,3
AU,JAUNDICE,3
AU,JAUNDICE CHOLESTATIC,3
AU,KETOACIDOSIS,3
AU,LARGE INTESTINE POLYP,3
AU,LIVER DISORDER,3
AU,METABOLIC SYNDROME,3
AU,MOUTH ULCERATION,3
AU,MULTI-ORGAN FAILURE,3
AU,MUSCLE SPASMS,3
AU,MUSCLE TWITCHING,3
AU,NECK PAIN,3
AU,OSTEOARTHRITIS,3
AU,PLATELET COUNT DECREASED,3
AU,PLATELET COUNT INCREASED,3
AU,POSTPARTUM HAEMORRHAGE,3
AU,PRESYNCOPE,3
AU,PRODUCT USE IN UNAPPROVED INDICATION,3
AU,PROTEIN TOTAL DECREASED,3
AU,PROTHROMBIN LEVEL DECREASED,3
AU,RED BLOOD CELL COUNT INCREASED,3
AU,SCHIZOAFFECTIVE DISORDER,3
AU,SEIZURE,3
AU,SHOCK,3
AU,SKIN ULCER,3
AU,SPINAL CORD COMPRESSION,3
AU,SPLENIC INFARCTION,3
AU,SPLENOMEGALY,3
AU,SWOLLEN TONGUE,3
AU,SYSTOLIC DYSFUNCTION,3
AU,TANGENTIALITY,3
AU,THERAPEUTIC RESPONSE INCREASED,3
AU,TRANSFERRIN SATURATION DECREASED,3
AU,TROPONIN T INCREASED,3
AU,TUBULOINTERSTITIAL NEPHRITIS,3
AU,UNDERDOSE,3
AU,URINARY RETENTION,3
AU,URINE ANALYSIS ABNORMAL,3
AU,VASOPLEGIA SYNDROME,3
AU,VISION BLURRED,3
AU,VISUAL IMPAIRMENT,3
AU,VITAMIN D DEFICIENCY,3
AU,ABDOMINAL DISCOMFORT,2
AU,ACCIDENTAL EXPOSURE TO PRODUCT,2
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,2
AU,ACUTE HEPATIC FAILURE,2
AU,ACUTE MYELOID LEUKAEMIA,2
AU,AMNESIA,2
AU,ANAPHYLACTIC REACTION,2
AU,ANGIOPATHY,2
AU,ANTICHOLINERGIC SYNDROME,2
AU,ANTISOCIAL BEHAVIOUR,2
AU,ANURIA,2
AU,ATRIAL SEPTAL DEFECT,2
AU,ATRIOVENTRICULAR BLOCK COMPLETE,2
AU,BASAL CELL CARCINOMA,2
AU,BASE EXCESS DECREASED,2
AU,BITE,2
AU,BLINDNESS,2
AU,BLOOD CHLORIDE INCREASED,2
AU,BLOOD DISORDER,2
AU,BLOOD GLUCOSE ABNORMAL,2
AU,BLOOD GLUCOSE FLUCTUATION,2
AU,BLOOD PARATHYROID HORMONE INCREASED,2
AU,BLOOD UREA NITROGEN/CREATININE RATIO DECREASED,2
AU,BLOOD URIC ACID INCREASED,2
AU,BODY TEMPERATURE ABNORMAL,2
AU,BODY TEMPERATURE INCREASED,2
AU,BREATHING-RELATED SLEEP DISORDER,2
AU,CANDIDA INFECTION,2
AU,CARDIAC ANEURYSM,2
AU,CARDIAC FAILURE CHRONIC,2
AU,CATARACT,2
AU,CENTRAL OBESITY,2
AU,CEREBRAL INFARCTION,2
AU,CHOLELITHIASIS,2
AU,CIRCULATORY COLLAPSE,2
AU,COGNITIVE DISORDER,2
AU,COGWHEEL RIGIDITY,2
AU,COLITIS,2
AU,COLORECTAL CANCER METASTATIC,2
AU,CONTINUOUS HAEMODIAFILTRATION,2
AU,CONTUSION,2
AU,CORONARY ARTERIAL STENT INSERTION,2
AU,CORONARY ARTERY DISEASE,2
AU,COSTOVERTEBRAL ANGLE TENDERNESS,2
AU,CREATININE URINE INCREASED,2
AU,CYANOSIS,2
AU,DEPRESSED MOOD,2
AU,DIALYSIS,2
AU,DISORIENTATION,2
AU,DRUG HYPERSENSITIVITY,2
AU,DRUG INTOLERANCE,2
AU,DRUG WITHDRAWAL SYNDROME NEONATAL,2
AU,DRY SKIN,2
AU,DRY THROAT,2
AU,DYSPHONIA,2
AU,DYSSTASIA,2
AU,EAR INFECTION,2
AU,ECZEMA,2
AU,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
AU,EMPHYSEMA,2
AU,EPILEPSY,2
AU,EXTRAPYRAMIDAL DISORDER,2
AU,EYE SWELLING,2
AU,FAECAL INCONTINENCE,2
AU,FEELING JITTERY,2
AU,FLUID RETENTION,2
AU,FOETAL GROWTH RESTRICTION,2
AU,FOETAL MACROSOMIA,2
AU,FRUSTRATION TOLERANCE DECREASED,2
AU,GASTRIC HAEMORRHAGE,2
AU,GASTRITIS EROSIVE,2
AU,GESTATIONAL DIABETES,2
AU,HAEMATOCHEZIA,2
AU,HALLUCINATIONS_ MIXED,2
AU,HEAD INJURY,2
AU,HEMIPARESIS,2
AU,HEPATIC CIRRHOSIS,2
AU,HEPATIC ENCEPHALOPATHY,2
AU,HEPATIC ENZYME INCREASED,2
AU,HEPATITIS C,2
AU,HEPATOMEGALY,2
AU,HIP FRACTURE,2
AU,HOSPITALISATION,2
AU,HYDRONEPHROSIS,2
AU,HYPERAMMONAEMIC ENCEPHALOPATHY,2
AU,HYPERCALCAEMIA,2
AU,HYPERSPLENISM,2
AU,HYPERTHYROIDISM,2
AU,HYPOAESTHESIA,2
AU,HYPOCALCAEMIA,2
AU,HYPOTHERMIA,2
AU,ILEUS,2
AU,INFLUENZA,2
AU,INJECTION SITE BRUISING,2
AU,INJECTION SITE MASS,2
AU,INJECTION SITE PAIN,2
AU,INTENTIONAL PRODUCT MISUSE,2
AU,INTESTINAL ISCHAEMIA,2
AU,INTESTINAL OBSTRUCTION,2
AU,IRON BINDING CAPACITY TOTAL DECREASED,2
AU,IRRITABILITY,2
AU,ISCHAEMIA,2
AU,ISCHAEMIC HEPATITIS,2
AU,JOINT DISLOCATION,2
AU,KIDNEY INFECTION,2
AU,KNEE ARTHROPLASTY,2
AU,LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED,2
AU,LEFT VENTRICULAR HYPERTROPHY,2
AU,LIMBIC ENCEPHALITIS,2
AU,LIPASE INCREASED,2
AU,LIVE BIRTH,2
AU,LIVER FUNCTION TEST INCREASED,2
AU,LIVING IN RESIDENTIAL INSTITUTION,2
AU,LOW BIRTH WEIGHT BABY,2
AU,LYMPHOMA,2
AU,LYMPHOPENIA,2
AU,MACROSOMIA,2
AU,MATERNAL EXPOSURE DURING PREGNANCY,2
AU,METABOLIC ENCEPHALOPATHY,2
AU,METAMYELOCYTE COUNT INCREASED,2
AU,MITRAL VALVE DISEASE,2
AU,MULTIPLE PREGNANCY,2
AU,MUSCLE RIGIDITY,2
AU,MUSCULOSKELETAL PAIN,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,MYELOCYTE COUNT INCREASED,2
AU,NASOPHARYNGITIS,2
AU,NEEDLE ISSUE,2
AU,NEOPLASM,2
AU,NERVE INJURY,2
AU,NEUROLEPTIC MALIGNANT SYNDROME,2
AU,NEUTROPHIL COUNT DECREASED,2
AU,NON-HODGKIN^S LYMPHOMA,2
AU,NORMAL NEWBORN,2
AU,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
AU,NYSTAGMUS,2
AU,OBSTRUCTED LABOUR,2
AU,OESOPHAGEAL VARICES HAEMORRHAGE,2
AU,OESTROGEN RECEPTOR POSITIVE BREAST CANCER,2
AU,OXYGEN SATURATION,2
AU,PALLOR,2
AU,PANCREATIC CARCINOMA,2
AU,PANCREATITIS RELAPSING,2
AU,PCO2 DECREASED,2
AU,PETECHIAE,2
AU,PLASMA CELL MYELOMA,2
AU,PLEURITIC PAIN,2
AU,PNEUMONIA ASPIRATION,2
AU,PNEUMONITIS,2
AU,POLLAKIURIA,2
AU,POLYDIPSIA,2
AU,POLYURIA,2
AU,PRESCRIBED OVERDOSE,2
AU,PRODUCT PHYSICAL ISSUE,2
AU,PRODUCT QUALITY ISSUE,2
AU,PRODUCTIVE COUGH,2
AU,PROSTATE CANCER,2
AU,PULMONARY THROMBOSIS,2
AU,RASH GENERALISED,2
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
AU,RENAL CELL CARCINOMA,2
AU,RENAL INJURY,2
AU,RENAL TUBULAR NECROSIS,2
AU,RESPIRATORY DISTRESS,2
AU,RETCHING,2
AU,RETROGRADE AMNESIA,2
AU,RIB FRACTURE,2
AU,SEROTONIN SYNDROME,2
AU,SKIN EXFOLIATION,2
AU,SLEEP DISORDER,2
AU,SNORING,2
AU,SPINAL FRACTURE,2
AU,STATUS EPILEPTICUS,2
AU,SUBSTANCE ABUSE,2
AU,SURGERY,2
AU,SWELLING,2
AU,SYNOVIAL CYST,2
AU,TACHYARRHYTHMIA,2
AU,TEMPORAL ARTERITIS,2
AU,THERAPEUTIC RESPONSE DECREASED,2
AU,THERMAL BURN,2
AU,TINEA INFECTION,2
AU,URINARY INCONTINENCE,2
AU,URINARY TRACT INFECTION PSEUDOMONAL,2
AU,URTICARIA,2
AU,VENTRICULAR EXTRASYSTOLES,2
AU,VENTRICULAR HYPERTROPHY,2
AU,VERTIGO,2
AU,VITAMIN B COMPLEX DEFICIENCY,2
AU,VITAMIN B1 DECREASED,2
AU,WHITE BLOOD CELL ANALYSIS ABNORMAL,2
AU,WRONG DRUG ADMINISTERED,2
AU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
AU,ABDOMINAL PAIN LOWER,1
AU,ABDOMINAL SEPSIS,1
AU,ABNORMAL DREAMS,1
AU,ABORTION MISSED,1
AU,ABSCESS,1
AU,ACCIDENTAL DEATH,1
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
AU,ACUTE LEFT VENTRICULAR FAILURE,1
AU,ACUTE LYMPHOCYTIC LEUKAEMIA,1
AU,ACUTE PSYCHOSIS,1
AU,ACUTE RESPIRATORY FAILURE,1
AU,ADACTYLY,1
AU,ADENOCARCINOMA OF COLON,1
AU,ADHESION,1
AU,ADVERSE EVENT,1
AU,ADVERSE REACTION,1
AU,ALBUMIN URINE PRESENT,1
AU,ALCOHOL POISONING,1
AU,ALOPECIA,1
AU,AMMONIA INCREASED,1
AU,ANAEMIA OF CHRONIC DISEASE,1
AU,ANAL HAEMORRHAGE,1
AU,ANGINA UNSTABLE,1
AU,ANGIOPLASTY,1
AU,ANION GAP DECREASED,1
AU,ANKLE FRACTURE,1
AU,AORTIC ANEURYSM RUPTURE,1
AU,AORTIC DISSECTION,1
AU,AORTIC DISSECTION RUPTURE,1
AU,AORTIC VALVE INCOMPETENCE,1
AU,AORTIC VALVE SCLEROSIS,1
AU,APNOEA,1
AU,APPENDICEAL ABSCESS,1
AU,ARRHYTHMIA,1
AU,ARRHYTHMIA SUPRAVENTRICULAR,1
AU,ARTERIAL OCCLUSIVE DISEASE,1
AU,ARTERIAL THROMBOSIS,1
AU,ARTHRITIS BACTERIAL,1
AU,ARTHRITIS FUNGAL,1
AU,ARTHRODESIS,1
AU,ASTHMA,1
AU,ATONIC SEIZURES,1
AU,ATRIOVENTRICULAR BLOCK,1
AU,ATROPHIC VULVOVAGINITIS,1
AU,BACK DISORDER,1
AU,BACTERAEMIA,1
AU,BACTERIAL PAROTITIS,1
AU,BACTERIAL SEPSIS,1
AU,BALANCE DISORDER,1
AU,BALANITIS CANDIDA,1
AU,BALANOPOSTHITIS,1
AU,BARRETT^S OESOPHAGUS,1
AU,BILE DUCT STONE,1
AU,BIOPSY LYMPH GLAND,1
AU,BLADDER CANCER,1
AU,BLADDER NEOPLASM,1
AU,BLADDER PROLAPSE,1
AU,BLADDER TRANSITIONAL CELL CARCINOMA,1
AU,BLAST CELLS PRESENT,1
AU,BLOOD ALBUMIN INCREASED,1
AU,BLOOD BICARBONATE ABNORMAL,1
AU,BLOOD BILIRUBIN DECREASED,1
AU,BLOOD CALCITONIN INCREASED,1
AU,BLOOD CHOLESTEROL INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
AU,BLOOD CULTURE POSITIVE,1
AU,BLOOD LACTATE DEHYDROGENASE,1
AU,BLOOD OSMOLARITY DECREASED,1
AU,BLOOD PHOSPHORUS DECREASED,1
AU,BLOOD PHOSPHORUS INCREASED,1
AU,BLOOD PRESSURE DIASTOLIC DECREASED,1
AU,BLOOD PRESSURE FLUCTUATION,1
AU,BLOOD PRESSURE SYSTOLIC DECREASED,1
AU,BLOOD URINE PRESENT,1
AU,BODY MASS INDEX INCREASED,1
AU,BONE CANCER METASTATIC,1
AU,BONE DISORDER,1
AU,BRAIN ABSCESS,1
AU,BRAIN STEM STROKE,1
AU,BREAST CANCER METASTATIC,1
AU,BRONCHIAL CARCINOMA,1
AU,BRONCHIAL SECRETION RETENTION,1
AU,BRUXISM,1
AU,BURNING SENSATION,1
AU,BURSITIS,1
AU,CALCINOSIS,1
AU,CANDIDA SEPSIS,1
AU,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
AU,CARDIAC HYPERTROPHY,1
AU,CARDIAC INFECTION,1
AU,CARDIAC OUTPUT DECREASED,1
AU,CARDIAC TAMPONADE,1
AU,CARDIOVASCULAR DISORDER,1
AU,CATATONIA,1
AU,CEREBELLAR INFARCTION,1
AU,CEREBRAL ATROPHY,1
AU,CHANGE OF BOWEL HABIT,1
AU,CHOKING,1
AU,CHOLANGITIS,1
AU,CHOLECYSTITIS,1
AU,CHRONIC KIDNEY DISEASE,1
AU,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
AU,CLAVICLE FRACTURE,1
AU,COAGULOPATHY,1
AU,COLITIS ISCHAEMIC,1
AU,COLON ADENOMA,1
AU,COLON CANCER METASTATIC,1
AU,COLONOSCOPY,1
AU,CONJUNCTIVAL HAEMORRHAGE,1
AU,CORONARY ARTERY OCCLUSION,1
AU,CORTISOL INCREASED,1
AU,CREPITATIONS,1
AU,CUSHING^S SYNDROME,1
AU,CYSTOID MACULAR OEDEMA,1
AU,DEAFNESS,1
AU,DEFAECATION URGENCY,1
AU,DELUSIONAL PERCEPTION,1
AU,DEPENDENCE ON OXYGEN THERAPY,1
AU,DEPOSIT EYE,1
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AU,DERMATITIS BULLOUS,1
AU,DEVICE ISSUE,1
AU,DIAPHRAGMATIC DISORDER,1
AU,DIARRHOEA HAEMORRHAGIC,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DILATATION VENTRICULAR,1
AU,DISINHIBITION,1
AU,DIVERTICULITIS,1
AU,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
AU,DIVERTICULUM,1
AU,DIZZINESS POSTURAL,1
AU,DRUG DEPENDENCE,1
AU,DRUG RESISTANCE,1
AU,DRUG TOLERANCE,1
AU,DRUG WITHDRAWAL MAINTENANCE THERAPY,1
AU,DRUG WITHDRAWAL SYNDROME,1
AU,DRY EYE,1
AU,DUODENAL ULCER HAEMORRHAGE,1
AU,DYSGRAPHIA,1
AU,DYSKINESIA,1
AU,DYSMETRIA,1
AU,DYSPEPSIA,1
AU,EARLY SATIETY,1
AU,ECHOCARDIOGRAM ABNORMAL,1
AU,EJECTION FRACTION ABNORMAL,1
AU,ELDERLY,1
AU,ELECTROCARDIOGRAM AMBULATORY ABNORMAL,1
AU,ELECTROCARDIOGRAM Q WAVE ABNORMAL,1
AU,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,1
AU,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,1
AU,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
AU,ELECTROCARDIOGRAM ST-T CHANGE,1
AU,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
AU,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,1
AU,ENCOPRESIS,1
AU,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
AU,ENDOTRACHEAL INTUBATION COMPLICATION,1
AU,ENTEROCOCCAL BACTERAEMIA,1
AU,EOSINOPHILIC COLITIS,1
AU,EOSINOPHILIC FASCIITIS,1
AU,EROSIVE DUODENITIS,1
AU,ERYTHEMA OF EYELID,1
AU,ESCHERICHIA INFECTION,1
AU,EXOMPHALOS,1
AU,EXPOSURE VIA BODY FLUID,1
AU,EXTRA DOSE ADMINISTERED,1
AU,EXTRASYSTOLES,1
AU,EYE HAEMORRHAGE,1
AU,EYE PAIN,1
AU,FACIAL PAIN,1
AU,FAECES PALE,1
AU,FEELING HOT,1
AU,FEELING OF BODY TEMPERATURE CHANGE,1
AU,FEMUR FRACTURE,1
AU,FIBRIN D DIMER INCREASED,1
AU,FINGER DEFORMITY,1
AU,FOOD POISONING,1
AU,FOOT FRACTURE,1
AU,FREQUENT BOWEL MOVEMENTS,1
AU,FUNGAL INFECTION,1
AU,GALLBLADDER DISORDER,1
AU,GASTRIC ANTRAL VASCULAR ECTASIA,1
AU,GASTRIC CANCER,1
AU,GASTRIC DISORDER,1
AU,GASTRIC ULCER,1
AU,GASTROENTERITIS SALMONELLA,1
AU,GASTROENTERITIS VIRAL,1
AU,GASTROINTESTINAL ANGIODYSPLASIA,1
AU,GASTROINTESTINAL CANCER METASTATIC,1
AU,GASTROINTESTINAL HYPOMOTILITY,1
AU,GASTROINTESTINAL OBSTRUCTION,1
AU,GASTROINTESTINAL SURGERY,1
AU,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
AU,GENERALISED ERYTHEMA,1
AU,GIARDIASIS,1
AU,GINGIVAL BLEEDING,1
AU,GLAUCOMA,1
AU,GLIOBLASTOMA MULTIFORME,1
AU,GOUT,1
AU,GROIN ABSCESS,1
AU,HAEMATOMA INFECTION,1
AU,HAEMOGLOBIN INCREASED,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGE URINARY TRACT,1
AU,HAEMORRHAGIC INFARCTION,1
AU,HAEMORRHOID OPERATION,1
AU,HAEMORRHOIDS,1
AU,HEAD DISCOMFORT,1
AU,HEART RATE DECREASED,1
AU,HEART RATE IRREGULAR,1
AU,HEMIANOPIA HOMONYMOUS,1
AU,HEPATIC CANCER,1
AU,HEPATIC PAIN,1
AU,HEPATIC VEIN THROMBOSIS,1
AU,HEPATITIS ACUTE,1
AU,HEPATITIS B,1
AU,HEPATITIS B CORE ANTIBODY POSITIVE,1
AU,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
AU,HEPATOCELLULAR CARCINOMA,1
AU,HEPATOCELLULAR INJURY,1
AU,HIGH FREQUENCY ABLATION,1
AU,HIP ARTHROPLASTY,1
AU,HOMELESS,1
AU,HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR NEGATIVE,1
AU,HUMAN RHINOVIRUS TEST POSITIVE,1
AU,HYDROURETER,1
AU,HYPERLIPIDAEMIA,1
AU,HYPERSENSITIVITY VASCULITIS,1
AU,HYPERTHERMIA MALIGNANT,1
AU,HYPERTONIA,1
AU,HYPERTRIGLYCERIDAEMIA,1
AU,HYPERTROPHY,1
AU,HYPERVENTILATION,1
AU,HYPHAEMA,1
AU,HYPOCHONDRIASIS,1
AU,HYPOGLYCAEMIA NEONATAL,1
AU,HYPOKINESIA,1
AU,HYPOPHYSITIS,1
AU,HYPOTONIA,1
AU,HYPOVITAMINOSIS,1
AU,ILEAL FISTULA,1
AU,ILL-DEFINED DISORDER,1
AU,IMMUNE SYSTEM DISORDER,1
AU,IMMUNE THROMBOCYTOPENIC PURPURA,1
AU,IMPAIRED GASTRIC EMPTYING,1
AU,IMPAIRED HEALING,1
AU,INCARCERATED HERNIA,1
AU,INCONTINENCE,1
AU,INCORRECT PRODUCT STORAGE,1
AU,INDUCED LABOUR,1
AU,INFECTED VARICOSE VEIN,1
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
AU,INFLAMMATION,1
AU,INFUSION RELATED REACTION,1
AU,INFUSION SITE RASH,1
AU,INGROWING NAIL,1
AU,INJECTION SITE ABSCESS,1
AU,INJECTION SITE DISCOMFORT,1
AU,INJECTION SITE EXTRAVASATION,1
AU,INJECTION SITE INFECTION,1
AU,INJURY,1
AU,INSULINOMA,1
AU,INTERTRIGO,1
AU,INTERVERTEBRAL DISC PROTRUSION,1
AU,INTESTINAL FIBROSIS,1
AU,INTESTINAL HAEMORRHAGE,1
AU,INTESTINAL PERFORATION,1
AU,INTRA-ABDOMINAL HAEMORRHAGE,1
AU,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
AU,INTRAOCULAR PRESSURE INCREASED,1
AU,INTRASPINAL ABSCESS,1
AU,IRON DEFICIENCY,1
AU,JOINT DISLOCATION REDUCTION,1
AU,JOINT RANGE OF MOTION DECREASED,1
AU,JOINT STIFFNESS,1
AU,JOINT SWELLING,1
AU,JUDGEMENT IMPAIRED,1
AU,KLEBSIELLA INFECTION,1
AU,KLEBSIELLA SEPSIS,1
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
AU,LACERATION,1
AU,LACUNAR INFARCTION,1
AU,LEFT VENTRICULAR FAILURE,1
AU,LEUKAEMIA,1
AU,LEUKOCYTURIA,1
AU,LIGAMENT RUPTURE,1
AU,LIMB DISCOMFORT,1
AU,LIP SWELLING,1
AU,LIPIDS INCREASED,1
AU,LOCAL SWELLING,1
AU,LUMBAR SPINAL STENOSIS,1
AU,LUNG DISORDER,1
AU,LUNG INFECTION,1
AU,LUNG INFILTRATION,1
AU,LUNG NEOPLASM,1
AU,LYMPHADENOPATHY MEDIASTINAL,1
AU,LYMPHOCYTE PERCENTAGE DECREASED,1
AU,LYMPHOEDEMA,1
AU,MACULAR DEGENERATION,1
AU,MALIGNANT NEOPLASM PROGRESSION,1
AU,MARROW HYPERPLASIA,1
AU,MATERNAL DRUGS AFFECTING FOETUS,1
AU,MEDICATION ERROR,1
AU,METASTASES TO BONE,1
AU,METASTASES TO GASTROINTESTINAL TRACT,1
AU,METASTASES TO LIVER,1
AU,METASTASES TO PERITONEUM,1
AU,METASTASES TO SPINE,1
AU,METASTATIC RENAL CELL CARCINOMA,1
AU,MICROALBUMINURIA,1
AU,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
AU,MOOD SWINGS,1
AU,MOVEMENT DISORDER,1
AU,MUSCLE CONTRACTIONS INVOLUNTARY,1
AU,MUSCLE NECROSIS,1
AU,MUSCULOSKELETAL CHEST PAIN,1
AU,MUSCULOSKELETAL DISCOMFORT,1
AU,MUSCULOSKELETAL DISORDER,1
AU,MYOSITIS,1
AU,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
AU,NAEVUS HAEMORRHAGE,1
AU,NASAL CONGESTION,1
AU,NASAL DISCOMFORT,1
AU,NECROTISING FASCIITIS,1
AU,NECROTISING MYOSITIS,1
AU,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
AU,NEOPLASM MALIGNANT,1
AU,NEPHRITIS,1
AU,NEPHROLITHIASIS,1
AU,NEPHROPATHY TOXIC,1
AU,NERVOUS SYSTEM DISORDER,1
AU,NEURALGIA,1
AU,NEUROENDOCRINE CARCINOMA METASTATIC,1
AU,NEUTROPHIL PERCENTAGE INCREASED,1
AU,NEUTROPHIL TOXIC GRANULATION PRESENT,1
AU,NIGHTMARE,1
AU,NO ADVERSE EVENT,1
AU,NO THERAPEUTIC RESPONSE,1
AU,NOCTURIA,1
AU,NODAL RHYTHM,1
AU,NON-CARDIAC CHEST PAIN,1
AU,NON-SMALL CELL LUNG CANCER METASTATIC,1
AU,OBSTRUCTION GASTRIC,1
AU,OESOPHAGEAL RUPTURE,1
AU,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
AU,OESOPHAGITIS,1
AU,OROMANDIBULAR DYSTONIA,1
AU,OROPHARYNGEAL PAIN,1
AU,ORTHOPNOEA,1
AU,OSTEOMYELITIS,1
AU,OSTEOPOROSIS,1
AU,PANCREAS INFECTION,1
AU,PANCREATECTOMY,1
AU,PANCREATIC CARCINOMA METASTATIC,1
AU,PANCREATIC CYST,1
AU,PANCREATIC PSEUDOCYST,1
AU,PAPILLOEDEMA,1
AU,PARACENTESIS,1
AU,PARKINSONISM,1
AU,PEDAL PULSE ABNORMAL,1
AU,PELVIC PAIN,1
AU,PERIHEPATIC ABSCESS,1
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AU,PERIPHERAL ISCHAEMIA,1
AU,PERIPHERAL SWELLING,1
AU,PERIPROSTHETIC FRACTURE,1
AU,PERITONEAL HAEMORRHAGE,1
AU,PERITONITIS,1
AU,PERONEAL NERVE PALSY,1
AU,PITUITARY-DEPENDENT CUSHING^S SYNDROME,1
AU,PLATELET COUNT ABNORMAL,1
AU,PLEURAL FIBROSIS,1
AU,PNEUMONIA PSEUDOMONAL,1
AU,PO2 INCREASED,1
AU,POISONING,1
AU,POLYARTHRITIS,1
AU,POLYNEUROPATHY,1
AU,POLYP,1
AU,POOR PERIPHERAL CIRCULATION,1
AU,POOR VENOUS ACCESS,1
AU,POST PROCEDURAL COMPLICATION,1
AU,POST PROCEDURAL INFECTION,1
AU,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
AU,POSTOPERATIVE FEVER,1
AU,POUCHITIS,1
AU,PRE-ECLAMPSIA,1
AU,PRECURSOR B-LYMPHOBLASTIC LYMPHOMA,1
AU,PREMATURE BABY,1
AU,PREMATURE DELIVERY,1
AU,PREMATURE RUPTURE OF MEMBRANES,1
AU,PRIAPISM,1
AU,PROCEDURAL COMPLICATION,1
AU,PROCTITIS,1
AU,PRODUCT DIFFICULT TO SWALLOW,1
AU,PROGRESSIVE SUPRANUCLEAR PALSY,1
AU,PROSTATIC OPERATION,1
AU,PROSTATITIS,1
AU,PROTEIN DEFICIENCY,1
AU,PROTEIN TOTAL INCREASED,1
AU,PROTEINURIA,1
AU,PROTHROMBIN TIME PROLONGED,1
AU,PSORIASIS,1
AU,PSORIATIC ARTHROPATHY,1
AU,PSYCHOTIC SYMPTOM,1
AT,LACTIC ACIDOSIS,33
AT,KETOACIDOSIS,29
AT,DIABETIC KETOACIDOSIS,20
AT,PERICARDIAL HAEMORRHAGE,15
AT,ACUTE KIDNEY INJURY,11
AT,NAUSEA,6
AT,ALTERED STATE OF CONSCIOUSNESS,5
AT,ATRIAL FIBRILLATION,5
AT,DYSPNOEA,5
AT,FALL,5
AT,GASTRITIS HAEMORRHAGIC,5
AT,PNEUMONIA,5
AT,SOMNOLENCE,5
AT,ANAEMIA,4
AT,DEHYDRATION,4
AT,DRUG INEFFECTIVE,4
AT,HAEMOGLOBIN DECREASED,4
AT,PLEURAL EFFUSION,4
AT,SYNCOPE,4
AT,WEIGHT DECREASED,4
AT,CHRONIC KIDNEY DISEASE,3
AT,DIABETES MELLITUS,3
AT,DIARRHOEA,3
AT,INTERVERTEBRAL DISC PROTRUSION,3
AT,KUSSMAUL RESPIRATION,3
AT,MELAENA,3
AT,OEDEMA PERIPHERAL,3
AT,PANCREATITIS,3
AT,RENAL FAILURE,3
AT,RENAL IMPAIRMENT,3
AT,VOMITING,3
AT,ACUTE MYOCARDIAL INFARCTION,2
AT,ANAPHYLACTIC SHOCK,2
AT,AORTIC ARTERIOSCLEROSIS,2
AT,ASPARTATE AMINOTRANSFERASE INCREASED,2
AT,BLOOD GLUCOSE INCREASED,2
AT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AT,BLOOD SODIUM DECREASED,2
AT,C-REACTIVE PROTEIN INCREASED,2
AT,CARDIAC FAILURE,2
AT,CHEST PAIN,2
AT,DEPRESSION,2
AT,FATIGUE,2
AT,GROIN PAIN,2
AT,HEADACHE,2
AT,HEPATIC ENZYME INCREASED,2
AT,HYPERGLYCAEMIA,2
AT,HYPOTENSION,2
AT,HYPOTHERMIA,2
AT,HYPOTHYROIDISM,2
AT,INFLUENZA,2
AT,INTESTINAL HAEMORRHAGE,2
AT,MUSCLE SPASMS,2
AT,NEUROPATHY PERIPHERAL,2
AT,OSTEOARTHRITIS,2
AT,PNEUMONITIS,2
AT,PYREXIA,2
AT,RENAL FAILURE ACUTE,2
AT,SEPSIS,2
AT,SPINAL OSTEOARTHRITIS,2
AT,SPLENOMEGALY,2
AT,SQUAMOUS CELL CARCINOMA OF THE VAGINA,2
AT,THROMBOCYTOPENIA,2
AT,TRANSAMINASES INCREASED,2
AT,WHITE BLOOD CELL COUNT INCREASED,2
AT,ABDOMINAL PAIN,1
AT,ABDOMINAL PAIN UPPER,1
AT,ABDOMINAL WALL ABSCESS,1
AT,ABSCESS LIMB,1
AT,ADENOCARCINOMA OF COLON,1
AT,ALANINE AMINOTRANSFERASE INCREASED,1
AT,ALCOHOL POISONING,1
AT,ANAL ABSCESS,1
AT,ANEURYSM,1
AT,ANGINA PECTORIS,1
AT,ANOSMIA,1
AT,AORTIC STENOSIS,1
AT,ARTERIOSCLEROSIS,1
AT,ARTERIOSCLEROSIS MOENCKEBERG-TYPE,1
AT,ARTHRALGIA,1
AT,ARTHRITIS,1
AT,BACTERIAL TEST POSITIVE,1
AT,BENIGN HYDATIDIFORM MOLE,1
AT,BILE DUCT STONE,1
AT,BLOOD CALCIUM DECREASED,1
AT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AT,BLOOD CREATININE INCREASED,1
AT,BLOOD FOLATE DECREASED,1
AT,BLOOD PRESSURE INCREASED,1
AT,BLOOD UREA INCREASED,1
AT,BLOOD URIC ACID INCREASED,1
AT,BODY TEMPERATURE DECREASED,1
AT,BODY TEMPERATURE INCREASED,1
AT,BRADYCARDIA,1
AT,BRAIN STEM STROKE,1
AT,BRONCHITIS,1
AT,CARDIAC DEATH,1
AT,CARDIAC DISORDER,1
AT,CARDIOMEGALY,1
AT,CARDIOMYOPATHY,1
AT,CAROTID ARTERIOSCLEROSIS,1
AT,CEREBROVASCULAR ACCIDENT,1
AT,CHILLS,1
AT,CHOLANGITIS INFECTIVE,1
AT,CHOLECYSTITIS CHRONIC,1
AT,CHOLELITHIASIS,1
AT,CHOLESTASIS,1
AT,CONDITION AGGRAVATED,1
AT,CONSTIPATION,1
AT,COR PULMONALE,1
AT,CORONARY ARTERY DISEASE,1
AT,COUGH,1
AT,DEATH,1
AT,DECREASED APPETITE,1
AT,DIABETES MELLITUS INADEQUATE CONTROL,1
AT,DIABETIC FOOT,1
AT,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,1
AT,DIVERTICULITIS,1
AT,DIZZINESS,1
AT,DRUG LEVEL INCREASED,1
AT,DRY MOUTH,1
AT,DYSGEUSIA,1
AT,ENCEPHALITIS,1
AT,EPILEPSY,1
AT,EPISTAXIS,1
AT,ERYSIPELAS,1
AT,ERYTHEMA,1
AT,ESCHERICHIA INFECTION,1
AT,ESCHERICHIA URINARY TRACT INFECTION,1
AT,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
AT,EXPOSED BONE IN JAW,1
AT,FAECES DISCOLOURED,1
AT,FEBRILE INFECTION,1
AT,FLUID RETENTION,1
AT,GAIT DISTURBANCE,1
AT,GASTRIC ULCER,1
AT,GASTRITIS,1
AT,GASTROENTERITIS,1
AT,GENERAL PHYSICAL HEALTH DETERIORATION,1
AT,GLAUCOMA,1
AT,GLOSSODYNIA,1
AT,GLYCOSURIA,1
AT,HAEMATEMESIS,1
AT,HAEMATOMA,1
AT,HAEMOLYSIS,1
AT,HEMIPARESIS,1
AT,HEPATOCELLULAR CARCINOMA,1
AT,HERPES ZOSTER,1
AT,HERPES ZOSTER MENINGITIS,1
AT,HOSPITALISATION,1
AT,HYPERKALAEMIA,1
AT,HYPERNATRAEMIA,1
AT,HYPERTENSION,1
AT,HYPERTHYROIDISM,1
AT,HYPERVENTILATION,1
AT,HYPOAESTHESIA,1
AT,HYPOALBUMINAEMIA,1
AT,HYPOGEUSIA,1
AT,HYPOKALAEMIA,1
AT,INCORRECT DRUG ADMINISTRATION DURATION,1
AT,INFECTED DERMAL CYST,1
AT,INFECTION,1
AT,INFLAMMATORY MARKER INCREASED,1
AT,INSOMNIA,1
AT,INTENTIONAL OVERDOSE,1
AT,INTERLEUKIN LEVEL INCREASED,1
AT,JAUNDICE,1
AT,LIVER DISORDER,1
AT,LOCAL SWELLING,1
AT,LUNG ADENOCARCINOMA METASTATIC,1
AT,LUNG DISORDER,1
AT,LUNG INFECTION,1
AT,LYMPHOCYTE PERCENTAGE DECREASED,1
AT,LYMPHOPENIA,1
AT,MALAISE,1
AT,MASTITIS,1
AT,MATERNAL EXPOSURE DURING PREGNANCY,1
AT,MENORRHAGIA,1
AT,MENTAL DISORDER,1
AT,METABOLIC ACIDOSIS,1
AT,MITRAL VALVE INCOMPETENCE,1
AT,MUSCLE HAEMORRHAGE,1
AT,MYOGLOBIN BLOOD INCREASED,1
AT,MYOPATHY,1
AT,NECK PAIN,1
AT,NECROTISING OESOPHAGITIS,1
AT,NEPHROTIC SYNDROME,1
AT,NEURALGIC AMYOTROPHY,1
AT,NEUTROPHIL PERCENTAGE INCREASED,1
AT,NON-SMALL CELL LUNG CANCER,1
AT,OEDEMA,1
AT,OEDEMATOUS PANCREATITIS,1
AT,ORAL HERPES,1
AT,ORAL MUCOSAL ERYTHEMA,1
AT,OSTEONECROSIS OF JAW,1
AT,PACEMAKER GENERATED ARRHYTHMIA,1
AT,PAIN,1
AT,PAIN IN EXTREMITY,1
AT,PALPITATIONS,1
AT,PAPILLARY THYROID CANCER,1
AT,PAPILLOEDEMA,1
AT,PARAESTHESIA,1
AT,PERICARDIAL DRAINAGE,1
AT,PERICARDIAL EFFUSION,1
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AT,PERIPHERAL SWELLING,1
AT,PLATELET COUNT DECREASED,1
AT,PLEURAL DISORDER,1
AT,POLYNEUROPATHY,1
AT,POST PROCEDURAL HAEMORRHAGE,1
AT,POTENTIATING DRUG INTERACTION,1
AT,PRERENAL FAILURE,1
AT,PRODUCT USE ISSUE,1
AT,PROTEIN TOTAL DECREASED,1
AT,PSOAS ABSCESS,1
AT,PULMONARY EMBOLISM,1
AT,RASH,1
AT,RENAL ABSCESS,1
AT,RENAL CANCER RECURRENT,1
AT,RENAL CELL CARCINOMA,1
AT,RHABDOMYOLYSIS,1
AT,SARCOIDOSIS,1
AT,SEDATION,1
AT,SEIZURE,1
AT,SEMINOMA,1
AT,SERUM FERRITIN INCREASED,1
AT,SHOCK,1
AT,SKIN IRRITATION,1
AT,SLEEP DISORDER,1
AT,SPINAL PAIN,1
AT,STAPHYLOCOCCUS TEST POSITIVE,1
AT,STUPOR,1
AT,SUBCUTANEOUS ABSCESS,1
AT,SUICIDE ATTEMPT,1
AT,THYROGLOBULIN INCREASED,1
AT,THYROID NEOPLASM,1
AT,TONGUE BITING,1
AT,TOXICITY TO VARIOUS AGENTS,1
AT,UMBILICAL HERNIA,1
AT,URINARY TRACT INFECTION,1
AT,VASCULAR STENT THROMBOSIS,1
AT,VASCULITIS,1
AT,VENOUS THROMBOSIS LIMB,1
AT,VENTRICULAR HYPOKINESIA,1
AT,VERTEBRAL FORAMINAL STENOSIS,1
AT,VERTIGO,1
AT,VIRAL INFECTION,1
AT,WHITE BLOOD CELL COUNT DECREASED,1
AZ,BLOOD GLUCOSE INCREASED,1
AZ,BLOOD PRESSURE INCREASED,1
AZ,HEART RATE INCREASED,1
AZ,LOSS OF CONSCIOUSNESS,1
AZ,TREMOR,1
BH,METABOLIC ACIDOSIS,11
BH,RHABDOMYOLYSIS,11
BH,OVERDOSE,9
BH,HYPERLACTACIDAEMIA,3
BH,CHRONIC KIDNEY DISEASE,2
BH,HYPERTENSION,2
BH,MOUTH ULCERATION,2
BH,NEUTROPENIA,2
BH,RESPIRATORY TRACT INFECTION,2
BH,TOXICITY TO VARIOUS AGENTS,2
BH,HAEMODIALYSIS,1
BH,HYPERGLYCAEMIA,1
BH,INTENTIONAL OVERDOSE,1
BH,NEUROPATHY PERIPHERAL,1
BD,ABORTION,8
BD,MATERNAL EXPOSURE DURING PREGNANCY,8
BD,BLIGHTED OVUM,3
BD,ECTOPIC PREGNANCY,2
BD,HYPERSENSITIVITY,1
BD,SKIN REACTION,1
BD,SYNCOPE,1
BB,ACUTE MYOCARDIAL INFARCTION,1
BB,CARDIAC TAMPONADE,1
BB,DRY SKIN,1
BB,EATING DISORDER,1
BB,FORCEPS DELIVERY,1
BB,HEPATIC HAEMATOMA,1
BB,HYPOGLYCAEMIA,1
BB,MATERNAL EXPOSURE DURING PREGNANCY,1
BB,MYOCARDIAL ISCHAEMIA,1
BB,PARAPSORIASIS,1
BB,PYREXIA,1
BB,RASH ERYTHEMATOUS,1
BB,RASH PAPULAR,1
BB,STILLBIRTH,1
BB,UROSEPSIS,1
BY,AMYLASE INCREASED,1
BY,DIZZINESS,1
BY,MEDICATION ERROR,1
BY,NEPHROPATHY,1
BY,PALPITATIONS,1
BE,ACUTE KIDNEY INJURY,21
BE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,21
BE,METABOLIC ACIDOSIS,12
BE,LACTIC ACIDOSIS,11
BE,STUPOR,11
BE,VOMITING,10
BE,HYPERLACTACIDAEMIA,8
BE,HYPONATRAEMIA,8
BE,TOXICITY TO VARIOUS AGENTS,8
BE,CONFUSIONAL STATE,7
BE,DEHYDRATION,7
BE,DIARRHOEA,7
BE,HYPOTENSION,7
BE,RESPIRATORY FAILURE,7
BE,RHABDOMYOLYSIS,7
BE,THORACIC VERTEBRAL FRACTURE,7
BE,DYSPNOEA,6
BE,FATIGUE,6
BE,RENAL FAILURE ACUTE,6
BE,SINUS BRADYCARDIA,6
BE,ACUTE MYOCARDIAL INFARCTION,5
BE,ASPERGILLOMA,5
BE,DRUG INEFFECTIVE,5
BE,HYPERTENSION,5
BE,HYPERVENTILATION,5
BE,MALAISE,5
BE,PNEUMONIA PSEUDOMONAL,5
BE,RENAL FAILURE,5
BE,TOXIC EPIDERMAL NECROLYSIS,5
BE,TRANSPLANT REJECTION,5
BE,WEIGHT DECREASED,5
BE,ABDOMINAL PAIN,4
BE,ABSCESS JAW,4
BE,BRADYCARDIA,4
BE,CARDIAC ARREST,4
BE,CHEST PAIN,4
BE,CYTOMEGALOVIRUS VIRAEMIA,4
BE,HEPATIC FAILURE,4
BE,HYPERGLYCAEMIA,4
BE,MULTI-ORGAN FAILURE,4
BE,MYOCLONUS,4
BE,NEPHROPATHY TOXIC,4
BE,RENAL INFARCT,4
BE,SINUSITIS BACTERIAL,4
BE,ALANINE AMINOTRANSFERASE INCREASED,3
BE,ASPARTATE AMINOTRANSFERASE INCREASED,3
BE,ASTHENIA,3
BE,ATRIAL FIBRILLATION,3
BE,ATRIOVENTRICULAR BLOCK,3
BE,COMA,3
BE,DECREASED APPETITE,3
BE,DIABETES MELLITUS INADEQUATE CONTROL,3
BE,DYSPEPSIA,3
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
BE,GASTROINTESTINAL DISORDER,3
BE,GENERAL PHYSICAL HEALTH DETERIORATION,3
BE,HEADACHE,3
BE,HYPERKALAEMIA,3
BE,HYPERTHERMIA,3
BE,LOSS OF CONSCIOUSNESS,3
BE,MENTAL STATUS CHANGES,3
BE,NEPHROLITHIASIS,3
BE,RENAL IMPAIRMENT,3
BE,RENAL TUBULAR ACIDOSIS,3
BE,SINUS TACHYCARDIA,3
BE,ACIDOSIS,2
BE,ANAEMIA,2
BE,ANGIOEDEMA,2
BE,ASPERGILLUS INFECTION,2
BE,BLOOD LACTIC ACID INCREASED,2
BE,BRONCHOPNEUMONIA,2
BE,CARDIAC FAILURE,2
BE,CENTRAL NERVOUS SYSTEM LESION,2
BE,CHILLS,2
BE,DEMENTIA,2
BE,DERMATITIS BULLOUS,2
BE,DISEASE PROGRESSION,2
BE,DISSEMINATED INTRAVASCULAR COAGULATION,2
BE,DRUG INTOLERANCE,2
BE,ECZEMA,2
BE,ENCEPHALOPATHY,2
BE,EPISTAXIS,2
BE,GASTROENTERITIS,2
BE,GENERALISED TONIC-CLONIC SEIZURE,2
BE,GLUCOSE TOLERANCE IMPAIRED,2
BE,HAEMORRHAGE,2
BE,HALLUCINATION_ VISUAL,2
BE,HEPATIC STEATOSIS,2
BE,HIP FRACTURE,2
BE,HYPERBILIRUBINAEMIA,2
BE,HYPERSENSITIVITY VASCULITIS,2
BE,HYPOGLYCAEMIA,2
BE,INTESTINAL OBSTRUCTION,2
BE,LIVEDO RETICULARIS,2
BE,MUSCLE NECROSIS,2
BE,NAUSEA,2
BE,OSTEONECROSIS OF JAW,2
BE,OVERDOSE,2
BE,PALLOR,2
BE,PANCYTOPENIA,2
BE,PETECHIAE,2
BE,POLYNEUROPATHY,2
BE,PSEUDOMONAS INFECTION,2
BE,PYREXIA,2
BE,RASH ERYTHEMATOUS,2
BE,RESTLESSNESS,2
BE,SPEECH DISORDER,2
BE,SUDDEN DEATH,2
BE,SURGERY,2
BE,THIRST,2
BE,THROMBOCYTOPENIA,2
BE,UPPER RESPIRATORY TRACT INFECTION,2
BE,VISION BLURRED,2
BE,WEIGHT INCREASED,2
BE,ABDOMINAL TENDERNESS,1
BE,ABORTION INDUCED,1
BE,ABSCESS,1
BE,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
BE,ADENOCARCINOMA PANCREAS,1
BE,ADVERSE EVENT,1
BE,ANAPHYLACTIC SHOCK,1
BE,ANXIETY,1
BE,APACHE II SCORE INCREASED,1
BE,ARRHYTHMIA,1
BE,ARTHRALGIA,1
BE,ARTHROPOD BITE,1
BE,ASCITES,1
BE,ATRIAL THROMBOSIS,1
BE,ATROPHY,1
BE,BALANCE DISORDER,1
BE,BENIGN PROSTATIC HYPERPLASIA,1
BE,BILE DUCT STENOSIS,1
BE,BILE DUCT STONE,1
BE,BLADDER OBSTRUCTION,1
BE,BLISTER,1
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
BE,BLOOD CREATININE INCREASED,1
BE,BLOOD GLUCOSE DECREASED,1
BE,BLOOD URINE PRESENT,1
BE,BRAIN INJURY,1
BE,BRONCHOPULMONARY ASPERGILLOSIS,1
BE,C-REACTIVE PROTEIN INCREASED,1
BE,CAMPYLOBACTER TEST POSITIVE,1
BE,CARDIO-RESPIRATORY ARREST,1
BE,CARDIOGENIC SHOCK,1
BE,CATATONIA,1
BE,CEREBRAL INFARCTION,1
BE,CEREBRAL THROMBOSIS,1
BE,CHOLELITHIASIS,1
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BE,CIRCULATORY COLLAPSE,1
BE,COAGULOPATHY,1
BE,COGNITIVE DISORDER,1
BE,COLITIS,1
BE,CONGENITAL SYPHILITIC OSTEOCHONDRITIS,1
BE,CORNEAL DEGENERATION,1
BE,CORONARY ARTERY DISEASE,1
BE,COUGH,1
BE,CREATININE URINE INCREASED,1
BE,CYTOTOXIC OEDEMA,1
BE,DIABETES MELLITUS,1
BE,DIABETIC KETOACIDOSIS,1
BE,DIPLOPIA,1
BE,DISEASE RECURRENCE,1
BE,DIZZINESS,1
BE,DRUG ABUSE,1
BE,DRUG LEVEL INCREASED,1
BE,DRUG-DISEASE INTERACTION,1
BE,DYSKINESIA,1
BE,DYSPHAGIA,1
BE,DYSPNOEA EXERTIONAL,1
BE,DYSTONIA,1
BE,EATING DISORDER,1
BE,EMBOLISM,1
BE,ENCEPHALITIS,1
BE,EPILEPSY,1
BE,ERYTHEMA,1
BE,EXPOSURE DURING PREGNANCY,1
BE,FEBRILE NEUTROPENIA,1
BE,FEELING JITTERY,1
BE,FEMUR FRACTURE,1
BE,FIBRIN D DIMER INCREASED,1
BE,FRACTURE,1
BE,FRACTURE PAIN,1
BE,GAIT DISTURBANCE,1
BE,GASTROINTESTINAL HAEMORRHAGE,1
BE,GASTROINTESTINAL INFLAMMATION,1
BE,GASTROINTESTINAL TOXICITY,1
BE,GLOMERULAR FILTRATION RATE DECREASED,1
BE,GLYCOSYLATED HAEMOGLOBIN,1
BE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
BE,GRANULOMATOSIS WITH POLYANGIITIS,1
BE,HALLUCINATION_ AUDITORY,1
BE,HEPATIC CIRRHOSIS,1
BE,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
BE,HEPATITIS TOXIC,1
BE,HEPATOCELLULAR INJURY,1
BE,HEPATOTOXICITY,1
BE,HERPES ZOSTER,1
BE,HIGH DENSITY LIPOPROTEIN INCREASED,1
BE,HYDROCEPHALUS,1
BE,HYDRONEPHROSIS,1
BE,HYDROURETER,1
BE,HYPERADRENOCORTICISM,1
BE,HYPERCALCAEMIA,1
BE,HYPERCHOLESTEROLAEMIA,1
BE,HYPEROXALURIA,1
BE,HYPERURICAEMIA,1
BE,HYPERVISCOSITY SYNDROME,1
BE,HYPOAESTHESIA,1
BE,HYPOCALCAEMIA,1
BE,HYPOKINESIA,1
BE,HYPOMAGNESAEMIA,1
BE,HYPOXIA,1
BE,INFLUENZA,1
BE,INJECTION SITE ERYTHEMA,1
BE,INJECTION SITE INDURATION,1
BE,INJECTION SITE REACTION,1
BE,INSOMNIA,1
BE,INTESTINAL HAEMORRHAGE,1
BE,INTRACRANIAL PRESSURE INCREASED,1
BE,IRON DEFICIENCY ANAEMIA,1
BE,IRRITABLE BOWEL SYNDROME,1
BE,LACERATION,1
BE,LEUKAEMOID REACTION,1
BE,LEUKOPENIA,1
BE,LIVER DISORDER,1
BE,LIVER FUNCTION TEST INCREASED,1
BE,LOW DENSITY LIPOPROTEIN INCREASED,1
BE,LOWER LIMB FRACTURE,1
BE,LYMPHOCYTE TRANSFORMATION TEST POSITIVE,1
BE,MALIGNANT NEOPLASM PROGRESSION,1
BE,MEMORY IMPAIRMENT,1
BE,MENTAL DISORDER,1
BE,METASTASES TO PERITONEUM,1
BE,METASTASES TO PLEURA,1
BE,MICROLITHIASIS,1
BE,MUSCLE RUPTURE,1
BE,MYOCARDIAL INFARCTION,1
BE,MYOCARDIAL ISCHAEMIA,1
BE,NAIL BED INFLAMMATION,1
BE,NASOPHARYNGITIS,1
BE,NEPHROPATHY,1
BE,NERVOUSNESS,1
BE,NIKOLSKY^S SIGN,1
BE,NO THERAPEUTIC RESPONSE,1
BE,NODULE,1
BE,NON-CARDIAC CHEST PAIN,1
BE,OEDEMA,1
BE,OEDEMA PERIPHERAL,1
BE,OESOPHAGEAL CANDIDIASIS,1
BE,OLIGURIA,1
BE,ON AND OFF PHENOMENON,1
BE,OPTIC ATROPHY,1
BE,OPTIC ISCHAEMIC NEUROPATHY,1
BE,OSTEOPOROTIC FRACTURE,1
BE,OVARIAN CANCER,1
BE,PAIN IN JAW,1
BE,PALPITATIONS,1
BE,PANCREATITIS ACUTE,1
BE,PAPILLOEDEMA,1
BE,PARVOVIRUS B19 INFECTION,1
BE,PEMPHIGOID,1
BE,PITUITARY TUMOUR RECURRENT,1
BE,PLEURAL EFFUSION,1
BE,PNEUMONIA,1
BE,PNEUMONIA ASPIRATION,1
BE,PNEUMONITIS,1
BE,POLLAKIURIA,1
BE,POOR QUALITY SLEEP,1
BE,PRODUCT USE IN UNAPPROVED INDICATION,1
BE,PRODUCT USE ISSUE,1
BE,PROPHYLAXIS,1
BE,PROSTATE CANCER,1
BE,PROTEINURIA,1
BE,PRURITUS,1
BE,PSYCHOMOTOR HYPERACTIVITY,1
BE,PSYCHOTIC BEHAVIOUR,1
BE,PYROGLUTAMATE INCREASED,1
BE,RADIATION SKIN INJURY,1
BE,RADIOTHERAPY,1
BE,RASH,1
BE,RASH GENERALISED,1
BE,RASH MACULO-PAPULAR,1
BE,RECTAL ADENOCARCINOMA,1
BE,REFLUX GASTRITIS,1
BE,REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS,1
BE,RESPIRATORY DISORDER,1
BE,RETCHING,1
BE,RETINAL INFILTRATES,1
BE,RHINITIS,1
BE,SCAN MYOCARDIAL PERFUSION ABNORMAL,1
BE,SEROTONIN SYNDROME,1
BE,SERUM FERRITIN DECREASED,1
BE,SHOCK,1
BE,SINUSITIS,1
BE,SKIN FISSURES,1
BE,SKIN NECROSIS,1
BE,SPINAL COMPRESSION FRACTURE,1
BE,SUSPECTED COUNTERFEIT PRODUCT,1
BE,SWELLING,1
BE,SYNOVIAL SARCOMA,1
BE,TACHYPNOEA,1
BE,THERAPEUTIC RESPONSE DECREASED,1
BE,TOOTH FRACTURE,1
BE,TOOTHACHE,1
BE,TOXIC ENCEPHALOPATHY,1
BE,TRANSAMINASES INCREASED,1
BE,TUBULOINTERSTITIAL NEPHRITIS,1
BE,TYPE 1 DIABETES MELLITUS,1
BE,URETEROLITHIASIS,1
BE,URINARY RETENTION,1
BE,URINARY RETENTION POSTOPERATIVE,1
BE,URINARY TRACT INFECTION ENTEROCOCCAL,1
BE,VASODILATATION,1
BE,VISUAL ACUITY REDUCED,1
BE,VISUAL IMPAIRMENT,1
BW,ABDOMINAL PAIN UPPER,1
BW,DIARRHOEA,1
BW,HAEMATEMESIS,1
BR,DRUG INEFFECTIVE,184
BR,MALAISE,182
BR,WEIGHT DECREASED,181
BR,BLOOD GLUCOSE INCREASED,168
BR,DIABETES MELLITUS,159
BR,PAIN IN EXTREMITY,154
BR,PAIN,151
BR,HYPERTENSION,135
BR,DYSPNOEA,130
BR,ARTHRALGIA,120
BR,HEADACHE,114
BR,ASTHENIA,111
BR,PNEUMONIA,105
BR,FATIGUE,99
BR,DIZZINESS,96
BR,HYPERGLYCAEMIA,91
BR,DIARRHOEA,90
BR,FALL,84
BR,COUGH,82
BR,GAIT DISTURBANCE,81
BR,BLOOD PRESSURE INCREASED,79
BR,CATARACT,78
BR,NAUSEA,78
BR,URINARY TRACT INFECTION,77
BR,INFLUENZA,76
BR,PYREXIA,76
BR,VISUAL IMPAIRMENT,76
BR,MEMORY IMPAIRMENT,72
BR,CEREBROVASCULAR ACCIDENT,67
BR,VOMITING,67
BR,WEIGHT INCREASED,67
BR,DECREASED APPETITE,63
BR,PERIPHERAL SWELLING,63
BR,INJECTION SITE PAIN,62
BR,BACK PAIN,61
BR,DEPRESSION,61
BR,ANAEMIA,60
BR,FEELING ABNORMAL,59
BR,CARDIAC DISORDER,58
BR,BLOOD CHOLESTEROL INCREASED,57
BR,INSOMNIA,56
BR,HYPOGLYCAEMIA,55
BR,TREMOR,55
BR,CHEST PAIN,53
BR,DIABETES MELLITUS INADEQUATE CONTROL,53
BR,NERVOUSNESS,52
BR,PRURITUS,51
BR,OSTEOARTHRITIS,50
BR,SWELLING,48
BR,ABDOMINAL PAIN,46
BR,MYOCARDIAL INFARCTION,46
BR,SYNCOPE,46
BR,SOMNOLENCE,45
BR,VISION BLURRED,45
BR,DRUG DOSE OMISSION,42
BR,RHEUMATOID ARTHRITIS,42
BR,ANXIETY,41
BR,HYPOAESTHESIA,40
BR,INFECTION,39
BR,PRODUCT USE ISSUE,38
BR,INFARCTION,37
BR,ABDOMINAL PAIN UPPER,36
BR,ERYTHEMA,36
BR,WOUND,36
BR,IMMUNODEFICIENCY,35
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,35
BR,CORONARY ARTERY OCCLUSION,34
BR,NASOPHARYNGITIS,34
BR,ABASIA,32
BR,BLOOD GLUCOSE DECREASED,32
BR,HAEMORRHAGE,32
BR,ARRHYTHMIA,31
BR,BLOOD GLUCOSE ABNORMAL,31
BR,BLOOD PRESSURE DECREASED,31
BR,HYPERSENSITIVITY,31
BR,PSORIASIS,31
BR,ABDOMINAL DISTENSION,30
BR,BLOOD GLUCOSE FLUCTUATION,29
BR,RENAL DISORDER,29
BR,THROMBOSIS,29
BR,ARTHROPATHY,28
BR,CONDITION AGGRAVATED,28
BR,DEATH,28
BR,BURNING SENSATION,27
BR,CONFUSIONAL STATE,27
BR,HYPERHIDROSIS,27
BR,SPEECH DISORDER,27
BR,SPINAL PAIN,27
BR,VISUAL ACUITY REDUCED,27
BR,GLAUCOMA,26
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,26
BR,HYPOTENSION,26
BR,JOINT SWELLING,26
BR,ARTERIAL OCCLUSIVE DISEASE,25
BR,EATING DISORDER,24
BR,INTENTIONAL PRODUCT MISUSE,24
BR,MUSCLE SPASMS,24
BR,MUSCULAR WEAKNESS,24
BR,OEDEMA PERIPHERAL,24
BR,ASTHMA,23
BR,TYPE 2 DIABETES MELLITUS,23
BR,BLINDNESS,22
BR,BRONCHITIS,22
BR,DISEASE PROGRESSION,22
BR,EYE PAIN,22
BR,INTERVERTEBRAL DISC PROTRUSION,22
BR,VENOUS OCCLUSION,22
BR,CHOLELITHIASIS,21
BR,DEMENTIA ALZHEIMER^S TYPE,21
BR,GASTROINTESTINAL DISORDER,21
BR,SKIN DISCOLOURATION,21
BR,ANGINA PECTORIS,20
BR,ARTHRITIS,20
BR,BLOOD TRIGLYCERIDES INCREASED,20
BR,DRY SKIN,20
BR,DYSPHONIA,20
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,20
BR,ACUTE MYOCARDIAL INFARCTION,19
BR,ALOPECIA,19
BR,BODY HEIGHT DECREASED,19
BR,FEELING HOT,19
BR,HYPOPHAGIA,19
BR,MUSCULOSKELETAL PAIN,19
BR,NEPHROLITHIASIS,19
BR,OSTEOPOROSIS,19
BR,PARAESTHESIA,19
BR,PLATELET COUNT DECREASED,19
BR,DEPRESSED MOOD,18
BR,DYSENTERY,18
BR,DYSSTASIA,18
BR,LIVER DISORDER,18
BR,PULMONARY OEDEMA,18
BR,STRESS,18
BR,BLOOD PRESSURE ABNORMAL,17
BR,BLOOD PRESSURE FLUCTUATION,17
BR,EYE SWELLING,17
BR,INJECTION SITE ERYTHEMA,17
BR,INJECTION SITE MASS,17
BR,LIMB INJURY,17
BR,LUNG INFECTION,17
BR,RENAL FAILURE,17
BR,RENAL IMPAIRMENT,17
BR,SEIZURE,17
BR,SWELLING FACE,17
BR,THYROID DISORDER,17
BR,ABDOMINAL DISCOMFORT,16
BR,BLISTER,16
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,16
BR,BONE PAIN,16
BR,DYSGEUSIA,16
BR,DYSPEPSIA,16
BR,EYE HAEMORRHAGE,16
BR,HEART RATE INCREASED,16
BR,HEPATIC STEATOSIS,16
BR,INCORRECT DOSE ADMINISTERED,16
BR,LUNG DISORDER,16
BR,TACHYCARDIA,16
BR,AGITATION,15
BR,CARDIAC ARREST,15
BR,CONSTIPATION,15
BR,DENGUE FEVER,15
BR,DYSPHAGIA,15
BR,EYE DISORDER,15
BR,INJECTION SITE PRURITUS,15
BR,LOSS OF CONSCIOUSNESS,15
BR,MASS,15
BR,MOVEMENT DISORDER,15
BR,RETCHING,15
BR,RETINAL DETACHMENT,15
BR,SINUSITIS,15
BR,BLINDNESS UNILATERAL,14
BR,BLOOD CHOLESTEROL ABNORMAL,14
BR,CARDIO-RESPIRATORY ARREST,14
BR,CHILLS,14
BR,COMA,14
BR,DEHYDRATION,14
BR,DRUG INTOLERANCE,14
BR,FEAR,14
BR,INJECTION SITE BRUISING,14
BR,MOBILITY DECREASED,14
BR,MUSCULOSKELETAL STIFFNESS,14
BR,PRURITUS GENERALISED,14
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,14
BR,BALANCE DISORDER,13
BR,BLOOD GROWTH HORMONE INCREASED,13
BR,CRYING,13
BR,DIVERTICULITIS,13
BR,DRY MOUTH,13
BR,EYE IRRITATION,13
BR,FEMUR FRACTURE,13
BR,FLUID RETENTION,13
BR,GENERAL PHYSICAL HEALTH DETERIORATION,13
BR,LOCALISED INFECTION,13
BR,PULMONARY EMBOLISM,13
BR,RASH,13
BR,SKIN EXFOLIATION,13
BR,SLUGGISHNESS,13
BR,SPINAL DISORDER,13
BR,THYROID NEOPLASM,13
BR,AGEUSIA,12
BR,BLOOD CREATININE INCREASED,12
BR,BREAST CANCER,12
BR,CARDIAC FAILURE,12
BR,DYSURIA,12
BR,EMOTIONAL DISORDER,12
BR,GAIT INABILITY,12
BR,HEAD INJURY,12
BR,INCORRECT PRODUCT STORAGE,12
BR,LABYRINTHITIS,12
BR,OVERDOSE,12
BR,PRODUCT QUALITY ISSUE,12
BR,SCIATICA,12
BR,SEPSIS,12
BR,SLEEP DISORDER,12
BR,ASTHMATIC CRISIS,11
BR,BEDRIDDEN,11
BR,DIABETIC RETINOPATHY,11
BR,DISCOMFORT,11
BR,EPISTAXIS,11
BR,GASTRITIS,11
BR,HAND DEFORMITY,11
BR,HYPOACUSIS,11
BR,HYPOKINESIA,11
BR,HYPOTHYROIDISM,11
BR,INFLAMMATION,11
BR,INJECTION SITE SWELLING,11
BR,ISCHAEMIC STROKE,11
BR,LOCAL SWELLING,11
BR,MYALGIA,11
BR,NEOPLASM,11
BR,NEOPLASM PROGRESSION,11
BR,NODULE,11
BR,PARKINSON^S DISEASE,11
BR,PHARYNGITIS,11
BR,RESPIRATORY DISORDER,11
BR,SEPTIC SHOCK,11
BR,UPPER LIMB FRACTURE,11
BR,WHEEZING,11
BR,YELLOW SKIN,11
BR,AGGRESSION,10
BR,AMNESIA,10
BR,CARDIOMEGALY,10
BR,CHEST DISCOMFORT,10
BR,DECREASED IMMUNE RESPONSIVENESS,10
BR,DRUG PRESCRIBING ERROR,10
BR,ERYSIPELAS,10
BR,GASTROINTESTINAL HAEMORRHAGE,10
BR,HEPATIC CIRRHOSIS,10
BR,IMPAIRED HEALING,10
BR,INJECTION SITE INDURATION,10
BR,LIMB DISCOMFORT,10
BR,LUNG NEOPLASM MALIGNANT,10
BR,MUSCULOSKELETAL DISORDER,10
BR,OCULAR HYPERAEMIA,10
BR,PLEURAL EFFUSION,10
BR,RESPIRATORY FAILURE,10
BR,RHINORRHOEA,10
BR,ROAD TRAFFIC ACCIDENT,10
BR,UNEVALUABLE EVENT,10
BR,APPARENT DEATH,9
BR,BONE DISORDER,9
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,9
BR,COLD SWEAT,9
BR,CONVULSION,9
BR,EMPHYSEMA,9
BR,FLATULENCE,9
BR,FOOT DEFORMITY,9
BR,GALLBLADDER DISORDER,9
BR,HEAD DISCOMFORT,9
BR,HYPERTENSIVE CRISIS,9
BR,INJECTION SITE DISCOLOURATION,9
BR,INJECTION SITE HAEMORRHAGE,9
BR,INTESTINAL HAEMORRHAGE,9
BR,MENTAL DISORDER,9
BR,MULTI-ORGAN FAILURE,9
BR,NEUROPATHY PERIPHERAL,9
BR,PALLOR,9
BR,POLLAKIURIA,9
BR,POOR PERIPHERAL CIRCULATION,9
BR,PULMONARY MASS,9
BR,RENAL PAIN,9
BR,RHEUMATIC DISORDER,9
BR,TENDON RUPTURE,9
BR,THERAPEUTIC RESPONSE DECREASED,9
BR,THIRST,9
BR,URINARY INCONTINENCE,9
BR,VARICOSE VEIN,9
BR,VERTIGO,9
BR,VIRAL INFECTION,9
BR,ANGINA UNSTABLE,8
BR,APHONIA,8
BR,ATRIAL FIBRILLATION,8
BR,BLOOD PRESSURE SYSTOLIC INCREASED,8
BR,CHROMATURIA,8
BR,CORONARY ARTERY DISEASE,8
BR,DEMENTIA,8
BR,DRUG EFFECT DECREASED,8
BR,EXOSTOSIS,8
BR,FEEDING DISORDER,8
BR,GASTRIC DISORDER,8
BR,HAEMATOCHEZIA,8
BR,HAEMOGLOBIN DECREASED,8
BR,HALLUCINATION,8
BR,JOINT INJURY,8
BR,NECK PAIN,8
BR,NEEDLE ISSUE,8
BR,NEOPLASM MALIGNANT,8
BR,OROPHARYNGEAL PAIN,8
BR,PANCREATITIS,8
BR,PARALYSIS,8
BR,PRODUCTIVE COUGH,8
BR,SHOCK,8
BR,STOMATITIS,8
BR,TENDONITIS,8
BR,THERAPEUTIC RESPONSE UNEXPECTED,8
BR,THROAT TIGHTNESS,8
BR,UNDERDOSE,8
BR,ABNORMAL BEHAVIOUR,7
BR,ACCIDENT,7
BR,APPLICATION SITE ERYTHEMA,7
BR,ASCITES,7
BR,BRADYCARDIA,7
BR,BURSITIS,7
BR,CAROTID ARTERY OCCLUSION,7
BR,CHOKING,7
BR,CYSTITIS,7
BR,DEEP VEIN THROMBOSIS,7
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,7
BR,DIABETIC NEUROPATHY,7
BR,DRUG ADMINISTRATION ERROR,7
BR,ENCEPHALOPATHY,7
BR,EXPOSURE DURING PREGNANCY,7
BR,GASTROINTESTINAL INFECTION,7
BR,GASTROOESOPHAGEAL REFLUX DISEASE,7
BR,GLUCOSE TOLERANCE IMPAIRED,7
BR,HAEMATOMA,7
BR,HAEMATURIA,7
BR,HEMIPLEGIA,7
BR,HIGH DENSITY LIPOPROTEIN DECREASED,7
BR,HYPONATRAEMIA,7
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,7
BR,INFUSION RELATED REACTION,7
BR,INSULIN-LIKE GROWTH FACTOR INCREASED,7
BR,IRRITABILITY,7
BR,JOINT RANGE OF MOTION DECREASED,7
BR,KETOACIDOSIS,7
BR,LOWER LIMB FRACTURE,7
BR,MEDICATION ERROR,7
BR,MUSCLE RIGIDITY,7
BR,OXYGEN SATURATION DECREASED,7
BR,PALPITATIONS,7
BR,PANCREATIC DISORDER,7
BR,PRODUCT USE IN UNAPPROVED INDICATION,7
BR,RESTLESSNESS,7
BR,SLEEP APNOEA SYNDROME,7
BR,SPINAL OSTEOARTHRITIS,7
BR,SUBCUTANEOUS ABSCESS,7
BR,THYROID MASS,7
BR,TINNITUS,7
BR,TOXICITY TO VARIOUS AGENTS,7
BR,URTICARIA,7
BR,WEIGHT FLUCTUATION,7
BR,ACUTE PULMONARY OEDEMA,6
BR,APHAGIA,6
BR,APHASIA,6
BR,APPLICATION SITE PAIN,6
BR,BACTERIAL INFECTION,6
BR,BODY MASS INDEX INCREASED,6
BR,BREAST MASS,6
BR,CARDIOVASCULAR DISORDER,6
BR,CARPAL TUNNEL SYNDROME,6
BR,CARTILAGE INJURY,6
BR,CROHN^S DISEASE,6
BR,CYST,6
BR,DEAFNESS,6
BR,DERMATITIS ALLERGIC,6
BR,DRUG EFFECT INCOMPLETE,6
BR,DRUG-INDUCED LIVER INJURY,6
BR,EAR INFECTION,6
BR,EAR PAIN,6
BR,GASTROINTESTINAL CARCINOMA,6
BR,HEPATIC CANCER,6
BR,HERPES ZOSTER,6
BR,HIATUS HERNIA,6
BR,ILL-DEFINED DISORDER,6
BR,INTRAOCULAR PRESSURE INCREASED,6
BR,KIDNEY INFECTION,6
BR,LACRIMATION INCREASED,6
BR,NERVOUS SYSTEM DISORDER,6
BR,NOSOCOMIAL INFECTION,6
BR,OBESITY,6
BR,ORAL PAIN,6
BR,PANCREATITIS ACUTE,6
BR,PANIC DISORDER,6
BR,POSTOPERATIVE WOUND INFECTION,6
BR,RENAL CYST,6
BR,RETINAL HAEMORRHAGE,6
BR,RIB FRACTURE,6
BR,SKIN LESION,6
BR,SURGERY,6
BR,THROAT IRRITATION,6
BR,THYROID CANCER,6
BR,TONGUE DISORDER,6
BR,TUBERCULOSIS,6
BR,URINARY RETENTION,6
BR,VITAMIN D DECREASED,6
BR,VITAMIN D DEFICIENCY,6
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,5
BR,ANAPHYLACTIC SHOCK,5
BR,APATHY,5
BR,APNOEA,5
BR,BLOOD SODIUM DECREASED,5
BR,BLOOD TRIGLYCERIDES ABNORMAL,5
BR,BLOOD UREA INCREASED,5
BR,CATARRH,5
BR,CHIKUNGUNYA VIRUS INFECTION,5
BR,COLITIS,5
BR,DEAFNESS UNILATERAL,5
BR,DIABETIC KETOACIDOSIS,5
BR,DIABETIC METABOLIC DECOMPENSATION,5
BR,DISORIENTATION,5
BR,DISTURBANCE IN ATTENTION,5
BR,DRUG HYPERSENSITIVITY,5
BR,DRY EYE,5
BR,DYSARTHRIA,5
BR,EYE INFLAMMATION,5
BR,EYE PRURITUS,5
BR,FAECES DISCOLOURED,5
BR,FEELING COLD,5
BR,FIBROMYALGIA,5
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,5
BR,GOITRE,5
BR,HAEMORRHAGIC STROKE,5
BR,HEPATIC NEOPLASM,5
BR,HERPES VIRUS INFECTION,5
BR,HORMONE LEVEL ABNORMAL,5
BR,HOSPITALISATION,5
BR,HUNGER,5
BR,HYPOCALCAEMIA,5
BR,HYPOMAGNESAEMIA,5
BR,HYPOPARATHYROIDISM,5
BR,INGUINAL HERNIA,5
BR,INJECTION SITE HAEMATOMA,5
BR,INJECTION SITE NODULE,5
BR,INJECTION SITE REACTION,5
BR,INTRAOCULAR PRESSURE TEST ABNORMAL,5
BR,ISCHAEMIA,5
BR,JOINT DISLOCATION,5
BR,KNEE DEFORMITY,5
BR,LOW DENSITY LIPOPROTEIN INCREASED,5
BR,MALIGNANT NEOPLASM PROGRESSION,5
BR,METASTATIC RENAL CELL CARCINOMA,5
BR,MUSCLE ATROPHY,5
BR,OEDEMA,5
BR,POISONING,5
BR,POLYURIA,5
BR,PROSTATE CANCER,5
BR,PULMONARY HAEMORRHAGE,5
BR,PULMONARY HYPERTENSION,5
BR,PULMONARY PAIN,5
BR,RASH MACULAR,5
BR,SENSORY LOSS,5
BR,SKIN ATROPHY,5
BR,SKIN HAEMORRHAGE,5
BR,STENT PLACEMENT,5
BR,SUICIDAL IDEATION,5
BR,TOOTH LOSS,5
BR,URINE ODOUR ABNORMAL,5
BR,VEIN DISORDER,5
BR,ABDOMINAL HERNIA,4
BR,ABSCESS LIMB,4
BR,ANEURYSM,4
BR,ANGIOPLASTY,4
BR,ANKYLOSING SPONDYLITIS,4
BR,ANURIA,4
BR,AORTIC ANEURYSM,4
BR,ARTERIAL DISORDER,4
BR,ARTERIOSCLEROSIS CORONARY ARTERY,4
BR,BLOOD CHOLESTEROL DECREASED,4
BR,BLOOD POTASSIUM INCREASED,4
BR,BLOOD THYROID STIMULATING HORMONE INCREASED,4
BR,BLOOD URIC ACID INCREASED,4
BR,BRONCHOSPASM,4
BR,CARDIAC FAILURE CONGESTIVE,4
BR,CARDIAC OPERATION,4
BR,CONJUNCTIVITIS,4
BR,CONTUSION,4
BR,DEFORMITY,4
BR,DERMATITIS,4
BR,DEVICE DISLOCATION,4
BR,DIPLOPIA,4
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,4
BR,ELECTROCARDIOGRAM QT PROLONGED,4
BR,FEELING OF DESPAIR,4
BR,FLAVIVIRUS INFECTION,4
BR,FORMICATION,4
BR,FURUNCLE,4
BR,GRIP STRENGTH DECREASED,4
BR,HAEMATOCRIT DECREASED,4
BR,HAEMOPTYSIS,4
BR,HEARING IMPAIRED,4
BR,HEPATIC PAIN,4
BR,HEPATITIS C,4
BR,HIP DEFORMITY,4
BR,HIP FRACTURE,4
BR,HYPOKALAEMIA,4
BR,INJECTION SITE WARMTH,4
BR,IRON DEFICIENCY ANAEMIA,4
BR,JAUNDICE,4
BR,JOINT STIFFNESS,4
BR,LABORATORY TEST ABNORMAL,4
BR,LACERATION,4
BR,LEUKOCYTOSIS,4
BR,LIMB DEFORMITY,4
BR,LIMB MASS,4
BR,LIPASE INCREASED,4
BR,LYMPHOMA,4
BR,METABOLIC ENCEPHALOPATHY,4
BR,METASTASES TO BONE,4
BR,MOUTH INJURY,4
BR,MUSCULOSKELETAL CHEST PAIN,4
BR,MYOCARDIAL ISCHAEMIA,4
BR,NASAL CONGESTION,4
BR,NECROSIS,4
BR,NEURALGIA,4
BR,OSTEOMYELITIS,4
BR,PHARYNGEAL DISORDER,4
BR,PIGMENTATION DISORDER,4
BR,POST PROCEDURAL INFECTION,4
BR,PROCEDURAL PAIN,4
BR,PROTEINURIA,4
BR,PSORIATIC ARTHROPATHY,4
BR,PULMONARY CONGESTION,4
BR,PULMONARY FIBROSIS,4
BR,RENAL CANCER,4
BR,RENAL INJURY,4
BR,RETINAL DISORDER,4
BR,RHINITIS,4
BR,SENSORY DISTURBANCE,4
BR,SERUM FERRITIN INCREASED,4
BR,SKIN BURNING SENSATION,4
BR,SKIN CANCER,4
BR,SKIN DISORDER,4
BR,SKIN FISSURES,4
BR,SKIN INJURY,4
BR,SKIN IRRITATION,4
BR,SKIN SENSITISATION,4
BR,SKIN WOUND,4
BR,SNEEZING,4
BR,SUFFOCATION FEELING,4
BR,SUICIDE ATTEMPT,4
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,4
BR,THROMBOCYTOPENIA,4
BR,THROMBOPHLEBITIS,4
BR,TOOTH DISORDER,4
BR,TOOTH FRACTURE,4
BR,TOOTH INFECTION,4
BR,ULCER,4
BR,URINARY TRACT INFECTION BACTERIAL,4
BR,VENOUS THROMBOSIS,4
BR,VITAMIN B12 DEFICIENCY,4
BR,WAIST CIRCUMFERENCE INCREASED,4
BR,WOUND COMPLICATION,4
BR,WOUND INFECTION,4
BR,WRONG DRUG ADMINISTERED,4
BR,ACCIDENTAL EXPOSURE TO PRODUCT,3
BR,ACCIDENTAL OVERDOSE,3
BR,ACUTE KIDNEY INJURY,3
BR,ADVERSE EVENT,3
BR,ALLERGIC COUGH,3
BR,ANAL HAEMORRHAGE,3
BR,ANAL SQUAMOUS CELL CARCINOMA,3
BR,ANGIOEDEMA,3
BR,APPENDICITIS,3
BR,APPLICATION SITE DISCOLOURATION,3
BR,ARTERIOSCLEROSIS,3
BR,BILE DUCT OBSTRUCTION,3
BR,BLEPHARITIS,3
BR,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
BR,BLOOD CREATININE ABNORMAL,3
BR,BLOOD POTASSIUM DECREASED,3
BR,BLOOD TEST ABNORMAL,3
BR,BLOOD URINE PRESENT,3
BR,BONE LOSS,3
BR,BRAIN NEOPLASM BENIGN,3
BR,BREAST CANCER FEMALE,3
BR,BREATH ODOUR,3
BR,BRONCHOPNEUMONIA,3
BR,CALCINOSIS,3
BR,CARDIOGENIC SHOCK,3
BR,CAROTID ARTERY STENOSIS,3
BR,CATARACT OPERATION,3
BR,CENTRAL OBESITY,3
BR,CEREBRAL HAEMORRHAGE,3
BR,CHONDROPATHY,3
BR,COAGULOPATHY,3
BR,COGNITIVE DISORDER,3
BR,COLON CANCER,3
BR,COORDINATION ABNORMAL,3
BR,CORONARY ARTERY STENOSIS,3
BR,CRANIOCEREBRAL INJURY,3
BR,DAYDREAMING,3
BR,DELIRIUM,3
BR,DEVICE ISSUE,3
BR,DEVICE MALFUNCTION,3
BR,DEVICE RELATED INFECTION,3
BR,DIABETIC COMPLICATION,3
BR,DRUG DISPENSING ERROR,3
BR,DYSGRAPHIA,3
BR,EMBOLISM,3
BR,ENTERITIS INFECTIOUS,3
BR,ENURESIS,3
BR,EXPIRED PRODUCT ADMINISTERED,3
BR,EYE DISCHARGE,3
BR,EYELID OEDEMA,3
BR,FACE INJURY,3
BR,FACIAL PARALYSIS,3
BR,FEAR OF DEATH,3
BR,FEBRILE NEUTROPENIA,3
BR,FINGER DEFORMITY,3
BR,FOOD INTOLERANCE,3
BR,FOOT FRACTURE,3
BR,FREQUENT BOWEL MOVEMENTS,3
BR,FUNGAL INFECTION,3
BR,GASTRIC HAEMORRHAGE,3
BR,GASTROENTERITIS,3
BR,GASTROINTESTINAL NEOPLASM,3
BR,GASTROINTESTINAL PAIN,3
BR,GENERAL PHYSICAL CONDITION ABNORMAL,3
BR,GENERALISED OEDEMA,3
BR,H1N1 INFLUENZA,3
BR,HAEMATEMESIS,3
BR,HAEMORRHOIDS,3
BR,HEART RATE DECREASED,3
BR,HEART RATE IRREGULAR,3
BR,HEMIPARESIS,3
BR,HEPATIC ENCEPHALOPATHY,3
BR,HEPATITIS,3
BR,HEPATOMEGALY,3
BR,HOT FLUSH,3
BR,HYPERAEMIA,3
BR,HYPERAESTHESIA,3
BR,HYPERCHOLESTEROLAEMIA,3
BR,HYPERPHAGIA,3
BR,HYPERSOMNIA,3
BR,HYPOTHALAMO-PITUITARY DISORDER,3
BR,INCORRECT DRUG ADMINISTRATION DURATION,3
BR,INCREASED APPETITE,3
BR,INFLUENZA LIKE ILLNESS,3
BR,INJURY,3
BR,INTESTINAL POLYP,3
BR,JOINT EFFUSION,3
BR,KNEE ARTHROPLASTY,3
BR,LARYNGEAL OEDEMA,3
BR,LAZINESS,3
BR,LEIOMYOMA,3
BR,LETHARGY,3
BR,LEUKOPENIA,3
BR,LIGAMENT SPRAIN,3
BR,LIQUID PRODUCT PHYSICAL ISSUE,3
BR,LONG QT SYNDROME,3
BR,LYMPHADENOPATHY,3
BR,MATERNAL EXPOSURE DURING PREGNANCY,3
BR,MENISCUS INJURY,3
BR,MENORRHAGIA,3
BR,MENTAL IMPAIRMENT,3
BR,METABOLIC DISORDER,3
BR,MITRAL VALVE INCOMPETENCE,3
BR,MOTOR DYSFUNCTION,3
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
BR,MUSCLE FATIGUE,3
BR,NAIL DISORDER,3
BR,NASAL DISCOMFORT,3
BR,NASAL POLYPS,3
BR,NEOPLASM RECURRENCE,3
BR,NERVE INJURY,3
BR,NEUTROPENIA,3
BR,NONINFECTIVE GINGIVITIS,3
BR,OCULAR DISCOMFORT,3
BR,OESOPHAGITIS,3
BR,ORAL CANDIDIASIS,3
BR,ORAL DISCOMFORT,3
BR,ORAL DISORDER,3
BR,OSTEONECROSIS,3
BR,OSTEOPENIA,3
BR,PANCREATIC CARCINOMA,3
BR,PANCREATIC CYST,3
BR,PARAPLEGIA,3
BR,PAROSMIA,3
BR,PATELLA FRACTURE,3
BR,PERICARDIAL EFFUSION,3
BR,POLYDIPSIA,3
BR,POLYMYOSITIS,3
BR,POST PROCEDURAL COMPLICATION,3
BR,PRESYNCOPE,3
BR,PRODUCT ADHESION ISSUE,3
BR,PRODUCT PHYSICAL ISSUE,3
BR,PROSTATOMEGALY,3
BR,PRURITUS ALLERGIC,3
BR,PULPITIS DENTAL,3
BR,PURULENT DISCHARGE,3
BR,PYOMYOSITIS,3
BR,READING DISORDER,3
BR,RECTAL CANCER,3
BR,RED BLOOD CELL COUNT DECREASED,3
BR,RENAL CELL CARCINOMA,3
BR,RESPIRATORY RATE INCREASED,3
BR,RESPIRATORY TRACT INFECTION,3
BR,RETINOPATHY,3
BR,SALIVARY HYPERSECRETION,3
BR,SCROTAL SWELLING,3
BR,SECOND PRIMARY MALIGNANCY,3
BR,SECRETION DISCHARGE,3
BR,SKIN HYPERTROPHY,3
BR,SKIN PAPILLOMA,3
BR,SKIN REACTION,3
BR,SKIN ULCER,3
BR,SPINAL COLUMN INJURY,3
BR,SPLENOMEGALY,3
BR,TENSION,3
BR,TONGUE DISCOLOURATION,3
BR,TRANSIENT ISCHAEMIC ATTACK,3
BR,TUMOUR COMPRESSION,3
BR,URINE OUTPUT INCREASED,3
BR,UTERINE CANCER,3
BR,UVEITIS,3
BR,VAGINAL HAEMORRHAGE,3
BR,VARICES OESOPHAGEAL,3
BR,VASCULITIS,3
BR,VENTRICULAR TACHYCARDIA,3
BR,WALKING DISABILITY,3
BR,ABDOMINAL ADHESIONS,2
BR,ABNORMAL SENSATION IN EYE,2
BR,ABORTION SPONTANEOUS,2
BR,ACUTE RESPIRATORY FAILURE,2
BR,ALANINE AMINOTRANSFERASE INCREASED,2
BR,ALTERED STATE OF CONSCIOUSNESS,2
BR,AMYLASE INCREASED,2
BR,ANAL ABSCESS,2
BR,ANAL FISTULA,2
BR,ANGER,2
BR,ANGIOPATHY,2
BR,ANKLE FRACTURE,2
BR,ANOSMIA,2
BR,AORTIC CALCIFICATION,2
BR,AORTIC DISORDER,2
BR,APHTHOUS ULCER,2
BR,APPLICATION SITE PRURITUS,2
BR,APPLICATION SITE SWELLING,2
BR,ARTERIAL INJURY,2
BR,ARTHRITIS INFECTIVE,2
BR,ASPARTATE AMINOTRANSFERASE INCREASED,2
BR,ASPIRATION,2
BR,ATROPHY,2
BR,ATYPICAL PNEUMONIA,2
BR,BACK DISORDER,2
BR,BASAL CELL CARCINOMA,2
BR,BENIGN NEOPLASM OF THYROID GLAND,2
BR,BLADDER CANCER,2
BR,BLOOD CALCIUM INCREASED,2
BR,BLOOD CHOLESTEROL,2
BR,BLOOD COUNT ABNORMAL,2
BR,BLOOD DISORDER,2
BR,BLOOD GROWTH HORMONE ABNORMAL,2
BR,BLOOD POTASSIUM ABNORMAL,2
BR,BLOOD PROLACTIN INCREASED,2
BR,BLOOD SODIUM ABNORMAL,2
BR,BONE CANCER,2
BR,BONE DECALCIFICATION,2
BR,BONE MARROW DISORDER,2
BR,BRADYARRHYTHMIA,2
BR,BRADYKINESIA,2
BR,BRAIN NEOPLASM,2
BR,BREAST CANCER RECURRENT,2
BR,BREATH SOUNDS ABNORMAL,2
BR,BRONCHITIS CHRONIC,2
BR,BRONCHOPULMONARY ASPERGILLOSIS,2
BR,BUNDLE BRANCH BLOCK BILATERAL,2
BR,CACHEXIA,2
BR,CALCIUM DEFICIENCY,2
BR,CALCULUS BLADDER,2
BR,CARDIAC PACEMAKER INSERTION,2
BR,CARDIAC VALVE DISEASE,2
BR,CATARACT DIABETIC,2
BR,CATHETERISATION CARDIAC,2
BR,CELLULITIS,2
BR,CEREBRAL ATROPHY,2
BR,CEREBRAL DISORDER,2
BR,CEREBRAL INFARCTION,2
BR,CEREBRAL ISCHAEMIA,2
BR,CEREBRAL THROMBOSIS,2
BR,CHAPPED LIPS,2
BR,CHOLECYSTECTOMY,2
BR,CHOLECYSTITIS ACUTE,2
BR,CHOLECYSTITIS INFECTIVE,2
BR,CLAVICLE FRACTURE,2
BR,COLOUR BLINDNESS ACQUIRED,2
BR,CONCOMITANT DISEASE AGGRAVATED,2
BR,CONJUNCTIVAL HAEMORRHAGE,2
BR,CORONARY ARTERY BYPASS,2
BR,DECREASED INTEREST,2
BR,DELUSION,2
BR,DERMATITIS CONTACT,2
BR,DEVICE OCCLUSION,2
BR,DEVICE USE ISSUE,2
BR,DIABETIC COMA,2
BR,DIASTOLIC DYSFUNCTION,2
BR,DISEASE RECURRENCE,2
BR,DISSEMINATED TUBERCULOSIS,2
BR,DIVERTICULUM,2
BR,DRUG EFFECT DELAYED,2
BR,DYSKINESIA,2
BR,DYSLIPIDAEMIA,2
BR,EAR DISORDER,2
BR,ELECTROCARDIOGRAM ABNORMAL,2
BR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
BR,EMOTIONAL DISTRESS,2
BR,ENDOMETRIOSIS,2
BR,EPILEPSY,2
BR,ERYTHEMA NODOSUM,2
BR,ESCHAR,2
BR,EXTREMITY NECROSIS,2
BR,EYE INFECTION,2
BR,EYE INJURY,2
BR,FACIAL PAIN,2
BR,FILOVIRUS INFECTION,2
BR,FISTULA,2
BR,FLUID INTAKE REDUCED,2
BR,FLUSHING,2
BR,FOOT OPERATION,2
BR,FRUSTRATION TOLERANCE DECREASED,2
BR,GALLBLADDER OPERATION,2
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BR,GASTRIC ULCER,2
BR,GASTRITIS EROSIVE,2
BR,GASTROINTESTINAL HYPOMOTILITY,2
BR,GASTROINTESTINAL MOTILITY DISORDER,2
BR,GENERALISED ERYTHEMA,2
BR,GENITAL ERYTHEMA,2
BR,GINGIVAL BLEEDING,2
BR,GINGIVAL DISORDER,2
BR,GINGIVAL PAIN,2
BR,GLOSSODYNIA,2
BR,HAEMODYNAMIC INSTABILITY,2
BR,HAEMORRHAGIC ANAEMIA,2
BR,HAND FRACTURE,2
BR,HEART RATE ABNORMAL,2
BR,HEPATIC CYST,2
BR,HEPATIC ENZYME ABNORMAL,2
BR,HEPATIC ENZYME INCREASED,2
BR,HEPATIC FUNCTION ABNORMAL,2
BR,HEPATIC INFECTION,2
BR,HEPATOCELLULAR CARCINOMA,2
BR,HEPATOTOXICITY,2
BR,HERNIA,2
BR,HYDROCEPHALUS,2
BR,HYPERKALAEMIA,2
BR,HYPERTHYROIDISM,2
BR,HYPOGLYCAEMIC COMA,2
BR,HYPOTONIA,2
BR,HYPOVITAMINOSIS,2
BR,HYPOVOLAEMIC SHOCK,2
BR,HYPOXIA,2
BR,HYSTERECTOMY,2
BR,ILEUS PARALYTIC,2
BR,INCARCERATED HERNIA,2
BR,INCREASED BRONCHIAL SECRETION,2
BR,INFLAMMATION OF WOUND,2
BR,INJECTION SITE HYPERSENSITIVITY,2
BR,INJECTION SITE INJURY,2
BR,INJECTION SITE RASH,2
BR,INSULIN RESISTANCE,2
BR,INTENTIONAL PRODUCT USE ISSUE,2
BR,INTERSTITIAL LUNG DISEASE,2
BR,INTESTINAL OBSTRUCTION,2
BR,INTRACRANIAL ANEURYSM,2
BR,IRON DEFICIENCY,2
BR,ISCHAEMIC CARDIOMYOPATHY,2
BR,KIDNEY ENLARGEMENT,2
BR,KNEE OPERATION,2
BR,LACTIC ACIDOSIS,2
BR,LARYNGEAL DISORDER,2
BR,LEFT VENTRICULAR FAILURE,2
BR,LEG AMPUTATION,2
BR,LIP DRY,2
BR,LIP SWELLING,2
BR,LIPODYSTROPHY ACQUIRED,2
BR,LIPOMA,2
BR,LIVER INJURY,2
BR,LOGORRHOEA,2
BR,LOW DENSITY LIPOPROTEIN DECREASED,2
BR,LOWER RESPIRATORY TRACT CONGESTION,2
BR,MACULAR HOLE,2
BR,MACULE,2
BR,MALABSORPTION,2
BR,MALABSORPTION FROM APPLICATION SITE,2
BR,MEDICAL DEVICE COMPLICATION,2
BR,MENSTRUATION IRREGULAR,2
BR,METABOLIC ACIDOSIS,2
BR,METASTASES TO CENTRAL NERVOUS SYSTEM,2
BR,METASTASES TO LUNG,2
BR,MICROALBUMINURIA,2
BR,MICTURITION FREQUENCY DECREASED,2
BR,MIDDLE INSOMNIA,2
BR,MITRAL VALVE DISEASE,2
BR,MONOPLEGIA,2
BR,MOOD SWINGS,2
BR,MOUTH SWELLING,2
BR,MULTIPLE SCLEROSIS RELAPSE,2
BR,MUSCLE DISORDER,2
BR,MYOPIA,2
BR,NAIL BED INFECTION,2
BR,NASAL OEDEMA,2
BR,NEUROTOXICITY,2
BR,NOCTURIA,2
BR,OBSTRUCTIVE AIRWAYS DISORDER,2
BR,OCULAR ICTERUS,2
BR,OCULAR VASCULAR DISORDER,2
BR,ONYCHALGIA,2
BR,ONYCHOCLASIS,2
BR,ONYCHOMADESIS,2
BR,ONYCHOMYCOSIS,2
BR,OPTIC NERVE DISORDER,2
BR,OSTEONECROSIS OF JAW,2
BR,PANCREATIC NEUROENDOCRINE TUMOUR,2
BR,PANIC REACTION,2
BR,PANNICULITIS,2
BR,PARKINSONISM,2
BR,PATIENT-DEVICE INCOMPATIBILITY,2
BR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
BR,PERIPHERAL EMBOLISM,2
BR,PERIPHERAL VASCULAR DISORDER,2
BR,PETIT MAL EPILEPSY,2
BR,PITUITARY TUMOUR RECURRENT,2
BR,PLANTAR FASCIITIS,2
BR,PLASMA CELL MYELOMA,2
BR,PNEUMONIA BACTERIAL,2
BR,PNEUMONITIS,2
BR,POOR QUALITY SLEEP,2
BR,POSTOPERATIVE WOUND COMPLICATION,2
BR,PROCEDURAL COMPLICATION,2
BR,PROCEDURAL HAEMORRHAGE,2
BR,PROCEDURAL SITE REACTION,2
BR,PRODUCT STORAGE ERROR,2
BR,PROSTATIC DISORDER,2
BR,PROSTATIC OPERATION,2
BR,PSYCHIATRIC SYMPTOM,2
BR,RASH PRURITIC,2
BR,RECTAL HAEMORRHAGE,2
BR,RECTAL NEOPLASM,2
BR,RECTAL POLYP,2
BR,RENAL COLIC,2
BR,RENAL FAILURE ACUTE,2
BR,RENAL FAILURE CHRONIC,2
BR,RESPIRATORY DISTRESS,2
BR,RHINALGIA,2
BR,RHINITIS ALLERGIC,2
BR,ROTATOR CUFF SYNDROME,2
BR,SCAR,2
BR,SCRATCH,2
BR,SCREAMING,2
BR,SJOGREN^S SYNDROME,2
BR,SKIN ABRASION,2
BR,SKIN HYPERPIGMENTATION,2
BR,SKIN INFECTION,2
BR,SKIN MASS,2
BR,SLEEP STUDY ABNORMAL,2
BR,SPINAL DEFORMITY,2
BR,SPINAL FRACTURE,2
BR,STAPHYLOCOCCAL INFECTION,2
BR,STARVATION,2
BR,STEVENS-JOHNSON SYNDROME,2
BR,SYNOVIAL CYST,2
BR,SYNOVIAL DISORDER,2
BR,TACHYARRHYTHMIA,2
BR,TACHYPNOEA,2
BR,TENDERNESS,2
BR,TESTICULAR INJURY,2
BR,THERMAL BURN,2
BR,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,2
BR,TOXIC ENCEPHALOPATHY,2
BR,TOXIC EPIDERMAL NECROLYSIS,2
BR,TREATMENT NONCOMPLIANCE,2
BR,TRICUSPID VALVE INCOMPETENCE,2
BR,TUMOUR PAIN,2
BR,UMBILICAL HERNIA,2
BR,UPPER RESPIRATORY TRACT INFECTION,2
BR,URINE OUTPUT DECREASED,2
BR,UTERINE HAEMORRHAGE,2
BR,UTERINE LEIOMYOMA,2
BR,VARICELLA,2
BR,VASCULAR CATHETERISATION,2
BR,VASCULAR STENT THROMBOSIS,2
BR,VENTRICULAR ARRHYTHMIA,2
BR,VITAMIN D ABNORMAL,2
BR,WEIGHT GAIN POOR,2
BR,WRIST FRACTURE,2
BR,ABDOMINAL CAVITY DRAINAGE,1
BG,DRUG LEVEL INCREASED,20
BG,LACTIC ACIDOSIS,19
BG,ACUTE KIDNEY INJURY,13
BG,ASTHENIA,4
BG,ATRIAL FIBRILLATION,4
BG,COMA,4
BG,COMPLETED SUICIDE,4
BG,CONDITION AGGRAVATED,4
BG,DYSPNOEA,4
BG,INTENTIONAL OVERDOSE,4
BG,METABOLIC ACIDOSIS,4
BG,PULMONARY EMBOLISM,4
BG,ALANINE AMINOTRANSFERASE INCREASED,3
BG,GENERAL PHYSICAL HEALTH DETERIORATION,3
BG,SUICIDE ATTEMPT,3
BG,TOXICITY TO VARIOUS AGENTS,3
BG,WEIGHT DECREASED,3
BG,ABNORMAL BEHAVIOUR,2
BG,ACIDOSIS,2
BG,ANGER,2
BG,BLINDNESS,2
BG,BLOOD CREATININE INCREASED,2
BG,BLOOD LACTIC ACID INCREASED,2
BG,BLOOD POTASSIUM INCREASED,2
BG,BLOOD THYROID STIMULATING HORMONE DECREASED,2
BG,CARDIAC FAILURE CONGESTIVE,2
BG,CARDIOPULMONARY FAILURE,2
BG,CHEMICAL POISONING,2
BG,CHRONIC GASTRITIS,2
BG,DIABETIC KETOACIDOSIS,2
BG,DIASTOLIC DYSFUNCTION,2
BG,DRUG CLEARANCE DECREASED,2
BG,FATIGUE,2
BG,GASTRODUODENITIS,2
BG,GASTROENTERITIS,2
BG,GASTROOESOPHAGEAL REFLUX DISEASE,2
BG,HAEMODYNAMIC INSTABILITY,2
BG,HYPERTHYROIDISM,2
BG,LEFT ATRIAL DILATATION,2
BG,MYOCARDIAL ISCHAEMIA,2
BG,ORTHOPNOEA,2
BG,PALPITATIONS,2
BG,PERIPHERAL SWELLING,2
BG,PLEURAL EFFUSION,2
BG,POISONING,2
BG,PULMONARY CONGESTION,2
BG,RENAL FAILURE,2
BG,TUBULOINTERSTITIAL NEPHRITIS,2
BG,URINE OUTPUT DECREASED,2
BG,UROSEPSIS,2
BG,ACUTE CORONARY SYNDROME,1
BG,ACUTE MYELOID LEUKAEMIA,1
BG,ACUTE MYOCARDIAL INFARCTION,1
BG,ANGINA PECTORIS,1
BG,ANGINA UNSTABLE,1
BG,ASPARTATE AMINOTRANSFERASE INCREASED,1
BG,ATRIAL FLUTTER,1
BG,BLADDER CANCER,1
BG,BLOOD GLUCOSE ABNORMAL,1
BG,BRAIN OEDEMA,1
BG,CEREBRAL HAEMORRHAGE,1
BG,CONVULSION,1
BG,CREATININE RENAL CLEARANCE ABNORMAL,1
BG,DECREASED APPETITE,1
BG,DEPRESSION,1
BG,DIABETES MELLITUS INADEQUATE CONTROL,1
BG,DIABETIC NEUROPATHY,1
BG,DUODENAL ULCER HAEMORRHAGE,1
BG,DUODENITIS HAEMORRHAGIC,1
BG,DYSLIPIDAEMIA,1
BG,DYSPHAGIA,1
BG,ELECTROCARDIOGRAM ABNORMAL,1
BG,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
BG,ESCHERICHIA URINARY TRACT INFECTION,1
BG,FOETAL EXPOSURE DURING PREGNANCY,1
BG,GASTRIC ULCER,1
BG,GASTRITIS EROSIVE,1
BG,GOUT,1
BG,HEADACHE,1
BG,HEART RATE DECREASED,1
BG,HEPATOCELLULAR CARCINOMA,1
BG,HERPES ZOSTER,1
BG,HIATUS HERNIA,1
BG,HYPERINSULINAEMIA,1
BG,HYPOGLYCAEMIA,1
BG,HYPOGLYCAEMIA NEONATAL,1
BG,INJECTION SITE REACTION,1
BG,ISCHAEMIC STROKE,1
BG,METABOLIC ENCEPHALOPATHY,1
BG,METASTASES TO BONE,1
BG,NEOPLASM SKIN,1
BG,OEDEMA PERIPHERAL,1
BG,OSTEOPOROSIS,1
BG,PREMATURE BABY,1
BG,PRODUCT USE ISSUE,1
BG,PYREXIA,1
BG,RASH GENERALISED,1
BG,RED BLOOD CELL COUNT DECREASED,1
BG,SYNCOPE,1
BG,TACHYARRHYTHMIA,1
BG,TACHYCARDIA,1
BG,VOMITING,1
CM,ABDOMINAL DISTENSION,1
CM,ABDOMINAL PAIN,1
CM,ANKYLOGLOSSIA CONGENITAL,1
CM,DECREASED APPETITE,1
CM,DYSPNOEA,1
CM,NAUSEA,1
CM,OEDEMA PERIPHERAL,1
CM,VOMITING,1
CA,FATIGUE,343
CA,DRUG INEFFECTIVE,340
CA,NAUSEA,297
CA,DYSPNOEA,286
CA,DIARRHOEA,266
CA,PAIN,266
CA,ASTHENIA,230
CA,FALL,228
CA,WEIGHT DECREASED,227
CA,MALAISE,225
CA,PNEUMONIA,223
CA,ARTHRALGIA,210
CA,VOMITING,206
CA,HEADACHE,203
CA,DIZZINESS,193
CA,BLOOD PRESSURE INCREASED,184
CA,DEATH,177
CA,COUGH,167
CA,PAIN IN EXTREMITY,167
CA,BLOOD GLUCOSE INCREASED,165
CA,NASOPHARYNGITIS,163
CA,BACK PAIN,143
CA,RHEUMATOID ARTHRITIS,143
CA,PYREXIA,139
CA,ABDOMINAL PAIN,132
CA,DECREASED APPETITE,132
CA,HYPOTENSION,132
CA,HAEMOGLOBIN DECREASED,120
CA,DIABETIC KETOACIDOSIS,118
CA,HYPERTENSION,112
CA,URINARY TRACT INFECTION,104
CA,CONDITION AGGRAVATED,101
CA,MYOCARDIAL INFARCTION,100
CA,WEIGHT INCREASED,98
CA,DEHYDRATION,97
CA,JOINT SWELLING,96
CA,DIABETES MELLITUS,95
CA,BLOOD PRESSURE SYSTOLIC INCREASED,94
CA,INFUSION RELATED REACTION,94
CA,CHEST PAIN,93
CA,HEART RATE INCREASED,93
CA,GAIT DISTURBANCE,90
CA,INSOMNIA,90
CA,PRURITUS,88
CA,INFLUENZA,87
CA,RASH,84
CA,CHILLS,82
CA,ANAEMIA,81
CA,CONSTIPATION,79
CA,LOWER RESPIRATORY TRACT INFECTION,79
CA,PERIPHERAL SWELLING,78
CA,CONFUSIONAL STATE,76
CA,INFECTION,75
CA,ABDOMINAL PAIN UPPER,73
CA,ASTHMA,73
CA,OEDEMA PERIPHERAL,73
CA,ABDOMINAL DISCOMFORT,71
CA,MUSCLE SPASMS,71
CA,CHEST DISCOMFORT,67
CA,HEPATIC ENZYME INCREASED,66
CA,OXYGEN SATURATION DECREASED,66
CA,ACUTE KIDNEY INJURY,65
CA,MYALGIA,65
CA,MUSCULAR WEAKNESS,64
CA,BLOOD CREATININE INCREASED,63
CA,GENERAL PHYSICAL HEALTH DETERIORATION,63
CA,ANXIETY,60
CA,HYPERHIDROSIS,60
CA,HYPOAESTHESIA,60
CA,LOSS OF CONSCIOUSNESS,60
CA,OROPHARYNGEAL PAIN,59
CA,RENAL FAILURE,59
CA,WHEEZING,59
CA,CELLULITIS,58
CA,ERYTHEMA,57
CA,FEELING ABNORMAL,56
CA,MUSCULOSKELETAL PAIN,56
CA,INJECTION SITE PAIN,55
CA,ABDOMINAL DISTENSION,54
CA,HYPOGLYCAEMIA,54
CA,PRODUCT USE ISSUE,53
CA,ATRIAL FIBRILLATION,52
CA,CATARACT,52
CA,PRODUCTIVE COUGH,52
CA,ARTHRITIS,51
CA,PALPITATIONS,51
CA,RENAL IMPAIRMENT,50
CA,MOBILITY DECREASED,49
CA,BALANCE DISORDER,48
CA,MALIGNANT NEOPLASM PROGRESSION,48
CA,ARTHROPATHY,47
CA,BLOOD GLUCOSE DECREASED,47
CA,BRONCHITIS,47
CA,CARDIAC DISORDER,46
CA,DYSPEPSIA,46
CA,PULMONARY OEDEMA,46
CA,SINUSITIS,46
CA,SOMNOLENCE,46
CA,TOXICITY TO VARIOUS AGENTS,46
CA,TYPE 2 DIABETES MELLITUS,46
CA,CONTUSION,44
CA,HEART RATE DECREASED,44
CA,OSTEOARTHRITIS,44
CA,SYNCOPE,44
CA,BLOOD PRESSURE DIASTOLIC DECREASED,43
CA,CARDIAC FAILURE CONGESTIVE,43
CA,DEPRESSION,43
CA,HYPERGLYCAEMIA,43
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,43
CA,PLATELET COUNT DECREASED,43
CA,CEREBROVASCULAR ACCIDENT,42
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,42
CA,DIABETES MELLITUS INADEQUATE CONTROL,42
CA,BLOOD PRESSURE DECREASED,41
CA,PSORIASIS,41
CA,SEPSIS,41
CA,DYSPNOEA EXERTIONAL,40
CA,HYPERSENSITIVITY,40
CA,PANCREATITIS,40
CA,DRUG EFFECT DECREASED,39
CA,DRUG HYPERSENSITIVITY,39
CA,DRUG INTOLERANCE,39
CA,WHITE BLOOD CELL COUNT DECREASED,39
CA,PULMONARY EMBOLISM,38
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,38
CA,SWELLING,38
CA,IMPAIRED WORK ABILITY,37
CA,PARAESTHESIA,36
CA,STRESS,36
CA,BLOOD GLUCOSE ABNORMAL,35
CA,BODY TEMPERATURE DECREASED,35
CA,HERPES ZOSTER,35
CA,LACTIC ACIDOSIS,35
CA,TREMOR,35
CA,URTICARIA,35
CA,CYSTITIS,34
CA,GASTROINTESTINAL HAEMORRHAGE,34
CA,INFLAMMATION,34
CA,INTERSTITIAL LUNG DISEASE,34
CA,LUNG INFECTION,34
CA,PLEURAL EFFUSION,34
CA,THROMBOSIS,34
CA,DISEASE PROGRESSION,33
CA,MUSCULOSKELETAL STIFFNESS,33
CA,BLOOD PRESSURE FLUCTUATION,32
CA,ACUTE MYOCARDIAL INFARCTION,31
CA,DRY MOUTH,31
CA,OVERDOSE,31
CA,TACHYCARDIA,31
CA,CHOLELITHIASIS,30
CA,OEDEMA,30
CA,POLLAKIURIA,30
CA,PRODUCT SUBSTITUTION ISSUE,30
CA,WHITE BLOOD CELL COUNT INCREASED,30
CA,FLATULENCE,29
CA,CARDIAC FAILURE,28
CA,DRUG DOSE OMISSION,28
CA,HEPATIC CIRRHOSIS,28
CA,LUNG DISORDER,28
CA,NEPHROLITHIASIS,28
CA,EPISTAXIS,27
CA,HYPOMAGNESAEMIA,27
CA,INFLUENZA LIKE ILLNESS,27
CA,JAUNDICE,27
CA,LOCALISED INFECTION,27
CA,PHARYNGITIS,27
CA,RENAL DISORDER,27
CA,BONE PAIN,26
CA,DYSPHAGIA,26
CA,METABOLIC ACIDOSIS,26
CA,OSTEOPOROSIS,26
CA,RIB FRACTURE,26
CA,VISUAL IMPAIRMENT,26
CA,ALANINE AMINOTRANSFERASE INCREASED,25
CA,ANAPHYLACTIC REACTION,25
CA,FEELING HOT,25
CA,FLUSHING,25
CA,HAEMORRHAGE,25
CA,PALLOR,25
CA,SEPTIC SHOCK,25
CA,ABASIA,24
CA,DISCOMFORT,24
CA,GASTROOESOPHAGEAL REFLUX DISEASE,24
CA,HEART RATE IRREGULAR,24
CA,HOT FLUSH,24
CA,LOCAL SWELLING,24
CA,SWELLING FACE,24
CA,VISION BLURRED,24
CA,ANGINA PECTORIS,23
CA,DYSURIA,23
CA,HEPATIC STEATOSIS,23
CA,HYPONATRAEMIA,23
CA,MALIGNANT MELANOMA,23
CA,SKIN ULCER,23
CA,ALOPECIA,22
CA,BLOOD TEST ABNORMAL,22
CA,HEPATIC FAILURE,22
CA,RENAL FAILURE ACUTE,22
CA,SLEEP DISORDER,22
CA,TOOTHACHE,22
CA,UNRESPONSIVE TO STIMULI,22
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,22
CA,WOUND,22
CA,BLOOD CHOLESTEROL INCREASED,21
CA,CARPAL TUNNEL SYNDROME,21
CA,COMA,21
CA,EAR INFECTION,21
CA,FLUID RETENTION,21
CA,FREQUENT BOWEL MOVEMENTS,21
CA,FUNGAL INFECTION,21
CA,HOSPITALISATION,21
CA,IMPAIRED HEALING,21
CA,INCORRECT DOSE ADMINISTERED,21
CA,LIVER FUNCTION TEST ABNORMAL,21
CA,LYMPHADENOPATHY,21
CA,MULTIPLE FRACTURES,21
CA,NASAL CONGESTION,21
CA,NECK PAIN,21
CA,ROAD TRAFFIC ACCIDENT,21
CA,URINARY INCONTINENCE,21
CA,BLOOD IRON DECREASED,20
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,20
CA,DISORIENTATION,20
CA,HYPOPHAGIA,20
CA,MEMORY IMPAIRMENT,20
CA,NEUTROPHIL COUNT INCREASED,20
CA,RESPIRATORY DISORDER,20
CA,THROMBOCYTOPENIA,20
CA,UPPER LIMB FRACTURE,20
CA,VERTIGO,20
CA,ANGIOEDEMA,19
CA,CARDIAC ARREST,19
CA,DELIRIUM,19
CA,DIVERTICULITIS,19
CA,DRY SKIN,19
CA,DYSGEUSIA,19
CA,FIBROMYALGIA,19
CA,GASTROINTESTINAL DISORDER,19
CA,INTERNATIONAL NORMALISED RATIO INCREASED,19
CA,RECTAL HAEMORRHAGE,19
CA,RHINORRHOEA,19
CA,SLEEP APNOEA SYNDROME,19
CA,SPUTUM DISCOLOURED,19
CA,URINARY RETENTION,19
CA,VIRAL INFECTION,19
CA,BURNING SENSATION,18
CA,HAEMATOCHEZIA,18
CA,HYPOCALCAEMIA,18
CA,HYPOKINESIA,18
CA,INJECTION SITE MASS,18
CA,INTESTINAL OBSTRUCTION,18
CA,IRRITABILITY,18
CA,NEOPLASM MALIGNANT,18
CA,NEUROPATHY PERIPHERAL,18
CA,OBSTRUCTIVE AIRWAYS DISORDER,18
CA,RASH GENERALISED,18
CA,UROSEPSIS,18
CA,ACNE,17
CA,AGITATION,17
CA,ASCITES,17
CA,BLISTER,17
CA,CROHN^S DISEASE,17
CA,DEEP VEIN THROMBOSIS,17
CA,DEPRESSED MOOD,17
CA,DRUG EFFECT INCOMPLETE,17
CA,DYSPHONIA,17
CA,FEBRILE NEUTROPENIA,17
CA,HYPERSOMNIA,17
CA,LETHARGY,17
CA,OSTEOMYELITIS,17
CA,RASH PRURITIC,17
CA,RESPIRATORY RATE INCREASED,17
CA,SHOCK,17
CA,SUICIDE ATTEMPT,17
CA,THROAT IRRITATION,17
CA,TOOTH DISORDER,17
CA,UPPER RESPIRATORY TRACT INFECTION,17
CA,AMNESIA,16
CA,BLOOD MAGNESIUM DECREASED,16
CA,BLOOD POTASSIUM DECREASED,16
CA,BLOOD PRESSURE ABNORMAL,16
CA,BURSITIS,16
CA,FAECES DISCOLOURED,16
CA,GOUT,16
CA,HYPOKALAEMIA,16
CA,LIMB INJURY,16
CA,MASS,16
CA,MIGRAINE,16
CA,MUSCLE ATROPHY,16
CA,MUSCULOSKELETAL CHEST PAIN,16
CA,PNEUMONIA ASPIRATION,16
CA,POOR VENOUS ACCESS,16
CA,RESPIRATORY FAILURE,16
CA,RESPIRATORY TRACT INFECTION,16
CA,ROTATOR CUFF SYNDROME,16
CA,SPEECH DISORDER,16
CA,TENDONITIS,16
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,15
CA,BLOOD PRESSURE DIASTOLIC INCREASED,15
CA,BODY TEMPERATURE INCREASED,15
CA,EATING DISORDER,15
CA,FEMUR FRACTURE,15
CA,GLOMERULAR FILTRATION RATE DECREASED,15
CA,INTENTIONAL PRODUCT MISUSE,15
CA,KNEE ARTHROPLASTY,15
CA,LIP SWELLING,15
CA,LIPASE INCREASED,15
CA,MENTAL DISORDER,15
CA,MENTAL STATUS CHANGES,15
CA,MOVEMENT DISORDER,15
CA,NIGHT SWEATS,15
CA,PANCREATITIS ACUTE,15
CA,POLYP,15
CA,RED BLOOD CELL COUNT DECREASED,15
CA,SEIZURE,15
CA,SUICIDAL IDEATION,15
CA,TOOTH INFECTION,15
CA,TREATMENT FAILURE,15
CA,TREATMENT NONCOMPLIANCE,15
CA,APHASIA,14
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,14
CA,BLOOD GLUCOSE FLUCTUATION,14
CA,DYSKINESIA,14
CA,EXERCISE TOLERANCE DECREASED,14
CA,EYE INFECTION,14
CA,HAEMOPTYSIS,14
CA,HAND DEFORMITY,14
CA,HIP FRACTURE,14
CA,INJECTION SITE BRUISING,14
CA,MIDDLE INSOMNIA,14
CA,MUSCULOSKELETAL DISCOMFORT,14
CA,NEEDLE ISSUE,14
CA,NEUTROPHIL COUNT DECREASED,14
CA,PROSTATE CANCER,14
CA,TRANSIENT ISCHAEMIC ATTACK,14
CA,ARRHYTHMIA,13
CA,ASPARTATE AMINOTRANSFERASE INCREASED,13
CA,BLOOD PRESSURE SYSTOLIC DECREASED,13
CA,BRADYCARDIA,13
CA,COLON CANCER,13
CA,DRUG LEVEL INCREASED,13
CA,EYE HAEMORRHAGE,13
CA,GAIT INABILITY,13
CA,GASTROENTERITIS VIRAL,13
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,13
CA,HAEMATEMESIS,13
CA,HAEMATURIA,13
CA,HEAD INJURY,13
CA,HEPATIC CANCER,13
CA,HYPERTONIC BLADDER,13
CA,KETOACIDOSIS,13
CA,LIMB DISCOMFORT,13
CA,LIVER INJURY,13
CA,LUNG NEOPLASM MALIGNANT,13
CA,OCULAR HYPERAEMIA,13
CA,ORAL HERPES,13
CA,PANCYTOPENIA,13
CA,RESPIRATORY DISTRESS,13
CA,SINUS CONGESTION,13
CA,SYNOVITIS,13
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,13
CA,BLOOD URINE PRESENT,12
CA,DYSARTHRIA,12
CA,DYSSTASIA,12
CA,EYE PAIN,12
CA,FLANK PAIN,12
CA,GASTRIC ULCER,12
CA,HYPERKALAEMIA,12
CA,INJECTION SITE SWELLING,12
CA,KIDNEY INFECTION,12
CA,LIVER DISORDER,12
CA,METASTASES TO LIVER,12
CA,MUSCULOSKELETAL DISORDER,12
CA,NERVOUSNESS,12
CA,NEUTROPENIA,12
CA,NODULE,12
CA,PLASMA CELL MYELOMA,12
CA,PROCEDURAL PAIN,12
CA,PULMONARY CONGESTION,12
CA,PULMONARY MASS,12
CA,RESPIRATORY TRACT CONGESTION,12
CA,SCOLIOSIS,12
CA,SECRETION DISCHARGE,12
CA,TOOTH ABSCESS,12
CA,ADRENAL INSUFFICIENCY,11
CA,ADVERSE EVENT,11
CA,BLOOD POTASSIUM INCREASED,11
CA,BREAST CANCER,11
CA,BREATH SOUNDS ABNORMAL,11
CA,CHOLECYSTITIS,11
CA,CLOSTRIDIUM DIFFICILE INFECTION,11
CA,DRUG-INDUCED LIVER INJURY,11
CA,FORCED VITAL CAPACITY DECREASED,11
CA,GASTRIC DISORDER,11
CA,HAEMOGLOBIN INCREASED,11
CA,HAEMORRHAGE INTRACRANIAL,11
CA,HAEMORRHOIDS,11
CA,HEAD DISCOMFORT,11
CA,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,11
CA,INJECTION SITE HAEMORRHAGE,11
CA,JOINT INJURY,11
CA,LACERATION,11
CA,LIVER FUNCTION TEST INCREASED,11
CA,MELAENA,11
CA,NERVE INJURY,11
CA,NEURALGIA,11
CA,OBESITY,11
CA,PROSTATE CANCER METASTATIC,11
CA,PULMONARY FUNCTION TEST ABNORMAL,11
CA,SKIN CANCER,11
CA,SKIN EXFOLIATION,11
CA,SKIN LESION,11
CA,SPINAL FRACTURE,11
CA,THROAT TIGHTNESS,11
CA,UNDERDOSE,11
CA,VISUAL ACUITY REDUCED,11
CA,BLADDER CANCER,10
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,10
CA,BLOOD DISORDER,10
CA,CHRONIC KIDNEY DISEASE,10
CA,COGNITIVE DISORDER,10
CA,COLITIS ULCERATIVE,10
CA,COMA SCALE ABNORMAL,10
CA,DRUG ADMINISTRATION ERROR,10
CA,ECZEMA,10
CA,ELECTROCARDIOGRAM QT PROLONGED,10
CA,EYE PRURITUS,10
CA,FEELING COLD,10
CA,FURUNCLE,10
CA,GALLBLADDER DISORDER,10
CA,GLAUCOMA,10
CA,HERNIA,10
CA,INJECTION SITE ERYTHEMA,10
CA,INJECTION SITE REACTION,10
CA,LYMPHOMA,10
CA,NEOPLASM,10
CA,PARALYSIS,10
CA,PERIARTHRITIS,10
CA,POSTOPERATIVE WOUND INFECTION,10
CA,RED CELL DISTRIBUTION WIDTH INCREASED,10
CA,SKIN INFECTION,10
CA,SWOLLEN TONGUE,10
CA,VAGINAL HAEMORRHAGE,10
CA,WOUND INFECTION,10
CA,ABSCESS,9
CA,ACIDOSIS,9
CA,AGEUSIA,9
CA,APHTHOUS ULCER,9
CA,BLINDNESS,9
CA,BLOOD LACTIC ACID INCREASED,9
CA,BONE DISORDER,9
CA,BRONCHOSPASM,9
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,9
CA,COLITIS,9
CA,CORONARY ARTERY DISEASE,9
CA,GASTROENTERITIS,9
CA,GASTROINTESTINAL INFLAMMATION,9
CA,GROIN PAIN,9
CA,HEPATIC FIBROSIS,9
CA,HEPATIC FUNCTION ABNORMAL,9
CA,HEPATIC NEOPLASM,9
CA,ILL-DEFINED DISORDER,9
CA,INTESTINAL ISCHAEMIA,9
CA,JOINT STIFFNESS,9
CA,LEFT VENTRICULAR DYSFUNCTION,9
CA,MOOD SWINGS,9
CA,NEOPLASM PROGRESSION,9
CA,ORAL PAIN,9
CA,OSTEOPENIA,9
CA,PANCREATIC CARCINOMA,9
CA,PHARYNGEAL OEDEMA,9
CA,POLYURIA,9
CA,PRODUCT USE IN UNAPPROVED INDICATION,9
CA,PRURITUS GENERALISED,9
CA,PULMONARY FUNCTION TEST DECREASED,9
CA,RALES,9
CA,RENAL CANCER,9
CA,RESTLESSNESS,9
CA,SCIATICA,9
CA,SNEEZING,9
CA,SPINAL COLUMN STENOSIS,9
CA,SURGERY,9
CA,THERAPEUTIC RESPONSE DECREASED,9
CA,THIRST,9
CA,ACUTE CORONARY SYNDROME,8
CA,BACTERIAL INFECTION,8
CA,BLOOD ALBUMIN DECREASED,8
CA,BLOOD CALCIUM INCREASED,8
CA,BONE CANCER,8
CA,BONE MARROW FAILURE,8
CA,CANDIDA INFECTION,8
CA,CARDIOGENIC SHOCK,8
CA,CARDIOMYOPATHY,8
CA,CERVICAL VERTEBRAL FRACTURE,8
CA,DRY THROAT,8
CA,EAR PAIN,8
CA,EYE SWELLING,8
CA,FISTULA,8
CA,HALLUCINATION,8
CA,HEPATORENAL SYNDROME,8
CA,HYPERVENTILATION,8
CA,HYPOTHYROIDISM,8
CA,IMMUNE SYSTEM DISORDER,8
CA,JOINT CREPITATION,8
CA,JOINT RANGE OF MOTION DECREASED,8
CA,MONOCYTE COUNT INCREASED,8
CA,MULTI-ORGAN FAILURE,8
CA,MYELODYSPLASTIC SYNDROME,8
CA,PANCREATITIS CHRONIC,8
CA,PARANOIA,8
CA,PERICARDITIS,8
CA,POST PROCEDURAL INFECTION,8
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,8
CA,PULMONARY FIBROSIS,8
CA,PULMONARY THROMBOSIS,8
CA,RASH ERYTHEMATOUS,8
CA,RASH MACULO-PAPULAR,8
CA,SINUS DISORDER,8
CA,SKIN DISORDER,8
CA,SPINAL DISORDER,8
CA,STOMATITIS,8
CA,URINE KETONE BODY PRESENT,8
CA,WEIGHT FLUCTUATION,8
CA,ABDOMINAL PAIN LOWER,7
CA,ACCIDENTAL OVERDOSE,7
CA,ARTHRITIS INFECTIVE,7
CA,ATRIOVENTRICULAR BLOCK,7
CA,AUTOIMMUNE HEPATITIS,7
CA,BLOOD BILIRUBIN INCREASED,7
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,7
CA,C-REACTIVE PROTEIN INCREASED,7
CA,CEREBRAL HAEMORRHAGE,7
CA,COLD SWEAT,7
CA,CONVULSION,7
CA,CORONARY ARTERY OCCLUSION,7
CA,DELUSION,7
CA,DISTURBANCE IN ATTENTION,7
CA,DYSLIPIDAEMIA,7
CA,EMOTIONAL DISORDER,7
CA,ERUCTATION,7
CA,FEEDING DISORDER,7
CA,FINGER DEFORMITY,7
CA,FOOT DEFORMITY,7
CA,GENERALISED OEDEMA,7
CA,GLUCOSE URINE PRESENT,7
CA,HAEMATOCRIT DECREASED,7
CA,HAEMATOMA,7
CA,HAEMOGLOBIN ABNORMAL,7
CA,HAND FRACTURE,7
CA,HIDRADENITIS,7
CA,HYPOACUSIS,7
CA,HYSTERECTOMY,7
CA,IMMUNODEFICIENCY,7
CA,INCREASED APPETITE,7
CA,IRON DEFICIENCY ANAEMIA,7
CA,JOINT EFFUSION,7
CA,LACRIMATION INCREASED,7
CA,LUNG INFILTRATION,7
CA,MACULAR DEGENERATION,7
CA,MEDICATION ERROR,7
CA,MENISCUS INJURY,7
CA,MIXED DEMENTIA,7
CA,MOTOR DYSFUNCTION,7
CA,NIGHTMARE,7
CA,OSTEONECROSIS,7
CA,OVARIAN CYST,7
CA,PERICARDIAL EFFUSION,7
CA,PERIPHERAL ISCHAEMIA,7
CA,PNEUMONITIS,7
CA,POOR QUALITY SLEEP,7
CA,PRESYNCOPE,7
CA,PRODUCT QUALITY ISSUE,7
CA,PROTEINURIA,7
CA,PSORIATIC ARTHROPATHY,7
CA,PYELONEPHRITIS,7
CA,RENAL CYST,7
CA,RENAL FUNCTION TEST ABNORMAL,7
CA,RETINAL DETACHMENT,7
CA,SEASONAL ALLERGY,7
CA,SECOND PRIMARY MALIGNANCY,7
CA,SENSORY LOSS,7
CA,SEROTONIN SYNDROME,7
CA,SKIN INJURY,7
CA,STAPHYLOCOCCAL INFECTION,7
CA,TACHYPNOEA,7
CA,TENDERNESS,7
CA,TRANSFUSION,7
CA,ULCER,7
CA,URINE OUTPUT DECREASED,7
CA,VENTRICULAR TACHYCARDIA,7
CA,AFFECT LABILITY,6
CA,AORTIC ANEURYSM,6
CA,AORTIC STENOSIS,6
CA,APPARENT DEATH,6
CA,ARTERIAL OCCLUSIVE DISEASE,6
CA,BASAL CELL CARCINOMA,6
CA,BLOOD BICARBONATE DECREASED,6
CA,BLOOD COUNT ABNORMAL,6
CA,BLOOD GROWTH HORMONE INCREASED,6
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,6
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,6
CA,CARDIOMEGALY,6
CA,CATARACT OPERATION,6
CA,CHROMATURIA,6
CA,CONCUSSION,6
CA,COORDINATION ABNORMAL,6
CA,CUSHING^S SYNDROME,6
CA,DECUBITUS ULCER,6
CA,DEMENTIA,6
CA,DENTAL CARIES,6
CA,DEVICE FAILURE,6
CA,DEVICE RELATED INFECTION,6
CA,DIVERTICULUM INTESTINAL,6
CA,DRUG WITHDRAWAL SYNDROME,6
CA,EMOTIONAL DISTRESS,6
CA,EOSINOPHILIA,6
CA,EXPOSURE DURING PREGNANCY,6
CA,FACE INJURY,6
CA,FAECES SOFT,6
CA,FEELING OF BODY TEMPERATURE CHANGE,6
CA,FLUID INTAKE REDUCED,6
CA,FORCED EXPIRATORY VOLUME DECREASED,6
CA,FULL BLOOD COUNT DECREASED,6
CA,GANGRENE,6
CA,GASTROINTESTINAL INFECTION,6
CA,GINGIVAL PAIN,6
CA,HEMIPARESIS,6
CA,HEPATIC LESION,6
CA,HEPATITIS C,6
CA,HIP ARTHROPLASTY,6
CA,HUMERUS FRACTURE,6
CA,HYPERCHOLESTEROLAEMIA,6
CA,HYPOAESTHESIA ORAL,6
CA,HYPOVOLAEMIA,6
CA,HYPOXIA,6
CA,INJECTION SITE DISCOMFORT,6
CA,INJURY,6
CA,INTENTIONAL OVERDOSE,6
CA,INTERVERTEBRAL DISC PROTRUSION,6
CA,INTESTINAL PERFORATION,6
CA,LIP DISCOLOURATION,6
CA,LOWER RESPIRATORY TRACT CONGESTION,6
CA,MELANOCYTIC NAEVUS,6
CA,MOUTH ULCERATION,6
CA,MUSCLE STRAIN,6
CA,MUSCLE TIGHTNESS,6
CA,NERVOUS SYSTEM DISORDER,6
CA,NEUROLEPTIC MALIGNANT SYNDROME,6
CA,OCULAR ICTERUS,6
CA,OLIGURIA,6
CA,ORAL DISORDER,6
CA,ORAL MUCOSAL DISCOLOURATION,6
CA,PAIN IN JAW,6
CA,PARAESTHESIA ORAL,6
CA,PHOTOPHOBIA,6
CA,PORTAL VEIN THROMBOSIS,6
CA,POST PROCEDURAL COMPLICATION,6
CA,PSYCHOTIC DISORDER,6
CA,PULMONARY HYPERTENSION,6
CA,RASH PAPULAR,6
CA,RENAL PAIN,6
CA,RETROPERITONEAL HAEMATOMA,6
CA,RHABDOMYOLYSIS,6
CA,SCAR,6
CA,SCHIZOPHRENIA,6
CA,SINUS TACHYCARDIA,6
CA,SKIN DISCOLOURATION,6
CA,SKIN FISSURES,6
CA,SKIN HAEMORRHAGE,6
CA,SPINAL OPERATION,6
CA,SPLENOMEGALY,6
CA,SUBARACHNOID HAEMORRHAGE,6
CA,SUBDURAL HAEMATOMA,6
CA,TINNITUS,6
CA,TOOTH LOSS,6
CA,TRANSAMINASES INCREASED,6
CA,VEIN DISORDER,6
CA,VISUAL FIELD DEFECT,6
CA,VULVOVAGINAL MYCOTIC INFECTION,6
CA,WOUND SECRETION,6
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,6
CA,ABDOMINAL TENDERNESS,5
CA,ADDISON^S DISEASE,5
CA,ADVERSE DRUG REACTION,5
CA,ALANINE AMINOTRANSFERASE ABNORMAL,5
CA,ALTERED STATE OF CONSCIOUSNESS,5
CA,ANAPHYLACTIC SHOCK,5
CA,ANGLE CLOSURE GLAUCOMA,5
CA,BACK INJURY,5
CA,BEDRIDDEN,5
CA,BLOOD IMMUNOGLOBULIN E INCREASED,5
CA,BLOOD PH DECREASED,5
CA,BLOOD SODIUM DECREASED,5
CA,BLOOD TRIGLYCERIDES INCREASED,5
CA,BREAST PAIN,5
CA,CALCULUS BLADDER,5
CA,CARDIAC VALVE DISEASE,5
CA,CHVOSTEK^S SIGN,5
CA,CIRCULATORY COLLAPSE,5
CA,CONCOMITANT DISEASE AGGRAVATED,5
CA,CONJUNCTIVITIS,5
CA,CORNEAL OEDEMA,5
CA,CREATININE RENAL CLEARANCE DECREASED,5
CA,CREPITATIONS,5
CA,CYST,5
CA,DEMENTIA ALZHEIMER^S TYPE,5
CA,DERMATITIS EXFOLIATIVE,5
CA,DRUG PRESCRIBING ERROR,5
CA,DRUG RESISTANCE,5
CA,EAR PRURITUS,5
CA,EJECTION FRACTION DECREASED,5
CA,EPIGASTRIC DISCOMFORT,5
CA,EYE DISCHARGE,5
CA,EYE DISORDER,5
CA,FACIAL PARALYSIS,5
CA,FAECALOMA,5
CA,FEAR,5
CA,GASTRITIS EROSIVE,5
CA,GINGIVITIS,5
CA,GRANULOCYTOPENIA,5
CA,GRANULOMATOSIS WITH POLYANGIITIS,5
CA,HAEMOLYSIS,5
CA,HAEMORRHAGE URINARY TRACT,5
CA,HAEMORRHAGIC STROKE,5
CA,HEMIPLEGIA,5
CA,HEPATITIS,5
CA,HIATUS HERNIA,5
CA,HYPERLIPIDAEMIA,5
CA,HYPERSENSITIVITY VASCULITIS,5
CA,HYPERTRIGLYCERIDAEMIA,5
CA,HYPOVENTILATION,5
CA,INCREASED VISCOSITY OF BRONCHIAL SECRETION,5
CA,INJECTION SITE EXTRAVASATION,5
CA,IRITIS,5
CA,KERATITIS,5
CA,LEUKOCYTOSIS,5
CA,LUMBAR VERTEBRAL FRACTURE,5
CA,MEAN CELL HAEMOGLOBIN DECREASED,5
CA,METASTASES TO LUNG,5
CA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
CA,MUSCLE SPASTICITY,5
CA,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,5
CA,MYOCLONUS,5
CA,ORAL CANDIDIASIS,5
CA,ORAL INFECTION,5
CA,ORTHOPNOEA,5
CA,ORTHOSTATIC HYPOTENSION,5
CA,OSTEONECROSIS OF JAW,5
CA,PANCREATIC DISORDER,5
CA,PANIC ATTACK,5
CA,PATELLA FRACTURE,5
CA,PLATELET COUNT INCREASED,5
CA,PNEUMOTHORAX,5
CA,RASH MACULAR,5
CA,RECURRENT CANCER,5
CA,RESTLESS LEGS SYNDROME,5
CA,SEDATION,5
CA,SENSITIVITY TO WEATHER CHANGE,5
CA,SKIN ABRASION,5
CA,SMALL INTESTINAL OBSTRUCTION,5
CA,SPLEEN DISORDER,5
CA,SUDDEN DEATH,5
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,5
CA,TIBIA FRACTURE,5
CA,TOOTH EXTRACTION,5
CA,TRANSITIONAL CELL CARCINOMA,5
CA,TRIGGER FINGER,5
CA,URINARY TRACT INFECTION BACTERIAL,5
CA,UTERINE LEIOMYOMA,5
CA,VIRAL MUTATION IDENTIFIED,5
CA,VIROLOGIC FAILURE,5
CA,WEIGHT BEARING DIFFICULTY,5
CA,WHITE BLOOD CELL COUNT ABNORMAL,5
CA,ABDOMINAL HERNIA,4
CA,ABDOMINAL INFECTION,4
CA,ABDOMINAL MASS,4
CA,ABNORMAL BEHAVIOUR,4
CA,ABSCESS LIMB,4
CA,ACCIDENT,4
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
CA,ANGINA UNSTABLE,4
CA,ARTERIOSCLEROSIS,4
CA,ARTHROPOD BITE,4
CA,ATELECTASIS,4
CA,ATRIAL FLUTTER,4
CA,ATYPICAL FEMUR FRACTURE,4
CA,AUTONOMIC NERVOUS SYSTEM IMBALANCE,4
CA,BLADDER DISORDER,4
CA,BLADDER NEOPLASM,4
CA,BLOOD ELECTROLYTES DECREASED,4
CA,BLOOD UREA INCREASED,4
CA,BONE LOSS,4
CA,BOWEL MOVEMENT IRREGULARITY,4
CA,BRAIN NEOPLASM,4
CA,BREAST MASS,4
CA,BRONCHIECTASIS,4
CA,CACHEXIA,4
CA,CARDIAC OPERATION,4
CA,CEREBRAL ATROPHY,4
CA,COAGULOPATHY,4
CA,CONTRAINDICATED PRODUCT ADMINISTERED,4
CA,CORONARY ARTERY BYPASS,4
CA,CYANOSIS,4
CA,DECREASED ACTIVITY,4
CA,DERMATITIS,4
CA,DIABETIC FOOT,4
CA,DIABETIC NEUROPATHY,4
CA,DIPLOPIA,4
CA,DIVERTICULUM,4
CA,DRUG DEPENDENCE,4
CA,DRUG LEVEL DECREASED,4
CA,DRY EYE,4
CA,DUODENITIS,4
CA,DYSTONIA,4
CA,ELECTROLYTE IMBALANCE,4
CA,EMPHYSEMA,4
CA,ENCEPHALOPATHY,4
CA,ERECTILE DYSFUNCTION,4
CA,EROSIVE DUODENITIS,4
CA,FAECES HARD,4
CA,FEAR OF INJECTION,4
CA,FOETAL EXPOSURE DURING PREGNANCY,4
CA,FOOT FRACTURE,4
CA,FRUSTRATION TOLERANCE DECREASED,4
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
CA,GASTRITIS,4
CA,GASTROINTESTINAL CARCINOMA,4
CA,GINGIVAL SWELLING,4
CA,HAEMODYNAMIC INSTABILITY,4
CA,HALLUCINATION_ AUDITORY,4
CA,HALLUCINATION_ VISUAL,4
CA,HALO VISION,4
CA,HEART RATE ABNORMAL,4
CA,HEPATIC ENCEPHALOPATHY,4
CA,HEPATOMEGALY,4
CA,HICCUPS,4
CA,HIP SURGERY,4
CA,HYPERKERATOSIS,4
CA,IDIOPATHIC PULMONARY FIBROSIS,4
CA,IMMUNE THROMBOCYTOPENIC PURPURA,4
CA,INCREASED UPPER AIRWAY SECRETION,4
CA,INJECTION SITE PRURITUS,4
CA,INTERNAL HAEMORRHAGE,4
CA,INTESTINAL RESECTION,4
CA,IRRITABLE BOWEL SYNDROME,4
CA,ISCHAEMIC STROKE,4
CA,JOINT DISLOCATION,4
CA,JOINT NOISE,4
CA,KETONURIA,4
CA,LABYRINTHITIS,4
CA,LARGE INTESTINE POLYP,4
CA,LARYNGITIS,4
CA,LEUKOPENIA,4
CA,LIGAMENT RUPTURE,4
CA,LIMB OPERATION,4
CA,LIP OEDEMA,4
CA,LOWER GASTROINTESTINAL HAEMORRHAGE,4
CA,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,4
CA,LYMPHOCYTE COUNT DECREASED,4
CA,LYMPHOEDEMA,4
CA,MACULAR HOLE,4
CA,MATERNAL EXPOSURE DURING PREGNANCY,4
CA,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,4
CA,MENORRHAGIA,4
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,4
CA,MOOD ALTERED,4
CA,MOUTH SWELLING,4
CA,MUSCLE TWITCHING,4
CA,MYOCARDIAL ISCHAEMIA,4
CA,NAIL INFECTION,4
CA,NECK MASS,4
CA,NECROTISING FASCIITIS,4
CA,NEPHROPATHY TOXIC,4
CA,NERVE COMPRESSION,4
CA,NON-CARDIAC CHEST PAIN,4
CA,OESOPHAGEAL CARCINOMA,4
CA,OESOPHAGEAL VARICES HAEMORRHAGE,4
CA,OPTIC ISCHAEMIC NEUROPATHY,4
CA,PANCREATIC CARCINOMA METASTATIC,4
CA,PANCREATIC CYST,4
CA,PANCREATIC MASS,4
CA,PANCREATITIS NECROTISING,4
CA,PARKINSON^S DISEASE,4
CA,PELVIC FRACTURE,4
CA,PEMPHIGOID,4
CA,PERSONALITY DISORDER,4
CA,PHOTOSENSITIVITY REACTION,4
CA,PILOERECTION,4
CA,PLATELET COUNT ABNORMAL,4
CA,POLYDIPSIA,4
CA,POOR PERIPHERAL CIRCULATION,4
CA,PRERENAL FAILURE,4
CA,PROCTALGIA,4
CA,PURULENT DISCHARGE,4
CA,RENAL NEOPLASM,4
CA,SLOW SPEECH,4
CA,SPINAL PAIN,4
CA,SQUAMOUS CELL CARCINOMA,4
CA,SUBCUTANEOUS ABSCESS,4
CA,SYNOVIAL CYST,4
CA,TENDON RUPTURE,4
CA,TENSION,4
CA,TERMINAL STATE,4
CA,THYROID DISORDER,4
CA,TINEA PEDIS,4
CA,TONGUE OEDEMA,4
CA,TRISMUS,4
CA,TUBERCULOSIS,4
CA,UNEVALUABLE EVENT,4
CA,URINARY TRACT OBSTRUCTION,4
CA,URINE KETONE BODY,4
CA,UTERINE CANCER,4
CA,VAGINAL INFECTION,4
CA,VARICES OESOPHAGEAL,4
CA,VARICOSE VEIN,4
CA,WHITE BLOOD CELLS URINE POSITIVE,4
CA,WRIST FRACTURE,4
CA,ABDOMINAL RIGIDITY,3
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,3
CA,ADENOCARCINOMA,3
CA,ADRENAL DISORDER,3
CA,ADRENAL MASS,3
CA,AGGRESSION,3
CA,AGRANULOCYTOSIS,3
CA,ANGER,3
CA,ANKLE FRACTURE,3
CA,ANURIA,3
CA,APHONIA,3
CA,APPETITE DISORDER,3
CA,ARTHRITIS BACTERIAL,3
CA,ASPIRATION,3
CA,AZOTAEMIA,3
CA,BLINDNESS UNILATERAL,3
CA,BLOOD BILIRUBIN ABNORMAL,3
CA,BLOOD CHROMOGRANIN A INCREASED,3
CA,BLOOD CREATININE DECREASED,3
CA,BLOOD GLUCOSE NORMAL,3
CA,BLOOD KETONE BODY,3
CA,BONE DENSITY ABNORMAL,3
CA,BONE DENSITY DECREASED,3
CA,BONE FRAGMENTATION,3
CA,BRAIN OEDEMA,3
CA,BRONCHIAL OBSTRUCTION,3
CA,CARDIAC FAILURE CHRONIC,3
CA,CARDIAC FLUTTER,3
CA,CARDIAC MURMUR,3
CA,CARDIOVASCULAR DISORDER,3
CA,CATATONIA,3
CA,CENTRAL NERVOUS SYSTEM LESION,3
CA,CEREBRAL INFARCTION,3
CA,CHOKING,3
CA,CHOROIDAL EFFUSION,3
CA,CORNEAL THINNING,3
CA,CUSHINGOID,3
CA,CYTOTOXIC CARDIOMYOPATHY,3
CA,DEVICE BREAKAGE,3
CA,DISEASE RECURRENCE,3
CA,DRAIN PLACEMENT,3
CA,DRUG TOLERANCE INCREASED,3
CA,EAR DISCOMFORT,3
CA,EAR DISORDER,3
CA,ECCHYMOSIS,3
CA,ELECTROCARDIOGRAM T WAVE PEAKED,3
CA,EMBOLIC STROKE,3
CA,END STAGE RENAL DISEASE,3
CA,ENDOTRACHEAL INTUBATION,3
CA,EOSINOPHIL COUNT INCREASED,3
CA,EUGLYCAEMIC DIABETIC KETOACIDOSIS,3
CA,EXCORIATION,3
CA,EXOSTOSIS,3
CA,EYE IRRITATION,3
CA,EYE LASER SURGERY,3
CA,FACE OEDEMA,3
CA,FACIAL PAIN,3
CA,FAECES PALE,3
CA,FIBRIN D DIMER INCREASED,3
CA,FOOD POISONING,3
CA,FOOT OPERATION,3
CA,FORCED EXPIRATORY VOLUME ABNORMAL,3
CA,GASTRIC HAEMORRHAGE,3
CA,GASTROINTESTINAL ULCER,3
CA,GENITAL HERPES,3
CA,GRIP STRENGTH DECREASED,3
CA,GROIN ABSCESS,3
CA,HAEMATOCRIT INCREASED,3
CA,HAEMOGLOBINURIA,3
CA,HANGOVER,3
CA,HEART VALVE INCOMPETENCE,3
CA,HELICOBACTER INFECTION,3
CA,HEPATIC PAIN,3
CA,HEPATITIS B,3
CA,HEPATOCELLULAR CARCINOMA,3
CA,HEPATOTOXICITY,3
CA,HUMIDITY INTOLERANCE,3
CA,HUNGER,3
CA,HYDROCEPHALUS,3
CA,HYPERBILIRUBINAEMIA,3
CA,HYPERTHYROIDISM,3
KY,DIZZINESS,1
KY,HYPERSENSITIVITY,1
KY,PALPITATIONS,1
CL,LACTIC ACIDOSIS,19
CL,HYPERKALAEMIA,14
CL,DIARRHOEA,13
CL,PAIN,13
CL,VOMITING,13
CL,ABDOMINAL PAIN UPPER,12
CL,NAUSEA,12
CL,OVERDOSE,12
CL,FATIGUE,11
CL,HYPOAESTHESIA,11
CL,CATARACT,10
CL,DECREASED APPETITE,10
CL,DEPRESSED MOOD,10
CL,DRUG INEFFECTIVE,10
CL,SKIN DISCOLOURATION,9
CL,WOUND,9
CL,HYPOTENSION,8
CL,MALAISE,8
CL,PARAESTHESIA,8
CL,ABDOMINAL PAIN,7
CL,BLOOD GLUCOSE INCREASED,7
CL,DISORIENTATION,7
CL,DYSPNOEA,7
CL,SWELLING,7
CL,DIZZINESS,6
CL,HEADACHE,6
CL,HYPOGLYCAEMIA,6
CL,IMMUNE SYSTEM DISORDER,6
CL,PLATELET COUNT DECREASED,6
CL,PYREXIA,6
CL,ANAEMIA,5
CL,ARTHRALGIA,5
CL,BRADYARRHYTHMIA,5
CL,DISEASE PROGRESSION,5
CL,ERYTHEMA,5
CL,LOSS OF CONSCIOUSNESS,5
CL,MUSCULAR WEAKNESS,5
CL,NASOPHARYNGITIS,5
CL,PRURITUS,5
CL,SINUS BRADYCARDIA,5
CL,THROMBOSIS,5
CL,ATRIOVENTRICULAR BLOCK,4
CL,BONE PAIN,4
CL,COUGH,4
CL,DEHYDRATION,4
CL,FALL,4
CL,GLUCOSE TOLERANCE IMPAIRED,4
CL,HYPERGLYCAEMIA,4
CL,HYPERTENSION,4
CL,INSOMNIA,4
CL,MULTI-ORGAN FAILURE,4
CL,PNEUMONIA,4
CL,SYNCOPE,4
CL,TACHYCARDIA,4
CL,VISUAL ACUITY REDUCED,4
CL,WEIGHT DECREASED,4
CL,ABDOMINAL DISTENSION,3
CL,ACUTE KIDNEY INJURY,3
CL,AGITATION,3
CL,AMNESIA,3
CL,BURNING SENSATION,3
CL,DEATH,3
CL,DIABETES MELLITUS,3
CL,DYSGEUSIA,3
CL,DYSPHAGIA,3
CL,DYSURIA,3
CL,ECHOCARDIOGRAM ABNORMAL,3
CL,GASTRIC ULCER,3
CL,GLAUCOMA,3
CL,MEMORY IMPAIRMENT,3
CL,METASTASIS,3
CL,MYALGIA,3
CL,OSTEOARTHRITIS,3
CL,PERICARDIAL EFFUSION,3
CL,PERIPHERAL SWELLING,3
CL,PLEURAL EFFUSION,3
CL,PNEUMONITIS,3
CL,POLYURIA,3
CL,PORTAL HYPERTENSION,3
CL,SKIN EXFOLIATION,3
CL,SOMNOLENCE,3
CL,SWELLING FACE,3
CL,URINARY TRACT INFECTION,3
CL,WHITE BLOOD CELL COUNT DECREASED,3
CL,ABDOMINAL DISCOMFORT,2
CL,ABNORMAL FAECES,2
CL,ALOPECIA,2
CL,ARTHRITIS,2
CL,ASTHENIA,2
CL,AZOTAEMIA,2
CL,BACK PAIN,2
CL,BLOOD BILIRUBIN INCREASED,2
CL,BLOOD CHOLESTEROL ABNORMAL,2
CL,BLOOD CREATININE INCREASED,2
CL,BRAIN NATRIURETIC PEPTIDE INCREASED,2
CL,CARCINOEMBRYONIC ANTIGEN INCREASED,2
CL,CARDIAC DISORDER,2
CL,CARDIAC FAILURE,2
CL,CEREBROVASCULAR ACCIDENT,2
CL,CHEST PAIN,2
CL,COLITIS ULCERATIVE,2
CL,CONSTIPATION,2
CL,DEPRESSION,2
CL,DISCOMFORT,2
CL,DRY MOUTH,2
CL,DRY SKIN,2
CL,EAR DISCOMFORT,2
CL,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
CL,ELECTROCARDIOGRAM QT PROLONGED,2
CL,FOOD AVERSION,2
CL,GAIT DISTURBANCE,2
CL,GASTRIC INFECTION,2
CL,HEAD DISCOMFORT,2
CL,HEART RATE DECREASED,2
CL,HERPES ZOSTER,2
CL,HIP FRACTURE,2
CL,HYPERAESTHESIA,2
CL,HYPERSENSITIVITY,2
CL,HYPOPERFUSION,2
CL,INFLAMMATION,2
CL,INFLUENZA,2
CL,LABORATORY TEST ABNORMAL,2
CL,LIMB INJURY,2
CL,LIVER DISORDER,2
CL,LIVER INJURY,2
CL,LUNG DISORDER,2
CL,METABOLIC ACIDOSIS,2
CL,METASTASES TO CENTRAL NERVOUS SYSTEM,2
CL,METASTASES TO LIVER,2
CL,MUSCLE SPASMS,2
CL,MUSCULOSKELETAL STIFFNESS,2
CL,NEUTROPENIA,2
CL,OCULAR ICTERUS,2
CL,PANCREATITIS,2
CL,RENAL DISORDER,2
CL,RENAL IMPAIRMENT,2
CL,RESPIRATORY FAILURE,2
CL,SEPTIC SHOCK,2
CL,TUMOUR PAIN,2
CL,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CL,UPPER LIMB FRACTURE,2
CL,URINE ODOUR ABNORMAL,2
CL,VARICES OESOPHAGEAL,2
CL,WEIGHT INCREASED,2
CL,ABDOMINAL MASS,1
CL,ACNE,1
CL,ACUTE MYOCARDIAL INFARCTION,1
CL,AFFECT LABILITY,1
CL,ALANINE AMINOTRANSFERASE INCREASED,1
CL,ALTERED STATE OF CONSCIOUSNESS,1
CL,AMMONIA INCREASED,1
CL,ANOGENITAL WARTS,1
CL,ANXIETY,1
CL,AORTIC ARTERIOSCLEROSIS,1
CL,AORTIC VALVE INCOMPETENCE,1
CL,APHONIA,1
CL,ARRHYTHMIA,1
CL,ASCITES,1
CL,ASPARTATE AMINOTRANSFERASE INCREASED,1
CL,AVERSION,1
CL,AXILLARY PAIN,1
CL,BALANCE DISORDER,1
CL,BLINDNESS,1
CL,BLINDNESS UNILATERAL,1
CL,BLISTER,1
CL,BLOOD CHOLESTEROL INCREASED,1
CL,BLOOD CREATINE INCREASED,1
CL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CL,BLOOD GLUCOSE ABNORMAL,1
CL,BLOOD PRESSURE INCREASED,1
CL,BLOOD TEST ABNORMAL,1
CL,BLOOD TRIGLYCERIDES ABNORMAL,1
CL,BLOOD UREA INCREASED,1
CL,BLOOD URIC ACID INCREASED,1
CL,BLOOD ZINC DECREASED,1
CL,BRADYPHRENIA,1
CL,BRAIN INJURY,1
CL,BRAIN NATRIURETIC PEPTIDE ABNORMAL,1
CL,BRAIN NEOPLASM,1
CL,BREAST CANCER,1
CL,BREAST DISCOMFORT,1
CL,BREAST DISORDER,1
CL,BREAST MASS,1
CL,BREAST NEOPLASM,1
CL,BREAST PAIN,1
CL,BREAST SWELLING,1
CL,BRONCHIAL OBSTRUCTION,1
CL,BRONCHITIS,1
CL,CARDIAC TAMPONADE,1
CL,CARDIO-RESPIRATORY ARREST,1
CL,CARDIOMEGALY,1
CL,CELLULITIS,1
CL,CHILLS,1
CL,CHOKING,1
CL,CHOLANGITIS CHRONIC,1
CL,CHOLESTASIS,1
CL,CHROMATURIA,1
CL,COLON ADENOMA,1
CL,CONFUSIONAL STATE,1
CL,CORONARY ARTERY DISEASE,1
CL,CRANIOCEREBRAL INJURY,1
CL,DEFECT CONDUCTION INTRAVENTRICULAR,1
CL,DIABETIC NEUROPATHY,1
CL,DRUG DOSE OMISSION,1
CL,DRUG EFFECT DELAYED,1
CL,DYSPEPSIA,1
CL,ELECTROCARDIOGRAM T WAVE PEAKED,1
CL,EXPOSURE DURING PREGNANCY,1
CL,EYE PRURITUS,1
CL,EYE SWELLING,1
CL,EYELID DISORDER,1
CL,FEBRILE NEUTROPENIA,1
CL,FEEDING DISORDER,1
CL,FLATULENCE,1
CL,FOETAL EXPOSURE DURING PREGNANCY,1
CL,GALLBLADDER POLYP,1
CL,GASTRITIS,1
CL,GASTROENTERITIS,1
CL,GASTROINTESTINAL NEOPLASM,1
CL,GASTROINTESTINAL SOUNDS ABNORMAL,1
CL,GASTROINTESTINAL STOMA COMPLICATION,1
CL,GENERAL PHYSICAL HEALTH DETERIORATION,1
CL,HAEMATOCRIT DECREASED,1
CL,HAEMODYNAMIC INSTABILITY,1
CL,HAEMOGLOBIN DECREASED,1
CL,HAIR GROWTH ABNORMAL,1
CL,HEARING AID USER,1
CL,HEARING IMPAIRED,1
CL,HEMIPLEGIA,1
CL,HEPATIC ENCEPHALOPATHY,1
CL,HEPATITIS,1
CL,HEPATOMEGALY,1
CL,HERNIA,1
CL,HERPES OESOPHAGITIS,1
CL,HERPES VIRUS INFECTION,1
CL,HICCUPS,1
CL,HOT FLUSH,1
CL,HYPERHIDROSIS,1
CL,HYPOACUSIS,1
CL,HYPOGEUSIA,1
CL,HYPOKINESIA,1
CL,HYPOTHERMIA,1
CL,ILL-DEFINED DISORDER,1
CL,IMPAIRED HEALING,1
CL,INCORRECT DOSE ADMINISTERED,1
CL,INCREASED UPPER AIRWAY SECRETION,1
CL,INFECTION,1
CL,INGUINAL HERNIA,1
CL,INJURY,1
CL,INNER EAR DISORDER,1
CL,INSULIN RESISTANCE,1
CL,INTESTINAL OBSTRUCTION,1
CL,INTRAOCULAR PRESSURE INCREASED,1
CL,IRIDOTOMY,1
CL,KETOACIDOSIS,1
CL,LACRIMATION DISORDER,1
CL,LACUNAR INFARCTION,1
CL,LIMB IMMOBILISATION,1
CL,LOCAL SWELLING,1
CL,LOCALISED INFECTION,1
CL,LUMBAR RADICULOPATHY,1
CL,LUNG INFECTION,1
CL,MACULAR DEGENERATION,1
CL,MACULOPATHY,1
CL,MALIGNANT NEOPLASM PROGRESSION,1
CL,MASS,1
CL,METABOLIC DISORDER,1
CL,METASTASES TO LUNG,1
CL,MITRAL VALVE STENOSIS,1
CL,MOBILITY DECREASED,1
CL,MOUTH INJURY,1
CL,MOUTH SWELLING,1
CL,MUCOSAL INFLAMMATION,1
CL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CL,MUSCULOSKELETAL PAIN,1
CL,MYOCARDIAL INFARCTION,1
CL,NAIL AVULSION,1
CL,NAIL DISCOLOURATION,1
CL,NECK MASS,1
CL,NERVOUSNESS,1
CL,NEUROTOXICITY,1
CL,NIGHT BLINDNESS,1
CL,NON-HODGKIN^S LYMPHOMA,1
CL,OCULAR DISCOMFORT,1
CL,OCULAR HYPERAEMIA,1
CL,OEDEMATOUS PANCREATITIS,1
CL,ONYCHOCLASIS,1
CL,ORAL MUCOSAL BLISTERING,1
CL,ORAL MUCOSAL DISCOLOURATION,1
CL,OXYGEN SATURATION DECREASED,1
CL,PAIN IN EXTREMITY,1
CL,PAIN IN JAW,1
CL,PALLOR,1
CL,PALMAR ERYTHEMA,1
CL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CL,PALPITATIONS,1
CL,PELVIC PAIN,1
CL,PHARYNGEAL OEDEMA,1
CL,PLEURISY,1
CL,POLYMERASE CHAIN REACTION POSITIVE,1
CL,PORTAL VEIN THROMBOSIS,1
CL,POST HERPETIC NEURALGIA,1
CL,POST PROCEDURAL INFECTION,1
CL,POSTOPERATIVE WOUND INFECTION,1
CL,PREMATURE DELIVERY,1
CL,PRESYNCOPE,1
CL,PROCTITIS ULCERATIVE,1
CL,PRODUCT USE IN UNAPPROVED INDICATION,1
CL,PULMONARY FIBROSIS,1
CL,PULMONARY MASS,1
CL,PULMONARY OEDEMA,1
CL,PULMONARY PAIN,1
CL,PYRAMIDAL TRACT SYNDROME,1
CL,RED BLOOD CELL COUNT DECREASED,1
CL,RENAL CANCER,1
CL,RENAL FAILURE ACUTE,1
CL,RESPIRATORY DISTRESS,1
CL,RETINAL INJURY,1
CL,RETINOPATHY,1
CL,RHEUMATOID ARTHRITIS,1
CL,RHINALGIA,1
CL,RIGHT VENTRICULAR DYSFUNCTION,1
CL,SCAB,1
CL,SEIZURE,1
CL,SHOCK,1
CL,SKIN HAEMORRHAGE,1
CL,SKIN ULCER,1
CL,SLEEP APNOEA SYNDROME,1
CL,STOMA SITE REACTION,1
CL,STOMATITIS,1
CL,SWOLLEN TONGUE,1
CL,TELANGIECTASIA,1
CL,TERMINAL STATE,1
CL,THROMBOCYTOPENIA,1
CL,TINNITUS,1
CL,TONGUE DISORDER,1
CL,TOOTH DISORDER,1
CL,TOOTH INFECTION,1
CL,TOOTHACHE,1
CL,TREMOR,1
CL,TROPONIN INCREASED,1
CL,TYPE 2 DIABETES MELLITUS,1
CL,ULCER,1
CL,URINE OUTPUT DECREASED,1
CL,VASCULAR PAIN,1
CL,VIRAL LOAD INCREASED,1
CL,VIRAL TEST POSITIVE,1
CL,VISION BLURRED,1
CL,VISUAL IMPAIRMENT,1
CN,BLOOD GLUCOSE INCREASED,60
CN,RENAL IMPAIRMENT,47
CN,LACTIC ACIDOSIS,29
CN,HYPOGLYCAEMIA,25
CN,DIZZINESS,22
CN,VOMITING,22
CN,NAUSEA,20
CN,BLOOD GLUCOSE ABNORMAL,19
CN,DRUG DOSE OMISSION,18
CN,DIABETES MELLITUS INADEQUATE CONTROL,17
CN,WEIGHT DECREASED,16
CN,ASTHENIA,15
CN,CEREBRAL INFARCTION,14
CN,HYPERGLYCAEMIA,14
CN,DIABETES MELLITUS,13
CN,CHEST DISCOMFORT,12
CN,HEPATIC FUNCTION ABNORMAL,12
CN,HYPOGLYCAEMIC COMA,12
CN,ABDOMINAL DISCOMFORT,11
CN,DECREASED APPETITE,11
CN,DRUG INEFFECTIVE,11
CN,ANGINA UNSTABLE,9
CN,DIABETIC KETOACIDOSIS,9
CN,DYSPNOEA,9
CN,FATIGUE,9
CN,GLYCOSYLATED HAEMOGLOBIN INCREASED,9
CN,LUNG INFECTION,9
CN,PALPITATIONS,9
CN,PYREXIA,9
CN,RENAL INJURY,9
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,9
CN,ABDOMINAL PAIN,8
CN,BLOOD GLUCOSE FLUCTUATION,8
CN,HYPERTENSION,8
CN,ACUTE KIDNEY INJURY,7
CN,CORONARY ARTERY DISEASE,7
CN,MUSCULAR WEAKNESS,7
CN,THERAPEUTIC RESPONSE DECREASED,7
CN,COUGH,6
CN,DIARRHOEA,6
CN,DRUG-INDUCED LIVER INJURY,6
CN,GASTRIC ULCER,6
CN,INTENTIONAL PRODUCT MISUSE,6
CN,PRURITUS,6
CN,SUICIDE ATTEMPT,6
CN,ARTHRALGIA,5
CN,CARDIAC FAILURE,5
CN,CAROTID ARTERIOSCLEROSIS,5
CN,CONSTIPATION,5
CN,DEHYDRATION,5
CN,DIABETIC NEPHROPATHY,5
CN,DIABETIC RETINOPATHY,5
CN,FALL,5
CN,HEAD DISCOMFORT,5
CN,LIVER INJURY,5
CN,MATERNAL EXPOSURE DURING PREGNANCY,5
CN,MYALGIA,5
CN,NASOPHARYNGITIS,5
CN,OVERDOSE,5
CN,PNEUMONIA,5
CN,RETINAL DETACHMENT,5
CN,ABDOMINAL DISTENSION,4
CN,ALANINE AMINOTRANSFERASE INCREASED,4
CN,ATRIAL FIBRILLATION,4
CN,BLOOD GLUCOSE DECREASED,4
CN,CEREBRAL HAEMORRHAGE,4
CN,COMA,4
CN,DIABETIC NEUROPATHY,4
CN,DISCOMFORT,4
CN,DRUG HYPERSENSITIVITY,4
CN,GAIT DISTURBANCE,4
CN,HEPATIC STEATOSIS,4
CN,HYPOAESTHESIA,4
CN,HYPOGLYCAEMIC ENCEPHALOPATHY,4
CN,HYPOTENSION,4
CN,INCORRECT DOSE ADMINISTERED,4
CN,INTENTIONAL OVERDOSE,4
CN,LOSS OF CONSCIOUSNESS,4
CN,NEUROPATHY PERIPHERAL,4
CN,OSTEOPOROSIS,4
CN,PRODUCT USE IN UNAPPROVED INDICATION,4
CN,PRURITUS GENERALISED,4
CN,RASH,4
CN,RENAL FAILURE ACUTE,4
CN,RESPIRATORY ARREST,4
CN,RETINAL HAEMORRHAGE,4
CN,TACHYPNOEA,4
CN,TRANSAMINASES INCREASED,4
CN,VISION BLURRED,4
CN,ABDOMINAL PAIN UPPER,3
CN,ACUTE MYOCARDIAL INFARCTION,3
CN,ARRHYTHMIA,3
CN,BLOOD PRESSURE DECREASED,3
CN,CARDIAC DISORDER,3
CN,CATARACT,3
CN,CHEST PAIN,3
CN,DEATH,3
CN,DRY MOUTH,3
CN,EYE DISORDER,3
CN,FEELING HOT,3
CN,GASTROINTESTINAL DISORDER,3
CN,GASTROINTESTINAL HAEMORRHAGE,3
CN,HEADACHE,3
CN,HEART RATE INCREASED,3
CN,HEPATIC ENZYME INCREASED,3
CN,HUNGER,3
CN,HYPERHIDROSIS,3
CN,HYPERSENSITIVITY,3
CN,HYPERURICAEMIA,3
CN,LACUNAR INFARCTION,3
CN,MYOCARDIAL ISCHAEMIA,3
CN,PAIN IN EXTREMITY,3
CN,PLATELET COUNT DECREASED,3
CN,PRODUCT QUALITY ISSUE,3
CN,PRODUCT USE ISSUE,3
CN,RASH GENERALISED,3
CN,SHOCK,3
CN,SOMNOLENCE,3
CN,SPINAL FRACTURE,3
CN,STEVENS-JOHNSON SYNDROME,3
CN,SYNCOPE,3
CN,THROMBOCYTOPENIA,3
CN,TREMOR,3
CN,URINARY RETENTION,3
CN,URINE KETONE BODY PRESENT,3
CN,URTICARIA,3
CN,WEIGHT INCREASED,3
CN,ABORTION INDUCED,2
CN,ABORTION SPONTANEOUS,2
CN,ADNEXA UTERI PAIN,2
CN,AGITATION,2
CN,ANAEMIA,2
CN,ANAPHYLACTIC SHOCK,2
CN,ANGINA PECTORIS,2
CN,ANION GAP INCREASED,2
CN,ANXIETY,2
CN,BENIGN PROSTATIC HYPERPLASIA,2
CN,BIOCHEMICAL PREGNANCY,2
CN,BLINDNESS,2
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
CN,BLOOD PRESSURE FLUCTUATION,2
CN,BLOOD PRESSURE INCREASED,2
CN,CACHEXIA,2
CN,CARDIAC ARREST,2
CN,CEREBRAL THROMBOSIS,2
CN,COLD SWEAT,2
CN,CONDITION AGGRAVATED,2
CN,CORONARY ARTERY STENOSIS,2
CN,CYANOSIS,2
CN,DEAFNESS,2
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CN,DIABETIC FOOT,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,EYE HAEMORRHAGE,2
CN,EYELID OEDEMA,2
CN,FACE OEDEMA,2
CN,FREQUENT BOWEL MOVEMENTS,2
CN,GASTRIC DISORDER,2
CN,HAEMODIALYSIS,2
CN,HAEMOGLOBIN DECREASED,2
CN,HAEMOPTYSIS,2
CN,HAEMORRHAGE,2
CN,HYPERTHYROIDISM,2
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
CN,INFUSION SITE REACTION,2
CN,INJECTION SITE HAEMORRHAGE,2
CN,INSOMNIA,2
CN,INTERVERTEBRAL DISC PROTRUSION,2
CN,INTESTINAL OBSTRUCTION,2
CN,KETOACIDOSIS,2
CN,LIVER DISORDER,2
CN,LIVER FUNCTION TEST ABNORMAL,2
CN,MALIGNANT NEOPLASM PROGRESSION,2
CN,METABOLIC ACIDOSIS,2
CN,METRORRHAGIA,2
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
CN,MYOCARDIAL INFARCTION,2
CN,MYOPATHY,2
CN,NEPHROLITHIASIS,2
CN,NEPHROPATHY,2
CN,OEDEMA,2
CN,PRODUCT COUNTERFEIT,2
CN,PULMONARY EMBOLISM,2
CN,RASH ERYTHEMATOUS,2
CN,RENAL DISORDER,2
CN,RENAL FAILURE,2
CN,RHABDOMYOLYSIS,2
CN,ROAD TRAFFIC ACCIDENT,2
CN,SINUS BRADYCARDIA,2
CN,SINUS TACHYCARDIA,2
CN,SPINAL OSTEOARTHRITIS,2
CN,SUICIDAL IDEATION,2
CN,SUSPECTED COUNTERFEIT PRODUCT,2
CN,THIRST,2
CN,THYROID CANCER,2
CN,TOXICITY TO VARIOUS AGENTS,2
CN,TYPE 2 DIABETES MELLITUS,2
CN,UNDERDOSE,2
CN,URINARY INCONTINENCE,2
CN,VISUAL IMPAIRMENT,2
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CN,ABNORMAL FAECES,1
CN,ACIDOSIS,1
CN,ACNE,1
CN,ACUTE CORONARY SYNDROME,1
CN,ADVERSE EVENT,1
CN,AMAUROSIS FUGAX,1
CN,AMNESIA,1
CN,ANAL ABSCESS,1
CN,ANAL INCONTINENCE,1
CN,ANAPHYLACTIC REACTION,1
CN,APPENDICITIS,1
CN,ARTERIAL STENOSIS,1
CN,ARTERIAL THROMBOSIS,1
CN,ARTERIOGRAM CORONARY,1
CN,ARTERIOSCLEROSIS,1
CN,ASCITES,1
CN,ASPARTATE AMINOTRANSFERASE INCREASED,1
CN,ASTHMA,1
CN,ATRIOVENTRICULAR BLOCK,1
CN,ATRIOVENTRICULAR BLOCK COMPLETE,1
CN,BACK PAIN,1
CN,BASE EXCESS NEGATIVE,1
CN,BENIGN NEOPLASM OF THYROID GLAND,1
CN,BILE DUCT STONE,1
CN,BLINDNESS UNILATERAL,1
CN,BLOOD ALBUMIN DECREASED,1
CN,BLOOD BICARBONATE DECREASED,1
CN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
CN,BLOOD CREATININE INCREASED,1
CN,BLOOD LACTIC ACID INCREASED,1
CN,BLOOD PH DECREASED,1
CN,BLOOD POTASSIUM INCREASED,1
CN,BLOOD PRESSURE ABNORMAL,1
CN,BLOOD PRESSURE SYSTOLIC INCREASED,1
CN,BLOOD TRIGLYCERIDES INCREASED,1
CN,BLOOD UREA INCREASED,1
CN,BONE MARROW FAILURE,1
CN,BONE PAIN,1
CN,BRAIN HERNIATION,1
CN,BRAIN NEOPLASM,1
CN,BRAIN TUMOUR OPERATION,1
CN,BREAST CANCER,1
CN,BREAST CANCER METASTATIC,1
CN,BREATH SOUNDS ABNORMAL,1
CN,BRONCHITIS CHRONIC,1
CN,C-REACTIVE PROTEIN INCREASED,1
CN,CALCULUS URETHRAL,1
CN,CALCULUS URINARY,1
CN,CARDIAC ANEURYSM,1
CN,CARDIO-RESPIRATORY ARREST,1
CN,CAROTID ARTERY STENOSIS,1
CN,CEREBRAL ISCHAEMIA,1
CN,CEREBROVASCULAR DISORDER,1
CN,CEREBROVASCULAR INSUFFICIENCY,1
CN,CHILLS,1
CN,CHOLECYSTECTOMY,1
CN,CHOLECYSTITIS,1
CN,CHOLELITHIASIS,1
CN,CHRONIC GASTRITIS,1
CN,COLON CANCER STAGE 0,1
CN,COMMINUTED FRACTURE,1
CN,COMPUTERISED TOMOGRAM ABNORMAL,1
CN,CONCOMITANT DISEASE AGGRAVATED,1
CN,CONTRAINDICATED PRODUCT ADMINISTERED,1
CN,CORONARY ARTERY OCCLUSION,1
CN,DEAFNESS NEUROSENSORY,1
CN,DEAFNESS UNILATERAL,1
CN,DEEP VEIN THROMBOSIS,1
CN,DEGENERATIVE AORTIC VALVE DISEASE,1
CN,DEGENERATIVE MITRAL VALVE DISEASE,1
CN,DEMYELINATION,1
CN,DEPRESSION,1
CN,DERMATITIS,1
CN,DIABETIC EYE DISEASE,1
CN,DIABETIC KETOSIS,1
CN,DIABETIC VASCULAR DISORDER,1
CN,DIFFUSE LARGE B-CELL LYMPHOMA,1
CN,DISEASE PROGRESSION,1
CN,DISEASE RECURRENCE,1
CN,DRUG EFFECT INCREASED,1
CN,DRUG ERUPTION,1
CN,DRUG INTOLERANCE,1
CN,DRUG LEVEL INCREASED,1
CN,DRY EYE,1
CN,DUODENAL ULCER,1
CN,DYSACUSIS,1
CN,DYSPHEMIA,1
CN,DYSPHONIA,1
CN,DYSPNOEA EXERTIONAL,1
CN,DYSURIA,1
CN,EAR DISORDER,1
CN,ELECTROCARDIOGRAM ABNORMAL,1
CN,EMBOLISM,1
CN,EMOTIONAL DISORDER,1
CN,ENDOCRINE DISORDER,1
CN,EOSINOPHILIA,1
CN,EPILEPSY,1
CN,ERYSIPELAS,1
CN,ERYTHEMA,1
CN,ERYTHEMA OF EYELID,1
CN,EXPIRED PRODUCT ADMINISTERED,1
CN,EXPOSURE DURING PREGNANCY,1
CN,EYE HAEMANGIOMA,1
CN,EYE MOVEMENT DISORDER,1
CN,EYE OEDEMA,1
CN,FACE INJURY,1
CN,FAECES DISCOLOURED,1
CN,FIBRIN D DIMER INCREASED,1
CN,FIBULA FRACTURE,1
CN,FLATULENCE,1
CN,FLUID RETENTION,1
CN,FUNDOSCOPY ABNORMAL,1
CN,GALLBLADDER DISORDER,1
CN,GASTRIC CANCER,1
CN,GASTRIC ULCER HELICOBACTER,1
CN,GASTRITIS EROSIVE,1
CN,GASTROINTESTINAL CARCINOMA,1
CN,GASTROINTESTINAL PAIN,1
CN,GENERALISED ERYTHEMA,1
CN,GENERALISED OEDEMA,1
CN,GLOMERULONEPHRITIS CHRONIC,1
CN,GLUCOSE TOLERANCE IMPAIRED,1
CN,GLUCOSE URINE PRESENT,1
CN,HAEMATEMESIS,1
CN,HAEMORRHAGE URINARY TRACT,1
CN,HAEMORRHOIDS,1
CN,HEART VALVE INCOMPETENCE,1
CN,HEPATIC FAILURE,1
CN,HEPATIC LESION,1
CN,HYDRONEPHROSIS,1
CN,HYPERLIPIDAEMIA,1
CN,HYPERTENSIVE CRISIS,1
CN,HYPERTENSIVE EMERGENCY,1
CN,HYPERTRIGLYCERIDAEMIA,1
CN,HYPOAESTHESIA ORAL,1
CN,HYPONATRAEMIA,1
CN,HYPOTHYROIDISM,1
CN,IMPAIRED GASTRIC EMPTYING,1
CN,IMPAIRED HEALING,1
CN,INCISION SITE PAIN,1
CN,INFECTION,1
CN,INFLUENZA LIKE ILLNESS,1
CN,INFUSION RELATED REACTION,1
CN,INJECTION SITE INDURATION,1
CN,INJECTION SITE PAIN,1
CN,INJECTION SITE RASH,1
CN,INJURY,1
CN,INSULIN RESISTANCE,1
CN,INTRA-ABDOMINAL HAEMORRHAGE,1
CN,JAUNDICE,1
CN,JOINT DISLOCATION,1
CN,KARNOFSKY SCALE WORSENED,1
CN,KETOSIS,1
CN,KIDNEY INFECTION,1
CN,LACRIMATION INCREASED,1
CN,LACUNAR STROKE,1
CN,LARGE INTESTINE POLYP,1
CN,LEFT ATRIAL DILATATION,1
CN,LEFT VENTRICULAR DYSFUNCTION,1
CN,LEUKAEMIA RECURRENT,1
CN,LIBIDO DECREASED,1
CN,LIMB DISCOMFORT,1
CN,LIMB INJURY,1
CN,LIP DISCOLOURATION,1
CN,LIPID METABOLISM DISORDER,1
CN,LIPIDS ABNORMAL,1
CN,LIPIDS DECREASED,1
CN,LIVER FUNCTION TEST INCREASED,1
CN,LOCALISED INFECTION,1
CN,LUMBAR VERTEBRAL FRACTURE,1
CN,LUNG CANCER METASTATIC,1
CN,LYMPHOCYTE COUNT DECREASED,1
CN,MACULOPATHY,1
CN,MANIA,1
CN,MARASMUS,1
CN,MATERNAL EXPOSURE BEFORE PREGNANCY,1
CN,MELAENA,1
CN,MEMORY IMPAIRMENT,1
CN,MENTAL DISORDER,1
CN,MENTAL IMPAIRMENT,1
CN,MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS,1
CN,METABOLIC DISORDER,1
CN,METABOLIC SYNDROME,1
CN,METAL POISONING,1
CN,MUSCLE INJURY,1
CN,MUSCLE TWITCHING,1
CN,MYELODYSPLASTIC SYNDROME,1
CN,MYOCARDIAL NECROSIS MARKER INCREASED,1
CN,NASAL OBSTRUCTION,1
CN,NASAL OPERATION,1
CN,NASAL POLYPS,1
CN,NEOPLASM,1
CN,NEOPLASM PROGRESSION,1
CN,NEPHROPATHY TOXIC,1
CN,NEPHROTIC SYNDROME,1
CN,NERVE INJURY,1
CN,NEUTROPHIL COUNT DECREASED,1
CN,NEUTROPHIL COUNT INCREASED,1
CN,NOCTURIA,1
CN,NORMAL NEWBORN,1
CN,OCULAR DISCOMFORT,1
CN,OCULAR HYPERAEMIA,1
CN,OCULAR VASCULAR DISORDER,1
CN,OEDEMA PERIPHERAL,1
CN,OLIGURIA,1
CN,OPEN ANGLE GLAUCOMA,1
CN,OROPHARYNGEAL PAIN,1
CN,OSTEOPOROTIC FRACTURE,1
CN,PALLOR,1
CN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CN,PANCREATIC CARCINOMA,1
CN,PANCREATITIS ACUTE,1
CN,PANCYTOPENIA,1
CN,PAPILLOEDEMA,1
CN,PARAESTHESIA,1
CN,PARALYSIS,1
CN,PCO2 INCREASED,1
CN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CN,PERIPHERAL SWELLING,1
CN,PERIPHERAL VASCULAR DISORDER,1
CN,PERITONSILLAR ABSCESS,1
CN,PHARYNGEAL DISORDER,1
CN,PHOTOSENSITIVITY REACTION,1
CN,PO2 DECREASED,1
CN,POLYCYSTIC OVARIES,1
CN,POLYDIPSIA,1
CN,POLYURIA,1
CN,POOR QUALITY SLEEP,1
CN,PREGNANCY ON CONTRACEPTIVE,1
CN,PRESCRIBED OVERDOSE,1
CN,PRODUCTIVE COUGH,1
CN,PROTEIN URINE,1
CN,PROTEIN URINE PRESENT,1
CN,PSORIASIS,1
CN,PULMONARY CONGESTION,1
CN,PULMONARY HYPERTENSION,1
CN,PULSE ABSENT,1
CN,QUALITY OF LIFE DECREASED,1
CN,RASH PUSTULAR,1
CN,RECTAL POLYP,1
CN,REGURGITATION,1
CN,RESPIRATORY DISTRESS,1
CN,RESPIRATORY FAILURE,1
CN,RESPIRATORY TRACT INFECTION,1
CN,RETINAL DEGENERATION,1
CN,RETINAL DISORDER,1
CN,RETINOPATHY,1
CN,RHEUMATOID ARTHRITIS,1
CN,RHINITIS,1
CN,RHINORRHOEA,1
CN,RIB FRACTURE,1
CN,SENSE OF OPPRESSION,1
CN,SENSORY DISTURBANCE,1
CN,SINUSITIS,1
CN,SKIN ULCER,1
CN,SLOW RESPONSE TO STIMULI,1
CN,STENT PLACEMENT,1
CN,STRESS FRACTURE,1
CN,SURGERY,1
CN,SYNOVIAL CYST,1
CN,TACHYCARDIA,1
CN,THALAMUS HAEMORRHAGE,1
CN,THROMBOCYTOPENIC PURPURA,1
CN,THYMOMA MALIGNANT,1
CN,TIBIA FRACTURE,1
CN,TOXIC EPIDERMAL NECROLYSIS,1
CN,TRACHOMA,1
CN,TRANSIENT ISCHAEMIC ATTACK,1
CN,TREATMENT NONCOMPLIANCE,1
CN,TUBERCULOUS PLEURISY,1
CN,UPPER RESPIRATORY TRACT INFECTION,1
CN,URETERAL STENT INSERTION,1
CN,URINARY HESITATION,1
CN,URINARY TRACT DISORDER,1
CN,URINARY TRACT INFECTION,1
CN,URINARY TRACT INFECTION BACTERIAL,1
CN,UROGENITAL INFECTION FUNGAL,1
CN,VARICOSE ULCERATION,1
CN,VERTEBROBASILAR INSUFFICIENCY,1
CN,WEIGHT ABNORMAL,1
CN,WEIGHT FLUCTUATION,1
CN,WHEEZING,1
CN,WHITE BLOOD CELL COUNT DECREASED,1
CN,WRONG DRUG ADMINISTERED,1
CO,DIZZINESS,37
CO,MALAISE,37
CO,HEADACHE,36
CO,BLOOD GLUCOSE INCREASED,34
CO,DIARRHOEA,33
CO,VOMITING,32
CO,PAIN,30
CO,PYREXIA,30
CO,PAIN IN EXTREMITY,24
CO,URINARY TRACT INFECTION,24
CO,ABDOMINAL PAIN,23
CO,ASTHENIA,23
CO,ARTHRALGIA,21
CO,WEIGHT DECREASED,21
CO,PLATELET COUNT DECREASED,20
CO,VISUAL IMPAIRMENT,20
CO,NAUSEA,19
CO,COUGH,18
CO,HYPERGLYCAEMIA,18
CO,DYSPNOEA,16
CO,FATIGUE,16
CO,VISION BLURRED,16
CO,DRUG INEFFECTIVE,15
CO,BACK PAIN,14
CO,HYPERTENSION,14
CO,ABDOMINAL PAIN UPPER,13
CO,DEATH,13
CO,DIABETES MELLITUS,13
CO,GAIT DISTURBANCE,13
CO,INFLAMMATION,13
CO,ANAEMIA,12
CO,BLINDNESS,12
CO,DECREASED APPETITE,12
CO,CHEST PAIN,11
CO,EYE HAEMORRHAGE,11
CO,FALL,11
CO,HAEMOGLOBIN DECREASED,11
CO,INFLUENZA,11
CO,PNEUMONIA,11
CO,CEREBROVASCULAR ACCIDENT,10
CO,DEPRESSED MOOD,10
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,10
CO,MALIGNANT NEOPLASM PROGRESSION,10
CO,ABDOMINAL DISTENSION,9
CO,GENERAL PHYSICAL HEALTH DETERIORATION,9
CO,MOBILITY DECREASED,9
CO,BLOOD PRESSURE INCREASED,8
CO,BONE PAIN,8
CO,CARDIAC FAILURE,8
CO,CATARACT,8
CO,DEPRESSION,8
CO,ERYTHEMA,8
CO,PERIPHERAL SWELLING,8
CO,RASH,8
CO,RENAL DISORDER,8
CO,ACUTE MYOCARDIAL INFARCTION,7
CO,ASPHYXIA,7
CO,BLOOD CREATININE INCREASED,7
CO,CHOLELITHIASIS,7
CO,FEELING ABNORMAL,7
CO,HYPOGLYCAEMIA,7
CO,INCORRECT DOSE ADMINISTERED,7
CO,INFARCTION,7
CO,LOSS OF CONSCIOUSNESS,7
CO,MUSCLE SPASMS,7
CO,PULMONARY OEDEMA,7
CO,ROAD TRAFFIC ACCIDENT,7
CO,BLOOD GLUCOSE ABNORMAL,6
CO,CARDIO-RESPIRATORY ARREST,6
CO,CHOKING,6
CO,EYE PAIN,6
CO,GLAUCOMA,6
CO,HYPERHIDROSIS,6
CO,HYPERTENSIVE CRISIS,6
CO,HYPOAESTHESIA,6
CO,NEPHROLITHIASIS,6
CO,OROPHARYNGEAL PAIN,6
CO,RENAL FAILURE,6
CO,ABDOMINAL DISCOMFORT,5
CO,BLOOD URINE PRESENT,5
CO,CARDIAC DISORDER,5
CO,CHILLS,5
CO,FEEDING DISORDER,5
CO,FEELING OF DESPAIR,5
CO,FLUID RETENTION,5
CO,HAEMATURIA,5
CO,HYPOTENSION,5
CO,INFECTION,5
CO,INSOMNIA,5
CO,LUNG DISORDER,5
CO,MUSCULOSKELETAL PAIN,5
CO,MYOCARDIAL INFARCTION,5
CO,OEDEMA PERIPHERAL,5
CO,OSTEOARTHRITIS,5
CO,PSORIASIS,5
CO,PSYCHIATRIC SYMPTOM,5
CO,RENAL IMPAIRMENT,5
CO,RESPIRATORY DISTRESS,5
CO,SOMNOLENCE,5
CO,SYNCOPE,5
CO,VIRAL INFECTION,5
CO,ACNE,4
CO,ANXIETY,4
CO,ARTHRITIS,4
CO,BLINDNESS UNILATERAL,4
CO,BLOOD GLUCOSE DECREASED,4
CO,BLOOD PRESSURE DECREASED,4
CO,BLOOD TRIGLYCERIDES INCREASED,4
CO,CELLULITIS,4
CO,CONSTIPATION,4
CO,CONTRAINDICATED PRODUCT ADMINISTERED,4
CO,DIABETIC FOOT,4
CO,DISCOMFORT,4
CO,DYSURIA,4
CO,EATING DISORDER,4
CO,EPISTAXIS,4
CO,FEELING HOT,4
CO,GASTROENTERITIS,4
CO,GASTROINTESTINAL HAEMORRHAGE,4
CO,HEPATIC CIRRHOSIS,4
CO,JAUNDICE,4
CO,JOINT SWELLING,4
CO,MYALGIA,4
CO,NEOPLASM PROGRESSION,4
CO,OCULAR HYPERAEMIA,4
CO,PRODUCT USE IN UNAPPROVED INDICATION,4
CO,RESPIRATORY FAILURE,4
CO,RETINAL DETACHMENT,4
CO,SKIN LESION,4
CO,SKIN ULCER,4
CO,SOFT TISSUE INFECTION,4
CO,STOMATITIS,4
CO,TACHYCARDIA,4
CO,THYROID DISORDER,4
CO,VERTIGO,4
CO,ACUTE MYELOID LEUKAEMIA,3
CO,ANGINA UNSTABLE,3
CO,ARRHYTHMIA,3
CO,ARTERIAL OCCLUSIVE DISEASE,3
CO,BLISTER,3
CO,BLOOD CHOLESTEROL INCREASED,3
CO,BLOOD GROWTH HORMONE INCREASED,3
CO,BRONCHITIS,3
CO,CONCOMITANT DISEASE AGGRAVATED,3
CO,CONTUSION,3
CO,DEEP VEIN THROMBOSIS,3
CO,DEHYDRATION,3
CO,DRUG EFFECT DECREASED,3
CO,EXPOSURE DURING BREAST FEEDING,3
CO,EYE IRRITATION,3
CO,FEELING COLD,3
CO,GAIT INABILITY,3
CO,GASTRITIS,3
CO,GOITRE,3
CO,HEAD INJURY,3
CO,HEART RATE DECREASED,3
CO,HEPATIC STEATOSIS,3
CO,HYPOKALAEMIA,3
CO,INSULIN-LIKE GROWTH FACTOR INCREASED,3
CO,INTESTINAL OBSTRUCTION,3
CO,LIVER DISORDER,3
CO,LOCAL SWELLING,3
CO,MENTAL DISORDER,3
CO,MOVEMENT DISORDER,3
CO,PARAESTHESIA,3
CO,PETECHIAE,3
CO,PLATELET COUNT INCREASED,3
CO,PLEURAL EFFUSION,3
CO,PRODUCTIVE COUGH,3
CO,PRURITUS,3
CO,RENAL FAILURE CHRONIC,3
CO,SLEEP DISORDER,3
CO,SWELLING,3
CO,TENSION,3
CO,THROMBOSIS,3
CO,TUMOUR MARKER INCREASED,3
CO,VISUAL ACUITY REDUCED,3
CO,VITREOUS FLOATERS,3
CO,WHITE BLOOD CELL COUNT INCREASED,3
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
CO,ABDOMINAL MASS,2
CO,AGGRESSION,2
CO,AMNESIA,2
CO,ARTERIOSCLEROSIS,2
CO,ASCITES,2
CO,BACTERAEMIA,2
CO,BLOOD CORTISOL INCREASED,2
CO,BLOOD IRON INCREASED,2
CO,BLOOD PRESSURE ABNORMAL,2
CO,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
CO,BLOOD TEST ABNORMAL,2
CO,BONE MARROW DISORDER,2
CO,BREAST CANCER,2
CO,BREAST CYST,2
CO,BREAST DISCHARGE,2
CO,BURNING SENSATION,2
CO,CACHEXIA,2
CO,CARDIAC FAILURE CONGESTIVE,2
CO,CARPAL TUNNEL SYNDROME,2
CO,CEREBRAL HAEMORRHAGE,2
CO,CHOKING SENSATION,2
CO,CHOLECYSTECTOMY,2
CO,CHOLECYSTITIS,2
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CO,COAGULOPATHY,2
CO,COLON NEOPLASM,2
CO,CONDITION AGGRAVATED,2
CO,CORONARY ARTERY DISEASE,2
CO,CRANIOCEREBRAL INJURY,2
CO,CYTOGENETIC ANALYSIS ABNORMAL,2
CO,DECREASED IMMUNE RESPONSIVENESS,2
CO,DIABETIC NEPHROPATHY,2
CO,DIABETIC RETINOPATHY,2
CO,DIARRHOEA HAEMORRHAGIC,2
CO,DISORIENTATION,2
CO,DRUG INTOLERANCE,2
CO,DRY SKIN,2
CO,DYSARTHRIA,2
CO,DYSLIPIDAEMIA,2
CO,DYSSTASIA,2
CO,EAR PAIN,2
CO,EYE DISORDER,2
CO,EYE INFLAMMATION,2
CO,FINGER DEFORMITY,2
CO,GALLBLADDER DISORDER,2
CO,GANGRENE,2
CO,GASTRIC ULCER,2
CO,GASTRITIS EROSIVE,2
CO,GENERALISED OEDEMA,2
CO,GLUCOSE TOLERANCE IMPAIRED,2
CO,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
CO,HAEMANGIOMA,2
CO,HAEMATEMESIS,2
CO,HAEMOGLOBIN ABNORMAL,2
CO,HAEMOPTYSIS,2
CO,HAEMORRHAGE,2
CO,HEAD DISCOMFORT,2
CO,HEMIPLEGIA,2
CO,HEPATECTOMY,2
CO,HEPATIC CANCER,2
CO,HEPATIC FAILURE,2
CO,HEPATOMEGALY,2
CO,HYPERSENSITIVITY,2
CO,HYPERSOMNIA,2
CO,HYPONATRAEMIA,2
CO,HYPOTHYROIDISM,2
CO,IMMUNE SYSTEM DISORDER,2
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
CO,JOINT INJURY,2
CO,LACTIC ACIDOSIS,2
CO,MASS,2
CO,MATERNAL EXPOSURE DURING PREGNANCY,2
CO,METABOLIC DISORDER,2
CO,METASTASES TO LIVER,2
CO,METASTASES TO LUNG,2
CO,MOUTH HAEMORRHAGE,2
CO,MOUTH ULCERATION,2
CO,MUSCULAR WEAKNESS,2
CO,MYELOFIBROSIS,2
CO,NASOPHARYNGITIS,2
CO,NEOPLASM,2
CO,NERVOUS SYSTEM DISORDER,2
CO,NEUTROPHIL COUNT DECREASED,2
CO,OBESITY,2
CO,OPTIC NERVE DISORDER,2
CO,PALLOR,2
CO,PERICARDIAL EFFUSION,2
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
CO,PHARYNGITIS,2
CO,PHOTOPHOBIA,2
CO,POLYNEUROPATHY,2
CO,POSTOPERATIVE WOUND INFECTION,2
CO,PRODUCT USE ISSUE,2
CO,PTERYGIUM,2
CO,PULMONARY EMBOLISM,2
CO,RECTAL HAEMORRHAGE,2
CO,RESPIRATORY ARREST,2
CO,RETINAL HAEMORRHAGE,2
CO,RHEUMATOID ARTHRITIS,2
CO,RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION,2
CO,ROTATOR CUFF SYNDROME,2
CO,SALIVARY HYPERSECRETION,2
CO,SECOND PRIMARY MALIGNANCY,2
CO,SEIZURE,2
CO,SKIN DISCOLOURATION,2
CO,SKIN EXFOLIATION,2
CO,SKIN TOXICITY,2
CO,SLEEP APNOEA SYNDROME,2
CO,SPEECH DISORDER,2
CO,SPINAL COLUMN INJURY,2
CO,STOOL ANALYSIS ABNORMAL,2
CO,SUPERINFECTION,2
CO,SWELLING FACE,2
CO,SYNOVIAL CYST,2
CO,THROMBOCYTOPENIC PURPURA,2
CO,TOOTH EXTRACTION,2
CO,TOOTH LOSS,2
CO,TUMOUR RUPTURE,2
CO,TYPE 2 DIABETES MELLITUS,2
CO,UPPER LIMB FRACTURE,2
CO,URINARY INCONTINENCE,2
CO,VARICES OESOPHAGEAL,2
CO,VENOUS OCCLUSION,2
CO,WEIGHT INCREASED,2
CO,WHITE BLOOD CELL COUNT DECREASED,2
CO,WOUND,2
CO,YELLOW SKIN,2
CO,ABDOMINAL NEOPLASM,1
CO,ABDOMINAL PAIN LOWER,1
CO,ABDOMINOPLASTY,1
CO,ABORTION THREATENED,1
CO,ABSCESS,1
CO,ACCIDENT,1
CO,ACQUIRED CLAW TOE,1
CO,ACUTE CORONARY SYNDROME,1
CO,ADVERSE EVENT,1
CO,AFFECTIVE DISORDER,1
CO,AGITATION,1
CO,ALOPECIA,1
CO,AMOEBIASIS,1
CO,ANAL ABSCESS,1
CO,ANAL HAEMORRHAGE,1
CO,ANAPHYLACTIC REACTION,1
CO,ANGINA PECTORIS,1
CO,ANGLE CLOSURE GLAUCOMA,1
CO,AORTIC ANEURYSM,1
CO,AORTIC ARTERIOSCLEROSIS,1
CO,AORTIC CALCIFICATION,1
CO,APHASIA,1
CO,APHONIA,1
CO,APNOEA,1
CO,APPARENT DEATH,1
CO,ARTERIAL THROMBOSIS,1
CO,ARTHROPATHY,1
CO,ATRIAL FIBRILLATION,1
CO,BACTERIAL INFECTION,1
CO,BENIGN NEOPLASM OF OPTIC NERVE,1
CO,BILE DUCT OBSTRUCTION,1
CO,BILE DUCT STONE,1
CO,BILIARY CYST,1
CO,BIOPSY SITE UNSPECIFIED ABNORMAL,1
CO,BLADDER MASS,1
CO,BLOOD CALCIUM ABNORMAL,1
CO,BLOOD CHROMOGRANIN A INCREASED,1
CO,BLOOD CORTICOTROPHIN ABNORMAL,1
CO,BLOOD DISORDER,1
CO,BLOOD GLUCOSE FLUCTUATION,1
CO,BLOOD GROWTH HORMONE ABNORMAL,1
CO,BLOOD POTASSIUM ABNORMAL,1
CO,BLOOD PRESSURE FLUCTUATION,1
CO,BLOOD PRESSURE SYSTOLIC INCREASED,1
CO,BLOOD SODIUM DECREASED,1
CO,BLOOD URIC ACID INCREASED,1
CO,BLOOD VISCOSITY ABNORMAL,1
CO,BONE CANCER,1
CO,BONE DISORDER,1
CO,BRAIN NEOPLASM,1
CO,BREAST PAIN,1
CO,BRONCHIAL DISORDER,1
CO,CALCIUM DEFICIENCY,1
CO,CALCULUS URINARY,1
CO,CARBOHYDRATE INTOLERANCE,1
CO,CARDIAC ARREST,1
CO,CARDIAC TAMPONADE,1
CO,CARDIOMEGALY,1
CO,CATARACT OPERATION,1
CO,CATHETER PLACEMENT,1
CO,CD4 LYMPHOCYTES INCREASED,1
CO,CEREBRAL HAEMATOMA,1
CO,CEREBRAL INFARCTION,1
CO,CEREBRAL ISCHAEMIA,1
CO,CHEILITIS,1
CO,CHEST DISCOMFORT,1
CO,CHOLECYSTITIS ACUTE,1
CO,CHOLECYSTITIS INFECTIVE,1
CO,CHRONIC GASTRITIS,1
CO,CHRONIC KIDNEY DISEASE,1
CO,CHRONIC MYELOID LEUKAEMIA,1
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CO,COLD SWEAT,1
CO,COLITIS,1
CO,COLONIC ABSCESS,1
CO,COMA,1
CO,COMA SCALE,1
CO,CONFUSIONAL STATE,1
CO,CONGENITAL INGUINAL HERNIA,1
CO,CONGESTIVE CARDIOMYOPATHY,1
CO,CONJUNCTIVAL HAEMORRHAGE,1
CO,COORDINATION ABNORMAL,1
CO,CORNEAL DISORDER,1
CO,CORONARY ARTERY OCCLUSION,1
CO,CROHN^S DISEASE,1
CO,DEAFNESS,1
CO,DEAFNESS UNILATERAL,1
CO,DELIRIUM,1
CO,DEMENTIA,1
CO,DENGUE FEVER,1
CO,DERMATITIS ACNEIFORM,1
CO,DERMATITIS ALLERGIC,1
CO,DEVICE EXPULSION,1
CO,DEVICE ISSUE,1
CO,DIABETES MELLITUS INADEQUATE CONTROL,1
CO,DIABETIC COMA,1
CO,DIABETIC COMPLICATION,1
CO,DIABETIC METABOLIC DECOMPENSATION,1
CO,DIABETIC NEUROPATHY,1
CO,DIVERTICULAR PERFORATION,1
CO,DIVERTICULITIS,1
CO,DIVERTICULUM INTESTINAL,1
CO,DRUG ADMINISTRATION ERROR,1
CO,DRUG DISPENSING ERROR,1
CO,DRUG DOSE OMISSION,1
CO,DRUG HYPERSENSITIVITY,1
CO,DRUG RESISTANCE,1
CO,DRUG THERAPEUTIC INCOMPATIBILITY,1
CO,DRY MOUTH,1
CO,DRY THROAT,1
CO,DYSGEUSIA,1
CO,DYSPAREUNIA,1
CO,DYSPEPSIA,1
CO,DYSPHAGIA,1
CO,ECCHYMOSIS,1
CO,ELECTROLYTE DEPLETION,1
CO,ELECTROLYTE IMBALANCE,1
CO,ELEPHANTIASIS,1
CO,ENCEPHALOPATHY,1
CO,EPILEPSY,1
CO,EROSIVE OESOPHAGITIS,1
CO,ERUCTATION,1
CO,ERYSIPELAS,1
CO,ESSENTIAL HYPERTENSION,1
CO,EXCESSIVE CERUMEN PRODUCTION,1
CO,EXERCISE LACK OF,1
CO,EXOSTOSIS,1
CO,EXTRAPYRAMIDAL DISORDER,1
CO,EXTRAVASATION,1
CO,EYE EXCISION,1
CO,EYE INFECTION,1
CO,EYE MOVEMENT DISORDER,1
CO,EYE SWELLING,1
CO,EYELID DISORDER,1
CO,FEAR,1
CO,FLANK PAIN,1
CO,FLATULENCE,1
CO,FOETAL EXPOSURE DURING PREGNANCY,1
CO,FOOD ALLERGY,1
CO,FOOD POISONING,1
CO,FOOT DEFORMITY,1
CO,FOREIGN BODY IN RESPIRATORY TRACT,1
CO,FOREIGN BODY SENSATION IN EYES,1
CO,FREQUENT BOWEL MOVEMENTS,1
CO,FULL BLOOD COUNT ABNORMAL,1
CO,FULL BLOOD COUNT DECREASED,1
CO,FUNGAL INFECTION,1
CO,FURUNCLE,1
CO,GALLBLADDER INJURY,1
CO,GALLBLADDER PAIN,1
CO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CO,GASTRIC BYPASS,1
CO,GASTRIC CANCER,1
CO,GASTRIC DISORDER,1
CO,GASTRIC ULCER HAEMORRHAGE,1
CO,GASTROINTESTINAL DISORDER,1
CO,GASTROINTESTINAL FISTULA,1
CO,GENE MUTATION,1
CO,GENITAL DISCOMFORT,1
CO,GINGIVAL ABSCESS,1
CO,GLUCOSE TOLERANCE INCREASED,1
CO,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
CO,GROIN PAIN,1
CO,HAEMARTHROSIS,1
CO,HAEMATOCHEZIA,1
CO,HAEMATOCRIT DECREASED,1
CO,HAEMOBILIA,1
CO,HAEMORRHAGE INTRACRANIAL,1
CO,HAEMORRHAGE URINARY TRACT,1
CO,HAEMORRHAGIC OVARIAN CYST,1
CO,HAEMORRHOIDS,1
CO,HAND DEFORMITY,1
CO,HEART VALVE STENOSIS,1
CO,HELICOBACTER GASTRITIS,1
CO,HELICOBACTER INFECTION,1
CO,HEMIPARESIS,1
CO,HEPATIC ADENOMA,1
CO,HEPATIC ENZYME ABNORMAL,1
CO,HEPATIC LESION,1
CO,HEPATIC PAIN,1
CO,HEPATITIS,1
CO,HEPATOBILIARY DISEASE,1
CO,HERPES ZOSTER INFECTION NEUROLOGICAL,1
CO,HIGH DENSITY LIPOPROTEIN DECREASED,1
CO,HORMONE LEVEL ABNORMAL,1
CO,HOSPITALISATION,1
CO,HYPERKALAEMIA,1
CO,HYPERTENSIVE CARDIOMYOPATHY,1
CO,HYPERTENSIVE ENCEPHALOPATHY,1
CO,HYPERTENSIVE HEART DISEASE,1
CO,HYPERTENSIVE NEPHROPATHY,1
CO,HYPOACUSIS,1
CO,HYPOPHAGIA,1
CO,HYPOPHYSITIS,1
CO,HYPOPITUITARISM,1
CO,HYPOTHERMIA,1
CO,HYPOVENTILATION,1
CO,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CO,IMMUNODEFICIENCY,1
CO,IMMUNOSUPPRESSION,1
CO,IMPAIRED HEALING,1
CO,INCORRECT PRODUCT FORMULATION ADMINISTERED,1
CO,INFECTED VARICOSE VEIN,1
CO,INFLUENZA LIKE ILLNESS,1
CO,INFREQUENT BOWEL MOVEMENTS,1
CO,INFUSION RELATED REACTION,1
CO,INGROWING NAIL,1
CO,INJECTION SITE BRUISING,1
CO,INJECTION SITE HYPERSENSITIVITY,1
CO,INJECTION SITE MASS,1
CO,INJECTION SITE PAIN,1
CO,INJURY,1
CO,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
CO,INTERVERTEBRAL DISC COMPRESSION,1
CO,INTERVERTEBRAL DISC PROTRUSION,1
CO,INTESTINAL ISCHAEMIA,1
CO,INTRAOCULAR PRESSURE INCREASED,1
CO,INTRAOCULAR PRESSURE TEST ABNORMAL,1
CO,INVASIVE LOBULAR BREAST CARCINOMA,1
CO,IRRITABILITY,1
CO,IRRITABLE BOWEL SYNDROME,1
CO,ISCHAEMIC CARDIOMYOPATHY,1
CO,ISCHAEMIC STROKE,1
CO,JAW DISORDER,1
CO,JOINT DISLOCATION,1
CO,JOINT EFFUSION,1
CO,JOINT RANGE OF MOTION DECREASED,1
CO,KIDNEY INFECTION,1
CO,KIDNEY TRANSPLANT REJECTION,1
CO,LABORATORY TEST ABNORMAL,1
CO,LACERATION,1
CO,LACRIMATION INCREASED,1
CO,LARGE INTESTINAL ULCER,1
CO,LEFT VENTRICULAR DILATATION,1
CO,LEG AMPUTATION,1
CO,LEIOMYOMA,1
CO,LEUKOCYTOSIS,1
CO,LEUKOCYTURIA,1
CO,LEUKOPENIA,1
CO,LIMB DISCOMFORT,1
CO,LIMB INJURY,1
CO,LIMB MASS,1
CO,LIP DRY,1
CO,LIVER INJURY,1
CO,LOCALISED OEDEMA,1
CO,LOWER LIMB FRACTURE,1
CO,LUMBAR SPINAL STENOSIS,1
CO,LUNG CONSOLIDATION,1
CO,LUNG INFECTION,1
CO,LUNG NEOPLASM MALIGNANT,1
CO,LYMPHADENOPATHY,1
CO,LYMPHOPENIA,1
CO,MAJOR DEPRESSION,1
CO,MALIGNANT MELANOMA OF SITES OTHER THAN SKIN,1
CO,MASTICATION DISORDER,1
CO,MEMORY IMPAIRMENT,1
CO,MENISCUS INJURY,1
CO,METABOLIC SYNDROME,1
CO,METAPLASTIC BREAST CARCINOMA,1
CO,METASTASES TO BONE,1
CO,METASTASES TO HEART,1
CO,METASTASES TO PELVIS,1
CO,METASTASIS,1
CO,MOUTH INJURY,1
CO,MULTI-ORGAN FAILURE,1
CO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CO,MUSCLE STRAIN,1
CO,MUSCLE TIGHTNESS,1
CO,MUSCULOSKELETAL STIFFNESS,1
CO,MYOCARDIAL ISCHAEMIA,1
CO,NAIL DISCOLOURATION,1
CO,NAIL INJURY,1
CO,NASAL INFLAMMATION,1
CO,NECK PAIN,1
CO,NEOPLASM MALIGNANT,1
CO,NEOPLASM RECURRENCE,1
CO,NEPHROSCLEROSIS,1
CO,NERVOUSNESS,1
CO,NEUROENDOCRINE TUMOUR,1
CO,NEUROPATHY PERIPHERAL,1
CO,NEUROPSYCHIATRIC SYNDROME,1
CO,NONINFECTIVE GINGIVITIS,1
CO,OBSTRUCTIVE PANCREATITIS,1
CO,OCULAR DISCOMFORT,1
CO,OCULAR VASCULAR DISORDER,1
CO,OEDEMA,1
CO,OEDEMATOUS KIDNEY,1
CO,OLIGURIA,1
CO,ONCOLOGIC COMPLICATION,1
CO,ONYCHOCLASIS,1
CO,ONYCHOMADESIS,1
CO,OPHTHALMIC HERPES SIMPLEX,1
CO,ORCHITIS,1
CO,ORCHITIS NONINFECTIVE,1
CO,OROPHARYNGEAL PLAQUE,1
CO,OSTEOCHONDRITIS,1
CO,OSTEOMYELITIS CHRONIC,1
CO,OSTEOSCLEROSIS,1
CO,OVARIAN CYST,1
CO,OVARIAN NEOPLASM,1
CO,OVERDOSE,1
CO,PAIN IN JAW,1
CO,PANCREATIC NEUROENDOCRINE TUMOUR,1
CO,PANCREATITIS,1
CO,PANCREATOLITHIASIS,1
CO,PANCYTOPENIA,1
CO,PAPILLARY THYROID CANCER,1
CO,PARAESTHESIA ORAL,1
CO,PARKINSON^S DISEASE,1
CO,PELVIC PAIN,1
CO,PEMPHIGUS,1
CO,PERICARDIAL HAEMORRHAGE,1
CO,PERIORBITAL CONTUSION,1
CO,PERIPHERAL ARTERY STENOSIS,1
CO,PERIPHERAL VASCULAR DISORDER,1
CO,PERIPHERAL VENOUS DISEASE,1
CO,PHANTOM PAIN,1
CO,PITUITARY TUMOUR BENIGN,1
CO,PLATELET COUNT ABNORMAL,1
CO,PLEURITIC PAIN,1
CO,PNEUMONIA ASPIRATION,1
CO,PNEUMONIA BACTERIAL,1
CO,PNEUMONITIS,1
CO,POLLAKIURIA,1
CO,POLYMEDICATION,1
CO,POOR PERIPHERAL CIRCULATION,1
CO,POOR QUALITY SLEEP,1
CO,PRE-ECLAMPSIA,1
CO,PRESBYACUSIS,1
CO,PROCEDURAL COMPLICATION,1
CO,PROCEDURAL HAEMORRHAGE,1
CO,PROCEDURAL PAIN,1
CO,PRODUCT QUALITY ISSUE,1
CO,PRODUCT SUPPLY ISSUE,1
CO,PROGNATHISM,1
CO,PROSTATE CANCER,1
CO,PROSTATE CANCER METASTATIC,1
CO,PROSTATIC DISORDER,1
CO,PROSTATIC OBSTRUCTION,1
CO,PROSTATITIS,1
CO,PROSTATOMEGALY,1
CO,PROTEINURIA,1
CO,PRURITUS ALLERGIC,1
CO,PRURITUS GENERALISED,1
CO,PULMONARY ARTERIAL HYPERTENSION,1
CO,PULMONARY CONGESTION,1
CO,PULMONARY FUNCTION TEST ABNORMAL,1
CO,PULMONARY PAIN,1
CO,PULMONARY THROMBOSIS,1
CO,PULPITIS DENTAL,1
CO,PURULENCE,1
CO,PURULENT DISCHARGE,1
CO,PYODERMA GANGRENOSUM,1
CO,RADIATION SKIN INJURY,1
CO,RADIUS FRACTURE,1
CO,RASH PUSTULAR,1
CO,RECURRENT CANCER,1
CO,RENAL ANEURYSM,1
CO,RENAL CYST,1
CO,RENAL FUNCTION TEST ABNORMAL,1
CO,RENAL HYPERTENSION,1
CO,RENAL MASS,1
CO,RENAL TUBERCULOSIS,1
CO,RESPIRATORY DISORDER,1
CO,RESPIRATORY TRACT INFECTION,1
CO,RESTLESSNESS,1
CO,RETINAL DEPIGMENTATION,1
CO,RETINAL DISORDER,1
CO,RHEUMATOID NODULE,1
CO,SALIVA ALTERED,1
CO,SELF INJURIOUS BEHAVIOUR,1
CO,SELF-INJURIOUS IDEATION,1
CO,SEPSIS,1
CO,SEROTONIN SYNDROME,1
CO,SEROUS CYSTADENOCARCINOMA OVARY,1
CO,SERUM FERRITIN INCREASED,1
CO,SINUS BRADYCARDIA,1
CO,SKIN HAEMORRHAGE,1
CO,SKIN INJURY,1
CO,SKIN WRINKLING,1
CO,SLOW SPEECH,1
CO,SNORING,1
CO,SPINAL CORD INJURY,1
CO,SPINAL OSTEOARTHRITIS,1
CO,SPINAL PAIN,1
CO,SQUAMOUS CELL CARCINOMA,1
CO,STAB WOUND,1
CO,STAPHYLOCOCCAL INFECTION,1
CO,STITCH ABSCESS,1
CO,STRABISMUS CORRECTION,1
CO,SUBCUTANEOUS ABSCESS,1
CO,SUBCUTANEOUS HAEMATOMA,1
CO,SUBDURAL HAEMATOMA,1
CO,TENDON INJURY,1
CO,TENDON RUPTURE,1
CO,TERMINAL STATE,1
CO,TESTICULAR PAIN,1
CO,THERAPY CESSATION,1
CO,THERMAL BURN,1
CO,THIRST,1
CO,THROMBOCYTOPENIA,1
CO,THROMBOPHLEBITIS,1
CO,THYROID CANCER,1
CO,TIBIA FRACTURE,1
CO,TONGUE BITING,1
CO,TONSILLAR INFLAMMATION,1
CO,TONSILLITIS,1
CO,TOOTH DEPOSIT,1
CO,TOOTH INFECTION,1
CO,TOOTHACHE,1
CO,TRANSFUSION,1
CO,TRANSIENT ISCHAEMIC ATTACK,1
CO,TRAUMATIC HAEMATOMA,1
CO,TRAUMATIC LUNG INJURY,1
CO,TREATMENT NONCOMPLIANCE,1
CO,TREMOR,1
CO,TUBERCULOSIS,1
CO,TUMOUR HAEMORRHAGE,1
CO,UMBILICAL HERNIA,1
CO,UNEVALUABLE EVENT,1
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,1
CO,URINARY RETENTION,1
CO,URINARY TRACT INFECTION BACTERIAL,1
CO,URINARY TRACT OBSTRUCTION,1
CO,URINE ODOUR ABNORMAL,1
CO,URINE OUTPUT DECREASED,1
CO,UROSEPSIS,1
CO,UTERINE LEIOMYOMA,1
CO,UTERINE PROLAPSE,1
CO,VAGINAL ABSCESS,1
CO,VARICOSE ULCERATION,1
CO,VASCULAR PAIN,1
CO,VASCULAR RUPTURE,1
CO,VASCULITIS,1
CO,VIITH NERVE PARALYSIS,1
CO,VITREOUS HAEMORRHAGE,1
CO,VULVOVAGINAL INFLAMMATION,1
CO,WHEEZING,1
CO,WOUND SECRETION,1
CO,WRIST FRACTURE,1
CO,ZIKA VIRUS INFECTION,1
CD,CARDIOGENIC SHOCK,1
CD,DIARRHOEA,1
CD,SUPRAVENTRICULAR EXTRASYSTOLES,1
CD,VENTRICULAR EXTRASYSTOLES,1
CD,VOMITING,1
CR,ARTHRALGIA,5
CR,FATIGUE,5
CR,INSOMNIA,4
CR,MALAISE,4
CR,PAIN,4
CR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
CR,ARRHYTHMIA,3
CR,ASTHENIA,3
CR,BACK PAIN,3
CR,BONE PAIN,3
CR,DIARRHOEA,3
CR,DYSPNOEA,3
CR,HEADACHE,3
CR,HYPERHIDROSIS,3
CR,HYPOACUSIS,3
CR,INFLUENZA,3
CR,PAIN IN EXTREMITY,3
CR,PYREXIA,3
CR,VOMITING,3
CR,ARTHROPATHY,2
CR,BLOOD CHOLESTEROL INCREASED,2
CR,BLOOD GLUCOSE INCREASED,2
CR,BLOOD GROWTH HORMONE INCREASED,2
CR,BLOOD PRESSURE INCREASED,2
CR,CARDIAC DISORDER,2
CR,CEREBROVASCULAR ACCIDENT,2
CR,CHOLELITHIASIS,2
CR,DIZZINESS,2
CR,DRUG HYPERSENSITIVITY,2
CR,DRUG INEFFECTIVE,2
CR,EMOTIONAL DISORDER,2
CR,FEELING ABNORMAL,2
CR,HYPERSENSITIVITY,2
CR,HYPERTENSION,2
CR,HYPOTENSION,2
CR,INFECTION,2
CR,MEMORY IMPAIRMENT,2
CR,NAUSEA,2
CR,NEOPLASM,2
CR,NEOPLASM PROGRESSION,2
CR,PERIPHERAL ISCHAEMIA,2
CR,RASH MACULAR,2
CR,SOMNOLENCE,2
CR,URTICARIA,2
CR,VISION BLURRED,2
CR,VISUAL IMPAIRMENT,2
CR,ABDOMINAL ABSCESS,1
CR,ABDOMINAL DISTENSION,1
CR,ABDOMINAL PAIN,1
CR,ABSCESS,1
CR,ABSCESS LIMB,1
CR,ACUTE MYOCARDIAL INFARCTION,1
CR,ACUTE PULMONARY OEDEMA,1
CR,AFFECTIVE DISORDER,1
CR,AGITATION,1
CR,AGNOSIA,1
CR,APNOEA,1
CR,ASPHYXIA,1
CR,ATRIOVENTRICULAR BLOCK,1
CR,BENIGN BONE NEOPLASM,1
CR,BLOOD CREATININE INCREASED,1
CR,BLOOD TEST ABNORMAL,1
CR,BLOOD TRIGLYCERIDES INCREASED,1
CR,CATARACT,1
CR,CEREBROSPINAL FLUID LEAKAGE,1
CR,CHEST DISCOMFORT,1
CR,CHEST PAIN,1
CR,CHIKUNGUNYA VIRUS INFECTION,1
CR,CHONDROMALACIA,1
CR,CHROMATURIA,1
CR,COLD SWEAT,1
CR,CONCOMITANT DISEASE AGGRAVATED,1
CR,CONDITION AGGRAVATED,1
CR,CONTRAST MEDIA ALLERGY,1
CR,CONTUSION,1
CR,DEAFNESS,1
CR,DECREASED APPETITE,1
CR,DEHYDRATION,1
CR,DENGUE FEVER,1
CR,DEPRESSION,1
CR,DIABETES MELLITUS,1
CR,DISEASE RECURRENCE,1
CR,DISSOCIATION,1
CR,DRUG PRESCRIBING ERROR,1
CR,DYSPHAGIA,1
CR,DYSSTASIA,1
CR,DYSURIA,1
CR,EATING DISORDER,1
CR,EYE DISORDER,1
CR,EYE PAIN,1
CR,EYELID OEDEMA,1
CR,FALL,1
CR,FEAR,1
CR,FEELING COLD,1
CR,FISTULA,1
CR,FLUSHING,1
CR,GAIT INABILITY,1
CR,HAEMATOMA,1
CR,HAEMORRHOIDS,1
CR,HEART RATE DECREASED,1
CR,HEMIPARESIS,1
CR,HYPERGLYCAEMIA,1
CR,HYPOAESTHESIA,1
CR,INCORRECT DRUG ADMINISTRATION DURATION,1
CR,INFARCTION,1
CR,INFLAMMATION,1
CR,INFLUENZA LIKE ILLNESS,1
CR,ISCHAEMIA,1
CR,JAUNDICE,1
CR,JOINT SWELLING,1
CR,KETOACIDOSIS,1
CR,LACRIMATION INCREASED,1
CR,LEUKAEMIA,1
CR,LIGAMENT DISORDER,1
CR,LIMB INJURY,1
CR,LIVER INJURY,1
CR,LUNG NEOPLASM MALIGNANT,1
CR,MIGRAINE,1
CR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CR,MULTIPLE SCLEROSIS,1
CR,MYALGIA,1
CR,MYELOFIBROSIS,1
CR,MYOCARDIAL INFARCTION,1
CR,NASAL CONGESTION,1
CR,NASOPHARYNGITIS,1
CR,NERVOUS SYSTEM DISORDER,1
CR,NO ADVERSE EVENT,1
CR,OBESITY,1
CR,OPTIC NEURITIS,1
CR,PALPITATIONS,1
CR,PARAESTHESIA,1
CR,PHOTOPHOBIA,1
CR,PNEUMONIA,1
CR,PROCEDURAL SITE REACTION,1
CR,PRODUCT STORAGE ERROR,1
CR,PRODUCTIVE COUGH,1
CR,PRURITUS,1
CR,RENAL DISORDER,1
CR,RENAL PAIN,1
CR,RESPIRATORY ARREST,1
CR,RHINORRHOEA,1
CR,SCLERAL DISCOLOURATION,1
CR,SEPSIS,1
CR,SEPTIC SHOCK,1
CR,SEXUAL DYSFUNCTION,1
CR,SIGHT DISABILITY,1
CR,SINUSITIS,1
CR,SKIN FISSURES,1
CR,SKIN LESION,1
CR,SLEEP APNOEA SYNDROME,1
CR,SPEECH DISORDER,1
CR,SUICIDE ATTEMPT,1
CR,SWELLING FACE,1
CR,TACHYCARDIA,1
CR,TACHYPNOEA,1
CR,TERMINAL STATE,1
CR,THROMBOSIS,1
CR,ULCER,1
CR,UTERINE ENLARGEMENT,1
CR,VAGINAL ABSCESS,1
CR,VAGINAL HAEMORRHAGE,1
CR,WEIGHT DECREASED,1
HR,LACTIC ACIDOSIS,11
HR,HYPOGLYCAEMIA,9
HR,ATRIAL FIBRILLATION,8
HR,DIARRHOEA,8
HR,HYPOTHERMIA,8
HR,RENAL FAILURE,8
HR,BRADYCARDIA,7
HR,DYSPNOEA,7
HR,VOMITING,7
HR,ASTHENIA,5
HR,AZOTAEMIA,5
HR,DEHYDRATION,5
HR,DRY SKIN,5
HR,ERYTHEMA,5
HR,GAIT DISTURBANCE,5
HR,HYPOTENSION,5
HR,NEUROPATHY PERIPHERAL,5
HR,OEDEMA,5
HR,PALLOR,5
HR,RESPIRATORY FAILURE,5
HR,SKIN TURGOR DECREASED,5
HR,BLOOD CHLORIDE DECREASED,4
HR,BLOOD PH DECREASED,4
HR,BLOOD POTASSIUM INCREASED,4
HR,CARDIO-RESPIRATORY ARREST,4
HR,LOSS OF CONSCIOUSNESS,4
HR,PAIN,4
HR,PCO2 DECREASED,4
HR,PO2 INCREASED,4
HR,HYPERTROPHIC CARDIOMYOPATHY,3
HR,INTENTIONAL OVERDOSE,3
HR,MITRAL VALVE INCOMPETENCE,3
HR,PLEURAL EFFUSION,3
HR,SUICIDE ATTEMPT,3
HR,SUPRAVENTRICULAR EXTRASYSTOLES,3
HR,TRICUSPID VALVE INCOMPETENCE,3
HR,BLOOD BICARBONATE DECREASED,2
HR,BLOOD BICARBONATE INCREASED,2
HR,CHEST DISCOMFORT,2
HR,COLITIS,2
HR,CONDITION AGGRAVATED,2
HR,DEEP VEIN THROMBOSIS,2
HR,EXERCISE TOLERANCE DECREASED,2
HR,HEADACHE,2
HR,NAUSEA,2
HR,PAIN IN EXTREMITY,2
HR,PALPITATIONS,2
HR,PERIPHERAL SWELLING,2
HR,ABDOMINAL PAIN UPPER,1
HR,AGRANULOCYTOSIS,1
HR,ANAEMIA,1
HR,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
HR,ANGINA PECTORIS,1
HR,ANURIA,1
HR,BACK PAIN,1
HR,BLOOD BILIRUBIN INCREASED,1
HR,BLOOD PRESSURE INCREASED,1
HR,BRADYARRHYTHMIA,1
HR,BRONCHOSPASM PARADOXICAL,1
HR,BURNING SENSATION,1
HR,CARDIAC FAILURE,1
HR,COGNITIVE DISORDER,1
HR,CORONARY ARTERY STENOSIS,1
HR,DEMENTIA,1
HR,DENTAL NECROSIS,1
HR,DIABETIC KETOACIDOSIS,1
HR,DIZZINESS,1
HR,DYSPNOEA EXERTIONAL,1
HR,EPISTAXIS,1
HR,FALL,1
HR,GANGRENE,1
HR,GROIN PAIN,1
HR,HAEMODIALYSIS,1
HR,HEAD INJURY,1
HR,HYPERPHOSPHATAEMIA,1
HR,HYPERTENSION,1
HR,IRON DEFICIENCY ANAEMIA,1
HR,ISCHAEMIC CARDIOMYOPATHY,1
HR,JAUNDICE,1
HR,KETOACIDOSIS,1
HR,LEUKOCYTOSIS,1
HR,METABOLIC ACIDOSIS,1
HR,METASTASES TO LIVER,1
HR,METHAEMOGLOBINAEMIA,1
HR,MUSCULOSKELETAL DISCOMFORT,1
HR,NORMOCYTIC ANAEMIA,1
HR,PARAESTHESIA,1
HR,PARKINSON^S DISEASE,1
HR,PNEUMONIA,1
HR,SOMNOLENCE,1
HR,SYNCOPE,1
HR,TACHYARRHYTHMIA,1
HR,VERTIGO,1
CY,AMYLASE INCREASED,1
CY,BLOOD CREATININE INCREASED,1
CY,CARDIAC ARREST,1
CY,DIARRHOEA,1
CY,GAIT DISTURBANCE,1
CY,GENERAL PHYSICAL HEALTH DETERIORATION,1
CY,LUMBAR VERTEBRAL FRACTURE,1
CY,NAUSEA,1
CY,NYSTAGMUS,1
CY,OSCILLOPSIA,1
CY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CY,PANCREATITIS,1
CY,PENILE ULCERATION,1
CY,RENAL IMPAIRMENT,1
CZ,ACUTE KIDNEY INJURY,89
CZ,LACTIC ACIDOSIS,82
CZ,METABOLIC ACIDOSIS,47
CZ,TOXICITY TO VARIOUS AGENTS,39
CZ,HYPOVOLAEMIA,38
CZ,GASTROINTESTINAL DISORDER,37
CZ,HYPERLACTACIDAEMIA,36
CZ,SYSTEMIC INFECTION,31
CZ,BLOOD CREATININE INCREASED,30
CZ,ANION GAP INCREASED,29
CZ,BLOOD BICARBONATE DECREASED,29
CZ,BLOOD PH DECREASED,28
CZ,CREATININE RENAL CLEARANCE DECREASED,28
CZ,HYPOGLYCAEMIA,28
CZ,PCO2 DECREASED,28
CZ,BASE EXCESS DECREASED,27
CZ,HYPOCAPNIA,27
CZ,DIARRHOEA,26
CZ,BLOOD CHLORIDE DECREASED,25
CZ,VOMITING,24
CZ,BLOOD PHOSPHORUS INCREASED,20
CZ,FALL,18
CZ,BLOOD SODIUM DECREASED,17
CZ,DIABETES MELLITUS INADEQUATE CONTROL,16
CZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,16
CZ,SEPSIS,16
CZ,BLOOD POTASSIUM INCREASED,14
CZ,PO2 INCREASED,14
CZ,DEEP VEIN THROMBOSIS,13
CZ,SEPTIC SHOCK,13
CZ,SHOCK,13
CZ,SYNCOPE,13
CZ,COAGULOPATHY,12
CZ,ENCEPHALOPATHY,12
CZ,MUSCULAR WEAKNESS,12
CZ,MYOCARDIAL INFARCTION,12
CZ,URTICARIA,12
CZ,COMA,11
CZ,VASOPLEGIA SYNDROME,11
CZ,BLOOD MAGNESIUM INCREASED,9
CZ,DIABETIC RETINOPATHY,8
CZ,DRUG INEFFECTIVE,8
CZ,HAEMATURIA,8
CZ,LIVER DISORDER,8
CZ,RENAL FAILURE,8
CZ,BLOOD MAGNESIUM DECREASED,7
CZ,DIABETES MELLITUS,7
CZ,DYSPNOEA,7
CZ,HYPERGLYCAEMIA,7
CZ,HYPOTENSION,7
CZ,WEIGHT INCREASED,7
CZ,ANAEMIA,6
CZ,DEHYDRATION,6
CZ,DIABETIC METABOLIC DECOMPENSATION,6
CZ,DIABETIC NEUROPATHY,5
CZ,DYSPEPSIA,5
CZ,PO2 DECREASED,5
CZ,TACHYPNOEA,5
CZ,ALTERED STATE OF CONSCIOUSNESS,4
CZ,BLOOD POTASSIUM DECREASED,4
CZ,DIABETIC NEPHROPATHY,4
CZ,GASTROENTERITIS,4
CZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
CZ,PERIPHERAL SWELLING,4
CZ,RADIUS FRACTURE,4
CZ,TREATMENT FAILURE,4
CZ,ALCOHOL INTERACTION,3
CZ,ANURIA,3
CZ,BLOOD LACTIC ACID INCREASED,3
CZ,BLOOD PHOSPHORUS DECREASED,3
CZ,CHOLELITHIASIS,3
CZ,CONFUSIONAL STATE,3
CZ,DIARRHOEA HAEMORRHAGIC,3
CZ,DISEASE PROGRESSION,3
CZ,DRUG INTOLERANCE,3
CZ,DYSPNOEA AT REST,3
CZ,HAEMODIALYSIS,3
CZ,PRURITUS,3
CZ,PYREXIA,3
CZ,RENAL IMPAIRMENT,3
CZ,RESPIRATORY FAILURE,3
CZ,THROMBOCYTOPENIA,3
CZ,URINARY TRACT INFECTION,3
CZ,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
CZ,ASTHENIA,2
CZ,ATRIAL FIBRILLATION,2
CZ,BASE EXCESS NEGATIVE,2
CZ,BLOOD CALCIUM DECREASED,2
CZ,BLOOD GLUCOSE INCREASED,2
CZ,BRONCHOPNEUMONIA,2
CZ,CONDITION AGGRAVATED,2
CZ,COUGH,2
CZ,DIABETIC KETOACIDOSIS,2
CZ,DISORIENTATION,2
CZ,DRUG ABUSE,2
CZ,DRUG LEVEL INCREASED,2
CZ,FATIGUE,2
CZ,FEMUR FRACTURE,2
CZ,FLATULENCE,2
CZ,HYPOGLYCAEMIC COMA,2
CZ,HYPOKALAEMIA,2
CZ,LIVER FUNCTION TEST INCREASED,2
CZ,LOSS OF CONSCIOUSNESS,2
CZ,MATERNAL EXPOSURE DURING PREGNANCY,2
CZ,NEPHRITIS,2
CZ,NERVOUS SYSTEM DISORDER,2
CZ,NEUTROPENIA,2
CZ,NORMAL NEWBORN,2
CZ,OEDEMA PERIPHERAL,2
CZ,OVERDOSE,2
CZ,PNEUMONIA,2
CZ,RASH,2
CZ,RENAL COLIC,2
CZ,RESTLESSNESS,2
CZ,SOMNOLENCE,2
CZ,TREMOR,2
CZ,ABDOMINAL PAIN,1
CZ,ACCELERATED HYPERTENSION,1
CZ,ACIDOSIS,1
CZ,ACUTE RESPIRATORY FAILURE,1
CZ,ANAPHYLACTIC SHOCK,1
CZ,APHTHOUS ULCER,1
CZ,ASPARTATE AMINOTRANSFERASE INCREASED,1
CZ,ATRIAL TACHYCARDIA,1
CZ,AUTOIMMUNE THYROIDITIS,1
CZ,BACK PAIN,1
CZ,BASAL CELL CARCINOMA,1
CZ,BLADDER CANCER,1
CZ,BLADDER TRANSITIONAL CELL CARCINOMA,1
CZ,BLOOD CALCIUM INCREASED,1
CZ,BLOOD CHLORIDE INCREASED,1
CZ,BLOOD PRESSURE INCREASED,1
CZ,BRONCHITIS,1
CZ,C-REACTIVE PROTEIN INCREASED,1
CZ,CARDIAC FAILURE,1
CZ,CARDIOVASCULAR DISORDER,1
CZ,CEREBROVASCULAR ACCIDENT,1
CZ,CHILLS,1
CZ,CHOLECYSTITIS ACUTE,1
CZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CZ,CLOSTRIDIUM COLITIS,1
CZ,COAGULATION TIME PROLONGED,1
CZ,CONJUNCTIVITIS,1
CZ,CONSTIPATION,1
CZ,CONTINUOUS HAEMODIAFILTRATION,1
CZ,DEATH,1
CZ,DIABETIC GANGRENE,1
CZ,DIZZINESS,1
CZ,DRUG DEPENDENCE,1
CZ,DRUG EFFECT INCOMPLETE,1
CZ,DRUG ERUPTION,1
CZ,DRUG WITHDRAWAL SYNDROME,1
CZ,DYSGEUSIA,1
CZ,ECZEMA,1
CZ,ESCHERICHIA TEST POSITIVE,1
CZ,EXPOSURE DURING PREGNANCY,1
CZ,EXTRAVASATION,1
CZ,FACE INJURY,1
CZ,FLUID INTAKE REDUCED,1
CZ,FOLLICULITIS,1
CZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
CZ,GENITAL DISCHARGE,1
CZ,HAEMATOMA,1
CZ,HAEMODYNAMIC INSTABILITY,1
CZ,HAEMOGLOBIN DECREASED,1
CZ,HAEMOPTYSIS,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,HEPATIC STEATOSIS,1
CZ,HEPATITIS E,1
CZ,HERPES VIRUS INFECTION,1
CZ,HICCUPS,1
CZ,HYPERKALAEMIA,1
CZ,HYPERSOMNIA,1
CZ,HYPONATRAEMIA,1
CZ,IMPETIGO,1
CZ,INCREASED APPETITE,1
CZ,INJECTION SITE REACTION,1
CZ,INSULIN C-PEPTIDE INCREASED,1
CZ,INTENTIONAL PRODUCT MISUSE,1
CZ,INTESTINAL HAEMORRHAGE,1
CZ,ISCHAEMIC STROKE,1
CZ,JOINT SWELLING,1
CZ,KETOACIDOSIS,1
CZ,KUSSMAUL RESPIRATION,1
CZ,LEFT VENTRICULAR HYPERTROPHY,1
CZ,LEUKOCYTOSIS,1
CZ,LEUKOPENIA,1
CZ,LIPODYSTROPHY ACQUIRED,1
CZ,LIVE BIRTH,1
CZ,LIVER ABSCESS,1
CZ,LIVER INJURY,1
CZ,LYMPHOCYTIC INFILTRATION,1
CZ,MICROALBUMINURIA,1
CZ,MINERAL METABOLISM DISORDER,1
CZ,MUSCLE SPASMS,1
CZ,MYALGIA,1
CZ,NAUSEA,1
CZ,NEPHRITIS ALLERGIC,1
CZ,NEUROPATHY PERIPHERAL,1
CZ,NIGHT SWEATS,1
CZ,NON-HODGKIN^S LYMPHOMA,1
CZ,OLIGURIA,1
CZ,OSTEOMYELITIS,1
CZ,OXYGEN SATURATION DECREASED,1
CZ,PANCYTOPENIA,1
CZ,PAPULE,1
CZ,PATIENT RESTRAINT,1
CZ,PEMPHIGOID,1
CZ,PERIORBITAL HAEMATOMA,1
CZ,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CZ,PERIPHERAL SENSORY NEUROPATHY,1
CZ,PHIMOSIS,1
CZ,PLATELET COUNT DECREASED,1
CZ,POLLAKIURIA,1
CZ,PRESYNCOPE,1
CZ,PRODUCT QUALITY ISSUE,1
CZ,PRODUCT USE ISSUE,1
CZ,PROSTATOMEGALY,1
CZ,PRURITUS GENERALISED,1
CZ,PYELONEPHRITIS ACUTE,1
CZ,RASH GENERALISED,1
CZ,RASH PRURITIC,1
CZ,RENAL INJURY,1
CZ,RESPIRATORY GAS EXCHANGE DISORDER,1
CZ,RESPIRATORY TRACT HAEMORRHAGE,1
CZ,RESPIRATORY TRACT INFECTION,1
CZ,RESPIRATORY TRACT INFECTION BACTERIAL,1
CZ,ROTATOR CUFF SYNDROME,1
CZ,SINUS TACHYCARDIA,1
CZ,SKIN DISCOLOURATION,1
CZ,SOMATOFORM DISORDER,1
CZ,STEATOHEPATITIS,1
CZ,STOMATITIS,1
CZ,SUICIDE ATTEMPT,1
CZ,TACHYCARDIA,1
CZ,THERAPEUTIC RESPONSE DECREASED,1
CZ,THROMBOPHLEBITIS SUPERFICIAL,1
CZ,TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER LOCALISED,1
CZ,TYPE 2 DIABETES MELLITUS,1
CZ,URETHRAL CANCER,1
CZ,UROSEPSIS,1
CZ,VENTRICULAR FIBRILLATION,1
CZ,VENTRICULAR SEPTAL DEFECT,1
CZ,VENTRICULAR TACHYCARDIA,1
CZ,VERTIGO,1
CZ,WHITE BLOOD CELL COUNT DECREASED,1
CZ,XANTHOMA,1
DK,NAUSEA,21
DK,LACTIC ACIDOSIS,20
DK,MALAISE,19
DK,VOMITING,18
DK,WEIGHT DECREASED,18
DK,DYSPNOEA,15
DK,CARDIAC ARREST,14
DK,FATIGUE,13
DK,HYPOTENSION,13
DK,RENAL IMPAIRMENT,13
DK,DECREASED APPETITE,12
DK,DIZZINESS,11
DK,MYALGIA,11
DK,HYPERKALAEMIA,10
DK,BLOOD CREATININE INCREASED,9
DK,DEHYDRATION,9
DK,DIABETIC KETOACIDOSIS,9
DK,RHABDOMYOLYSIS,9
DK,SYNCOPE,9
DK,ABDOMINAL PAIN,8
DK,ANAEMIA,8
DK,DIARRHOEA,8
DK,PNEUMONIA,8
DK,ACUTE KIDNEY INJURY,7
DK,ACUTE MYOCARDIAL INFARCTION,7
DK,CARDIAC FAILURE,7
DK,HEART RATE DECREASED,7
DK,RENAL FAILURE,7
DK,VISUAL ACUITY REDUCED,7
DK,BRADYCARDIA,6
DK,HAEMOGLOBIN DECREASED,6
DK,MUSCULAR WEAKNESS,6
DK,PULMONARY OEDEMA,6
DK,ABDOMINAL PAIN UPPER,5
DK,AORTIC VALVE STENOSIS,5
DK,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
DK,BRAIN NEOPLASM,5
DK,CONFUSIONAL STATE,5
DK,DRY MOUTH,5
DK,HYPOKALAEMIA,5
DK,INTERNATIONAL NORMALISED RATIO INCREASED,5
DK,PYREXIA,5
DK,SEPSIS,5
DK,ALANINE AMINOTRANSFERASE INCREASED,4
DK,ANURIA,4
DK,ASPARTATE AMINOTRANSFERASE INCREASED,4
DK,BACK PAIN,4
DK,BLOOD GLUCOSE INCREASED,4
DK,CEREBROVASCULAR ACCIDENT,4
DK,COAGULATION FACTOR INCREASED,4
DK,DIFFUSE LARGE B-CELL LYMPHOMA,4
DK,EYE PRURITUS,4
DK,HAEMATEMESIS,4
DK,HYPERHIDROSIS,4
DK,HYPOGLYCAEMIA,4
DK,JAUNDICE,4
DK,KETOACIDOSIS,4
DK,KNEE OPERATION,4
DK,MICTURITION URGENCY,4
DK,MOTOR DYSFUNCTION,4
DK,PAIN,4
DK,ABORTION SPONTANEOUS,3
DK,ALTERED STATE OF CONSCIOUSNESS,3
DK,ARTERIOSCLEROSIS,3
DK,ASTHENIA,3
DK,ATRIAL FIBRILLATION,3
DK,BLADDER CANCER,3
DK,BRAIN OEDEMA,3
DK,BUNDLE BRANCH BLOCK RIGHT,3
DK,C-REACTIVE PROTEIN INCREASED,3
DK,CONSTIPATION,3
DK,COUGH,3
DK,DEPRESSION,3
DK,FALL,3
DK,FOOD AVERSION,3
DK,GASTRIC HAEMORRHAGE,3
DK,HELLP SYNDROME,3
DK,HEMIANOPIA HOMONYMOUS,3
DK,HYPONATRAEMIA,3
DK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
DK,LETHARGY,3
DK,MATERNAL EXPOSURE DURING PREGNANCY,3
DK,METASTASES TO LIVER,3
DK,MUSCLE ATROPHY,3
DK,MUSCLE FATIGUE,3
DK,MYOCARDIAL INFARCTION,3
DK,MYOGLOBIN BLOOD INCREASED,3
DK,NEONATAL RESPIRATORY DISTRESS SYNDROME,3
DK,PAIN IN EXTREMITY,3
DK,PANCREATIC CARCINOMA,3
DK,PERIPHERAL COLDNESS,3
DK,PREGNANCY,3
DK,RENAL CYST,3
DK,RESPIRATORY ARREST,3
DK,RESTLESSNESS,3
DK,SEIZURE,3
DK,SOMNOLENCE,3
DK,TUMOUR LYSIS SYNDROME,3
DK,WEIGHT INCREASED,3
DK,ANAPHYLACTIC REACTION,2
DK,ANXIETY,2
DK,APNOEA,2
DK,ARRHYTHMIA,2
DK,ARTHRALGIA,2
DK,ATRIAL SEPTAL DEFECT,2
DK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
DK,BLADDER PAIN,2
DK,BLINDNESS,2
DK,BLOOD CALCIUM INCREASED,2
DK,BLOOD GLUCOSE DECREASED,2
DK,BLOOD LACTIC ACID INCREASED,2
DK,BLOOD POTASSIUM INCREASED,2
DK,BLOOD UREA INCREASED,2
DK,BRAIN MIDLINE SHIFT,2
DK,CARDIAC FAILURE ACUTE,2
DK,CEREBRAL HAEMATOMA,2
DK,CEREBRAL HAEMORRHAGE,2
DK,CHOLECYSTITIS,2
DK,CHOLELITHIASIS,2
DK,COLD SWEAT,2
DK,CONGENITAL HEART VALVE DISORDER,2
DK,CONVULSION,2
DK,DEMENTIA,2
DK,DEPRESSED MOOD,2
DK,DERMATITIS PSORIASIFORM,2
DK,DIABETES MELLITUS,2
DK,DIABETES MELLITUS INADEQUATE CONTROL,2
DK,DISCOMFORT,2
DK,DISEASE PROGRESSION,2
DK,DRUG INEFFECTIVE,2
DK,ELECTROCARDIOGRAM QT PROLONGED,2
DK,EYE PAIN,2
DK,FAECES DISCOLOURED,2
DK,FEBRILE NEUTROPENIA,2
DK,FOETAL EXPOSURE DURING PREGNANCY,2
DK,GAIT DISTURBANCE,2
DK,GASTROINTESTINAL DISORDER,2
DK,GLOMERULAR FILTRATION RATE DECREASED,2
DK,HAEMATURIA,2
DK,HAEMOPTYSIS,2
DK,HEADACHE,2
DK,HEART DISEASE CONGENITAL,2
DK,HEART RATE INCREASED,2
DK,HEMIPARESIS,2
DK,HEPATIC ENZYME INCREASED,2
DK,HYPERSOMNIA,2
DK,HYPERTENSION,2
DK,HYPOVOLAEMIA,2
DK,IMMUNE THROMBOCYTOPENIC PURPURA,2
DK,INFECTED SKIN ULCER,2
DK,INFECTION,2
DK,INTENTIONAL PRODUCT MISUSE,2
DK,JOINT SWELLING,2
DK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
DK,LIP SWELLING,2
DK,LIVER DISORDER,2
DK,LOSS OF CONSCIOUSNESS,2
DK,MACULAR OEDEMA,2
DK,MACULOPATHY,2
DK,MEDICATION ERROR,2
DK,MEMORY IMPAIRMENT,2
DK,MITRAL VALVE INCOMPETENCE,2
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
DK,MUSCLE SPASMS,2
DK,OEDEMA PERIPHERAL,2
DK,OLIGURIA,2
DK,OSTEONECROSIS OF JAW,2
DK,OVERDOSE,2
DK,PALLOR,2
DK,PALPITATIONS,2
DK,PANCREATIC CARCINOMA METASTATIC,2
DK,PANCREATITIS,2
DK,PATENT DUCTUS ARTERIOSUS,2
DK,PENILE CANCER,2
DK,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
DK,PREGNANCY ON ORAL CONTRACEPTIVE,2
DK,PSORIATIC ARTHROPATHY,2
DK,PULMONARY CONGESTION,2
DK,PULMONARY FIBROSIS,2
DK,PULMONARY FUNCTION TEST DECREASED,2
DK,PUSTULAR PSORIASIS,2
DK,RENAL FAILURE ACUTE,2
DK,RESPIRATORY DEPRESSION,2
DK,RESPIRATORY FAILURE,2
DK,SEPTIC SHOCK,2
DK,SKIN ULCER,2
DK,TACHYPNOEA,2
DK,TENDERNESS,2
DK,THIRST,2
DK,TOXICITY TO VARIOUS AGENTS,2
DK,ULCER,2
DK,UNINTENDED PREGNANCY,2
DK,UNRESPONSIVE TO STIMULI,2
DK,URINARY RETENTION,2
DK,URINARY TRACT INFECTION,2
DK,VASCULAR MALFORMATION,2
DK,VISUAL IMPAIRMENT,2
DK,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
DK,ABDOMINAL HERNIA,1
DK,ABNORMAL LOSS OF WEIGHT,1
DK,ABSCESS ORAL,1
DK,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
DK,ACUTE RESPIRATORY FAILURE,1
DK,ADENOCARCINOMA PANCREAS,1
DK,AGITATION,1
DK,ANAL ABSCESS,1
DK,ANAL INCONTINENCE,1
DK,ANAPHYLACTIC SHOCK,1
DK,ANGINA PECTORIS,1
DK,ANGIOPATHY,1
DK,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED,1
DK,AORTIC THROMBOSIS,1
DK,AORTIC VALVE INCOMPETENCE,1
DK,APGAR SCORE ABNORMAL,1
DK,ATRIAL FLUTTER,1
DK,BICUSPID AORTIC VALVE,1
DK,BLOOD ALBUMIN DECREASED,1
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,1
DK,BLOOD BILIRUBIN INCREASED,1
DK,BLOOD GLUCOSE ABNORMAL,1
DK,BLOOD GLUCOSE FLUCTUATION,1
DK,BLOOD LACTATE DEHYDROGENASE INCREASED,1
DK,BLOOD PRESSURE DECREASED,1
DK,BLOOD PRESSURE INCREASED,1
DK,BRAIN HERNIATION,1
DK,BRAIN INJURY,1
DK,BREAST CANCER METASTATIC,1
DK,BREAST PAIN,1
DK,BUNDLE BRANCH BLOCK LEFT,1
DK,CARDIAC OUTPUT DECREASED,1
DK,CARDIAC TAMPONADE,1
DK,CATARACT,1
DK,CHEST DISCOMFORT,1
DK,CHOLANGITIS,1
DK,CHROMATURIA,1
DK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
DK,CLINICALLY ISOLATED SYNDROME,1
DK,COGNITIVE DISORDER,1
DK,COLORECTAL CANCER,1
DK,COMA,1
DK,CONGENITAL AORTIC VALVE STENOSIS,1
DK,CONGENITAL DIAPHRAGMATIC HERNIA,1
DK,CREPITATIONS,1
DK,CULTURE URINE POSITIVE,1
DK,DEATH,1
DK,DECREASED IMMUNE RESPONSIVENESS,1
DK,DELIRIUM,1
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DK,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,1
DK,DIABETIC NEUROPATHY,1
DK,DIALYSIS,1
DK,DIAPHRAGMALGIA,1
DK,DISORIENTATION,1
DK,DRUG ABUSE,1
DK,DRUG LEVEL INCREASED,1
DK,DRUG PRESCRIBING ERROR,1
DK,DYSARTHRIA,1
DK,DYSURIA,1
DK,EJACULATION DISORDER,1
DK,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
DK,EMBOLISM VENOUS,1
DK,ENDOPHTHALMITIS,1
DK,ENDOTRACHEAL INTUBATION,1
DK,EPIGASTRIC DISCOMFORT,1
DK,EPILEPSY,1
DK,EXPOSURE DURING PREGNANCY,1
DK,EXTRADURAL HAEMATOMA,1
DK,EYE HAEMORRHAGE,1
DK,EYE INFECTION,1
DK,FEELING HOT,1
DK,FISTULA,1
DK,FISTULA DISCHARGE,1
DK,FLUID INTAKE REDUCED,1
DK,FREEZING PHENOMENON,1
DK,GALLBLADDER ENLARGEMENT,1
DK,GANGRENE,1
DK,GASTRIC ULCER,1
DK,GASTRIC ULCER PERFORATION,1
DK,GASTROINTESTINAL CANCER METASTATIC,1
DK,GASTROINTESTINAL OEDEMA,1
DK,GENERAL PHYSICAL CONDITION ABNORMAL,1
DK,GENERAL PHYSICAL HEALTH DETERIORATION,1
DK,GENERALISED OEDEMA,1
DK,GINGIVAL HYPERPLASIA,1
DK,GRANULOMA,1
DK,GRANULOMATOSIS WITH POLYANGIITIS,1
DK,HAEMODIALYSIS,1
DK,HAEMORRHAGE INTRACRANIAL,1
DK,HAEMORRHAGIC STROKE,1
DK,HEAD DISCOMFORT,1
DK,HEPARIN-INDUCED THROMBOCYTOPENIA,1
DK,HEPATIC CANCER,1
DK,HEPATIC FAILURE,1
DK,HEPATIC STEATOSIS,1
DK,HEPATITIS C,1
DK,HEPATITIS TOXIC,1
DK,HOSPITALISATION,1
DK,HYDROCHOLECYSTIS,1
DK,HYPERSENSITIVITY,1
DK,HYPOGLYCAEMIC COMA,1
DK,HYPOGLYCAEMIC ENCEPHALOPATHY,1
DK,HYPOPHAGIA,1
DK,INFLUENZA LIKE ILLNESS,1
DK,INSOMNIA,1
DK,INTENTIONAL PRODUCT USE ISSUE,1
DK,KUSSMAUL RESPIRATION,1
DK,LARYNGEAL CANCER,1
DK,LARYNGEAL OEDEMA,1
DK,LARYNGITIS,1
DK,LEG AMPUTATION,1
DK,LEUKOCYTOSIS,1
DK,LEUKOPENIA,1
DK,LIVER ABSCESS,1
DK,LIVER FUNCTION TEST ABNORMAL,1
DK,LOCAL SWELLING,1
DK,LOOSE TOOTH,1
DK,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
DK,LUNG ADENOCARCINOMA METASTATIC,1
DK,LUNG INFILTRATION,1
DK,LYMPHOCYTE COUNT DECREASED,1
DK,MALIGNANT NEOPLASM PROGRESSION,1
DK,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
DK,METABOLIC SYNDROME,1
DK,METASTASES TO BONE,1
DK,METASTASES TO LYMPH NODES,1
DK,METASTASES TO PERITONEUM,1
DK,MIGRAINE,1
DK,MOBILITY DECREASED,1
DK,MOUTH ULCERATION,1
DK,MULTI-ORGAN FAILURE,1
DK,MUSCULOSKELETAL PAIN,1
DK,MYELODYSPLASTIC SYNDROME,1
DK,MYOPATHY,1
DK,NECROSIS,1
DK,NEOPLASM MALIGNANT,1
DK,NEPHROPATHY,1
DK,NEURODERMATITIS,1
DK,NEUROPATHY PERIPHERAL,1
DK,NIGHT SWEATS,1
DK,NOCTURIA,1
DK,OBSTRUCTIVE AIRWAYS DISORDER,1
DK,ORAL CAVITY FISTULA,1
DK,ORAL INFECTION,1
DK,ORAL PAIN,1
DK,OSTEOPOROSIS,1
DK,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
DK,PANCREATECTOMY,1
DK,PANCREATITIS ACUTE,1
DK,PAPILLARY THYROID CANCER,1
DK,PARAESTHESIA,1
DK,PCO2 INCREASED,1
DK,PERINEPHRIC ABSCESS,1
DK,PLASMA CELL MYELOMA,1
DK,PLATELET COUNT INCREASED,1
DK,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
DK,PNEUMONIA ASPIRATION,1
DK,PNEUMONIA INFLUENZAL,1
DK,POLYMYOSITIS,1
DK,POLYNEUROPATHY,1
DK,POOR PERIPHERAL CIRCULATION,1
DK,POSTOPERATIVE THROMBOSIS,1
DK,PREMATURE BABY,1
DK,PREMATURE DELIVERY,1
DK,PRESCRIBED OVERDOSE,1
DK,PRODUCT SUBSTITUTION ISSUE,1
DK,PRODUCT USE IN UNAPPROVED INDICATION,1
DK,PRODUCT USE ISSUE,1
DK,PROSTATE CANCER,1
DK,PRURITUS,1
DK,PRURITUS GENERALISED,1
DK,PULMONARY EMBOLISM,1
DK,PULMONARY HYPERTENSION,1
DK,PULMONARY HYPOPLASIA,1
DK,PULSE ABNORMAL,1
DK,RABBIT SYNDROME,1
DK,RASH,1
DK,RASH GENERALISED,1
DK,RECTAL HAEMORRHAGE,1
DK,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
DK,RENAL CANCER METASTATIC,1
DK,RESPIRATORY THERAPY,1
DK,SARCOIDOSIS,1
DK,SCRATCH,1
DK,SECRETION DISCHARGE,1
DK,SENSORY DISTURBANCE,1
DK,SKIN DISCOLOURATION,1
DK,SKIN EXFOLIATION,1
DK,SKIN NECROSIS,1
DK,SKIN WOUND,1
DK,SLEEP DISORDER,1
DK,SPEECH DISORDER,1
DK,SPINAL OSTEOARTHRITIS,1
DK,SPLENECTOMY,1
DK,SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED,1
DK,SPUTUM DISCOLOURED,1
DK,SQUAMOUS CELL CARCINOMA OF SKIN,1
DK,STAPHYLOCOCCAL SEPSIS,1
DK,STILLBIRTH,1
DK,SUBCUTANEOUS ABSCESS,1
DK,SUBDURAL HAEMATOMA,1
DK,SUBSTANCE ABUSE,1
DK,SUICIDAL IDEATION,1
DK,SURGERY,1
DK,SWELLING FACE,1
DK,SWOLLEN TONGUE,1
DK,TACHYCARDIA,1
DK,TACHYPHRENIA,1
DK,TEMPERATURE INTOLERANCE,1
DK,TESTIS CANCER,1
DK,THINKING ABNORMAL,1
DK,THROAT IRRITATION,1
DK,THROMBOSIS,1
DK,TOE AMPUTATION,1
DK,TONGUE OEDEMA,1
DK,TOOTH DISORDER,1
DK,TRANSFUSION,1
DK,TRANSPOSITION OF THE GREAT VESSELS,1
DK,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
DK,TREMOR,1
DK,TUMOUR NECROSIS,1
DK,UPPER GASTROINTESTINAL HAEMORRHAGE,1
DK,URINARY INCONTINENCE,1
DK,URINARY TRACT NEOPLASM,1
DK,URINE OUTPUT DECREASED,1
DK,UROSEPSIS,1
DK,UVEITIS,1
DK,VASCULITIC RASH,1
DK,VENTRICULAR ARRHYTHMIA,1
DK,VENTRICULAR FAILURE,1
DK,VENTRICULAR FIBRILLATION,1
DK,VENTRICULAR HYPOKINESIA,1
DK,VENTRICULAR TACHYCARDIA,1
DK,VISUAL FIELD DEFECT,1
DK,WHEELCHAIR USER,1
DK,WHITE BLOOD CELL COUNT INCREASED,1
DK,WOUND,1
DK,WOUND DEHISCENCE,1
DK,WOUND HAEMORRHAGE,1
DK,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
DO,ACUTE CORONARY SYNDROME,1
DO,ACUTE KIDNEY INJURY,1
DO,ASTHENIA,1
DO,AXILLARY MASS,1
DO,BREAST DISCOMFORT,1
DO,HYPERGLYCAEMIA,1
DO,NO ADVERSE EVENT,1
EC,ABASIA,1
EC,ASTHENIA,1
EC,BALANCE DISORDER,1
EC,CEREBRAL HYPOPERFUSION,1
EC,DEEP VEIN THROMBOSIS,1
EC,DEPRESSED LEVEL OF CONSCIOUSNESS,1
EC,DIABETIC COMA,1
EC,DIZZINESS,1
EC,DYSPNOEA,1
EC,HYPOGLYCAEMIA,1
EC,MUSCLE SPASMS,1
EC,MYASTHENIC SYNDROME,1
EC,NEURALGIA,1
EC,PULMONARY EMBOLISM,1
EC,THROMBOSIS,1
EC,URINARY TRACT INFECTION,1
EC,VASCULAR PAIN,1
EG,CEREBROVASCULAR ACCIDENT,3
EG,ACCIDENT,1
EG,ANGINA PECTORIS,1
EG,BLOOD GLUCOSE ABNORMAL,1
EG,CHEST PAIN,1
EG,CONCUSSION,1
EG,DIABETIC KETOACIDOSIS,1
EG,GASTROINTESTINAL FUNGAL INFECTION,1
EG,HYPERGLYCAEMIA,1
EG,LEUKOCYTOSIS,1
EG,MUSCULOSKELETAL PAIN,1
EG,RENAL FAILURE,1
EG,VOMITING,1
SV,BLOOD BICARBONATE DECREASED,1
SV,BLOOD GLUCOSE INCREASED,1
SV,BONE LESION,1
SV,HYPERGLYCAEMIA,1
SV,METABOLIC ACIDOSIS,1
SV,RASH,1
SV,URTICARIA,1
EE,CEREBRAL INFARCTION,6
EE,MUSCULAR WEAKNESS,6
EE,THROMBOSIS,6
EE,PROSTATE CANCER,4
EE,WOUND,4
EE,WALKING AID USER,3
EE,CHOLECYSTITIS,2
EE,DEVICE OCCLUSION,2
EE,DIABETIC KETOACIDOSIS,2
EE,FOETAL EXPOSURE DURING PREGNANCY,2
EE,SINUSITIS,2
EE,URINARY BLADDER HAEMORRHAGE,2
EE,ALANINE AMINOTRANSFERASE INCREASED,1
EE,BLISTER,1
EE,BRAIN OEDEMA,1
EE,CAESAREAN SECTION,1
EE,CARDIOPULMONARY FAILURE,1
EE,CEREBROVASCULAR ACCIDENT,1
EE,DIABETES MELLITUS INADEQUATE CONTROL,1
EE,DRUG DISPENSING ERROR,1
EE,EXPOSURE DURING PREGNANCY,1
EE,FOETAL DISTRESS SYNDROME,1
EE,FOETAL GROWTH RESTRICTION,1
EE,FOETAL HYPOKINESIA,1
EE,FOETAL MACROSOMIA,1
EE,HAEMORRHAGIC STROKE,1
EE,HEADACHE,1
EE,HYPERTENSION,1
EE,HYPOGLYCAEMIA,1
EE,HYPOGLYCAEMIA NEONATAL,1
EE,HYPOTONIA,1
EE,KETOACIDOSIS,1
EE,LIMB MALFORMATION,1
EE,LIVE BIRTH,1
EE,LOSS OF CONSCIOUSNESS,1
EE,LOW BIRTH WEIGHT BABY,1
EE,MATERNAL EXPOSURE DURING PREGNANCY,1
EE,MESENTERIC ARTERIAL OCCLUSION,1
EE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
EE,NAUSEA,1
EE,OLIGOHYDRAMNIOS,1
EE,PEMPHIGOID,1
EE,PROSTATIC HAEMORRHAGE,1
EE,PULMONARY HYPOPLASIA,1
EE,RENAL FAILURE,1
EE,SKIN EROSION,1
EE,SKIN PLAQUE,1
EE,SKULL MALFORMATION,1
EE,URINARY TRACT INFECTION,1
EE,UTERINE LEIOMYOSARCOMA,1
EE,WEIGHT DECREASED,1
EE,WRONG DRUG ADMINISTERED,1
FJ,CEREBROVASCULAR ACCIDENT,1
FI,TOXICITY TO VARIOUS AGENTS,48
FI,LACTIC ACIDOSIS,21
FI,KETOACIDOSIS,13
FI,FATIGUE,8
FI,DIZZINESS,7
FI,HYPOTENSION,7
FI,NAUSEA,7
FI,PAIN IN EXTREMITY,7
FI,PYREXIA,6
FI,ACIDOSIS,5
FI,ACUTE KIDNEY INJURY,5
FI,ARTHRALGIA,5
FI,DIARRHOEA,5
FI,KETOSIS,5
FI,MUSCULAR WEAKNESS,5
FI,ALCOHOL POISONING,4
FI,BLINDNESS,4
FI,BLOOD CREATININE INCREASED,4
FI,DYSARTHRIA,4
FI,DYSPNOEA,4
FI,HYPERKALAEMIA,4
FI,TIBIA FRACTURE,4
FI,TYPE 2 DIABETES MELLITUS,4
FI,WEIGHT DECREASED,4
FI,ABDOMINAL PAIN,3
FI,ASTHENIA,3
FI,BRONCHITIS,3
FI,COMPLETED SUICIDE,3
FI,CONFUSIONAL STATE,3
FI,DEATH,3
FI,ELECTROCARDIOGRAM ABNORMAL,3
FI,FALL,3
FI,GAIT DISTURBANCE,3
FI,HYPERGLYCAEMIA,3
FI,HYPERTENSION,3
FI,HYPOGLYCAEMIA,3
FI,HYPOKALAEMIA,3
FI,MEMORY IMPAIRMENT,3
FI,METABOLIC ACIDOSIS,3
FI,PNEUMONIA ASPIRATION,3
FI,RASH,3
FI,RENAL FAILURE,3
FI,TOE AMPUTATION,3
FI,WEIGHT INCREASED,3
FI,ABDOMINAL PAIN UPPER,2
FI,ALCOHOL ABUSE,2
FI,ARTERIOSCLEROSIS,2
FI,ATRIAL FIBRILLATION,2
FI,BACK PAIN,2
FI,BLOOD LACTIC ACID INCREASED,2
FI,BLOOD PH DECREASED,2
FI,BLOOD PRESSURE INCREASED,2
FI,C-REACTIVE PROTEIN INCREASED,2
FI,CEREBRAL HAEMORRHAGE,2
FI,CHILLS,2
FI,DEHYDRATION,2
FI,DELIRIUM,2
FI,DIABETES MELLITUS,2
FI,DIABETES MELLITUS MALNUTRITION-RELATED,2
FI,DISEASE PROGRESSION,2
FI,DRY MOUTH,2
FI,FEELING DRUNK,2
FI,GENERAL PHYSICAL HEALTH DETERIORATION,2
FI,HEADACHE,2
FI,HEART RATE ABNORMAL,2
FI,HEART RATE INCREASED,2
FI,HYPOMAGNESAEMIA,2
FI,IMPAIRED HEALING,2
FI,INFECTION,2
FI,INTENTIONAL OVERDOSE,2
FI,INTESTINAL OBSTRUCTION,2
FI,LEUKOCYTOSIS,2
FI,LOSS OF CONSCIOUSNESS,2
FI,MALAISE,2
FI,METABOLIC ALKALOSIS,2
FI,MYALGIA,2
FI,MYOCARDIAL INFARCTION,2
FI,OSTEONECROSIS OF JAW,2
FI,OVERDOSE,2
FI,PANCREATITIS,2
FI,PERIPHERAL SWELLING,2
FI,PLEURAL EFFUSION,2
FI,PULMONARY EMBOLISM,2
FI,RASH ERYTHEMATOUS,2
FI,RENAL IMPAIRMENT,2
FI,SCHIZOPHRENIA,2
FI,SOMNOLENCE,2
FI,TACHYCARDIA,2
FI,TREMOR,2
FI,VERTIGO,2
FI,VISION BLURRED,2
FI,VOMITING,2
FI,ACNE,1
FI,ACUTE MYOCARDIAL INFARCTION,1
FI,AFFECT LABILITY,1
FI,AGITATION,1
FI,AGRAPHIA,1
FI,AKATHISIA,1
FI,ALBUMIN URINE PRESENT,1
FI,ALCOHOL USE,1
FI,ALOPECIA,1
FI,ALTERED VISUAL DEPTH PERCEPTION,1
FI,ANAEMIA,1
FI,ANTICOAGULATION DRUG LEVEL INCREASED,1
FI,ANURIA,1
FI,APATHY,1
FI,ARTHRITIS,1
FI,ARTHRITIS BACTERIAL,1
FI,ASPIRATION,1
FI,ATRIOVENTRICULAR BLOCK,1
FI,BALANCE DISORDER,1
FI,BALANOPOSTHITIS,1
FI,BASE EXCESS NEGATIVE,1
FI,BLINDNESS TRANSIENT,1
FI,BLOOD BICARBONATE DECREASED,1
FI,BLOOD BILIRUBIN INCREASED,1
FI,BLOOD CALCIUM DECREASED,1
FI,BLOOD GLUCOSE DECREASED,1
FI,BLOOD GLUCOSE FLUCTUATION,1
FI,BLOOD GLUCOSE INCREASED,1
FI,BLOOD KETONE BODY,1
FI,BLOOD POTASSIUM INCREASED,1
FI,BLOOD UREA INCREASED,1
FI,BLOOD URIC ACID INCREASED,1
FI,BONE DISORDER,1
FI,BONE MARROW FAILURE,1
FI,BONE MARROW OEDEMA,1
FI,BRAIN DEATH,1
FI,BRAIN OEDEMA,1
FI,BRUXISM,1
FI,CARDIAC FIBRILLATION,1
FI,CARDIOGENIC SHOCK,1
FI,CHEST DISCOMFORT,1
FI,CHEST PAIN,1
FI,CIRCULATORY COLLAPSE,1
FI,CIRRHOSIS ALCOHOLIC,1
FI,CLUMSINESS,1
FI,COGNITIVE DISORDER,1
FI,COLD SWEAT,1
FI,COLITIS,1
FI,COLON ADENOMA,1
FI,CONDITION AGGRAVATED,1
FI,CONSTIPATION,1
FI,COUGH,1
FI,CUSHING^S SYNDROME,1
FI,CYANOPSIA,1
FI,CYSTITIS,1
FI,DEMENTIA ALZHEIMER^S TYPE,1
FI,DENTAL CARIES,1
FI,DENTAL FISTULA,1
FI,DEPRESSED LEVEL OF CONSCIOUSNESS,1
FI,DEPRESSION,1
FI,DIABETIC KETOACIDOSIS,1
FI,DISORIENTATION,1
FI,DRUG ABUSE,1
FI,DRUG DOSE OMISSION,1
FI,DRUG EFFECT DECREASED,1
FI,DRY SKIN,1
FI,DYSKINESIA,1
FI,DYSSTASIA,1
FI,DYSURIA,1
FI,ECTOPIC ACTH SYNDROME,1
FI,EPISTAXIS,1
FI,EXERCISE TOLERANCE DECREASED,1
FI,EXOSTOSIS,1
FI,EYE IRRITATION,1
FI,EYE SYMPTOM,1
FI,FAECAL CALPROTECTIN INCREASED,1
FI,FEBRILE NEUTROPENIA,1
FI,FEELING ABNORMAL,1
FI,FEELING HOT,1
FI,FEMUR FRACTURE,1
FI,FOOT FRACTURE,1
FI,FUNGAL INFECTION,1
FI,GASTRITIS HAEMORRHAGIC,1
FI,GASTROENTERITIS,1
FI,GASTROENTERITIS VIRAL,1
FI,GASTROINTESTINAL EROSION,1
FI,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
FI,HAEMANGIOMA OF BONE,1
FI,HAEMATOMA,1
FI,HAEMATOTOXICITY,1
FI,HAEMORRHOIDS,1
FI,HEART RATE IRREGULAR,1
FI,HEPATIC CIRRHOSIS,1
FI,HEPATIC CYST,1
FI,HEPATIC STEATOSIS,1
FI,HYPOAESTHESIA,1
FI,HYPOKINESIA,1
FI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
FI,INJECTION SITE MASS,1
FI,INSOMNIA,1
FI,INTERSTITIAL LUNG DISEASE,1
FI,INTERVERTEBRAL DISC DISORDER,1
FI,JOINT EFFUSION,1
FI,JOINT STIFFNESS,1
FI,JOINT SWELLING,1
FI,JOINT WARMTH,1
FI,LATENT AUTOIMMUNE DIABETES IN ADULTS,1
FI,LETHARGY,1
FI,LIPOMA,1
FI,LIVER FUNCTION TEST ABNORMAL,1
FI,LIVER FUNCTION TEST INCREASED,1
FI,LUNG DISORDER,1
FI,LUNG INFILTRATION,1
FI,LUNG NEOPLASM MALIGNANT,1
FI,LYMPHADENOPATHY,1
FI,MALNUTRITION,1
FI,MEAN CELL VOLUME INCREASED,1
FI,MENISCUS INJURY,1
FI,METABOLIC SYNDROME,1
FI,METASTASES TO BONE,1
FI,MICTURITION DISORDER,1
FI,MIGRAINE,1
FI,MULTIPLE SCLEROSIS,1
FI,MUSCLE ATROPHY,1
FI,MUSCULOSKELETAL PAIN,1
FI,MUSCULOSKELETAL STIFFNESS,1
FI,NEURALGIA,1
FI,NEUROLOGICAL DECOMPENSATION,1
FI,NEUROTOXICITY,1
FI,NEUTROPENIA,1
FI,NEUTROPENIC INFECTION,1
FI,OBSTRUCTION GASTRIC,1
FI,ONYCHOMYCOSIS,1
FI,ORAL DISCHARGE,1
FI,ORAL PAIN,1
FI,OSTEOARTHRITIS,1
FI,OSTEOMYELITIS,1
FI,OSTEONECROSIS,1
FI,OSTEOPOROSIS,1
FI,PAIN,1
FI,PALLOR,1
FI,PALPITATIONS,1
FI,PANCREATIC CARCINOMA,1
FI,PANCREATIC DISORDER,1
FI,PANCREATITIS ACUTE,1
FI,PANCYTOPENIA,1
FI,PARAESTHESIA,1
FI,PARKINSONISM,1
FI,PHOTOPSIA,1
FI,PLATELET COUNT INCREASED,1
FI,POISONING,1
FI,POISONING DELIBERATE,1
FI,PRODUCT USE ISSUE,1
FI,PROSTATE CANCER,1
FI,PRURITUS,1
FI,RASH PRURITIC,1
FI,READING DISORDER,1
FI,RESPIRATORY RATE DECREASED,1
FI,RESPIRATORY RATE INCREASED,1
FI,RESPIRATORY TRACT INFECTION,1
FI,RESTLESSNESS,1
FI,RETINAL VASCULAR DISORDER,1
FI,RHABDOMYOLYSIS,1
FI,SCIATICA,1
FI,SCLERITIS,1
FI,SECRETION DISCHARGE,1
FI,SEDATION,1
FI,SKIN TOXICITY,1
FI,SLEEP DISORDER,1
FI,SPEECH DISORDER,1
FI,STOMATITIS,1
FI,SYNOVIAL FLUID CRYSTAL PRESENT,1
FI,TENDONITIS,1
FI,THERAPEUTIC RESPONSE INCREASED,1
FI,THROMBOCYTOPENIA,1
FI,TONGUE HAEMORRHAGE,1
FI,TOOTH LOSS,1
FI,URINARY TRACT INFECTION,1
FI,URINE KETONE BODY,1
FI,URINE OUTPUT INCREASED,1
FI,URTICARIA,1
FI,VENOUS THROMBOSIS LIMB,1
FI,VISUAL ACUITY REDUCED,1
FI,VISUAL FIELD DEFECT,1
FI,VISUAL IMPAIRMENT,1
FI,VITAMIN B12 DEFICIENCY,1
FI,VITAMIN D DECREASED,1
FI,WEIGHT ABNORMAL,1
FI,WHITE BLOOD CELL COUNT DECREASED,1
FR,ACUTE KIDNEY INJURY,334
FR,LACTIC ACIDOSIS,272
FR,DIARRHOEA,137
FR,HYPERKALAEMIA,135
FR,RENAL FAILURE,105
FR,VOMITING,104
FR,PEMPHIGOID,97
FR,FALL,93
FR,HYPOTENSION,85
FR,HYPOGLYCAEMIA,80
FR,CONFUSIONAL STATE,75
FR,ANAEMIA,72
FR,OVERDOSE,72
FR,DEHYDRATION,71
FR,GENERAL PHYSICAL HEALTH DETERIORATION,67
FR,PYREXIA,67
FR,RENAL FAILURE ACUTE,62
FR,ASTHENIA,60
FR,COMA,59
FR,NAUSEA,58
FR,HEPATOCELLULAR INJURY,57
FR,HYPONATRAEMIA,55
FR,THROMBOCYTOPENIA,55
FR,METABOLIC ACIDOSIS,54
FR,MALAISE,53
FR,DECREASED APPETITE,52
FR,DYSPNOEA,51
FR,PANCREATITIS ACUTE,48
FR,ABDOMINAL PAIN,45
FR,RASH,45
FR,WEIGHT DECREASED,45
FR,SOMNOLENCE,42
FR,EOSINOPHILIA,41
FR,PRURITUS,41
FR,BRADYCARDIA,38
FR,FATIGUE,38
FR,CARDIAC FAILURE,36
FR,DRUG INEFFECTIVE,35
FR,PANCYTOPENIA,35
FR,SEPSIS,35
FR,HEADACHE,33
FR,HYPERTENSION,33
FR,AGRANULOCYTOSIS,32
FR,INTERSTITIAL LUNG DISEASE,32
FR,DIABETES MELLITUS INADEQUATE CONTROL,31
FR,INTERNATIONAL NORMALISED RATIO INCREASED,31
FR,NEUTROPENIA,31
FR,CHOLESTASIS,30
FR,DISORIENTATION,29
FR,HAEMATOMA,29
FR,LIPASE INCREASED,29
FR,OEDEMA PERIPHERAL,29
FR,RHABDOMYOLYSIS,29
FR,SHOCK,29
FR,LUNG DISORDER,28
FR,TACHYCARDIA,28
FR,GAIT DISTURBANCE,27
FR,HEPATITIS,27
FR,ANURIA,26
FR,CARDIAC ARREST,26
FR,RASH MACULO-PAPULAR,26
FR,DIZZINESS,25
FR,LOSS OF CONSCIOUSNESS,25
FR,ERYTHEMA,24
FR,HYPERGLYCAEMIA,24
FR,HYPERLACTACIDAEMIA,24
FR,HYPOKALAEMIA,24
FR,RENAL TUBULAR NECROSIS,24
FR,DRUG LEVEL INCREASED,23
FR,PANCREATIC CARCINOMA,22
FR,PNEUMONIA,22
FR,ABDOMINAL PAIN UPPER,21
FR,PULMONARY EMBOLISM,21
FR,BLOOD CREATININE INCREASED,20
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,20
FR,RENAL IMPAIRMENT,20
FR,ATRIAL FIBRILLATION,19
FR,DIABETES MELLITUS,19
FR,MELAENA,19
FR,MYALGIA,19
FR,RESPIRATORY DISTRESS,19
FR,SEPTIC SHOCK,19
FR,TOXICITY TO VARIOUS AGENTS,19
FR,ANGIOEDEMA,18
FR,ENCEPHALOPATHY,18
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,18
FR,PAIN IN EXTREMITY,18
FR,CONDITION AGGRAVATED,17
FR,DEATH,17
FR,ISCHAEMIC STROKE,17
FR,ABNORMAL BEHAVIOUR,16
FR,CEREBRAL HAEMATOMA,16
FR,HEPATIC FAILURE,16
FR,HYPERAMMONAEMIA,16
FR,HYPERTHERMIA,16
FR,INFLAMMATION,16
FR,LEUKOPENIA,16
FR,SEIZURE,16
FR,URTICARIA,16
FR,VERTIGO,16
FR,CEREBROVASCULAR ACCIDENT,15
FR,COGNITIVE DISORDER,15
FR,COUGH,15
FR,FEBRILE NEUTROPENIA,15
FR,OEDEMA,15
FR,PRODUCT USE IN UNAPPROVED INDICATION,15
FR,SHOCK HAEMORRHAGIC,15
FR,TREMOR,15
FR,ALTERED STATE OF CONSCIOUSNESS,14
FR,ARTHRALGIA,14
FR,BALANCE DISORDER,14
FR,FACE OEDEMA,14
FR,INSOMNIA,14
FR,MUSCLE SPASMS,14
FR,PLEURAL EFFUSION,14
FR,TUBULOINTERSTITIAL NEPHRITIS,14
FR,BONE MARROW FAILURE,13
FR,CARDIO-RESPIRATORY ARREST,13
FR,CHILLS,13
FR,DEPRESSION,13
FR,GASTROINTESTINAL HAEMORRHAGE,13
FR,HYPOGLYCAEMIC UNCONSCIOUSNESS,13
FR,PAIN,13
FR,PANCREATITIS,13
FR,TRANSAMINASES INCREASED,13
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,12
FR,ALANINE AMINOTRANSFERASE INCREASED,12
FR,BLOOD PRESSURE DECREASED,12
FR,COLITIS,12
FR,EPISTAXIS,12
FR,HAEMATEMESIS,12
FR,HEAD INJURY,12
FR,HYPERHIDROSIS,12
FR,INFECTION,12
FR,MULTI-ORGAN FAILURE,12
FR,AGITATION,11
FR,ARRHYTHMIA,11
FR,ASPARTATE AMINOTRANSFERASE INCREASED,11
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,11
FR,CHEST PAIN,11
FR,DEEP VEIN THROMBOSIS,11
FR,ERYSIPELAS,11
FR,HAEMORRHAGE,11
FR,HEPATOCELLULAR CARCINOMA,11
FR,HYPOTHERMIA,11
FR,JAUNDICE,11
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,11
FR,RECTAL HAEMORRHAGE,11
FR,TOXIC SKIN ERUPTION,11
FR,ACUTE PRERENAL FAILURE,10
FR,AGGRESSION,10
FR,BLOOD BILIRUBIN INCREASED,10
FR,CARDIOGENIC SHOCK,10
FR,CONSTIPATION,10
FR,DERMATITIS BULLOUS,10
FR,DIALYSIS,10
FR,DISTURBANCE IN ATTENTION,10
FR,ELECTROCARDIOGRAM QT PROLONGED,10
FR,EXTRAPYRAMIDAL DISORDER,10
FR,HYPOKINESIA,10
FR,INCORRECT DOSE ADMINISTERED,10
FR,INTENTIONAL OVERDOSE,10
FR,LYMPHOPENIA,10
FR,MALIGNANT NEOPLASM PROGRESSION,10
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,10
FR,PRODUCT SUBSTITUTION ISSUE,10
FR,PROTEINURIA,10
FR,PULMONARY ARTERIAL HYPERTENSION,10
FR,SYNCOPE,10
FR,WEIGHT INCREASED,10
FR,ACUTE PULMONARY OEDEMA,9
FR,ASCITES,9
FR,BRADYPHRENIA,9
FR,CEREBRAL HAEMORRHAGE,9
FR,COMPLETED SUICIDE,9
FR,DRUG PRESCRIBING ERROR,9
FR,HAEMOGLOBIN DECREASED,9
FR,HYPOGAMMAGLOBULINAEMIA,9
FR,HYPOVOLAEMIC SHOCK,9
FR,MYELODYSPLASTIC SYNDROME,9
FR,MYOCARDIAL INFARCTION,9
FR,PANCREATIC CARCINOMA METASTATIC,9
FR,PNEUMONIA ASPIRATION,9
FR,PSORIASIS,9
FR,PURPURA,9
FR,TENDON RUPTURE,9
FR,BACK PAIN,8
FR,BLOOD LACTIC ACID INCREASED,8
FR,C-REACTIVE PROTEIN INCREASED,8
FR,CELL DEATH,8
FR,DISEASE PROGRESSION,8
FR,DYSPEPSIA,8
FR,DYSPHAGIA,8
FR,EPILEPSY,8
FR,FAECALOMA,8
FR,GASTROENTERITIS,8
FR,GASTROINTESTINAL DISORDER,8
FR,HALLUCINATION,8
FR,HEPATITIS ACUTE,8
FR,HYPERTHYROIDISM,8
FR,HYPOCALCAEMIA,8
FR,IMMUNE THROMBOCYTOPENIC PURPURA,8
FR,IRON DEFICIENCY ANAEMIA,8
FR,ORTHOSTATIC HYPOTENSION,8
FR,PALLOR,8
FR,PARAESTHESIA,8
FR,PERICARDITIS,8
FR,PHLEBITIS,8
FR,PRODUCT USE ISSUE,8
FR,RASH ERYTHEMATOUS,8
FR,STATUS EPILEPTICUS,8
FR,SUBDURAL HAEMATOMA,8
FR,TACHYPNOEA,8
FR,TOXIC ENCEPHALOPATHY,8
FR,VISUAL ACUITY REDUCED,8
FR,ACCIDENTAL OVERDOSE,7
FR,AGEUSIA,7
FR,ANAPHYLACTIC SHOCK,7
FR,DELIRIUM,7
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,7
FR,DRUG-INDUCED LIVER INJURY,7
FR,DYSPHONIA,7
FR,GASTRIC ULCER,7
FR,GLYCOSYLATED HAEMOGLOBIN INCREASED,7
FR,HAEMATURIA,7
FR,HEPATOMEGALY,7
FR,HYPOMAGNESAEMIA,7
FR,HYPOXIA,7
FR,INTESTINAL ISCHAEMIA,7
FR,LEUKOCYTOSIS,7
FR,METABOLIC ENCEPHALOPATHY,7
FR,NEUROPATHY PERIPHERAL,7
FR,OSTEOARTHRITIS,7
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,7
FR,PRESYNCOPE,7
FR,PYELONEPHRITIS,7
FR,SUDDEN DEATH,7
FR,TOXIC EPIDERMAL NECROLYSIS,7
FR,ACUTE CORONARY SYNDROME,6
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,6
FR,ANXIETY,6
FR,ATRIOVENTRICULAR BLOCK,6
FR,ATRIOVENTRICULAR BLOCK COMPLETE,6
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,6
FR,BLOOD GLUCOSE INCREASED,6
FR,BREAST CANCER,6
FR,BRONCHITIS,6
FR,CHOLANGITIS,6
FR,CHOLELITHIASIS,6
FR,DRUG LEVEL ABOVE THERAPEUTIC,6
FR,EPSTEIN-BARR VIRUS INFECTION,6
FR,EXPOSURE DURING PREGNANCY,6
FR,FLUSHING,6
FR,FOETAL EXPOSURE DURING PREGNANCY,6
FR,GENERAL PHYSICAL CONDITION ABNORMAL,6
FR,HAEMORRHAGIC STROKE,6
FR,HEPATIC STEATOSIS,6
FR,HOT FLUSH,6
FR,HYPERTRIGLYCERIDAEMIA,6
FR,HYPOGLYCAEMIC COMA,6
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,6
FR,MUCOSAL INFLAMMATION,6
FR,MUSCULAR WEAKNESS,6
FR,NASAL CONGESTION,6
FR,ORGANISING PNEUMONIA,6
FR,OXYGEN SATURATION DECREASED,6
FR,PACKED RED BLOOD CELL TRANSFUSION,6
FR,PALPITATIONS,6
FR,PERICARDIAL EFFUSION,6
FR,POLYARTHRITIS,6
FR,SINUS BRADYCARDIA,6
FR,SUBARACHNOID HAEMORRHAGE,6
FR,SUICIDE ATTEMPT,6
FR,TRANSFUSION,6
FR,URINARY RETENTION,6
FR,VISION BLURRED,6
FR,VITAMIN B12 DEFICIENCY,6
FR,ACIDOSIS,5
FR,ACUTE MYELOID LEUKAEMIA,5
FR,ACUTE RESPIRATORY FAILURE,5
FR,ALOPECIA,5
FR,APHASIA,5
FR,B-CELL LYMPHOMA,5
FR,BLISTER,5
FR,BLOOD BICARBONATE DECREASED,5
FR,BLOOD LACTIC ACID,5
FR,BLOOD PRESSURE INCREASED,5
FR,BLOOD SODIUM DECREASED,5
FR,CHRONIC KIDNEY DISEASE,5
FR,CIRCULATORY COLLAPSE,5
FR,CRANIOCEREBRAL INJURY,5
FR,CRYSTALLURIA,5
FR,DERMATITIS EXFOLIATIVE,5
FR,DIABETIC KETOACIDOSIS,5
FR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,5
FR,FACIAL PARALYSIS,5
FR,HAEMODIALYSIS,5
FR,HAEMOPTYSIS,5
FR,HERPES SIMPLEX,5
FR,HERPES SIMPLEX ENCEPHALITIS,5
FR,HOSPITALISATION,5
FR,HYPOALBUMINAEMIA,5
FR,IMPULSE-CONTROL DISORDER,5
FR,INJECTION SITE PAIN,5
FR,INTESTINAL OBSTRUCTION,5
FR,LIVER FUNCTION TEST ABNORMAL,5
FR,LYMPHADENOPATHY,5
FR,MEMORY IMPAIRMENT,5
FR,METASTASES TO LIVER,5
FR,MUSCLE HAEMORRHAGE,5
FR,NECROSIS,5
FR,NEPHROPATHY,5
FR,OEDEMATOUS PANCREATITIS,5
FR,OLIGURIA,5
FR,OSTEITIS,5
FR,OSTEONECROSIS,5
FR,PERIPHERAL SWELLING,5
FR,PERITONITIS,5
FR,PORTAL HYPERTENSION,5
FR,PRERENAL FAILURE,5
FR,PULMONARY FIBROSIS,5
FR,SINOATRIAL BLOCK,5
FR,SPEECH DISORDER,5
FR,STRESS CARDIOMYOPATHY,5
FR,STUPOR,5
FR,TYPE 2 DIABETES MELLITUS,5
FR,URINARY TRACT INFECTION,5
FR,VASCULAR PURPURA,5
FR,VISUAL IMPAIRMENT,5
FR,WOUND,5
FR,ADENOCARCINOMA PANCREAS,4
FR,AKINESIA,4
FR,ANAEMIA MACROCYTIC,4
FR,APHTHOUS ULCER,4
FR,APLASIA,4
FR,ARTERIAL DISORDER,4
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,4
FR,BLINDNESS,4
FR,BLOOD GLUCOSE ABNORMAL,4
FR,BLOOD UREA INCREASED,4
FR,CHONDROCALCINOSIS,4
FR,COAGULATION FACTOR DECREASED,4
FR,CREATININE RENAL CLEARANCE DECREASED,4
FR,CUTANEOUS VASCULITIS,4
FR,DEMENTIA,4
FR,DUODENAL ULCER,4
FR,ECZEMA,4
FR,ELECTROCARDIOGRAM ABNORMAL,4
FR,ENCEPHALITIS,4
FR,ESCHERICHIA PYELONEPHRITIS,4
FR,FRACTURE,4
FR,GASTRITIS,4
FR,GASTROINTESTINAL ANGIODYSPLASIA,4
FR,HAEMOLYTIC ANAEMIA,4
FR,HEART RATE INCREASED,4
FR,HEPATIC ENCEPHALOPATHY,4
FR,HYPERLIPASAEMIA,4
FR,HYPERNATRAEMIA,4
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
FR,INFECTION REACTIVATION,4
FR,INJECTION SITE NODULE,4
FR,INTRACRANIAL MASS,4
FR,JAUNDICE CHOLESTATIC,4
FR,LIVER INJURY,4
FR,MEDICATION ERROR,4
FR,NEPHROPATHY TOXIC,4
FR,NIGHTMARE,4
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,4
FR,OESOPHAGITIS,4
FR,POISONING DELIBERATE,4
FR,PREMATURE RUPTURE OF MEMBRANES,4
FR,PRODUCTIVE COUGH,4
FR,PROSTATE CANCER,4
FR,RENAL COLIC,4
FR,RESPIRATORY ARREST,4
FR,RHEUMATOID ARTHRITIS,4
FR,SKIN EXFOLIATION,4
FR,SKIN LESION,4
FR,SOMNAMBULISM,4
FR,SPLENIC RUPTURE,4
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,4
FR,TENDON DISORDER,4
FR,TORSADE DE POINTES,4
FR,TRANSIENT ISCHAEMIC ATTACK,4
FR,TREATMENT NONCOMPLIANCE,4
FR,UROSEPSIS,4
FR,VENTRICULAR HYPOKINESIA,4
FR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
FR,ABASIA,3
FR,ABDOMINAL PAIN LOWER,3
FR,ADRENAL INSUFFICIENCY,3
FR,ALVEOLITIS,3
FR,AMNIOTIC CAVITY INFECTION,3
FR,ANION GAP INCREASED,3
FR,AORTIC STENOSIS,3
FR,ATELECTASIS,3
FR,BACTERIAL SEPSIS,3
FR,BLOOD POTASSIUM INCREASED,3
FR,BRAIN OEDEMA,3
FR,BRONCHOSPASM,3
FR,BUNDLE BRANCH BLOCK LEFT,3
FR,C-REACTIVE PROTEIN DECREASED,3
FR,CARDIAC DISORDER,3
FR,CHEILITIS,3
FR,CHOLECYSTITIS ACUTE,3
FR,CLOSTRIDIUM DIFFICILE COLITIS,3
FR,COAGULATION FACTOR V LEVEL DECREASED,3
FR,COLITIS MICROSCOPIC,3
FR,COLITIS ULCERATIVE,3
FR,COMA SCALE ABNORMAL,3
FR,CONJUNCTIVITIS,3
FR,CONTRAINDICATED PRODUCT ADMINISTERED,3
FR,CSF PROTEIN INCREASED,3
FR,CYSTITIS ESCHERICHIA,3
FR,CYTOMEGALOVIRUS TEST POSITIVE,3
FR,DERMO-HYPODERMITIS,3
FR,DIPLOPIA,3
FR,DIVERTICULUM INTESTINAL,3
FR,DRUG EFFECT INCOMPLETE,3
FR,DRUG INTOLERANCE,3
FR,DYSAESTHESIA,3
FR,DYSPNOEA EXERTIONAL,3
FR,ECCHYMOSIS,3
FR,EJECTION FRACTION DECREASED,3
FR,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
FR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
FR,ELECTROCARDIOGRAM T WAVE INVERSION,3
FR,ELECTROENCEPHALOGRAM ABNORMAL,3
FR,ENTEROBACTER TEST POSITIVE,3
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,3
FR,ESCHAR,3
FR,ESCHERICHIA SEPSIS,3
FR,EYELID OEDEMA,3
FR,FACIAL BONES FRACTURE,3
FR,FAECES DISCOLOURED,3
FR,FEBRILE BONE MARROW APLASIA,3
FR,FEEDING DISORDER,3
FR,FOLATE DEFICIENCY,3
FR,GENERALISED TONIC-CLONIC SEIZURE,3
FR,GLOMERULAR FILTRATION RATE DECREASED,3
FR,HAEMORRHAGIC ANAEMIA,3
FR,HAEMORRHAGIC TRANSFORMATION STROKE,3
FR,HALLUCINATION_ VISUAL,3
FR,HEMIPLEGIA,3
FR,HEPATIC CIRRHOSIS,3
FR,HEPATIC ENZYME INCREASED,3
FR,HEPATITIS CHOLESTATIC,3
FR,HEPATITIS FULMINANT,3
FR,HIATUS HERNIA,3
FR,HYPERCALCAEMIA,3
FR,HYPERCHOLESTEROLAEMIA,3
FR,HYPERKINETIC HEART SYNDROME,3
FR,HYPERSENSITIVITY,3
FR,IMPAIRED HEALING,3
FR,INFUSION RELATED REACTION,3
FR,INJECTION SITE INDURATION,3
FR,INTENTIONAL PRODUCT MISUSE,3
FR,INTERMITTENT CLAUDICATION,3
FR,IRRITABILITY,3
FR,ISCHAEMIA,3
FR,JOINT EFFUSION,3
FR,JUGULAR VEIN THROMBOSIS,3
FR,LARGE INTESTINAL HAEMORRHAGE,3
FR,LEFT VENTRICULAR FAILURE,3
FR,LIMB DISCOMFORT,3
FR,LIP OEDEMA,3
FR,LIVER DISORDER,3
FR,LUNG INFECTION,3
FR,MALIGNANT MELANOMA,3
FR,MALNUTRITION,3
FR,MATERNAL EXPOSURE DURING PREGNANCY,3
FR,MESENTERIC VEIN THROMBOSIS,3
FR,MIOSIS,3
FR,MYOCARDIAL ISCHAEMIA,3
FR,MYOCARDITIS,3
FR,MYOSITIS,3
FR,NECROTISING FASCIITIS,3
FR,NEPHROTIC SYNDROME,3
FR,NERVOUS SYSTEM DISORDER,3
FR,NEUROLEPTIC MALIGNANT SYNDROME,3
FR,NEUROLOGICAL DECOMPENSATION,3
FR,OLIGOHYDRAMNIOS,3
FR,OSTEONECROSIS OF JAW,3
FR,PAPULE,3
FR,PERIPHERAL ISCHAEMIA,3
FR,PETECHIAE,3
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
FR,PRESCRIBED OVERDOSE,3
FR,PRURITUS GENERALISED,3
FR,PSYCHOMOTOR HYPERACTIVITY,3
FR,PULMONARY CONGESTION,3
FR,PULMONARY MASS,3
FR,PULMONARY OEDEMA,3
FR,RASH GENERALISED,3
FR,RASH PUSTULAR,3
FR,RASH VESICULAR,3
FR,RED BLOOD CELL COUNT DECREASED,3
FR,RENAL CYST,3
FR,RENAL TUBULAR DISORDER,3
FR,RESPIRATORY FAILURE,3
FR,RHINITIS,3
FR,RIGHT VENTRICULAR FAILURE,3
FR,SALIVARY HYPERSECRETION,3
FR,SKIN DISCOLOURATION,3
FR,SLEEP DISORDER,3
FR,STOMATITIS,3
FR,THIRST,3
FR,URINARY INCONTINENCE,3
FR,VASCULITIS,3
FR,VASOPLEGIA SYNDROME,3
FR,VENOOCCLUSIVE LIVER DISEASE,3
FR,VENTRICULAR TACHYCARDIA,3
FR,VIRAL INFECTION,3
FR,VITREOUS HAEMORRHAGE,3
FR,WHITE BLOOD CELL COUNT INCREASED,3
FR,ABDOMINAL DISCOMFORT,2
FR,ABORTION SPONTANEOUS,2
FR,ACNE,2
FR,ACTINIC KERATOSIS,2
FR,ACUTE HEPATITIS B,2
FR,ACUTE MYOCARDIAL INFARCTION,2
FR,ACUTE PROMYELOCYTIC LEUKAEMIA,2
FR,ALBUMINURIA,2
FR,AMNESIA,2
FR,ANAL INCONTINENCE,2
FR,ANGINA PECTORIS,2
FR,APATHY,2
FR,APHAGIA,2
FR,APLASIA PURE RED CELL,2
FR,APLASTIC ANAEMIA,2
FR,APRAXIA,2
FR,ARTERIAL OCCLUSIVE DISEASE,2
FR,ARTERIAL STENOSIS,2
FR,ARTERIOSCLEROSIS,2
FR,ARTHROPATHY,2
FR,ASPERGILLUS INFECTION,2
FR,ASPIRATION,2
FR,ATRIAL FLUTTER,2
FR,AZOTAEMIA,2
FR,BICYTOPENIA,2
FR,BILIRUBIN CONJUGATED INCREASED,2
FR,BLINDNESS UNILATERAL,2
FR,BLOOD CREATINE ABNORMAL,2
FR,BLOOD CREATININE DECREASED,2
FR,BLOOD GLUCOSE FLUCTUATION,2
FR,BLOOD PH DECREASED,2
FR,BLOOD POTASSIUM ABNORMAL,2
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
FR,BLOOD TRIGLYCERIDES INCREASED,2
FR,BONE PAIN,2
FR,BRAIN DEATH,2
FR,BRAIN HERNIATION,2
FR,BRAIN NEOPLASM,2
FR,BRAIN STEM HAEMATOMA,2
FR,BREAST CANCER FEMALE,2
FR,BREAST NEOPLASM,2
FR,BRONCHITIS BACTERIAL,2
FR,BRONCHOPNEUMOPATHY,2
FR,BRONCHOPULMONARY ASPERGILLOSIS,2
FR,BUNDLE BRANCH BLOCK,2
FR,BUNDLE BRANCH BLOCK RIGHT,2
FR,BURNING SENSATION,2
FR,CANDIDA SEPSIS,2
FR,CARDIAC FAILURE ACUTE,2
FR,CARDIAC PACEMAKER INSERTION,2
FR,CARDIOMEGALY,2
FR,CEREBRAL INFARCTION,2
FR,CEREBRAL ISCHAEMIA,2
FR,CERVICAL INCOMPETENCE,2
FR,CHEST DISCOMFORT,2
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
FR,CLEFT LIP AND PALATE,2
FR,CLOSTRIDIUM DIFFICILE INFECTION,2
FR,COGWHEEL RIGIDITY,2
FR,CONDUCTION DISORDER,2
FR,CONTRAINDICATED DRUG ADMINISTERED,2
FR,CONTUSION,2
FR,CORONARY ARTERY DISEASE,2
FR,CRANIOFACIAL DYSOSTOSIS,2
FR,CUSHING^S SYNDROME,2
FR,CYTOMEGALOVIRUS INFECTION,2
FR,DELUSION,2
FR,DIABETIC COMA,2
FR,DIABETIC HYPEROSMOLAR COMA,2
FR,DIABETIC METABOLIC DECOMPENSATION,2
FR,DIABETIC RETINOPATHY,2
FR,DRUG EFFECT DELAYED,2
FR,DRY MOUTH,2
FR,DRY SKIN,2
FR,DYSKINESIA,2
FR,DYSSTASIA,2
FR,DYSURIA,2
FR,ECHOCARDIOGRAM ABNORMAL,2
FR,ENDOPHTHALMITIS,2
FR,ENTERITIS,2
FR,EOSINOPHILIC PNEUMONIA,2
FR,ERECTILE DYSFUNCTION,2
FR,ESCHERICHIA TEST POSITIVE,2
FR,ESCHERICHIA URINARY TRACT INFECTION,2
FR,EXFOLIATIVE RASH,2
FR,EXTREMITY NECROSIS,2
FR,EYE HAEMORRHAGE,2
FR,EYE PAIN,2
FR,FALSE POSITIVE INVESTIGATION RESULT,2
FR,FEELING HOT,2
FR,FOLLICULITIS,2
FR,FORMICATION,2
FR,FRONTOTEMPORAL DEMENTIA,2
FR,FUNGAL INFECTION,2
FR,GASTRIC DISORDER,2
FR,GASTROOESOPHAGEAL REFLUX DISEASE,2
FR,GENERALISED ERYTHEMA,2
FR,GESTATIONAL DIABETES,2
FR,GINGIVAL BLEEDING,2
FR,HAEMANGIOMA,2
FR,HALLUCINATION_ AUDITORY,2
FR,HEMIPARESIS,2
FR,HEPARIN-INDUCED THROMBOCYTOPENIA,2
FR,HEPATIC SIDEROSIS,2
FR,HEPATOTOXICITY,2
FR,HISTIOCYTOSIS HAEMATOPHAGIC,2
FR,HYDROCEPHALUS,2
FR,HYPERKINESIA,2
FR,HYPERPYREXIA,2
FR,HYPERSEXUALITY,2
FR,HYPERSOMNIA,2
FR,HYPERTENSIVE CRISIS,2
FR,HYPOAESTHESIA,2
FR,HYPOPERFUSION,2
FR,HYPOPHOSPHATAEMIA,2
FR,HYPOPROTHROMBINAEMIA,2
FR,HYPOTHYROIDISM,2
FR,HYPOVITAMINOSIS,2
FR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
FR,IMPAIRED GASTRIC EMPTYING,2
FR,INCOHERENT,2
FR,INCONTINENCE,2
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
FR,INFECTED FISTULA,2
FR,INJECTION SITE ERYTHEMA,2
FR,INJECTION SITE REACTION,2
FR,INJURY,2
FR,INTESTINAL INFARCTION,2
FR,INTRACRANIAL PRESSURE INCREASED,2
FR,ISCHAEMIC HEPATITIS,2
FR,JOINT SWELLING,2
FR,KETOACIDOSIS,2
FR,KLEBSIELLA INFECTION,2
FR,KLEBSIELLA SEPSIS,2
FR,LACRIMATION INCREASED,2
FR,LARGE INTESTINAL ULCER,2
FR,LEFT VENTRICULAR DYSFUNCTION,2
FR,LETHARGY,2
FR,LEUKOCYTURIA,2
FR,LIVER TRANSPLANT,2
FR,LIVER TRANSPLANT REJECTION,2
FR,LUNG CANCER METASTATIC,2
FR,LUNG NEOPLASM MALIGNANT,2
FR,LYMPHOMA,2
FR,MACROGLOSSIA,2
FR,MENTAL DISORDER,2
FR,METASTASES TO BONE,2
FR,METASTASES TO LUNG,2
FR,MIDDLE INSOMNIA,2
FR,MIGRAINE,2
FR,MITRAL VALVE INCOMPETENCE,2
FR,MOTOR DYSFUNCTION,2
FR,MUSCLE RUPTURE,2
FR,MYOPATHY,2
FR,NEOPLASM MALIGNANT,2
FR,NEOPLASM PROGRESSION,2
FR,NEOPLASM PROSTATE,2
FR,NIGHT SWEATS,2
FR,OBLITERATIVE BRONCHIOLITIS,2
FR,OEDEMA MOUTH,2
FR,OESOPHAGEAL VARICES HAEMORRHAGE,2
FR,ORAL CANDIDIASIS,2
FR,ORAL MUCOSA EROSION,2
FR,OROMANDIBULAR DYSTONIA,2
FR,PANCREATIC ENZYMES ABNORMAL,2
FR,PANCREATIC ISLETS HYPERPLASIA,2
FR,PAPILLOEDEMA,2
FR,PARKINSONISM,2
FR,PARTIAL SEIZURES,2
FR,PATHOLOGICAL GAMBLING,2
FR,PERIPHERAL ARTERY THROMBOSIS,2
FR,PERIPHERAL VENOUS DISEASE,2
FR,PLATELET COUNT DECREASED,2
FR,PLEURAL MESOTHELIOMA,2
FR,PNEUMONIA KLEBSIELLA,2
FR,POLYDIPSIA,2
FR,POLYMYALGIA RHEUMATICA,2
FR,POLYNEUROPATHY,2
FR,POLYURIA,2
FR,POOR QUALITY SLEEP,2
FR,PORTAL VEIN THROMBOSIS,2
FR,POST PROCEDURAL HAEMATOMA,2
FR,POST PROCEDURAL SEPSIS,2
FR,PROTHROMBIN LEVEL DECREASED,2
FR,PROTHROMBIN TIME SHORTENED,2
FR,PSEUDOMEMBRANOUS COLITIS,2
FR,PSEUDOMONAS INFECTION,2
FR,PSYCHOMOTOR SKILLS IMPAIRED,2
FR,PULMONARY ALVEOLAR HAEMORRHAGE,2
FR,PULMONARY HYPERTENSION,2
FR,PULMONARY HYPOPLASIA,2
FR,PULMONARY SEPSIS,2
FR,RALES,2
FR,RASH PAPULAR,2
FR,RENAL APLASIA,2
FR,RESPIRATORY ACIDOSIS,2
FR,RESPIRATORY RATE INCREASED,2
FR,RETROPERITONEAL FIBROSIS,2
FR,RETROPERITONEAL HAEMATOMA,2
FR,RHINORRHOEA,2
FR,RIB FRACTURE,2
FR,SARCOIDOSIS,2
FR,SCIATICA,2
FR,SEDATION,2
FR,SERUM FERRITIN INCREASED,2
FR,SKIN PLAQUE,2
FR,SKIN SWELLING,2
FR,SKIN ULCER,2
FR,SLEEP APNOEA SYNDROME,2
FR,STAPHYLOCOCCAL SEPSIS,2
FR,STAPHYLOCOCCUS TEST POSITIVE,2
FR,STENT PLACEMENT,2
FR,STEVENS-JOHNSON SYNDROME,2
FR,STREPTOCOCCUS TEST POSITIVE,2
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
FR,TENDONITIS,2
FR,TETANY,2
FR,THERAPEUTIC EMBOLISATION,2
FR,THROMBECTOMY,2
FR,THROMBOCYTOSIS,2
FR,THYROIDITIS,2
FR,TINNITUS,2
FR,TONGUE OEDEMA,2
FR,TRANSPOSITION OF THE GREAT VESSELS,2
FR,TUMOUR LYSIS SYNDROME,2
FR,URETERIC CANCER,2
FR,URINARY TRACT INFECTION BACTERIAL,2
FR,VAGINAL INFECTION,2
FR,VENOUS THROMBOSIS,2
FR,VENTRICULAR FIBRILLATION,2
FR,VIRAL PERICARDITIS,2
FR,WHEEZING,2
FR,WHITE BLOOD CELL COUNT DECREASED,2
FR,WITHDRAWAL SYNDROME,2
FR,ABDOMINAL ABSCESS,1
FR,ABDOMINAL INJURY,1
FR,ABDOMINAL RIGIDITY,1
FR,ABDOMINAL WALL HAEMATOMA,1
FR,ABNORMAL LOSS OF WEIGHT,1
FR,ABORTION INDUCED,1
FR,ACCOMMODATION DISORDER,1
FR,ACQUIRED HAEMOPHILIA WITH ANTI FVIII_ XI_ OR XIII,1
FR,ACTINOMYCOSIS,1
FR,ACUTE MYELOMONOCYTIC LEUKAEMIA,1
FR,ACUTE POLYNEUROPATHY,1
FR,ADENOCARCINOMA GASTRIC,1
FR,ADENOCARCINOMA OF COLON,1
FR,ADRENAL ADENOMA,1
FR,ADRENAL MASS,1
FR,ADVERSE EVENT,1
FR,AFFECTIVE DISORDER,1
FR,AGE-RELATED MACULAR DEGENERATION,1
FR,ALCOHOL ABUSE,1
FR,ALCOHOL POISONING,1
FR,ALCOHOLISM,1
FR,ALKALOSIS HYPOCHLORAEMIC,1
FR,ALOPECIA AREATA,1
FR,ALVEOLITIS ALLERGIC,1
FR,AMMONIA INCREASED,1
FR,AMNESTIC DISORDER,1
FR,AMYLOIDOSIS,1
FR,AMYOTROPHY,1
FR,ANAL FISTULA,1
FR,ANAL ULCER,1
FR,ANAPHYLACTIC REACTION,1
FR,ANAPHYLACTOID REACTION,1
FR,ANGIOSARCOMA,1
FR,ANGLE CLOSURE GLAUCOMA,1
FR,ANISOCYTOSIS,1
FR,ANORECTAL VARICES,1
FR,ANTI-THYROID ANTIBODY,1
FR,ANTI-THYROID ANTIBODY POSITIVE,1
FR,ANTINUCLEAR ANTIBODY,1
FR,ANTINUCLEAR ANTIBODY POSITIVE,1
FR,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
FR,AORTIC ARTERIOSCLEROSIS,1
FR,AORTIC VALVE DISEASE,1
FR,AORTITIS,1
FR,APNOEA,1
FR,APPENDICITIS,1
FR,APPLICATION SITE PARAESTHESIA,1
FR,ARTERIAL INJURY,1
FR,ARTERIAL THROMBOSIS,1
FR,ARTERIOSCLEROSIS CORONARY ARTERY,1
FR,ARTHRITIS,1
FR,ASPIRATION PLEURAL CAVITY,1
FR,ASTHMA,1
FR,ASTHMATIC CRISIS,1
FR,ATHEROEMBOLISM,1
FR,ATROPHY,1
FR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
FR,AUTOIMMUNE HEPATITIS,1
FR,AUTOIMMUNE NEPHRITIS,1
FR,BACILLUS INFECTION,1
FR,BACTERIAL DIARRHOEA,1
FR,BACTERIAL PROSTATITIS,1
FR,BASAL CELL CARCINOMA,1
FR,BENCE JONES PROTEINURIA,1
FR,BENIGN NEOPLASM,1
FR,BENIGN OESOPHAGEAL NEOPLASM,1
FR,BETA 2 MICROGLOBULIN INCREASED,1
FR,BILIARY CYST,1
FR,BILIARY FISTULA,1
FR,BLADDER CANCER,1
FR,BLADDER CANCER STAGE 0_ WITH CANCER IN SITU,1
FR,BLADDER CATHETERISATION,1
FR,BLADDER DISORDER,1
FR,BLADDER TRANSITIONAL CELL CARCINOMA,1
FR,BLAST CELL COUNT INCREASED,1
FR,BLEEDING TIME PROLONGED,1
FR,BLOOD BICARBONATE,1
FR,BLOOD BICARBONATE INCREASED,1
FR,BLOOD BILIRUBIN DECREASED,1
FR,BLOOD BLISTER,1
FR,BLOOD CHOLESTEROL INCREASED,1
FR,BLOOD CHROMOGRANIN A INCREASED,1
FR,BLOOD CORTISOL DECREASED,1
FR,BLOOD CULTURE POSITIVE,1
FR,BLOOD FOLATE DECREASED,1
FR,BLOOD GLUCOSE DECREASED,1
FR,BLOOD IMMUNOGLOBULIN E INCREASED,1
FR,BLOOD IMMUNOGLOBULIN G ABNORMAL,1
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
FR,BLOOD PRESSURE DIASTOLIC DECREASED,1
FR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
FR,BLOOD PRESSURE SYSTOLIC INCREASED,1
FR,BLOOD PROLACTIN INCREASED,1
FR,BLOOD THYROID STIMULATING HORMONE,1
FR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE NORMAL,1
FR,BLOOD URIC ACID INCREASED,1
FR,BLOOD URINE PRESENT,1
FR,BODY TEMPERATURE INCREASED,1
FR,BONE FISSURE,1
FR,BONE MARROW RETICULIN FIBROSIS,1
FR,BRADYKINESIA,1
FR,BRADYPNOEA,1
FR,BRAIN CONTUSION,1
FR,BRAIN INJURY,1
FR,BREAST CANCER MALE,1
FR,BREAST CANCER METASTATIC,1
FR,BRONCHIAL DISORDER,1
FR,BRONCHIAL HAEMORRHAGE,1
FR,BRONCHIAL OBSTRUCTION,1
FR,BRONCHIECTASIS,1
FR,BRONCHITIS FUNGAL,1
FR,BURSITIS,1
FR,BURSITIS INFECTIVE,1
FR,CACHEXIA,1
FR,CAESAREAN SECTION,1
FR,CALCULUS URETHRAL,1
FR,CALCULUS URINARY,1
FR,CANDIDA INFECTION,1
FR,CANDIDIASIS,1
FR,CAPILLARITIS,1
FR,CAPILLARY LEAK SYNDROME,1
FR,CARBOHYDRATE ANTIGEN 15-3 INCREASED,1
FR,CARDIAC TAMPONADE,1
FR,CARDIOACTIVE DRUG LEVEL INCREASED,1
FR,CARDIOMYOPATHY,1
FR,CARDIOPULMONARY FAILURE,1
FR,CARDIORENAL SYNDROME,1
FR,CARDIOTOXICITY,1
FR,CARDIOVASCULAR DISORDER,1
FR,CARDIOVASCULAR INSUFFICIENCY,1
FR,CARPAL TUNNEL SYNDROME,1
FR,CATARACT,1
FR,CATARRH,1
FR,CELLULITIS,1
FR,CEREBELLAR INFARCTION,1
FR,CEREBELLAR SYNDROME,1
FR,CEREBRAL VENOUS THROMBOSIS,1
FR,CERVICAL VERTEBRAL FRACTURE,1
FR,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,1
FR,CHEST X-RAY ABNORMAL,1
FR,CHILLBLAINS,1
FR,CHOLANGIOCARCINOMA,1
FR,CHOLECYSTITIS,1
FR,CHOLECYSTITIS CHRONIC,1
FR,CHOLESTATIC LIVER INJURY,1
FR,CHROMATURIA,1
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
FR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
FR,CIRRHOSIS ALCOHOLIC,1
FR,COLD SWEAT,1
FR,COLON CANCER,1
FR,COLORECTAL CANCER METASTATIC,1
FR,COLOUR BLINDNESS,1
FR,COMMUNICATION DISORDER,1
FR,COMPARTMENT SYNDROME,1
FR,COMPLEX REGIONAL PAIN SYNDROME,1
FR,COMPLICATION OF DELIVERY,1
FR,COMPULSIVE SHOPPING,1
FR,CONCOMITANT DISEASE AGGRAVATED,1
FR,CONGENITAL ANOMALY IN OFFSPRING,1
FR,CONGENITAL CYSTIC KIDNEY DISEASE,1
FR,CONGESTIVE CARDIOMYOPATHY,1
FR,CONJUNCTIVAL HAEMORRHAGE,1
FR,CONTINUOUS HAEMODIAFILTRATION,1
FR,CONTRAINDICATION TO MEDICAL TREATMENT,1
FR,CONVULSION,1
FR,COOMBS POSITIVE HAEMOLYTIC ANAEMIA,1
FR,CORONARY ARTERY STENOSIS,1
FR,CRANIAL SUTURES WIDENING,1
FR,CRANIECTOMY,1
FR,CRANIOPHARYNGIOMA,1
FR,CREATININE RENAL CLEARANCE ABNORMAL,1
FR,CREPITATIONS,1
FR,CRYING,1
FR,CRYSTAL URINE PRESENT,1
FR,CULTURE URINE POSITIVE,1
FR,CYSTITIS,1
FR,CYSTOID MACULAR OEDEMA,1
FR,DEEP BRAIN STIMULATION,1
FR,DEEP VEIN THROMBOSIS POSTOPERATIVE,1
FR,DEFORMITY,1
FR,DEPENDENCE,1
FR,DERMATITIS CONTACT,1
FR,DERMATITIS EXFOLIATIVE GENERALISED,1
FR,DERMATOMYOSITIS,1
FR,DEVICE USE ERROR,1
FR,DIABETIC COMPLICATION,1
FR,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,1
FR,DIABETIC NEUROPATHY,1
FR,DIARRHOEA INFECTIOUS,1
FR,DILATATION ATRIAL,1
FR,DISCOMFORT,1
FR,DISEASE COMPLICATION,1
FR,DISINHIBITION,1
FR,DISSEMINATED INTRAVASCULAR COAGULATION,1
FR,DISSEMINATED TUBERCULOSIS,1
FR,DRUG ADMINISTRATION ERROR,1
FR,DRUG DOSE OMISSION,1
FR,DRUG EFFECT DECREASED,1
FR,DRUG ERUPTION,1
FR,DRUG LEVEL DECREASED,1
FR,DRUG USE DISORDER,1
FR,DRUG WITHDRAWAL SYNDROME,1
FR,DUODENAL ULCER HAEMORRHAGE,1
FR,DUODENAL ULCER PERFORATION,1
FR,DUODENITIS,1
FR,DYSARTHRIA,1
FR,DYSGEUSIA,1
FR,DYSGRAPHIA,1
FR,DYSHIDROTIC ECZEMA,1
FR,EAR SWELLING,1
FR,EATING DISORDER,1
FR,ECZEMA INFECTED,1
FR,EMBOLISM,1
FR,EMOTIONAL DISTRESS,1
FR,ENCEPHALITIS AUTOIMMUNE,1
FR,ENCEPHALITIS TOXIC,1
FR,ENCEPHALITIS VIRAL,1
FR,ENDOMETRIAL HYPERPLASIA,1
FR,ENDOMETRITIS,1
FR,ENTEROCOCCAL INFECTION,1
FR,ENTEROCUTANEOUS FISTULA,1
FR,EPIDIDYMITIS,1
FR,ERUCTATION,1
FR,ERYTHEMA MULTIFORME,1
FR,ERYTHEMA OF EYELID,1
FR,ERYTHROMELALGIA,1
FR,ESCHERICHIA BACTERAEMIA,1
FR,ESCHERICHIA INFECTION,1
FR,EXCESSIVE GRANULATION TISSUE,1
FR,EXECUTIVE DYSFUNCTION,1
FR,EYE DISORDER,1
FR,EYE OEDEMA,1
FR,EYELID PTOSIS,1
FR,FAHR^S DISEASE,1
FR,FEAR OF FALLING,1
FR,FEELING COLD,1
FR,FEELING DRUNK,1
FR,FEMORAL NECK FRACTURE,1
FR,FEMUR FRACTURE,1
FR,FIBULA FRACTURE,1
FR,FILARIASIS,1
FR,FISTULA DISCHARGE,1
FR,FIXED ERUPTION,1
FR,FLATULENCE,1
FR,FLUID RETENTION,1
FR,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
GE,COLITIS,3
GE,LACTIC ACIDOSIS,3
GE,OVERDOSE,3
GE,RESPIRATORY FAILURE,3
GE,ABDOMINAL PAIN,1
GE,HAEMATEMESIS,1
GE,MENTAL STATUS CHANGES,1
DE,LACTIC ACIDOSIS,335
DE,DIARRHOEA,132
DE,NAUSEA,132
DE,RENAL FAILURE ACUTE,113
DE,ACUTE KIDNEY INJURY,110
DE,RENAL FAILURE,109
DE,GENERAL PHYSICAL HEALTH DETERIORATION,108
DE,PNEUMONIA,104
DE,VOMITING,103
DE,DYSPNOEA,102
DE,FOETAL EXPOSURE DURING PREGNANCY,94
DE,DIZZINESS,81
DE,FATIGUE,71
DE,BLOOD GLUCOSE INCREASED,70
DE,DEHYDRATION,69
DE,FALL,69
DE,WEIGHT DECREASED,69
DE,HYPOGLYCAEMIA,65
DE,HYPERKALAEMIA,64
DE,KETOACIDOSIS,64
DE,HYPOTENSION,62
DE,ASTHENIA,59
DE,METABOLIC ACIDOSIS,59
DE,PYREXIA,57
DE,CARDIAC FAILURE,54
DE,DRUG INEFFECTIVE,52
DE,TOXICITY TO VARIOUS AGENTS,52
DE,ANAEMIA,49
DE,DECREASED APPETITE,49
DE,EXPOSURE DURING PREGNANCY,45
DE,SEPSIS,44
DE,SOMNOLENCE,43
DE,URINARY TRACT INFECTION,43
DE,ATRIAL FIBRILLATION,42
DE,PRURITUS,42
DE,SMALL FOR DATES BABY,42
DE,HYPONATRAEMIA,41
DE,MULTI-ORGAN FAILURE,41
DE,HEADACHE,40
DE,SYNCOPE,40
DE,CIRCULATORY COLLAPSE,39
DE,HYPERHIDROSIS,39
DE,ABDOMINAL PAIN UPPER,38
DE,BLOOD PRESSURE INCREASED,38
DE,MYOCARDIAL INFARCTION,38
DE,ATRIAL SEPTAL DEFECT,37
DE,CONFUSIONAL STATE,37
DE,DEATH,36
DE,PAIN IN EXTREMITY,36
DE,PULMONARY EMBOLISM,36
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,35
DE,CARDIAC ARREST,34
DE,DIABETES MELLITUS,34
DE,RHABDOMYOLYSIS,34
DE,PLEURAL EFFUSION,33
DE,ARTHRALGIA,32
DE,VERTIGO,32
DE,ANGINA PECTORIS,31
DE,C-REACTIVE PROTEIN INCREASED,31
DE,CEREBROVASCULAR ACCIDENT,31
DE,HYPERGLYCAEMIA,31
DE,OEDEMA PERIPHERAL,31
DE,RESTLESSNESS,31
DE,ABDOMINAL PAIN,30
DE,OVERDOSE,30
DE,RESPIRATORY FAILURE,30
DE,BLOOD CREATININE INCREASED,29
DE,COUGH,29
DE,HEPATIC ENZYME INCREASED,29
DE,PAIN,29
DE,THROMBOCYTOPENIA,29
DE,GASTROINTESTINAL HAEMORRHAGE,28
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,28
DE,MYALGIA,28
DE,ACIDOSIS,27
DE,HYPERTENSION,27
DE,INFECTION,27
DE,TACHYCARDIA,27
DE,ABDOMINAL DISCOMFORT,26
DE,ALANINE AMINOTRANSFERASE INCREASED,26
DE,BLOOD GLUCOSE ABNORMAL,26
DE,CONSTIPATION,26
DE,HAEMOGLOBIN DECREASED,26
DE,HYPOTHERMIA,26
DE,DELIRIUM,25
DE,COMA,24
DE,DRUG-INDUCED LIVER INJURY,24
DE,PANCREATITIS,24
DE,PANCYTOPENIA,24
DE,CORONARY ARTERY DISEASE,23
DE,HAEMORRHAGE,23
DE,HYPERTENSIVE CRISIS,23
DE,LOSS OF CONSCIOUSNESS,23
DE,ARRHYTHMIA,22
DE,DEPRESSION,22
DE,MUSCLE SPASMS,22
DE,SUICIDE ATTEMPT,22
DE,CEREBRAL HAEMORRHAGE,21
DE,CONTUSION,21
DE,DISTURBANCE IN ATTENTION,21
DE,GAIT DISTURBANCE,21
DE,HAEMATOMA,21
DE,HEPATIC FAILURE,21
DE,LIPASE INCREASED,21
DE,SELECTIVE EATING DISORDER,21
DE,SHOCK,21
DE,SLEEP DISORDER,21
DE,ACUTE MYOCARDIAL INFARCTION,20
DE,ASPARTATE AMINOTRANSFERASE INCREASED,20
DE,CEREBRAL INFARCTION,20
DE,CONDITION AGGRAVATED,20
DE,DRUG LEVEL INCREASED,20
DE,HYPOKALAEMIA,20
DE,IMPAIRED HEALING,20
DE,SEPTIC SHOCK,20
DE,WEIGHT INCREASED,20
DE,ASCITES,19
DE,BRONCHITIS,19
DE,GASTRIC HAEMORRHAGE,19
DE,MATERNAL EXPOSURE DURING PREGNANCY,19
DE,MELAENA,19
DE,PANCREATITIS ACUTE,19
DE,PLEUROTHOTONUS,19
DE,RASH,19
DE,UROSEPSIS,19
DE,ANURIA,18
DE,CARDIOVASCULAR DISORDER,18
DE,CHEST PAIN,18
DE,CHILLS,18
DE,GASTROENTERITIS,18
DE,HEPATIC STEATOSIS,18
DE,INTESTINAL HAEMORRHAGE,18
DE,MUSCULOSKELETAL PAIN,18
DE,OEDEMA,18
DE,TRANSAMINASES INCREASED,18
DE,VISUAL IMPAIRMENT,18
DE,GLOMERULAR FILTRATION RATE DECREASED,17
DE,HOSPITALISATION,17
DE,MALIGNANT NEOPLASM PROGRESSION,17
DE,PANCREATIC CARCINOMA,17
DE,PRERENAL FAILURE,17
DE,RENAL IMPAIRMENT,17
DE,RESUSCITATION,17
DE,TYPE 2 DIABETES MELLITUS,17
DE,BACK PAIN,16
DE,ISCHAEMIC STROKE,16
DE,JAUNDICE,16
DE,OSTEOARTHRITIS,16
DE,TACHYPNOEA,16
DE,URINARY INCONTINENCE,16
DE,VENTRICULAR SEPTAL DEFECT,16
DE,BLOOD LACTIC ACID INCREASED,15
DE,DYSPNOEA EXERTIONAL,15
DE,NEUTROPENIA,15
DE,URINARY RETENTION,15
DE,AGITATION,14
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,14
DE,CAESAREAN SECTION,14
DE,DEEP VEIN THROMBOSIS,14
DE,DIABETES MELLITUS INADEQUATE CONTROL,14
DE,DIALYSIS,14
DE,MEMORY IMPAIRMENT,14
DE,MITRAL VALVE INCOMPETENCE,14
DE,PERIPHERAL SWELLING,14
DE,PULMONARY OEDEMA,14
DE,VENTRICULAR EXTRASYSTOLES,14
DE,ANGIOEDEMA,13
DE,BEDRIDDEN,13
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,13
DE,GASTRITIS,13
DE,HYPOAESTHESIA,13
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
DE,PSORIASIS,13
DE,RESPIRATORY DISTRESS,13
DE,WOUND,13
DE,ADVERSE DRUG REACTION,12
DE,ALTERED STATE OF CONSCIOUSNESS,12
DE,CHOLELITHIASIS,12
DE,DISORIENTATION,12
DE,FEBRILE NEUTROPENIA,12
DE,GASTROINTESTINAL DISORDER,12
DE,HYPERSENSITIVITY,12
DE,LEUKOPENIA,12
DE,MALAISE,12
DE,MICROCEPHALY,12
DE,MUSCULAR WEAKNESS,12
DE,PANCREATITIS CHRONIC,12
DE,PREMATURE BABY,12
DE,PULMONARY HYPERTENSION,12
DE,SPEECH DISORDER,12
DE,STUPOR,12
DE,BLOOD SODIUM DECREASED,11
DE,BRAIN STEM INFARCTION,11
DE,CARDIAC DISORDER,11
DE,CONGENITAL CYSTIC KIDNEY DISEASE,11
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,11
DE,DIABETIC NEPHROPATHY,11
DE,DRUG INTOLERANCE,11
DE,DYSURIA,11
DE,ERYTHEMA,11
DE,GASTROINTESTINAL PAIN,11
DE,HEMIPARESIS,11
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,11
DE,INSOMNIA,11
DE,INTENTIONAL OVERDOSE,11
DE,INTESTINAL ISCHAEMIA,11
DE,MOBILITY DECREASED,11
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,11
DE,PALLOR,11
DE,PNEUMONIA ASPIRATION,11
DE,POLLAKIURIA,11
DE,RASH GENERALISED,11
DE,VENTRICULAR TACHYCARDIA,11
DE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,11
DE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,10
DE,AGITATION NEONATAL,10
DE,ANAEMIA OF MALIGNANT DISEASE,10
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,10
DE,BLOOD GLUCOSE FLUCTUATION,10
DE,CARDIOVASCULAR INSUFFICIENCY,10
DE,CHOLESTASIS,10
DE,CONGENITAL HYDROCEPHALUS,10
DE,DEPRESSED MOOD,10
DE,DRUG WITHDRAWAL CONVULSIONS,10
DE,DYSARTHRIA,10
DE,EPILEPSY,10
DE,EPISTAXIS,10
DE,GASTRIC ULCER,10
DE,HAEMANGIOMA CONGENITAL,10
DE,HEPATITIS,10
DE,HYPERNATRAEMIA,10
DE,HYPERVENTILATION,10
DE,INFLAMMATORY MARKER INCREASED,10
DE,KIDNEY DUPLEX,10
DE,LIVER FUNCTION TEST ABNORMAL,10
DE,NASOPHARYNGITIS,10
DE,OEDEMA MUCOSAL,10
DE,PALPITATIONS,10
DE,POLYHYDRAMNIOS,10
DE,PREMATURE LABOUR,10
DE,PYLORIC STENOSIS,10
DE,RABBIT SYNDROME,10
DE,RENAL APLASIA,10
DE,SEIZURE,10
DE,SQUAMOUS CELL CARCINOMA,10
DE,SUDDEN DEATH,10
DE,THROMBOSIS,10
DE,TRANSIENT ISCHAEMIC ATTACK,10
DE,VESICOURETERIC REFLUX,10
DE,VISION BLURRED,10
DE,ABORTION INDUCED,9
DE,ABORTION MISSED,9
DE,ANAL INCONTINENCE,9
DE,APHASIA,9
DE,BLOOD BILIRUBIN INCREASED,9
DE,CEREBRAL ISCHAEMIA,9
DE,CHRONIC KIDNEY DISEASE,9
DE,COAGULOPATHY,9
DE,COGNITIVE DISORDER,9
DE,CORONARY ARTERY STENOSIS,9
DE,DRUG HYPERSENSITIVITY,9
DE,DYSPHAGIA,9
DE,DYSSOMNIA,9
DE,ERYSIPELAS,9
DE,FEELING HOT,9
DE,GASTROOESOPHAGEAL REFLUX DISEASE,9
DE,GESTATIONAL DIABETES,9
DE,HEPATIC FUNCTION ABNORMAL,9
DE,LABORATORY TEST ABNORMAL,9
DE,METASTASES TO LIVER,9
DE,OSTEONECROSIS OF JAW,9
DE,PANCREATIC INSUFFICIENCY,9
DE,PLATELET COUNT DECREASED,9
DE,POTENTIATING DRUG INTERACTION,9
DE,TREMOR,9
DE,ALOPECIA,8
DE,BLISTER,8
DE,BLOOD CHOLESTEROL INCREASED,8
DE,BRADYCARDIA,8
DE,CARDIOMYOPATHY,8
DE,CORNEA VERTICILLATA,8
DE,CORRECTED TRANSPOSITION OF GREAT VESSELS,8
DE,CUTANEOUS VASCULITIS,8
DE,DIABETIC FOETOPATHY,8
DE,FAECALOMA,8
DE,FAECES DISCOLOURED,8
DE,FEBRILE INFECTION,8
DE,HAEMORRHAGE INTRACRANIAL,8
DE,HALLUCINATION,8
DE,HALLUCINATION_ AUDITORY,8
DE,HEPATIC CIRRHOSIS,8
DE,HYPERLACTACIDAEMIA,8
DE,HYPOGLYCAEMIA NEONATAL,8
DE,HYPOPLASTIC LEFT HEART SYNDROME,8
DE,INCREASED APPETITE,8
DE,INFANTILE HAEMANGIOMA,8
DE,LARGE FOR DATES BABY,8
DE,LOCAL SWELLING,8
DE,LOGORRHOEA,8
DE,LUNG INFILTRATION,8
DE,METASTASES TO BONE,8
DE,NIGHT SWEATS,8
DE,OEDEMATOUS PANCREATITIS,8
DE,OLIGOHYDRAMNIOS,8
DE,PANCREATIC ATROPHY,8
DE,PANCREATIC PSEUDOCYST,8
DE,PATENT DUCTUS ARTERIOSUS,8
DE,POLYNEUROPATHY,8
DE,PRODUCT USE ISSUE,8
DE,PULMONARY HYPOPLASIA,8
DE,PULMONARY VALVE STENOSIS CONGENITAL,8
DE,SALIVARY HYPERSECRETION,8
DE,STOMATITIS,8
DE,SWOLLEN TONGUE,8
DE,TALIPES,8
DE,TEMPERATURE REGULATION DISORDER,8
DE,THROMBOCYTOPENIA NEONATAL,8
DE,URINARY HESITATION,8
DE,AMYLASE INCREASED,7
DE,ANGINA UNSTABLE,7
DE,AORTA HYPOPLASIA,7
DE,APPETITE DISORDER,7
DE,ARTERIOSCLEROSIS CORONARY ARTERY,7
DE,ASPLENIA,7
DE,ATRIAL THROMBOSIS,7
DE,BASAL CELL CARCINOMA,7
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,7
DE,BLOOD PRESSURE DECREASED,7
DE,BRACHYDACTYLY,7
DE,BRONCHOPNEUMONIA,7
DE,CARDIOGENIC SHOCK,7
DE,CARDIOMEGALY,7
DE,CAROTID ARTERY STENOSIS,7
DE,CATARACT,7
DE,CHEST DISCOMFORT,7
DE,CHOLECYSTITIS,7
DE,COMPLETED SUICIDE,7
DE,CRYPTORCHISM,7
DE,DIABETIC KETOACIDOSIS,7
DE,DRUG PRESCRIBING ERROR,7
DE,DRY MOUTH,7
DE,DUODENAL ULCER,7
DE,EMBOLIC STROKE,7
DE,EYELID PTOSIS CONGENITAL,7
DE,FEELING COLD,7
DE,FLATULENCE,7
DE,HICCUPS,7
DE,HYPERKINESIA,7
DE,INTERNATIONAL NORMALISED RATIO INCREASED,7
DE,INTERVERTEBRAL DISC PROTRUSION,7
DE,IRON DEFICIENCY ANAEMIA,7
DE,LEUKOCYTOSIS,7
DE,LIVER FUNCTION TEST INCREASED,7
DE,MITRAL VALVE ATRESIA,7
DE,NEPHROTIC SYNDROME,7
DE,OBESITY,7
DE,PARAESTHESIA,7
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,7
DE,PERITONITIS,7
DE,PNEUMOTHORAX,7
DE,PRESCRIBED UNDERDOSE,7
DE,PSYCHOTIC DISORDER,7
DE,PULMONARY ALVEOLAR HAEMORRHAGE,7
DE,PULMONARY CONGESTION,7
DE,RENAL FUNCTION TEST ABNORMAL,7
DE,RHINITIS,7
DE,SKIN EXFOLIATION,7
DE,SKIN ULCER,7
DE,STAPHYLOCOCCAL INFECTION,7
DE,SUICIDAL IDEATION,7
DE,SWELLING FACE,7
DE,TACHYARRHYTHMIA,7
DE,TENDON RUPTURE,7
DE,URTICARIA,7
DE,VIRAL INFECTION,7
DE,WHITE BLOOD CELL COUNT INCREASED,7
DE,ABDOMINAL RIGIDITY,6
DE,ABNORMAL LOSS OF WEIGHT,6
DE,ABORTION SPONTANEOUS,6
DE,ACTINIC KERATOSIS,6
DE,ACUTE RESPIRATORY FAILURE,6
DE,AKINESIA,6
DE,BALANCE DISORDER,6
DE,BICUSPID AORTIC VALVE,6
DE,BLOOD KETONE BODY INCREASED,6
DE,BRAIN INJURY,6
DE,BREAST CANCER,6
DE,CARTILAGE INJURY,6
DE,CHROMATURIA,6
DE,COARCTATION OF THE AORTA,6
DE,CONGENITAL AORTIC VALVE STENOSIS,6
DE,DEATH NEONATAL,6
DE,DELUSION,6
DE,DEMENTIA,6
DE,DISEASE PROGRESSION,6
DE,DRY SKIN,6
DE,DYSMORPHISM,6
DE,ECTOPIA CORDIS,6
DE,ELECTROCARDIOGRAM QT PROLONGED,6
DE,EMBOLISM,6
DE,ERUCTATION,6
DE,FEELING ABNORMAL,6
DE,GASTROSCHISIS,6
DE,GLAUCOMA,6
DE,GRAND MAL CONVULSION,6
DE,HAEMATOCHEZIA,6
DE,HEART RATE INCREASED,6
DE,HELLP SYNDROME,6
DE,HEPATOSPLENOMEGALY NEONATAL,6
DE,HERPES ZOSTER,6
DE,HYPOSPADIAS,6
DE,INTESTINAL OBSTRUCTION,6
DE,IRON DEFICIENCY,6
DE,ISCHAEMIC CEREBRAL INFARCTION,6
DE,JOINT SWELLING,6
DE,KETONURIA,6
DE,LACERATION,6
DE,LEFT VENTRICULAR DYSFUNCTION,6
DE,LIVER DISORDER,6
DE,LIVER INJURY,6
DE,MENINGOMYELOCELE,6
DE,MUCOSAL INFLAMMATION,6
DE,MULTIPLE CARDIAC DEFECTS,6
DE,PANCREATIC CARCINOMA METASTATIC,6
DE,PANCREATIC ENZYMES INCREASED,6
DE,PLASMA CELL MYELOMA,6
DE,PNEUMONITIS,6
DE,POLYCYTHAEMIA,6
DE,POLYURIA,6
DE,PREMATURE BABY DEATH,6
DE,PRODUCTIVE COUGH,6
DE,PULMONARY VEIN STENOSIS,6
DE,RENAL CYST,6
DE,RHEUMATOID ARTHRITIS,6
DE,SHOCK HAEMORRHAGIC,6
DE,SINUS TACHYCARDIA,6
DE,SKIN DISORDER,6
DE,STAPHYLOCOCCAL SEPSIS,6
DE,SUBILEUS,6
DE,SUDDEN CARDIAC DEATH,6
DE,SUPRAVENTRICULAR TACHYCARDIA,6
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,6
DE,VENTRICULAR FIBRILLATION,6
DE,ABASIA,5
DE,ABDOMINAL PAIN LOWER,5
DE,ACUTE HEPATIC FAILURE,5
DE,ADACTYLY,5
DE,AGEUSIA,5
DE,AGGRESSION,5
DE,ANAL ATRESIA,5
DE,ANXIETY,5
DE,APATHY,5
DE,ARTERIOSCLEROSIS,5
DE,ASTHMA,5
DE,ATAXIA,5
DE,ATELECTASIS,5
DE,ATRIOVENTRICULAR BLOCK COMPLETE,5
DE,BALANOPOSTHITIS,5
DE,BLOOD PRESSURE ABNORMAL,5
DE,BLOOD PRESSURE SYSTOLIC INCREASED,5
DE,BLOOD TRIGLYCERIDES INCREASED,5
DE,BRAIN OEDEMA,5
DE,COLD SWEAT,5
DE,CONGENITAL ABSENCE OF BILE DUCTS,5
DE,CONGENITAL UTERINE ANOMALY,5
DE,COORDINATION ABNORMAL,5
DE,CYSTITIS,5
DE,DERMATITIS ALLERGIC,5
DE,DEVELOPMENTAL DELAY,5
DE,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,5
DE,DRUG EFFECT DECREASED,5
DE,DYSPEPSIA,5
DE,DYSSTASIA,5
DE,EMBOLIC CEREBRAL INFARCTION,5
DE,FALLOT^S TETRALOGY,5
DE,FLUID RETENTION,5
DE,GASTRIC DISORDER,5
DE,GASTRITIS EROSIVE,5
DE,HAEMATEMESIS,5
DE,HAEMATURIA,5
DE,HAEMOPTYSIS,5
DE,HALLUCINATION_ VISUAL,5
DE,HEART DISEASE CONGENITAL,5
DE,HEPATOMEGALY,5
DE,HOT FLUSH,5
DE,HYPERBILIRUBINAEMIA,5
DE,HYPERTENSIVE HEART DISEASE,5
DE,HYPERTHYROIDISM,5
DE,IMPAIRED QUALITY OF LIFE,5
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,5
DE,INSULIN C-PEPTIDE DECREASED,5
DE,LIP SWELLING,5
DE,LIVE BIRTH,5
DE,LUNG DISORDER,5
DE,LYMPHADENOPATHY,5
DE,MATERNAL DRUGS AFFECTING FOETUS,5
DE,ORAL DISORDER,5
DE,ORAL HERPES,5
DE,PARESIS,5
DE,PERSECUTORY DELUSION,5
DE,PERSISTENT CLOACA,5
DE,PERSISTENT LEFT SUPERIOR VENA CAVA,5
DE,PHIMOSIS,5
DE,PRE-ECLAMPSIA,5
DE,PREMATURE DELIVERY,5
DE,RADIUS FRACTURE,5
DE,RIGHT AORTIC ARCH,5
DE,SPINAL PAIN,5
DE,SPINE MALFORMATION,5
DE,STRESS,5
DE,SUPRAVENTRICULAR EXTRASYSTOLES,5
DE,THROMBOSIS IN DEVICE,5
DE,TREATMENT NONCOMPLIANCE,5
DE,TRICUSPID VALVE INCOMPETENCE,5
DE,TYPE 1 DIABETES MELLITUS,5
DE,UPPER RESPIRATORY TRACT INFECTION,5
DE,URETHRAL VALVES,5
DE,VISUAL ACUITY REDUCED,5
DE,VITAMIN D DEFICIENCY,5
DE,ABDOMINAL DISTENSION,4
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
DE,ACUTE MYELOID LEUKAEMIA,4
DE,AORTIC VALVE STENOSIS,4
DE,ATRIAL FLUTTER,4
DE,ATRIOVENTRICULAR BLOCK,4
DE,AUTOIMMUNE HEPATITIS,4
DE,BLOOD POTASSIUM DECREASED,4
DE,BLOOD POTASSIUM INCREASED,4
DE,BLOOD UREA INCREASED,4
DE,BLOOD URINE PRESENT,4
DE,BONE PAIN,4
DE,BRADYARRHYTHMIA,4
DE,BURNING SENSATION,4
DE,COLITIS,4
DE,COLITIS ULCERATIVE,4
DE,CROHN^S DISEASE,4
DE,DEVICE OCCLUSION,4
DE,DIABETIC NEUROPATHY,4
DE,DIPLOPIA,4
DE,DRUG EFFECT INCOMPLETE,4
DE,DRUG LEVEL ABOVE THERAPEUTIC,4
DE,DUODENITIS,4
DE,DYSGEUSIA,4
DE,EJACULATION DISORDER,4
DE,ELECTROLYTE IMBALANCE,4
DE,EOSINOPHILIA,4
DE,EXTRASYSTOLES,4
DE,EYELID OEDEMA,4
DE,FACIAL PARESIS,4
DE,FIBRIN D DIMER INCREASED,4
DE,FLUSHING,4
DE,GANGRENE,4
DE,GASTRIC POLYPS,4
DE,GASTROINTESTINAL INFECTION,4
DE,GENERAL PHYSICAL CONDITION ABNORMAL,4
DE,GLUCOSE URINE PRESENT,4
DE,GLYCOSURIA,4
DE,GOITRE,4
DE,HAEMATOCRIT DECREASED,4
DE,HAEMODIALYSIS,4
DE,HAEMORRHAGIC ANAEMIA,4
DE,HAEMOTHORAX,4
DE,HALO VISION,4
DE,HEMIANOPIA,4
DE,HIATUS HERNIA,4
DE,HYPERCALCAEMIA,4
DE,HYPOACUSIS,4
DE,HYPOPHAGIA,4
DE,HYPOTHYROIDISM,4
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
DE,INFECTIOUS PLEURAL EFFUSION,4
DE,INFLUENZA LIKE ILLNESS,4
DE,INJECTION SITE ABSCESS,4
DE,INJECTION SITE NODULE,4
DE,INTENTIONAL PRODUCT MISUSE,4
DE,INTERNATIONAL NORMALISED RATIO DECREASED,4
DE,INTERVERTEBRAL DISCITIS,4
DE,JOINT INJURY,4
DE,LARGE INTESTINE POLYP,4
DE,LOW DENSITY LIPOPROTEIN INCREASED,4
DE,MENTAL DISORDER,4
DE,MOVEMENT DISORDER,4
DE,MULTIPLE SCLEROSIS RELAPSE,4
DE,MUSCLE HAEMORRHAGE,4
DE,MUSCLE TIGHTNESS,4
DE,MYOPATHY,4
DE,NERVOUSNESS,4
DE,OESOPHAGEAL CANDIDIASIS,4
DE,OESOPHAGITIS,4
DE,OLIGURIA,4
DE,ORTHOPNOEA,4
DE,OSTEOCHONDROSIS,4
DE,PARKINSONISM,4
DE,PARKINSON^S DISEASE,4
DE,PAROTITIS,4
DE,PETECHIAE,4
DE,PHOTOPSIA,4
DE,POST PROCEDURAL COMPLICATION,4
DE,PRECANCEROUS SKIN LESION,4
DE,PROTHROMBIN TIME PROLONGED,4
DE,PRURITUS GENERALISED,4
DE,PULMONARY FIBROSIS,4
DE,PULMONARY MASS,4
DE,PYODERMA GANGRENOSUM,4
DE,RASH MACULO-PAPULAR,4
DE,RESTLESS LEGS SYNDROME,4
DE,SCHIZOAFFECTIVE DISORDER,4
DE,SKIN BURNING SENSATION,4
DE,SKIN DISCOLOURATION,4
DE,SPLENOMEGALY,4
DE,SUBACUTE HEPATIC FAILURE,4
DE,TESTICULAR PAIN,4
DE,THROAT TIGHTNESS,4
DE,URETERIC OBSTRUCTION,4
DE,VASCULITIS,4
DE,VITAMIN B12 DEFICIENCY,4
DE,ABORTION,3
DE,ABSCESS,3
DE,ACCIDENTAL OVERDOSE,3
DE,ANAPHYLACTIC REACTION,3
DE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,3
DE,ANXIETY DISORDER,3
DE,AORTIC ARTERIOSCLEROSIS,3
DE,AORTIC VALVE SCLEROSIS,3
DE,APPENDICITIS,3
DE,ARTERIAL OCCLUSIVE DISEASE,3
DE,ARTHROPATHY,3
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,3
DE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,3
DE,ATYPICAL PNEUMONIA,3
DE,BACTERIAL INFECTION,3
DE,BILE DUCT STENOSIS,3
DE,BLOOD GLUCOSE DECREASED,3
DE,BLOOD PRESSURE FLUCTUATION,3
DE,BONE MARROW FAILURE,3
DE,BREAST CANCER METASTATIC,3
DE,BRONCHIAL CARCINOMA,3
DE,BRONCHITIS BACTERIAL,3
DE,BUNDLE BRANCH BLOCK LEFT,3
DE,BUNDLE BRANCH BLOCK RIGHT,3
DE,BURSITIS,3
DE,CAMPYLOBACTER INFECTION,3
DE,CARDIAC FAILURE ACUTE,3
DE,CARDIAC VALVE DISEASE,3
DE,CARPAL TUNNEL SYNDROME,3
DE,CEREBELLAR INFARCTION,3
DE,CEREBRAL ARTERY EMBOLISM,3
DE,CEREBRAL ARTERY OCCLUSION,3
DE,CHAPPED LIPS,3
DE,CHOLANGIOCARCINOMA,3
DE,CLOSTRIDIUM DIFFICILE INFECTION,3
DE,COMPARTMENT SYNDROME,3
DE,CONCOMITANT DISEASE AGGRAVATED,3
DE,CONTRAINDICATED PRODUCT ADMINISTERED,3
DE,CONVULSION NEONATAL,3
DE,CORONARY ARTERY OCCLUSION,3
DE,CYST,3
DE,DEFAECATION URGENCY,3
DE,DERMATITIS,3
DE,DEVICE DISLOCATION,3
DE,DIASTOLIC DYSFUNCTION,3
DE,DIVERTICULAR PERFORATION,3
DE,DIVERTICULUM,3
DE,DRUG ERUPTION,3
DE,DYSAESTHESIA,3
DE,DYSPHONIA,3
DE,ENCEPHALITIS,3
DE,ENCEPHALOPATHY,3
DE,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,3
DE,ENURESIS,3
DE,ERECTILE DYSFUNCTION,3
DE,FAECES HARD,3
DE,FEAR,3
DE,FLUID INTAKE REDUCED,3
DE,FOETAL GROWTH RESTRICTION,3
DE,FUNGAL INFECTION,3
DE,GASTRITIS HAEMORRHAGIC,3
DE,GASTROINTESTINAL TUBE INSERTION,3
DE,GRANULOMATOSIS WITH POLYANGIITIS,3
DE,GYNAECOMASTIA,3
DE,HABITUAL ABORTION,3
DE,HAEMOGLOBIN INCREASED,3
DE,HAEMOLYTIC ANAEMIA,3
DE,HAEMORRHAGIC DIATHESIS,3
DE,HEART RATE DECREASED,3
DE,HEART RATE IRREGULAR,3
DE,HEART VALVE INCOMPETENCE,3
DE,HEPATIC CYST,3
DE,HEPATIC FIBROSIS,3
DE,HEPATOCELLULAR CARCINOMA,3
DE,HYPERLIPIDAEMIA,3
DE,HYPOCALCAEMIA,3
DE,HYPOTONIA,3
DE,ILEUS,3
DE,ILEUS PARALYTIC,3
DE,IMPAIRED SELF-CARE,3
DE,INCORRECT DOSE ADMINISTERED,3
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
DE,INFLUENZA,3
DE,INTERSTITIAL LUNG DISEASE,3
DE,INTRAVENTRICULAR HAEMORRHAGE,3
DE,IRITIS,3
DE,JOINT DISLOCATION,3
DE,JOINT RANGE OF MOTION DECREASED,3
DE,LACRIMATION INCREASED,3
DE,LEFT VENTRICULAR FAILURE,3
DE,LOSS OF LIBIDO,3
DE,LUNG INFECTION,3
DE,MAJOR DEPRESSION,3
DE,MENISCUS INJURY,3
DE,METABOLIC SYNDROME,3
DE,METASTASES TO LUNG,3
DE,MICTURITION URGENCY,3
DE,MONOPARESIS,3
DE,MUSCLE DISORDER,3
DE,MUSCULOSKELETAL STIFFNESS,3
DE,MYOCARDIAL ISCHAEMIA,3
DE,MYOCARDITIS,3
DE,MYOSCLEROSIS,3
DE,NEPHROPATHY,3
DE,NEUROPATHY PERIPHERAL,3
DE,NEUTROPENIC SEPSIS,3
DE,NOCTURIA,3
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
DE,ORAL CANDIDIASIS,3
DE,OSTEOPOROSIS,3
DE,PACKED RED BLOOD CELL TRANSFUSION,3
DE,PAIN OF SKIN,3
DE,PANCREATIC DISORDER,3
DE,PARTIAL SEIZURES,3
DE,PATHOGEN RESISTANCE,3
DE,PERFORMANCE STATUS DECREASED,3
DE,PERICARDIAL EFFUSION,3
DE,PERIPHERAL COLDNESS,3
DE,PERIPHERAL EMBOLISM,3
DE,PERSONALITY DISORDER,3
DE,PITUITARY TUMOUR BENIGN,3
DE,PLEURISY,3
DE,POLYDIPSIA,3
DE,POST PROCEDURAL INFECTION,3
DE,PRODUCT SUBSTITUTION ISSUE,3
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
DE,PROSTATE CANCER,3
DE,PROTEINURIA,3
DE,PROTHROMBIN TIME SHORTENED,3
DE,PULMONARY HAEMORRHAGE,3
DE,RASH ERYTHEMATOUS,3
DE,RASH PRURITIC,3
DE,RASH PUSTULAR,3
DE,RED BLOOD CELL COUNT DECREASED,3
DE,RENAL CELL CARCINOMA,3
DE,RENAL COLIC,3
DE,RENAL DISORDER,3
DE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
DE,RETINAL DETACHMENT,3
DE,RHEUMATOID NODULE,3
DE,RIB FRACTURE,3
DE,SALMONELLOSIS,3
DE,SECOND PRIMARY MALIGNANCY,3
DE,SINUSITIS,3
DE,SKIN HAEMORRHAGE,3
DE,SKIN INFECTION,3
DE,SLEEP APNOEA SYNDROME,3
DE,SPINAL COLUMN STENOSIS,3
DE,SPINAL OSTEOARTHRITIS,3
DE,SPUTUM DISCOLOURED,3
DE,STATUS EPILEPTICUS,3
DE,SUBARACHNOID HAEMORRHAGE,3
DE,SUBDURAL HAEMATOMA,3
DE,SUBDURAL HAEMORRHAGE,3
DE,SWELLING,3
DE,TINNITUS,3
DE,TROPONIN I INCREASED,3
DE,TROPONIN INCREASED,3
DE,TUMOUR PAIN,3
DE,UPPER LIMB FRACTURE,3
DE,URINE KETONE BODY PRESENT,3
DE,VENOUS THROMBOSIS LIMB,3
DE,WOUND COMPLICATION,3
DE,ABDOMINAL ABSCESS,2
DE,ACCIDENT,2
DE,ACNE,2
DE,ACTIVITIES OF DAILY LIVING IMPAIRED,2
DE,ACUTE ABDOMEN,2
DE,ACUTE CORONARY SYNDROME,2
DE,ACUTE PRERENAL FAILURE,2
DE,ADENOCARCINOMA GASTRIC,2
DE,ALCOHOL ABUSE,2
DE,ALCOHOL POISONING,2
DE,AMNESIA,2
DE,ANAL PRURITUS,2
DE,ANASTOMOTIC LEAK,2
DE,ANEURYSM,2
DE,ANKLE FRACTURE,2
DE,ANORECTAL DISCOMFORT,2
DE,ANOSMIA,2
DE,AORTIC VALVE INCOMPETENCE,2
DE,APHTHOUS ULCER,2
DE,APNOEA,2
DE,ARTHRITIS,2
DE,ARTHRITIS INFECTIVE,2
DE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
DE,AZOTAEMIA,2
DE,BASAL GANGLIA HAEMORRHAGE,2
DE,BASE EXCESS DECREASED,2
DE,BILE DUCT CANCER STAGE II,2
DE,BILIARY DILATATION,2
DE,BLADDER CANCER RECURRENT,2
DE,BLINDNESS,2
DE,BLOOD CALCIUM DECREASED,2
DE,BLOOD CREATINE INCREASED,2
DE,BLOOD MAGNESIUM DECREASED,2
DE,BRAIN NEOPLASM,2
DE,BRAIN STEM ISCHAEMIA,2
DE,BREAST MASS,2
DE,BRONCHOSPASM,2
DE,CALCULUS BLADDER,2
DE,CANDIDA INFECTION,2
DE,CARDIAC FAILURE CONGESTIVE,2
DE,CATHETERISATION CARDIAC,2
DE,CELLULITIS,2
DE,CENTRAL NERVOUS SYSTEM LESION,2
DE,CEREBRAL ARTERY STENOSIS,2
DE,CHEST X-RAY ABNORMAL,2
DE,CHOLANGITIS,2
DE,CHOLANGITIS INFECTIVE,2
DE,CHOLECYSTECTOMY,2
DE,CLEAR CELL RENAL CELL CARCINOMA,2
DE,CLOSTRIDIUM DIFFICILE COLITIS,2
DE,COLONOSCOPY,2
DE,COLORECTAL CANCER METASTATIC,2
DE,CONCUSSION,2
DE,CONGESTIVE CARDIOMYOPATHY,2
DE,CONJUNCTIVAL HAEMORRHAGE,2
DE,CONJUNCTIVITIS,2
DE,CONVULSION,2
DE,CORONARY ANGIOPLASTY,2
DE,CORONARY ARTERIAL STENT INSERTION,2
DE,CORONARY ARTERY BYPASS,2
DE,CRANIAL NERVE DISORDER,2
DE,CREATININE RENAL CLEARANCE DECREASED,2
DE,CYANOSIS,2
DE,CYSTITIS HAEMORRHAGIC,2
DE,CYSTITIS NONINFECTIVE,2
DE,DEAFNESS,2
DE,DECREASED IMMUNE RESPONSIVENESS,2
DE,DECUBITUS ULCER,2
DE,DEREALISATION,2
DE,DEVICE ISSUE,2
DE,DEVICE RELATED INFECTION,2
DE,DIABETIC FOOT,2
DE,DIABETIC HYPERGLYCAEMIC COMA,2
DE,DISEASE RECURRENCE,2
DE,DIVERTICULITIS,2
DE,DIVERTICULUM INTESTINAL,2
DE,DRUG ABUSE,2
DE,DRUG ADMINISTRATION ERROR,2
DE,DRUG DEPENDENCE,2
DE,DRUG DOSE OMISSION,2
DE,DRUG RESISTANCE,2
DE,DRUG WITHDRAWAL SYNDROME,2
DE,DYSKINESIA,2
DE,DYSPNOEA AT REST,2
DE,DYSTROPHIC CALCIFICATION,2
DE,EAR DISCOMFORT,2
DE,EAR DISORDER,2
DE,EJECTION FRACTION ABNORMAL,2
DE,EJECTION FRACTION DECREASED,2
DE,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
DE,ENTEROCOCCAL SEPSIS,2
DE,EYE CONTUSION,2
DE,EYE HAEMORRHAGE,2
DE,EYE IRRITATION,2
DE,FACE INJURY,2
DE,FAECAL VOMITING,2
DE,FAECES PALE,2
DE,FAMILIAL PERIODIC PARALYSIS,2
DE,FEMORAL NECK FRACTURE,2
DE,FOETAL HEART RATE ABNORMAL,2
DE,FOOT FRACTURE,2
DE,FORMICATION,2
DE,FRACTURED SACRUM,2
DE,FURUNCLE,2
DE,GASTRIC ATONY,2
DE,GASTROINTESTINAL ANGIODYSPLASIA,2
DE,GASTROINTESTINAL PERFORATION,2
DE,GENERALISED OEDEMA,2
DE,GENERALISED TONIC-CLONIC SEIZURE,2
DE,GENITAL HERPES,2
DE,GINGIVAL RECESSION,2
DE,GINGIVAL SWELLING,2
DE,GLOMERULAR FILTRATION RATE INCREASED,2
DE,GOUT,2
DE,HAEMORRHAGE URINARY TRACT,2
DE,HAEMORRHOIDS,2
DE,HEAD DISCOMFORT,2
DE,HEPATIC ENCEPHALOPATHY,2
DE,HEPATITIS ALCOHOLIC,2
DE,HEPATITIS TOXIC,2
DE,HERPES VIRUS INFECTION,2
DE,HIGH DENSITY LIPOPROTEIN INCREASED,2
DE,HIP FRACTURE,2
DE,HYDROCHOLECYSTIS,2
DE,HYDRONEPHROSIS,2
DE,HYPERCHOLESTEROLAEMIA,2
DE,HYPERSENSITIVITY VASCULITIS,2
DE,HYPERTONIA,2
DE,HYPERTRIGLYCERIDAEMIA,2
DE,HYPERURICAEMIA,2
DE,HYPOAESTHESIA ORAL,2
DE,HYPOALBUMINAEMIA,2
DE,HYPOCHROMIC ANAEMIA,2
DE,HYPOKINESIA,2
DE,HYPOMANIA,2
DE,HYPOPHYSITIS,2
DE,HYPOVOLAEMIA,2
DE,HYPOXIA,2
DE,IDIOPATHIC PULMONARY FIBROSIS,2
DE,ILL-DEFINED DISORDER,2
DE,IMMUNODEFICIENCY,2
DE,INCREASED BRONCHIAL SECRETION,2
DE,INDUCED LABOUR,2
DE,INJECTION SITE ERYTHEMA,2
DE,INJECTION SITE INDURATION,2
DE,INJECTION SITE PAIN,2
DE,INJURY,2
DE,INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS,2
DE,INTRAOCULAR PRESSURE INCREASED,2
DE,IRON OVERLOAD,2
DE,IRRITABLE BOWEL SYNDROME,2
DE,JAW FRACTURE,2
DE,KLEBSIELLA TEST POSITIVE,2
DE,KNEE ARTHROPLASTY,2
DE,LARGE INTESTINE PERFORATION,2
DE,LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED,2
DE,LEFT VENTRICULAR HYPERTROPHY,2
DE,LIGAMENT SPRAIN,2
DE,LIMB DISCOMFORT,2
DE,LIPID METABOLISM DISORDER,2
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,2
DE,LUMBAR SPINAL STENOSIS,2
DE,LUMBAR VERTEBRAL FRACTURE,2
DE,LUNG ABSCESS,2
DE,LUNG NEOPLASM MALIGNANT,2
DE,LYMPHOCYTE COUNT DECREASED,2
DE,LYMPHOEDEMA,2
DE,MACULAR DEGENERATION,2
DE,MALIGNANT MELANOMA,2
DE,MALIGNANT PLEURAL EFFUSION,2
DE,MANIA,2
DE,MATERNAL EXPOSURE BEFORE PREGNANCY,2
DE,MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED,2
DE,MENORRHAGIA,2
DE,MENTAL IMPAIRMENT,2
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,2
DE,METASTASES TO PLEURA,2
DE,METASTASIS,2
DE,METASTATIC RENAL CELL CARCINOMA,2
DE,MICROANGIOPATHY,2
DE,MICROCYTIC ANAEMIA,2
DE,MIGRAINE WITH AURA,2
DE,MITRAL VALVE SCLEROSIS,2
DE,MONOCYTE PERCENTAGE INCREASED,2
DE,MUCOSAL DRYNESS,2
DE,MUSCLE ATROPHY,2
DE,MUSCULOSKELETAL DISCOMFORT,2
DE,MYASTHENIA GRAVIS,2
DE,NECK PAIN,2
DE,NECROSIS,2
DE,NEPHROLITHIASIS,2
DE,NEURODERMATITIS,2
DE,NEUROLOGIC NEGLECT SYNDROME,2
DE,NEUROPATHIC ULCER,2
DE,NO ADVERSE EVENT,2
DE,OBSTRUCTIVE PANCREATITIS,2
DE,OBSTRUCTIVE UROPATHY,2
DE,OCULAR HYPERAEMIA,2
DE,ODYNOPHAGIA,2
DE,ON AND OFF PHENOMENON,2
DE,OPTIC ISCHAEMIC NEUROPATHY,2
DE,OROPHARYNGEAL PAIN,2
DE,OSTEITIS,2
DE,OVARIAN CYST,2
DE,OXYGEN SATURATION DECREASED,2
DE,PANCREATIC CYST,2
DE,PANCREATIC MASS,2
DE,PANCREATITIS NECROTISING,2
DE,PEMPHIGOID,2
DE,PERFORATION,2
DE,PERIPHERAL VASCULAR DISORDER,2
DE,PHARYNGEAL OEDEMA,2
DE,PHLEBITIS,2
DE,PICKWICKIAN SYNDROME,2
DE,PLACENTAL INSUFFICIENCY,2
DE,POISONING,2
DE,POLYARTHRITIS,2
DE,POLYCYSTIC OVARIES,2
DE,PORTAL VEIN THROMBOSIS,2
GH,ASTHENIA,1
GH,RASH PRURITIC,1
GH,STEVENS-JOHNSON SYNDROME,1
GH,URTICARIA,1
GR,HYPERKALAEMIA,9
GR,PEMPHIGOID,8
GR,DRUG INEFFECTIVE,7
GR,DRUG-INDUCED LIVER INJURY,6
GR,ACUTE KIDNEY INJURY,5
GR,ASTHENIA,5
GR,DECREASED APPETITE,5
GR,DIABETIC KETOACIDOSIS,5
GR,DIARRHOEA,5
GR,LACTIC ACIDOSIS,5
GR,PYREXIA,5
GR,RENAL FAILURE,5
GR,RENAL IMPAIRMENT,5
GR,CEREBROVASCULAR ACCIDENT,4
GR,HYPOGLYCAEMIA,4
GR,MILK-ALKALI SYNDROME,4
GR,ANAEMIA,3
GR,DYSPNOEA,3
GR,FATIGUE,3
GR,HYPERGLYCAEMIA,3
GR,METABOLIC ACIDOSIS,3
GR,RENAL FAILURE ACUTE,3
GR,SEPTIC SHOCK,3
GR,ANAPHYLACTIC REACTION,2
GR,BLOOD CREATININE INCREASED,2
GR,BLOOD UREA INCREASED,2
GR,CARDIAC ARREST,2
GR,CHRONIC KIDNEY DISEASE,2
GR,CONDITION AGGRAVATED,2
GR,CONTRAINDICATED PRODUCT ADMINISTERED,2
GR,DEATH,2
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
GR,DIABETES MELLITUS,2
GR,DIABETES MELLITUS INADEQUATE CONTROL,2
GR,DISEASE PROGRESSION,2
GR,DIZZINESS,2
GR,ERYTHEMA,2
GR,FAECES DISCOLOURED,2
GR,FEBRILE NEUTROPENIA,2
GR,GINGIVAL HYPERPLASIA,2
GR,HYPOPHOSPHATAEMIA,2
GR,LUNG INFECTION,2
GR,NAUSEA,2
GR,OEDEMA PERIPHERAL,2
GR,ORAL DISCOMFORT,2
GR,PLATELET COUNT DECREASED,2
GR,PLEURAL EFFUSION,2
GR,PRODUCT USE ISSUE,2
GR,PRURITUS,2
GR,PULMONARY ARTERIAL HYPERTENSION,2
GR,RECTAL TENESMUS,2
GR,RIGHT VENTRICULAR FAILURE,2
GR,TOXICITY TO VARIOUS AGENTS,2
GR,URINARY TRACT INFECTION,2
GR,VITAMIN B12 DEFICIENCY,2
GR,VOMITING,2
GR,WHITE BLOOD CELL COUNT DECREASED,2
GR,ABDOMINAL PAIN,1
GR,ACUTE HEPATIC FAILURE,1
GR,ACUTE MYELOID LEUKAEMIA,1
GR,ANEURYSM,1
GR,ANGIOPATHY,1
GR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
GR,ATYPICAL FEMUR FRACTURE,1
GR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
GR,AUTOIMMUNE PANCREATITIS,1
GR,BIPOLAR I DISORDER,1
GR,BLADDER CANCER,1
GR,BLOOD GLUCOSE INCREASED,1
GR,BLOOD KETONE BODY INCREASED,1
GR,C-REACTIVE PROTEIN INCREASED,1
GR,CANDIDA TEST POSITIVE,1
GR,CARDIO-RESPIRATORY ARREST,1
GR,CATARACT,1
GR,CATARACT OPERATION,1
GR,CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THERAPEUTIC,1
GR,CHEST DISCOMFORT,1
GR,CHROMATURIA,1
GR,CHRONIC GASTRITIS,1
GR,CONJUNCTIVAL EROSION,1
GR,CONSTIPATION,1
GR,CONTRAINDICATED DRUG ADMINISTERED,1
GR,CORNEAL OEDEMA,1
GR,CORNEAL SCAR,1
GR,DEEP VEIN THROMBOSIS,1
GR,DEHYDRATION,1
GR,DEVICE RELATED INFECTION,1
GR,DIABETIC NEPHROPATHY,1
GR,DISCOMFORT,1
GR,DRUG HYPERSENSITIVITY,1
GR,DRUG PRESCRIBING ERROR,1
GR,DYSARTHRIA,1
GR,DYSKINESIA,1
GR,DYSLIPIDAEMIA,1
GR,DYSPNOEA EXERTIONAL,1
GR,ELECTROCARDIOGRAM QT PROLONGED,1
GR,ENCAPSULATING PERITONEAL SCLEROSIS,1
GR,EPISTAXIS,1
GR,FEELING HOT,1
GR,FIBROSIS,1
GR,FOREIGN BODY SENSATION IN EYES,1
GR,GASTRIC CANCER,1
GR,GASTROENTERITIS,1
GR,GLOMERULAR FILTRATION RATE DECREASED,1
GR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
GR,GRANULOMA,1
GR,HAEMATOMA,1
GR,HAEMODIALYSIS,1
GR,HAEMODYNAMIC INSTABILITY,1
GR,HAEMORRHAGE INTRACRANIAL,1
GR,HEADACHE,1
GR,HELICOBACTER INFECTION,1
GR,HEPATIC ENZYME INCREASED,1
GR,HEPATITIS CHOLESTATIC,1
GR,HEPATOMEGALY,1
GR,HEREDITARY NEUROPATHIC AMYLOIDOSIS,1
GR,HIP FRACTURE,1
GR,HYDRONEPHROSIS,1
GR,HYPERCALCAEMIA,1
GR,HYPERHOMOCYSTEINAEMIA,1
GR,HYPERSENSITIVITY,1
GR,HYPERTENSION,1
GR,HYPERTRANSAMINASAEMIA,1
GR,HYPOGLYCAEMIC COMA,1
GR,HYPONATRAEMIA,1
GR,HYPOVOLAEMIA,1
GR,ILEUS,1
GR,ILEUS PARALYTIC,1
GR,IMPLANT SITE INFLAMMATION,1
GR,INFECTION,1
GR,INJECTION SITE PRURITUS,1
GR,JAUNDICE,1
GR,KERATITIS,1
GR,KETOACIDOSIS,1
GR,KLEBSIELLA TEST POSITIVE,1
GR,LACRIMATION INCREASED,1
GR,LARYNGEAL OEDEMA,1
GR,LEUKOENCEPHALOPATHY,1
GR,LEUKOPENIA,1
GR,LIP OEDEMA,1
GR,LIVER DISORDER,1
GR,LOSS OF CONSCIOUSNESS,1
GR,LUNG DISORDER,1
GR,MALIGNANT NEOPLASM PROGRESSION,1
GR,MEDICATION ERROR,1
GR,METABOLIC ALKALOSIS,1
GR,MICROALBUMINURIA,1
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GR,MUSCULAR WEAKNESS,1
GR,NEPHROLITHIASIS,1
GR,NEPHROPATHY,1
GR,NEUROPATHY PERIPHERAL,1
GR,OCULAR ICTERUS,1
GR,OROPHARYNGEAL PAIN,1
GR,ORTHOSTATIC HYPOTENSION,1
GR,OVERWEIGHT,1
GR,PAIN,1
GR,PAIN IN EXTREMITY,1
GR,PALLOR,1
GR,PALPITATIONS,1
GR,PANCREATIC CARCINOMA,1
GR,PANCREATITIS ACUTE,1
GR,PANCYTOPENIA,1
GR,PERIPHERAL VASCULAR DISORDER,1
GR,PNEUMONITIS,1
GR,POLYDIPSIA,1
GR,POLYURIA,1
GR,PORTAL VEIN THROMBOSIS,1
GR,PROTEINURIA,1
GR,RASH GENERALISED,1
GR,RASH MACULO-PAPULAR,1
GR,RENAL TUBULAR NECROSIS,1
GR,RESPIRATORY FAILURE,1
GR,RESPIRATORY TRACT INFECTION,1
GR,RETINOPATHY,1
GR,RETROPERITONEAL FIBROSIS,1
GR,SINUS BRADYCARDIA,1
GR,SOMNOLENCE,1
GR,SPINAL DISORDER,1
GR,STEROID WITHDRAWAL SYNDROME,1
GR,SUICIDAL IDEATION,1
GR,SUPRAVENTRICULAR EXTRASYSTOLES,1
GR,SURGERY,1
GR,SWELLING,1
GR,SYNCOPE,1
GR,TACHYARRHYTHMIA,1
GR,THERAPY CHANGE,1
GR,THROMBOPHLEBITIS SUPERFICIAL,1
GR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
GR,THYROIDITIS SUBACUTE,1
GR,TREATMENT NONCOMPLIANCE,1
GR,URINE OUTPUT DECREASED,1
GR,VENTRICULAR EXTRASYSTOLES,1
GR,VERTIGO,1
GR,VISION BLURRED,1
GR,VISUAL ACUITY REDUCED,1
GR,WEIGHT DECREASED,1
GR,XANTHELASMA,1
GR,ZYGOMYCOSIS,1
GU,DIARRHOEA,1
GU,RASH,1
GT,DIZZINESS,4
GT,PAIN,4
GT,MALAISE,3
GT,PAIN IN EXTREMITY,3
GT,CARDIAC ARREST,2
GT,DIARRHOEA,2
GT,DISCOMFORT,2
GT,DYSPHAGIA,2
GT,DYSPNOEA,2
GT,FATIGUE,2
GT,FOETAL DISTRESS SYNDROME,2
GT,FOETAL EXPOSURE DURING PREGNANCY,2
GT,FOETAL GROWTH RESTRICTION,2
GT,HEADACHE,2
GT,OROPHARYNGEAL DISCOMFORT,2
GT,SOMNOLENCE,2
GT,URINARY TRACT INFECTION,2
GT,ABDOMINAL DISCOMFORT,1
GT,ABDOMINAL PAIN,1
GT,ABDOMINAL PAIN UPPER,1
GT,ACUTE RESPIRATORY FAILURE,1
GT,APHTHOUS ULCER,1
GT,ASPHYXIA,1
GT,ATRIAL FIBRILLATION,1
GT,BLINDNESS,1
GT,BLOOD GLUCOSE INCREASED,1
GT,BLOOD PRESSURE DECREASED,1
GT,BLOOD PRESSURE INCREASED,1
GT,BLOOD URINE PRESENT,1
GT,BRAIN NEOPLASM,1
GT,CAESAREAN SECTION,1
GT,CARDIAC DISORDER,1
GT,CARDIOMEGALY,1
GT,CHEST PAIN,1
GT,CHIKUNGUNYA VIRUS INFECTION,1
GT,COLITIS,1
GT,CONCOMITANT DISEASE PROGRESSION,1
GT,CORONARY ARTERY OCCLUSION,1
GT,COUGH,1
GT,DRUG INEFFECTIVE,1
GT,DYSPHONIA,1
GT,DYSURIA,1
GT,EAR DISORDER,1
GT,EPISTAXIS,1
GT,FAECES DISCOLOURED,1
GT,FALL,1
GT,FEEDING DISORDER,1
GT,GAIT DISTURBANCE,1
GT,GASTRITIS,1
GT,GESTATIONAL HYPERTENSION,1
GT,GINGIVAL BLEEDING,1
GT,GLAUCOMA,1
GT,HAEMATOCHEZIA,1
GT,HEPATIC STEATOSIS,1
GT,HYPOTENSION,1
GT,INFARCTION,1
GT,LIMB DISCOMFORT,1
GT,LIVE BIRTH,1
GT,MATERNAL EXPOSURE DURING DELIVERY,1
GT,MATERNAL EXPOSURE DURING PREGNANCY,1
GT,MENTAL IMPAIRMENT,1
GT,MESENTERIC VEIN THROMBOSIS,1
GT,MOBILITY DECREASED,1
GT,MYOCARDIAL INFARCTION,1
GT,NASAL CONGESTION,1
GT,NAUSEA,1
GT,OLIGOHYDRAMNIOS,1
GT,ORAL DISCOMFORT,1
GT,OROPHARYNGEAL PAIN,1
GT,PHARYNGEAL ULCERATION,1
GT,PNEUMONIA,1
GT,PREMATURE BABY,1
GT,PREMATURE DELIVERY,1
GT,PRODUCTIVE COUGH,1
GT,PULMONARY EMBOLISM,1
GT,PYREXIA,1
GT,SEPSIS,1
GT,SHOCK HYPOGLYCAEMIC,1
GT,SKIN FISSURES,1
GT,SKIN REACTION,1
GT,SYNCOPE,1
GT,TACHYCARDIA,1
GT,TONGUE DISCOMFORT,1
GT,WEIGHT DECREASED,1
GT,WERNER^S SYNDROME,1
GT,WOUND,1
HN,ABDOMINAL PAIN,1
HN,ANEMBRYONIC GESTATION,1
HN,ARTHRALGIA,1
HN,ASTHENIA,1
HN,BACK PAIN,1
HN,BLINDNESS,1
HN,BLOOD PRESSURE SYSTOLIC INCREASED,1
HN,CATARACT,1
HN,CHEST DISCOMFORT,1
HN,COMPLICATION OF PREGNANCY,1
HN,COUGH,1
HN,DIABETES MELLITUS INADEQUATE CONTROL,1
HN,DYSSTASIA,1
HN,EXPOSURE DURING PREGNANCY,1
HN,EYE HAEMORRHAGE,1
HN,GAIT DISTURBANCE,1
HN,HAEMORRHAGE IN PREGNANCY,1
HN,LIVE BIRTH,1
HN,MATERNAL EXPOSURE DURING PREGNANCY,1
HN,MEMORY IMPAIRMENT,1
HN,MENSTRUATION DELAYED,1
HN,MOVEMENT DISORDER,1
HN,OSTEOARTHRITIS,1
HN,PAIN IN EXTREMITY,1
HN,PREGNANCY WITH INJECTABLE CONTRACEPTIVE,1
HN,PYREXIA,1
HN,RETINAL DETACHMENT,1
HN,RETINAL VASCULAR OCCLUSION,1
HN,SCOLIOSIS,1
HK,LACTIC ACIDOSIS,26
HK,RENAL IMPAIRMENT,25
HK,OVERDOSE,7
HK,SHOCK,7
HK,INTENTIONAL OVERDOSE,5
HK,HYPOGLYCAEMIA,3
HK,HYPOTENSION,3
HK,ACUTE KIDNEY INJURY,2
HK,ANAEMIA,2
HK,CARDIAC ARREST,2
HK,CARDIOTOXICITY,2
HK,DIABETES MELLITUS INADEQUATE CONTROL,2
HK,DIABETIC KETOACIDOSIS,2
HK,DIZZINESS,2
HK,MALAISE,2
HK,METABOLIC ACIDOSIS,2
HK,POLYMYOSITIS,2
HK,PYREXIA,2
HK,SOMNOLENCE,2
HK,VOMITING,2
HK,ABDOMINAL DISCOMFORT,1
HK,ABDOMINAL DISTENSION,1
HK,ABDOMINAL PAIN,1
HK,ACUTE HEPATIC FAILURE,1
HK,ADENOCARCINOMA,1
HK,ANGINA PECTORIS,1
HK,ASCITES,1
HK,BLOOD GLUCOSE INCREASED,1
HK,CARDIAC FAILURE,1
HK,CARDIAC FAILURE CONGESTIVE,1
HK,CARDIOVASCULAR DISORDER,1
HK,CEREBRAL ARTERY THROMBOSIS,1
HK,CEREBRAL INFARCTION,1
HK,CEREBROVASCULAR ACCIDENT,1
HK,CHEST PAIN,1
HK,CHOLECYSTITIS ACUTE,1
HK,COMA SCALE ABNORMAL,1
HK,CRANIOCEREBRAL INJURY,1
HK,DECREASED APPETITE,1
HK,DEEP VEIN THROMBOSIS,1
HK,DEHYDRATION,1
HK,DIARRHOEA,1
HK,DISEASE PROGRESSION,1
HK,DRUG DISPENSING ERROR,1
HK,DYSPHAGIA,1
HK,DYSPNOEA,1
HK,FATIGUE,1
HK,FEELING ABNORMAL,1
HK,GENERAL PHYSICAL HEALTH DETERIORATION,1
HK,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
HK,HAEMORRHAGIC STROKE,1
HK,HEMIPLEGIA,1
HK,HEPARIN-INDUCED THROMBOCYTOPENIA,1
HK,HYPERTRIGLYCERIDAEMIA,1
HK,HYPONATRAEMIA,1
HK,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
HK,INJECTION SITE HAEMORRHAGE,1
HK,INJECTION SITE PAIN,1
HK,INTESTINAL ISCHAEMIA,1
HK,JOINT INJURY,1
HK,METASTASES TO LUNG,1
HK,MYOCARDIAL INFARCTION,1
HK,MYOCARDIAL ISCHAEMIA,1
HK,NAUSEA,1
HK,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
HK,PANCREATIC CARCINOMA,1
HK,PANCREATITIS,1
HK,PANCREATITIS ACUTE,1
HK,PANCREATITIS NECROTISING,1
HK,PERIPHERAL SWELLING,1
HK,PNEUMONIA,1
HK,POSTOPERATIVE FEVER,1
HK,RECTAL CANCER,1
HK,RENAL FAILURE ACUTE,1
HK,RESPIRATORY DISTRESS,1
HK,RESPIRATORY FAILURE,1
HK,RIGHT VENTRICULAR FAILURE,1
HK,ROTATOR CUFF SYNDROME,1
HK,SLEEP APNOEA SYNDROME,1
HK,SUBDURAL EFFUSION,1
HK,TREATMENT NONCOMPLIANCE,1
HK,UPPER GASTROINTESTINAL HAEMORRHAGE,1
HK,URINARY TRACT INFECTION,1
HK,URINARY TRACT INFECTION BACTERIAL,1
HK,VERTIGO,1
HK,WEIGHT INCREASED,1
HU,HYPOGLYCAEMIA,11
HU,BLOOD GLUCOSE ABNORMAL,8
HU,HYPERTENSION,7
HU,COUGH,6
HU,GLYCOSYLATED HAEMOGLOBIN INCREASED,6
HU,LIPIDS ABNORMAL,6
HU,MATERNAL EXPOSURE DURING PREGNANCY,6
HU,BLOOD GLUCOSE INCREASED,4
HU,CARDIAC FAILURE,4
HU,DRUG INEFFECTIVE,4
HU,PREMATURE RUPTURE OF MEMBRANES,4
HU,PRODUCT USE ISSUE,4
HU,ANAEMIA,3
HU,ANGINA PECTORIS,3
HU,ANGIOPATHY,3
HU,ASTHENIA,3
HU,DIABETES MELLITUS INADEQUATE CONTROL,3
HU,DIARRHOEA,3
HU,DIZZINESS,3
HU,DYSPNOEA,3
HU,EXPOSURE DURING PREGNANCY,3
HU,GLOMERULAR FILTRATION RATE DECREASED,3
HU,PANCREATIC CARCINOMA,3
HU,RENAL IMPAIRMENT,3
HU,WEIGHT INCREASED,3
HU,ABORTION INDUCED,2
HU,ATRIAL FIBRILLATION,2
HU,BALANCE DISORDER,2
HU,CEREBROVASCULAR ACCIDENT,2
HU,DIABETIC METABOLIC DECOMPENSATION,2
HU,DRUG INTOLERANCE,2
HU,DYSPNOEA EXERTIONAL,2
HU,ERYTHEMA,2
HU,FATIGUE,2
HU,FOETAL EXPOSURE DURING PREGNANCY,2
HU,GASTROINTESTINAL HAEMORRHAGE,2
HU,GLAUCOMA,2
HU,HYPONATRAEMIA,2
HU,HYPOTENSION,2
HU,MALAISE,2
HU,MUSCULAR WEAKNESS,2
HU,PERIPHERAL SWELLING,2
HU,PNEUMONIA,2
HU,POLYDIPSIA,2
HU,PREMATURE BABY,2
HU,PREMATURE DELIVERY,2
HU,WEIGHT DECREASED,2
HU,ABDOMINAL DISCOMFORT,1
HU,ABDOMINAL DISTENSION,1
HU,ABDOMINAL PAIN,1
HU,ABORTION,1
HU,ABORTION EARLY,1
HU,ABORTION SPONTANEOUS,1
HU,ACNE,1
HU,ACUTE CORONARY SYNDROME,1
HU,ACUTE KIDNEY INJURY,1
HU,ALANINE AMINOTRANSFERASE INCREASED,1
HU,AMNIORRHEXIS,1
HU,AMNIOTIC MEMBRANE RUPTURE TEST POSITIVE,1
HU,ANAL ABSCESS,1
HU,ANGIOEDEMA,1
HU,AORTIC STENOSIS,1
HU,APTYALISM,1
HU,ARTERIOGRAM CORONARY,1
HU,ASPARTATE AMINOTRANSFERASE INCREASED,1
HU,ASTHMA,1
HU,ATRIOVENTRICULAR BLOCK COMPLETE,1
HU,ATROPHY,1
HU,BLOOD GLUCOSE DECREASED,1
HU,BLOOD PRESSURE ABNORMAL,1
HU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
HU,BLOOD TEST,1
HU,BRAIN NEOPLASM,1
HU,BRAIN OEDEMA,1
HU,BUNDLE BRANCH BLOCK LEFT,1
HU,BURNING SENSATION,1
HU,CARBOHYDRATE METABOLISM DISORDER,1
HU,CATARACT,1
HU,CEREBROVASCULAR DISORDER,1
HU,CHEST PAIN,1
HU,CHOLECYSTECTOMY,1
HU,COAGULOPATHY,1
HU,CONDITION AGGRAVATED,1
HU,CONSTIPATION,1
HU,DEATH,1
HU,DECREASED APPETITE,1
HU,DEHYDRATION,1
HU,DIABETES MELLITUS,1
HU,DIABETIC HYPERGLYCAEMIC COMA,1
HU,DIABETIC KETOACIDOSIS,1
HU,DIABETIC NEUROPATHY,1
HU,DISTURBANCE IN ATTENTION,1
HU,DRUG PRESCRIBING ERROR,1
HU,DRY MOUTH,1
HU,DYSPHONIA,1
HU,EJECTION FRACTION DECREASED,1
HU,ELECTROCARDIOGRAM QT PROLONGED,1
HU,ENCEPHALOPATHY,1
HU,FEAR OF DEATH,1
HU,FULL BLOOD COUNT ABNORMAL,1
HU,GAIT DISTURBANCE,1
HU,GANGRENE,1
HU,GASTRIC ULCER,1
HU,GINGIVAL SWELLING,1
HU,HAEMATOCHEZIA,1
HU,HAEMATOMA,1
HU,HAEMORRHAGIC TRANSFORMATION STROKE,1
HU,HEADACHE,1
HU,HEPATIC CIRRHOSIS,1
HU,HIATUS HERNIA,1
HU,HUNGER,1
HU,HYPERGLYCAEMIA,1
HU,HYPERSENSITIVITY,1
HU,HYPOACUSIS,1
HU,HYPOAESTHESIA,1
HU,HYPOALBUMINAEMIA,1
HU,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
HU,HYPOMETABOLISM,1
HU,IMPAIRED HEALING,1
HU,INJECTION SITE MASS,1
HU,INTENTIONAL OVERDOSE,1
HU,INVASIVE DUCTAL BREAST CARCINOMA,1
HU,JAUNDICE,1
HU,KETOACIDOSIS,1
HU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
HU,LATENT TUBERCULOSIS,1
HU,LETHARGY,1
HU,LIP SWELLING,1
HU,LIVE BIRTH,1
HU,LIVER INJURY,1
HU,LOW BIRTH WEIGHT BABY,1
HU,LUNG NEOPLASM MALIGNANT,1
HU,MALIGNANT NEOPLASM PROGRESSION,1
HU,MELAENA,1
HU,METABOLIC ACIDOSIS,1
HU,METABOLIC DISORDER,1
HU,MYOCARDIAL INFARCTION,1
HU,NERVOUSNESS,1
HU,NIGHTMARE,1
HU,NOCTURNAL DYSPNOEA,1
HU,OEDEMA PERIPHERAL,1
HU,OESOPHAGEAL ULCER HAEMORRHAGE,1
HU,OSTEOARTHRITIS,1
HU,OSTEONECROSIS,1
HU,PANCYTOPENIA,1
HU,PARKINSON^S DISEASE,1
HU,POLYNEUROPATHY,1
HU,POLYURIA,1
HU,PREGNANCY ON CONTRACEPTIVE,1
HU,PROSTATITIS,1
HU,PSYCHOMOTOR HYPERACTIVITY,1
HU,PSYCHOTIC DISORDER,1
HU,PULMONARY EMBOLISM,1
HU,PULMONARY FIBROSIS,1
HU,PYREXIA,1
HU,RENAL DISORDER,1
HU,RHINORRHOEA,1
HU,SENSATION OF HEAVINESS,1
HU,SHOCK,1
HU,SKIN REACTION,1
HU,STRIDOR,1
HU,SUICIDE ATTEMPT,1
HU,SWELLING,1
HU,SWOLLEN TONGUE,1
HU,THERAPEUTIC RESPONSE UNEXPECTED,1
HU,THYROID DISORDER,1
HU,TINNITUS,1
HU,TOE AMPUTATION,1
HU,TREATMENT FAILURE,1
HU,URINARY RETENTION,1
HU,UTERINE HAEMORRHAGE,1
HU,VERTIGO,1
HU,VIRAL INFECTION,1
HU,VISUAL IMPAIRMENT,1
HU,VOMITING,1
HU,WEIGHT ABNORMAL,1
HU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
HU,YELLOW SKIN,1
IS,ABORTION SPONTANEOUS,1
IS,EXPOSURE DURING PREGNANCY,1
IN,HYPOGLYCAEMIA,22
IN,OVERDOSE,17
IN,DRUG ABUSE,16
IN,HYPOGLYCAEMIC COMA,13
IN,CONDITION AGGRAVATED,10
IN,DYSPNOEA,10
IN,PYREXIA,10
IN,TOXICITY TO VARIOUS AGENTS,9
IN,FATIGUE,8
IN,FOETAL EXPOSURE DURING PREGNANCY,8
IN,MATERNAL EXPOSURE DURING PREGNANCY,8
IN,SHOCK,8
IN,DECREASED APPETITE,7
IN,LACTIC ACIDOSIS,7
IN,PAIN,7
IN,URINARY TRACT INFECTION,7
IN,VOMITING,7
IN,AMENORRHOEA,6
IN,ANAEMIA,6
IN,ARTHROPATHY,6
IN,AUTOIMMUNE HAEMOLYTIC ANAEMIA,6
IN,CHOLELITHIASIS,6
IN,DIABETIC KETOACIDOSIS,6
IN,HYPERGLYCAEMIA,6
IN,HYPOTENSION,6
IN,JAUNDICE,6
IN,MYOCARDIAL INFARCTION,6
IN,PULMONARY OEDEMA,6
IN,SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA,6
IN,VOLVULUS,6
IN,ABSCESS INTESTINAL,5
IN,CARDIAC FAILURE CONGESTIVE,5
IN,CHEST PAIN,5
IN,COLITIS,5
IN,DEATH,5
IN,DIABETES MELLITUS,5
IN,DIARRHOEA,5
IN,DRUG INEFFECTIVE,5
IN,INSOMNIA,5
IN,INTENTIONAL OVERDOSE,5
IN,METABOLIC ACIDOSIS,5
IN,NAUSEA,5
IN,OEDEMA PERIPHERAL,5
IN,PARAESTHESIA,5
IN,PLEURAL EFFUSION,5
IN,WEIGHT DECREASED,5
IN,ACUTE MYOCARDIAL INFARCTION,4
IN,ARTHRALGIA,4
IN,ARTHRITIS,4
IN,BLOOD LACTATE DEHYDROGENASE INCREASED,4
IN,BRONCHITIS,4
IN,CARDIAC FAILURE,4
IN,CELLULITIS,4
IN,CEREBROVASCULAR ACCIDENT,4
IN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
IN,CONGESTIVE CARDIOMYOPATHY,4
IN,DELIRIUM,4
IN,DEPRESSED LEVEL OF CONSCIOUSNESS,4
IN,DEPRESSION,4
IN,DISSEMINATED TUBERCULOSIS,4
IN,FALL,4
IN,HYPONATRAEMIA,4
IN,INFLAMMATION,4
IN,LOSS OF CONSCIOUSNESS,4
IN,PANCREATITIS,4
IN,PANCREATITIS ACUTE,4
IN,PREMATURE BABY,4
IN,RENAL TUBULAR NECROSIS,4
IN,SEIZURE,4
IN,SEROTONIN SYNDROME,4
IN,SPLENIC INFARCTION,4
IN,THROAT TIGHTNESS,4
IN,URETERIC OBSTRUCTION,4
IN,ABDOMINAL DISTENSION,3
IN,ABDOMINAL PAIN,3
IN,ABORTION THREATENED,3
IN,APHASIA,3
IN,ASTHENIA,3
IN,BLOOD BILIRUBIN INCREASED,3
IN,BLOOD GLUCOSE INCREASED,3
IN,BRADYCARDIA,3
IN,BURNING SENSATION,3
IN,COUGH,3
IN,DEEP VEIN THROMBOSIS,3
IN,DIABETES MELLITUS INADEQUATE CONTROL,3
IN,DRUG DEPENDENCE,3
IN,DRUG ERUPTION,3
IN,DRUG INTOLERANCE,3
IN,DRUG WITHDRAWAL SYNDROME,3
IN,DRUG-INDUCED LIVER INJURY,3
IN,ELECTROCARDIOGRAM QT PROLONGED,3
IN,EOSINOPHILIA,3
IN,FLUID RETENTION,3
IN,HAEMATOCHEZIA,3
IN,HAEMOGLOBIN DECREASED,3
IN,HEART RATE DECREASED,3
IN,HEPATITIS,3
IN,HERPES ZOSTER,3
IN,HICCUPS,3
IN,HYPERCHOLESTEROLAEMIA,3
IN,HYPERTENSION,3
IN,INFECTION,3
IN,INTERVERTEBRAL DISC PROTRUSION,3
IN,INTESTINAL OBSTRUCTION,3
IN,JAUNDICE HEPATOCELLULAR,3
IN,KETOACIDOSIS,3
IN,KETONURIA,3
IN,LIVE BIRTH,3
IN,MALAISE,3
IN,MENORRHAGIA,3
IN,MOUTH ULCERATION,3
IN,MUSCLE ABSCESS,3
IN,MYXOEDEMA COMA,3
IN,NEUROLEPTIC MALIGNANT SYNDROME,3
IN,NEUROPATHY PERIPHERAL,3
IN,OCULAR ICTERUS,3
IN,OLIGOHYDRAMNIOS,3
IN,OSTEOARTHRITIS,3
IN,PALLOR,3
IN,PREMATURE DELIVERY,3
IN,PREMATURE RUPTURE OF MEMBRANES,3
IN,PRODUCTIVE COUGH,3
IN,PRURITUS,3
IN,PSORIASIS,3
IN,PULMONARY EMBOLISM,3
IN,PULMONARY MASS,3
IN,RASH MACULO-PAPULAR,3
IN,SKIN ULCER,3
IN,SYNCOPE,3
IN,TUBERCULOSIS,3
IN,URETEROLITHIASIS,3
IN,UTERINE LEIOMYOMA,3
IN,VAGINAL HAEMORRHAGE,3
IN,WEIGHT INCREASED,3
IN,ABDOMINAL LYMPHADENOPATHY,2
IN,ABDOMINAL PAIN UPPER,2
IN,ABDOMINAL TENDERNESS,2
IN,ACUTE KIDNEY INJURY,2
IN,AGGRESSION,2
IN,ALANINE AMINOTRANSFERASE INCREASED,2
IN,ANAEMIA VITAMIN B12 DEFICIENCY,2
IN,AORTIC VALVE INCOMPETENCE,2
IN,ARTHRODESIS,2
IN,ASPARTATE AMINOTRANSFERASE INCREASED,2
IN,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
IN,BACK PAIN,2
IN,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,2
IN,BLADDER CANCER,2
IN,BLADDER DISORDER,2
IN,BLINDNESS,2
IN,BLISTER,2
IN,BLOOD BLISTER,2
IN,BLOOD CREATININE INCREASED,2
IN,BLOOD PRESSURE DECREASED,2
IN,BLOOD PRESSURE FLUCTUATION,2
IN,BRAIN NEOPLASM,2
IN,BRAIN OEDEMA,2
IN,CANDIDA INFECTION,2
IN,CARDIO-RESPIRATORY ARREST,2
IN,CHILLS,2
IN,CLINODACTYLY,2
IN,CONSTIPATION,2
IN,CONTUSION,2
IN,CORONARY ARTERY DISEASE,2
IN,CUSHINGOID,2
IN,DEAFNESS,2
IN,DEHYDRATION,2
IN,DELAYED RECOVERY FROM ANAESTHESIA,2
IN,DISEASE PROGRESSION,2
IN,DISORIENTATION,2
IN,DYSPEPSIA,2
IN,DYSPNOEA EXERTIONAL,2
IN,DYSURIA,2
IN,EAR SWELLING,2
IN,EATING DISORDER,2
IN,ELECTROCARDIOGRAM PR PROLONGATION,2
IN,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
IN,ENCEPHALITIS,2
IN,EXPOSURE DURING PREGNANCY,2
IN,FIBROSIS,2
IN,FOETAL GROWTH RESTRICTION,2
IN,GAIT DISTURBANCE,2
IN,GASTRIC DISORDER,2
IN,GASTROINTESTINAL DISORDER,2
IN,GASTROINTESTINAL INJURY,2
IN,GASTROINTESTINAL PERFORATION,2
IN,GASTROINTESTINAL WALL THICKENING,2
IN,GENERALISED TONIC-CLONIC SEIZURE,2
IN,HAEMORRHAGE,2
IN,HALLUCINATION_ VISUAL,2
IN,HAPTOGLOBIN DECREASED,2
IN,HEPATIC CYST,2
IN,HEPATIC STEATOSIS,2
IN,HIATUS HERNIA,2
IN,HYPERCHLORHYDRIA,2
IN,HYPERHIDROSIS,2
IN,HYPERSENSITIVITY,2
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
IN,INFLUENZA LIKE ILLNESS,2
IN,INTENTIONAL PRODUCT MISUSE,2
IN,INTERVERTEBRAL DISC DEGENERATION,2
IN,INTESTINAL PERFORATION,2
IN,INTESTINAL SCARRING,2
IN,INTESTINAL STENOSIS,2
IN,IRON DEFICIENCY ANAEMIA,2
IN,JOINT INJURY,2
IN,JOINT STIFFNESS,2
IN,LARGE INTESTINAL OBSTRUCTION,2
IN,LARGE INTESTINE PERFORATION,2
IN,LIPASE INCREASED,2
IN,LIVER FUNCTION TEST ABNORMAL,2
IN,LIVER INJURY,2
IN,LOW BIRTH WEIGHT BABY,2
IN,LYMPHADENOPATHY,2
IN,MASTOID EFFUSION,2
IN,METASTASIS,2
IN,MILIARIA,2
IN,MITRAL VALVE INCOMPETENCE,2
IN,MOVEMENT DISORDER,2
IN,MUSCLE RIGIDITY,2
IN,MUSCULAR WEAKNESS,2
IN,MUSCULOSKELETAL STIFFNESS,2
IN,MYOCLONUS,2
IN,NEOPLASM MALIGNANT,2
IN,OSTEOPOROSIS,2
IN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
IN,PHOTOSENSITIVITY REACTION,2
IN,PNEUMONIA,2
IN,POLYP,2
IN,PRODUCT USE ISSUE,2
IN,PROTEIN TOTAL DECREASED,2
IN,PULMONARY FIBROSIS,2
IN,RENAL DISORDER,2
IN,RENAL IMPAIRMENT,2
IN,RENAL NEOPLASM,2
IN,RESTLESSNESS,2
IN,SEPSIS,2
IN,SKIN DISCOLOURATION,2
IN,SKIN DISORDER,2
IN,SPEECH DISORDER,2
IN,SPINAL DISORDER,2
IN,SPUTUM INCREASED,2
IN,SUICIDAL IDEATION,2
IN,SUICIDE ATTEMPT,2
IN,TACHYCARDIA,2
IN,TACHYPNOEA,2
IN,TALIPES,2
IN,TENDON DISORDER,2
IN,TENDON RUPTURE,2
IN,THROMBOPHLEBITIS SUPERFICIAL,2
IN,THROMBOSIS,2
IN,TREMOR,2
IN,URACHAL ABNORMALITY,2
IN,VENTRICULAR FIBRILLATION,2
IN,VERTIGO,2
IN,VISUAL IMPAIRMENT,2
IN,VITELLO-INTESTINAL DUCT REMNANT,2
IN,VULVOVAGINAL MYCOTIC INFECTION,2
IN,WHITE BLOOD CELL COUNT INCREASED,2
IN,WOUND,2
IN,ABDOMINAL ABSCESS,1
IN,ABDOMINAL PAIN LOWER,1
IN,ABDOMINAL WALL ABSCESS,1
IN,ABDOMINAL WALL ANOMALY,1
IN,ABDOMINAL WALL DISORDER,1
IN,ABNORMAL BEHAVIOUR,1
IN,ABORTION SPONTANEOUS,1
IN,ABSCESS DRAINAGE,1
IN,ABSCESS LIMB,1
IN,ACANTHOSIS,1
IN,ACETONAEMIA,1
IN,ACNE,1
IN,ACQUIRED CLAW TOE,1
IN,ACUTE CORONARY SYNDROME,1
IN,ACUTE HEPATIC FAILURE,1
IN,ADENOCARCINOMA,1
IN,ADENOCARCINOMA GASTRIC,1
IN,ADRENAL DISORDER,1
IN,ADRENAL INSUFFICIENCY,1
IN,ADRENAL NEOPLASM,1
IN,ADVERSE DRUG REACTION,1
IN,AGITATION,1
IN,ALCOHOL ABUSE,1
IN,ALCOHOL WITHDRAWAL SYNDROME,1
IN,ALOPECIA,1
IN,ALTERED STATE OF CONSCIOUSNESS,1
IN,AMYLASE INCREASED,1
IN,ANAL ABSCESS,1
IN,ANAL ATRESIA,1
IN,ANAL INCONTINENCE,1
IN,ANAPHYLACTIC SHOCK,1
IN,ANGINA PECTORIS,1
IN,ANGIOEDEMA,1
IN,ANORECTAL DISCOMFORT,1
IN,ANOREXIA NERVOSA,1
IN,APPENDICITIS,1
IN,ARTERIAL OCCLUSIVE DISEASE,1
IN,ATRIAL FIBRILLATION,1
IN,ATRIOVENTRICULAR BLOCK,1
IN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
IN,AURA,1
IN,AUTISM SPECTRUM DISORDER,1
IN,AZOTAEMIA,1
IN,B-CELL LYMPHOMA,1
IN,BACK DISORDER,1
IN,BACTERIAL INFECTION,1
IN,BALANOPOSTHITIS,1
IN,BENIGN PROSTATIC HYPERPLASIA,1
IN,BIPOLAR DISORDER,1
IN,BLISTER INFECTED,1
IN,BLOOD ALBUMIN DECREASED,1
IN,BLOOD CALCIUM DECREASED,1
IN,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IN,BLOOD FOLLICLE STIMULATING HORMONE DECREASED,1
IN,BLOOD GLUCOSE DECREASED,1
IN,BLOOD IRON DECREASED,1
IN,BLOOD LUTEINISING HORMONE DECREASED,1
IN,BLOOD PHOSPHORUS INCREASED,1
IN,BLOOD POTASSIUM INCREASED,1
IN,BLOOD PRESSURE SYSTOLIC INCREASED,1
IN,BLOOD SODIUM DECREASED,1
IN,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IN,BLOOD UREA ABNORMAL,1
IN,BLOOD URINE PRESENT,1
IN,BODY FAT DISORDER,1
IN,BONE DISORDER,1
IN,BONE LOSS,1
IN,BONE NEOPLASM,1
IN,BONE TUBERCULOSIS,1
IN,BRAIN ABSCESS,1
IN,BREAST ABSCESS,1
IN,BREAST FEEDING,1
IN,BREAST MASS,1
IN,BREATH SOUNDS ABNORMAL,1
IN,BRONCHIECTASIS,1
IN,BRONCHOPNEUMONIA,1
IN,C-REACTIVE PROTEIN INCREASED,1
IN,CAESAREAN SECTION,1
IN,CARDIAC VALVE ABSCESS,1
IN,CARDIOMEGALY,1
IN,CARDIOMYOPATHY,1
IN,CAROTID ARTERY DISEASE,1
IN,CARPAL TUNNEL SYNDROME,1
IN,CARTILAGE ATROPHY,1
IN,CATARACT,1
IN,CATARRH,1
IN,CENTRAL NERVOUS SYSTEM INFECTION,1
IN,CENTRAL NERVOUS SYSTEM LESION,1
IN,CEREBRAL HAEMATOMA,1
IN,CEREBRAL HAEMORRHAGE,1
IN,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,1
IN,CERVICAL INCOMPETENCE,1
IN,CHAPPED LIPS,1
IN,CHEST DISCOMFORT,1
IN,CHEST WALL CYST,1
IN,CHOLECYSTITIS ACUTE,1
IN,CHOLECYSTITIS CHRONIC,1
IN,CHONDROPATHY,1
IN,CHRONIC GRANULOMATOUS DISEASE,1
IN,CHRONIC KIDNEY DISEASE,1
IN,CIRCULATORY COLLAPSE,1
IN,COLD SWEAT,1
IN,COLON CANCER METASTATIC,1
IN,COLON INJURY,1
IN,COLONIC FISTULA,1
IN,CONFUSIONAL STATE,1
IN,CONGENITAL GENITOURINARY ABNORMALITY,1
IN,CONJUNCTIVAL HAEMORRHAGE,1
IN,CONJUNCTIVALISATION,1
IN,CONTINUOUS HAEMODIAFILTRATION,1
IN,CORNEAL DEFECT,1
IN,CSF TEST ABNORMAL,1
IN,CUTANEOUS SPOROTRICHOSIS,1
IN,CYANOSIS,1
IN,CYANOSIS CENTRAL,1
IN,CYST,1
IN,CYSTITIS,1
IN,CYSTITIS HAEMORRHAGIC,1
IN,DACRYOCYSTITIS,1
IN,DEAFNESS NEUROSENSORY,1
IN,DECUBITUS ULCER,1
IN,DENTAL CARIES,1
IN,DEPRESSED MOOD,1
IN,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
IN,DEVICE OCCLUSION,1
IN,DEVICE RELATED INFECTION,1
IN,DIABETIC AMYOTROPHY,1
IN,DIABETIC COMPLICATION,1
IN,DIARRHOEA HAEMORRHAGIC,1
IN,DISCOLOURED VOMIT,1
IN,DISCOMFORT,1
IN,DISORGANISED SPEECH,1
IN,DISTURBANCE IN ATTENTION,1
IN,DIZZINESS,1
IN,DIZZINESS POSTURAL,1
IN,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
IN,DRUG EFFECT DECREASED,1
IN,DRUG HYPERSENSITIVITY,1
IN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IN,DRUG RESISTANCE,1
IN,DRUG SPECIFIC ANTIBODY PRESENT,1
IN,DRUG-DISEASE INTERACTION,1
IN,DRY MOUTH,1
IN,DRY THROAT,1
IN,DYSCHEZIA,1
IN,DYSGEUSIA,1
IN,DYSMORPHISM,1
IN,ECG SIGNS OF MYOCARDIAL ISCHAEMIA,1
IN,ECHINOCOCCIASIS,1
IN,ECZEMA,1
IN,EMBEDDED DEVICE,1
IN,EMBOLISM,1
IN,EMOTIONAL DISTRESS,1
IN,EMPHYSEMA,1
IN,ENANTHEMA,1
IN,ENCEPHALITIS VIRAL,1
IN,END STAGE RENAL DISEASE,1
IN,ENDOCARDITIS,1
IN,ENDOMETRIAL DISORDER,1
IN,ENTEROCOLITIS HAEMORRHAGIC,1
IN,ENTEROPATHIC SPONDYLITIS,1
IN,EOSINOPHIL COUNT DECREASED,1
IN,EPIGASTRIC DISCOMFORT,1
IN,ERYSIPELAS,1
IN,ERYTHEMA,1
IN,EXPOSURE DURING BREAST FEEDING,1
IN,EXTRASYSTOLES,1
IN,EYE DISORDER,1
IN,EYE PAIN,1
IN,EYELID PTOSIS,1
IN,FAMILIAL PERIODIC PARALYSIS,1
IN,FAT INTOLERANCE,1
IN,FEMUR FRACTURE,1
IN,FISTULA,1
IN,FISTULA DISCHARGE,1
IN,FIXED DRUG ERUPTION,1
IN,FLANK PAIN,1
IN,FLATULENCE,1
IN,FLUSHING,1
IN,FOETAL ANAEMIA,1
IN,FOETAL DEATH,1
IN,FRACTURED COCCYX,1
IN,FREQUENT BOWEL MOVEMENTS,1
IN,FURUNCLE,1
IN,GALLBLADDER CANCER,1
IN,GASTRIC HAEMORRHAGE,1
IN,GASTRIC MUCOSAL LESION,1
IN,GASTRITIS,1
IN,GASTROENTERITIS,1
IN,GASTROINTESTINAL CARCINOMA,1
IN,GASTROOESOPHAGEAL REFLUX DISEASE,1
IN,GASTROSTOMY TUBE SITE COMPLICATION,1
IN,GENERAL PHYSICAL HEALTH DETERIORATION,1
IN,GENERALISED ERYTHEMA,1
IN,GENERALISED OEDEMA,1
IN,GENITAL DISORDER MALE,1
IN,GENITAL INFECTION FUNGAL,1
IN,GENITAL NEOPLASM MALIGNANT FEMALE,1
IN,GESTATIONAL DIABETES,1
IN,GESTATIONAL HYPERTENSION,1
IN,GINGIVAL HYPERTROPHY,1
IN,GOUT,1
IN,GRANULOMA,1
IN,GROIN ABSCESS,1
IN,GROIN INFECTION,1
IN,GROIN PAIN,1
IN,HAEMANGIOMA OF LIVER,1
IN,HAEMATEMESIS,1
IN,HAEMODIALYSIS,1
IN,HAEMOLYSIS,1
IN,HAEMOLYTIC ANAEMIA,1
IN,HAEMOPERFUSION,1
IN,HAEMOPHILIA,1
IN,HAEMORRHAGE SUBCUTANEOUS,1
IN,HAEMORRHAGIC DIATHESIS,1
IN,HAND DEFORMITY,1
IN,HEADACHE,1
IN,HEART RATE INCREASED,1
IN,HEPATIC ENZYME INCREASED,1
IN,HEPATIC MASS,1
IN,HEPATIC VASCULAR THROMBOSIS,1
IN,HER-2 PROTEIN OVEREXPRESSION,1
IN,HERNIA,1
IN,HIV TEST POSITIVE,1
IN,HOMICIDAL IDEATION,1
IN,HYDRONEPHROSIS,1
IN,HYPERKALAEMIA,1
IN,HYPERMOBILITY SYNDROME,1
IN,HYPERPARATHYROIDISM PRIMARY,1
IN,HYPERTONIA,1
IN,HYPERTRIGLYCERIDAEMIA,1
IN,HYPERTROPHY,1
IN,HYPERVENTILATION,1
IN,HYPOAESTHESIA,1
IN,HYPOCHROMIC ANAEMIA,1
IN,HYPOGLYCAEMIA NEONATAL,1
IN,HYPOKINESIA,1
IN,HYPORESPONSIVE TO STIMULI,1
IN,HYPOTHERMIA,1
IN,HYPOVITAMINOSIS,1
IN,ILIAC ARTERY OCCLUSION,1
IN,IMMUNE SYSTEM DISORDER,1
IN,INADEQUATE DIET,1
IN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IN,INCISION SITE ABSCESS,1
IN,INCISION SITE COMPLICATION,1
IN,INCREASED UPPER AIRWAY SECRETION,1
IN,INGUINAL HERNIA,1
IN,INGUINAL MASS,1
IN,INTELLECTUAL DISABILITY,1
IN,INTERSTITIAL LUNG DISEASE,1
IN,INTESTINAL DILATATION,1
IN,INTRACRANIAL ANEURYSM,1
IN,INVESTIGATION,1
IN,JAW DISORDER,1
IN,JOINT INSTABILITY,1
IN,JOINT LOCK,1
IN,JOINT STABILISATION,1
IN,KETOSIS,1
IN,KIDNEY ENLARGEMENT,1
IN,KNEE ARTHROPLASTY,1
IN,KNEE DEFORMITY,1
IN,LARGE INTESTINAL STENOSIS,1
IN,LARGE INTESTINE POLYP,1
IN,LARYNGEAL OEDEMA,1
IN,LEFT VENTRICULAR DYSFUNCTION,1
IN,LEFT VENTRICULAR FAILURE,1
IN,LETHARGY,1
IN,LEUKOCYTOSIS,1
IN,LID LAG,1
IN,LIGAMENT SPRAIN,1
IN,LIP DISORDER,1
IN,LIP HAEMORRHAGE,1
IN,LIVEDO RETICULARIS,1
IN,LIVER ABSCESS,1
IN,LIVER DISORDER,1
IN,LIVER FUNCTION TEST INCREASED,1
IN,LOWER RESPIRATORY TRACT INFECTION,1
IN,LUNG HYPERINFLATION,1
IN,LYMPHADENOPATHY MEDIASTINAL,1
IN,LYMPHOCYTE COUNT DECREASED,1
IN,MACULE,1
IN,MAJOR DEPRESSION,1
IN,MASTOPTOSIS,1
IN,MATERNAL EXPOSURE DURING DELIVERY,1
IN,MEDICATION ERROR,1
IN,MENISCUS INJURY,1
IN,MENSTRUATION NORMAL,1
IN,MESENTERIC ARTERIAL OCCLUSION,1
IN,METABOLIC SYNDROME,1
IN,METASTASES TO BONE,1
IN,METASTASES TO CENTRAL NERVOUS SYSTEM,1
IN,METASTASES TO LIVER,1
IN,METRORRHAGIA,1
IN,MICROCEPHALY,1
IN,MICTURITION DISORDER,1
IN,MICTURITION URGENCY,1
IN,MIDDLE INSOMNIA,1
IN,MORTON^S NEURALGIA,1
IN,MUCOSAL INFLAMMATION,1
IN,MULTIPLE FRACTURES,1
IN,MUSCLE ATROPHY,1
IN,MUSCLE RUPTURE,1
IN,MUSCLE SPASMS,1
IN,MUSCULOSKELETAL CHEST PAIN,1
IN,MUSCULOSKELETAL DISORDER,1
IN,MUTISM,1
IN,MYALGIA,1
IN,MYCOBACTERIUM CHELONAE INFECTION,1
IN,MYOCARDIAL OEDEMA,1
IN,NASAL CONGESTION,1
IN,NASAL SINUS CANCER,1
IN,NASOPHARYNGITIS,1
IN,NECK PAIN,1
IN,NECROTISING RETINITIS,1
IN,NEOPLASM,1
IN,NEOPLASM PROGRESSION,1
IN,NEURALGIA,1
IN,NEUTROPHIL COUNT INCREASED,1
IN,NOCTURIA,1
IN,NODULE,1
IN,NON-CARDIAC CHEST PAIN,1
IN,NONINFECTIVE MYRINGITIS,1
IN,NORMAL NEWBORN,1
IN,OBESITY,1
IN,OBSTRUCTION GASTRIC,1
IN,OBSTRUCTIVE AIRWAYS DISORDER,1
IN,OEDEMA,1
IN,OEDEMATOUS KIDNEY,1
IN,OESOPHAGEAL RUPTURE,1
IN,OESOPHAGITIS,1
IN,OESTROGEN RECEPTOR ASSAY POSITIVE,1
IN,OPTIC ATROPHY,1
IN,ORAL LICHEN PLANUS,1
IN,ORAL MUCOSAL ERYTHEMA,1
IN,ORAL PAIN,1
IN,ORAL PUSTULE,1
IN,OROPHARYNGEAL PAIN,1
IN,ORTHOSTATIC HYPOTENSION,1
IN,ORTHOSTATIC INTOLERANCE,1
IN,OSTEOSIS,1
IN,OSTEOSYNTHESIS,1
IN,OVARIAN CYST,1
IN,OVARIAN DRILLING,1
IN,OVERLAP SYNDROME,1
IN,PAIN IN EXTREMITY,1
IN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IN,PANCREATIC CARCINOMA,1
IN,PANCREATIC NEOPLASM,1
IN,PAPULE,1
IN,PARKINSONISM,1
IN,PARONYCHIA,1
IN,PAROTID GLAND ENLARGEMENT,1
IN,PARTIAL SEIZURES,1
IN,PEMPHIGOID,1
IN,PERIARTHRITIS,1
IN,PERIPARTUM CARDIOMYOPATHY,1
IN,PERIPHERAL EMBOLISM,1
IN,PERIRECTAL ABSCESS,1
IN,PETECHIAE,1
IN,PHARYNGEAL ABSCESS,1
IN,PHARYNGEAL OEDEMA,1
IN,PHARYNGEAL ULCERATION,1
IN,PHARYNGITIS STREPTOCOCCAL,1
IN,PHOBIA,1
IN,PHOTOPHOBIA,1
IN,PIGMENTATION DISORDER,1
IN,PITUITARY TUMOUR BENIGN,1
IN,PLATELET COUNT DECREASED,1
IN,PLATELET COUNT INCREASED,1
IN,PLEUROPERICARDITIS,1
IN,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,1
IN,PNEUMONITIS,1
IN,POLLAKIURIA,1
IN,POLYDIPSIA,1
IN,POLYURIA,1
IN,POOR PERIPHERAL CIRCULATION,1
IN,POST-TRAUMATIC PAIN,1
IN,POSTICTAL PARALYSIS,1
IN,PRE-ECLAMPSIA,1
IN,PRESYNCOPE,1
IN,PRIAPISM,1
IN,PROCEDURAL PAIN,1
IN,PROTEINURIA,1
IN,PRURITUS GENERALISED,1
IN,PSOAS ABSCESS,1
IN,PSYCHIATRIC DECOMPENSATION,1
IN,PSYCHOMOTOR RETARDATION,1
IN,PSYCHOTIC DISORDER,1
IN,PULMONARY CONGESTION,1
IN,PULMONARY PAIN,1
IN,PURPURA,1
IN,PURULENCE,1
IN,PYODERMA GANGRENOSUM,1
IN,RADIUS FRACTURE,1
IN,RALES,1
IN,RASH PUSTULAR,1
IN,RAYNAUD^S PHENOMENON,1
IN,RECTAL DISCHARGE,1
IN,RED BLOOD CELL COUNT DECREASED,1
IN,RED CELL DISTRIBUTION WIDTH INCREASED,1
IN,RENAL MALPOSITION,1
IN,RESPIRATION ABNORMAL,1
IN,RESPIRATORY DISORDER,1
IN,RESPIRATORY FAILURE,1
IN,RETICULOCYTE COUNT ABNORMAL,1
IN,RETICULOCYTE COUNT INCREASED,1
IN,RETINAL OEDEMA,1
IN,RHEUMATOID ARTHRITIS,1
IN,RHINITIS,1
IN,RHINORRHOEA,1
IN,RUPTURED ECTOPIC PREGNANCY,1
IN,SACRAL HYPOPLASIA,1
IN,SACROILIITIS,1
IN,SALIVARY GLAND CANCER,1
IN,SALIVARY HYPERSECRETION,1
IN,SCAB,1
IN,SCIATICA,1
IN,SECRETION DISCHARGE,1
IN,SEDATION,1
IN,SELF-MEDICATION,1
IN,SENILE ANKYLOSING VERTEBRAL HYPEROSTOSIS,1
IN,SENSATION OF FOREIGN BODY,1
IN,SENSORY LOSS,1
IN,SEPTIC SHOCK,1
IN,SHORT-BOWEL SYNDROME,1
IN,SINUS BRADYCARDIA,1
IN,SINUS CONGESTION,1
IN,SINUS POLYP,1
IN,SKELETAL INJURY,1
IN,SKIN EXFOLIATION,1
IN,SKIN HYPERPIGMENTATION,1
IN,SKIN HYPERPLASIA,1
IN,SKIN PLAQUE,1
IN,SOCIAL AVOIDANT BEHAVIOUR,1
IN,SPASMODIC DYSPHONIA,1
IN,SPINAL COMPRESSION FRACTURE,1
IN,SPINAL CORD INJURY,1
IN,SPINAL FRACTURE,1
IN,SPUTUM DISCOLOURED,1
IN,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
IN,STAPHYLOCOCCAL INFECTION,1
IN,STEVENS-JOHNSON SYNDROME,1
IN,STOMA SITE INFECTION,1
IN,STOMACH MASS,1
IN,STRABISMUS,1
IN,STRESS FRACTURE,1
IN,STRESS URINARY INCONTINENCE,1
IN,SUBILEUS,1
IN,SUNBURN,1
IN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
IN,TENDINOUS CONTRACTURE,1
IN,TESTICULAR MASS,1
IN,THERAPEUTIC RESPONSE UNEXPECTED,1
IN,THERAPY PARTIAL RESPONDER,1
IN,THIRST,1
IN,THROAT IRRITATION,1
IN,THROAT LESION,1
IN,THROMBOCYTOSIS,1
IN,THYROID DISORDER,1
IN,THYROID MASS,1
IN,TINNITUS,1
IN,TONGUE DRY,1
IN,TONGUE OEDEMA,1
IN,TOXIC EPIDERMAL NECROLYSIS,1
IN,TRANSAMINASES INCREASED,1
IN,TRANSFUSION,1
IN,TRIPLE NEGATIVE BREAST CANCER,1
IN,TUBULOINTERSTITIAL NEPHRITIS,1
IN,TUMOUR HAEMORRHAGE,1
IN,TYMPANIC MEMBRANE DISORDER,1
IN,UMBILICAL CORD CYST,1
IN,UMBILICAL MALFORMATION,1
IN,UNEVALUABLE EVENT,1
IN,UPPER RESPIRATORY TRACT INFECTION,1
IN,URAEMIC ENCEPHALOPATHY,1
IN,URETERAL DISORDER,1
IN,URINARY BLADDER RUPTURE,1
IN,URINARY INCONTINENCE,1
IN,URINE OUTPUT INCREASED,1
IN,UROGENITAL DISORDER,1
IN,URTICARIA,1
IN,USE OF ACCESSORY RESPIRATORY MUSCLES,1
IN,UTERINE PAIN,1
IN,UTERINE SPASM,1
IN,VAGINAL INFECTION,1
IN,VASCULAR COMPRESSION,1
IN,VASCULAR STENT OCCLUSION,1
IN,VASODILATATION,1
IN,VASOSPASM,1
IN,VENOUS THROMBOSIS,1
IN,VIOLENCE-RELATED SYMPTOM,1
IN,VISION BLURRED,1
IN,VOCAL CORD DISORDER,1
IN,VOCAL CORD POLYP,1
IN,VULVAL ABSCESS,1
IN,VULVAR EROSION,1
IN,VULVOVAGINAL CANDIDIASIS,1
IN,VULVOVAGINAL DISCOMFORT,1
IN,VULVOVAGINAL PRURITUS,1
IN,VULVOVAGINITIS,1
IN,WHEEZING,1
IN,WOUND DEHISCENCE,1
IN,WOUND INFECTION STAPHYLOCOCCAL,1
ID,DIARRHOEA,2
ID,HYPERHIDROSIS,2
ID,PAIN,2
ID,ANAL INJURY,1
ID,ASTHENIA,1
ID,BLOOD CALCIUM DECREASED,1
ID,C-REACTIVE PROTEIN INCREASED,1
ID,CONSTIPATION,1
ID,DEATH,1
ID,GASTROINTESTINAL STROMAL TUMOUR,1
ID,GLOMERULAR FILTRATION RATE DECREASED,1
ID,MALIGNANT NEOPLASM PROGRESSION,1
ID,NO THERAPEUTIC RESPONSE,1
ID,URINARY TRACT INFECTION,1
ID,WEIGHT DECREASED,1
IR,ECTOPIC PREGNANCY,6
IR,OVARIAN ADENOMA,5
IR,TOXICITY TO VARIOUS AGENTS,4
IR,LOSS OF CONSCIOUSNESS,3
IR,MATERNAL EXPOSURE DURING PREGNANCY,3
IR,ABDOMINAL PAIN UPPER,2
IR,EXPOSURE DURING PREGNANCY,2
IR,HYPOGLYCAEMIA,2
IR,NECROTISING FASCIITIS,2
IR,ABDOMINAL TENDERNESS,1
IR,ABORTION SPONTANEOUS,1
IR,ACUTE KIDNEY INJURY,1
IR,ANAEMIA,1
IR,ASTHENIA,1
IR,BLOOD GLUCOSE DECREASED,1
IR,BRADYARRHYTHMIA,1
IR,CHEST PAIN,1
IR,CONVULSION,1
IR,COUGH,1
IR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IR,DRUG INEFFECTIVE,1
IR,EMPHYSEMATOUS PYELONEPHRITIS,1
IR,FOETAL DEATH,1
IR,HAEMATOCRIT DECREASED,1
IR,HEART RATE INCREASED,1
IR,HYDRONEPHROSIS,1
IR,HYPOVOLAEMIC SHOCK,1
IR,INJECTION SITE INFLAMMATION,1
IR,INJECTION SITE VESICLES,1
IR,INTENTIONAL OVERDOSE,1
IR,INTENTIONAL PRODUCT USE ISSUE,1
IR,LACTIC ACIDOSIS,1
IR,MATERNAL EXPOSURE BEFORE PREGNANCY,1
IR,METABOLIC ACIDOSIS,1
IR,MUSCULOSKELETAL STIFFNESS,1
IR,NAUSEA,1
IR,OEDEMA PERIPHERAL,1
IR,OVARIAN CYST,1
IR,OVERDOSE,1
IR,PALPITATIONS,1
IR,PRETERM PREMATURE RUPTURE OF MEMBRANES,1
IR,PROCEDURAL HAEMORRHAGE,1
IR,PULMONARY FIBROSIS,1
IR,RUPTURED ECTOPIC PREGNANCY,1
IR,TACHYCARDIA,1
IR,URINARY INCONTINENCE,1
IR,VOMITING,1
IE,DIABETIC KETOACIDOSIS,27
IE,PRODUCT USE ISSUE,12
IE,VOMITING,12
IE,HYPOGLYCAEMIA,11
IE,BLOOD GLUCOSE INCREASED,10
IE,DIABETES MELLITUS INADEQUATE CONTROL,9
IE,LOWER RESPIRATORY TRACT INFECTION,9
IE,EXPOSURE DURING PREGNANCY,7
IE,DIARRHOEA,6
IE,DYSPNOEA,6
IE,ECZEMA,6
IE,MALAISE,6
IE,POSTPARTUM HAEMORRHAGE,6
IE,ACUTE KIDNEY INJURY,5
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
IE,CONFUSIONAL STATE,5
IE,CONSTIPATION,5
IE,HAEMOGLOBIN DECREASED,5
IE,INFLUENZA,5
IE,INSOMNIA,5
IE,LACTIC ACIDOSIS,5
IE,NAUSEA,5
IE,URINARY TRACT INFECTION,5
IE,ABDOMINAL DISCOMFORT,4
IE,ANAEMIA MACROCYTIC,4
IE,CAESAREAN SECTION,4
IE,CHEST PAIN,4
IE,DEHYDRATION,4
IE,DIABETIC NEUROPATHY,4
IE,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,4
IE,DYSPEPSIA,4
IE,FEELING HOT,4
IE,FOETAL EXPOSURE DURING PREGNANCY,4
IE,GLYCOSYLATED HAEMOGLOBIN,4
IE,INFECTION,4
IE,LIVER FUNCTION TEST ABNORMAL,4
IE,PANCREATIC CARCINOMA,4
IE,PRURITUS,4
IE,PULSE ABNORMAL,4
IE,RASH,4
IE,SENSORY LOSS,4
IE,VITAMIN B12 DEFICIENCY,4
IE,WHITE BLOOD CELL COUNT DECREASED,4
IE,WHITE BLOOD CELL COUNT INCREASED,4
IE,ABDOMINAL DISTENSION,3
IE,BACK PAIN,3
IE,BLOOD PRESSURE ABNORMAL,3
IE,CARDIOVASCULAR DISORDER,3
IE,CELLULITIS,3
IE,COUGH,3
IE,DEPRESSED MOOD,3
IE,DYSURIA,3
IE,EMOTIONAL DISTRESS,3
IE,FATIGUE,3
IE,HYPERTENSION,3
IE,HYPOTENSION,3
IE,NEUTROPHIL COUNT INCREASED,3
IE,OEDEMA,3
IE,PAIN OF SKIN,3
IE,PANCYTOPENIA,3
IE,PLATELET COUNT DECREASED,3
IE,PNEUMONIA,3
IE,POLLAKIURIA,3
IE,PRE-ECLAMPSIA,3
IE,ACUTE RESPIRATORY FAILURE,2
IE,ANAEMIA MEGALOBLASTIC,2
IE,ANAPHYLACTOID REACTION,2
IE,ANKYLOGLOSSIA CONGENITAL,2
IE,ANXIETY,2
IE,ATAXIA,2
IE,BLOOD BICARBONATE DECREASED,2
IE,BLOOD PH DECREASED,2
IE,CONVULSION NEONATAL,2
IE,CYANOSIS,2
IE,DEATH,2
IE,DECREASED APPETITE,2
IE,DECREASED INSULIN REQUIREMENT,2
IE,DRUG INEFFECTIVE,2
IE,FACIAL PARALYSIS,2
IE,FALL,2
IE,GAIT DISTURBANCE,2
IE,GASTROINTESTINAL HAEMORRHAGE,2
IE,GOUT,2
IE,HAEMATEMESIS,2
IE,HEADACHE,2
IE,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,2
IE,HYPOGLYCAEMIA NEONATAL,2
IE,INTERTRIGO,2
IE,IRON DEFICIENCY ANAEMIA,2
IE,KETOACIDOSIS,2
IE,KETONURIA,2
IE,LEUKOPENIA,2
IE,MATERNAL EXPOSURE DURING PREGNANCY,2
IE,MUSCULOSKELETAL STIFFNESS,2
IE,NEUTROPENIA,2
IE,PANCREATITIS,2
IE,POST PROCEDURAL COMPLICATION,2
IE,PREMATURE BABY,2
IE,PRODUCT USE IN UNAPPROVED INDICATION,2
IE,PULMONARY EMBOLISM,2
IE,RENAL FAILURE,2
IE,RESPIRATORY FAILURE,2
IE,SCHIZOPHRENIA,2
IE,SYNCOPE,2
IE,TACHYPNOEA,2
IE,TOXICITY TO VARIOUS AGENTS,2
IE,TRANSFUSION REACTION,2
IE,TRANSIENT ISCHAEMIC ATTACK,2
IE,WEIGHT DECREASED,2
IE,WEIGHT INCREASED,2
IE,ABDOMINAL PAIN,1
IE,ABDOMINAL PAIN LOWER,1
IE,ABSCESS,1
IE,ACUTE MYOCARDIAL INFARCTION,1
IE,AMNESIA,1
IE,ANAEMIA,1
IE,ANGINA PECTORIS,1
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IE,ANURIA,1
IE,ARRHYTHMIA,1
IE,ARTHRALGIA,1
IE,ASCITES,1
IE,ASPARTATE AMINOTRANSFERASE INCREASED,1
IE,ASTHENIA,1
IE,ATRIAL FIBRILLATION,1
IE,BED REST,1
IE,BILE DUCT STONE,1
IE,BLOOD BILIRUBIN INCREASED,1
IE,BLOOD CALCIUM INCREASED,1
IE,BLOOD CREATININE INCREASED,1
IE,BLOOD DISORDER,1
IE,BLOOD FOLATE DECREASED,1
IE,BLOOD GLUCOSE FLUCTUATION,1
IE,BLOOD IRON DECREASED,1
IE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IE,BLOOD POTASSIUM INCREASED,1
IE,BLOOD TEST ABNORMAL,1
IE,BONE CANCER,1
IE,BRADYCARDIA,1
IE,BRONCHOPNEUMONIA,1
IE,BRONCHOSPASM,1
IE,C-REACTIVE PROTEIN INCREASED,1
IE,CANDIDA INFECTION,1
IE,CARDIAC ARREST,1
IE,CEREBELLAR INFARCTION,1
IE,CEREBRAL INFARCTION,1
IE,CHEST DISCOMFORT,1
IE,CHOLELITHIASIS,1
IE,CIRCULATORY COLLAPSE,1
IE,COLORECTAL CANCER,1
IE,COMA SCALE ABNORMAL,1
IE,CONDITION AGGRAVATED,1
IE,CORONARY ARTERY DISEASE,1
IE,CUSHING^S SYNDROME,1
IE,DELUSIONAL PERCEPTION,1
IE,DIABETIC RETINOPATHY,1
IE,DISEASE PROGRESSION,1
IE,DISORIENTATION,1
IE,DIVERTICULUM,1
IE,DIZZINESS,1
IE,DRUG DOSE OMISSION,1
IE,DRUG HYPERSENSITIVITY,1
IE,DRUG-INDUCED LIVER INJURY,1
IE,DRY MOUTH,1
IE,DRY THROAT,1
IE,DYSGEUSIA,1
IE,DYSPHAGIA,1
IE,EAR CONGESTION,1
IE,EAR INFECTION,1
IE,ENDOCARDITIS,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,ERECTILE DYSFUNCTION,1
IE,ERYTHEMA MULTIFORME,1
IE,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
IE,EXCORIATION,1
IE,EXPOSURE DURING BREAST FEEDING,1
IE,EXPOSURE VIA BREAST MILK,1
IE,FAECES DISCOLOURED,1
IE,FIBROMYALGIA,1
IE,FRACTURED SACRUM,1
IE,GASTROENTERITIS,1
IE,GASTROINTESTINAL CANCER METASTATIC,1
IE,GASTROINTESTINAL NECROSIS,1
IE,GASTROOESOPHAGEAL REFLUX DISEASE,1
IE,GENITAL INFECTION MALE,1
IE,GLOMERULAR FILTRATION RATE DECREASED,1
IE,HAEMOGLOBIN INCREASED,1
IE,HAEMOLYSIS,1
IE,HAEMORRHAGE INTRACRANIAL,1
IE,HAEMOTHORAX,1
IE,HEART RATE INCREASED,1
IE,HEPATIC FAILURE,1
IE,HEPATIC FUNCTION ABNORMAL,1
IE,HYPERGLYCAEMIA,1
IE,HYPERPROTEINAEMIA,1
IE,HYPOAESTHESIA,1
IE,HYPOKALAEMIA,1
IE,HYPONATRAEMIA,1
IE,HYPOTHALAMO-PITUITARY DISORDER,1
IE,IDIOPATHIC PULMONARY FIBROSIS,1
IE,INFLUENZA LIKE ILLNESS,1
IE,INJURY,1
IE,INTERNATIONAL NORMALISED RATIO INCREASED,1
IE,JAUNDICE,1
IE,LUMBOSACRAL PLEXUS LESION,1
IE,LYMPHOCYTE COUNT DECREASED,1
IE,MALIGNANT MELANOMA,1
IE,MEGACOLON,1
IE,MELAENA,1
IE,MEMORY IMPAIRMENT,1
IE,METABOLIC ACIDOSIS,1
IE,MYALGIA,1
IE,MYOCARDIAL INFARCTION,1
IE,MYOPATHY,1
IE,NASAL DISCOMFORT,1
IE,NASAL DRYNESS,1
IE,NECK PAIN,1
IE,NECROTISING FASCIITIS,1
IE,NEOPLASM MALIGNANT,1
IE,NEUROGENIC BLADDER,1
IE,NEUROGENIC BOWEL,1
IE,NEUROLOGICAL SYMPTOM,1
IE,NEUTROPHIL COUNT DECREASED,1
IE,OESOPHAGEAL CANCER METASTATIC,1
IE,OESOPHAGEAL CARCINOMA,1
IE,ORAL CANDIDIASIS,1
IE,OVERDOSE,1
IE,PAIN,1
IE,PAIN IN EXTREMITY,1
IE,PALLOR,1
IE,PALPITATIONS,1
IE,PANCREATIC CARCINOMA METASTATIC,1
IE,PANCREATIC MASS,1
IE,PEPTIC ULCER,1
IE,PERIPHERAL SWELLING,1
IE,PETIT MAL EPILEPSY,1
IE,PLATELET COUNT INCREASED,1
IE,PLEURAL EFFUSION,1
IE,PNEUMONIA ASPIRATION,1
IE,POLYDIPSIA,1
IE,POST PROCEDURAL INFECTION,1
IE,PREMATURE DELIVERY,1
IE,PRODUCT SUBSTITUTION ISSUE,1
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IE,PROSTATE CANCER,1
IE,PSYCHOTIC DISORDER,1
IE,PUBIS FRACTURE,1
IE,PULMONARY HAEMORRHAGE,1
IE,PYREXIA,1
IE,RASH MACULO-PAPULAR,1
IE,RASH PAPULAR,1
IE,RECTAL HAEMORRHAGE,1
IE,RENAL FAILURE ACUTE,1
IE,RENAL IMPAIRMENT,1
IE,RESPIRATORY DISTRESS,1
IE,RESTLESSNESS,1
IE,RETROPERITONEAL HAEMATOMA,1
IE,RHEUMATOID FACTOR INCREASED,1
IE,SCROTAL IRRITATION,1
IE,SENSORY DISTURBANCE,1
IE,SEPSIS,1
IE,SKIN BACTERIAL INFECTION,1
IE,SKIN IRRITATION,1
IE,SMALL CELL LUNG CANCER METASTATIC,1
IE,SMALL CELL LUNG CANCER RECURRENT,1
IE,STAPHYLOCOCCAL INFECTION,1
IE,STOMATITIS,1
IE,SUPERINFECTION BACTERIAL,1
IE,SWOLLEN TONGUE,1
IE,TACHYCARDIA,1
IE,TENDERNESS,1
IE,THIRST,1
IE,TYPE 2 DIABETES MELLITUS,1
IE,UPPER RESPIRATORY TRACT INFECTION,1
IE,URINE ODOUR ABNORMAL,1
IE,VEIN DISORDER,1
IE,VISION BLURRED,1
IE,VISUAL ACUITY REDUCED,1
IE,VOLVULUS,1
IE,WOUND,1
IM,MUSCULOSKELETAL DISORDER,1
IM,NEUROPATHY PERIPHERAL,1
IL,DIABETIC KETOACIDOSIS,12
IL,NAUSEA,12
IL,ASTHENIA,10
IL,DIARRHOEA,10
IL,FALL,10
IL,ABDOMINAL PAIN,9
IL,DYSPNOEA,9
IL,ACUTE KIDNEY INJURY,8
IL,PANCREATIC CARCINOMA,8
IL,RENAL FAILURE ACUTE,8
IL,ATRIAL FIBRILLATION,7
IL,PNEUMONITIS,7
IL,URINARY TRACT INFECTION,7
IL,CHEST PAIN,6
IL,DECREASED APPETITE,6
IL,VOMITING,6
IL,ACUTE MYOCARDIAL INFARCTION,5
IL,ACUTE RESPIRATORY DISTRESS SYNDROME,5
IL,ANAEMIA,5
IL,BLOOD GLUCOSE INCREASED,5
IL,DIZZINESS,5
IL,FATIGUE,5
IL,FEELING ABNORMAL,5
IL,HYPOGLYCAEMIA,5
IL,JAUNDICE,5
IL,LACTIC ACIDOSIS,5
IL,OEDEMA PERIPHERAL,5
IL,PNEUMONIA,5
IL,PYREXIA,5
IL,RENAL FAILURE,5
IL,CIRCULATORY COLLAPSE,4
IL,CONGENITAL HYPOTHYROIDISM,4
IL,FOETAL EXPOSURE DURING PREGNANCY,4
IL,HAEMOGLOBIN DECREASED,4
IL,PULMONARY EMBOLISM,4
IL,SYNCOPE,4
IL,WEIGHT DECREASED,4
IL,BACK PAIN,3
IL,BLOOD ALBUMIN DECREASED,3
IL,BLOOD SODIUM DECREASED,3
IL,BURNING SENSATION,3
IL,GASTROENTERITIS,3
IL,HAEMATOMA,3
IL,HYPOTENSION,3
IL,MALAISE,3
IL,MIXED LIVER INJURY,3
IL,PANCREATITIS ACUTE,3
IL,PLASMA CELL MYELOMA,3
IL,PRURITUS,3
IL,PULMONARY OEDEMA,3
IL,TOXICITY TO VARIOUS AGENTS,3
IL,ABDOMINAL DISTENSION,2
IL,ACIDOSIS,2
IL,ALANINE AMINOTRANSFERASE INCREASED,2
IL,ANGINA UNSTABLE,2
IL,ASCITES,2
IL,ASPARTATE AMINOTRANSFERASE INCREASED,2
IL,BLOOD ALKALINE PHOSPHATASE INCREASED,2
IL,BLOOD CREATININE INCREASED,2
IL,BLOOD IRON DECREASED,2
IL,BLOOD PRESSURE DECREASED,2
IL,BLOOD PRESSURE INCREASED,2
IL,BONE PAIN,2
IL,CARDIAC FAILURE CONGESTIVE,2
IL,CARDIOGENIC SHOCK,2
IL,CELLULITIS,2
IL,CHOLESTATIC LIVER INJURY,2
IL,CONFUSIONAL STATE,2
IL,CONSTIPATION,2
IL,CONTUSION,2
IL,DIABETES MELLITUS INADEQUATE CONTROL,2
IL,DISEASE PROGRESSION,2
IL,DRUG INEFFECTIVE,2
IL,DRY SKIN,2
IL,DYSGEUSIA,2
IL,FACE OEDEMA,2
IL,FLUID RETENTION,2
IL,GAIT DISTURBANCE,2
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IL,GASTRITIS,2
IL,GASTROINTESTINAL HAEMORRHAGE,2
IL,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
IL,HAEMATEMESIS,2
IL,HAEMORRHAGE INTRACRANIAL,2
IL,HEADACHE,2
IL,HEPATIC ENZYME INCREASED,2
IL,HYPERHIDROSIS,2
IL,INFECTION,2
IL,INTERNATIONAL NORMALISED RATIO INCREASED,2
IL,KETOACIDOSIS,2
IL,LIMB INJURY,2
IL,LOCALISED OEDEMA,2
IL,METABOLIC ACIDOSIS,2
IL,MICTURITION URGENCY,2
IL,MYOCARDIAL INFARCTION,2
IL,MYOCARDIAL ISCHAEMIA,2
IL,OVERDOSE,2
IL,PAIN,2
IL,PANCREATITIS,2
IL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
IL,PULMONARY CONGESTION,2
IL,RASH PRURITIC,2
IL,SEPSIS,2
IL,SEPTIC SHOCK,2
IL,SKIN LESION,2
IL,SLEEP DISORDER,2
IL,SOMNOLENCE,2
IL,SWELLING FACE,2
IL,THROMBOCYTOPENIA,2
IL,VASCULAR GRAFT,2
IL,VENTRICULAR TACHYCARDIA,2
IL,VIRAL INFECTION,2
IL,ABDOMINAL DISCOMFORT,1
IL,ABDOMINAL PAIN UPPER,1
IL,ACNE,1
IL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
IL,ACUTE RESPIRATORY FAILURE,1
IL,ACUTE VESTIBULAR SYNDROME,1
IL,ALTERED STATE OF CONSCIOUSNESS,1
IL,ANAL ABSCESS,1
IL,ANGIOEDEMA,1
IL,ANKLE FRACTURE,1
IL,ANTINUCLEAR ANTIBODY POSITIVE,1
IL,APHTHOUS STOMATITIS,1
IL,ARTHRALGIA,1
IL,ASPERGILLUS INFECTION,1
IL,ASPIRATION,1
IL,ATRIOVENTRICULAR BLOCK COMPLETE,1
IL,AURICULAR HAEMATOMA,1
IL,BACK DISORDER,1
IL,BACTERIAL INFECTION,1
IL,BASAL CELL CARCINOMA,1
IL,BIOPSY SKIN ABNORMAL,1
IL,BLISTER,1
IL,BLOOD CREATINE INCREASED,1
IL,BLOOD GLUCOSE DECREASED,1
IL,BLOOD LACTIC ACID INCREASED,1
IL,BLOOD POTASSIUM INCREASED,1
IL,BLOOD TEST ABNORMAL,1
IL,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IL,BLOOD TRIGLYCERIDES INCREASED,1
IL,BLOOD URIC ACID INCREASED,1
IL,BRAIN INJURY,1
IL,BREAST CANCER,1
IL,BRONCHITIS,1
IL,BURSITIS,1
IL,C-REACTIVE PROTEIN INCREASED,1
IL,CAPILLARY DISORDER,1
IL,CARDIAC ARREST,1
IL,CARDIAC FAILURE,1
IL,CARDIAC FAILURE CHRONIC,1
IL,CARDIAC FIBRILLATION,1
IL,CERVICAL SPINAL STENOSIS,1
IL,CHEST DISCOMFORT,1
IL,CHILLS,1
IL,CHOLELITHIASIS,1
IL,CHOREA,1
IL,CLOSTRIDIUM DIFFICILE COLITIS,1
IL,COAGULATION TIME PROLONGED,1
IL,COAGULOPATHY,1
IL,COLITIS,1
IL,COLON CANCER,1
IL,COMA,1
IL,COUGH,1
IL,DEATH,1
IL,DEMENTIA,1
IL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IL,DEPRESSION,1
IL,DIABETES MELLITUS,1
IL,DIABETIC NEUROPATHY,1
IL,DIARRHOEA HAEMORRHAGIC,1
IL,DISCOMFORT,1
IL,DRUG ADMINISTERED IN WRONG DEVICE,1
IL,DRUG DOSE OMISSION,1
IL,DRUG HYPERSENSITIVITY,1
IL,DRUG INTOLERANCE,1
IL,DRY EYE,1
IL,DRY MOUTH,1
IL,DYSPHAGIA,1
IL,DYSPHONIA,1
IL,DYSPNOEA EXERTIONAL,1
IL,EAR INFECTION,1
IL,EAR PAIN,1
IL,EATING DISORDER,1
IL,EMBOLIC STROKE,1
IL,ENCEPHALOPATHY,1
IL,ERUCTATION,1
IL,ERYTHEMA,1
IL,EXPOSURE DURING PREGNANCY,1
IL,FAT TISSUE INCREASED,1
IL,FEELING COLD,1
IL,FEELING HOT,1
IL,FISTULA,1
IL,FLUSHING,1
IL,FOOD AVERSION,1
IL,FOOT FRACTURE,1
IL,FOREARM FRACTURE,1
IL,FUNGAL INFECTION,1
IL,GASTRITIS EROSIVE,1
IL,GASTROINTESTINAL ANGIODYSPLASIA,1
IL,GASTROINTESTINAL ULCER HAEMORRHAGE,1
IL,GENERAL PHYSICAL HEALTH DETERIORATION,1
IL,GENERALISED TONIC-CLONIC SEIZURE,1
IL,GENITAL HERPES,1
IL,GINGIVAL BLEEDING,1
IL,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
IL,HAEMATOCHEZIA,1
IL,HAEMOLYTIC ANAEMIA,1
IL,HAEMOPTYSIS,1
IL,HAEMORRHAGE,1
IL,HAIR TEXTURE ABNORMAL,1
IL,HEAD INJURY,1
IL,HEART RATE INCREASED,1
IL,HEPATIC CONGESTION,1
IL,HEPATIC ENCEPHALOPATHY,1
IL,HEPATIC FAILURE,1
IL,HEPATIC FUNCTION ABNORMAL,1
IL,HEPATITIS CHOLESTATIC,1
IL,HEPATOCELLULAR INJURY,1
IL,HERNIA,1
IL,HIP FRACTURE,1
IL,HYDROCEPHALUS,1
IL,HYPERAESTHESIA,1
IL,HYPERBILIRUBINAEMIA,1
IL,HYPERGLYCAEMIA,1
IL,HYPERKALAEMIA,1
IL,HYPERLIPIDAEMIA,1
IL,HYPERPYREXIA,1
IL,HYPERSENSITIVITY,1
IL,HYPERSENSITIVITY VASCULITIS,1
IL,HYPERTENSION,1
IL,HYPOKINESIA,1
IL,HYPOMAGNESAEMIA,1
IL,HYPOTHERMIA,1
IL,HYPOXIA,1
IL,INADEQUATE ANALGESIA,1
IL,INCORRECT DOSE ADMINISTERED,1
IL,INCREASED APPETITE,1
IL,INFLAMMATION,1
IL,INFLUENZA,1
IL,INJECTION SITE RASH,1
IL,INSOMNIA,1
IL,INTENTIONAL DRUG MISUSE,1
IL,INTENTIONAL PRODUCT MISUSE,1
IL,INTERMITTENT CLAUDICATION,1
IL,INTRAVENTRICULAR HAEMORRHAGE,1
IL,ISCHAEMIC CEREBRAL INFARCTION,1
IL,ISCHAEMIC STROKE,1
IL,JOINT SWELLING,1
IL,KIDNEY INFECTION,1
IL,LARYNGEAL OEDEMA,1
IL,LEFT VENTRICULAR DYSFUNCTION,1
IL,LEIOMYOMA,1
IL,LEUKOPENIA,1
IL,LIPOMA,1
IL,LIVER FUNCTION TEST INCREASED,1
IL,LIVER INJURY,1
IL,LOSS OF CONSCIOUSNESS,1
IL,LUMBAR SPINAL STENOSIS,1
IL,LUNG INFECTION,1
IL,LUNG INFILTRATION,1
IL,LYMPHADENECTOMY,1
IL,MALIGNANT MELANOMA,1
IL,MALIGNANT NEOPLASM OF AMPULLA OF VATER,1
IL,MALIGNANT NEOPLASM PROGRESSION,1
IL,MEDIASTINAL MASS,1
IL,MENINGIOMA,1
IL,METASTASES TO LIVER,1
IL,METASTASES TO LUNG,1
IL,METASTASES TO LYMPH NODES,1
IL,METASTATIC MALIGNANT MELANOMA,1
IL,MUSCLE DISORDER,1
IL,MUSCLE SPASMS,1
IL,MYALGIA,1
IL,MYOCARDITIS,1
IL,NAIL DISORDER,1
IL,NASOPHARYNGITIS,1
IL,NEURALGIA,1
IL,NEUROSURGERY,1
IL,NEUTROPENIC SEPSIS,1
IL,NIGHTMARE,1
IL,OESOPHAGEAL PERFORATION,1
IL,ONYCHOCLASIS,1
IL,ONYCHOMYCOSIS,1
IL,OVARIAN CYST,1
IL,OXYGEN SATURATION DECREASED,1
IL,PAIN IN EXTREMITY,1
IL,PALPITATIONS,1
IL,PANCREATIC CARCINOMA METASTATIC,1
IL,PANCYTOPENIA,1
IL,PATHOGEN RESISTANCE,1
IL,PERCUTANEOUS CORONARY INTERVENTION,1
IL,PERICARDIAL EFFUSION,1
IL,PERIPHERAL SWELLING,1
IL,PLANTAR FASCIITIS,1
IL,PLATELET COUNT DECREASED,1
IL,POLYNEUROPATHY,1
IL,POLYURIA,1
IL,PRESYNCOPE,1
IL,PRODUCT ADMINISTERED AT INAPPROPRIATE SITE,1
IL,PRODUCTIVE COUGH,1
IL,PROSTATOMEGALY,1
IL,PROTHROMBIN TIME PROLONGED,1
IL,PRURITUS ALLERGIC,1
IL,PULMONARY HYPERTENSION,1
IL,PURPURA,1
IL,RASH,1
IL,RASH PAPULAR,1
IL,RECTAL ADENOCARCINOMA,1
IL,RENAL CELL CARCINOMA,1
IL,RENAL FAILURE CHRONIC,1
IL,RENAL INJURY,1
IL,RENAL TUBULAR ACIDOSIS,1
IL,RIGHT VENTRICULAR FAILURE,1
IL,ROAD TRAFFIC ACCIDENT,1
IL,SCOLIOSIS,1
IL,SECOND PRIMARY MALIGNANCY,1
IL,SEIZURE,1
IL,SERUM FERRITIN INCREASED,1
IL,SHOCK,1
IL,SHOCK HAEMORRHAGIC,1
IL,SKIN ABRASION,1
IL,SKIN CANCER,1
IL,SKIN DISCOLOURATION,1
IL,SKIN EXFOLIATION,1
IL,SKIN ULCER,1
IL,SKIN WRINKLING,1
IL,SPINAL COLUMN STENOSIS,1
IL,SQUAMOUS CELL CARCINOMA OF LUNG,1
IL,SQUAMOUS CELL CARCINOMA OF SKIN,1
IL,STOMATITIS,1
IL,SUBCUTANEOUS HAEMATOMA,1
IL,SUBDURAL HAEMORRHAGE,1
IL,SUPERFICIAL VEIN PROMINENCE,1
IL,SYRINGOMYELIA,1
IL,THIRST DECREASED,1
IL,THROMBOSIS,1
IL,THROMBOSIS IN DEVICE,1
IL,TONGUE OEDEMA,1
IL,TRANSFUSION,1
IL,TUBULOINTERSTITIAL NEPHRITIS,1
IL,TUMOUR EXCISION,1
IL,UNRESPONSIVE TO STIMULI,1
IL,UPPER LIMB FRACTURE,1
IL,UPPER RESPIRATORY TRACT INFECTION,1
IL,URINE KETONE BODY PRESENT,1
IL,VASCULAR OPERATION,1
IL,VENTRICULAR ASYSTOLE,1
IL,VENTRICULAR DYSFUNCTION,1
IL,VERTIGO,1
IL,VESTIBULAR DISORDER,1
IL,VISUAL ACUITY REDUCED,1
IL,VISUAL IMPAIRMENT,1
IL,VOCAL CORD PARALYSIS,1
IL,VULVOVAGINAL MYCOTIC INFECTION,1
IL,WHITE BLOOD CELL COUNT INCREASED,1
IT,HYPOGLYCAEMIA,636
IT,LACTIC ACIDOSIS,625
IT,ACUTE KIDNEY INJURY,503
IT,METABOLIC ACIDOSIS,305
IT,DIARRHOEA,218
IT,HYPOTENSION,202
IT,CONFUSIONAL STATE,188
IT,TOXICITY TO VARIOUS AGENTS,181
IT,SOPOR,169
IT,VOMITING,166
IT,ASTHENIA,163
IT,DYSPNOEA,150
IT,DRUG ABUSE,146
IT,HYPOGLYCAEMIC COMA,119
IT,HYPERKALAEMIA,114
IT,ANURIA,106
IT,MALAISE,106
IT,NAUSEA,105
IT,PRESYNCOPE,101
IT,HYPERGLYCAEMIA,99
IT,LOSS OF CONSCIOUSNESS,96
IT,ABDOMINAL PAIN,94
IT,SYNCOPE,93
IT,ANAEMIA,91
IT,HYPERHIDROSIS,88
IT,DEHYDRATION,86
IT,OVERDOSE,83
IT,DRUG INEFFECTIVE,82
IT,DIABETES MELLITUS INADEQUATE CONTROL,77
IT,RENAL FAILURE ACUTE,76
IT,BLOOD CREATININE INCREASED,67
IT,TREMOR,66
IT,RENAL FAILURE,62
IT,VERTIGO,59
IT,CARDIAC ARREST,58
IT,INTENTIONAL OVERDOSE,58
IT,ABDOMINAL PAIN UPPER,55
IT,SOMNOLENCE,55
IT,DIABETIC METABOLIC DECOMPENSATION,54
IT,SHOCK,54
IT,DECREASED APPETITE,53
IT,DYSARTHRIA,53
IT,HYPOKALAEMIA,53
IT,HYPONATRAEMIA,53
IT,MEDICATION ERROR,50
IT,HYPOMAGNESAEMIA,49
IT,INTENTIONAL SELF-INJURY,48
IT,SUICIDE ATTEMPT,48
IT,PYREXIA,46
IT,ERYTHEMA,45
IT,HEAD INJURY,45
IT,BRADYCARDIA,44
IT,PRURITUS,44
IT,RESPIRATORY FAILURE,43
IT,FALL,40
IT,COMA,38
IT,GLYCOSYLATED HAEMOGLOBIN INCREASED,38
IT,BRADYPHRENIA,37
IT,CARDIAC FAILURE,37
IT,HYPERLACTACIDAEMIA,37
IT,PANCREATITIS ACUTE,37
IT,DISORIENTATION,35
IT,HYPOCALCAEMIA,34
IT,APHASIA,33
IT,MELAENA,33
IT,BRADYKINESIA,30
IT,COLD SWEAT,30
IT,GAIT DISTURBANCE,29
IT,RASH,29
IT,TACHYCARDIA,29
IT,AGITATION,28
IT,INTERNATIONAL NORMALISED RATIO INCREASED,28
IT,BLOOD LACTIC ACID INCREASED,27
IT,CHEST PAIN,27
IT,CONDITION AGGRAVATED,26
IT,HYPERTENSION,26
IT,RHABDOMYOLYSIS,26
IT,ABDOMINAL DISCOMFORT,25
IT,BALANCE DISORDER,25
IT,HEADACHE,25
IT,SEPSIS,25
IT,TACHYPNOEA,25
IT,ATRIOVENTRICULAR BLOCK COMPLETE,24
IT,BLOOD GLUCOSE INCREASED,24
IT,CEREBRAL HAEMORRHAGE,24
IT,MULTI-ORGAN FAILURE,24
IT,PARAESTHESIA,24
IT,WEIGHT INCREASED,24
IT,ALTERED STATE OF CONSCIOUSNESS,23
IT,DIABETIC KETOACIDOSIS,23
IT,DIZZINESS,23
IT,OEDEMA PERIPHERAL,22
IT,RENAL IMPAIRMENT,22
IT,ANGIOEDEMA,21
IT,DROP ATTACKS,21
IT,HYPOTHERMIA,21
IT,THROMBOCYTOPENIA,21
IT,URTICARIA,21
IT,HAEMODIALYSIS,20
IT,HEMIPLEGIA,20
IT,PALLOR,20
IT,UNRESPONSIVE TO STIMULI,20
IT,WEIGHT DECREASED,20
IT,ATRIAL FIBRILLATION,19
IT,DYSSTASIA,19
IT,EPILEPSY,19
IT,HAEMATEMESIS,19
IT,PSYCHOMOTOR HYPERACTIVITY,19
IT,ACCIDENTAL OVERDOSE,18
IT,DEATH,18
IT,DIABETES MELLITUS,18
IT,DRUG LEVEL INCREASED,18
IT,RECTAL HAEMORRHAGE,18
IT,ACIDOSIS,17
IT,DYSPEPSIA,17
IT,SEPTIC SHOCK,17
IT,SPEECH DISORDER,17
IT,VISION BLURRED,17
IT,ARTHRALGIA,16
IT,ATAXIA,16
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,16
IT,GASTROINTESTINAL DISORDER,16
IT,HAEMATURIA,16
IT,HALLUCINATION,16
IT,INJURY,16
IT,METABOLIC DISORDER,16
IT,RESPIRATORY ARREST,16
IT,VITAMIN B12 DEFICIENCY,16
IT,BLOOD PRESSURE INCREASED,15
IT,CHRONIC KIDNEY DISEASE,15
IT,DRUG USE DISORDER,15
IT,EPISTAXIS,15
IT,SEIZURE,15
IT,TACHYARRHYTHMIA,15
IT,URINE ALBUMIN/CREATININE RATIO ABNORMAL,15
IT,CEREBRAL ISCHAEMIA,14
IT,LEUKOCYTOSIS,14
IT,PSYCHOMOTOR RETARDATION,14
IT,WERNICKE^S ENCEPHALOPATHY,14
IT,AMYLASE INCREASED,13
IT,DYSPHAGIA,13
IT,ELECTROCARDIOGRAM QT PROLONGED,13
IT,HYPERTENSIVE CRISIS,13
IT,HYPOPARATHYROIDISM,13
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,13
IT,JAUNDICE,13
IT,OLIGURIA,13
IT,PHARYNGEAL OEDEMA,13
IT,SENSORY DISTURBANCE,13
IT,TONGUE OEDEMA,13
IT,BASILAR ARTERY THROMBOSIS,12
IT,BLOOD PRESSURE DECREASED,12
IT,DYSENTERY,12
IT,HYPONATRAEMIC SYNDROME,12
IT,LIPASE INCREASED,12
IT,SUBDURAL HAEMATOMA,12
IT,ABDOMINAL PAIN LOWER,11
IT,ALANINE AMINOTRANSFERASE INCREASED,11
IT,ANION GAP INCREASED,11
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,11
IT,FATIGUE,11
IT,FOETAL EXPOSURE DURING PREGNANCY,11
IT,HEMIPARESIS,11
IT,HYPERTRANSAMINASAEMIA,11
IT,HYPOVOLAEMIC SHOCK,11
IT,INCORRECT DOSE ADMINISTERED,11
IT,LIP OEDEMA,11
IT,MUSCLE RIGIDITY,11
IT,MYOCARDIAL ISCHAEMIA,11
IT,NEUTROPENIA,11
IT,PAIN,11
IT,PALPITATIONS,11
IT,PNEUMONIA,11
IT,RETCHING,11
IT,SKIN ULCER,11
IT,TUBULOINTERSTITIAL NEPHRITIS,11
IT,VITAMIN B12 DECREASED,11
IT,BLOOD UREA INCREASED,10
IT,CEREBELLAR SYNDROME,10
IT,CHEST DISCOMFORT,10
IT,COUGH,10
IT,DRUG EFFECT INCOMPLETE,10
IT,DYSKINESIA,10
IT,GASTROINTESTINAL HAEMORRHAGE,10
IT,HYPERTHYROIDISM,10
IT,MYALGIA,10
IT,OSTEONECROSIS OF JAW,10
IT,PANCREATITIS,10
IT,PRESCRIBED OVERDOSE,10
IT,PRURITUS GENERALISED,10
IT,ACUTE CORONARY SYNDROME,9
IT,ASPARTATE AMINOTRANSFERASE INCREASED,9
IT,BLOOD PH DECREASED,9
IT,CEREBELLAR ISCHAEMIA,9
IT,CHILLS,9
IT,DERMATITIS BULLOUS,9
IT,FEBRILE NEUTROPENIA,9
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
IT,GASTRIC HAEMORRHAGE,9
IT,HAEMATOMA,9
IT,HEPATIC FAILURE,9
IT,HYPERSENSITIVITY,9
IT,HYPOGLYCAEMIA NEONATAL,9
IT,INFLAMMATORY BOWEL DISEASE,9
IT,INTERSTITIAL LUNG DISEASE,9
IT,LEUKOPENIA,9
IT,MEMORY IMPAIRMENT,9
IT,MICROALBUMINURIA,9
IT,NEUROLOGICAL DECOMPENSATION,9
IT,OXYGEN SATURATION DECREASED,9
IT,PLEURAL EFFUSION,9
IT,PNEUMONITIS,9
IT,PULSELESS ELECTRICAL ACTIVITY,9
IT,RENAL TUBULAR NECROSIS,9
IT,TROPONIN I INCREASED,9
IT,ABDOMINAL TENDERNESS,8
IT,BACK PAIN,8
IT,BLOOD BICARBONATE DECREASED,8
IT,BLOOD FOLATE DECREASED,8
IT,BLOOD POTASSIUM INCREASED,8
IT,CAROTID ARTERIOSCLEROSIS,8
IT,DRUG HYPERSENSITIVITY,8
IT,DRUG INTOLERANCE,8
IT,DRUG-INDUCED LIVER INJURY,8
IT,FEMUR FRACTURE,8
IT,HEART RATE INCREASED,8
IT,HYPERBILIRUBINAEMIA,8
IT,HYPOKINESIA,8
IT,KETONURIA,8
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,8
IT,MALABSORPTION,8
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,8
IT,PAIN IN EXTREMITY,8
IT,PARAESTHESIA ORAL,8
IT,PETECHIAE,8
IT,POLYURIA,8
IT,RALES,8
IT,SINUS BRADYCARDIA,8
IT,SUBARACHNOID HAEMORRHAGE,8
IT,URINARY TRACT INFECTION,8
IT,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,7
IT,ANGULAR CHEILITIS,7
IT,CARDIOVASCULAR DISORDER,7
IT,CEREBRAL HYGROMA,7
IT,CONDUCTION DISORDER,7
IT,DEPRESSION,7
IT,DIALYSIS,7
IT,ELECTROLYTE IMBALANCE,7
IT,EXTRAPYRAMIDAL DISORDER,7
IT,GASTROOESOPHAGEAL REFLUX DISEASE,7
IT,GENERAL PHYSICAL HEALTH DETERIORATION,7
IT,HAEMOGLOBIN DECREASED,7
IT,HYPERCREATININAEMIA,7
IT,HYPEROXALURIA,7
IT,HYPERPYREXIA,7
IT,LUNG INFECTION,7
IT,MENTAL STATUS CHANGES,7
IT,MYOCARDIAL INFARCTION,7
IT,NO THERAPEUTIC RESPONSE,7
IT,ORTHOSTATIC HYPOTENSION,7
IT,OVERWEIGHT,7
IT,PANCYTOPENIA,7
IT,PEMPHIGOID,7
IT,PORPHYRIA NON-ACUTE,7
IT,POSTPRANDIAL HYPOGLYCAEMIA,7
IT,RASH GENERALISED,7
IT,RESPIRATORY ALKALOSIS,7
IT,SKIN EXFOLIATION,7
IT,SKIN LESION,7
IT,SUICIDAL IDEATION,7
IT,THROAT IRRITATION,7
IT,THROAT TIGHTNESS,7
IT,ACUTE MYOCARDIAL INFARCTION,6
IT,ANAPHYLACTIC SHOCK,6
IT,BRONCHOSPASM,6
IT,CARDIAC DISORDER,6
IT,CARDIAC FAILURE CONGESTIVE,6
IT,COGNITIVE DISORDER,6
IT,CONSTIPATION,6
IT,DRUG ADMINISTRATION ERROR,6
IT,DYSPNOEA AT REST,6
IT,GRAVITATIONAL OEDEMA,6
IT,HALLUCINATION_ VISUAL,6
IT,HYPERSENSITIVITY VASCULITIS,6
IT,HYPOCOAGULABLE STATE,6
IT,HYPOGLYCAEMIC UNCONSCIOUSNESS,6
IT,INTENTIONAL PRODUCT MISUSE,6
IT,LIVER INJURY,6
IT,MEDICATION RESIDUE PRESENT,6
IT,METABOLIC ALKALOSIS,6
IT,MICROCYTIC ANAEMIA,6
IT,MITRAL VALVE INCOMPETENCE,6
IT,OEDEMA,6
IT,OSCILLOPSIA,6
IT,PANCREATITIS CHRONIC,6
IT,PRODUCT USE ISSUE,6
IT,PULMONARY OEDEMA,6
IT,SENSORY LOSS,6
IT,STOMATITIS,6
IT,TRANSIENT ISCHAEMIC ATTACK,6
IT,URINARY INCONTINENCE,6
IT,URINARY RETENTION,6
IT,VITAMIN B1 DECREASED,6
IT,ABDOMINAL DISTENSION,5
IT,ANAL INCONTINENCE,5
IT,ANGINA PECTORIS,5
IT,BLADDER SPHINCTER ATONY,5
IT,BLOOD SODIUM DECREASED,5
IT,C-REACTIVE PROTEIN INCREASED,5
IT,CACHEXIA,5
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
IT,CLOSTRIDIUM DIFFICILE COLITIS,5
IT,COAGULATION TEST ABNORMAL,5
IT,CORONARY ARTERY DISEASE,5
IT,CYANOSIS,5
IT,DEEP VEIN THROMBOSIS,5
IT,DIPLOPIA,5
IT,DISEASE PROGRESSION,5
IT,DRUG PRESCRIBING ERROR,5
IT,DUODENAL ULCER,5
IT,DYSPHONIA,5
IT,DYSURIA,5
IT,EJECTION FRACTION DECREASED,5
IT,FISTULA,5
IT,GASTROENTERITIS,5
IT,HEAD TITUBATION,5
IT,HEPATIC ENZYME INCREASED,5
IT,HEPATITIS A,5
IT,HEPATITIS ACUTE,5
IT,HEPATOTOXICITY,5
IT,HYPERCHOLESTEROLAEMIA,5
IT,HYPERTONIA,5
IT,ILEUS PARALYTIC,5
IT,INFUSION RELATED REACTION,5
IT,INSOMNIA,5
IT,INTENTIONAL PRODUCT USE ISSUE,5
IT,LUNG CONSOLIDATION,5
IT,MUCOSAL INFLAMMATION,5
IT,NEPHROLITHIASIS,5
IT,PERICARDIAL EFFUSION,5
IT,SUDDEN CARDIAC DEATH,5
IT,SUDDEN DEATH,5
IT,TOXIC SKIN ERUPTION,5
IT,TRANSAMINASES INCREASED,5
IT,TRANSFUSION,5
IT,TREATMENT FAILURE,5
IT,VASCULITIS NECROTISING,5
IT,ABNORMAL WEIGHT GAIN,4
IT,ACUTE PULMONARY OEDEMA,4
IT,ADENOCARCINOMA PANCREAS,4
IT,ARRHYTHMIA,4
IT,ARTERIOSCLEROSIS CORONARY ARTERY,4
IT,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,4
IT,AZOTAEMIA,4
IT,BILIARY COLIC,4
IT,BLOOD GLUCOSE ABNORMAL,4
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,4
IT,BRADYARRHYTHMIA,4
IT,BRAIN INJURY,4
IT,BUNDLE BRANCH BLOCK RIGHT,4
IT,CAESAREAN SECTION,4
IT,CEREBRAL HAEMATOMA,4
IT,CIRCULATORY COLLAPSE,4
IT,CONGESTIVE CARDIOMYOPATHY,4
IT,CONTINUOUS HAEMODIAFILTRATION,4
IT,COORDINATION ABNORMAL,4
IT,DELIRIUM,4
IT,DERMATITIS ALLERGIC,4
IT,DIABETIC FOOT INFECTION,4
IT,DISORGANISED SPEECH,4
IT,DRUG CLEARANCE DECREASED,4
IT,DRUG ERUPTION,4
IT,ESCHERICHIA URINARY TRACT INFECTION,4
IT,EYELID OEDEMA,4
IT,FEELING COLD,4
IT,GASTRITIS,4
IT,GASTRITIS EROSIVE,4
IT,GASTROINTESTINAL NECROSIS,4
IT,GLOMERULAR FILTRATION RATE DECREASED,4
IT,GLYCOSURIA,4
IT,HAEMATOCHEZIA,4
IT,HAEMORRHAGE,4
IT,HEPATIC FUNCTION ABNORMAL,4
IT,HYPERAEMIA,4
IT,HYPERCREATINAEMIA,4
IT,HYPOCHLORAEMIA,4
IT,INTESTINAL HAEMORRHAGE,4
IT,INTRACARDIAC THROMBUS,4
IT,IRON DEFICIENCY,4
IT,ISCHAEMIC STROKE,4
IT,KERATITIS,4
IT,LETHARGY,4
IT,LONG QT SYNDROME,4
IT,MYOPATHY,4
IT,NECROTISING OESOPHAGITIS,4
IT,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,4
IT,PANCREATIC CARCINOMA,4
IT,PARKINSONISM,4
IT,POISONING DELIBERATE,4
IT,PRODUCT MEASURED POTENCY ISSUE,4
IT,PRODUCT USE IN UNAPPROVED INDICATION,4
IT,PULMONARY EMBOLISM,4
IT,PYELONEPHRITIS ACUTE,4
IT,ROMBERG TEST POSITIVE,4
IT,SINUS TACHYCARDIA,4
IT,SUBCUTANEOUS HAEMATOMA,4
IT,VASCULITIS CEREBRAL,4
IT,VITAMIN B1 DEFICIENCY,4
IT,ABASIA,3
IT,ACETONAEMIA,3
IT,AFFECT LABILITY,3
IT,ALLERGIC OEDEMA,3
IT,AMNESIA,3
IT,ANAEMIA MACROCYTIC,3
IT,APLASTIC ANAEMIA,3
IT,APRAXIA,3
IT,ASCITES,3
IT,ASTHMA,3
IT,ASTRINGENT THERAPY,3
IT,BASAL CELL CARCINOMA,3
IT,BLADDER CANCER,3
IT,BLOOD GASES ABNORMAL,3
IT,BRONCHIOLITIS,3
IT,BUNDLE BRANCH BLOCK LEFT,3
IT,BURNING SENSATION,3
IT,CARDIO-RESPIRATORY ARREST,3
IT,CEPHALHAEMATOMA,3
IT,CEREBROVASCULAR ACCIDENT,3
IT,CHRONIC GASTRITIS,3
IT,CONJUNCTIVITIS,3
IT,CONTRAINDICATED PRODUCT ADMINISTERED,3
IT,CORONARY ARTERY OCCLUSION,3
IT,CORONARY ARTERY STENOSIS,3
IT,DEPRESSED MOOD,3
IT,DERMATITIS,3
IT,DISCOMFORT,3
IT,DISTRIBUTIVE SHOCK,3
IT,DRUG ABUSER,3
IT,DRUG EFFECT DECREASED,3
IT,DRY MOUTH,3
IT,DYSGEUSIA,3
IT,ECCHYMOSIS,3
IT,ECZEMA,3
IT,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,3
IT,EXTRASYSTOLES,3
IT,FACE OEDEMA,3
IT,FACIAL BONES FRACTURE,3
IT,FAECALOMA,3
IT,FLUSHING,3
IT,GASTRIC ULCER,3
IT,GASTROINTESTINAL STOMA COMPLICATION,3
IT,GENERALISED ERYTHEMA,3
IT,HAEMODYNAMIC INSTABILITY,3
IT,HAEMOLYTIC ANAEMIA,3
IT,HAEMORRHAGE INTRACRANIAL,3
IT,HEPATIC CIRRHOSIS,3
IT,HYPERAMMONAEMIA,3
IT,HYPERCAPNIA,3
IT,HYPEROSMOLAR STATE,3
IT,HYPERPHAGIA,3
IT,HYPOAESTHESIA,3
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
IT,INFECTION,3
IT,INFLAMMATORY MARKER INCREASED,3
IT,INSULIN C-PEPTIDE DECREASED,3
IT,INTENTIONAL DRUG MISUSE,3
IT,IRON DEFICIENCY ANAEMIA,3
IT,JOINT INJURY,3
IT,JOINT SWELLING,3
IT,LIVE BIRTH,3
IT,LIVER DISORDER,3
IT,MALIGNANT NEOPLASM PROGRESSION,3
IT,MANTLE CELL LYMPHOMA STAGE III,3
IT,METASTASES TO LIVER,3
IT,MUSCULAR WEAKNESS,3
IT,MUSCULOSKELETAL PAIN,3
IT,MYOCARDIAL FIBROSIS,3
IT,MYOSITIS,3
IT,NERVOUS SYSTEM DISORDER,3
IT,NEUROPATHY PERIPHERAL,3
IT,OSTEONECROSIS,3
IT,PCO2 DECREASED,3
IT,PHOTOPSIA,3
IT,PLATELET COUNT DECREASED,3
IT,PO2 DECREASED,3
IT,PRERENAL FAILURE,3
IT,PROTEINURIA,3
IT,PULMONARY HYPERTENSION,3
IT,RED BLOOD CELL COUNT DECREASED,3
IT,RENAL COLIC,3
IT,RESPIRATORY DISORDER,3
IT,SEDATION,3
IT,SELF INJURIOUS BEHAVIOUR,3
IT,SERUM FERRITIN DECREASED,3
IT,SHOCK HAEMORRHAGIC,3
IT,SKIN REACTION,3
IT,SLOW SPEECH,3
IT,SLUGGISHNESS,3
IT,STRANGURY,3
IT,SUBDURAL HAEMORRHAGE,3
IT,TWIN PREGNANCY,3
IT,VENTRICULAR TACHYCARDIA,3
IT,VITAMIN D DECREASED,3
IT,VULVOVAGINITIS,3
IT,ABSCESS,2
IT,ACUTE RESPIRATORY DISTRESS SYNDROME,2
IT,ADRENAL INSUFFICIENCY,2
IT,AEROPHAGIA,2
IT,ALCOHOL ABUSE,2
IT,ALOPECIA,2
IT,ANAEMIA VITAMIN B12 DEFICIENCY,2
IT,ANOSMIA,2
IT,ANXIETY,2
IT,AORTIC ANEURYSM,2
IT,AORTIC ARTERIOSCLEROSIS,2
IT,AORTIC DILATATION,2
IT,ATRIOVENTRICULAR BLOCK,2
IT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
IT,BASE EXCESS,2
IT,BASEDOW^S DISEASE,2
IT,BLISTER,2
IT,BLOOD BILIRUBIN INCREASED,2
IT,BLOOD FIBRINOGEN INCREASED,2
IT,BLOOD OSMOLARITY ABNORMAL,2
IT,BLOOD POTASSIUM DECREASED,2
IT,BLOOD TRIGLYCERIDES INCREASED,2
IT,BONE MARROW FAILURE,2
IT,BREATH SOUNDS ABNORMAL,2
IT,BRONCHITIS,2
IT,CARDIAC FAILURE ACUTE,2
IT,CARDIOTOXICITY,2
IT,CELL DEATH,2
IT,CELLULITIS,2
IT,CEREBELLAR HAEMORRHAGE,2
IT,CHOLECYSTITIS ACUTE,2
IT,CHOLESTASIS,2
IT,COELIAC DISEASE,2
IT,COMA SCALE ABNORMAL,2
IT,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,2
IT,DISSEMINATED INTRAVASCULAR COAGULATION,2
IT,DIVERTICULITIS,2
IT,DRUG LEVEL ABOVE THERAPEUTIC,2
IT,DUODENAL STENOSIS,2
IT,DUODENITIS HAEMORRHAGIC,2
IT,DYSPHORIA,2
IT,DYSPNOEA EXERTIONAL,2
IT,ELECTROCARDIOGRAM T WAVE INVERSION,2
IT,ELECTROLYTE DEPLETION,2
IT,ENTERITIS,2
IT,ENTEROBACTER TEST POSITIVE,2
IT,ENTEROCOCCAL INFECTION,2
IT,ERYTHEMA MULTIFORME,2
IT,ERYTHRODERMIC PSORIASIS,2
IT,ESCHERICHIA TEST POSITIVE,2
IT,EXPOSURE DURING PREGNANCY,2
IT,EYE OEDEMA,2
IT,EYELIDS PRURITUS,2
IT,FAECAL INCONTINENCE,2
IT,FAECES DISCOLOURED,2
IT,FEELING ABNORMAL,2
IT,FLUID RETENTION,2
IT,FOAMING AT MOUTH,2
IT,FOLATE DEFICIENCY,2
IT,FRACTURE,2
IT,FREQUENT BOWEL MOVEMENTS,2
IT,GAZE PALSY,2
IT,GINGIVAL BLEEDING,2
IT,GRANULOMA ANNULARE,2
IT,GROSS MOTOR DELAY,2
IT,HAEMATOCRIT DECREASED,2
IT,HAEMOLYTIC URAEMIC SYNDROME,2
IT,HAEMOPTYSIS,2
IT,HAEMORRHAGIC ANAEMIA,2
IT,HAEMORRHOIDS,2
IT,HEART RATE DECREASED,2
IT,HEART SOUNDS ABNORMAL,2
IT,HEMIPARAESTHESIA,2
IT,HEPATIC CANCER METASTATIC,2
IT,HEPATIC NEOPLASM,2
IT,HEPATITIS,2
IT,HEPATOCELLULAR CARCINOMA,2
IT,HEPATOCELLULAR INJURY,2
IT,HERPES ZOSTER,2
IT,HIATUS HERNIA,2
IT,HYPERAMYLASAEMIA,2
IT,HYPERPHOSPHATAEMIA,2
IT,HYPERTHERMIA,2
IT,HYPERURICAEMIA,2
IT,HYPOGLYCAEMIC SEIZURE,2
IT,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
IT,IMMUNE-MEDIATED NECROTISING MYOPATHY,2
IT,INFLAMMATION,2
IT,INJECTION SITE ERYTHEMA,2
IT,INTESTINAL OBSTRUCTION,2
IT,INTRACRANIAL MASS,2
IT,ISCHAEMIA,2
IT,KLEBSIELLA INFECTION,2
IT,LIVER FUNCTION TEST ABNORMAL,2
IT,LOCAL SWELLING,2
IT,LOW BIRTH WEIGHT BABY,2
IT,LUNG ADENOCARCINOMA,2
IT,LUNG DISORDER,2
IT,MANIA,2
IT,MATERNAL EXPOSURE DURING PREGNANCY,2
IT,METABOLIC ENCEPHALOPATHY,2
IT,METASTASES TO CENTRAL NERVOUS SYSTEM,2
IT,MIGRAINE,2
IT,MOVEMENT DISORDER,2
IT,MULTIPLE SCLEROSIS RELAPSE,2
IT,MUSCLE CONTRACTIONS INVOLUNTARY,2
IT,MUSCLE SPASMS,2
IT,MUSCULOSKELETAL STIFFNESS,2
IT,MYELODYSPLASTIC SYNDROME,2
IT,MYOCARDITIS,2
IT,MYOGLOBIN BLOOD INCREASED,2
IT,NEPHRITIS,2
IT,NEUTROPHILIA,2
IT,OBSTRUCTIVE AIRWAYS DISORDER,2
IT,ORBITAL OEDEMA,2
IT,ORTHOPNOEA,2
IT,OSTEOARTHRITIS,2
IT,PANCREATIC ENZYMES INCREASED,2
IT,PAPULE,2
IT,PARAPARESIS,2
IT,PERIPHERAL ISCHAEMIA,2
IT,PERITONITIS BACTERIAL,2
IT,PERSECUTORY DELUSION,2
IT,PETIT MAL EPILEPSY,2
IT,PNEUMOCOCCAL INFECTION,2
IT,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
IT,POISONING,2
IT,POLYDIPSIA,2
IT,PRESCRIBED UNDERDOSE,2
IT,PRODUCTIVE COUGH,2
IT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
IT,PSYCHOMOTOR SKILLS IMPAIRED,2
IT,PULMONARY SEPSIS,2
IT,PULMONARY TOXICITY,2
IT,PUPILS UNEQUAL,2
IT,PURPURA,2
IT,RASH ERYTHEMATOUS,2
IT,RASH PAPULAR,2
IT,RASH PRURITIC,2
IT,REACTIVE PSYCHOSIS,2
IT,RENAL TUBULAR DISORDER,2
IT,RESPIRATORY ACIDOSIS,2
IT,RESPIRATORY TRACT INFECTION,2
IT,RHONCHI,2
IT,SELF-INJURIOUS IDEATION,2
IT,SENSATION OF FOREIGN BODY,2
IT,SEPTIC ENCEPHALOPATHY,2
IT,SKIN DISCOLOURATION,2
IT,SLOW RESPONSE TO STIMULI,2
IT,STAPHYLOCOCCAL SEPSIS,2
IT,STATUS EPILEPTICUS,2
IT,STREPTOCOCCUS TEST POSITIVE,2
IT,STRESS,2
IT,SUPERINFECTION,2
IT,SWELLING,2
IT,SYSTOLIC HYPERTENSION,2
IT,TACHYCARDIA PAROXYSMAL,2
IT,TENDONITIS,2
IT,THROMBOCYTOSIS,2
IT,TINNITUS,2
IT,TRAUMATIC HAEMATOMA,2
IT,VASCULAR ENCEPHALOPATHY,2
IT,VASCULITIS,2
IT,VASOCONSTRICTION,2
IT,VASODILATATION,2
IT,VASOGENIC CEREBRAL OEDEMA,2
IT,VENTRICULAR FIBRILLATION,2
IT,VISUAL ACUITY REDUCED,2
IT,VITAMIN B12 ABNORMAL,2
IT,WHEEZING,2
IT,WHITE BLOOD CELL COUNT DECREASED,2
IT,WHITE BLOOD CELL COUNT INCREASED,2
IT,ABNORMAL DREAMS,1
IT,ABORTION SPONTANEOUS,1
IT,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
IT,ACIDOSIS HYPERCHLORAEMIC,1
IT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
IT,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IT,ACUTE PRERENAL FAILURE,1
IT,ACUTE RESPIRATORY FAILURE,1
IT,ADVERSE DRUG REACTION,1
IT,AGEUSIA,1
IT,AGRANULOCYTOSIS,1
IT,ALCOHOL POISONING,1
IT,AMMONIA INCREASED,1
IT,ANAL ABSCESS,1
IT,ANGER,1
IT,ANGINA UNSTABLE,1
IT,ANKLE FRACTURE,1
IT,ANORECTAL DISORDER,1
IT,ANTICHOLINERGIC SYNDROME,1
IT,ANTIDEPRESSANT DRUG CLEARANCE DECREASED,1
IT,ANTIPHOSPHOLIPID SYNDROME,1
IT,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IT,AORTIC STENOSIS,1
IT,AORTIC VALVE ATRESIA,1
IT,AORTIC VALVE SCLEROSIS,1
IT,AORTIC VALVE STENOSIS,1
IT,APATHY,1
IT,APHTHOUS STOMATITIS,1
IT,APHTHOUS ULCER,1
IT,APLASIA,1
IT,APNOEA,1
IT,ARTERIAL DISORDER,1
IT,ARTERIOSCLEROSIS,1
IT,ASPIRATION PLEURAL CAVITY,1
IT,ATRIAL TACHYCARDIA,1
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
IT,BACTERIAL SEPSIS,1
IT,BACTERIAL TEST POSITIVE,1
IT,BASE EXCESS DECREASED,1
IT,BENIGN PROSTATIC HYPERPLASIA,1
IT,BILIARY ABSCESS,1
IT,BILIARY CIRRHOSIS,1
IT,BLADDER CATHETERISATION,1
IT,BLADDER MASS,1
IT,BLADDER PAPILLOMA,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLOOD ALKALINE PHOSPHATASE,1
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IT,BLOOD CREATINE ABNORMAL,1
IT,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
IT,BLOOD CREATININE ABNORMAL,1
IT,BLOOD CREATININE DECREASED,1
IT,BLOOD GLUCOSE DECREASED,1
IT,BLOOD GLUCOSE FLUCTUATION,1
IT,BLOOD IRON DECREASED,1
IT,BLOOD OSMOLARITY DECREASED,1
IT,BLOOD PH INCREASED,1
IT,BLOOD PRESSURE ABNORMAL,1
IT,BLOOD TEST ABNORMAL,1
IT,BLOOD URIC ACID INCREASED,1
IT,BODY MASS INDEX INCREASED,1
IT,BODY TEMPERATURE DECREASED,1
IT,BODY TEMPERATURE INCREASED,1
IT,BONE ABSCESS,1
IT,BONE DENSITY DECREASED,1
IT,BONE PAIN,1
IT,BONE SWELLING,1
IT,BRAIN NATRIURETIC PEPTIDE INCREASED,1
IT,BREAST DISORDER MALE,1
IT,BREECH PRESENTATION,1
IT,BRONCHOPNEUMONIA,1
IT,CALCINOSIS,1
IT,CARDIAC HYPERTROPHY,1
IT,CARDIOACTIVE DRUG LEVEL INCREASED,1
IT,CARDIOGENIC SHOCK,1
IT,CARDIOMEGALY,1
IT,CARDIOMYOPATHY,1
IT,CARDIOPULMONARY FAILURE,1
IT,CAROTID ARTERY DISSECTION,1
IT,CATARACT OPERATION,1
IT,CATHETER PLACEMENT,1
IT,CEREBRAL HYPOPERFUSION,1
IT,CEREBRAL INFARCTION,1
IT,CEREBROVASCULAR DISORDER,1
IT,CHEST X-RAY ABNORMAL,1
IT,CHEYNE-STOKES RESPIRATION,1
IT,CHOLECYSTITIS,1
IT,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IT,COAGULATION TIME PROLONGED,1
IT,COAGULOPATHY,1
IT,COLITIS ULCERATIVE,1
IT,COLLATERAL CIRCULATION,1
IT,COLON DYSPLASIA,1
IT,COLORECTAL CANCER,1
IT,COMPLETED SUICIDE,1
IT,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
IT,CONFABULATION,1
IT,CONTRAINDICATED DRUG ADMINISTERED,1
IT,CONVULSION,1
IT,CORTISOL INCREASED,1
IT,CYSTITIS,1
IT,CYSTOID MACULAR OEDEMA,1
IT,DECUBITUS ULCER,1
IT,DELUSION,1
IT,DEMENTIA,1
IT,DERMATITIS EXFOLIATIVE,1
IT,DERMATITIS HERPETIFORMIS,1
IT,DERMATOMYOSITIS,1
IT,DEVICE DEFECTIVE,1
IT,DEVICE RELATED SEPSIS,1
IT,DIABETIC COMA,1
IT,DIABETIC FOOT,1
IT,DIABETIC NEUROPATHY,1
IT,DIABETIC ULCER,1
IT,DIARRHOEA HAEMORRHAGIC,1
IT,DIASTOLIC DYSFUNCTION,1
IT,DIFFUSE ALOPECIA,1
IT,DILATATION ATRIAL,1
IT,DISEASE RECURRENCE,1
IT,DISTURBANCE IN ATTENTION,1
IT,DRUG DOSE OMISSION,1
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IT,DRUG SPECIFIC ANTIBODY PRESENT,1
IT,DRY SKIN,1
IT,DUODENAL ULCER HAEMORRHAGE,1
IT,DYSLALIA,1
IT,DYSTONIA,1
IT,DYSTONIC TREMOR,1
IT,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS IMPROVED,1
IT,ECTROPION,1
IT,ECZEMA IMPETIGINOUS,1
IT,ELECTROCARDIOGRAM ABNORMAL,1
IT,EMBOLIC CEREBRAL INFARCTION,1
IT,EMBOLIC STROKE,1
IT,EMBOLISM,1
IT,ENCEPHALITIS VIRAL,1
IT,ENDOMETRIAL ADENOCARCINOMA,1
IT,ENDOTRACHEAL INTUBATION,1
IT,ENTERAL NUTRITION,1
IT,ENTEROCOCCAL SEPSIS,1
IT,ENTEROCOLITIS,1
IT,ENZYME LEVEL INCREASED,1
IT,EOSINOPHILIC PNEUMONIA,1
IT,EPICONDYLITIS,1
IT,EPIDIDYMITIS,1
IT,EROSIVE DUODENITIS,1
IT,EROSIVE OESOPHAGITIS,1
IT,ERYSIPELAS,1
IT,ERYTHROSIS,1
IT,ESSENTIAL HYPERTENSION,1
IT,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
IT,EXOPHTHALMOS,1
IT,EXPOSED BONE IN JAW,1
IT,EXTRADURAL HAEMATOMA,1
IT,EXTRAVASATION BLOOD,1
IT,EYE HAEMORRHAGE,1
IT,EYE IRRITATION,1
IT,EYE PAIN,1
IT,FAECAL ELASTASE CONCENTRATION DECREASED,1
IT,FAECAL VOMITING,1
IT,FAECES PALE,1
IT,FAECES SOFT,1
IT,FEBRILE INFECTION,1
IT,FEEDING DISORDER,1
IT,FEELING HOT,1
IT,FEMALE SEXUAL AROUSAL DISORDER,1
IT,FEMORAL ARTERY ANEURYSM,1
IT,FIBRIN D DIMER INCREASED,1
IT,FLANK PAIN,1
IT,FLATULENCE,1
IT,FLUID INTAKE REDUCED,1
IT,FOETAL MALFORMATION,1
IT,FORCED VITAL CAPACITY DECREASED,1
IT,FREE FATTY ACIDS INCREASED,1
IT,GAIT INABILITY,1
IT,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
IT,GANGRENE,1
IT,GASTRIC POLYPS,1
IT,GASTRIC STENOSIS,1
IT,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,1
IT,GASTROINTESTINAL INFLAMMATION,1
IT,GASTROINTESTINAL MOTILITY DISORDER,1
IT,GASTROINTESTINAL STOMA OUTPUT INCREASED,1
IT,GENE MUTATION,1
IT,GENERAL PHYSICAL CONDITION ABNORMAL,1
IT,GENERALISED OEDEMA,1
IT,GINGIVAL SWELLING,1
IT,GINGIVITIS,1
IT,GLAUCOMA,1
IT,GLOMERULONEPHROPATHY,1
IT,GLOSSITIS,1
IT,GROIN PAIN,1
IT,GUILLAIN-BARRE SYNDROME,1
IT,GYNAECOMASTIA,1
IT,H1N1 INFLUENZA,1
IT,HAEMARTHROSIS,1
IT,HAEMATOCRIT,1
IT,HAEMOGLOBIN,1
IT,HAEMOLYSIS,1
IT,HAEMORRHAGIC STROKE,1
IT,HAEMOTHORAX,1
IT,HAND-EYE COORDINATION IMPAIRED,1
IT,HEART VALVE INCOMPETENCE,1
IT,HEPATIC ENCEPHALOPATHY,1
IT,HEPATIC ENZYME ABNORMAL,1
IT,HEPATITIS C,1
IT,HEPATITIS C RNA,1
IT,HEPATITIS TOXIC,1
IT,HIGH DENSITY LIPOPROTEIN,1
IT,HIGH DENSITY LIPOPROTEIN DECREASED,1
IT,HIGH DENSITY LIPOPROTEIN INCREASED,1
IT,HOT FLUSH,1
IT,HYDROCHOLECYSTIS,1
IT,HYPERCAPNIC COMA,1
IT,HYPERCHLORHYDRIA,1
IT,HYPERCHROMIC ANAEMIA,1
IT,HYPERGLYCAEMIC SEIZURE,1
IT,HYPERINSULINAEMIC HYPOGLYCAEMIA,1
IT,HYPERTRIGLYCERIDAEMIA,1
IT,HYPERVENTILATION,1
IT,HYPOACUSIS,1
IT,HYPOCAPNIA,1
IT,HYPOCHROMIC ANAEMIA,1
IT,HYPOPHONESIS,1
IT,HYPOPHOSPHATAEMIA,1
IT,HYPOPLASTIC LEFT HEART SYNDROME,1
IT,HYPOREFLEXIA,1
IT,HYPORESPONSIVE TO STIMULI,1
IT,HYPOVOLAEMIA,1
IT,HYPOXIA,1
IT,IATROGENIC INJURY,1
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IT,INJECTION SITE NECROSIS,1
IT,INJECTION SITE PAIN,1
IT,INJECTION SITE REACTION,1
IT,INTERMITTENT CLAUDICATION,1
IT,INTERVERTEBRAL DISC COMPRESSION,1
IT,INTERVERTEBRAL DISC PROTRUSION,1
IT,INTRA-ABDOMINAL HAEMATOMA,1
IT,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,1
IT,ISCHAEMIC CARDIOMYOPATHY,1
IT,ISCHAEMIC CEREBRAL INFARCTION,1
IT,JAUNDICE CHOLESTATIC,1
IT,KETOACIDOSIS,1
IT,KETOSIS,1
IT,KLEBSIELLA BACTERAEMIA,1
IT,LANGUAGE DISORDER,1
IT,LARYNGEAL OEDEMA,1
IT,LEFT VENTRICULAR DILATATION,1
IT,LEFT VENTRICULAR HYPERTROPHY,1
IT,LEIOMYOSARCOMA,1
IT,LIMB INJURY,1
IT,LIP DISORDER,1
IT,LIP EROSION,1
IT,LIP ULCERATION,1
IT,LIPASE ABNORMAL,1
IT,LIPODYSTROPHY ACQUIRED,1
IT,LIVER FUNCTION TEST INCREASED,1
IT,LOCALISED OEDEMA,1
IT,LOWER RESPIRATORY TRACT INFECTION,1
IT,LUMBAR VERTEBRAL FRACTURE,1
IT,LUNG INFILTRATION,1
IT,LUNG NEOPLASM MALIGNANT,1
IT,LYMPHADENOPATHY,1
IT,LYMPHANGITIS,1
IT,LYMPHOPENIA,1
IT,MACROGLOSSIA,1
IT,MACULAR DETACHMENT,1
IT,MACULAR OEDEMA,1
IT,MANTLE CELL LYMPHOMA,1
IT,MATERNAL DRUGS AFFECTING FOETUS,1
IT,MELANOMA RECURRENT,1
IT,MENINGIOMA,1
IT,MENINGIOMA BENIGN,1
IT,MENINGITIS,1
IT,MENTAL DISORDER,1
IT,MESENTERIC ARTERY THROMBOSIS,1
IT,METASTASES TO LUNG,1
IT,METASTASIS,1
IT,MIOSIS,1
IT,MITOCHONDRIAL TOXICITY,1
IT,MITRAL VALVE ATRESIA,1
IT,MOTOR DYSFUNCTION,1
IT,MOUTH ULCERATION,1
IT,MUCOUS STOOLS,1
IT,MUSCLE ATROPHY,1
IT,MUSCLE CONTRACTURE,1
IT,MUSCLE INJURY,1
IT,MYOCARDIAL NECROSIS,1
IT,MYXOEDEMA,1
IT,NAIL DISORDER,1
IT,NASAL ODOUR,1
IT,NECK PAIN,1
IT,NEOPLASM PROGRESSION,1
IT,NEPHROCALCINOSIS,1
IT,NEPHROTIC SYNDROME,1
IT,NEUROLOGICAL SYMPTOM,1
IT,NEUROTOXICITY,1
IT,NEUTROPHIL COUNT DECREASED,1
IT,NEUTROPHIL COUNT INCREASED,1
IT,NODULE,1
IT,NON-HODGKIN^S LYMPHOMA,1
IT,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
IT,OBESITY,1
IT,OBSESSIVE THOUGHTS,1
IT,ODYNOPHAGIA,1
IT,OEDEMA MOUTH,1
IT,OESOPHAGEAL CANDIDIASIS,1
IT,OPTIC ISCHAEMIC NEUROPATHY,1
IT,ORAL CANDIDIASIS,1
IT,ORAL DYSAESTHESIA,1
IT,ORAL MUCOSAL ERYTHEMA,1
IT,ORCHITIS,1
IT,OSTEOPENIA,1
IT,OXYGEN SATURATION,1
IT,OXYGEN SATURATION ABNORMAL,1
IT,OXYGEN SATURATION INCREASED,1
IT,PACEMAKER GENERATED RHYTHM,1
IT,PAIN IN JAW,1
IT,PALPABLE PURPURA,1
IT,PANCREATIC CARCINOMA METASTATIC,1
JM,DEATH,2
JM,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
JM,CARDIAC FAILURE CONGESTIVE,1
JM,CHRONIC MYELOID LEUKAEMIA,1
JM,DECUBITUS ULCER,1
JM,HAEMORRHAGE,1
JM,MALIGNANT NEOPLASM PROGRESSION,1
JM,PNEUMONIA,1
JM,POLYP,1
JM,RECTAL HAEMORRHAGE,1
JM,THROMBOCYTOPENIA,1
JP,LACTIC ACIDOSIS,93
JP,HYPOGLYCAEMIA,89
JP,INTENTIONAL OVERDOSE,45
JP,SUICIDE ATTEMPT,39
JP,RENAL IMPAIRMENT,36
JP,DECREASED APPETITE,31
JP,MALAISE,31
JP,NAUSEA,31
JP,INTERSTITIAL LUNG DISEASE,29
JP,VOMITING,28
JP,ALTERED STATE OF CONSCIOUSNESS,27
JP,DEHYDRATION,27
JP,DIABETES MELLITUS,27
JP,CEREBRAL INFARCTION,23
JP,DIABETIC KETOACIDOSIS,23
JP,PYREXIA,23
JP,BLOOD GLUCOSE INCREASED,22
JP,ACUTE KIDNEY INJURY,21
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,21
JP,CONDITION AGGRAVATED,20
JP,CARDIAC FAILURE,18
JP,HEPATIC FUNCTION ABNORMAL,18
JP,RASH,18
JP,SHOCK,18
JP,DIARRHOEA,17
JP,HYPERGLYCAEMIA,17
JP,DIABETES MELLITUS INADEQUATE CONTROL,16
JP,ANAEMIA,15
JP,DIZZINESS,15
JP,ACUTE MYOCARDIAL INFARCTION,14
JP,LOSS OF CONSCIOUSNESS,14
JP,OVERDOSE,14
JP,PNEUMONIA ASPIRATION,14
JP,SEPSIS,14
JP,AORTITIS,13
JP,BLOOD PRESSURE DECREASED,13
JP,HYPOGLYCAEMIC COMA,12
JP,PLATELET COUNT DECREASED,12
JP,COMA,11
JP,DISSEMINATED INTRAVASCULAR COAGULATION,11
JP,DRUG INEFFECTIVE,11
JP,LIVER DISORDER,11
JP,PNEUMONIA,11
JP,WEIGHT DECREASED,11
JP,BLOOD CREATININE INCREASED,10
JP,C-REACTIVE PROTEIN INCREASED,10
JP,FALL,10
JP,RHABDOMYOLYSIS,10
JP,URINARY TRACT INFECTION,10
JP,WHITE BLOOD CELL COUNT DECREASED,10
JP,CEREBRAL HAEMORRHAGE,9
JP,GAIT DISTURBANCE,9
JP,HEART INJURY,9
JP,HYPERKALAEMIA,9
JP,HYPERTENSION,9
JP,HYPOTHERMIA,9
JP,METABOLIC ACIDOSIS,9
JP,PRURITUS,9
JP,SEPTIC SHOCK,9
JP,ANGINA PECTORIS,8
JP,BACK PAIN,8
JP,CONSTIPATION,8
JP,DRUG ERUPTION,8
JP,FATIGUE,8
JP,FEBRILE NEUTROPENIA,8
JP,HYPOKALAEMIA,8
JP,HYPONATRAEMIA,8
JP,HYPOPHAGIA,8
JP,KETOACIDOSIS,8
JP,MATERNAL EXPOSURE DURING PREGNANCY,8
JP,PEMPHIGOID,8
JP,TACHYCARDIA,8
JP,TOXICITY TO VARIOUS AGENTS,8
JP,WEIGHT INCREASED,8
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,7
JP,INFECTION,7
JP,OEDEMA PERIPHERAL,7
JP,PYELONEPHRITIS,7
JP,RENAL FAILURE,7
JP,WHITE BLOOD CELL COUNT INCREASED,7
JP,ACUTE RESPIRATORY FAILURE,6
JP,ALANINE AMINOTRANSFERASE INCREASED,6
JP,ASPARTATE AMINOTRANSFERASE INCREASED,6
JP,ATRIAL FIBRILLATION,6
JP,BLADDER CANCER,6
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
JP,CELLULITIS,6
JP,DYSARTHRIA,6
JP,ERYTHEMA,6
JP,FOETAL EXPOSURE DURING PREGNANCY,6
JP,HAEMATURIA,6
JP,HEPATIC STEATOSIS,6
JP,INSOMNIA,6
JP,MYALGIA,6
JP,NASOPHARYNGITIS,6
JP,OEDEMA,6
JP,TUBULOINTERSTITIAL NEPHRITIS,6
JP,VENTRICULAR FIBRILLATION,6
JP,CARDIAC ARREST,5
JP,CHILLS,5
JP,CHOLELITHIASIS,5
JP,CORONARY ARTERY STENOSIS,5
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,5
JP,DRUG DOSE OMISSION,5
JP,DRUG-INDUCED LIVER INJURY,5
JP,DYSLALIA,5
JP,DYSPNOEA,5
JP,EMBOLIC STROKE,5
JP,HYPOTENSION,5
JP,INTESTINAL ISCHAEMIA,5
JP,IRON DEFICIENCY ANAEMIA,5
JP,LARGE INTESTINE POLYP,5
JP,LUNG DISORDER,5
JP,MALIGNANT NEOPLASM PROGRESSION,5
JP,MYOCARDIAL INFARCTION,5
JP,OSTEONECROSIS OF JAW,5
JP,PERIPHERAL CIRCULATORY FAILURE,5
JP,STOMATITIS,5
JP,URINARY RETENTION,5
JP,URINE KETONE BODY PRESENT,5
JP,UTERINE LEIOMYOMA,5
JP,VITREOUS HAEMORRHAGE,5
JP,ABDOMINAL DISCOMFORT,4
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,4
JP,ARTHRALGIA,4
JP,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,4
JP,BLOOD KETONE BODY INCREASED,4
JP,BLOOD PH DECREASED,4
JP,BRADYCARDIA,4
JP,CARDIAC FAILURE ACUTE,4
JP,CARDIAC FAILURE CONGESTIVE,4
JP,CHOLECYSTITIS,4
JP,CYSTITIS,4
JP,DEPRESSION,4
JP,DISEASE PROGRESSION,4
JP,DRUG LEVEL INCREASED,4
JP,ECZEMA,4
JP,EYELID OEDEMA,4
JP,GASTROENTERITIS,4
JP,HEADACHE,4
JP,HEAT ILLNESS,4
JP,HEMIPLEGIA,4
JP,HEPATITIS FULMINANT,4
JP,HYPERHIDROSIS,4
JP,ILEUS,4
JP,JAUNDICE,4
JP,KETOSIS,4
JP,LUNG NEOPLASM MALIGNANT,4
JP,MELAENA,4
JP,MUSCULOSKELETAL PAIN,4
JP,NEUTROPENIA,4
JP,NEUTROPHIL COUNT DECREASED,4
JP,PANCREATIC CARCINOMA,4
JP,PANCREATITIS ACUTE,4
JP,POLYURIA,4
JP,RENAL DISORDER,4
JP,RESPIRATORY DISORDER,4
JP,RESPIRATORY FAILURE,4
JP,SEIZURE,4
JP,SPINAL COMPRESSION FRACTURE,4
JP,STRESS CARDIOMYOPATHY,4
JP,VISUAL ACUITY REDUCED,4
JP,WERNICKE^S ENCEPHALOPATHY,4
JP,ABDOMINAL PAIN,3
JP,ABDOMINAL PAIN UPPER,3
JP,ACUTE LUNG INJURY,3
JP,ANTI-INSULIN ANTIBODY POSITIVE,3
JP,ARRHYTHMIA,3
JP,ASCITES,3
JP,ASPHYXIA,3
JP,ASTHENIA,3
JP,BACTERIAL INFECTION,3
JP,BLOOD PRESSURE INCREASED,3
JP,BLOOD SODIUM DECREASED,3
JP,BLOOD URINE PRESENT,3
JP,BRONCHITIS,3
JP,CEREBELLAR INFARCTION,3
JP,COLITIS ULCERATIVE,3
JP,COLLAGEN DISORDER,3
JP,COMPLETED SUICIDE,3
JP,DIPLOPIA,3
JP,DRUG ADMINISTRATION ERROR,3
JP,DYSPHONIA,3
JP,ENTEROCOLITIS,3
JP,EPISTAXIS,3
JP,ESCHERICHIA URINARY TRACT INFECTION,3
JP,FEELING ABNORMAL,3
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
JP,GASTROINTESTINAL DISORDER,3
JP,GASTROINTESTINAL NECROSIS,3
JP,GASTROOESOPHAGEAL REFLUX DISEASE,3
JP,GENERALISED ERYTHEMA,3
JP,GLUCOSE URINE PRESENT,3
JP,HAEMATEMESIS,3
JP,HAEMATOMA,3
JP,HAEMODIALYSIS,3
JP,HEART RATE INCREASED,3
JP,HEPATIC CIRRHOSIS,3
JP,HYPERCALCAEMIA,3
JP,HYPERINSULINAEMIA,3
JP,HYPOAESTHESIA,3
JP,HYPOXIA,3
JP,IDIOPATHIC PULMONARY FIBROSIS,3
JP,ILEUS PARALYTIC,3
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
JP,INJECTION SITE INDURATION,3
JP,INTESTINAL OBSTRUCTION,3
JP,INTESTINAL PERFORATION,3
JP,LACUNAR INFARCTION,3
JP,LOW BIRTH WEIGHT BABY,3
JP,LYMPHOMA,3
JP,MUSCULAR WEAKNESS,3
JP,OROPHARYNGEAL PAIN,3
JP,PALPITATIONS,3
JP,PIGMENTATION DISORDER,3
JP,PLEURAL EFFUSION,3
JP,PRODUCT USE ISSUE,3
JP,PROSTATITIS,3
JP,PROTEINURIA,3
JP,PULMONARY CONGESTION,3
JP,PURPURA,3
JP,RASH PRURITIC,3
JP,RESPIRATORY ARREST,3
JP,RESPIRATORY RATE INCREASED,3
JP,SKIN DISORDER,3
JP,SKIN INDURATION,3
JP,SOMNOLENCE,3
JP,SUICIDAL IDEATION,3
JP,THROMBOTIC CEREBRAL INFARCTION,3
JP,TRAUMATIC LUNG INJURY,3
JP,TROPONIN I INCREASED,3
JP,UPPER RESPIRATORY TRACT INFECTION,3
JP,URTICARIA,3
JP,ABDOMINAL PAIN LOWER,2
JP,ABORTION,2
JP,ABORTION SPONTANEOUS,2
JP,ACCIDENTAL OVERDOSE,2
JP,ACUTE HEPATIC FAILURE,2
JP,AMYLASE INCREASED,2
JP,ANAPHYLACTIC REACTION,2
JP,ANGINA UNSTABLE,2
JP,ANURIA,2
JP,ANXIETY,2
JP,APLASIA PURE RED CELL,2
JP,AREFLEXIA,2
JP,ATAXIA,2
JP,ATRIOVENTRICULAR BLOCK,2
JP,BALANCE DISORDER,2
JP,BASAL CELL CARCINOMA,2
JP,BENIGN PROSTATIC HYPERPLASIA,2
JP,BLISTER,2
JP,BLOOD BILIRUBIN INCREASED,2
JP,BLOOD CHLORIDE DECREASED,2
JP,BLOOD GLUCOSE ABNORMAL,2
JP,BLOOD GLUCOSE FLUCTUATION,2
JP,BLOOD INSULIN INCREASED,2
JP,BLOOD LACTIC ACID INCREASED,2
JP,BLOOD POTASSIUM DECREASED,2
JP,BLOOD PRESSURE SYSTOLIC DECREASED,2
JP,BLOOD TRIGLYCERIDES INCREASED,2
JP,BLOOD UREA INCREASED,2
JP,BLOOD URIC ACID INCREASED,2
JP,BONE MARROW FAILURE,2
JP,BRAIN STEM AUDITORY EVOKED RESPONSE ABNORMAL,2
JP,BREAST CANCER,2
JP,CARDIAC FAILURE CHRONIC,2
JP,CARDIO-RESPIRATORY ARREST,2
JP,CATARACT OPERATION,2
JP,CEREBELLAR ATAXIA,2
JP,CHEILITIS,2
JP,CIRCULATORY COLLAPSE,2
JP,CLEFT LIP AND PALATE,2
JP,COLD SWEAT,2
JP,COLITIS ISCHAEMIC,2
JP,CONJUNCTIVAL HAEMORRHAGE,2
JP,CORONARY ARTERY DISEASE,2
JP,DEATH,2
JP,DIABETIC GANGRENE,2
JP,DIABETIC NEPHROPATHY,2
JP,DISSEMINATED CRYPTOCOCCOSIS,2
JP,DRUG EFFECT INCOMPLETE,2
JP,DRUG HYPERSENSITIVITY,2
JP,DRUG PRESCRIBING ERROR,2
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
JP,DRUG TOLERANCE,2
JP,DUODENAL ULCER,2
JP,ELECTROCARDIOGRAM QT PROLONGED,2
JP,ENCEPHALOPATHY,2
JP,EOSINOPHIL COUNT INCREASED,2
JP,EOSINOPHILIA,2
JP,ERYTHEMA MULTIFORME,2
JP,EYE MOVEMENT DISORDER,2
JP,FACE OEDEMA,2
JP,FAT TISSUE INCREASED,2
JP,FULMINANT TYPE 1 DIABETES MELLITUS,2
JP,FUNGAL INFECTION,2
JP,GASTRIC ULCER,2
JP,GASTROINTESTINAL HAEMORRHAGE,2
JP,GENERAL PHYSICAL HEALTH DETERIORATION,2
JP,GINGIVAL HYPERPLASIA,2
JP,GLAUCOMA,2
JP,GLOSSITIS,2
JP,GLUCOSE TOLERANCE IMPAIRED,2
JP,HAEMATOCHEZIA,2
JP,HAEMOGLOBIN DECREASED,2
JP,HAEMOLYTIC ANAEMIA,2
JP,HAEMORRHAGE,2
JP,HEART SOUNDS ABNORMAL,2
JP,HELICOBACTER GASTRITIS,2
JP,HEPATIC CANCER,2
JP,HEPATITIS C,2
JP,HEPATOTOXICITY,2
JP,HUNGER,2
JP,HYDRONEPHROSIS,2
JP,HYPERCHOLESTEROLAEMIA,2
JP,HYPEROSMOLAR HYPERGLYCAEMIC STATE,2
JP,HYPERPHAGIA,2
JP,HYPERTHYROIDISM,2
JP,HYPOGLYCAEMIA NEONATAL,2
JP,HYPOGLYCAEMIC ENCEPHALOPATHY,2
JP,HYPOKINESIA,2
JP,HYPOMAGNESAEMIA,2
JP,HYPOREFLEXIA,2
JP,HYPOTHYROIDISM,2
JP,INCREASED APPETITE,2
JP,INJECTION SITE HAEMORRHAGE,2
JP,INTESTINAL RESECTION,2
JP,IRRITABILITY,2
JP,JOINT RANGE OF MOTION DECREASED,2
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
JP,LEUKOENCEPHALOPATHY,2
JP,LEUKOPENIA,2
JP,LIPASE INCREASED,2
JP,LIVER ABSCESS,2
JP,LIVER FUNCTION TEST ABNORMAL,2
JP,MALABSORPTION,2
JP,MALNUTRITION,2
JP,MENTAL DISORDER,2
JP,METASTASES TO LIVER,2
JP,METASTASES TO LYMPH NODES,2
JP,MONOPARESIS,2
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
JP,MUSCLE HAEMORRHAGE,2
JP,MYOCARDIAL ISCHAEMIA,2
JP,MYOSITIS,2
JP,NAIL DISCOLOURATION,2
JP,NECROTISING SOFT TISSUE INFECTION,2
JP,NEOPLASM PROGRESSION,2
JP,NEPHROGENIC SYSTEMIC FIBROSIS,2
JP,NEUROLEPTIC MALIGNANT SYNDROME,2
JP,NEUROPATHY PERIPHERAL,2
JP,NORMAL NEWBORN,2
JP,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,2
JP,NYSTAGMUS,2
JP,ORTHOSTATIC HYPOTENSION,2
JP,OSTEOGENESIS IMPERFECTA,2
JP,PAIN,2
JP,PAIN IN EXTREMITY,2
JP,PANCREATITIS CHRONIC,2
JP,PERFORMANCE STATUS DECREASED,2
JP,PERITONEAL DISORDER,2
JP,PHOTOSENSITIVITY REACTION,2
JP,PNEUMONIA PNEUMOCOCCAL,2
JP,POLLAKIURIA,2
JP,PRESCRIBED UNDERDOSE,2
JP,PROSTATE CANCER,2
JP,PROTEIN URINE PRESENT,2
JP,PRURITUS GENERALISED,2
JP,PYELONEPHRITIS ACUTE,2
JP,RASH ERYTHEMATOUS,2
JP,RASH MACULO-PAPULAR,2
JP,RENAL FAILURE ACUTE,2
JP,RESPIRATORY ALKALOSIS,2
JP,RESPIRATORY DISTRESS,2
JP,RETINOPATHY,2
JP,RHEUMATOID ARTHRITIS,2
JP,ROAD TRAFFIC ACCIDENT,2
JP,SALIVARY HYPERSECRETION,2
JP,SERONEGATIVE ARTHRITIS,2
JP,SHOCK HAEMORRHAGIC,2
JP,SKIN ULCER,2
JP,SOFT TISSUE INFECTION,2
JP,SUBCUTANEOUS ABSCESS,2
JP,SUDDEN HEARING LOSS,2
JP,SURGERY,2
JP,TINNITUS,2
JP,TOOTH LOSS,2
JP,TREATMENT NONCOMPLIANCE,2
JP,TREMOR,2
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,2
JP,UTERINE CONTRACTIONS ABNORMAL,2
JP,VENOUS THROMBOSIS LIMB,2
JP,VENTRICULAR TACHYCARDIA,2
JP,VERTIGO,2
JP,VERTIGO POSITIONAL,2
JP,VISUAL IMPAIRMENT,2
JP,VITAMIN B1 DECREASED,2
JP,VITAMIN B12 DEFICIENCY,2
JP,ABASIA,1
JP,ABDOMINAL ABSCESS,1
JP,ABDOMINAL DISTENSION,1
JP,ABDOMINAL TENDERNESS,1
JP,ABNORMAL BEHAVIOUR,1
JP,ABORTION EARLY,1
JP,ABORTION INDUCED,1
JP,ABULIA,1
JP,ACID BASE BALANCE ABNORMAL,1
JP,ACIDOSIS,1
JP,ACIDOSIS HYPERCHLORAEMIC,1
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
JP,ACTIVITIES OF DAILY LIVING IMPAIRED,1
JP,ACUTE CORONARY SYNDROME,1
JP,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
JP,ACUTE MYELOID LEUKAEMIA,1
JP,ADRENAL INSUFFICIENCY,1
JP,AGRANULOCYTOSIS,1
JP,ALCOHOL INTERACTION,1
JP,ALCOHOLIC PANCREATITIS,1
JP,ALOPECIA,1
JP,ALVEOLITIS ALLERGIC,1
JP,ANAEMIA MEGALOBLASTIC,1
JP,ANAPHYLACTIC SHOCK,1
JP,ANAPHYLACTOID REACTION,1
JP,ANAPHYLACTOID SHOCK,1
JP,ANGIOPATHY,1
JP,ANION GAP INCREASED,1
JP,ANTI-INSULIN ANTIBODY,1
JP,ANTI-INSULIN ANTIBODY INCREASED,1
JP,ANTIBODY TEST POSITIVE,1
JP,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED,1
JP,ANTINUCLEAR ANTIBODY POSITIVE,1
JP,AORTIC DISSECTION,1
JP,APATHY,1
JP,ARRHYTHMIA NEONATAL,1
JP,ARTERIOSCLEROSIS,1
JP,ARTERIOSCLEROSIS CORONARY ARTERY,1
JP,ARTHRITIS,1
JP,ARTHRITIS BACTERIAL,1
JP,ASTHMA,1
JP,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
JP,AUTOANTIBODY POSITIVE,1
JP,AUTOIMMUNE HEPATITIS,1
JP,AUTOIMMUNE PANCREATITIS,1
JP,AZOTAEMIA,1
JP,BASE EXCESS DECREASED,1
JP,BASEDOW^S DISEASE,1
JP,BENIGN HYDATIDIFORM MOLE,1
JP,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
JP,BILIARY COLIC,1
JP,BILIARY TRACT INFECTION,1
JP,BILIRUBINURIA,1
JP,BLADDER CANCER STAGE 0_ WITH CANCER IN SITU,1
JP,BLADDER TAMPONADE,1
JP,BLINDNESS UNILATERAL,1
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,1
JP,BLOOD ANTIDIURETIC HORMONE ABNORMAL,1
JP,BLOOD BETA-D-GLUCAN INCREASED,1
JP,BLOOD BICARBONATE DECREASED,1
JP,BLOOD BILIRUBIN ABNORMAL,1
JP,BLOOD CHOLESTEROL INCREASED,1
JP,BLOOD CREATININE DECREASED,1
JP,BLOOD GLUCOSE DECREASED,1
JP,BLOOD HOMOCYSTEINE INCREASED,1
JP,BLOOD INSULIN DECREASED,1
JP,BLOOD OSMOLARITY DECREASED,1
JP,BLOOD PRESSURE ABNORMAL,1
JP,BLOOD PRESSURE SYSTOLIC INCREASED,1
JP,BODY TEMPERATURE DECREASED,1
JP,BONE DENSITY DECREASED,1
JP,BONE LESION,1
JP,BONE SARCOMA,1
JP,BRAIN STEM HAEMORRHAGE,1
JP,BRAIN STEM INFARCTION,1
JP,BREECH PRESENTATION,1
JP,BRONCHOSPASM,1
JP,BUNDLE BRANCH BLOCK RIGHT,1
JP,C-REACTIVE PROTEIN ABNORMAL,1
JP,CAESAREAN SECTION,1
JP,CARDIAC HYPERTROPHY,1
JP,CARDIAC SARCOIDOSIS,1
JP,CARDIAC VALVE RUPTURE,1
JP,CARDIOGENIC SHOCK,1
JP,CARDIOMEGALY,1
JP,CARDIOMYOPATHY,1
JP,CAROTID ARTERY OCCLUSION,1
JP,CARPAL TUNNEL SYNDROME,1
JP,CATARACT,1
JP,CATHETER SITE RELATED REACTION,1
JP,CELL MARKER INCREASED,1
JP,CENTRAL NERVOUS SYSTEM LESION,1
JP,CEREBELLAR HAEMORRHAGE,1
JP,CEREBRAL ARTERIOSCLEROSIS,1
JP,CEREBRAL ARTERY THROMBOSIS,1
JP,CEREBRAL THROMBOSIS,1
JP,CERVICAL MYELOPATHY,1
JP,CHOLANGITIS,1
JP,CHOLANGITIS ACUTE,1
JP,CHOLECYSTITIS ACUTE,1
JP,CHOLECYSTOCHOLANGITIS,1
JP,CHOLESTASIS,1
JP,CHOLINERGIC SYNDROME,1
JP,CHRONIC GASTRITIS,1
JP,CHRONIC HEPATITIS,1
JP,CHRONIC KIDNEY DISEASE,1
JP,COLITIS MICROSCOPIC,1
JP,COLORECTAL CANCER,1
JP,CONCOMITANT DISEASE AGGRAVATED,1
JP,CONGESTIVE CARDIOMYOPATHY,1
JP,CONJUNCTIVITIS,1
JP,CONVULSION,1
JP,CORONARY ARTERY RESTENOSIS,1
JP,COSTOVERTEBRAL ANGLE TENDERNESS,1
JP,COUGH,1
JP,CRANIOCEREBRAL INJURY,1
JP,CRYPTORCHISM,1
JP,CUSHING^S SYNDROME,1
JP,CYANOSIS,1
JP,CYTOMEGALOVIRUS INFECTION,1
JP,CYTOMEGALOVIRUS VIRAEMIA,1
JP,DECREASED VIBRATORY SENSE,1
JP,DECUBITUS ULCER,1
JP,DELIRIUM,1
JP,DEMENTIA,1
JP,DENTAL CARIES,1
JP,DENTOFACIAL ANOMALY,1
JP,DEPRESSED MOOD,1
JP,DEPRESSIVE SYMPTOM,1
JP,DERMATITIS ACNEIFORM,1
JP,DERMATITIS HERPETIFORMIS,1
JP,DERMATOMYOSITIS,1
JP,DEVICE ALARM ISSUE,1
JP,DIABETES MELLITUS MANAGEMENT,1
JP,DIABETES WITH HYPEROSMOLARITY,1
JP,DIABETIC KETOSIS,1
JP,DIABETIC RETINAL OEDEMA,1
JP,DIABETIC RETINOPATHY,1
JP,DIABETIC ULCER,1
JP,DISCOMFORT,1
JP,DISORIENTATION,1
JP,DISTURBANCE IN ATTENTION,1
JP,DISUSE SYNDROME,1
JP,DIVERTICULUM INTESTINAL,1
JP,DRUG ABUSE,1
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
JP,DRUG RESISTANCE,1
JP,DRUG WITHDRAWAL SYNDROME,1
JP,DRY MOUTH,1
JP,DUODENAL ULCER HAEMORRHAGE,1
JP,DUODENITIS,1
JP,DYSAESTHESIA,1
JP,DYSGEUSIA,1
JP,DYSLIPIDAEMIA,1
JP,DYSPHAGIA,1
JP,DYSPNOEA EXERTIONAL,1
JP,DYSSTASIA,1
JP,EAR DISCOMFORT,1
JP,ECCHYMOSIS,1
JP,ELECTROCARDIOGRAM CHANGE,1
JP,ELECTROCARDIOGRAM ST-T CHANGE,1
JP,ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL,1
JP,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
JP,EMBOLIC CEREBRAL INFARCTION,1
JP,EMBOLISM,1
JP,ENDOCARDITIS,1
JP,ENTERITIS INFECTIOUS,1
JP,ERECTILE DYSFUNCTION,1
JP,ERYTHEMA OF EYELID,1
JP,ERYTHROBLAST COUNT DECREASED,1
JP,ESCHERICHIA TEST POSITIVE,1
JP,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
JP,EXPLORATORY OPERATION,1
JP,EXPOSURE DURING BREAST FEEDING,1
JP,EXPOSURE DURING PREGNANCY,1
JP,EYE IRRITATION,1
JP,EYE PAIN,1
JP,EYELID DISORDER,1
JP,FACIAL PARALYSIS,1
JP,FAECALOMA,1
JP,FAECES DISCOLOURED,1
JP,FAT TISSUE DECREASED,1
JP,FEAR,1
JP,FEEDING DISORDER,1
JP,FEELING HOT,1
JP,FLUID INTAKE REDUCED,1
JP,FLUSHING,1
JP,FOOD ALLERGY,1
JP,FOOD INTERACTION,1
JP,FOREIGN BODY IN EYE,1
JP,FOREIGN BODY SENSATION IN EYES,1
JP,FRACTURE,1
JP,GALLBLADDER DISORDER,1
JP,GALLBLADDER ENLARGEMENT,1
JP,GASTRIC CANCER,1
JP,GASTRIC PERFORATION,1
JP,GASTRIC VARICES HAEMORRHAGE,1
JP,GENERALISED OEDEMA,1
JP,GESTATIONAL DIABETES,1
JP,GLOMERULAR FILTRATION RATE ABNORMAL,1
JP,GLOMERULAR FILTRATION RATE DECREASED,1
JP,GLUCOSE URINE,1
JP,GRANULOMATOUS DERMATITIS,1
JP,GRANULOMATOUS LIVER DISEASE,1
JP,HAEMODYNAMIC INSTABILITY,1
JP,HAEMORRHAGE INTRACRANIAL,1
JP,HAEMORRHAGE SUBCUTANEOUS,1
JP,HAEMORRHOIDAL HAEMORRHAGE,1
JP,HEART RATE DECREASED,1
JP,HEPATIC CANCER RECURRENT,1
JP,HEPATIC CYST,1
JP,HEPATIC ENZYME INCREASED,1
JP,HEPATITIS,1
JP,HEPATITIS ACUTE,1
JP,HEPATOCELLULAR CARCINOMA,1
JP,HERNIA,1
JP,HERPES ZOSTER,1
JP,HICCUPS,1
JP,HIP ARTHROPLASTY,1
JP,HIP FRACTURE,1
JP,HIV INFECTION,1
JP,HOSPITALISATION,1
JP,HYDROCELE,1
JP,HYPERKINESIA,1
JP,HYPERLACTACIDAEMIA,1
JP,HYPERNATRAEMIA,1
JP,HYPERSENSITIVITY,1
JP,HYPERSENSITIVITY VASCULITIS,1
JP,HYPERSOMNIA,1
JP,HYPERTENSIVE EMERGENCY,1
JP,HYPERTHERMIA MALIGNANT,1
JP,HYPERURICAEMIA,1
JP,HYPOACUSIS,1
JP,HYPOALBUMINAEMIA,1
JP,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
JP,HYPOPHOSPHATAEMIA,1
JP,HYPOPROTEINAEMIA,1
JP,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
JP,IMMUNE THROMBOCYTOPENIC PURPURA,1
JP,IMPAIRED GASTRIC EMPTYING,1
JP,IMPAIRED INSULIN SECRETION,1
JP,INCORRECT DOSE ADMINISTERED,1
JP,INDUCED LABOUR,1
JP,INDURATION,1
JP,INFECTIVE SPONDYLITIS,1
JP,INFLAMMATION,1
JP,INFLUENZA,1
JP,INFUSION RELATED REACTION,1
JP,INJECTION SITE BRUISING,1
JP,INJECTION SITE ERYTHEMA,1
JP,INJECTION SITE HAEMATOMA,1
JP,INJECTION SITE HYPERSENSITIVITY,1
JP,INJECTION SITE SWELLING,1
JP,INSULIN AUTOIMMUNE SYNDROME,1
JP,INSULIN C-PEPTIDE INCREASED,1
JP,INSULIN RESISTANCE SYNDROME,1
JP,INTENTIONAL SELF-INJURY,1
JP,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
JP,INTERNATIONAL NORMALISED RATIO INCREASED,1
JP,INTERVERTEBRAL DISC PROTRUSION,1
JP,INTRACRANIAL ANEURYSM,1
JP,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
JP,INTRAOCULAR PRESSURE INCREASED,1
JP,ISCHAEMIC STROKE,1
JP,JAUNDICE NEONATAL,1
JP,KETONURIA,1
JP,KLEBSIELLA TEST POSITIVE,1
JP,LARGE INTESTINAL ULCER,1
JP,LEFT VENTRICULAR FAILURE,1
JP,LETHARGY,1
JP,LEUKOCYTOSIS,1
JP,LIMB OPERATION,1
JP,LIPOHYPERTROPHY,1
JP,LIVE BIRTH,1
JP,LIVER SARCOIDOSIS,1
JP,LOWER LIMB FRACTURE,1
JP,LUPUS-LIKE SYNDROME,1
JP,LYMPHADENITIS,1
JP,LYMPHADENOPATHY,1
JP,LYMPHANGIOSIS CARCINOMATOSA,1
JP,LYMPHOCYTE COUNT DECREASED,1
JP,LYMPHOCYTE STIMULATION TEST POSITIVE,1
JP,MACULAR FIBROSIS,1
JP,MACULAR OEDEMA,1
JP,MALIGNANT ASCITES,1
JP,MALLORY-WEISS SYNDROME,1
JP,MANTLE CELL LYMPHOMA,1
JP,MARASMUS,1
JP,MATERNAL DRUGS AFFECTING FOETUS,1
JP,MECHANICAL ILEUS,1
JP,MENINGIOMA,1
JP,MENINGITIS VIRAL,1
JP,MENORRHAGIA,1
JP,MESENTERIC PHLEBOSCLEROSIS,1
JP,METASTASES TO BONE,1
JP,METASTASES TO LUNG,1
JP,METASTASES TO PERITONEUM,1
JP,MICROCEPHALY,1
JP,MICROSCOPIC POLYANGIITIS,1
JP,MOBILITY DECREASED,1
JP,MOUTH HAEMORRHAGE,1
JP,MULTI-ORGAN DISORDER,1
JP,MULTI-ORGAN FAILURE,1
JP,MULTIPLE SCLEROSIS,1
JP,MUSCLE SPASMS,1
JP,MUSCLE SWELLING,1
JP,MYOCARDIAL REPERFUSION INJURY,1
JP,NASAL INFLAMMATION,1
JP,NECK PAIN,1
JP,NECROSIS,1
JP,NECROTISING FASCIITIS,1
JP,NECROTISING OESOPHAGITIS,1
JP,NEOPLASM,1
JP,NEOPLASM MALIGNANT,1
JP,NEOPLASM RECURRENCE,1
JP,NEPHROLITHIASIS,1
JP,NEPHROPATHY,1
JP,NEPHROTIC SYNDROME,1
JP,NERVOUSNESS,1
JP,NEUROMYOPATHY,1
JP,NIGHTMARE,1
JP,NODULE,1
JP,NON-ALCOHOLIC STEATOHEPATITIS,1
JP,NORMAL LABOUR,1
JP,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
JP,OBESITY,1
JP,OBSESSIVE THOUGHTS,1
JP,OBSTRUCTIVE AIRWAYS DISORDER,1
JP,OCULAR HYPERAEMIA,1
JP,OESOPHAGEAL CANCER METASTATIC,1
JP,OESOPHAGEAL ULCER,1
JP,OESOPHAGEAL VARICES HAEMORRHAGE,1
JP,OESOPHAGITIS,1
JP,OLIGURIA,1
JP,ORGANISING PNEUMONIA,1
JP,OSMOTIC DEMYELINATION SYNDROME,1
JP,OTITIS EXTERNA,1
JP,OVARIAN HYPERSTIMULATION SYNDROME,1
JP,OXYGEN SATURATION DECREASED,1
JP,PACHYMENINGITIS,1
JP,PACKED RED BLOOD CELL TRANSFUSION,1
JP,PAIN OF SKIN,1
JP,PALLOR,1
JP,PANCREATIC ENZYMES INCREASED,1
JP,PANCYTOPENIA,1
JP,PANIC REACTION,1
JP,PANNICULITIS,1
JP,PARAESTHESIA,1
JP,PARKINSON^S DISEASE,1
JP,PARONYCHIA,1
JP,PAROTID GLAND ENLARGEMENT,1
JP,PATELLA FRACTURE,1
JP,PATENT DUCTUS ARTERIOSUS,1
JP,PCO2 INCREASED,1
JP,PELVIC FRACTURE,1
JP,PERICARDIAL HAEMORRHAGE,1
JP,PERINEAL INJURY,1
JP,PERIODONTITIS,1
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
JP,PERIPHERAL SENSORY NEUROPATHY,1
JP,PERITONITIS,1
JP,PERSISTENT DEPRESSIVE DISORDER,1
JP,PERSONALITY DISORDER,1
JP,PLATELET COUNT INCREASED,1
JP,PNEUMATOSIS INTESTINALIS,1
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
JP,PNEUMONIA KLEBSIELLA,1
JP,PNEUMONITIS,1
JP,PO2 DECREASED,1
JP,POST PROCEDURAL HAEMORRHAGE,1
JP,POST-TRAUMATIC STRESS DISORDER,1
JP,POVERTY OF SPEECH,1
JP,PRE-EXISTING CONDITION IMPROVED,1
JP,PREGNANCY,1
JP,PREMATURE RUPTURE OF MEMBRANES,1
JP,PREMENSTRUAL SYNDROME,1
JP,PRERENAL FAILURE,1
JP,PRINZMETAL ANGINA,1
JP,PROCEDURAL PAIN,1
JP,PRODUCT USE IN UNAPPROVED INDICATION,1
JP,PRODUCTIVE COUGH,1
JP,PRURITUS GENITAL,1
JP,PSOAS ABSCESS,1
JP,PSORIATIC ARTHROPATHY,1
JP,PULMONARY ALVEOLAR HAEMORRHAGE,1
JP,PULMONARY EMBOLISM,1
JP,PULMONARY HAEMORRHAGE,1
JP,PULMONARY HYPERTENSION,1
JP,PULMONARY OEDEMA,1
JP,PULMONARY TOXICITY,1
JP,PULMONARY TUBERCULOSIS,1
JP,PURULENCE,1
JP,RASH GENERALISED,1
JP,RASH PAPULAR,1
JP,RECTAL CANCER,1
JP,RENAL ABSCESS,1
JP,RENAL FUNCTION TEST ABNORMAL,1
JP,RENAL INJURY,1
JP,RENAL TUBULAR DISORDER,1
JP,RENAL TUBULAR DYSFUNCTION,1
JP,RESPIRATORY ACIDOSIS,1
JP,RESPIRATORY DEPRESSION,1
JP,RESPIRATORY TRACT HAEMORRHAGE,1
JP,RESTLESSNESS,1
JP,RETICULOCYTE COUNT DECREASED,1
JP,RETINAL HAEMORRHAGE,1
JP,RETINAL VEIN OCCLUSION,1
JP,RHEUMATIC DISORDER,1
JP,RIB FRACTURE,1
JP,RIGHT VENTRICULAR FAILURE,1
JP,RUPTURED CEREBRAL ANEURYSM,1
JP,SALIVARY GLAND NEOPLASM,1
JP,SARCOIDOSIS,1
JP,SCLEREMA,1
JP,SENSORY DISTURBANCE,1
JP,SENSORY LOSS,1
JP,SERUM FERRITIN INCREASED,1
JP,SINUS NODE DYSFUNCTION,1
JP,SKIN CANCER,1
JP,SKIN EROSION,1
JP,SKIN EXFOLIATION,1
JP,SKIN FIBROSIS,1
JP,SKIN INFECTION,1
JP,SKIN LESION,1
JP,SMALL FOR DATES BABY,1
JP,SMALL INTESTINAL HAEMORRHAGE,1
JP,SMALL INTESTINE ULCER,1
JP,SPINAL OSTEOARTHRITIS,1
JP,STAPHYLOCOCCUS TEST POSITIVE,1
JP,STEATOHEPATITIS,1
JP,STERNAL FRACTURE,1
JP,STEVENS-JOHNSON SYNDROME,1
JP,STILL^S DISEASE ADULT ONSET,1
JP,STRABISMUS,1
JP,SUBARACHNOID HAEMATOMA,1
JP,SUBARACHNOID HAEMORRHAGE,1
JP,SUBCUTANEOUS HAEMATOMA,1
JP,SUBDURAL HAEMATOMA,1
JP,SWELLING,1
JP,SWELLING FACE,1
JP,SWOLLEN TONGUE,1
JP,SYNCOPE,1
JP,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
JP,TACHYPNOEA,1
JP,TEMPOROMANDIBULAR JOINT SYNDROME,1
JP,THERAPEUTIC RESPONSE UNEXPECTED,1
JP,THERMAL BURN,1
JP,THIRST,1
JP,THREATENED LABOUR,1
JP,THROMBOCYTOPENIA,1
JP,THROMBOSIS,1
JP,THYROIDITIS,1
JP,THYROTOXIC CRISIS,1
JP,TINEA INFECTION,1
JP,TOOTHACHE,1
JP,TOXIC ENCEPHALOPATHY,1
JP,TOXIC SKIN ERUPTION,1
JP,TRANSAMINASES INCREASED,1
JP,TRANSIENT ISCHAEMIC ATTACK,1
JP,TYPE 1 DIABETES MELLITUS,1
JP,TYPE 2 DIABETES MELLITUS,1
JP,TYPE I HYPERSENSITIVITY,1
JP,ULCER HAEMORRHAGE,1
JP,UMBILICAL CORD ABNORMALITY,1
JP,UNRESPONSIVE TO STIMULI,1
JP,URINARY BLADDER HAEMORRHAGE,1
JP,URINARY INCONTINENCE,1
JP,URINE ANALYSIS ABNORMAL,1
JP,URINE OSMOLARITY INCREASED,1
JP,URINE OUTPUT DECREASED,1
JP,URINE SODIUM INCREASED,1
JP,UROSEPSIS,1
JP,UTERINE DILATION AND CURETTAGE,1
JP,UVEITIS,1
JP,VAGINAL DISCHARGE,1
JP,VARICES OESOPHAGEAL,1
JP,VASCULAR INSUFFICIENCY,1
JP,VASCULAR STENT STENOSIS,1
JP,VASCULITIS,1
JP,VENTRICULAR EXTRASYSTOLES,1
JP,VENTRICULAR HYPOKINESIA,1
JP,VIITH NERVE PARALYSIS,1
JP,VIRAL MUTATION IDENTIFIED,1
JP,VISION BLURRED,1
JP,VITAMIN B1 DEFICIENCY,1
JP,VITREOUS OPACITIES,1
JP,VOCAL CORD DYSFUNCTION,1
JP,VOGT-KOYANAGI-HARADA SYNDROME,1
JP,VULVOVAGINAL CANDIDIASIS,1
JP,WEIGHT FLUCTUATION,1
JP,WEIGHT LOSS POOR,1
JP,WHEEZING,1
JP,WRIST FRACTURE,1
JO,ACNE,1
JO,ACUTE KIDNEY INJURY,1
JO,ANGINA PECTORIS,1
JO,ATRIAL SEPTAL DEFECT,1
JO,CAESAREAN SECTION,1
JO,CARDIAC ARREST,1
JO,CAUDAL REGRESSION SYNDROME,1
JO,DIARRHOEA,1
JO,FOETAL EXPOSURE DURING PREGNANCY,1
JO,HELICOBACTER GASTRITIS,1
JO,HYPOAESTHESIA,1
JO,HYPOVOLAEMIA,1
JO,NEONATAL RESPIRATORY FAILURE,1
JO,PNEUMONITIS,1
JO,PRODUCT USE IN UNAPPROVED INDICATION,1
JO,TALIPES,1
JO,WEIGHT INCREASED,1
KZ,ADVERSE EVENT,1
KZ,BLOOD GLUCOSE INCREASED,1
KZ,DRUG DOSE OMISSION,1
KZ,KETOACIDOSIS,1
KZ,TREATMENT NONCOMPLIANCE,1
KZ,WEIGHT DECREASED,1
KE,CEREBROVASCULAR ACCIDENT,1
KE,HYPOGLYCAEMIA,1
KE,PARALYSIS,1
KE,RENAL FAILURE,1
KP,ALANINE AMINOTRANSFERASE INCREASED,1
KP,ASPARTATE AMINOTRANSFERASE INCREASED,1
KP,BLOOD BILIRUBIN INCREASED,1
KP,FEBRILE NEUTROPENIA,1
KR,ACUTE KIDNEY INJURY,42
KR,LACTIC ACIDOSIS,37
KR,DIARRHOEA,29
KR,PNEUMONIA,18
KR,DIABETES MELLITUS INADEQUATE CONTROL,10
KR,DECREASED APPETITE,9
KR,DEHYDRATION,9
KR,DIABETIC KETOACIDOSIS,8
KR,ENCEPHALOPATHY,8
KR,COUGH,7
KR,CONDITION AGGRAVATED,6
KR,DYSARTHRIA,6
KR,HYPEROSMOLAR HYPERGLYCAEMIC STATE,6
KR,NEUTROPENIA,6
KR,PYREXIA,6
KR,RENAL FAILURE ACUTE,6
KR,TOXICITY TO VARIOUS AGENTS,6
KR,VOMITING,6
KR,ADVERSE DRUG REACTION,5
KR,BRAIN ABSCESS,5
KR,CAESAREAN SECTION,5
KR,DISEASE RECURRENCE,5
KR,EXPOSURE VIA BODY FLUID,5
KR,HAEMODIALYSIS,5
KR,HYPOGLYCAEMIA,5
KR,HYPOKALAEMIA,5
KR,HYPOVOLAEMIA,5
KR,IN VITRO FERTILISATION,5
KR,KETOACIDOSIS,5
KR,MALABSORPTION FROM ADMINISTRATION SITE,5
KR,MYOCLONUS,5
KR,NORMAL NEWBORN,5
KR,PANCREATITIS ACUTE,5
KR,PLACENTA PRAEVIA,5
KR,THERAPEUTIC RESPONSE CHANGED,5
KR,TOXIC ENCEPHALOPATHY,5
KR,ANAEMIA,4
KR,BLOOD PRESSURE DECREASED,4
KR,CHOLECYSTITIS ACUTE,4
KR,COLONIC HAEMATOMA,4
KR,INSOMNIA,4
KR,NAUSEA,4
KR,PALPITATIONS,4
KR,PNEUMONIA ASPIRATION,4
KR,BLOOD CREATININE INCREASED,3
KR,BLOOD GLUCOSE INCREASED,3
KR,BLOOD PH DECREASED,3
KR,CHEST PAIN,3
KR,DEATH,3
KR,DYSPNOEA,3
KR,HEARING IMPAIRED,3
KR,INTERSTITIAL LUNG DISEASE,3
KR,LEUKOCYTOSIS,3
KR,ABDOMINAL DISCOMFORT,2
KR,ABDOMINAL DISTENSION,2
KR,ABDOMINAL PAIN,2
KR,ABDOMINAL TENDERNESS,2
KR,ANGINA UNSTABLE,2
KR,ATRIOVENTRICULAR BLOCK COMPLETE,2
KR,BENIGN PROSTATIC HYPERPLASIA,2
KR,BLOOD BICARBONATE DECREASED,2
KR,BLOOD LACTIC ACID INCREASED,2
KR,BLOOD POTASSIUM INCREASED,2
KR,BLOOD PRESSURE INCREASED,2
KR,BLOOD PRESSURE SYSTOLIC INCREASED,2
KR,CONTINUOUS HAEMODIAFILTRATION,2
KR,DISSEMINATED INTRAVASCULAR COAGULATION,2
KR,DIZZINESS,2
KR,DRUG INEFFECTIVE,2
KR,DYSKINESIA,2
KR,FEBRILE NEUTROPENIA,2
KR,GAIT DISTURBANCE,2
KR,GASTROINTESTINAL SOUNDS ABNORMAL,2
KR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
KR,HAEMATOCHEZIA,2
KR,HYPOACUSIS,2
KR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
KR,MALIGNANT NEOPLASM PROGRESSION,2
KR,MYOCARDIAL INFARCTION,2
KR,NERVOUS SYSTEM DISORDER,2
KR,OLIGURIA,2
KR,PANCREATIC CARCINOMA,2
KR,PLEURAL EFFUSION,2
KR,PULMONARY ALVEOLAR HAEMORRHAGE,2
KR,PYELONEPHRITIS ACUTE,2
KR,RASH,2
KR,RESPIRATORY RATE INCREASED,2
KR,SEPSIS,2
KR,SMALL INTESTINAL OBSTRUCTION,2
KR,SOMNOLENCE,2
KR,VESTIBULAR DISORDER,2
KR,WEIGHT DECREASED,2
KR,ABDOMINAL PAIN UPPER,1
KR,ABORTION SPONTANEOUS,1
KR,ALTERED STATE OF CONSCIOUSNESS,1
KR,AMYLASE INCREASED,1
KR,ANAL ABSCESS,1
KR,ANION GAP INCREASED,1
KR,ARTHRITIS BACTERIAL,1
KR,ASCITES,1
KR,ASPARTATE AMINOTRANSFERASE INCREASED,1
KR,ASTHENIA,1
KR,AUTOIMMUNE HEPATITIS,1
KR,AZOTAEMIA,1
KR,BACK PAIN,1
KR,BASILAR ARTERY OCCLUSION,1
KR,BENIGN GASTRIC NEOPLASM,1
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
KR,BLOOD CHLORIDE DECREASED,1
KR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KR,BLOOD GASES ABNORMAL,1
KR,BLOOD GLUCOSE ABNORMAL,1
KR,BLOOD KETONE BODY DECREASED,1
KR,BLOOD KETONE BODY INCREASED,1
KR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
KR,BLOOD PHOSPHORUS DECREASED,1
KR,BLOOD PHOSPHORUS INCREASED,1
KR,BLOOD POTASSIUM DECREASED,1
KR,BLOOD UREA INCREASED,1
KR,CARDIOGENIC SHOCK,1
KR,CARPAL TUNNEL SYNDROME,1
KR,CELLULITIS,1
KR,CEREBRAL INFARCTION,1
KR,CHEST DISCOMFORT,1
KR,CHEST TUBE INSERTION,1
KR,CHOLECYSTECTOMY,1
KR,CHRONIC KIDNEY DISEASE,1
KR,COLITIS,1
KR,COLITIS ISCHAEMIC,1
KR,CONSTIPATION,1
KR,CORONARY ARTERY DISEASE,1
KR,CORONARY ARTERY STENOSIS,1
KR,DELIRIUM,1
KR,DIABETES MELLITUS,1
KR,DIABETIC FOOT,1
KR,DIPLOPIA,1
KR,DRUG RESISTANCE,1
KR,DYSPNOEA EXERTIONAL,1
KR,DYSURIA,1
KR,ENTERITIS,1
KR,EPIGASTRIC DISCOMFORT,1
KR,FAECES SOFT,1
KR,FALL,1
KR,FUNCTIONAL GASTROINTESTINAL DISORDER,1
KR,GASTRIC ULCER HAEMORRHAGE,1
KR,GASTRITIS,1
KR,GASTROINTESTINAL PERFORATION,1
KR,GASTROINTESTINAL STROMAL TUMOUR,1
KR,HAEMOPTYSIS,1
KR,HAEMORRHAGE SUBCUTANEOUS,1
KR,HEADACHE,1
KR,HEART RATE DECREASED,1
KR,HEPATIC FUNCTION ABNORMAL,1
KR,HEPATOCELLULAR CARCINOMA,1
KR,HICCUPS,1
KR,HOSPITALISATION,1
KR,HYPERBILIRUBINAEMIA,1
KR,HYPERGLYCAEMIA,1
KR,HYPERKALAEMIA,1
KR,HYPOGLYCAEMIC COMA,1
KR,HYPOGLYCAEMIC ENCEPHALOPATHY,1
KR,HYPOPHYSITIS,1
KR,HYPOTENSION,1
KR,HYPOTHYROIDISM,1
KR,HYPOXIA,1
KR,INFECTION,1
KR,INFLUENZA,1
KR,INSULIN C-PEPTIDE DECREASED,1
KR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
KR,LEUKOPENIA,1
KR,LIPASE INCREASED,1
KR,LUMBAR VERTEBRAL FRACTURE,1
KR,LUNG INFILTRATION,1
KR,MACULOPATHY,1
KR,MALAISE,1
KR,MATERNAL EXPOSURE DURING PREGNANCY,1
KR,MENINGITIS,1
KR,METABOLIC ACIDOSIS,1
KR,MOVEMENT DISORDER,1
KR,MUCOSAL INFLAMMATION,1
KR,MUSCLE INJURY,1
KR,MUSCLE STRAIN,1
KR,MYOGLOBIN BLOOD INCREASED,1
KR,NUCHAL RIGIDITY,1
KR,OEDEMA,1
KR,OEDEMATOUS PANCREATITIS,1
KR,ORAL CANDIDIASIS,1
KR,OSTEOMYELITIS,1
KR,OXYGEN SATURATION DECREASED,1
KR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
KR,PANCREATIC DISORDER,1
KR,PANCREATITIS,1
KR,PANCYTOPENIA,1
KR,PARAESTHESIA,1
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
KR,PNEUMONIA NECROTISING,1
KR,PNEUMONIA PNEUMOCOCCAL,1
KR,PO2 DECREASED,1
KR,PO2 INCREASED,1
KR,POLLAKIURIA,1
KR,POLYURIA,1
KR,POST-TRAUMATIC NECK SYNDROME,1
KR,PREAURICULAR CYST,1
KR,PRODUCT USE ISSUE,1
KR,PRODUCTIVE COUGH,1
KR,PROSTATE CANCER,1
KR,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
KR,PROTRUSION TONGUE,1
KR,PULMONARY CONGESTION,1
KR,PULMONARY EMBOLISM,1
KR,PULMONARY OEDEMA,1
KR,PYOMYOSITIS,1
KR,RENAL ABSCESS,1
KR,RENAL IMPAIRMENT,1
KR,RESPIRATORY FAILURE,1
KR,RESTLESSNESS,1
KR,RHABDOMYOLYSIS,1
KR,RHINORRHOEA,1
KR,RHODOCOCCUS INFECTION,1
KR,RHONCHI,1
KR,ROAD TRAFFIC ACCIDENT,1
KR,SHOCK,1
KR,SKIN TURGOR DECREASED,1
KR,SKIN ULCER,1
KR,SYNCOPE,1
KR,TENDON RUPTURE,1
KR,TORSADE DE POINTES,1
KR,TOXIC EPIDERMAL NECROLYSIS,1
KR,TREMOR,1
KR,URETERIC CANCER,1
KR,WHITE BLOOD CELL COUNT INCREASED,1
KW,FOETAL GROWTH RESTRICTION,3
KW,MATERNAL EXPOSURE DURING PREGNANCY,2
KW,RESPIRATORY DISTRESS,2
KW,ABDOMINAL PAIN,1
KW,ARTERIOSCLEROSIS CORONARY ARTERY,1
KW,BLOOD BICARBONATE DECREASED,1
KW,BLOOD TRIGLYCERIDES INCREASED,1
KW,CARDIAC ARREST,1
KW,CHOLESTASIS OF PREGNANCY,1
KW,EXPOSURE DURING PREGNANCY,1
KW,FOETAL EXPOSURE DURING PREGNANCY,1
KW,FOETAL EXPOSURE TIMING UNSPECIFIED,1
KW,HAEMOLYTIC ANAEMIA,1
KW,HAEMORRHAGE IN PREGNANCY,1
KW,HEPATIC STEATOSIS,1
KW,HEPATOMEGALY,1
KW,LACTIC ACIDOSIS,1
KW,LIVE BIRTH,1
KW,LOW BIRTH WEIGHT BABY,1
KW,METABOLIC ACIDOSIS,1
KW,NEPHROLITHIASIS,1
KW,OVERDOSE,1
KW,PANCREATITIS,1
KW,PANCREATITIS ACUTE,1
KW,PLACENTA PRAEVIA,1
KW,PNEUMONIA ASPIRATION,1
KW,PREMATURE BABY,1
KW,PREMATURE DELIVERY,1
KW,RENAL IMPAIRMENT,1
KW,SEMINAL VESICULAR DISORDER,1
KW,SPONDYLOLYSIS,1
KW,TACHYPNOEA,1
KW,TOXICITY TO VARIOUS AGENTS,1
KW,VOMITING,1
LV,FEBRILE NEUTROPENIA,2
LV,THROMBOCYTOPENIA,2
LV,ACUTE KIDNEY INJURY,1
LV,AGGRESSION,1
LV,ANAEMIA,1
LV,CONVULSION,1
LV,DECREASED APPETITE,1
LV,DEMENTIA,1
LV,DIABETIC KETOACIDOSIS,1
LV,DISORIENTATION,1
LV,ENTEROCOLITIS,1
LV,EOSINOPHILIA,1
LV,GASTRIC ULCER HAEMORRHAGE,1
LV,HYDROTHORAX,1
LV,HYPOGLYCAEMIA,1
LV,KETOACIDOSIS,1
LV,LACTIC ACIDOSIS,1
LV,LOWER LIMB FRACTURE,1
LV,MENTAL DISORDER,1
LV,NAUSEA,1
LV,NEUTROPENIA,1
LV,OCCULT BLOOD POSITIVE,1
LV,PURPURA,1
LV,TINNITUS,1
LV,VOMITING,1
LV,WEIGHT DECREASED,1
LB,NAUSEA,4
LB,VOMITING,4
LB,ABDOMINAL PAIN,3
LB,DEHYDRATION,3
LB,DIARRHOEA,3
LB,ASCITES,2
LB,ASPARTATE AMINOTRANSFERASE INCREASED,2
LB,CARDIAC FAILURE CONGESTIVE,2
LB,FATIGUE,2
LB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
LB,GASTROENTERITIS,2
LB,GENERALISED OEDEMA,2
LB,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
LB,HAEMATOCHEZIA,2
LB,HYPERGLYCAEMIA,2
LB,HYPERKALAEMIA,2
LB,INFECTION,2
LB,PYREXIA,2
LB,RENAL FAILURE,2
LB,URINE OUTPUT DECREASED,2
LB,ABDOMINAL PAIN UPPER,1
LB,ABORTION,1
LB,ABORTION SPONTANEOUS,1
LB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
LB,ACUTE KIDNEY INJURY,1
LB,ALANINE AMINOTRANSFERASE INCREASED,1
LB,ASTHMA,1
LB,BIPOLAR DISORDER,1
LB,BLADDER CANCER,1
LB,BLOOD ALKALINE PHOSPHATASE INCREASED,1
LB,BLOOD GLUCOSE ABNORMAL,1
LB,BREATH ODOUR,1
LB,C-REACTIVE PROTEIN INCREASED,1
LB,CARDIAC FAILURE,1
LB,CEREBRAL ARTERY EMBOLISM,1
LB,CHEST PAIN,1
LB,CHOLECYSTITIS,1
LB,CHOLELITHIASIS,1
LB,CONSTIPATION,1
LB,DECREASED APPETITE,1
LB,DIARRHOEA HAEMORRHAGIC,1
LB,DIASTOLIC DYSFUNCTION,1
LB,DRUG INEFFECTIVE,1
LB,DRUG RESISTANCE,1
LB,DYSPNOEA,1
LB,EJECTION FRACTION DECREASED,1
LB,EXPOSURE DURING PREGNANCY,1
LB,FEAR,1
LB,FEEDING DISORDER,1
LB,GALLBLADDER OPERATION,1
LB,GASTRECTOMY,1
LB,GASTROINTESTINAL INFECTION,1
LB,GENERAL PHYSICAL HEALTH DETERIORATION,1
LB,HAEMATURIA,1
LB,HAEMOGLOBIN DECREASED,1
LB,HEADACHE,1
LB,HEART RATE DECREASED,1
LB,HEPATIC CIRRHOSIS,1
LB,HEPATIC FAILURE,1
LB,HEPATORENAL SYNDROME,1
LB,HOT FLUSH,1
LB,HYPERSENSITIVITY,1
LB,HYPERTHERMIA,1
LB,HYPERTRIGLYCERIDAEMIA,1
LB,HYPOTENSION,1
LB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
LB,INCREASED APPETITE,1
LB,INFLAMMATION,1
LB,INFLUENZA,1
LB,JAUNDICE,1
LB,LETHARGY,1
LB,LIBIDO DECREASED,1
LB,LIVER INJURY,1
LB,LOSS OF CONSCIOUSNESS,1
LB,LUNG INFECTION,1
LB,MALNUTRITION,1
LB,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
LB,MUSCULAR WEAKNESS,1
LB,MYALGIA,1
LB,MYOCARDIAL INFARCTION,1
LB,OEDEMA PERIPHERAL,1
LB,PAIN IN EXTREMITY,1
LB,PALLOR,1
LB,PANCREATITIS ACUTE,1
LB,PANCREATITIS HAEMORRHAGIC,1
LB,PERIPHERAL SWELLING,1
LB,POLYURIA,1
LB,PROSTATE CANCER METASTATIC,1
LB,PSEUDOHYPONATRAEMIA,1
LB,PULMONARY OEDEMA,1
LB,ROSACEA,1
LB,SECOND PRIMARY MALIGNANCY,1
LB,SEPTIC SHOCK,1
LB,SKIN EXFOLIATION,1
LB,TOE AMPUTATION,1
LB,TYPE 2 DIABETES MELLITUS,1
LB,URINE KETONE BODY PRESENT,1
LB,UTERINE LEIOMYOMA,1
LB,VIRAL INFECTION,1
LB,WEIGHT FLUCTUATION,1
LB,WEIGHT INCREASED,1
LB,YELLOW SKIN,1
LS,RESPIRATORY DISTRESS,1
LY,PAPILLARY THYROID CANCER,1
LT,BLOOD GLUCOSE FLUCTUATION,1
LT,CHOLECYSTITIS ACUTE,1
LT,DRUG ADMINISTRATION ERROR,1
LT,DYSPNOEA,1
LT,EXOSTOSIS,1
LT,GENERALISED OEDEMA,1
LT,HYPOAESTHESIA,1
LT,LYMPHADENOPATHY,1
LT,NEUROLEPTIC MALIGNANT SYNDROME,1
LT,PAIN IN EXTREMITY,1
LT,PANCREATIC CARCINOMA METASTATIC,1
LT,TRANSIENT ISCHAEMIC ATTACK,1
LU,SEPSIS,1
MO,ACUTE RESPIRATORY FAILURE,1
MO,ENCEPHALOPATHY,1
MO,HEPATIC FAILURE,1
MO,PLASMA CELL MYELOMA,1
MO,PULMONARY OEDEMA,1
MK,FATIGUE,3
MK,PERIPHERAL SWELLING,2
MK,ABDOMINAL PAIN UPPER,1
MK,BLOOD PRESSURE FLUCTUATION,1
MK,BLOOD PRESSURE INCREASED,1
MK,DEPRESSION,1
MK,DRUG INEFFECTIVE,1
MK,DYSPNOEA,1
MK,ERYTHEMA,1
MK,FALL,1
MK,INJECTION SITE ERYTHEMA,1
MK,MULTI-ORGAN FAILURE,1
MK,NAUSEA,1
MK,PAIN IN EXTREMITY,1
MK,PAIN IN JAW,1
MK,PARAESTHESIA,1
MK,POLYURIA,1
MK,SKIN NECROSIS,1
MK,SUBDURAL HAEMATOMA,1
MG,OEDEMA PERIPHERAL,1
MG,PULMONARY OEDEMA,1
MW,HYPOGLYCAEMIA,1
MY,ACUTE KIDNEY INJURY,9
MY,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,9
MY,HYPOGLYCAEMIA,8
MY,PNEUMONIA,7
MY,TOXICITY TO VARIOUS AGENTS,6
MY,DEAFNESS NEUROSENSORY,5
MY,DIARRHOEA,5
MY,WEIGHT DECREASED,5
MY,DELIRIUM,4
MY,DRUG INEFFECTIVE,4
MY,MACULOPATHY,4
MY,METABOLIC ACIDOSIS,4
MY,NEUROTOXICITY,4
MY,TINNITUS,4
MY,CHANGE OF BOWEL HABIT,3
MY,DIABETES MELLITUS INADEQUATE CONTROL,3
MY,DIABETIC KETOACIDOSIS,3
MY,DYSPNOEA,3
MY,HYPONATRAEMIA,3
MY,NAUSEA,3
MY,SEPSIS,3
MY,SOMNOLENCE,3
MY,ABSCESS LIMB,2
MY,ANAEMIA,2
MY,ANAEMIA VITAMIN B12 DEFICIENCY,2
MY,ASTHENIA,2
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,2
MY,CARDIAC FAILURE,2
MY,CEREBRAL INFARCTION,2
MY,ERYTHEMA,2
MY,FACE OEDEMA,2
MY,FOETAL EXPOSURE DURING PREGNANCY,2
MY,GASTROINTESTINAL STROMAL TUMOUR,2
MY,HYPOKALAEMIA,2
MY,HYPOMANIA,2
MY,INTERNATIONAL NORMALISED RATIO INCREASED,2
MY,LIP SWELLING,2
MY,LOW BIRTH WEIGHT BABY,2
MY,MALABSORPTION,2
MY,MALIGNANT NEOPLASM PROGRESSION,2
MY,OEDEMA PERIPHERAL,2
MY,PERIORBITAL OEDEMA,2
MY,PRURITUS,2
MY,UPPER GASTROINTESTINAL HAEMORRHAGE,2
MY,URINARY TRACT INFECTION,2
MY,VOMITING,2
MY,ABDOMINAL DISTENSION,1
MY,ABDOMINAL PAIN,1
MY,ABORTION SPONTANEOUS,1
MY,ABSCESS,1
MY,ACETONAEMIA,1
MY,ADJUSTMENT DISORDER,1
MY,ALANINE AMINOTRANSFERASE INCREASED,1
MY,ANAEMIA MACROCYTIC,1
MY,ANAPHYLACTIC REACTION,1
MY,ANGIOEDEMA,1
MY,ANXIETY,1
MY,ATRIAL FIBRILLATION,1
MY,BASAL GANGLIA HAEMATOMA,1
MY,BLINDNESS,1
MY,BLOOD BILIRUBIN INCREASED,1
MY,BLOOD GLUCOSE DECREASED,1
MY,BLOOD GLUCOSE INCREASED,1
MY,BLOOD PRESSURE ABNORMAL,1
MY,BRAIN OEDEMA,1
MY,BUNDLE BRANCH BLOCK RIGHT,1
MY,BURKHOLDERIA PSEUDOMALLEI INFECTION,1
MY,CARDIAC FAILURE CONGESTIVE,1
MY,CARDIAC FLUTTER,1
MY,CATHETER SITE ABSCESS,1
MY,CELLULITIS,1
MY,CEREBRAL HAEMATOMA,1
MY,CHILLS,1
MY,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
MY,COLONIC PSEUDO-OBSTRUCTION,1
MY,COUGH,1
MY,DEHYDRATION,1
MY,DELUSION,1
MY,DISORIENTATION,1
MY,DIZZINESS,1
MY,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
MY,DRY SKIN,1
MY,EAR DISCOMFORT,1
MY,EAR INFECTION,1
MY,ELECTROCARDIOGRAM QT PROLONGED,1
MY,ELECTROCARDIOGRAM T WAVE INVERSION,1
MY,ELEVATED MOOD,1
MY,EPISTAXIS,1
MY,ERYTHEMA MULTIFORME,1
MY,EXFOLIATIVE RASH,1
MY,EXPOSURE DURING PREGNANCY,1
MY,EYE IRRITATION,1
MY,FALL,1
MY,FATIGUE,1
MY,FEELING HOT,1
MY,FEMUR FRACTURE,1
MY,FOETAL GROWTH RESTRICTION,1
MY,GASTROOESOPHAGEAL REFLUX DISEASE,1
MY,GENERALISED OEDEMA,1
MY,GESTATIONAL DIABETES,1
MY,GLAUCOMA,1
MY,GLOSSITIS,1
MY,HAEMOLYTIC ANAEMIA,1
MY,HAEMORRHOIDAL HAEMORRHAGE,1
MY,HUNGER,1
MY,HYDROCEPHALUS,1
MY,HYDRONEPHROSIS,1
MY,HYPERACUSIS,1
MY,HYPERKALAEMIA,1
MY,HYPOTENSION,1
MY,INAPPROPRIATE AFFECT,1
MY,INCREASED APPETITE,1
MY,INJECTION SITE ERYTHEMA,1
MY,INJECTION SITE INDURATION,1
MY,INJECTION SITE SWELLING,1
MY,INTERVERTEBRAL DISC PROTRUSION,1
MY,INTRACRANIAL MASS,1
MY,INTRADUCTAL PAPILLOMA OF BREAST,1
MY,INTRAVENTRICULAR HAEMORRHAGE,1
MY,INVASIVE DUCTAL BREAST CARCINOMA,1
MY,IRIDOCYCLITIS,1
MY,JAUNDICE,1
MY,KETOSIS,1
MY,LACRIMATION INCREASED,1
MY,LOSS OF CONSCIOUSNESS,1
MY,LYMPHADENITIS,1
MY,MATERNAL EXPOSURE DURING PREGNANCY,1
MY,MEDICATION RESIDUE PRESENT,1
MY,MYOCARDIAL INFARCTION,1
MY,NECROTISING FASCIITIS,1
MY,NON-CARDIAC CHEST PAIN,1
MY,OLIGOHYDRAMNIOS,1
MY,ORBITAL OEDEMA,1
MY,PAIN IN EXTREMITY,1
MY,PERIPHERAL SWELLING,1
MY,PHOTOSENSITIVITY REACTION,1
MY,PLANTAR FASCIITIS,1
MY,PLASMA CELL MYELOMA,1
MY,PLEURAL EFFUSION,1
MY,PNEUMONIA ASPIRATION,1
MY,POLLAKIURIA,1
MY,POST PROCEDURAL INFECTION,1
MY,POTENTIATING DRUG INTERACTION,1
MY,PRESCRIBED OVERDOSE,1
MY,PRODUCT QUALITY ISSUE,1
MY,PROTHROMBIN TIME PROLONGED,1
MY,PRURITUS GENERALISED,1
MY,PULMONARY OEDEMA,1
MY,PURPURA,1
MY,RASH MACULO-PAPULAR,1
MY,RECTAL ABSCESS,1
MY,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
MY,RENAL CELL CARCINOMA,1
MY,RENAL CYST,1
MY,RENAL FAILURE ACUTE,1
MY,RENAL HAEMATOMA,1
MY,RETINAL VEIN OCCLUSION,1
MY,SEIZURE,1
MY,SKIN DISCOLOURATION,1
MY,SKIN ULCER,1
MY,SPEECH DISORDER,1
MY,SPINAL CORD HAEMORRHAGE,1
MY,SPINAL OSTEOARTHRITIS,1
MY,SURGERY,1
MY,SWOLLEN TONGUE,1
MY,THERAPEUTIC RESPONSE DECREASED,1
MY,THROMBOCYTOPENIA,1
MY,THROMBOCYTOSIS,1
MY,TRANSVERSE PRESENTATION,1
MY,TREMOR,1
MY,TUBERCULOSIS OF EYE,1
MY,UNRESPONSIVE TO STIMULI,1
MY,UROSEPSIS,1
MY,VERTIGO POSITIONAL,1
MY,VISION BLURRED,1
MY,VITAMIN B12 DEFICIENCY,1
MY,WHITE BLOOD CELL COUNT DECREASED,1
MT,AMYLASE INCREASED,4
MT,DYSPNOEA,3
MT,ASTHMA,2
MT,DYSPNOEA AT REST,2
MT,FOETAL EXPOSURE DURING PREGNANCY,2
MT,HYPERGLYCAEMIA,2
MT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
MT,JAUNDICE NEONATAL,2
MT,NASAL CONGESTION,2
MT,PRODUCT USE IN UNAPPROVED INDICATION,2
MT,PRODUCTIVE COUGH,2
MT,PULMONARY SENSITISATION,2
MT,ACUTE KIDNEY INJURY,1
MT,BLOOD CHLORIDE DECREASED,1
MT,BLOOD CHOLESTEROL INCREASED,1
MT,BLOOD GLUCOSE INCREASED,1
MT,BLOOD POTASSIUM INCREASED,1
MT,BLOOD URIC ACID INCREASED,1
MT,C-REACTIVE PROTEIN INCREASED,1
MT,CARDIAC FAILURE CHRONIC,1
MT,CHEST PAIN,1
MT,DEATH,1
MT,DISEASE PROGRESSION,1
MT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
MT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
MT,HIGH DENSITY LIPOPROTEIN DECREASED,1
MT,HIP FRACTURE,1
MT,INJECTION SITE PAIN,1
MT,LOSS OF CONSCIOUSNESS,1
MT,LOW DENSITY LIPOPROTEIN INCREASED,1
MT,LOWER RESPIRATORY TRACT INFECTION,1
MT,LUNG ADENOCARCINOMA METASTATIC,1
MT,MALAISE,1
MT,MYOCARDIAL INFARCTION,1
MT,PRODUCT USE ISSUE,1
MT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
MT,RETINAL HAEMORRHAGE,1
MT,SUDDEN DEATH,1
MT,TOTAL CHOLESTEROL/HDL RATIO INCREASED,1
MT,UNEVALUABLE EVENT,1
MT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MT,UPPER LIMB FRACTURE,1
MT,VISION BLURRED,1
MT,WALKING DISABILITY,1
MT,WHITE BLOOD CELL COUNT INCREASED,1
MU,ACUTE HEPATITIS B,1
MU,CHOLESTATIC LIVER INJURY,1
MU,DEATH,1
MU,DIABETIC KETOACIDOSIS,1
MU,HEPATIC FAILURE,1
MU,HEPATITIS ACUTE,1
MX,BLOOD GLUCOSE INCREASED,104
MX,HYPERGLYCAEMIA,40
MX,BLOOD GLUCOSE DECREASED,29
MX,BLOOD PRESSURE INCREASED,28
MX,HYPERTENSION,27
MX,LACTIC ACIDOSIS,25
MX,DIARRHOEA,23
MX,FALL,22
MX,FATIGUE,21
MX,DIABETES MELLITUS,20
MX,DIZZINESS,20
MX,HEADACHE,20
MX,NAUSEA,20
MX,PAIN IN EXTREMITY,20
MX,HYPOGLYCAEMIA,19
MX,GAIT DISTURBANCE,18
MX,VOMITING,18
MX,DRUG INEFFECTIVE,17
MX,MALAISE,17
MX,URINARY TRACT INFECTION,17
MX,PAIN,16
MX,ACUTE KIDNEY INJURY,15
MX,ARTHRALGIA,15
MX,DEPRESSION,15
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,15
MX,FEELING ABNORMAL,14
MX,MULTIPLE ORGAN DYSFUNCTION SYNDROME,14
MX,ANAEMIA,13
MX,ASTHENIA,13
MX,MYOCARDIAL INFARCTION,13
MX,SOMNOLENCE,13
MX,DRUG PRESCRIBING ERROR,12
MX,EPISTAXIS,12
MX,INTENTIONAL OVERDOSE,12
MX,WEIGHT DECREASED,12
MX,BLOOD PRESSURE DECREASED,11
MX,DEATH,11
MX,DECREASED APPETITE,11
MX,DEHYDRATION,11
MX,TOXICITY TO VARIOUS AGENTS,11
MX,ABDOMINAL PAIN,10
MX,ABDOMINAL PAIN UPPER,10
MX,COUGH,10
MX,GENERAL PHYSICAL HEALTH DETERIORATION,10
MX,INFARCTION,10
MX,MEMORY IMPAIRMENT,10
MX,PYREXIA,10
MX,SUICIDE ATTEMPT,10
MX,ANXIETY,9
MX,CATARACT,9
MX,PERIPHERAL SWELLING,9
MX,WEIGHT INCREASED,9
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,9
MX,ABASIA,8
MX,DIABETES MELLITUS INADEQUATE CONTROL,8
MX,HAEMODYNAMIC INSTABILITY,8
MX,PNEUMONIA,8
MX,PRODUCT USE IN UNAPPROVED INDICATION,8
MX,ALOPECIA,7
MX,AMNESIA,7
MX,BACK PAIN,7
MX,BONE PAIN,7
MX,CEREBROVASCULAR ACCIDENT,7
MX,COGNITIVE DISORDER,7
MX,CONSTIPATION,7
MX,DEPRESSED MOOD,7
MX,DISEASE PROGRESSION,7
MX,DISORIENTATION,7
MX,EYE HAEMORRHAGE,7
MX,PLATELET COUNT DECREASED,7
MX,RENAL FAILURE,7
MX,RETINAL HAEMORRHAGE,7
MX,SEPTIC SHOCK,7
MX,TREMOR,7
MX,VISION BLURRED,7
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,6
MX,HAEMOGLOBIN DECREASED,6
MX,HYPERHIDROSIS,6
MX,INSOMNIA,6
MX,LOSS OF CONSCIOUSNESS,6
MX,MUCOSAL INFLAMMATION,6
MX,MUSCLE SPASMS,6
MX,PALLOR,6
MX,PRODUCT USE ISSUE,6
MX,RENAL DISORDER,6
MX,RESPIRATORY FAILURE,6
MX,THROMBOSIS,6
MX,VISUAL IMPAIRMENT,6
MX,VITAMIN B12 DEFICIENCY,6
MX,APATHY,5
MX,APRAXIA,5
MX,DRY SKIN,5
MX,DYSPNOEA,5
MX,HYPERKALAEMIA,5
MX,INDIFFERENCE,5
MX,KIDNEY INFECTION,5
MX,NEPHROLITHIASIS,5
MX,OEDEMA PERIPHERAL,5
MX,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
MX,TACHYCARDIA,5
MX,BLINDNESS,4
MX,BLOOD GLUCOSE FLUCTUATION,4
MX,BLOOD UREA INCREASED,4
MX,CARDIAC ARREST,4
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
MX,CONTUSION,4
MX,CRYING,4
MX,DISCOMFORT,4
MX,DRY MOUTH,4
MX,EMBOLISM,4
MX,EMOTIONAL DISORDER,4
MX,EYE PAIN,4
MX,FACIAL PARALYSIS,4
MX,FOETAL EXPOSURE DURING PREGNANCY,4
MX,GASTRITIS,4
MX,HAEMORRHAGE,4
MX,HERPES ZOSTER,4
MX,HYPONATRAEMIA,4
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
MX,LIMB DISCOMFORT,4
MX,MATERNAL EXPOSURE DURING PREGNANCY,4
MX,MOOD ALTERED,4
MX,MUSCULAR WEAKNESS,4
MX,MUSCULOSKELETAL PAIN,4
MX,NERVOUSNESS,4
MX,RESPIRATORY ARREST,4
MX,SKIN DISCOLOURATION,4
MX,SPEECH DISORDER,4
MX,SWELLING FACE,4
MX,URTICARIA,4
MX,VISUAL ACUITY REDUCED,4
MX,ABDOMINAL DISTENSION,3
MX,AGGRESSION,3
MX,ANGER,3
MX,ANKLE FRACTURE,3
MX,ASPARTATE AMINOTRANSFERASE INCREASED,3
MX,ASPHYXIA,3
MX,BLOOD CREATININE INCREASED,3
MX,BRONCHITIS,3
MX,BURNING SENSATION,3
MX,CARDIAC DISORDER,3
MX,CEREBRAL INFARCTION,3
MX,CHEILITIS,3
MX,CHOLELITHIASIS,3
MX,CHONDROPATHY,3
MX,CHRONIC KIDNEY DISEASE,3
MX,CONFUSIONAL STATE,3
MX,DIABETIC COMPLICATION,3
MX,DYSLIPIDAEMIA,3
MX,EYE SWELLING,3
MX,FEMUR FRACTURE,3
MX,GASTROINTESTINAL DISORDER,3
MX,GLAUCOMA,3
MX,HEMIPLEGIA,3
MX,HEPATIC ARTERY THROMBOSIS,3
MX,HEPATIC INFARCTION,3
MX,HEPATIC STEATOSIS,3
MX,HIP FRACTURE,3
MX,HYPERKERATOSIS,3
MX,HYPERLACTACIDAEMIA,3
MX,HYPOAESTHESIA,3
MX,HYPOPHAGIA,3
MX,HYPOTENSION,3
MX,HYPOTHYROIDISM,3
MX,INFLAMMATION,3
MX,INFLUENZA,3
MX,JOINT INJURY,3
MX,LIMB INJURY,3
MX,LOCALISED INFECTION,3
MX,LOWER LIMB FRACTURE,3
MX,LUNG NEOPLASM MALIGNANT,3
MX,LYMPHOCYTE COUNT DECREASED,3
MX,METABOLIC ACIDOSIS,3
MX,METASTASES TO LIVER,3
MX,MUCOSAL ATROPHY,3
MX,NODAL ARRHYTHMIA,3
MX,ORAL CANDIDIASIS,3
MX,PARAESTHESIA,3
MX,POST INFLAMMATORY PIGMENTATION CHANGE,3
MX,PREGNANCY ON CONTRACEPTIVE,3
MX,PRURITUS,3
MX,RASH,3
MX,RENAL IMPAIRMENT,3
MX,RENAL INJURY,3
MX,RESPIRATORY TRACT INFECTION,3
MX,ROAD TRAFFIC ACCIDENT,3
MX,SEPSIS,3
MX,SKIN BURNING SENSATION,3
MX,SKIN FISSURES,3
MX,SLEEP DISORDER,3
MX,STRESS,3
MX,SYNCOPE,3
MX,THROMBOCYTOPENIA,3
MX,TOOTHACHE,3
MX,UPPER LIMB FRACTURE,3
MX,VAGINAL INFECTION,3
MX,WHITE BLOOD CELL COUNT INCREASED,3
MX,ABDOMINAL DISCOMFORT,2
MX,ACNE,2
MX,ALANINE AMINOTRANSFERASE INCREASED,2
MX,ANAL HAEMORRHAGE,2
MX,ANGINA UNSTABLE,2
MX,ANTEROGRADE AMNESIA,2
MX,ARRHYTHMIA,2
MX,ARTERIOSCLEROSIS,2
MX,ARTHROPATHY,2
MX,BLEPHAROSPASM,2
MX,BLINDNESS UNILATERAL,2
MX,BLISTER,2
MX,BLOOD CHOLESTEROL INCREASED,2
MX,BLOOD PRESSURE ABNORMAL,2
MX,BLOOD PRESSURE FLUCTUATION,2
MX,BLOOD TRIGLYCERIDES ABNORMAL,2
MX,BLOOD TRIGLYCERIDES INCREASED,2
MX,BONE DISORDER,2
MX,CAESAREAN SECTION,2
MX,CARDIO-RESPIRATORY ARREST,2
MX,CARDIOMEGALY,2
MX,CARDIOVASCULAR DISORDER,2
MX,CEREBRAL THROMBOSIS,2
MX,CHEST PAIN,2
MX,CONCOMITANT DISEASE AGGRAVATED,2
MX,CONDITION AGGRAVATED,2
MX,CONGENITAL ANOMALY,2
MX,CREATININE RENAL CLEARANCE DECREASED,2
MX,DEAFNESS,2
MX,DECREASED IMMUNE RESPONSIVENESS,2
MX,DEMENTIA ALZHEIMER^S TYPE,2
MX,DIABETIC NEUROPATHY,2
MX,DRUG DOSE OMISSION,2
MX,DRY EYE,2
MX,DYSGEUSIA,2
MX,DYSKINESIA,2
MX,DYSURIA,2
MX,ELECTROLYTE IMBALANCE,2
MX,ERYTHEMA,2
MX,EXPIRED PRODUCT ADMINISTERED,2
MX,EYE IRRITATION,2
MX,FEAR,2
MX,FEELING COLD,2
MX,FEELING OF DESPAIR,2
MX,FLUID RETENTION,2
MX,FOOT DEFORMITY,2
MX,GAIT INABILITY,2
MX,GALLBLADDER DISORDER,2
MX,GASTRIC ULCER,2
MX,GASTROINTESTINAL HAEMORRHAGE,2
MX,GASTROINTESTINAL INFECTION,2
MX,GOUTY ARTHRITIS,2
MX,HAEMATEMESIS,2
MX,HAEMATOCRIT DECREASED,2
MX,HAEMATURIA,2
MX,HALLUCINATION,2
MX,HEPATIC CANCER METASTATIC,2
MX,HEPATIC CIRRHOSIS,2
MX,HEPATITIS,2
MX,HERNIA,2
MX,HERPES VIRUS INFECTION,2
MX,HUNGER,2
MX,HYPERAESTHESIA,2
MX,HYPERCHOLESTEROLAEMIA,2
MX,HYPERSENSITIVITY,2
MX,HYPERTENSIVE CRISIS,2
MX,HYPERTHYROIDISM,2
MX,HYPERTRIGLYCERIDAEMIA,2
MX,INCORRECT DOSE ADMINISTERED,2
MX,INCORRECT DRUG ADMINISTRATION DURATION,2
MX,INCREASED APPETITE,2
MX,INJECTION SITE PAIN,2
MX,INTENTIONAL PRODUCT MISUSE,2
MX,INTENTIONAL PRODUCT USE ISSUE,2
MX,INTRAOCULAR PRESSURE INCREASED,2
MX,IRRITABILITY,2
MX,JOINT SWELLING,2
MX,KETOACIDOSIS,2
MX,LACRIMATION INCREASED,2
MX,LOCAL SWELLING,2
MX,MALNUTRITION,2
MX,MOBILITY DECREASED,2
MX,MOVEMENT DISORDER,2
MX,MULTI-ORGAN FAILURE,2
MX,MUSCULOSKELETAL CHEST PAIN,2
MX,NASOPHARYNGITIS,2
MX,NECK PAIN,2
MX,NEOPLASM MALIGNANT,2
MX,NERVOUS SYSTEM DISORDER,2
MX,NEUTROPENIA,2
MX,NODAL RHYTHM,2
MX,NORMAL NEWBORN,2
MX,OLIGURIA,2
MX,OXYGEN CONSUMPTION INCREASED,2
MX,PARAESTHESIA ORAL,2
MX,PARALYSIS,2
MX,PARKINSON^S DISEASE,2
MX,PERIPHERAL VASCULAR DISORDER,2
MX,PHARYNGEAL ULCERATION,2
MX,PLEURAL EFFUSION,2
MX,POTENTIATING DRUG INTERACTION,2
MX,PREMATURE BABY,2
MX,PRESCRIBED UNDERDOSE,2
MX,PRODUCT AVAILABILITY ISSUE,2
MX,PROSTATIC DISORDER,2
MX,PRURITUS GENERALISED,2
MX,PULMONARY OEDEMA,2
MX,RASH GENERALISED,2
MX,RESPIRATORY DISTRESS,2
MX,RESTLESSNESS,2
MX,RIB FRACTURE,2
MX,SCAB,2
MX,SECOND PRIMARY MALIGNANCY,2
MX,SEIZURE,2
MX,SHOCK,2
MX,SKIN CANCER,2
MX,SKIN HAEMORRHAGE,2
MX,SKIN LESION,2
MX,SKIN ULCER,2
MX,SPINAL FRACTURE,2
MX,SPINAL PAIN,2
MX,STILLBIRTH,2
MX,SWELLING,2
MX,TACHYPNOEA,2
MX,THERAPY CESSATION,2
MX,THORACIC VERTEBRAL FRACTURE,2
MX,THROAT IRRITATION,2
MX,TINNITUS,2
MX,TONGUE DISCOMFORT,2
MX,TRANSIENT ISCHAEMIC ATTACK,2
MX,UNEVALUABLE EVENT,2
MX,VEIN DISORDER,2
MX,VERTIGO,2
MX,WOUND,2
MX,ABDOMINAL HERNIA,1
MX,ABDOMINAL INFECTION,1
MX,ABDOMINAL SEPSIS,1
MX,ABDOMINAL TENDERNESS,1
MX,ABORTION INDUCED,1
MX,ABORTION SPONTANEOUS,1
MX,ABORTION THREATENED,1
MX,ABSCESS,1
MX,ACTIVITIES OF DAILY LIVING IMPAIRED,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,ACUTE RESPIRATORY DISTRESS SYNDROME,1
MX,ACUTE RESPIRATORY FAILURE,1
MX,ADENOCARCINOMA PANCREAS,1
MX,AGITATION,1
MX,ALTERED STATE OF CONSCIOUSNESS,1
MX,ANAL FISSURE,1
MX,ANGINA PECTORIS,1
MX,ANGIOPATHY,1
MX,ANTIPHOSPHOLIPID SYNDROME,1
MX,APALLIC SYNDROME,1
MX,APHASIA,1
MX,APPARENT DEATH,1
MX,APPLICATION SITE IRRITATION,1
MX,APPLICATION SITE PAIN,1
MX,ARACHNOID CYST,1
MX,ARTERIAL OCCLUSIVE DISEASE,1
MX,ARTHROPOD BITE,1
MX,ASPIRATION BRONCHIAL,1
MX,ASTHENOPIA,1
MX,ASTHMA,1
MX,ATELECTASIS,1
MX,ATRIAL FIBRILLATION,1
MX,ATRIAL PRESSURE INCREASED,1
MX,BACTERAEMIA,1
MX,BALANCE DISORDER,1
MX,BANDAEMIA,1
MX,BENIGN NEOPLASM OF PROSTATE,1
MX,BENIGN PROSTATIC HYPERPLASIA,1
MX,BILIRUBIN CONJUGATED INCREASED,1
MX,BLADDER CANCER,1
MX,BLADDER PROLAPSE,1
MX,BLIGHTED OVUM,1
MX,BLINDNESS TRANSIENT,1
MX,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MX,BLOOD BILIRUBIN INCREASED,1
MX,BLOOD CHOLESTEROL ABNORMAL,1
MX,BLOOD DISORDER,1
MX,BLOOD GROWTH HORMONE INCREASED,1
MX,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MX,BLOOD POTASSIUM INCREASED,1
MX,BLOOD URIC ACID INCREASED,1
MX,BONE DECALCIFICATION,1
MX,BONE EROSION,1
MX,BRADYCARDIA,1
MX,BRADYKINESIA,1
MX,BRAIN HYPOXIA,1
MX,BRAIN NEOPLASM,1
MX,BREAST CANCER,1
MX,BRONCHIAL DISORDER,1
MX,C-REACTIVE PROTEIN DECREASED,1
MX,CARDIAC FAILURE,1
MX,CARDIAC HYPERTROPHY,1
MX,CARDIAC MURMUR,1
MX,CARDIOMYOPATHY,1
MX,CARPAL TUNNEL SYNDROME,1
MX,CARTILAGE INJURY,1
MX,CELLULITIS,1
MX,CEREBRAL HAEMORRHAGE,1
MX,CERVIX CARCINOMA,1
MX,CERVIX CARCINOMA STAGE II,1
MX,CHIKUNGUNYA VIRUS INFECTION,1
MX,CHILLS,1
MX,CHOKING,1
MX,CHOLECYSTITIS,1
MX,CHOLECYSTITIS INFECTIVE,1
MX,CLUSTER HEADACHE,1
MX,COAGULATION TIME PROLONGED,1
MX,COLITIS ULCERATIVE,1
MX,CONGESTIVE CARDIOMYOPATHY,1
MX,CONTRAINDICATED PRODUCT ADMINISTERED,1
MX,COORDINATION ABNORMAL,1
MX,CORONARY ARTERY OCCLUSION,1
MX,CRYPTOGENIC CIRRHOSIS,1
MX,CYANOPSIA,1
MX,CYANOSIS,1
MX,DECREASED INTEREST,1
MX,DEMENTIA,1
MX,DEMYELINATION,1
MX,DERMATITIS CONTACT,1
MX,DEVICE RELATED INFECTION,1
MX,DIABETIC FOOT,1
MX,DIABETIC KETOACIDOSIS,1
MX,DIABETIC RETINOPATHY,1
MX,DIALYSIS,1
MX,DIPLEGIA,1
MX,DISABILITY,1
MX,DISSEMINATED TUBERCULOSIS,1
MX,DISTRACTIBILITY,1
MX,DISTURBANCE IN ATTENTION,1
MX,DROOLING,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG DEPENDENCE,1
MX,DRUG EFFECT DECREASED,1
MX,DRUG EFFECT INCOMPLETE,1
MX,DRUG HYPERSENSITIVITY,1
MX,DRUG INTOLERANCE,1
MX,DRUG LEVEL DECREASED,1
MX,DUST ALLERGY,1
MX,DYSPEPSIA,1
MX,DYSPHAGIA,1
MX,DYSPHEMIA,1
MX,DYSSTASIA,1
MX,EAR DISORDER,1
MX,EARLY SATIETY,1
MX,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
MX,EATING DISORDER,1
MX,EJACULATION FAILURE,1
MX,EMPHYSEMA,1
MX,ENDOMETRIAL CANCER STAGE IV,1
MX,ENDOMETRIOSIS,1
MX,ERECTILE DYSFUNCTION,1
MX,ERECTION INCREASED,1
MX,ESCHERICHIA URINARY TRACT INFECTION,1
MX,EXPIRED DRUG ADMINISTERED,1
MX,EXPOSURE DURING BREAST FEEDING,1
MX,EXPOSURE DURING PREGNANCY,1
MX,EYE DISCHARGE,1
MX,EYE DISORDER,1
MX,EYE INFLAMMATION,1
MX,EYELID BLEEDING,1
MX,EYELID DISORDER,1
MX,FACE INJURY,1
MX,FEEDING DISORDER,1
MX,FEELING DRUNK,1
MX,FIBROSIS,1
MX,FIBULA FRACTURE,1
MX,FLANK PAIN,1
MX,FOETAL MALPOSITION,1
MX,FOOD ALLERGY,1
MX,FRACTURE,1
MX,FUMBLING,1
MX,FUNCTIONAL GASTROINTESTINAL DISORDER,1
MX,GALLBLADDER POLYP,1
MX,GASTRIC DISORDER,1
MX,GASTRIC HAEMORRHAGE,1
MX,GASTRITIS EROSIVE,1
MX,GASTROENTERITIS,1
MX,GASTROENTERITIS EOSINOPHILIC,1
MX,GASTROENTERITIS VIRAL,1
MX,GASTROINTESTINAL OBSTRUCTION,1
MX,GASTROINTESTINAL ULCER HAEMORRHAGE,1
MX,GENERALISED ERYTHEMA,1
MX,GESTATIONAL DIABETES,1
MX,GINGIVAL BLEEDING,1
MX,GINGIVAL ULCERATION,1
MX,GLOMERULAR FILTRATION RATE DECREASED,1
MX,GLOSSITIS,1
MX,GLOSSODYNIA,1
MX,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
MX,GRAND MAL CONVULSION,1
MX,GYNAECOMASTIA,1
MX,HAEMATOTOXICITY,1
MX,HAEMOGLOBIN INCREASED,1
MX,HAEMOPTYSIS,1
MX,HAEMORRHAGIC STROKE,1
MX,HAEMORRHOIDAL HAEMORRHAGE,1
MX,HAEMORRHOIDS,1
MX,HANGOVER,1
MX,HEAD INJURY,1
MX,HEARING IMPAIRED,1
MX,HELICOBACTER GASTRITIS,1
MX,HEMIPARESIS,1
MX,HEPATIC CANCER,1
MX,HEPATIC FAILURE,1
MX,HERNIA PAIN,1
MX,HERNIA REPAIR,1
MX,HIGH DENSITY LIPOPROTEIN INCREASED,1
MX,HIP DEFORMITY,1
MX,HIRSUTISM,1
MX,HORDEOLUM,1
MX,HORMONE-REFRACTORY PROSTATE CANCER,1
MX,HOT FLUSH,1
MX,HYDROMETRA,1
MX,HYPERAEMIA,1
MX,HYPEROSMOLAR STATE,1
MX,HYPERTENSIVE EMERGENCY,1
MX,HYPERVENTILATION,1
MX,HYPERVOLAEMIA,1
MX,HYPOACUSIS,1
MX,HYPOAESTHESIA ORAL,1
MX,HYPOTHERMIA,1
MX,HYPOTONIA,1
MX,IDIOSYNCRATIC DRUG REACTION,1
MX,IIIRD NERVE PARALYSIS,1
MX,ILEUS,1
MX,ILEUS PARALYTIC,1
MX,IMMUNODEFICIENCY,1
MX,INCOHERENT,1
MX,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
MX,INFECTION,1
MX,INJECTION SITE HAEMATOMA,1
MX,INJURY,1
MX,INTERSTITIAL LUNG DISEASE,1
MX,INTERVERTEBRAL DISCITIS,1
MX,INTESTINAL DILATATION,1
MX,INTESTINAL OBSTRUCTION,1
MX,INTRA-ABDOMINAL FLUID COLLECTION,1
MX,INTRACARDIAC THROMBUS,1
MX,INTRAOCULAR PRESSURE DECREASED,1
MX,JOINT STIFFNESS,1
MX,LACUNAR INFARCTION,1
MX,LARYNGITIS,1
MX,LETHARGY,1
MX,LEUKOCYTOSIS,1
MX,LIGAMENT RUPTURE,1
MX,LIP DRY,1
MX,LIQUID PRODUCT PHYSICAL ISSUE,1
MX,LIVE BIRTH,1
MX,LIVER DISORDER,1
MX,LOBAR PNEUMONIA,1
MX,LOCALISED OEDEMA,1
MX,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
MX,LOWER RESPIRATORY TRACT INFECTION,1
MX,LUMBAR VERTEBRAL FRACTURE,1
MX,LUNG DISORDER,1
MX,LUNG INFECTION,1
MX,LYMPHADENOPATHY,1
MX,LYMPHADENOPATHY MEDIASTINAL,1
MX,LYMPHANGITIS,1
MX,MACROCORNEA,1
MX,MASS,1
MX,MASTICATION DISORDER,1
MX,MEDICATION ERROR,1
MX,MENINGITIS,1
MX,MENOPAUSE,1
MX,MENTAL DISORDER,1
MX,MENTAL IMPAIRMENT,1
MX,METABOLIC DISORDER,1
MX,METASTASES TO BONE,1
MX,METASTASES TO CENTRAL NERVOUS SYSTEM,1
MX,METASTASES TO LUNG,1
MX,METASTASES TO SPLEEN,1
MX,METASTASIS,1
MX,MICTURITION DISORDER,1
MX,MICTURITION URGENCY,1
MX,MITRAL VALVE DISEASE,1
MX,MOOD SWINGS,1
MX,MUSCULOSKELETAL STIFFNESS,1
MX,MUTISM,1
MX,MYALGIA,1
MX,MYELITIS,1
MX,MYOCARDIAL ISCHAEMIA,1
MX,NAIL DISORDER,1
MX,NASAL DISCHARGE DISCOLOURATION,1
MX,NASAL MUCOSAL DISORDER,1
MX,NECK MASS,1
MX,NECROSIS,1
MX,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
MX,NEOPLASM SKIN,1
MX,NEPHRITIS,1
MX,NEPHROTIC SYNDROME,1
MX,NERVE COMPRESSION,1
MX,NEURALGIA,1
MX,NEUROLOGICAL DECOMPENSATION,1
MX,NEUROMA,1
MX,NEUROTOXICITY,1
MX,NEUTROPHILIA,1
MX,NIGHTMARE,1
MX,NON-INFECTIOUS ENDOPHTHALMITIS,1
MX,OCULAR DISCOMFORT,1
MX,OCULAR HYPERAEMIA,1
MX,OEDEMA,1
MX,ONCOLOGIC COMPLICATION,1
MX,ONYCHOCLASIS,1
MX,ONYCHOMADESIS,1
MX,OPHTHALMOPLEGIA,1
MX,ORAL DISCOMFORT,1
MX,ORAL DISORDER,1
MX,ORAL PAIN,1
MX,OSTEOARTHRITIS,1
MX,OVERDOSE,1
MX,OVERWEIGHT,1
MX,PAIN OF SKIN,1
MX,PALPITATIONS,1
MX,PANCREATIC CARCINOMA,1
MX,PANCREATIC NEOPLASM,1
MX,PANCREATITIS,1
MX,PAPILLARY THYROID CANCER,1
MX,PATELLA FRACTURE,1
MX,PELVIC INFLAMMATORY DISEASE,1
MX,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
MX,PERIPHERAL COLDNESS,1
MX,PERSONALITY DISORDER,1
MX,PETECHIAE,1
MX,PETIT MAL EPILEPSY,1
MX,PHARYNGEAL DISORDER,1
MX,PHARYNGEAL MASS,1
MX,PHARYNGOTONSILLITIS,1
MX,PHOTOPHOBIA,1
MX,PHOTOPSIA,1
MX,PITUITARY TUMOUR BENIGN,1
MX,PLATELET COUNT ABNORMAL,1
MX,PNEUMONIA VIRAL,1
MX,PNEUMONITIS,1
MX,POLLAKIURIA,1
MX,POLYURIA,1
MX,PORTAL HYPERTENSION,1
MX,POSTOPERATIVE WOUND INFECTION,1
MX,PRE-ECLAMPSIA,1
MX,PREMATURE DELIVERY,1
MX,PREMATURE LABOUR,1
MX,PREMATURE RUPTURE OF MEMBRANES,1
MX,PRESCRIBED OVERDOSE,1
MX,PROCALCITONIN DECREASED,1
MX,PRODUCT SUBSTITUTION ISSUE,1
MX,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
MX,PROSTATE CANCER,1
MX,PROSTATECTOMY,1
MX,PROSTATOMEGALY,1
MX,PROTEINURIA,1
MX,PROTHROMBIN LEVEL INCREASED,1
MX,PSORIASIS,1
MX,PSYCHOTIC BEHAVIOUR,1
MX,PULMONARY CONGESTION,1
MX,PULMONARY CONTUSION,1
MX,PULMONARY EMBOLISM,1
MX,PULMONARY GRANULOMA,1
MX,PULMONARY MASS,1
MX,PULMONARY THROMBOSIS,1
MX,PULMONARY TUBERCULOSIS,1
MX,PURULENT DISCHARGE,1
MX,PYELONEPHRITIS,1
MX,PYURIA,1
MX,RADIATION SKIN INJURY,1
MX,RASH VESICULAR,1
MX,RECTAL HAEMORRHAGE,1
MX,RENAL FAILURE ACUTE,1
MX,RENAL FAILURE CHRONIC,1
MX,RENAL PAIN,1
MX,RENAL TUBULAR NECROSIS,1
MX,REPETITIVE SPEECH,1
MX,RESPIRATORY ACIDOSIS,1
MX,RESPIRATORY DISORDER,1
MX,RESPIRATORY RATE DECREASED,1
MX,RETINAL DETACHMENT,1
MX,RETINAL VASCULAR OCCLUSION,1
MX,RHEUMATOID ARTHRITIS,1
MX,RHINORRHOEA,1
MX,RIGHT VENTRICULAR FAILURE,1
MX,SALMONELLOSIS,1
MX,SCHIZOPHRENIA,1
MX,SCRATCH,1
MX,SCREAMING,1
MX,SELECTIVE MUTISM,1
MX,SENSATION OF FOREIGN BODY,1
MX,SHOCK HYPOGLYCAEMIC,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SINUSITIS,1
MX,SKIN DISORDER,1
MX,SKIN EXFOLIATION,1
MX,SKIN INJURY,1
MX,SKIN STRIAE,1
MX,SOFT TISSUE INFECTION,1
MX,SPINAL COLUMN INJURY,1
MX,SPINAL DEFORMITY,1
MX,SQUAMOUS CELL CARCINOMA,1
MX,STAB WOUND,1
MX,STAPHYLOCOCCUS TEST POSITIVE,1
MX,STUPOR,1
MX,SUDDEN DEATH,1
MX,SUSPECTED COUNTERFEIT PRODUCT,1
MX,TACITURNITY,1
MX,TESTICULAR PAIN,1
MX,THERAPEUTIC RESPONSE UNEXPECTED,1
MX,THIRST,1
MX,THROAT TIGHTNESS,1
MX,THROMBOSIS IN DEVICE,1
MX,THYROID DISORDER,1
MX,TOE AMPUTATION,1
MX,TONGUE PARALYSIS,1
MX,TONGUE ULCERATION,1
MX,TONIC CLONIC MOVEMENTS,1
MX,TOOTH EXTRACTION,1
MX,TOOTH LOSS,1
MX,TRANSAMINASES INCREASED,1
MX,TRANSFUSION,1
MX,TRANSPLANT REJECTION,1
MX,TUBERCULOSIS,1
MX,TUMOUR LYSIS SYNDROME,1
MX,TWIN PREGNANCY,1
MX,TYPE 2 DIABETES MELLITUS,1
MX,TYPHOID FEVER,1
MX,ULCER,1
MX,ULCERATIVE KERATITIS,1
MX,ULTRASOUND ABDOMEN ABNORMAL,1
MX,UMBILICAL HERNIA,1
MX,UNDERDOSE,1
MX,UNRESPONSIVE TO STIMULI,1
MX,URINARY INCONTINENCE,1
MX,URINE KETONE BODY,1
MX,UROSEPSIS,1
MX,UTERINE CERVIX ULCER,1
MX,UTERINE HAEMORRHAGE,1
MX,UTERINE INFLAMMATION,1
MX,UTERINE MALPOSITION,1
MX,VAGINAL HAEMORRHAGE,1
MX,VANISHING TWIN SYNDROME,1
MX,VARICES OESOPHAGEAL,1
MX,VARICOCELE,1
MX,VARICOSE VEIN,1
MX,VASCULAR PAIN,1
MX,VASCULAR RUPTURE,1
MX,VASODILATATION,1
MX,VENOUS THROMBOSIS,1
MX,VITREOUS FLOATERS,1
MX,VITREOUS HAEMORRHAGE,1
MX,WALKING DISABILITY,1
MX,WEIGHT ABNORMAL,1
MX,WHEEZING,1
MX,WOUND COMPLICATION,1
MX,WOUND NECROSIS,1
MX,WRIST FRACTURE,1
MX,WRONG DRUG ADMINISTERED,1
MX,YELLOW SKIN,1
MA,TOXIC SKIN ERUPTION,6
MA,DRUG ERUPTION,5
MA,PSORIASIS,5
MA,DERMATITIS PSORIASIFORM,4
MA,AGITATION,1
MA,COGNITIVE DISORDER,1
MA,DELIRIUM,1
MA,GASTROENTERITIS VIRAL,1
MA,HYPOGLYCAEMIA,1
MA,MACULE,1
MA,PAPULE,1
MA,SKIN LESION,1
MA,SLEEP DISORDER,1
NP,IRRITABLE BOWEL SYNDROME,1
NP,LIP SWELLING,1
NP,SWOLLEN TONGUE,1
NP,VOMITING,1
NL,TOXICITY TO VARIOUS AGENTS,61
NL,LACTIC ACIDOSIS,58
NL,DIARRHOEA,30
NL,DEATH,27
NL,SEPSIS,27
NL,NAUSEA,25
NL,ACUTE KIDNEY INJURY,24
NL,METABOLIC ACIDOSIS,23
NL,DYSPNOEA,22
NL,FALL,21
NL,DEHYDRATION,20
NL,MALAISE,20
NL,FATIGUE,19
NL,RENAL IMPAIRMENT,19
NL,SHOCK,18
NL,PYREXIA,17
NL,PNEUMONIA,16
NL,THROMBOCYTOPENIA,16
NL,HYPOGLYCAEMIA,15
NL,VOMITING,15
NL,PANCYTOPENIA,14
NL,SUICIDE ATTEMPT,14
NL,DIZZINESS,13
NL,DRUG LEVEL INCREASED,13
NL,INTENTIONAL OVERDOSE,13
NL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
NL,HYPOMAGNESAEMIA,12
NL,MUCOSAL INFLAMMATION,11
NL,RENAL TUBULAR NECROSIS,11
NL,WEIGHT DECREASED,11
NL,ABDOMINAL PAIN,10
NL,HYPONATRAEMIA,10
NL,HYPOTENSION,10
NL,RHABDOMYOLYSIS,10
NL,STOMATITIS,10
NL,CARDIAC FAILURE,9
NL,CONSTIPATION,9
NL,DECREASED APPETITE,9
NL,HYPERGLYCAEMIA,9
NL,HYPOCALCAEMIA,9
NL,OEDEMA,9
NL,PANCREATITIS,9
NL,RENAL FAILURE,9
NL,ARTHRALGIA,8
NL,BLOOD GLUCOSE INCREASED,8
NL,OVERDOSE,8
NL,URINARY TRACT INFECTION,8
NL,BACK PAIN,7
NL,CHEST PAIN,7
NL,DELIRIUM,7
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,7
NL,HYPERTENSION,7
NL,INTERNATIONAL NORMALISED RATIO INCREASED,7
NL,LOSS OF CONSCIOUSNESS,7
NL,MYOCARDIAL INFARCTION,7
NL,PAIN,7
NL,POTENTIATING DRUG INTERACTION,7
NL,RENAL FAILURE ACUTE,7
NL,SYNCOPE,7
NL,ANGIOEDEMA,6
NL,ASCITES,6
NL,ASTHENIA,6
NL,BILE DUCT STENOSIS,6
NL,BLOOD LACTIC ACID INCREASED,6
NL,CIRCULATORY COLLAPSE,6
NL,GASTROINTESTINAL TOXICITY,6
NL,HEADACHE,6
NL,HYPERHIDROSIS,6
NL,INFECTION,6
NL,MUSCULAR WEAKNESS,6
NL,OESOPHAGEAL OBSTRUCTION,6
NL,PAIN IN EXTREMITY,6
NL,PRODUCT USE ISSUE,6
NL,RASH,6
NL,RESPIRATORY FAILURE,6
NL,WEIGHT INCREASED,6
NL,ABASIA,5
NL,BLOOD PH DECREASED,5
NL,DISEASE PROGRESSION,5
NL,DRUG INEFFECTIVE,5
NL,FEBRILE NEUTROPENIA,5
NL,HAEMODYNAMIC INSTABILITY,5
NL,HOT FLUSH,5
NL,HYPERKALAEMIA,5
NL,LIVER DISORDER,5
NL,MEMORY IMPAIRMENT,5
NL,MYALGIA,5
NL,PRURITUS,5
NL,PULMONARY EMBOLISM,5
NL,SOMNOLENCE,5
NL,SWOLLEN TONGUE,5
NL,URINARY RETENTION,5
NL,ABDOMINAL PAIN UPPER,4
NL,APHASIA,4
NL,ARRHYTHMIA,4
NL,ARTHROPATHY,4
NL,BALANCE DISORDER,4
NL,BRADYCARDIA,4
NL,CEREBROVASCULAR ACCIDENT,4
NL,CONDITION AGGRAVATED,4
NL,DIARRHOEA HAEMORRHAGIC,4
NL,FEELING COLD,4
NL,GASTROINTESTINAL HAEMORRHAGE,4
NL,GENERAL PHYSICAL HEALTH DETERIORATION,4
NL,HAEMORRHAGE,4
NL,HEPATIC STEATOSIS,4
NL,HYPOKALAEMIA,4
NL,HYPOPHOSPHATAEMIA,4
NL,MOBILITY DECREASED,4
NL,MUSCLE SPASMS,4
NL,MUSCULOSKELETAL PAIN,4
NL,OEDEMA PERIPHERAL,4
NL,PARAESTHESIA,4
NL,PROSTATE CANCER METASTATIC,4
NL,RESPIRATORY DEPRESSION,4
NL,TERMINAL STATE,4
NL,TREMOR,4
NL,ABDOMINAL DISCOMFORT,3
NL,ABNORMAL FAECES,3
NL,ACIDOSIS,3
NL,ACUTE MYOCARDIAL INFARCTION,3
NL,ADVERSE DRUG REACTION,3
NL,ANAEMIA,3
NL,ANGINA PECTORIS,3
NL,ATRIAL FIBRILLATION,3
NL,BACTERIAL INFECTION,3
NL,BLOOD CREATININE INCREASED,3
NL,CARDIAC ASTHMA,3
NL,CARDIAC DISORDER,3
NL,CARDIOGENIC SHOCK,3
NL,CEREBRAL HAEMORRHAGE,3
NL,CEREBRAL INFARCTION,3
NL,CHEST DISCOMFORT,3
NL,CHOLESTASIS,3
NL,COGNITIVE DISORDER,3
NL,CONFUSIONAL STATE,3
NL,CRYING,3
NL,CYSTITIS NONINFECTIVE,3
NL,DIABETES MELLITUS,3
NL,DIABETIC KETOACIDOSIS,3
NL,DISTURBANCE IN ATTENTION,3
NL,DRUG-DISEASE INTERACTION,3
NL,DRY MOUTH,3
NL,DYSKINESIA,3
NL,ERYTHEMA,3
NL,FEELING ABNORMAL,3
NL,GAIT DISTURBANCE,3
NL,GESTATIONAL HYPERTENSION,3
NL,HAEMATEMESIS,3
NL,HAEMATOCHEZIA,3
NL,HEPATITIS,3
NL,HYPERBILIRUBINAEMIA,3
NL,HYPERNATRAEMIA,3
NL,HYPERSOMNIA,3
NL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
NL,INJECTION SITE PRURITUS,3
NL,LUNG DISORDER,3
NL,MALIGNANT NEOPLASM PROGRESSION,3
NL,METASTASES TO BONE,3
NL,METASTASIS,3
NL,MOOD SWINGS,3
NL,MULTI-ORGAN FAILURE,3
NL,MUSCULOSKELETAL STIFFNESS,3
NL,NORMAL NEWBORN,3
NL,PANCREATIC CARCINOMA,3
NL,PLEURAL EFFUSION,3
NL,PREGNANCY,3
NL,PROSTATE CANCER,3
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
NL,RESPIRATORY ACIDOSIS,3
NL,RESPIRATORY TRACT INFECTION,3
NL,SENSORY DISTURBANCE,3
NL,SEPTIC SHOCK,3
NL,SKIN EXFOLIATION,3
NL,SPINAL FRACTURE,3
NL,SUICIDAL IDEATION,3
NL,TACHYPNOEA,3
NL,THINKING ABNORMAL,3
NL,VENTRICULAR FIBRILLATION,3
NL,ACCIDENTAL OVERDOSE,2
NL,ACUTE CORONARY SYNDROME,2
NL,ACUTE PRERENAL FAILURE,2
NL,ALANINE AMINOTRANSFERASE INCREASED,2
NL,ANGIOPATHY,2
NL,ANORECTAL DISCOMFORT,2
NL,ARTERIAL OCCLUSIVE DISEASE,2
NL,ARTHRITIS,2
NL,ASPARTATE AMINOTRANSFERASE INCREASED,2
NL,ASPIRATION,2
NL,BEDRIDDEN,2
NL,BLADDER CANCER,2
NL,BLOOD PRESSURE INCREASED,2
NL,BLOOD TEST ABNORMAL,2
NL,BREAST CANCER,2
NL,BREAST CANCER METASTATIC,2
NL,BREAST PAIN,2
NL,CACHEXIA,2
NL,CALCULUS BLADDER,2
NL,CARDIAC SEPTAL HYPERTROPHY,2
NL,CATARACT,2
NL,COAGULATION TEST ABNORMAL,2
NL,COLITIS,2
NL,COLON CANCER,2
NL,CONCOMITANT DISEASE PROGRESSION,2
NL,CYSTITIS,2
NL,DERMATITIS EXFOLIATIVE,2
NL,DEVICE RELATED SEPSIS,2
NL,DISCOMFORT,2
NL,DYSGEUSIA,2
NL,DYSPHAGIA,2
NL,DYSURIA,2
NL,ELECTROCARDIOGRAM QT PROLONGED,2
NL,ENCEPHALOPATHY,2
NL,ENTEROCOLITIS,2
NL,EPILEPSY,2
NL,EPISTAXIS,2
NL,ERYSIPELAS,2
NL,ERYTHEMA NODOSUM,2
NL,FLATULENCE,2
NL,FLUID RETENTION,2
NL,FOETAL EXPOSURE DURING PREGNANCY,2
NL,FOOT FRACTURE,2
NL,GASTROINTESTINAL DISORDER,2
NL,GASTROOESOPHAGEAL REFLUX DISEASE,2
NL,HAEMOGLOBIN DECREASED,2
NL,HEMIPARESIS,2
NL,HEPATIC ENZYME INCREASED,2
NL,HEPATIC FAILURE,2
NL,HEPATOTOXICITY,2
NL,HYPERCHOLESTEROLAEMIA,2
NL,HYPERVENTILATION,2
NL,HYPOVOLAEMIA,2
NL,HYPOVOLAEMIC SHOCK,2
NL,ILEUS,2
NL,INCONTINENCE,2
NL,INCORRECT PRODUCT STORAGE,2
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
NL,INFLAMMATION,2
NL,INFLUENZA,2
NL,INFUSION RELATED REACTION,2
NL,INJECTION SITE ERYTHEMA,2
NL,INJECTION SITE REACTION,2
NL,INTENTIONAL PRODUCT MISUSE,2
NL,INTERNATIONAL NORMALISED RATIO DECREASED,2
NL,KETOACIDOSIS,2
NL,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,2
NL,LEFT VENTRICULAR FAILURE,2
NL,LIVER ABSCESS,2
NL,LIVER FUNCTION TEST ABNORMAL,2
NL,LUNG NEOPLASM MALIGNANT,2
NL,MELAENA,2
NL,METABOLIC DISORDER,2
NL,MUSCLE RIGIDITY,2
NL,NECK PAIN,2
NL,NEUTROPENIA,2
NL,NIGHT SWEATS,2
NL,OESOPHAGEAL CANDIDIASIS,2
NL,OESOPHAGEAL PAIN,2
NL,ON AND OFF PHENOMENON,2
NL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
NL,PARKINSON^S DISEASE,2
NL,PERIPHERAL SWELLING,2
NL,PERIPHERAL VASCULAR DISORDER,2
NL,PHARYNGEAL OEDEMA,2
NL,POLYNEUROPATHY,2
NL,PRODUCT QUALITY ISSUE,2
NL,PSYCHOTIC DISORDER,2
NL,SECOND PRIMARY MALIGNANCY,2
NL,SINUS ARREST,2
NL,SINUS BRADYCARDIA,2
NL,SLUGGISHNESS,2
NL,STAPHYLOCOCCAL SEPSIS,2
NL,SUPRAVENTRICULAR TACHYCARDIA,2
NL,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
NL,TRANSIENT ISCHAEMIC ATTACK,2
NL,TREATMENT FAILURE,2
NL,TUMOUR FLARE,2
NL,TYPE 2 DIABETES MELLITUS,2
NL,URINARY INCONTINENCE,2
NL,ABDOMINAL DISTENSION,1
NL,ABDOMINAL PAIN LOWER,1
NL,ABDOMINAL SYMPTOM,1
NL,ABDOMINAL TENDERNESS,1
NL,ABDOMINAL WALL HAEMORRHAGE,1
NL,ABNORMAL BEHAVIOUR,1
NL,ABNORMAL DREAMS,1
NL,ABORTION SPONTANEOUS,1
NL,ABSCESS,1
NL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NL,ADENOCARCINOMA,1
NL,ADENOCARCINOMA OF COLON,1
NL,ADRENAL INSUFFICIENCY,1
NL,ALCOHOL ABUSE,1
NL,ALOPECIA,1
NL,ALTERED STATE OF CONSCIOUSNESS,1
NL,ALVEOLITIS ALLERGIC,1
NL,AMYOTROPHIC LATERAL SCLEROSIS,1
NL,ANAL ATRESIA,1
NL,ANAL INFLAMMATION,1
NL,ANAPHYLACTIC SHOCK,1
NL,ANGINA UNSTABLE,1
NL,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT,1
NL,ANION GAP INCREASED,1
NL,AORTO-DUODENAL FISTULA,1
NL,APATHY,1
NL,ARTERECTOMY,1
NL,ARTERIOSCLEROSIS CORONARY ARTERY,1
NL,ARTERIOSPASM CORONARY,1
NL,ARTHRITIS BACTERIAL,1
NL,ASTIGMATISM,1
NL,ATRIOVENTRICULAR BLOCK,1
NL,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
NL,AZOTAEMIA,1
NL,BACTERAEMIA,1
NL,BACTERIAL PYELONEPHRITIS,1
NL,BLADDER NEOPLASM,1
NL,BLOOD ANTIDIURETIC HORMONE INCREASED,1
NL,BLOOD CHOLESTEROL INCREASED,1
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NL,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
NL,BLOOD GLUCOSE DECREASED,1
NL,BLOOD GLUCOSE FLUCTUATION,1
NL,BLOOD INSULIN INCREASED,1
NL,BLOOD POTASSIUM DECREASED,1
NL,BLOOD PRESSURE DIASTOLIC INCREASED,1
NL,BLOOD PRESSURE SYSTOLIC INCREASED,1
NL,BLOOD UREA INCREASED,1
NL,BODY TEMPERATURE INCREASED,1
NL,BONE DISORDER,1
NL,BONE MARROW FAILURE,1
NL,BONE PAIN,1
NL,BRADYKINESIA,1
NL,BRADYPHRENIA,1
NL,BRAIN HERNIATION,1
NL,BREATH ODOUR,1
NL,BRONCHIECTASIS,1
NL,BRONCHOSPASM,1
NL,CANCER SURGERY,1
NL,CANDIDA INFECTION,1
NL,CARDIAC ARREST,1
NL,CARDIAC VALVE DISEASE,1
NL,CARDIOMYOPATHY,1
NL,CARDIOPULMONARY FAILURE,1
NL,CAROTID ARTERY STENOSIS,1
NL,CARPAL TUNNEL SYNDROME,1
NL,CATARACT OPERATION,1
NL,CELLULITIS,1
NL,CEREBELLAR ISCHAEMIA,1
NL,CHANGE OF BOWEL HABIT,1
NL,CHEST INJURY,1
NL,CHILLS,1
NL,CHOLECYSTITIS,1
NL,CHOLELITHIASIS,1
NL,CHROMATURIA,1
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NL,CLEAR CELL RENAL CELL CARCINOMA,1
NL,COLD SWEAT,1
NL,COLITIS MICROSCOPIC,1
NL,COLON ADENOMA,1
NL,COMA,1
NL,COMPLETED SUICIDE,1
NL,CONCUSSION,1
NL,CONTINUOUS HAEMODIAFILTRATION,1
NL,CONTUSION,1
NL,COORDINATION ABNORMAL,1
NL,CORONARY ARTERY OCCLUSION,1
NL,CORONARY ARTERY STENOSIS,1
NL,COUGH,1
NL,CREATININE RENAL CLEARANCE DECREASED,1
NL,CRITICAL ILLNESS,1
NL,CYTOMEGALOVIRUS INFECTION,1
NL,DEEP VEIN THROMBOSIS,1
NL,DEMENTIA ALZHEIMER^S TYPE,1
NL,DEMYELINATION,1
NL,DEPRESSION,1
NL,DEVICE FAILURE,1
NL,DEVICE INTOLERANCE,1
NL,DIABETIC FOOT,1
NL,DIABETIC NEUROPATHY,1
NL,DIVERTICULUM,1
NL,DIVERTICULUM INTESTINAL,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG DISPENSING ERROR,1
NL,DRUG EFFECT INCOMPLETE,1
NL,DRUG ERUPTION,1
NL,DRUG LEVEL ABOVE THERAPEUTIC,1
NL,DRY EYE,1
NL,DUPUYTREN^S CONTRACTURE,1
NL,DYSSTASIA,1
NL,ELECTROCARDIOGRAM U WAVE PRESENT,1
NL,EMBOLISM,1
NL,EMOTIONAL DISORDER,1
NL,EMOTIONAL DISTRESS,1
NL,ENCEPHALITIS,1
NL,ENDOMETRIAL CANCER,1
NL,EOSINOPHILIA,1
NL,ESCHERICHIA BACTERAEMIA,1
NL,ESSENTIAL THROMBOCYTHAEMIA,1
NL,EXPOSURE DURING PREGNANCY,1
NL,EYE HAEMORRHAGE,1
NL,EYE OPERATION,1
NL,FACIAL BONES FRACTURE,1
NL,FACIAL PARESIS,1
NL,FAECAL INCONTINENCE,1
NL,FAECES SOFT,1
NL,FEMUR FRACTURE,1
NL,FLUID INTAKE REDUCED,1
NL,FLUSHING,1
NL,FOETAL DEATH,1
NL,FOOT DEFORMITY,1
NL,FRACTURE DELAYED UNION,1
NL,FREEZING PHENOMENON,1
NL,GALLBLADDER DISORDER,1
NL,GALLBLADDER POLYP,1
NL,GASTRIC CANCER,1
NL,GASTRIC DILATATION,1
NL,GASTRIC DISORDER,1
NL,GASTRIC HAEMORRHAGE,1
NL,GASTRIC ULCER,1
NL,GASTROENTERITIS,1
NL,GASTROINTESTINAL ANGIODYSPLASIA,1
NL,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
NL,GRAND MAL CONVULSION,1
NL,GRANULOMATOUS LYMPHADENITIS,1
NL,GROIN PAIN,1
NL,GYNAECOMASTIA,1
NL,HAEMATOMA,1
NL,HAEMATURIA,1
NL,HAEMODIALYSIS,1
NL,HAEMOLYTIC ANAEMIA,1
NL,HAEMORRHAGIC STROKE,1
NL,HEMIANOPIA HOMONYMOUS,1
NL,HEPATIC CANCER,1
NL,HEPATIC CIRRHOSIS,1
NL,HEPATIC FIBROSIS,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HEPATITIS TOXIC,1
NL,HEPATORENAL SYNDROME,1
NL,HERPES VIRUS INFECTION,1
NL,HERPES ZOSTER,1
NL,HIP FRACTURE,1
NL,HORMONE-REFRACTORY PROSTATE CANCER,1
NL,HOSPITALISATION,1
NL,HYPERKINESIA,1
NL,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
NL,HYPERSENSITIVITY,1
NL,HYPERTHYROIDISM,1
NL,HYPOAESTHESIA,1
NL,HYPOPHAGIA,1
NL,HYPOPHYSITIS,1
NL,HYPOVENTILATION,1
NL,IMPAIRED DRIVING ABILITY,1
NL,IMPAIRED HEALING,1
NL,IMPAIRED SELF-CARE,1
NL,IMPLANTABLE DEFIBRILLATOR INSERTION,1
NL,INCREASED APPETITE,1
NL,INFARCTION,1
NL,INGUINAL HERNIA,1
NL,INGUINAL MASS,1
NL,INJECTED LIMB MOBILITY DECREASED,1
NL,INJECTION SITE HAEMORRHAGE,1
NL,INJECTION SITE INDURATION,1
NL,INJECTION SITE MASS,1
NL,INJECTION SITE PAIN,1
NL,INJECTION SITE WARMTH,1
NL,INNER EAR DISORDER,1
NL,INSOMNIA,1
NL,INTERMITTENT CLAUDICATION,1
NL,INTERSTITIAL LUNG DISEASE,1
NL,INTESTINAL ANGIOEDEMA,1
NL,INTESTINAL ISCHAEMIA,1
NL,INTESTINAL OPERATION,1
NL,INTESTINAL PERFORATION,1
NL,INTESTINAL POLYP,1
NL,ISCHAEMIC STROKE,1
NL,JAUNDICE,1
NL,KNEE ARTHROPLASTY,1
NL,KUSSMAUL RESPIRATION,1
NL,LEFT VENTRICULAR HYPERTROPHY,1
NL,LEG AMPUTATION,1
NL,LETHARGY,1
NL,LEUKOPENIA,1
NL,LIP SWELLING,1
NL,LISTLESS,1
NL,LOCALISED INFECTION,1
NL,LUNG CANCER METASTATIC,1
NL,LUNG INFILTRATION,1
NL,LYMPH NODE TUBERCULOSIS,1
NL,LYMPHADENOPATHY,1
NL,LYMPHANGIOSIS CARCINOMATOSA,1
NL,MALIGNANT MELANOMA,1
NL,MASS,1
NL,MEDICATION ERROR,1
NL,MENINGITIS ASEPTIC,1
NL,METABOLIC SYNDROME,1
NL,METASTASES TO LIVER,1
NL,METASTASES TO PELVIS,1
NL,METASTASES TO SKIN,1
NL,METASTASES TO SPINE,1
NL,METASTATIC GASTRIC CANCER,1
NL,METHAEMOGLOBINAEMIA,1
NL,MIOSIS,1
NL,MOTOR DYSFUNCTION,1
NL,MOUTH HAEMORRHAGE,1
NL,MOUTH ULCERATION,1
NL,MUCOSAL DRYNESS,1
NL,MULTIPLE PREGNANCY,1
NL,MUSCLE DISORDER,1
NL,MUSCLE NECROSIS,1
NL,MUSCLE RUPTURE,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MYELOFIBROSIS,1
NL,MYELOPROLIFERATIVE DISORDER,1
NL,MYRINGITIS BULLOUS,1
NL,NASOPHARYNGITIS,1
NL,NEPHROLITHIASIS,1
NL,NEPHROTIC SYNDROME,1
NL,NEURALGIA,1
NL,NEUROLEPTIC MALIGNANT SYNDROME,1
NL,NO ADVERSE EVENT,1
NL,NON-SMALL CELL LUNG CANCER STAGE IV,1
NL,OESOPHAGEAL STENOSIS,1
NL,OESOPHAGEAL ULCER,1
NL,OOPHORECTOMY,1
NL,OPEN GLOBE INJURY,1
NL,OSTEONECROSIS,1
NL,OSTEONECROSIS OF JAW,1
NL,OVERGROWTH BACTERIAL,1
NL,OXYGEN SATURATION DECREASED,1
NL,PAINFUL RESPIRATION,1
NL,PALLOR,1
NL,PALPITATIONS,1
NL,PANCREATIC MASS,1
NL,PANCREATIC NEOPLASM,1
NL,PANCREATITIS ACUTE,1
NL,PARESIS,1
NL,PARTIAL SEIZURES,1
NL,PARVOVIRUS INFECTION,1
NL,PELVIC FRACTURE,1
NL,PERCUTANEOUS CORONARY INTERVENTION,1
NL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
NL,PERIPHERAL ARTERY THROMBOSIS,1
NL,PERITONITIS,1
NL,PETECHIAE,1
NL,PHIMOSIS,1
NL,PHLEBITIS SUPERFICIAL,1
NL,PLASMA CELL MYELOMA,1
NL,PLATELET COUNT DECREASED,1
NL,PLEURISY,1
NL,PNEUMOCOCCAL SEPSIS,1
NL,PNEUMONIA KLEBSIELLA,1
NL,POISONING,1
NL,POLYMYALGIA RHEUMATICA,1
NL,POLYP,1
NL,POST PROCEDURAL COMPLICATION,1
NL,PRE-EXISTING CONDITION IMPROVED,1
NL,PRERENAL FAILURE,1
NL,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,1
NL,PRIAPISM,1
NL,PRIMARY CILIARY DYSKINESIA,1
NL,PROCTALGIA,1
NL,PRODUCT AVAILABILITY ISSUE,1
NL,PRODUCT USE IN UNAPPROVED INDICATION,1
NL,PROTEIN TOTAL INCREASED,1
NL,PSORIASIS,1
NL,PULMONARY ARTERIAL HYPERTENSION,1
NL,PULMONARY FIBROSIS,1
NL,PULMONARY HYPERTENSION,1
NL,PULMONARY MASS,1
NL,PULMONARY OEDEMA,1
NL,PULMONARY SEPSIS,1
NL,PUPILLARY DISORDER,1
NL,RADICULAR SYNDROME,1
NL,RASH GENERALISED,1
NL,RECTAL ADENOCARCINOMA,1
NL,RECTAL HAEMORRHAGE,1
NL,RENAL CELL CARCINOMA,1
NL,RENAL COLIC,1
NL,RENAL NEOPLASM,1
NL,RESPIRATORY DISTRESS,1
NL,RESPIRATORY TRACT IRRITATION,1
NL,RETINAL DETACHMENT,1
NL,RHEUMATOID ARTHRITIS,1
NL,RHEUMATOID NODULE,1
NL,ROAD TRAFFIC ACCIDENT,1
NL,ROTATOR CUFF SYNDROME,1
NL,SCROTAL CYST,1
NL,SECRETION DISCHARGE,1
NL,SENSATION OF FOREIGN BODY,1
NL,SENSORY LOSS,1
NL,SKIN CANCER,1
NL,SKIN TURGOR DECREASED,1
NL,SLEEP APNOEA SYNDROME,1
NL,SOFT TISSUE INFLAMMATION,1
NL,SPEECH DISORDER,1
NL,SPLENOMEGALY,1
NL,SQUAMOUS CELL CARCINOMA,1
NL,STENT PLACEMENT,1
NL,STOMA SITE DISCHARGE,1
NL,STOMA SITE ERYTHEMA,1
NL,STOMA SITE IRRITATION,1
NL,SUDDEN DEATH,1
NL,SURGERY,1
NL,SUSPECTED COUNTERFEIT PRODUCT,1
NL,TARDIVE DYSKINESIA,1
NL,TENDONITIS,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THROAT CANCER,1
NL,THROMBOSIS,1
NL,THYROID FUNCTION TEST ABNORMAL,1
NL,TINNITUS,1
NL,TOBACCO INTERACTION,1
NL,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
NL,TOOTH EXTRACTION,1
NL,TOOTH LOSS,1
NL,TRANSITIONAL CELL CARCINOMA,1
NL,TREATMENT NONCOMPLIANCE,1
NL,TROPONIN T INCREASED,1
NL,TUBULOINTERSTITIAL NEPHRITIS,1
NL,TUMOUR MARKER INCREASED,1
NL,UNDERDOSE,1
NL,UPPER LIMB FRACTURE,1
NL,URETERIC CANCER,1
NL,URETHRAL STENOSIS,1
NL,URINARY BLADDER POLYP,1
NL,URINARY TRACT DISORDER,1
NL,URINE ALBUMIN/CREATININE RATIO INCREASED,1
NL,UROSEPSIS,1
NL,UTERINE POLYP,1
NL,VENOUS STENOSIS,1
NL,VISUAL ACUITY REDUCED,1
NL,VITREOUS DETACHMENT,1
NL,WAIST CIRCUMFERENCE INCREASED,1
NL,WEIGHT ABNORMAL,1
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NL,YAWNING,1
NZ,ACUTE KIDNEY INJURY,21
NZ,LACTIC ACIDOSIS,19
NZ,TYPE 2 DIABETES MELLITUS,7
NZ,WHITE BLOOD CELL COUNT INCREASED,7
NZ,ANAEMIA,6
NZ,VOMITING,6
NZ,DIABETES MELLITUS,5
NZ,LOSS OF CONSCIOUSNESS,5
NZ,LOWER RESPIRATORY TRACT INFECTION,5
NZ,MALAISE,5
NZ,MYOCARDIAL INFARCTION,5
NZ,AGITATION,4
NZ,CONFUSIONAL STATE,4
NZ,ELECTROCARDIOGRAM QT PROLONGED,4
NZ,PULMONARY EMBOLISM,4
NZ,PYREXIA,4
NZ,SYNCOPE,4
NZ,TACHYCARDIA,4
NZ,ALANINE AMINOTRANSFERASE INCREASED,3
NZ,ANAPHYLACTIC REACTION,3
NZ,ANTIPSYCHOTIC DRUG LEVEL DECREASED,3
NZ,BLOOD ALKALINE PHOSPHATASE INCREASED,3
NZ,BLOOD GLUCOSE INCREASED,3
NZ,C-REACTIVE PROTEIN INCREASED,3
NZ,CARDIAC FAILURE,3
NZ,CEREBROVASCULAR ACCIDENT,3
NZ,DELIRIUM,3
NZ,DIZZINESS,3
NZ,FEELING ABNORMAL,3
NZ,GASTROINTESTINAL HAEMORRHAGE,3
NZ,GLOMERULAR FILTRATION RATE DECREASED,3
NZ,HEPATIC FAILURE,3
NZ,HYPERGLYCAEMIA,3
NZ,HYPERLIPIDAEMIA,3
NZ,HYPERTENSION,3
NZ,HYPOTENSION,3
NZ,MENTAL DISORDER,3
NZ,NEUTROPHIL COUNT INCREASED,3
NZ,OBESITY,3
NZ,OVERDOSE,3
NZ,PNEUMONIA,3
NZ,RENAL IMPAIRMENT,3
NZ,SEDATION,3
NZ,SINUS TACHYCARDIA,3
NZ,SLEEP APNOEA SYNDROME,3
NZ,THROMBOSIS,3
NZ,WEIGHT INCREASED,3
NZ,ABDOMINAL DISTENSION,2
NZ,ANOSOGNOSIA,2
NZ,ASCITES,2
NZ,BASAL CELL CARCINOMA,2
NZ,BLOOD ALBUMIN DECREASED,2
NZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
NZ,BODY TEMPERATURE INCREASED,2
NZ,CARDIOGENIC SHOCK,2
NZ,CHEST PAIN,2
NZ,CHRONIC KIDNEY DISEASE,2
NZ,CIRCULATORY COLLAPSE,2
NZ,COLD SWEAT,2
NZ,COUGH,2
NZ,DEHYDRATION,2
NZ,DIABETES MELLITUS INADEQUATE CONTROL,2
NZ,DIARRHOEA,2
NZ,DRUG LEVEL INCREASED,2
NZ,DYSARTHRIA,2
NZ,DYSPNOEA,2
NZ,EMBOLISM VENOUS,2
NZ,EXTENSOR PLANTAR RESPONSE,2
NZ,EXTRAPYRAMIDAL DISORDER,2
NZ,FATIGUE,2
NZ,FEELING HOT,2
NZ,GAIT DISTURBANCE,2
NZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
NZ,GENERAL PHYSICAL HEALTH DETERIORATION,2
NZ,GOUT,2
NZ,HAEMATOCRIT DECREASED,2
NZ,HAEMOGLOBIN DECREASED,2
NZ,HEADACHE,2
NZ,HEART RATE INCREASED,2
NZ,HYPERVENTILATION,2
NZ,HYPOGLYCAEMIA,2
NZ,HYPOTHERMIA,2
NZ,HYPOXIA,2
NZ,JOINT SWELLING,2
NZ,LACERATION,2
NZ,LIVER FUNCTION TEST ABNORMAL,2
NZ,LUNG ADENOCARCINOMA,2
NZ,LYMPHADENOPATHY,2
NZ,MAJOR DEPRESSION,2
NZ,MATERNAL EXPOSURE DURING PREGNANCY,2
NZ,MEAN CELL HAEMOGLOBIN DECREASED,2
NZ,MELAENA,2
NZ,MEMORY IMPAIRMENT,2
NZ,MENTAL IMPAIRMENT,2
NZ,METASTASES TO BONE,2
NZ,METASTASES TO LUNG,2
NZ,METASTASES TO THE MEDIASTINUM,2
NZ,METASTATIC MALIGNANT MELANOMA,2
NZ,MIOSIS,2
NZ,MYOCARDIAL ISCHAEMIA,2
NZ,NAUSEA,2
NZ,NEPHROLITHIASIS,2
NZ,NEUTROPHILIA,2
NZ,NYSTAGMUS,2
NZ,ORTHOSTATIC HYPOTENSION,2
NZ,PAIN,2
NZ,PALLOR,2
NZ,PLATELET COUNT INCREASED,2
NZ,POLYHYDRAMNIOS,2
NZ,PRESCRIBED OVERDOSE,2
NZ,PSORIASIS,2
NZ,PSYCHOTIC DISORDER,2
NZ,RECTAL HAEMORRHAGE,2
NZ,RENAL FAILURE,2
NZ,RESPIRATORY ACIDOSIS,2
NZ,RHINORRHOEA,2
NZ,SCHIZOPHRENIA,2
NZ,SEPSIS,2
NZ,SOMNOLENCE,2
NZ,SUBARACHNOID HAEMORRHAGE,2
NZ,SUDDEN DEATH,2
NZ,THROMBOCYTOPENIA,2
NZ,TOXICITY TO VARIOUS AGENTS,2
NZ,URINARY INCONTINENCE,2
NZ,UROSEPSIS,2
NZ,UVEITIS,2
NZ,VISION BLURRED,2
NZ,ABDOMINAL DISCOMFORT,1
NZ,ABDOMINAL PAIN,1
NZ,ABDOMINAL PAIN UPPER,1
NZ,ABSCESS LIMB,1
NZ,ACCIDENTAL OVERDOSE,1
NZ,ACUTE MYOCARDIAL INFARCTION,1
NZ,ADENOCARCINOMA OF COLON,1
NZ,AGGRESSION,1
NZ,AGRANULOCYTOSIS,1
NZ,ANGINA UNSTABLE,1
NZ,ANGIOEDEMA,1
NZ,ANTINUCLEAR ANTIBODY POSITIVE,1
NZ,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
NZ,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
NZ,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
NZ,ANXIETY,1
NZ,APHASIA,1
NZ,APPLICATION SITE ERYTHEMA,1
NZ,APPLICATION SITE PAIN,1
NZ,APPLICATION SITE PRURITUS,1
NZ,ARTHRALGIA,1
NZ,ARTHRITIS INFECTIVE,1
NZ,ASPHYXIA,1
NZ,ASTHENIA,1
NZ,ASTHMA,1
NZ,ATAXIA,1
NZ,ATELECTASIS,1
NZ,B-CELL LYMPHOMA,1
NZ,BACK PAIN,1
NZ,BALANCE DISORDER,1
NZ,BILIARY SEPSIS,1
NZ,BLADDER CANCER,1
NZ,BLOOD BILIRUBIN INCREASED,1
NZ,BLOOD CALCIUM DECREASED,1
NZ,BLOOD CREATININE INCREASED,1
NZ,BLOOD GLUCOSE DECREASED,1
NZ,BLOOD PHOSPHORUS DECREASED,1
NZ,BLOOD POTASSIUM DECREASED,1
NZ,BLOOD POTASSIUM INCREASED,1
NZ,BLOOD PRESSURE INCREASED,1
NZ,BLOOD PRESSURE ORTHOSTATIC DECREASED,1
NZ,BLOOD SODIUM DECREASED,1
NZ,BLOOD TRIGLYCERIDES INCREASED,1
NZ,BLOOD UREA DECREASED,1
NZ,CARBOXYHAEMOGLOBIN INCREASED,1
NZ,CELLULITIS,1
NZ,CEREBELLAR INFARCTION,1
NZ,CEREBRAL HAEMORRHAGE,1
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,1
NZ,CHORIORETINOPATHY,1
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NZ,COLON ADENOMA,1
NZ,COLONOSCOPY,1
NZ,COMPLETED SUICIDE,1
NZ,CONDUCTION DISORDER,1
NZ,CONSTIPATION,1
NZ,CONTRAINDICATED DRUG PRESCRIBED,1
NZ,CONTUSION,1
NZ,CORONARY ARTERY BYPASS,1
NZ,CROHN^S DISEASE,1
NZ,DEATH,1
NZ,DECREASED APPETITE,1
NZ,DELUSION,1
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NZ,DEPRESSION,1
NZ,DIABETIC COMPLICATION,1
NZ,DIABETIC FOOT,1
NZ,DIABETIC FOOT INFECTION,1
NZ,DIABETIC NEPHROPATHY,1
NZ,DIABETIC RETINOPATHY,1
NZ,DISORIENTATION,1
NZ,DIVERTICULUM,1
NZ,DRUG ADMINISTRATION ERROR,1
NZ,DRUG DOSE OMISSION,1
NZ,DRUG INEFFECTIVE,1
NZ,DRUG-INDUCED LIVER INJURY,1
NZ,DRY THROAT,1
NZ,DUODENAL ULCER,1
NZ,DYSLIPIDAEMIA,1
NZ,DYSPHONIA,1
NZ,DYSPNOEA EXERTIONAL,1
NZ,DYSURIA,1
NZ,ELECTROCARDIOGRAM ABNORMAL,1
NZ,EMOTIONAL DISTRESS,1
NZ,ENURESIS,1
NZ,EOSINOPHIL COUNT INCREASED,1
NZ,EOSINOPHILIA,1
NZ,EPISTAXIS,1
NZ,ESCHERICHIA SEPSIS,1
NZ,EYE INJURY,1
NZ,EYE MOVEMENT DISORDER,1
NZ,EYELID PTOSIS,1
NZ,FACE OEDEMA,1
NZ,FALL,1
NZ,FAT TISSUE INCREASED,1
NZ,FIBROUS HISTIOCYTOMA,1
NZ,FLUID RETENTION,1
NZ,FOETAL EXPOSURE DURING PREGNANCY,1
NZ,FREQUENT BOWEL MOVEMENTS,1
NZ,FUNCTIONAL GASTROINTESTINAL DISORDER,1
NZ,FUNGAL INFECTION,1
NZ,GASTRIC ULCER,1
NZ,GASTROENTERITIS,1
NZ,GASTROENTERITIS AEROMONAS,1
NZ,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
NZ,GENERAL PHYSICAL CONDITION ABNORMAL,1
NZ,GLOBULINS INCREASED,1
NZ,GLUCOSE TOLERANCE IMPAIRED,1
NZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
NZ,GOITRE,1
NZ,HAEMATURIA,1
NZ,HAEMOPTYSIS,1
NZ,HAEMORRHAGE INTRACRANIAL,1
NZ,HALLUCINATION,1
NZ,HALLUCINATION_ AUDITORY,1
NZ,HEPATIC STEATOSIS,1
NZ,HOSPITALISATION,1
NZ,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
NZ,HYPERSEXUALITY,1
NZ,HYPOAESTHESIA,1
NZ,HYPONATRAEMIA,1
NZ,HYPORESPONSIVE TO STIMULI,1
NZ,IMPULSE-CONTROL DISORDER,1
NZ,INCOHERENT,1
NZ,INFECTION,1
NZ,INFLUENZA,1
NZ,INSOMNIA,1
NZ,INTENTIONAL OVERDOSE,1
NZ,IRIDOCYCLITIS,1
NZ,IRRITABILITY,1
NZ,ISCHAEMIC STROKE,1
NZ,JOINT EFFUSION,1
NZ,LARGE INTESTINE POLYP,1
NZ,LETHARGY,1
NZ,LEUKOCYTOSIS,1
NZ,LIMB DISCOMFORT,1
NZ,LIP SWELLING,1
NZ,LIPOHYPERTROPHY,1
NZ,LOBAR PNEUMONIA,1
NZ,LOCAL SWELLING,1
NZ,LUNG CONSOLIDATION,1
NZ,LYMPH NODE PAIN,1
NZ,LYMPHOCYTE COUNT DECREASED,1
NZ,MACULAR FIBROSIS,1
NZ,MALIGNANT LYMPHOID NEOPLASM,1
NZ,MALIGNANT MELANOMA IN SITU,1
NZ,MEAN CELL VOLUME DECREASED,1
NZ,MEDICATION ERROR,1
NZ,MENORRHAGIA,1
NZ,METASTASES TO LIVER,1
NZ,METASTASES TO MUSCLE,1
NZ,METASTASES TO PANCREAS,1
NZ,METASTASES TO PERITONEUM,1
NZ,METASTASES TO SKIN,1
NZ,METASTASES TO SMALL INTESTINE,1
NZ,METASTASES TO SPLEEN,1
NZ,MONOCYTE COUNT DECREASED,1
NZ,MONOCYTE COUNT INCREASED,1
NZ,MOUTH ULCERATION,1
NZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
NZ,MUSCULAR WEAKNESS,1
NZ,MUSCULOSKELETAL CHEST PAIN,1
NZ,MYALGIA,1
NZ,NECROBIOSIS LIPOIDICA DIABETICORUM,1
NZ,NEUTROPENIA,1
NZ,NIGHTMARE,1
NZ,NO ADVERSE EVENT,1
NZ,OCCULT BLOOD POSITIVE,1
NZ,OCULOGYRIC CRISIS,1
NZ,OEDEMA PERIPHERAL,1
NZ,OESOPHAGITIS,1
NZ,OSTEOMYELITIS,1
NZ,OSTEONECROSIS,1
NZ,PAIN IN EXTREMITY,1
NZ,PAIN IN JAW,1
NZ,PANCYTOPENIA,1
NZ,PARAESTHESIA,1
NZ,PCO2 DECREASED,1
NZ,PHARYNGEAL OEDEMA,1
NZ,POLYDIPSIA,1
NZ,POLYPECTOMY,1
NZ,POLYURIA,1
NZ,POST PROCEDURAL COMPLICATION,1
NZ,POST PROCEDURAL HAEMORRHAGE,1
NZ,PREMATURE BABY,1
NZ,PRODUCT BLISTER PACKAGING ISSUE,1
NZ,PRODUCT USE ISSUE,1
NZ,PROSTATOMEGALY,1
NZ,PROTEINURIA,1
NZ,PSYCHIATRIC SYMPTOM,1
NZ,PULMONARY HYPERTENSION,1
NZ,PULMONARY OEDEMA,1
NZ,PURPURA,1
NZ,RADIUS FRACTURE,1
NZ,RASH,1
NZ,RASH MACULO-PAPULAR,1
NZ,RED CELL DISTRIBUTION WIDTH INCREASED,1
NZ,RENAL COLIC,1
NZ,RESTLESSNESS,1
NZ,RHABDOMYOLYSIS,1
NZ,RHINITIS,1
NZ,ROTATOR CUFF REPAIR,1
NZ,SELF-MEDICATION,1
NZ,SKIN DISORDER,1
NZ,SKIN INFECTION,1
NZ,SOFT TISSUE INJURY,1
NZ,SPINAL COMPRESSION FRACTURE,1
NZ,SPINAL CORD HAEMATOMA,1
NZ,SPLENIC HAEMORRHAGE,1
NZ,SQUAMOUS CELL CARCINOMA,1
NZ,STOMATITIS,1
NZ,STRESS,1
NZ,SUICIDAL IDEATION,1
NZ,SUICIDE ATTEMPT,1
NZ,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,1
NZ,SUPRAVENTRICULAR TACHYCARDIA,1
NZ,SUTURE RUPTURE,1
NZ,SYSTEMIC LUPUS ERYTHEMATOSUS,1
NZ,TACHYPNOEA,1
NZ,TENDON RUPTURE,1
NZ,THERAPEUTIC RESPONSE DECREASED,1
NZ,THYROID GLAND SCAN ABNORMAL,1
NZ,TRANSIENT ISCHAEMIC ATTACK,1
NZ,TROPONIN T INCREASED,1
NZ,TUMOUR INVASION,1
NZ,TYPE IV HYPERSENSITIVITY REACTION,1
NZ,UNRESPONSIVE TO STIMULI,1
NZ,URINARY TRACT INFECTION,1
NZ,VAGINAL HAEMORRHAGE,1
NZ,VASCULAR STENT OCCLUSION,1
NZ,VASCULITIS,1
NZ,VERTIGO,1
NZ,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
NZ,VISUAL ACUITY REDUCED,1
NZ,VISUAL IMPAIRMENT,1
NZ,VITRITIS,1
NZ,WEIGHT LOSS POOR,1
NZ,WHEEZING,1
NZ,WHITE BLOOD CELL COUNT DECREASED,1
NI,ANAEMIA,1
NI,BLOOD CREATININE INCREASED,1
NI,BUNDLE BRANCH BLOCK RIGHT,1
NI,HYPERGLYCAEMIA,1
NI,HYPOKALAEMIA,1
NI,HYPONATRAEMIA,1
NI,HYPOTENSION,1
NI,NEUTROPHILIA,1
NI,TROPONIN INCREASED,1
NG,ALTERED STATE OF CONSCIOUSNESS,1
NG,ASTHENIA,1
NG,CHEILITIS,1
NG,COUGH,1
NG,DIZZINESS,1
NG,DRY SKIN,1
NG,HYPERHIDROSIS,1
NG,LYMPHADENITIS,1
NG,PALPITATIONS,1
NG,RESPIRATORY DEPRESSION,1
NG,SLEEP APNOEA SYNDROME,1
NG,TOXIC EPIDERMAL NECROLYSIS,1
NO,LACTIC ACIDOSIS,53
NO,RENAL FAILURE,29
NO,DIARRHOEA,22
NO,ACUTE KIDNEY INJURY,18
NO,ABDOMINAL PAIN,12
NO,PYREXIA,12
NO,CARCINOID TUMOUR OF THE STOMACH,10
NO,HYPOTENSION,10
NO,VOMITING,10
NO,CONFUSIONAL STATE,8
NO,HAEMATEMESIS,8
NO,HYPERGASTRINAEMIA,8
NO,HYPERTENSION,8
NO,HYPERVENTILATION,8
NO,MALAISE,8
NO,NEUROENDOCRINE TUMOUR,8
NO,NEUROLEPTIC MALIGNANT SYNDROME,8
NO,CIRCULATORY COLLAPSE,7
NO,DYSPEPSIA,7
NO,ENTEROCHROMAFFIN CELL HYPERPLASIA,7
NO,HYPERHIDROSIS,7
NO,HYPOTHERMIA,7
NO,PNEUMONIA,7
NO,VISUAL IMPAIRMENT,7
NO,AMNESIA,6
NO,ATRIAL FIBRILLATION,6
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
NO,DIABETIC KETOACIDOSIS,6
NO,DYSPHAGIA,6
NO,LEUKOCYTOSIS,6
NO,MUSCLE RIGIDITY,6
NO,MUSCULOSKELETAL STIFFNESS,6
NO,NEUTROPHILIA,6
NO,PERICARDITIS,6
NO,PLEURISY,6
NO,PULMONARY FIBROSIS,6
NO,RECTAL HAEMORRHAGE,6
NO,TRANSAMINASES INCREASED,6
NO,WEIGHT INCREASED,6
NO,CARDIAC ARREST,5
NO,CEREBRAL HAEMORRHAGE,5
NO,HYPOGLYCAEMIA,5
NO,HYPOKALAEMIA,5
NO,MYALGIA,5
NO,NEPHROLITHIASIS,5
NO,RENAL IMPAIRMENT,5
NO,RESPIRATORY ARREST,5
NO,ALANINE AMINOTRANSFERASE INCREASED,4
NO,ATRIOVENTRICULAR BLOCK COMPLETE,4
NO,BLOOD PRESSURE DECREASED,4
NO,CEREBRAL INFARCTION,4
NO,COLLAGEN DISORDER,4
NO,DECREASED APPETITE,4
NO,DEHYDRATION,4
NO,DRUG INEFFECTIVE,4
NO,LANGUAGE DISORDER,4
NO,MENTAL IMPAIRMENT,4
NO,METABOLIC ACIDOSIS,4
NO,NAUSEA,4
NO,PLATELET COUNT DECREASED,4
NO,RENAL FAILURE ACUTE,4
NO,SEPSIS,4
NO,TACHYCARDIA,4
NO,ABORTION SPONTANEOUS,3
NO,ALTERED STATE OF CONSCIOUSNESS,3
NO,ANAEMIA,3
NO,BLOOD GLUCOSE INCREASED,3
NO,BLOOD URINE PRESENT,3
NO,CHROMATURIA,3
NO,DIZZINESS,3
NO,DYSPNOEA,3
NO,EXPOSURE DURING PREGNANCY,3
NO,FOETAL EXPOSURE DURING PREGNANCY,3
NO,GENERAL PHYSICAL HEALTH DETERIORATION,3
NO,HYPERNATRAEMIA,3
NO,KETOACIDOSIS,3
NO,LATENT AUTOIMMUNE DIABETES IN ADULTS,3
NO,LISTLESS,3
NO,MATERNAL EXPOSURE DURING PREGNANCY,3
NO,MUTISM,3
NO,MYOCARDIAL INFARCTION,3
NO,MYOSITIS,3
NO,SOMNOLENCE,3
NO,TOXICITY TO VARIOUS AGENTS,3
NO,URINARY BLADDER HAEMORRHAGE,3
NO,WEIGHT DECREASED,3
NO,ABDOMINAL PAIN UPPER,2
NO,ACUTE MYOCARDIAL INFARCTION,2
NO,ANAPHYLACTIC SHOCK,2
NO,ANGINA UNSTABLE,2
NO,ANXIETY,2
NO,ASPARTATE AMINOTRANSFERASE INCREASED,2
NO,ASTHENIA,2
NO,BLOOD GLUCOSE DECREASED,2
NO,C-REACTIVE PROTEIN INCREASED,2
NO,CARDIAC FAILURE,2
NO,COMA,2
NO,CONSTIPATION,2
NO,DEATH,2
NO,DISSEMINATED INTRAVASCULAR COAGULATION,2
NO,ERYTHEMA,2
NO,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
NO,HEADACHE,2
NO,HYPERGLYCAEMIA,2
NO,HYPERKALAEMIA,2
NO,HYPOVENTILATION,2
NO,INFECTION,2
NO,INFLUENZA,2
NO,INSOMNIA,2
NO,LOSS OF CONSCIOUSNESS,2
NO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
NO,MUSCLE SPASMS,2
NO,NEUTROPENIA,2
NO,OESOPHAGEAL VARICES HAEMORRHAGE,2
NO,PAIN,2
NO,PAIN IN EXTREMITY,2
NO,PULMONARY HAEMORRHAGE,2
NO,SUDDEN DEATH,2
NO,TEMPOROMANDIBULAR JOINT SYNDROME,2
NO,THROMBOSIS,2
NO,THROMBOTIC CEREBRAL INFARCTION,2
NO,TINNITUS,2
NO,URINARY RETENTION,2
NO,ACCIDENTAL OVERDOSE,1
NO,ACIDOSIS,1
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NO,AGITATION NEONATAL,1
NO,AGRANULOCYTOSIS,1
NO,ANAPHYLACTIC REACTION,1
NO,AUTOIMMUNE HEPATITIS,1
NO,BALANCE DISORDER,1
NO,BASE EXCESS DECREASED,1
NO,BASEDOW^S DISEASE,1
NO,BIOPSY KIDNEY ABNORMAL,1
NO,BLADDER CANCER,1
NO,BLINDNESS,1
NO,BLOOD BILIRUBIN INCREASED,1
NO,BLOOD CHOLESTEROL INCREASED,1
NO,BLOOD CREATININE INCREASED,1
NO,BLOOD GLUCOSE FLUCTUATION,1
NO,BLOOD PRESSURE SYSTOLIC INCREASED,1
NO,BLOOD PROLACTIN INCREASED,1
NO,BLOOD UREA INCREASED,1
NO,BONE LESION,1
NO,BRADYCARDIA,1
NO,BURNING SENSATION,1
NO,CARPAL TUNNEL SYNDROME,1
NO,CENTRAL NERVOUS SYSTEM INFECTION,1
NO,CEREBELLAR SYNDROME,1
NO,CHILLS,1
NO,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
NO,COLITIS,1
NO,COLON CANCER,1
NO,CONTRAST MEDIA REACTION,1
NO,CONVULSION NEONATAL,1
NO,COUGH,1
NO,CYTOPENIA,1
NO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NO,DEPRESSION,1
NO,DIABETES MELLITUS,1
NO,DISABILITY,1
NO,DISCOMFORT,1
NO,DISTURBANCE IN ATTENTION,1
NO,DRUG ERUPTION,1
NO,DRUG WITHDRAWAL SYNDROME NEONATAL,1
NO,DUODENAL ULCER,1
NO,DYSKINESIA,1
NO,DYSPNOEA EXERTIONAL,1
NO,EAR PAIN,1
NO,EJECTION FRACTION DECREASED,1
NO,ENCEPHALOPATHY,1
NO,ENDOPHTHALMITIS,1
NO,EPISTAXIS,1
NO,ERYTHROBLASTOSIS FOETALIS,1
NO,EXPOSED BONE IN JAW,1
NO,EYE DISORDER,1
NO,FALL,1
NO,FAT NECROSIS,1
NO,FATIGUE,1
NO,FEELING HOT,1
NO,FINGER DEFORMITY,1
NO,FLATULENCE,1
NO,FLUSHING,1
NO,GASTRIC ULCER,1
NO,GASTROENTERITIS,1
NO,GASTROINTESTINAL HAEMORRHAGE,1
NO,GESTATIONAL DIABETES,1
NO,HAEMATOMA EVACUATION,1
NO,HAEMODYNAMIC INSTABILITY,1
NO,HAEMORRHAGE,1
NO,HAEMORRHAGE INTRACRANIAL,1
NO,HAEMORRHAGIC CEREBRAL INFARCTION,1
NO,HALLUCINATION,1
NO,HEPATIC CIRRHOSIS,1
NO,HEPATIC FAILURE,1
NO,HEPATOCELLULAR CARCINOMA,1
NO,HYDROPS FOETALIS,1
NO,HYPERSENSITIVITY,1
NO,HYPOAESTHESIA,1
NO,HYPOTHYROIDISM,1
NO,IMPAIRED FASTING GLUCOSE,1
NO,INCONTINENCE,1
NO,INCORRECT DRUG ADMINISTRATION DURATION,1
NO,INFLAMMATORY PSEUDOTUMOUR,1
NO,INJECTION SITE ABSCESS,1
NO,INJECTION SITE INFLAMMATION,1
NO,INTENTIONAL PRODUCT MISUSE,1
NO,INTERSTITIAL LUNG DISEASE,1
NO,INTRACRANIAL ANEURYSM,1
NO,IRON DEFICIENCY ANAEMIA,1
NO,IRRITABILITY,1
NO,LIVE BIRTH,1
NO,LIVER FUNCTION TEST ABNORMAL,1
NO,LUNG DISORDER,1
NO,MALNUTRITION,1
NO,MARROW HYPERPLASIA,1
NO,MEDICATION ERROR,1
NO,METASTASES TO LIVER,1
NO,METASTASES TO LUNG,1
NO,MIGRAINE WITH AURA,1
NO,MOBILITY DECREASED,1
NO,MOVEMENT DISORDER,1
NO,MULTI-ORGAN FAILURE,1
NO,MULTIPLE USE OF SINGLE-USE PRODUCT,1
NO,MUSCLE TWITCHING,1
NO,MYDRIASIS,1
NO,MYOPATHY,1
NO,NERVOUS SYSTEM DISORDER,1
NO,NEURALGIC AMYOTROPHY,1
NO,NEUTROPHIL COUNT DECREASED,1
NO,NIGHTMARE,1
NO,OEDEMA,1
NO,ORAL DISCOMFORT,1
NO,OROPHARYNGEAL PAIN,1
NO,OSTEOARTHRITIS,1
NO,OSTEONECROSIS OF JAW,1
NO,OVERDOSE,1
NO,PANCREATIC CARCINOMA,1
NO,PARAESTHESIA,1
NO,PARALYSIS,1
NO,PARKINSONISM,1
NO,PAROTITIS,1
NO,PHOTOSENSITIVITY REACTION,1
NO,PIGMENTATION DISORDER,1
NO,PNEUMONIA BACTERIAL,1
NO,POLYMYOSITIS,1
NO,POLYNEUROPATHY,1
NO,POOR QUALITY SLEEP,1
NO,PRE-ECLAMPSIA,1
NO,PREGNANCY,1
NO,PRERENAL FAILURE,1
NO,PRESCRIBED UNDERDOSE,1
NO,PRODUCT SUBSTITUTION ISSUE,1
NO,PRODUCT USE IN UNAPPROVED INDICATION,1
NO,PROGRESSIVE SUPRANUCLEAR PALSY,1
NO,PROSTATE CANCER,1
NO,PROSTATE CANCER METASTATIC,1
NO,PULMONARY EMBOLISM,1
NO,QUALITY OF LIFE DECREASED,1
NO,RASH,1
NO,RASH ERYTHEMATOUS,1
NO,RASH GENERALISED,1
NO,RASH MACULO-PAPULAR,1
NO,RASH PRURITIC,1
NO,RENAL DISORDER,1
NO,RESTLESSNESS,1
NO,SENSORY LOSS,1
NO,SINUS ARREST,1
NO,SKIN REACTION,1
NO,SMALL FOR DATES BABY,1
NO,SMALL INTESTINAL HAEMORRHAGE,1
NO,STILLBIRTH,1
NO,STRABISMUS,1
NO,SWELLING FACE,1
NO,TARDIVE DYSKINESIA,1
NO,TENSION,1
NO,THERAPEUTIC PRODUCT INEFFECTIVE,1
NO,THERMOANAESTHESIA,1
NO,THROMBOCYTOPENIA,1
NO,TONGUE MOVEMENT DISTURBANCE,1
NO,TRANSIENT ISCHAEMIC ATTACK,1
NO,TREMOR,1
NO,TREMOR NEONATAL,1
NO,ULCER HAEMORRHAGE,1
NO,UPPER RESPIRATORY TRACT INFECTION,1
NO,URINARY TRACT DISORDER,1
NO,UROSEPSIS,1
NO,VIRAL INFECTION,1
OM,ATRIAL TACHYCARDIA,3
OM,HYPOMAGNESAEMIA,3
OM,SUPRAVENTRICULAR TACHYCARDIA,3
OM,TOXICITY TO VARIOUS AGENTS,3
OM,BRADYCARDIA,2
OM,DIZZINESS,2
OM,DYSPNOEA,2
OM,HYPERSENSITIVITY VASCULITIS,2
OM,HYPERTENSION,2
OM,HYPOTENSION,2
OM,MATERNAL EXPOSURE DURING PREGNANCY,2
OM,NORMAL NEWBORN,2
OM,POLYHYDRAMNIOS,2
OM,UTERINE MALPOSITION,2
OM,ABDOMINAL DISCOMFORT,1
OM,ARRHYTHMIA,1
OM,BLOOD PRESSURE IMMEASURABLE,1
OM,CAESAREAN SECTION,1
OM,DIARRHOEA,1
OM,FOETAL MALPRESENTATION,1
OM,HYPERGLYCAEMIA,1
OM,HYPOGLYCAEMIA,1
OM,IDIOPATHIC PULMONARY FIBROSIS,1
OM,NAUSEA,1
OM,PALPITATIONS,1
OM,UNSTABLE FOETAL LIE,1
OM,VOMITING,1
PK,DIABETIC KETOACIDOSIS,8
PK,ANAEMIA,1
PK,ASPARTATE AMINOTRANSFERASE INCREASED,1
PK,BLOOD GLUCOSE INCREASED,1
PK,CONDITION AGGRAVATED,1
PK,FALSE NEGATIVE INVESTIGATION RESULT,1
PK,FOETAL EXPOSURE DURING PREGNANCY,1
PK,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
PK,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
PK,MYOCARDIAL INFARCTION,1
PK,NEUTROPHIL COUNT INCREASED,1
PK,POLYDACTYLY,1
PK,WEIGHT DECREASED,1
PS,ABORTION,1
PS,BLOOD GLUCOSE INCREASED,1
PS,DIABETES MELLITUS,1
PS,DIABETES MELLITUS INADEQUATE CONTROL,1
PS,MATERNAL EXPOSURE DURING PREGNANCY,1
PA,PAIN,8
PA,ASTHENIA,7
PA,MALAISE,7
PA,FATIGUE,5
PA,HEADACHE,4
PA,PAIN IN EXTREMITY,4
PA,BLOOD GLUCOSE INCREASED,3
PA,BLOOD GROWTH HORMONE INCREASED,3
PA,FALL,3
PA,FEELING ABNORMAL,3
PA,HAEMOGLOBIN DECREASED,3
PA,APPLICATION SITE PAIN,2
PA,ASTHMATIC CRISIS,2
PA,BLOOD GLUCOSE DECREASED,2
PA,BONE PAIN,2
PA,CHEST PAIN,2
PA,DECREASED APPETITE,2
PA,EYE PAIN,2
PA,GAIT DISTURBANCE,2
PA,HAEMATOCHEZIA,2
PA,HEART RATE DECREASED,2
PA,HORMONE LEVEL ABNORMAL,2
PA,INSOMNIA,2
PA,MEMORY IMPAIRMENT,2
PA,MYOCARDIAL INFARCTION,2
PA,NASOPHARYNGITIS,2
PA,NAUSEA,2
PA,PERIPHERAL SWELLING,2
PA,PLATELET COUNT DECREASED,2
PA,SYNCOPE,2
PA,TACHYCARDIA,2
PA,TREMOR,2
PA,VISION BLURRED,2
PA,WOUND,2
PA,ABASIA,1
PA,ABDOMINAL PAIN,1
PA,ABDOMINAL PAIN LOWER,1
PA,ABDOMINAL PAIN UPPER,1
PA,ACNE,1
PA,AGITATION,1
PA,ANAEMIA,1
PA,ANURIA,1
PA,ANXIETY,1
PA,APPARENT DEATH,1
PA,ARTHRALGIA,1
PA,BLOOD CHOLESTEROL INCREASED,1
PA,BLOOD COUNT ABNORMAL,1
PA,BLOOD DISORDER,1
PA,BONE DISORDER,1
PA,BRAIN NEOPLASM,1
PA,BURNING SENSATION,1
PA,CATARACT,1
PA,CHEST DISCOMFORT,1
PA,CHILLS,1
PA,CONSTIPATION,1
PA,DEEP VEIN THROMBOSIS,1
PA,DEMENTIA ALZHEIMER^S TYPE,1
PA,DENTAL CARIES,1
PA,DIABETES MELLITUS,1
PA,DIARRHOEA,1
PA,DIZZINESS,1
PA,DRUG INEFFECTIVE,1
PA,DRY MOUTH,1
PA,DYSPNOEA,1
PA,DYSURIA,1
PA,ERYTHEMA,1
PA,EXOPHTHALMOS,1
PA,EYE HAEMORRHAGE,1
PA,EYE INFECTION,1
PA,EYE IRRITATION,1
PA,EYE PRURITUS,1
PA,FACE OEDEMA,1
PA,FLATULENCE,1
PA,FOOT DEFORMITY,1
PA,GENERAL PHYSICAL HEALTH DETERIORATION,1
PA,GLAUCOMA,1
PA,GLOMERULAR FILTRATION RATE DECREASED,1
PA,GLOSSITIS,1
PA,HAEMORRHAGE,1
PA,HAND DEFORMITY,1
PA,HAND FRACTURE,1
PA,HEAD DISCOMFORT,1
PA,HEAD INJURY,1
PA,HEART RATE INCREASED,1
PA,HUNGER,1
PA,HYPERGLYCAEMIA,1
PA,HYPERHIDROSIS,1
PA,HYPOAESTHESIA,1
PA,HYPOPHYSITIS,1
PA,HYPOTHALAMO-PITUITARY DISORDER,1
PA,HYPOXIA,1
PA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PA,INCORRECT DOSE ADMINISTERED,1
PA,INCORRECT DRUG ADMINISTRATION DURATION,1
PA,INTRAOCULAR PRESSURE INCREASED,1
PA,ISCHAEMIC STROKE,1
PA,LIMB DEFORMITY,1
PA,LIMB DISCOMFORT,1
PA,LOWER EXTREMITY MASS,1
PA,MENINGIOMA,1
PA,METABOLIC DISORDER,1
PA,METASTASES TO BONE,1
PA,MUSCLE SPASMS,1
PA,MUSCULAR WEAKNESS,1
PA,MUSCULOSKELETAL PAIN,1
PA,NEOPLASM MALIGNANT,1
PA,OEDEMA PERIPHERAL,1
PA,OROPHARYNGEAL PAIN,1
PA,PALATAL DISORDER,1
PA,PALLOR,1
PA,PARAPLEGIA,1
PA,PELVIC PAIN,1
PA,PNEUMONIA,1
PA,PROTEINURIA,1
PA,PRURITUS,1
PA,RENAL PAIN,1
PA,RHINORRHOEA,1
PA,SINGLE FUNCTIONAL KIDNEY,1
PA,SKIN BURNING SENSATION,1
PA,SKIN DISORDER,1
PA,SOMNOLENCE,1
PA,SUBCUTANEOUS ABSCESS,1
PA,THROMBOSIS,1
PA,TOOTHACHE,1
PA,URINARY INCONTINENCE,1
PA,URINARY RETENTION,1
PA,URINARY TRACT INFECTION,1
PA,UTERINE LEIOMYOMA,1
PA,VARICOSE VEIN,1
PA,VIRAL INFECTION,1
PA,VISUAL ACUITY REDUCED,1
PA,VISUAL IMPAIRMENT,1
PA,WEIGHT DECREASED,1
PA,WHITE BLOOD CELL COUNT DECREASED,1
PA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
PY,CARDIAC MURMUR,2
PY,FOETAL EXPOSURE DURING PREGNANCY,2
PY,PREMATURE BABY,2
PY,BLOOD GLUCOSE DECREASED,1
PY,RED BLOOD CELL COUNT INCREASED,1
PE,DIABETES MELLITUS,5
PE,LACTIC ACIDOSIS,5
PE,WEIGHT DECREASED,5
PE,ACUTE KIDNEY INJURY,4
PE,CEREBROVASCULAR ACCIDENT,3
PE,DIARRHOEA,3
PE,DIZZINESS,3
PE,MYOCARDIAL INFARCTION,3
PE,VOMITING,3
PE,BILE DUCT STONE,2
PE,BLOOD GLUCOSE FLUCTUATION,2
PE,BLOOD GLUCOSE INCREASED,2
PE,DYSPNOEA,2
PE,GASTRIC CANCER,2
PE,GASTROINTESTINAL DISORDER,2
PE,HAEMOGLOBIN DECREASED,2
PE,HEADACHE,2
PE,KIDNEY INFECTION,2
PE,NAUSEA,2
PE,NEOPLASM MALIGNANT,2
PE,SEPSIS,2
PE,SURGERY,2
PE,SYNCOPE,2
PE,VISUAL ACUITY REDUCED,2
PE,ABDOMINAL PAIN,1
PE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PE,ALTERED STATE OF CONSCIOUSNESS,1
PE,AMNESIA,1
PE,ANAEMIA,1
PE,ANGINA UNSTABLE,1
PE,ANKLE FRACTURE,1
PE,ANKLE OPERATION,1
PE,ARTHRALGIA,1
PE,ARTHRITIS,1
PE,ASCITES,1
PE,ASPHYXIA,1
PE,BACK PAIN,1
PE,BLOOD CHOLESTEROL INCREASED,1
PE,BLOOD PRESSURE INCREASED,1
PE,BREAST CANCER,1
PE,CARCINOMA IN SITU,1
PE,CARDIAC MURMUR,1
PE,CATARACT,1
PE,CATARACT OPERATION,1
PE,CHOLELITHIASIS,1
PE,CHRONIC MYELOID LEUKAEMIA,1
PE,CONDITION AGGRAVATED,1
PE,DEATH,1
PE,DEEP VEIN THROMBOSIS,1
PE,DEHYDRATION,1
PE,DEPRESSION SUICIDAL,1
PE,DEVELOPMENTAL HIP DYSPLASIA,1
PE,DIABETIC KETOACIDOSIS,1
PE,DISCOMFORT,1
PE,DISORGANISED SPEECH,1
PE,DISORIENTATION,1
PE,DISTRIBUTIVE SHOCK,1
PE,DRUG INEFFECTIVE,1
PE,DYSENTERY,1
PE,DYSSTASIA,1
PE,ELECTROCARDIOGRAM QT PROLONGED,1
PE,EOSINOPHIL COUNT ABNORMAL,1
PE,EPISTAXIS,1
PE,ERYTHEMA,1
PE,EYE HAEMORRHAGE,1
PE,FALL,1
PE,FEELING ABNORMAL,1
PE,FLUID RETENTION,1
PE,FOETAL EXPOSURE DURING PREGNANCY,1
PE,FUNCTIONAL GASTROINTESTINAL DISORDER,1
PE,GALLBLADDER OPERATION,1
PE,GASTRIC DISORDER,1
PE,GASTRITIS,1
PE,GENERAL PHYSICAL HEALTH DETERIORATION,1
PE,HAEMATEMESIS,1
PE,HAEMODIALYSIS,1
PE,HAEMORRHAGE INTRACRANIAL,1
PE,HEART RATE INCREASED,1
PE,HEAT STROKE,1
PE,HEPATITIS,1
PE,HERNIA REPAIR,1
PE,HIP SURGERY,1
PE,HYPERGLYCAEMIA,1
PE,HYPERHIDROSIS,1
PE,HYPERTENSIVE CRISIS,1
PE,HYPOTENSION,1
PE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PE,INFECTED SKIN ULCER,1
PE,INFLUENZA,1
PE,INTENTIONAL OVERDOSE,1
PE,INTENTIONAL PRODUCT MISUSE,1
PE,JAUNDICE NEONATAL,1
PE,JOINT SWELLING,1
PE,LIMB INJURY,1
PE,LIVER INJURY,1
PE,LOSS OF CONSCIOUSNESS,1
PE,LOWER RESPIRATORY TRACT INFECTION,1
PE,LYMPHOPROLIFERATIVE DISORDER,1
PE,MACULAR HOLE,1
PE,MALAISE,1
PE,MALIGNANT MELANOMA,1
PE,MATERNAL EXPOSURE DURING PREGNANCY,1
PE,MEDICAL DEVICE COMPLICATION,1
PE,MUSCULAR WEAKNESS,1
PE,MYOSITIS,1
PE,NEUROPATHY PERIPHERAL,1
PE,OEDEMA PERIPHERAL,1
PE,OSTEOARTHRITIS,1
PE,OVERWEIGHT,1
PE,PAIN IN EXTREMITY,1
PE,PANCREATITIS ACUTE,1
PE,PARAESTHESIA,1
PE,PERIPHERAL COLDNESS,1
PE,PHLEBITIS,1
PE,PNEUMONIA,1
PE,PNEUMONIA BACTERIAL,1
PE,POLYDACTYLY,1
PE,PRESCRIBED OVERDOSE,1
PE,PRODUCT USE ISSUE,1
PE,PULMONARY HYPERTENSION,1
PE,PYREXIA,1
PE,RENAL CYST,1
PE,RENAL DISORDER,1
PE,RENAL HAEMORRHAGE,1
PE,RESPIRATORY FAILURE,1
PE,RETINAL INJURY,1
PE,SCIATICA,1
PE,SEIZURE,1
PE,SEPTIC SHOCK,1
PE,SKIN EXFOLIATION,1
PE,SPINAL CORD HERNIATION,1
PE,SPINAL OPERATION,1
PE,STAPHYLOCOCCAL INFECTION,1
PE,SWELLING,1
PE,THERAPEUTIC PROCEDURE,1
PE,THYROID NEOPLASM,1
PE,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
PE,TREMOR,1
PE,URINARY TRACT INFECTION,1
PE,URINARY TRACT INFLAMMATION,1
PE,UTERINE CANCER,1
PE,UTERINE HAEMORRHAGE,1
PE,VISUAL IMPAIRMENT,1
PE,WOLFF-PARKINSON-WHITE SYNDROME,1
PH,INTENTIONAL OVERDOSE,10
PH,LACTIC ACIDOSIS,10
PH,BLOOD GLUCOSE INCREASED,9
PH,MYOCARDIAL INFARCTION,7
PH,PNEUMONIA,6
PH,BLOOD PRESSURE INCREASED,5
PH,CHOLELITHIASIS,5
PH,DIABETIC COMPLICATION,5
PH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
PH,ABDOMINAL PAIN UPPER,4
PH,ASTHENIA,4
PH,CARDIAC ARREST,4
PH,DECREASED APPETITE,4
PH,NAUSEA,4
PH,TACHYCARDIA,4
PH,URINARY TRACT INFECTION,4
PH,VOMITING,4
PH,ACUTE RESPIRATORY FAILURE,3
PH,ANAEMIA,3
PH,ARRHYTHMIA,3
PH,CARDIO-RESPIRATORY ARREST,3
PH,CEREBROVASCULAR ACCIDENT,3
PH,DIZZINESS,3
PH,DYSPNOEA,3
PH,HAEMOGLOBIN DECREASED,3
PH,HEADACHE,3
PH,HYPERTENSION,3
PH,RENAL FAILURE,3
PH,ADVERSE EVENT,2
PH,BLOOD CHOLESTEROL INCREASED,2
PH,BLOOD CREATININE INCREASED,2
PH,BLOOD GLUCOSE ABNORMAL,2
PH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PH,DEATH,2
PH,DIABETES MELLITUS,2
PH,DRUG DOSE OMISSION,2
PH,DRUG INEFFECTIVE,2
PH,FATIGUE,2
PH,GASTROENTERITIS,2
PH,HEPATIC ENZYME INCREASED,2
PH,HYPOKALAEMIA,2
PH,INCORRECT DOSE ADMINISTERED,2
PH,INSOMNIA,2
PH,JAUNDICE,2
PH,LOSS OF CONSCIOUSNESS,2
PH,NEPHROLITHIASIS,2
PH,SUPRAVENTRICULAR TACHYCARDIA,2
PH,TUBERCULOSIS,2
PH,WEIGHT DECREASED,2
PH,ABDOMINAL DISCOMFORT,1
PH,ABDOMINAL PAIN,1
PH,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PH,ACUTE CORONARY SYNDROME,1
PH,AKINESIA,1
PH,ANAL INCONTINENCE,1
PH,ANXIETY,1
PH,APLASTIC ANAEMIA,1
PH,ARTERIAL OCCLUSIVE DISEASE,1
PH,ASTHMA,1
PH,ATAXIA,1
PH,BEDRIDDEN,1
PH,BLOOD CALCIUM INCREASED,1
PH,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PH,BLOOD GLUCOSE FLUCTUATION,1
PH,BLOOD POTASSIUM INCREASED,1
PH,BLOOD PRESSURE DECREASED,1
PH,BONE MARROW FAILURE,1
PH,BONE TUBERCULOSIS,1
PH,BRAIN HERNIATION,1
PH,BRAIN OEDEMA,1
PH,BRONCHOPNEUMONIA,1
PH,CARDIAC DISORDER,1
PH,CARDIAC FAILURE,1
PH,CARDIAC FAILURE CONGESTIVE,1
PH,CARDIAC PACEMAKER INSERTION,1
PH,CEREBRAL HAEMORRHAGE,1
PH,CHEST PAIN,1
PH,CHOLECYSTITIS,1
PH,CHOLECYSTITIS INFECTIVE,1
PH,CHROMATURIA,1
PH,CHRONIC KIDNEY DISEASE,1
PH,COLD SWEAT,1
PH,CONCOMITANT DISEASE PROGRESSION,1
PH,CONJUNCTIVITIS,1
PH,CORONARY ARTERY DISEASE,1
PH,COSTOVERTEBRAL ANGLE TENDERNESS,1
PH,DEEP VEIN THROMBOSIS,1
PH,DEHYDRATION,1
PH,DEPRESSION,1
PH,DIABETIC KETOACIDOSIS,1
PH,DIABETIC NEUROPATHY,1
PH,DIALYSIS,1
PH,DIARRHOEA INFECTIOUS,1
PH,DISORIENTATION,1
PH,DRUG-INDUCED LIVER INJURY,1
PH,EJACULATION DISORDER,1
PH,ELECTROLYTE IMBALANCE,1
PH,ENURESIS,1
PH,ERECTILE DYSFUNCTION,1
PH,EYE HAEMORRHAGE,1
PH,FAECES DISCOLOURED,1
PH,FAECES SOFT,1
PH,FALL,1
PH,FLUID RETENTION,1
PH,FRUSTRATION,1
PH,GAIT DISTURBANCE,1
PH,GASTRIC CANCER,1
PH,GASTRIC ULCER,1
PH,GASTRITIS,1
PH,GASTRITIS EROSIVE,1
PH,GASTROINTESTINAL HAEMORRHAGE,1
PH,GASTROINTESTINAL INFLAMMATION,1
PH,GASTROINTESTINAL MOTILITY DISORDER,1
PH,GASTROINTESTINAL STROMAL TUMOUR,1
PH,GASTROINTESTINAL TRACT IRRITATION,1
PH,GASTROLITHIASIS,1
PH,GESTATIONAL DIABETES,1
PH,HAEMATOCHEZIA,1
PH,HAEMATURIA,1
PH,HEPATIC STEATOSIS,1
PH,HEPATOMEGALY,1
PH,HEPATOTOXICITY,1
PH,HOSPITALISATION,1
PH,HYPERAMYLASAEMIA,1
PH,HYPERLIPASAEMIA,1
PH,HYPERLIPIDAEMIA,1
PH,HYPERSENSITIVITY,1
PH,HYPERURICAEMIA,1
PH,HYPOGLYCAEMIA,1
PH,IMPAIRED HEALING,1
PH,INTERMITTENT CLAUDICATION,1
PH,ISCHAEMIC STROKE,1
PH,KETOACIDOSIS,1
PH,LEUKOCYTOSIS,1
PH,LIMB INJURY,1
PH,LIVER INJURY,1
PH,LOSS OF LIBIDO,1
PH,LUMBAR SPINAL STENOSIS,1
PH,LUNG ADENOCARCINOMA,1
PH,LUNG NEOPLASM MALIGNANT,1
PH,MALAISE,1
PH,MANIA,1
PH,MOVEMENT DISORDER,1
PH,MULTIPLE FRACTURES,1
PH,MUSCULOSKELETAL DISCOMFORT,1
PH,MYELOFIBROSIS,1
PH,NERVE COMPRESSION,1
PH,NONINFECTIVE ENCEPHALITIS,1
PH,NORMAL NEWBORN,1
PH,OEDEMA,1
PH,OEDEMA PERIPHERAL,1
PH,OESOPHAGEAL NEOPLASM,1
PH,ONCOLOGIC COMPLICATION,1
PH,ORTHOSTATIC HYPOTENSION,1
PH,OVERDOSE,1
PH,PAIN,1
PH,PAIN IN EXTREMITY,1
PH,PARATHYROID GLAND OPERATION,1
PH,PERIARTHRITIS,1
PH,PNEUMOCOCCAL SEPSIS,1
PH,PNEUMONIA ASPIRATION,1
PH,PREGNANCY ON ORAL CONTRACEPTIVE,1
PH,PREMATURE LABOUR,1
PH,PRODUCT USE IN UNAPPROVED INDICATION,1
PH,PRODUCT USE ISSUE,1
PH,PROSTATOMEGALY,1
PH,PULMONARY CONGESTION,1
PH,PYREXIA,1
PH,RENAL COLIC,1
PH,RENAL DISORDER,1
PH,RENAL FAILURE ACUTE,1
PH,RENAL FAILURE CHRONIC,1
PH,RENAL INJURY,1
PH,SCROTAL SWELLING,1
PH,SEPSIS,1
PH,SOLILOQUY,1
PH,SPINAL DISORDER,1
PH,STEVENS-JOHNSON SYNDROME,1
PH,STRESS AT WORK,1
PH,SURGERY,1
PH,TESTICULAR MASS,1
PH,THROMBOCYTOPENIA,1
PH,TREATMENT NONCOMPLIANCE,1
PH,TYPE 2 DIABETES MELLITUS,1
PH,ULCER,1
PH,UNDERDOSE,1
PH,UNRESPONSIVE TO STIMULI,1
PH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PH,UPPER RESPIRATORY TRACT INFECTION,1
PH,URINARY INCONTINENCE,1
PH,URTICARIA,1
PH,UTERINE ATROPHY,1
PH,VASCULITIS,1
PH,VENOUS HAEMORRHAGE,1
PH,VENOUS OCCLUSION,1
PH,VENTRICULAR ARRHYTHMIA,1
PL,LACTIC ACIDOSIS,33
PL,METABOLIC ACIDOSIS,24
PL,TOXICITY TO VARIOUS AGENTS,21
PL,HYPOGLYCAEMIA,18
PL,RESPIRATORY FAILURE,14
PL,CONDITION AGGRAVATED,12
PL,BLOOD GLUCOSE INCREASED,11
PL,HYPERGLYCAEMIA,10
PL,HYPOTENSION,10
PL,CIRCULATORY COLLAPSE,9
PL,COMPLETED SUICIDE,9
PL,RENAL FAILURE,9
PL,WEIGHT INCREASED,9
PL,INTENTIONAL PRODUCT MISUSE,8
PL,LOSS OF CONSCIOUSNESS,8
PL,PNEUMONIA,8
PL,CHRONIC KIDNEY DISEASE,7
PL,INTENTIONAL OVERDOSE,7
PL,VOMITING,7
PL,ANAEMIA,6
PL,CYANOSIS,6
PL,DEATH,6
PL,DIABETES MELLITUS INADEQUATE CONTROL,6
PL,DRUG INEFFECTIVE,6
PL,HEPATORENAL SYNDROME,6
PL,HYPERTENSION,6
PL,MULTI-ORGAN FAILURE,6
PL,NAUSEA,6
PL,ACUTE KIDNEY INJURY,5
PL,ASTHENIA,5
PL,BLOOD PRESSURE INCREASED,5
PL,BRADYCARDIA,5
PL,INCREASED APPETITE,5
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
PL,OVERDOSE,5
PL,PAIN,5
PL,POOR QUALITY SLEEP,5
PL,PRINZMETAL ANGINA,5
PL,SUICIDE ATTEMPT,5
PL,ANGINA PECTORIS,4
PL,ARTERIAL SPASM,4
PL,BINGE EATING,4
PL,BLOOD GLUCOSE DECREASED,4
PL,CARDIAC FAILURE,4
PL,CHEST PAIN,4
PL,CONTUSION,4
PL,DECUBITUS ULCER,4
PL,GENERAL PHYSICAL HEALTH DETERIORATION,4
PL,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
PL,HYPERKALAEMIA,4
PL,HYPOVOLAEMIA,4
PL,INTERNATIONAL NORMALISED RATIO FLUCTUATION,4
PL,IRRITABILITY,4
PL,MYOCARDIAL INFARCTION,4
PL,PARAESTHESIA,4
PL,RENAL FAILURE ACUTE,4
PL,SEIZURE,4
PL,ALANINE AMINOTRANSFERASE INCREASED,3
PL,ANXIETY,3
PL,ASPARTATE AMINOTRANSFERASE INCREASED,3
PL,ATRIAL FIBRILLATION,3
PL,BALANCE DISORDER,3
PL,BLOOD GLUCOSE FLUCTUATION,3
PL,BODY MASS INDEX INCREASED,3
PL,CARDIAC ARREST,3
PL,CATARACT,3
PL,CHOLELITHIASIS,3
PL,DIET FAILURE,3
PL,DRUG RESISTANCE,3
PL,DYSPHORIA,3
PL,EJECTION FRACTION DECREASED,3
PL,ELECTROCARDIOGRAM QT PROLONGED,3
PL,EXTRAVASATION,3
PL,HAEMORRHAGE,3
PL,INSOMNIA,3
PL,LEFT ATRIAL DILATATION,3
PL,MITRAL VALVE INCOMPETENCE,3
PL,OBESITY,3
PL,POISONING,3
PL,RENAL IMPAIRMENT,3
PL,TENSION,3
PL,TYPE 2 DIABETES MELLITUS,3
PL,UNDERDOSE,3
PL,WEIGHT DECREASED,3
PL,ABDOMINAL PAIN,2
PL,ACUTE CORONARY SYNDROME,2
PL,AFFECT LABILITY,2
PL,AGRANULOCYTOSIS,2
PL,ALCOHOLISM,2
PL,ARRHYTHMIA,2
PL,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
PL,BLOOD GLUCOSE ABNORMAL,2
PL,BRONCHITIS,2
PL,BRONCHITIS BACTERIAL,2
PL,CACHEXIA,2
PL,CEREBRAL ISCHAEMIA,2
PL,CONVULSION,2
PL,DECREASED APPETITE,2
PL,DEHYDRATION,2
PL,DIABETES MELLITUS,2
PL,DIARRHOEA,2
PL,DIZZINESS,2
PL,DRY MOUTH,2
PL,DYSURIA,2
PL,FALL,2
PL,FEAR,2
PL,GASTRIC ULCER HAEMORRHAGE,2
PL,GLOMERULAR FILTRATION RATE DECREASED,2
PL,HAEMODIALYSIS,2
PL,HEART RATE INCREASED,2
PL,HEPATITIS TOXIC,2
PL,HYPERCHOLESTEROLAEMIA,2
PL,HYPERTHYROIDISM,2
PL,HYPOTHERMIA,2
PL,INITIAL INSOMNIA,2
PL,ISCHAEMIC STROKE,2
PL,LARYNGEAL SQUAMOUS CELL CARCINOMA,2
PL,LIVER INJURY,2
PL,LUNG NEOPLASM MALIGNANT,2
PL,MUSCULAR WEAKNESS,2
PL,MUSCULOSKELETAL PAIN,2
PL,NIGHTMARE,2
PL,OEDEMA,2
PL,OSTEONECROSIS OF JAW,2
PL,PAIN IN EXTREMITY,2
PL,PANCREATIC CARCINOMA,2
PL,PANCREATIC DISORDER,2
PL,PANCREATITIS ACUTE,2
PL,POLYNEUROPATHY,2
PL,PRURITUS,2
PL,PYREXIA,2
PL,RASH PAPULAR,2
PL,SOMNOLENCE,2
PL,TACHYCARDIA,2
PL,TEARFULNESS,2
PL,TONSILLITIS,2
PL,VASCULAR PSEUDOANEURYSM,2
PL,VERTIGO,2
PL,ABNORMAL LOSS OF WEIGHT,1
PL,ACUTE MYOCARDIAL INFARCTION,1
PL,ACUTE PRERENAL FAILURE,1
PL,ADENOCARCINOMA OF COLON,1
PL,ADHESION,1
PL,ADRENAL ADENOMA,1
PL,AGGRESSION,1
PL,AMYLASE INCREASED,1
PL,ANAEMIA VITAMIN B12 DEFICIENCY,1
PL,ANAL STENOSIS,1
PL,ANGINA UNSTABLE,1
PL,ANKLE FRACTURE,1
PL,ANTI-INSULIN ANTIBODY INCREASED,1
PL,ANURIA,1
PL,AORTIC BRUIT,1
PL,ARTERIOSCLEROSIS,1
PL,ARTHRALGIA,1
PL,ATONIC URINARY BLADDER,1
PL,ATRIAL FLUTTER,1
PL,BILIARY COLIC,1
PL,BLOOD CREATINE DECREASED,1
PL,BLOOD KETONE BODY,1
PL,BLOOD KETONE BODY INCREASED,1
PL,BLOOD LACTIC ACID INCREASED,1
PL,BLOOD PRESSURE ABNORMAL,1
PL,BLOOD PRESSURE DECREASED,1
PL,BLOOD PROLACTIN INCREASED,1
PL,BLOOD THYROID STIMULATING HORMONE INCREASED,1
PL,BLOOD UREA INCREASED,1
PL,BLOOD URIC ACID,1
PL,BONE MARROW FAILURE,1
PL,BRONCHOPNEUMONIA,1
PL,CARDIAC DEATH,1
PL,CARDIAC FAILURE CHRONIC,1
PL,CARDIAC FAILURE CONGESTIVE,1
PL,CARDIAC HYPERTROPHY,1
PL,CARDIAC MURMUR,1
PL,CARDIOGENIC SHOCK,1
PL,CARDIOPULMONARY FAILURE,1
PL,CENTRAL NERVOUS SYSTEM LESION,1
PL,CHOLECYSTITIS,1
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
PL,COAGULOPATHY,1
PL,COGNITIVE DISORDER,1
PL,COMMUNICATION DISORDER,1
PL,CONFUSIONAL STATE,1
PL,CONTRAINDICATED DRUG ADMINISTERED,1
PL,CREATININE RENAL CLEARANCE DECREASED,1
PL,CREPITATIONS,1
PL,CUSHING^S SYNDROME,1
PL,DEFORMITY,1
PL,DENTAL GANGRENE,1
PL,DERMAL CYST,1
PL,DIABETIC FOOT,1
PL,DIABETIC KETOACIDOSIS,1
PL,DIABETIC NEPHROPATHY,1
PL,DIABETIC RETINOPATHY,1
PL,DILATATION VENTRICULAR,1
PL,DISEASE PROGRESSION,1
PL,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
PL,DRUG DOSE OMISSION,1
PL,DRUG INTOLERANCE,1
PL,DRUG PRESCRIBING ERROR,1
PL,DRUG-INDUCED LIVER INJURY,1
PL,DYSPNOEA,1
PL,DYSSTASIA,1
PL,EMPHYSEMA,1
PL,EOSINOPHIL COUNT INCREASED,1
PL,ERYTHEMA,1
PL,EXERCISE TOLERANCE DECREASED,1
PL,EXPOSURE VIA INGESTION,1
PL,FEBRILE NEUTROPENIA,1
PL,FEMORAL NECK FRACTURE,1
PL,FOOT FRACTURE,1
PL,GAIT DISTURBANCE,1
PL,GALLBLADDER EMPYEMA,1
PL,GASTRIC ULCER,1
PL,GASTROENTERITIS,1
PL,GASTROINTESTINAL DISORDER,1
PL,GASTROINTESTINAL HAEMORRHAGE,1
PL,GASTROINTESTINAL OBSTRUCTION,1
PL,GASTROOESOPHAGEAL REFLUX DISEASE,1
PL,GENITAL HAEMORRHAGE,1
PL,GLAUCOMA,1
PL,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
PL,GLUCOSE URINE PRESENT,1
PL,GROIN PAIN,1
PL,GUILLAIN-BARRE SYNDROME,1
PL,HAEMORRHAGIC TRANSFORMATION STROKE,1
PL,HEAD INJURY,1
PL,HEPATIC FAILURE,1
PL,HEPATIC STEATOSIS,1
PL,HEPATITIS,1
PL,HYPERLIPIDAEMIA,1
PL,HYPERTRIGLYCERIDAEMIA,1
PL,HYPERURICAEMIA,1
PL,HYPOCALCAEMIA,1
PL,IMPAIRED SELF-CARE,1
PL,INFARCTION,1
PL,INFECTED SKIN ULCER,1
PL,INFECTION,1
PL,INJECTION SITE ERYTHEMA,1
PL,INJECTION SITE SWELLING,1
PL,INSULIN-LIKE GROWTH FACTOR INCREASED,1
PL,INTENTIONAL PRODUCT USE ISSUE,1
PL,INTERMITTENT CLAUDICATION,1
PL,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
PL,INTERNATIONAL NORMALISED RATIO INCREASED,1
PL,JOINT DESTRUCTION,1
PL,JOINT EFFUSION,1
PL,KETOACIDOSIS,1
PL,KETONURIA,1
PL,KUSSMAUL RESPIRATION,1
PL,LARYNGEAL CANCER STAGE I,1
PL,LIPID METABOLISM DISORDER,1
PL,LIPIDS INCREASED,1
PL,LIVER DISORDER,1
PL,MALAISE,1
PL,MALIGNANT NEOPLASM PROGRESSION,1
PL,MEDICATION ERROR,1
PL,MEDICATION RESIDUE PRESENT,1
PL,METASTASES TO CENTRAL NERVOUS SYSTEM,1
PL,MICROCYTIC ANAEMIA,1
PL,MIXED CONNECTIVE TISSUE DISEASE,1
PL,MOBILITY DECREASED,1
PL,MUSCLE SPASMS,1
PL,MYELOPATHY,1
PL,NEUROGLYCOPENIA,1
PL,NEUTROPENIA,1
PL,ORTHOSTATIC HYPOTENSION,1
PL,OSTEOARTHRITIS,1
PL,OTITIS MEDIA CHRONIC,1
PL,PANCREATIC INJURY,1
PL,PANCREATIC NECROSIS,1
PL,PERIPHERAL ARTERY OCCLUSION,1
PL,PITUITARY CYST,1
PL,PITUITARY-DEPENDENT CUSHING^S SYNDROME,1
PL,PNEUMONIA BACTERIAL,1
PL,POST PROCEDURAL COMPLICATION,1
PL,PRODUCT USE IN UNAPPROVED INDICATION,1
PL,PRODUCT USE ISSUE,1
PL,PROSTATOMEGALY,1
PL,PROTEINURIA,1
PL,PSORIASIS,1
PL,PSYCHOMOTOR RETARDATION,1
PL,PULMONARY HYPERTENSION,1
PL,PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME,1
PL,PULMONARY THROMBOSIS,1
PL,PULSE ABNORMAL,1
PL,PYODERMA GANGRENOSUM,1
PL,PYURIA,1
PL,REGURGITATION,1
PL,RENAL DISORDER,1
PL,RENAL HYPOPLASIA,1
PL,RESPIRATORY TRACT INFECTION,1
PL,RETINOPATHY PROLIFERATIVE,1
PL,SELF-MEDICATION,1
PL,SINUS NODE DYSFUNCTION,1
PL,SLEEP DISORDER,1
PL,SMALL INTESTINAL HAEMORRHAGE,1
PL,SUBCUTANEOUS HAEMATOMA,1
PL,SUICIDAL IDEATION,1
PL,TACHYPNOEA,1
PL,TENDON RUPTURE,1
PL,THROAT LESION,1
PL,THROMBOSIS,1
PL,TOOTH DISORDER,1
PL,TRANSFUSION,1
PL,TUBULOINTERSTITIAL NEPHRITIS,1
PL,TYPE 1 DIABETES MELLITUS,1
PL,UPPER RESPIRATORY TRACT INFECTION,1
PL,URINARY TRACT INFECTION,1
PL,URINE OUTPUT DECREASED,1
PL,UTERINE POLYP,1
PL,VITREOUS HAEMORRHAGE,1
PL,VULVOVAGINAL MYCOTIC INFECTION,1
PL,VULVOVAGINAL PRURITUS,1
PL,WHEEZING,1
PL,WOUND HAEMORRHAGE,1
PL,XANTHOMA,1
PT,LACTIC ACIDOSIS,46
PT,ACUTE KIDNEY INJURY,33
PT,SHOCK,18
PT,METABOLIC ACIDOSIS,17
PT,FATIGUE,14
PT,SUICIDE ATTEMPT,13
PT,VOMITING,13
PT,ASTHENIA,11
PT,BLOOD LACTIC ACID INCREASED,11
PT,HYPERKALAEMIA,11
PT,RENAL INJURY,11
PT,SEPSIS,11
PT,TOXICITY TO VARIOUS AGENTS,11
PT,DIARRHOEA,10
PT,THROMBOCYTOPENIA,10
PT,TOXIC EPIDERMAL NECROLYSIS,10
PT,ANAEMIA,9
PT,HYPONATRAEMIA,9
PT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,9
PT,PSYCHOTIC DISORDER,9
PT,DIZZINESS,8
PT,DRY MOUTH,8
PT,ERYTHEMA,8
PT,HYPERLACTACIDAEMIA,8
PT,NAUSEA,8
PT,NEUROLOGICAL SYMPTOM,8
PT,PERIPHERAL ISCHAEMIA,8
PT,PYREXIA,8
PT,SYNCOPE,8
PT,WEIGHT DECREASED,8
PT,DECREASED APPETITE,7
PT,DIABETIC FOOT INFECTION,7
PT,DRUG INEFFECTIVE,7
PT,FALL,7
PT,LEUKOCYTOSIS,7
PT,OEDEMA,7
PT,PAIN,7
PT,PNEUMONIA,7
PT,RENAL IMPAIRMENT,7
PT,RESPIRATORY FAILURE,7
PT,CARDIAC ARREST,6
PT,FINGER AMPUTATION,6
PT,HYPOMAGNESAEMIA,6
PT,HYPOTENSION,6
PT,INSOMNIA,6
PT,LUNG INFILTRATION,6
PT,MUSCULAR WEAKNESS,6
PT,MYALGIA,6
PT,NEUTROPENIA,6
PT,ABDOMINAL PAIN,5
PT,ARTHRALGIA,5
PT,BLOOD GLUCOSE INCREASED,5
PT,CHOLESTASIS,5
PT,DEHYDRATION,5
PT,DYSARTHRIA,5
PT,DYSPNOEA,5
PT,HEADACHE,5
PT,HYPERGLYCAEMIA,5
PT,MALAISE,5
PT,METABOLIC DISORDER,5
PT,PRURITUS GENERALISED,5
PT,TREMOR,5
PT,ABNORMAL BEHAVIOUR,4
PT,BLOOD ALKALINE PHOSPHATASE INCREASED,4
PT,BLOOD CREATININE INCREASED,4
PT,DIABETIC KETOACIDOSIS,4
PT,GASTRITIS,4
PT,HAEMATOCHEZIA,4
PT,HEPATOTOXICITY,4
PT,HYPERAMMONAEMIC ENCEPHALOPATHY,4
PT,HYPOGLYCAEMIA,4
PT,INTERSTITIAL LUNG DISEASE,4
PT,JAUNDICE,4
PT,LOSS OF CONSCIOUSNESS,4
PT,RASH,4
PT,ROAD TRAFFIC ACCIDENT,4
PT,SOMNOLENCE,4
PT,TACHYCARDIA,4
PT,TONGUE OEDEMA,4
PT,URINARY TRACT INFECTION,4
PT,ABDOMINAL DISCOMFORT,3
PT,ANGIOEDEMA,3
PT,APHASIA,3
PT,C-REACTIVE PROTEIN INCREASED,3
PT,CARDIAC FAILURE,3
PT,CONDITION AGGRAVATED,3
PT,DEATH,3
PT,DIABETES MELLITUS,3
PT,DIABETES MELLITUS INADEQUATE CONTROL,3
PT,DISORIENTATION,3
PT,DRUG HYPERSENSITIVITY,3
PT,DYSGEUSIA,3
PT,ERYTHRODERMIC PSORIASIS,3
PT,FEBRILE NEUTROPENIA,3
PT,GOUT,3
PT,HAEMOGLOBIN DECREASED,3
PT,HEMIPARESIS,3
PT,HIATUS HERNIA,3
PT,HYPERHIDROSIS,3
PT,LYMPHADENOPATHY,3
PT,OESOPHAGITIS,3
PT,OLIGURIA,3
PT,PERIPHERAL MOTOR NEUROPATHY,3
PT,PRODUCT QUALITY ISSUE,3
PT,PSORIASIS,3
PT,SKIN LESION,3
PT,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,3
PT,THROMBOCYTOSIS,3
PT,ABDOMINAL DISTENSION,2
PT,ABDOMINAL HERNIA,2
PT,ABORTION,2
PT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
PT,ACUTE CORONARY SYNDROME,2
PT,ALANINE AMINOTRANSFERASE INCREASED,2
PT,ALLERGIC COUGH,2
PT,AMNESIA,2
PT,APATHY,2
PT,ARRHYTHMIA,2
PT,ASPARTATE AMINOTRANSFERASE INCREASED,2
PT,BLOOD CHOLESTEROL INCREASED,2
PT,BLOOD GLUCOSE FLUCTUATION,2
PT,BLOOD PH DECREASED,2
PT,BLOOD TRIGLYCERIDES INCREASED,2
PT,CHEST PAIN,2
PT,COMA,2
PT,CONFUSIONAL STATE,2
PT,DELUSION,2
PT,DEPRESSION,2
PT,DERMATOSIS,2
PT,DIABETIC COMA,2
PT,DRUG LEVEL INCREASED,2
PT,DYSPHAGIA,2
PT,DYSURIA,2
PT,ELECTROLYTE IMBALANCE,2
PT,EOSINOPHILIA,2
PT,EXFOLIATIVE RASH,2
PT,EYE SWELLING,2
PT,FACE OEDEMA,2
PT,GAIT DISTURBANCE,2
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
PT,GASTROINTESTINAL DISORDER,2
PT,HAEMATURIA,2
PT,HEAD INJURY,2
PT,HYPERAMMONAEMIA,2
PT,HYPOAESTHESIA ORAL,2
PT,HYPOVOLAEMIC SHOCK,2
PT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
PT,INFECTION,2
PT,INFLAMMATORY MARKER INCREASED,2
PT,LIP DISORDER,2
PT,LUNG NEOPLASM,2
PT,MOUTH HAEMORRHAGE,2
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
PT,MULTIPLE SCLEROSIS,2
PT,NEPHRITIS ALLERGIC,2
PT,NERVOUSNESS,2
PT,NEUROTOXICITY,2
PT,PALPITATIONS,2
PT,PARAESTHESIA,2
PT,PLATELET COUNT DECREASED,2
PT,PROTEINURIA,2
PT,PRURITUS,2
PT,PUSTULAR PSORIASIS,2
PT,RASH ERYTHEMATOUS,2
PT,RASH MACULO-PAPULAR,2
PT,RECTAL HAEMORRHAGE,2
PT,RENAL FAILURE,2
PT,RENAL TUBULAR NECROSIS,2
PT,RHYTHM IDIOVENTRICULAR,2
PT,THINKING ABNORMAL,2
PT,THIRST,2
PT,THYROIDITIS,2
PT,TRANSIENT ISCHAEMIC ATTACK,2
PT,TREATMENT NONCOMPLIANCE,2
PT,TUBULOINTERSTITIAL NEPHRITIS,2
PT,UNRESPONSIVE TO STIMULI,2
PT,URINARY RETENTION,2
PT,URINARY TRACT DISORDER,2
PT,ABASIA,1
PT,ABDOMINAL PAIN LOWER,1
PT,ABDOMINAL SEPSIS,1
PT,ABNORMAL DREAMS,1
PT,ACETONAEMIA,1
PT,ACIDOSIS,1
PT,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
PT,ACUTE PRERENAL FAILURE,1
PT,ADENOCARCINOMA,1
PT,ADENOCARCINOMA OF COLON,1
PT,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
PT,AFFECT LABILITY,1
PT,AGGRESSION,1
PT,AGITATION,1
PT,AKINESIA,1
PT,ALOPECIA,1
PT,ALVEOLITIS ALLERGIC,1
PT,ANURIA,1
PT,APHTHOUS ULCER,1
PT,ARTERIOSCLEROSIS,1
PT,ARTHRITIS INFECTIVE,1
PT,ASCITES,1
PT,ASPHYXIA,1
PT,ATAXIA,1
PT,ATRIOVENTRICULAR BLOCK,1
PT,AUTOIMMUNE PANCREATITIS,1
PT,BACTERAEMIA,1
PT,BASEDOW^S DISEASE,1
PT,BLADDER TRANSITIONAL CELL CARCINOMA,1
PT,BLINDNESS TRANSIENT,1
PT,BLISTER,1
PT,BLOOD BICARBONATE DECREASED,1
PT,BLOOD BICARBONATE INCREASED,1
PT,BLOOD BILIRUBIN INCREASED,1
PT,BLOOD CULTURE POSITIVE,1
PT,BLOOD GLUCOSE ABNORMAL,1
PT,BLOOD GLUCOSE DECREASED,1
PT,BLOOD PH INCREASED,1
PT,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PT,BODY TEMPERATURE INCREASED,1
PT,BRADYCARDIA,1
PT,CAESAREAN SECTION,1
PT,CANDIDA INFECTION,1
PT,CARDIAC TAMPONADE,1
PT,CARDIO-RESPIRATORY ARREST,1
PT,CEREBELLAR HAEMORRHAGE,1
PT,CEREBRAL HAEMORRHAGE,1
PT,CEREBRAL SALT-WASTING SYNDROME,1
PT,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,1
PT,CEREBROVASCULAR ACCIDENT,1
PT,CHEST DISCOMFORT,1
PT,CHILLS,1
PT,CHROMATURIA,1
PT,CHRONIC KIDNEY DISEASE,1
PT,COAGULOPATHY,1
PT,COLD SWEAT,1
PT,COLITIS MICROSCOPIC,1
PT,COLON CANCER STAGE II,1
PT,COMA HEPATIC,1
PT,COMA SCALE,1
PT,CONSTIPATION,1
PT,CONVULSION,1
PT,COUGH,1
PT,CRANIOCEREBRAL INJURY,1
PT,CREATININE RENAL CLEARANCE DECREASED,1
PT,CRYING,1
PT,CSF GLUCOSE INCREASED,1
PT,CSF PROTEIN INCREASED,1
PT,DEEP VEIN THROMBOSIS,1
PT,DEMENTIA,1
PT,DEMYELINATION,1
PT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PT,DERMATITIS ACNEIFORM,1
PT,DERMATITIS CONTACT,1
PT,DIABETIC NEPHROPATHY,1
PT,DIALYSIS,1
PT,DISEASE PROGRESSION,1
PT,DIVERTICULITIS,1
PT,DRUG ABUSE,1
PT,DRUG DOSE OMISSION,1
PT,DRUG INTOLERANCE,1
PT,DRUG TOLERANCE,1
PT,DYSENTERY,1
PT,DYSPEPSIA,1
PT,DYSPHONIA,1
PT,DYSPNOEA EXERTIONAL,1
PT,EATING DISORDER,1
PT,ECCHYMOSIS,1
PT,ECZEMA,1
PT,EMBOLIC STROKE,1
PT,EPISTAXIS,1
PT,ERECTILE DYSFUNCTION,1
PT,ESCHERICHIA TEST POSITIVE,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EYE DISORDER,1
PT,EYE HAEMORRHAGE,1
PT,EYE INFLAMMATION,1
PT,FACIAL PARALYSIS,1
PT,FEELING HOT,1
PT,FEMORAL NECK FRACTURE,1
PT,FOETAL EXPOSURE DURING PREGNANCY,1
PT,GASTROINTESTINAL HAEMORRHAGE,1
PT,GASTROINTESTINAL TOXICITY,1
PT,GASTROOESOPHAGEAL REFLUX DISEASE,1
PT,GENERALISED ERYTHEMA,1
PT,GENERALISED OEDEMA,1
PT,GINGIVITIS,1
PT,HAEMOCHROMATOSIS,1
PT,HAEMOLYSIS,1
PT,HAEMOLYTIC ANAEMIA,1
PT,HAEMOPTYSIS,1
PT,HAEMORRHAGE,1
PT,HAEMORRHAGE INTRACRANIAL,1
PT,HAEMORRHAGIC STROKE,1
PT,HEPATIC CANCER,1
PT,HEPATIC ENZYME INCREASED,1
PT,HEPATIC PAIN,1
PT,HEPATIC STEATOSIS,1
PT,HEPATITIS CHOLESTATIC,1
PT,HIGH DENSITY LIPOPROTEIN INCREASED,1
PT,HYPERTENSION,1
PT,HYPERTHYROIDISM,1
PT,HYPOCALCAEMIA,1
PT,HYPOKALAEMIA,1
PT,HYPOPHOSPHATAEMIA,1
PT,HYPOTHERMIA,1
PT,HYPOVOLAEMIA,1
PT,HYPOXIA,1
PT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PT,INCORRECT DRUG ADMINISTRATION RATE,1
PT,INFLAMMATORY MYOFIBROBLASTIC TUMOUR,1
PT,INJECTION SITE BRUISING,1
PT,INJECTION SITE PAIN,1
PT,INTENTIONAL OVERDOSE,1
PT,INTERMITTENT CLAUDICATION,1
PT,INTESTINAL PERFORATION,1
PT,ISCHAEMIC STROKE,1
PT,JOINT STIFFNESS,1
PT,KLEBSIELLA INFECTION,1
PT,KLEBSIELLA TEST POSITIVE,1
PT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
PT,LACRIMATION INCREASED,1
PT,LARYNGEAL OEDEMA,1
PT,LEG AMPUTATION,1
PT,LETHARGY,1
PT,LEUKOCYTURIA,1
PT,LIVER DISORDER,1
PT,LYMPHOCYTOSIS,1
PT,MALABSORPTION,1
PT,MATERNAL EXPOSURE DURING PREGNANCY,1
PT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
PT,MELAENA,1
PT,MEMORY IMPAIRMENT,1
PT,MENINGITIS ASEPTIC,1
PT,MIGRAINE,1
PT,MOTOR DYSFUNCTION,1
PT,MOUTH SWELLING,1
PT,MUCOSAL INFLAMMATION,1
PT,MUSCLE DISORDER,1
PT,MUSCLE RIGIDITY,1
PT,MUSCLE TWITCHING,1
PT,MYOCARDIAL ISCHAEMIA,1
PT,MYOCLONUS,1
PT,NASAL CONGESTION,1
PT,NASOPHARYNGITIS,1
PT,NECROTISING FASCIITIS,1
PT,NECROTISING FASCIITIS STAPHYLOCOCCAL,1
PT,NEPHROLITHIASIS,1
PT,NEPHROPATHY TOXIC,1
PT,NEURODEGENERATIVE DISORDER,1
PT,NEUTROPHILIA,1
PT,NOCTURIA,1
PT,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
PT,OEDEMA PERIPHERAL,1
PT,OESOPHAGEAL PAIN,1
PT,OSTEONECROSIS,1
PT,OVERDOSE,1
PT,OXYGEN SATURATION DECREASED,1
PT,PAIN IN EXTREMITY,1
PT,PAIN IN JAW,1
PT,PALLOR,1
PT,PANCREATIC CARCINOMA,1
PT,PANCREATIC FAILURE,1
PT,PANCREATITIS ACUTE,1
PT,PARAESTHESIA ORAL,1
PT,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
PT,PERNICIOUS ANAEMIA,1
PT,PHARYNGEAL OEDEMA,1
PT,PNEUMONIA ASPIRATION,1
PT,PO2 DECREASED,1
PT,POISONING,1
PT,POLLAKIURIA,1
PT,PORTAL VEIN DILATATION,1
PT,POSTICTAL PARALYSIS,1
PT,PREMATURE BABY,1
PT,PRESCRIBED OVERDOSE,1
PT,PRESYNCOPE,1
PT,PRODUCT SUBSTITUTION ISSUE,1
PT,PRODUCT USE IN UNAPPROVED INDICATION,1
PT,PRODUCTIVE COUGH,1
PT,PROTHROMBIN TIME PROLONGED,1
PT,PSYCHOMOTOR RETARDATION,1
PT,PULMONARY EMBOLISM,1
PT,PYELONEPHRITIS,1
PT,RASH MORBILLIFORM,1
PT,RASH PUSTULAR,1
PT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PT,RENAL DISORDER,1
PT,RENAL PAIN,1
PT,RESPIRATORY ARREST,1
PT,RESPIRATORY DISTRESS,1
PT,RESPIRATORY RATE INCREASED,1
PT,RETROPERITONEAL HAEMORRHAGE,1
PT,RHABDOMYOLYSIS,1
PT,RHESUS ANTIBODIES POSITIVE,1
PT,SALIVARY HYPERSECRETION,1
PT,SEPTIC SHOCK,1
PT,SEROTONIN SYNDROME,1
PT,SINUS TACHYCARDIA,1
PT,SKIN DISCOLOURATION,1
PT,SKIN DISORDER,1
PT,SKIN EXFOLIATION,1
PT,SKIN REACTION,1
PT,SKIN WOUND,1
PT,SLOW RESPONSE TO STIMULI,1
PT,SPEECH DISORDER,1
PT,SPUTUM PURULENT,1
PT,SQUAMOUS CELL CARCINOMA OF LUNG,1
PT,STAPHYLOCOCCAL INFECTION,1
PT,STOMATITIS,1
PT,STUPOR,1
PT,SUPRAVENTRICULAR EXTRASYSTOLES,1
PT,SUPRAVENTRICULAR TACHYCARDIA,1
PT,TACHYPNOEA,1
PT,THROMBOSIS,1
PT,TONGUE DISORDER,1
PT,TOOTHACHE,1
PT,TOXIC ENCEPHALOPATHY,1
PT,TOXIC SKIN ERUPTION,1
PT,TYPE 1 DIABETES MELLITUS,1
PT,ULCERATIVE KERATITIS,1
PT,UNWANTED AWARENESS DURING ANAESTHESIA,1
PT,UPPER RESPIRATORY TRACT INFECTION,1
PT,URETHRAL HAEMORRHAGE,1
PT,URINE FLOW DECREASED,1
PT,URINE OUTPUT DECREASED,1
PT,UROSEPSIS,1
PT,URTICARIA,1
PT,UTERINE PROLAPSE,1
PT,VENTRICULAR EXTRASYSTOLES,1
PT,VESSEL PUNCTURE SITE BRUISE,1
PT,VISION BLURRED,1
PT,VITAMIN B12 DEFICIENCY,1
PT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
PR,NASOPHARYNGITIS,55
PR,INJECTION SITE PAIN,47
PR,PAIN,33
PR,ARTHRALGIA,30
PR,DRUG INEFFECTIVE,25
PR,PAIN IN EXTREMITY,23
PR,HEADACHE,22
PR,PSORIASIS,21
PR,ASTHMA,18
PR,FALL,17
PR,DIARRHOEA,16
PR,INFLAMMATION,15
PR,PYREXIA,15
PR,BRONCHITIS,14
PR,FATIGUE,14
PR,DIABETES MELLITUS,13
PR,MALAISE,13
PR,CATARACT,12
PR,BLOOD GLUCOSE INCREASED,11
PR,COUGH,11
PR,DEPRESSION,11
PR,DIZZINESS,11
PR,OROPHARYNGEAL PAIN,11
PR,URINARY TRACT INFECTION,11
PR,BACK PAIN,10
PR,HYPERTENSION,9
PR,MUSCLE SPASMS,9
PR,ERYTHEMA,8
PR,MUSCULOSKELETAL PAIN,8
PR,PRURITUS,8
PR,ASTHENIA,7
PR,DECREASED APPETITE,7
PR,GAIT DISTURBANCE,7
PR,HAEMOGLOBIN DECREASED,7
PR,HYPERSENSITIVITY,7
PR,HYPOAESTHESIA,7
PR,INJECTION SITE ERYTHEMA,7
PR,INJECTION SITE PRURITUS,7
PR,NAUSEA,7
PR,PERIPHERAL SWELLING,7
PR,SINUSITIS,7
PR,VOMITING,7
PR,BURNING SENSATION,6
PR,DYSPNOEA,6
PR,PNEUMONIA,6
PR,PRODUCTIVE COUGH,6
PR,RASH,6
PR,RHEUMATOID ARTHRITIS,6
PR,VISION BLURRED,6
PR,ANAEMIA,5
PR,CELLULITIS,5
PR,INFECTION,5
PR,NECK PAIN,5
PR,OSTEOARTHRITIS,5
PR,RESPIRATORY TRACT CONGESTION,5
PR,ABDOMINAL PAIN,4
PR,ARTHRITIS,4
PR,ARTHROPATHY,4
PR,BLOOD CHOLESTEROL INCREASED,4
PR,BONE PAIN,4
PR,CHIKUNGUNYA VIRUS INFECTION,4
PR,DEHYDRATION,4
PR,DISCOMFORT,4
PR,DYSPHONIA,4
PR,GASTRITIS,4
PR,HYPOTHYROIDISM,4
PR,INSOMNIA,4
PR,LIMB INJURY,4
PR,LOSS OF CONSCIOUSNESS,4
PR,MENISCUS INJURY,4
PR,MYALGIA,4
PR,NASAL CONGESTION,4
PR,PLATELET COUNT DECREASED,4
PR,RASH MACULAR,4
PR,SOMNOLENCE,4
PR,SWELLING FACE,4
PR,THYROID MASS,4
PR,URTICARIA,4
PR,VIRAL INFECTION,4
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
PR,ABDOMINAL DISCOMFORT,3
PR,ABDOMINAL DISTENSION,3
PR,ABDOMINAL PAIN UPPER,3
PR,ABSCESS,3
PR,ANXIETY,3
PR,BLOOD GLUCOSE ABNORMAL,3
PR,BLOOD GLUCOSE DECREASED,3
PR,BLOOD TRIGLYCERIDES INCREASED,3
PR,BREAST MASS,3
PR,CARDIAC FAILURE,3
PR,CARPAL TUNNEL SYNDROME,3
PR,CHEST PAIN,3
PR,CHILLS,3
PR,CONSTIPATION,3
PR,CYST,3
PR,DIABETIC NEUROPATHY,3
PR,DRUG PRESCRIBING ERROR,3
PR,EXOSTOSIS,3
PR,EYE DISORDER,3
PR,FEELING HOT,3
PR,FLUID RETENTION,3
PR,HYPERHIDROSIS,3
PR,IMMUNODEFICIENCY,3
PR,INJECTION SITE URTICARIA,3
PR,NERVOUSNESS,3
PR,OEDEMA PERIPHERAL,3
PR,OSTEOPENIA,3
PR,PHARYNGITIS,3
PR,PHLEBITIS,3
PR,POST PROCEDURAL INFECTION,3
PR,PRURITUS GENERALISED,3
PR,SUBCUTANEOUS ABSCESS,3
PR,SURGERY,3
PR,SWELLING,3
PR,THROMBOSIS,3
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,3
PR,VISUAL IMPAIRMENT,3
PR,VITAMIN D DEFICIENCY,3
PR,WEIGHT DECREASED,3
PR,WOUND,3
PR,ABSCESS LIMB,2
PR,ABSCESS NECK,2
PR,ALOPECIA,2
PR,ANAL ABSCESS,2
PR,ANGINA PECTORIS,2
PR,AORTIC ARTERIOSCLEROSIS,2
PR,ARTERIAL OCCLUSIVE DISEASE,2
PR,BLINDNESS,2
PR,CHEST DISCOMFORT,2
PR,COORDINATION ABNORMAL,2
PR,DEATH,2
PR,DEPRESSED MOOD,2
PR,DERMATITIS ALLERGIC,2
PR,DIABETES MELLITUS INADEQUATE CONTROL,2
PR,DRUG DOSE OMISSION,2
PR,DRUG EFFECT INCOMPLETE,2
PR,DYSARTHRIA,2
PR,DYSPEPSIA,2
PR,EAR DISORDER,2
PR,EYE INFLAMMATION,2
PR,EYE SWELLING,2
PR,FACIAL PARALYSIS,2
PR,FIBROMYALGIA,2
PR,FUNGAL INFECTION,2
PR,GROIN ABSCESS,2
PR,HAEMATOMA,2
PR,HAEMORRHAGE,2
PR,HAND FRACTURE,2
PR,HEAD DISCOMFORT,2
PR,HEAD INJURY,2
PR,HEPATIC STEATOSIS,2
PR,HOSPITALISATION,2
PR,HYPERCHOLESTEROLAEMIA,2
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
PR,INFLUENZA,2
PR,INJECTION SITE DISCOMFORT,2
PR,INJECTION SITE HAEMORRHAGE,2
PR,INJECTION SITE WARMTH,2
PR,INTERVERTEBRAL DISC DISORDER,2
PR,JOINT SWELLING,2
PR,LARYNGITIS,2
PR,LIGAMENT SPRAIN,2
PR,LIVER DISORDER,2
PR,LOCAL SWELLING,2
PR,LOCALISED INFECTION,2
PR,MEMORY IMPAIRMENT,2
PR,MOBILITY DECREASED,2
PR,MUSCULAR WEAKNESS,2
PR,MUSCULOSKELETAL DISCOMFORT,2
PR,NERVE COMPRESSION,2
PR,OEDEMA,2
PR,OSTEOMYELITIS,2
PR,OSTEOPOROSIS,2
PR,OVARIAN CYST,2
PR,PALPITATIONS,2
PR,PULMONARY MASS,2
PR,RHINORRHOEA,2
PR,SALIVARY DUCT OBSTRUCTION,2
PR,SKIN DISCOLOURATION,2
PR,SKIN DISORDER,2
PR,SLOW SPEECH,2
PR,SPINAL DISORDER,2
PR,SPINAL OPERATION,2
PR,STRESS,2
PR,SUICIDE ATTEMPT,2
PR,TACHYCARDIA,2
PR,TENDON INJURY,2
PR,UTERINE HAEMORRHAGE,2
PR,UTERINE LEIOMYOMA,2
PR,VAGINAL CANCER,2
PR,ABASIA,1
PR,ABDOMINAL ABSCESS,1
PR,ABSCESS BACTERIAL,1
PR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PR,ADNEXA UTERI CYST,1
PR,ADVERSE EVENT,1
PR,AGGRESSION,1
PR,ANAL NEOPLASM,1
PR,ANGIOEDEMA,1
PR,ANIMAL SCRATCH,1
PR,ANKLE FRACTURE,1
PR,ANTINUCLEAR ANTIBODY INCREASED,1
PR,APHONIA,1
PR,ARRHYTHMIA,1
PR,AZOOSPERMIA,1
PR,BACTERIAL INFECTION,1
PR,BENIGN HEPATIC NEOPLASM,1
PR,BLINDNESS TRANSIENT,1
PR,BLOOD BLISTER,1
PR,BLOOD CREATINE INCREASED,1
PR,BLOOD POTASSIUM INCREASED,1
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PR,BLOOD PRESSURE INCREASED,1
PR,BLOOD UREA INCREASED,1
PR,BLOOD URIC ACID INCREASED,1
PR,BLOOD URINE PRESENT,1
PR,BONE NEOPLASM,1
PR,BOREDOM,1
PR,BREAST DISORDER,1
PR,BREAST DISORDER FEMALE,1
PR,BREATH SOUNDS ABNORMAL,1
PR,BURNS SECOND DEGREE,1
PR,CANDIDA INFECTION,1
PR,CARDIAC ARREST,1
PR,CARDIAC DISORDER,1
PR,CARDIAC MURMUR,1
PR,CARDIOMEGALY,1
PR,CEREBRAL HAEMORRHAGE,1
PR,CEREBROVASCULAR ACCIDENT,1
PR,CERVICITIS,1
PR,CHOLELITHIASIS,1
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
PR,CLOSTRIDIUM DIFFICILE SEPSIS,1
PR,COLITIS ULCERATIVE,1
PR,COLON CANCER,1
PR,COSTOCHONDRITIS,1
PR,CROHN^S DISEASE,1
PR,DECREASED IMMUNE RESPONSIVENESS,1
PR,DENGUE FEVER,1
PR,DERMATITIS,1
PR,DEVICE MALFUNCTION,1
PR,DIPLOPIA,1
PR,DRUG EFFECT DECREASED,1
PR,DRUG ERUPTION,1
PR,DRUG HYPERSENSITIVITY,1
PR,DRY THROAT,1
PR,DYSGEUSIA,1
PR,DYSSTASIA,1
PR,DYSURIA,1
PR,EAR CANAL STENOSIS,1
PR,EAR PAIN,1
PR,EATING DISORDER,1
PR,EYE HAEMORRHAGE,1
PR,EYE PRURITUS,1
PR,EYELID OEDEMA,1
PR,EYELID PTOSIS,1
PR,FACE INJURY,1
PR,FEELING ABNORMAL,1
PR,FEELING COLD,1
PR,FEMUR FRACTURE,1
PR,FIBROMA,1
PR,FINGER DEFORMITY,1
PR,GALLBLADDER DISORDER,1
PR,GALLBLADDER OPERATION,1
PR,GANGRENE,1
PR,GASTRIC ULCER HAEMORRHAGE,1
PR,GASTROENTERITIS VIRAL,1
PR,GENERALISED OEDEMA,1
PR,GENITAL ABSCESS,1
PR,GINGIVAL SWELLING,1
PR,GLAUCOMA,1
PR,GOITRE,1
PR,HAEMATOCHEZIA,1
PR,HAEMATURIA,1
PR,HAEMOPTYSIS,1
PR,HAEMORRHAGIC STROKE,1
PR,HAIR COLOUR CHANGES,1
PR,HAIR DISORDER,1
PR,HAIR TEXTURE ABNORMAL,1
PR,HEART RATE DECREASED,1
PR,HELICOBACTER INFECTION,1
PR,HEPATIC CIRRHOSIS,1
PR,HEPATIC ENZYME INCREASED,1
PR,HEPATIC FAILURE,1
PR,HEPATIC MASS,1
PR,HEPATITIS C,1
PR,HYPOKINESIA,1
PR,HYPOXIA,1
PR,HYSTERECTOMY,1
PR,INCORRECT DOSE ADMINISTERED,1
PR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
PR,INCREASED UPPER AIRWAY SECRETION,1
PR,INFARCTION,1
PR,INFECTED SKIN ULCER,1
PR,INFLAMMATORY MARKER INCREASED,1
PR,INFUSION SITE EXTRAVASATION,1
PR,INGROWN HAIR,1
PR,INJECTION SITE HAEMATOMA,1
PR,INJECTION SITE HYPERSENSITIVITY,1
PR,INJECTION SITE INFLAMMATION,1
PR,INJECTION SITE RASH,1
PR,INJECTION SITE REACTION,1
PR,INJECTION SITE SWELLING,1
PR,INTERVERTEBRAL DISC DEGENERATION,1
PR,INTERVERTEBRAL DISC OPERATION,1
PR,INTERVERTEBRAL DISC PROTRUSION,1
PR,INTESTINAL OBSTRUCTION,1
PR,INTESTINAL POLYP,1
PR,INTRACRANIAL MASS,1
PR,IRRITABILITY,1
PR,JOINT INJURY,1
PR,JOINT STIFFNESS,1
PR,LACERATION,1
PR,LIGAMENT DISORDER,1
PR,LIPOMA,1
PR,LUNG DISORDER,1
PR,LUNG INFECTION,1
PR,LYMPHOMA,1
PR,MADAROSIS,1
PR,MENTAL STATUS CHANGES,1
PR,MIDDLE EAR EFFUSION,1
PR,MONOPLEGIA,1
PR,MOTOR DYSFUNCTION,1
PR,MULTIPLE SCLEROSIS,1
PR,MUSCLE STRAIN,1
PR,MUSCULOSKELETAL DISORDER,1
PR,MUSCULOSKELETAL STIFFNESS,1
PR,MYOCARDIAL INFARCTION,1
PR,MYOSITIS,1
PR,NEOPLASM MALIGNANT,1
PR,NEOPLASM PROGRESSION,1
PR,NEUROPATHY PERIPHERAL,1
PR,NODULE,1
PR,OESOPHAGEAL PAIN,1
PR,OPTIC NERVE DISORDER,1
PR,OPTIC NEURITIS,1
PR,ORAL INFECTION,1
PR,ORGANISING PNEUMONIA,1
PR,OTORRHOEA,1
PR,OVARIAN DISORDER,1
PR,OVERDOSE,1
PR,OXYGEN SATURATION DECREASED,1
PR,PANCREATIC CYST,1
PR,PANCREATIC ENZYMES INCREASED,1
PR,PANCREATITIS,1
PR,PANIC ATTACK,1
PR,PAPULE,1
PR,PARAESTHESIA,1
PR,PARAESTHESIA ORAL,1
PR,PEAU D^ORANGE,1
PR,PERIPHERAL VENOUS DISEASE,1
PR,PERIPROSTHETIC FRACTURE,1
PR,PHARYNGEAL CYST,1
PR,PHARYNGEAL NEOPLASM,1
PR,PHOTOSENSITIVITY REACTION,1
PR,PLASMA CELL MYELOMA,1
PR,PLATELET COUNT INCREASED,1
PR,PLATELET DISORDER,1
PR,POLYP,1
PR,POST PROCEDURAL CELLULITIS,1
PR,POSTOPERATIVE WOUND COMPLICATION,1
PR,POSTOPERATIVE WOUND INFECTION,1
PR,PRE-EXISTING CONDITION IMPROVED,1
PR,PRODUCT STORAGE ERROR,1
PR,PROSTATE CANCER,1
PR,PROTEIN URINE PRESENT,1
PR,PSORIATIC ARTHROPATHY,1
PR,PULMONARY OEDEMA,1
PR,PULMONARY PAIN,1
PR,RASH GENERALISED,1
PR,RASH PUSTULAR,1
PR,RECTAL HAEMORRHAGE,1
PR,RENAL DISORDER,1
PR,RENAL IMPAIRMENT,1
PR,RESPIRATORY ARREST,1
PR,RESPIRATORY DEPRESSION,1
PR,RESPIRATORY DISORDER,1
PR,RESPIRATORY TRACT INFECTION,1
PR,RETINOPATHY,1
PR,RHINITIS,1
PR,SALIVARY GLAND CALCULUS,1
PR,SCIATICA,1
PR,SEIZURE,1
PR,SENILE OSTEOPOROSIS,1
PR,SEPSIS,1
PR,SKELETAL INJURY,1
PR,SKIN ABRASION,1
PR,SKIN EXFOLIATION,1
PR,SKIN FISSURES,1
PR,SKIN HYPERPIGMENTATION,1
PR,SKIN HYPERPLASIA,1
PR,SKIN LESION,1
PR,SKIN MASS,1
PR,SKIN SWELLING,1
PR,SMALL INTESTINAL OBSTRUCTION,1
PR,SPINAL PAIN,1
PR,SPONDYLITIS,1
PR,STAPHYLOCOCCAL ABSCESS,1
PR,SUICIDAL IDEATION,1
PR,SYNCOPE,1
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PR,TESTICULAR HAEMORRHAGE,1
PR,THERAPEUTIC RESPONSE UNEXPECTED,1
PR,THIRST,1
PR,THROMBOCYTOPENIA,1
PR,THROMBOPHLEBITIS,1
PR,THYROID DISORDER,1
PR,THYROID FUNCTION TEST ABNORMAL,1
PR,THYROID NEOPLASM,1
PR,THYROID PAIN,1
PR,TONGUE DISORDER,1
PR,TOOTH ABSCESS,1
PR,TOOTH INFECTION,1
PR,TOOTHACHE,1
PR,TOXIC EPIDERMAL NECROLYSIS,1
PR,TRANSIENT ISCHAEMIC ATTACK,1
PR,TUBERCULIN TEST POSITIVE,1
PR,ULCER,1
PR,UPPER LIMB FRACTURE,1
PR,UTERINE DISORDER,1
PR,VAGINAL HAEMORRHAGE,1
PR,VAGINAL INFLAMMATION,1
PR,VARICOSE VEIN,1
PR,VASCULAR INSUFFICIENCY,1
PR,VENOUS OCCLUSION,1
PR,VITAMIN B12 DEFICIENCY,1
PR,VITAMIN D DECREASED,1
PR,VITREOUS FLOATERS,1
PR,WHITE BLOOD CELL COUNT DECREASED,1
PR,WHITE BLOOD CELL COUNT INCREASED,1
PR,WRIST FRACTURE,1
QA,MYOCARDIAL INFARCTION,3
QA,GASTRIC POLYPS,2
QA,IRON DEFICIENCY ANAEMIA,2
QA,MYALGIA,2
QA,RASH,2
QA,TOXICITY TO VARIOUS AGENTS,2
QA,ACANTHOSIS NIGRICANS,1
QA,ARRHYTHMIA,1
QA,ASPHYXIA,1
QA,CHEST PAIN,1
QA,DYSPNOEA,1
QA,FACE OEDEMA,1
QA,HYPERGLYCAEMIA,1
QA,INSULIN RESISTANCE,1
QA,MUCOSAL INFLAMMATION,1
QA,MUSCLE SPASMS,1
QA,SWELLING FACE,1
RO,ANGIOEDEMA,16
RO,URTICARIA,16
RO,ALLERGIC REACTION TO EXCIPIENT,14
RO,LACTIC ACIDOSIS,9
RO,SWELLING FACE,9
RO,COMA,8
RO,HAEMOGLOBIN DECREASED,6
RO,ACUTE KIDNEY INJURY,5
RO,CONDITION AGGRAVATED,5
RO,HAEMATOCRIT DECREASED,5
RO,TOXICITY TO VARIOUS AGENTS,5
RO,VITAMIN B12 DECREASED,5
RO,HYPONATRAEMIC ENCEPHALOPATHY,4
RO,POISONING,4
RO,BLOOD GLUCOSE INCREASED,3
RO,CARDIAC FAILURE CHRONIC,3
RO,IRON DEFICIENCY,3
RO,ABDOMINAL PAIN,2
RO,AGITATION,2
RO,ANXIETY,2
RO,ASTHENIA,2
RO,CEREBELLAR SYNDROME,2
RO,CONFUSIONAL STATE,2
RO,CONSTIPATION,2
RO,DIARRHOEA,2
RO,DISORIENTATION,2
RO,DUODENITIS,2
RO,EYE OEDEMA,2
RO,HAEMORRHOIDS,2
RO,HEADACHE,2
RO,HEPATITIS CHOLESTATIC,2
RO,HYPOGLYCAEMIA,2
RO,HYPONATRAEMIA,2
RO,KETOACIDOSIS,2
RO,NAUSEA,2
RO,RASH PRURITIC,2
RO,RECTAL HAEMORRHAGE,2
RO,VOMITING,2
RO,ABDOMINAL DISTENSION,1
RO,ACUTE MYOCARDIAL INFARCTION,1
RO,ADRENAL INSUFFICIENCY,1
RO,ADVERSE EVENT,1
RO,AMNESIA,1
RO,ANAEMIA,1
RO,ATRIAL FLUTTER,1
RO,BLOOD CHLORIDE DECREASED,1
RO,BLOOD CHOLESTEROL INCREASED,1
RO,BLOOD OSMOLARITY DECREASED,1
RO,BLOOD POTASSIUM DECREASED,1
RO,BLOOD PRESSURE FLUCTUATION,1
RO,BLOOD PRESSURE INCREASED,1
RO,CACHEXIA,1
RO,CARDIAC ARREST,1
RO,CHEST PAIN,1
RO,CHOLECYSTITIS INFECTIVE,1
RO,CHOLELITHIASIS,1
RO,CORONARY ARTERY STENOSIS,1
RO,CREATININE RENAL CLEARANCE DECREASED,1
RO,DEATH,1
RO,DECREASED APPETITE,1
RO,DEHYDRATION,1
RO,DELIRIUM,1
RO,DEPRESSION,1
RO,DIPLOPIA,1
RO,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
RO,DIZZINESS,1
RO,DRUG-INDUCED LIVER INJURY,1
RO,DYSPNOEA,1
RO,ELECTROCARDIOGRAM QT PROLONGED,1
RO,ENCEPHALOPATHY,1
RO,FATIGUE,1
RO,GASTROINTESTINAL OEDEMA,1
RO,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
RO,HEPATIC STEATOSIS,1
RO,HEPATOMEGALY,1
RO,HIGH DENSITY LIPOPROTEIN DECREASED,1
RO,HYPERGLYCAEMIA,1
RO,HYPERTENSION,1
RO,HYPOKALAEMIA,1
RO,HYPOTENSION,1
RO,INJECTION SITE NECROSIS,1
RO,INJECTION SITE URTICARIA,1
RO,INJURY,1
RO,LEFT VENTRICULAR HYPERTROPHY,1
RO,LIPODYSTROPHY ACQUIRED,1
RO,LOSS OF CONSCIOUSNESS,1
RO,LOW DENSITY LIPOPROTEIN INCREASED,1
RO,MYALGIA,1
RO,NEPHROLITHIASIS,1
RO,NEUROPATHY PERIPHERAL,1
RO,OEDEMA,1
RO,PARESIS,1
RO,PERIPHERAL SWELLING,1
RO,PERITONITIS,1
RO,PRODUCT USE ISSUE,1
RO,PROSTATE CANCER,1
RO,PRURITUS,1
RO,REACTION TO EXCIPIENT,1
RO,SELF-MEDICATION,1
RO,SHOCK HAEMORRHAGIC,1
RO,SYNCOPE,1
RO,TRANSIENT ISCHAEMIC ATTACK,1
RO,TREMOR,1
RO,URINE OSMOLARITY DECREASED,1
RO,VENTRICULAR TACHYCARDIA,1
RO,VITAMIN B12 DEFICIENCY,1
RO,WEIGHT DECREASED,1
RO,WHITE MATTER LESION,1
RU,BLOOD GLUCOSE INCREASED,18
RU,MYOCARDIAL INFARCTION,16
RU,HYPERGLYCAEMIA,13
RU,DRUG INEFFECTIVE,8
RU,DYSPNOEA,8
RU,PRODUCT USE ISSUE,8
RU,CHEST PAIN,7
RU,FOETAL EXPOSURE DURING PREGNANCY,7
RU,KETOACIDOSIS,7
RU,LIVE BIRTH,7
RU,MATERNAL EXPOSURE DURING PREGNANCY,7
RU,ACUTE MYOCARDIAL INFARCTION,6
RU,ANGINA UNSTABLE,6
RU,BLOOD PRESSURE INCREASED,6
RU,CAESAREAN SECTION,6
RU,HYPERTENSION,6
RU,PNEUMONIA,6
RU,TYPE 2 DIABETES MELLITUS,6
RU,EPISTAXIS,5
RU,HYPOGLYCAEMIA,5
RU,INTENTIONAL PRODUCT MISUSE,5
RU,LARGE FOR DATES BABY,5
RU,WEIGHT DECREASED,5
RU,ACUTE CORONARY SYNDROME,4
RU,ASTHENIA,4
RU,CEREBROVASCULAR ACCIDENT,4
RU,CONTUSION,4
RU,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
RU,ISCHAEMIC STROKE,4
RU,PRODUCT USE IN UNAPPROVED INDICATION,4
RU,STRESS,4
RU,WEIGHT INCREASED,4
RU,ANGINA PECTORIS,3
RU,BLOOD PRESSURE DECREASED,3
RU,BRADYCARDIA,3
RU,CARDIAC FAILURE,3
RU,DEATH,3
RU,FALL,3
RU,GASTRITIS,3
RU,HEADACHE,3
RU,HEART RATE DECREASED,3
RU,MALAISE,3
RU,MYOCARDIAL ISCHAEMIA,3
RU,OSTEOARTHRITIS,3
RU,PRURITUS GENITAL,3
RU,PULMONARY EMBOLISM,3
RU,PULMONARY OEDEMA,3
RU,RETINAL DETACHMENT,3
RU,TACHYCARDIA,3
RU,VASCULAR STENT THROMBOSIS,3
RU,ASTHMA,2
RU,BLOOD GLUCOSE ABNORMAL,2
RU,BLOOD GLUCOSE DECREASED,2
RU,BLOOD PRESSURE FLUCTUATION,2
RU,CARDIAC FAILURE ACUTE,2
RU,CORONARY ARTERY STENOSIS,2
RU,COUGH,2
RU,DIABETIC KETOACIDOSIS,2
RU,DIABETIC NEUROPATHY,2
RU,DIARRHOEA,2
RU,DUODENAL ULCER,2
RU,ENCEPHALOPATHY,2
RU,FOETAL GROWTH RESTRICTION,2
RU,GANGRENE,2
RU,GLAUCOMA,2
RU,HYPERTENSIVE CRISIS,2
RU,HYPOTENSION,2
RU,INCREASED APPETITE,2
RU,KETONURIA,2
RU,LEG AMPUTATION,2
RU,LOSS OF CONSCIOUSNESS,2
RU,LOW BIRTH WEIGHT BABY,2
RU,NAUSEA,2
RU,OEDEMA PERIPHERAL,2
RU,PANCREATITIS,2
RU,PANCREATITIS ACUTE,2
RU,PERIPHERAL ARTERY THROMBOSIS,2
RU,PRODUCT PRESCRIBING ISSUE,2
RU,PRURITUS,2
RU,SYNCOPE,2
RU,UPPER LIMB FRACTURE,2
RU,VASCULAR OCCLUSION,2
RU,VISUAL ACUITY REDUCED,2
RU,ABDOMINAL ABSCESS,1
RU,ABDOMINAL DISCOMFORT,1
RU,ABDOMINAL PAIN LOWER,1
RU,ACCIDENT,1
RU,ACNE,1
RU,ACUTE KIDNEY INJURY,1
RU,ACUTE LEFT VENTRICULAR FAILURE,1
RU,ADENOCARCINOMA GASTRIC,1
RU,ADRENAL DISORDER,1
RU,ALCOHOL POISONING,1
RU,ANGIOEDEMA,1
RU,ANKLE FRACTURE,1
RU,ANURIA,1
RU,AORTIC ARTERIOSCLEROSIS,1
RU,APHONIA,1
RU,APNOEA,1
RU,ARRHYTHMIA,1
RU,ARTERIAL OCCLUSIVE DISEASE,1
RU,ARTERIAL STENOSIS,1
RU,ARTERIOSCLEROSIS,1
RU,ARTERIOSCLEROSIS CORONARY ARTERY,1
RU,ATRIAL FIBRILLATION,1
RU,ATRIAL THROMBOSIS,1
RU,BLISTER,1
RU,BLOOD CREATININE INCREASED,1
RU,BLOOD GLUCOSE FLUCTUATION,1
RU,BLOOD PRESSURE ABNORMAL,1
RU,BODY TEMPERATURE INCREASED,1
RU,BRONCHOSPASM,1
RU,CALCULUS URINARY,1
RU,CANDIDA INFECTION,1
RU,CARDIAC ANEURYSM,1
RU,CARDIAC FAILURE CHRONIC,1
RU,CARDIOGENIC SHOCK,1
RU,CARDIOPULMONARY FAILURE,1
RU,CATARACT,1
RU,CELLULITIS,1
RU,CEREBRAL ISCHAEMIA,1
RU,CEREBROVASCULAR DISORDER,1
RU,CHILLS,1
RU,CHOLECYSTECTOMY,1
RU,CHOLECYSTITIS ACUTE,1
RU,CHOLELITHIASIS,1
RU,CHROMATURIA,1
RU,CHRONIC HEPATITIS,1
RU,CHRONIC KIDNEY DISEASE,1
RU,CLUBBING,1
RU,COLD SWEAT,1
RU,COMA,1
RU,COMPLICATION OF PREGNANCY,1
RU,CONTRAST MEDIA REACTION,1
RU,CONVULSION,1
RU,CORONARY ARTERY DISEASE,1
RU,CORONARY ARTERY OCCLUSION,1
RU,CORONARY ARTERY THROMBOSIS,1
RU,CRANIOCEREBRAL INJURY,1
RU,CUSHING^S SYNDROME,1
RU,CYST,1
RU,DEAFNESS UNILATERAL,1
RU,DEPRESSION,1
RU,DEVICE OCCLUSION,1
RU,DIABETES MELLITUS INADEQUATE CONTROL,1
RU,DIABETIC FOOT,1
RU,DIABETIC METABOLIC DECOMPENSATION,1
RU,DIABETIC NEPHROPATHY,1
RU,DISEASE PROGRESSION,1
RU,DIZZINESS,1
RU,DRUG DOSE OMISSION,1
RU,DRY MOUTH,1
RU,DYSLIPIDAEMIA,1
RU,DYSPEPSIA,1
RU,FATIGUE,1
RU,FEELING ABNORMAL,1
RU,FEMORAL NECK FRACTURE,1
RU,FINGER AMPUTATION,1
RU,FLATULENCE,1
RU,FOOT FRACTURE,1
RU,FRACTURE DISPLACEMENT,1
RU,FURUNCLE,1
RU,GAIT DISTURBANCE,1
RU,GASTRIC CANCER,1
RU,GASTRITIS EROSIVE,1
RU,GASTRODUODENITIS,1
RU,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
RU,GENERALISED OEDEMA,1
RU,GINGIVAL BLEEDING,1
RU,GLOMERULONEPHRITIS MEMBRANOUS,1
RU,GOUT,1
RU,HAEMATURIA,1
RU,HAEMOPTYSIS,1
RU,HEMIPLEGIA,1
RU,HEPATIC CANCER,1
RU,HEPATIC PAIN,1
RU,HEPATIC STEATOSIS,1
RU,HEPATOMEGALY,1
RU,HYPERCORTICOIDISM,1
RU,HYPERCREATINAEMIA,1
RU,HYPERHIDROSIS,1
RU,HYPOAESTHESIA,1
RU,HYPOGLYCAEMIC COMA,1
RU,INFLAMMATION,1
RU,INJECTION SITE HAEMORRHAGE,1
RU,INSOMNIA,1
RU,INSULIN C-PEPTIDE INCREASED,1
RU,IRON DEFICIENCY ANAEMIA,1
RU,LIGAMENT SPRAIN,1
RU,LOWER LIMB FRACTURE,1
RU,LUNG NEOPLASM MALIGNANT,1
RU,MEDICATION ERROR,1
RU,MEMORY IMPAIRMENT,1
RU,METASTASES TO BLADDER,1
RU,MUSCULOSKELETAL STIFFNESS,1
RU,NASOPHARYNGITIS,1
RU,NEONATAL DISORDER,1
RU,NEPHRECTOMY,1
RU,NEPHROTIC SYNDROME,1
RU,NERVOUSNESS,1
RU,NOCTURNAL DYSPNOEA,1
RU,NON-ALCOHOLIC FATTY LIVER,1
RU,OBESITY,1
RU,OROPHARYNGEAL PAIN,1
RU,PAIN,1
RU,PAIN IN EXTREMITY,1
RU,PANCREATIC NECROSIS,1
RU,PARONYCHIA,1
RU,PERIPHERAL ISCHAEMIA,1
RU,PLACENTAL INSUFFICIENCY,1
RU,PLEURISY,1
RU,PRODUCT PHYSICAL ISSUE,1
RU,PRODUCT QUALITY ISSUE,1
RU,PRODUCT SUBSTITUTION ISSUE,1
RU,PULMONARY CONGESTION,1
RU,PULMONARY HYPERTENSION,1
RU,PYELONEPHRITIS,1
RU,PYLORIC SPHINCTER INSUFFICIENCY,1
RU,RADIUS FRACTURE,1
RU,RENAL CANCER,1
RU,RENAL COLIC,1
RU,RESPIRATORY TRACT INFECTION VIRAL,1
RU,RETINAL NEOPLASM,1
RU,RETINAL OPERATION,1
RU,RETINOPATHY,1
RU,RHINITIS ALLERGIC,1
RU,RHINORRHOEA,1
RU,RIGHT VENTRICULAR FAILURE,1
RU,SALIVARY GLAND CALCULUS,1
RU,SCIATIC NERVE INJURY,1
RU,SEIZURE,1
RU,SIALOADENITIS,1
RU,SINUS ARREST,1
RU,SKIN BURNING SENSATION,1
RU,SKIN DISCOLOURATION,1
RU,SKIN HYPERTROPHY,1
RU,SLUGGISHNESS,1
RU,SMALL INTESTINAL HAEMORRHAGE,1
RU,SPEECH DISORDER,1
RU,SUPRAVENTRICULAR TACHYCARDIA,1
RU,SYNOVIAL CYST,1
RU,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
RU,TACHYCARDIA PAROXYSMAL,1
RU,TEARFULNESS,1
RU,THIRST,1
RU,THROMBOCYTOPENIA,1
RU,THROMBOSIS,1
RU,THYROID MASS,1
RU,THYROXINE INCREASED,1
RU,TIBIA FRACTURE,1
RU,TOE AMPUTATION,1
RU,TRANSAMINASES INCREASED,1
RU,TRANSIENT ISCHAEMIC ATTACK,1
RU,TREMOR,1
RU,TRI-IODOTHYRONINE INCREASED,1
RU,URINARY TRACT INFECTION,1
RU,UTERINE LEIOMYOMA,1
RU,VASCULAR STENT OCCLUSION,1
RU,VENTRICULAR EXTRASYSTOLES,1
RU,VERTIGO,1
RU,WOUND ABSCESS,1
RW,HYPOGLYCAEMIA,1
SA,NEUROLEPTIC MALIGNANT SYNDROME,9
SA,SEROTONIN SYNDROME,9
SA,NAUSEA,7
SA,LACTIC ACIDOSIS,6
SA,PANCREATITIS ACUTE,6
SA,BACTERIAL INFECTION,5
SA,DIABETIC KETOACIDOSIS,4
SA,HYPOGLYCAEMIA,3
SA,ACUTE KIDNEY INJURY,2
SA,ALANINE AMINOTRANSFERASE INCREASED,2
SA,ASTHENIA,2
SA,CONDITION AGGRAVATED,2
SA,CONFUSIONAL STATE,2
SA,DEHYDRATION,2
SA,DYSPNOEA,2
SA,HEPATOTOXICITY,2
SA,HYPERHIDROSIS,2
SA,HYPERTENSION,2
SA,MILK-ALKALI SYNDROME,2
SA,PYREXIA,2
SA,TREMOR,2
SA,VOMITING,2
SA,WEIGHT DECREASED,2
SA,ABDOMINAL PAIN UPPER,1
SA,ABDOMINAL TENDERNESS,1
SA,ALTERED STATE OF CONSCIOUSNESS,1
SA,AMYLASE INCREASED,1
SA,BILE DUCT STENOSIS,1
SA,BILIARY TRACT INFECTION,1
SA,BILIARY TRACT INFECTION BACTERIAL,1
SA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SA,BLOOD CREATININE INCREASED,1
SA,BLOOD KETONE BODY INCREASED,1
SA,BLOOD TRIGLYCERIDES INCREASED,1
SA,BRADYARRHYTHMIA,1
SA,C-REACTIVE PROTEIN INCREASED,1
SA,CARDIAC ARREST,1
SA,CARDIOMEGALY,1
SA,CLONUS,1
SA,DEATH,1
SA,DECREASED APPETITE,1
SA,DISORIENTATION,1
SA,DISSEMINATED INTRAVASCULAR COAGULATION,1
SA,DIZZINESS,1
SA,DRUG LEVEL INCREASED,1
SA,DRUG-INDUCED LIVER INJURY,1
SA,FATIGUE,1
SA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SA,GASTROINTESTINAL DISORDER,1
SA,GASTROINTESTINAL HAEMORRHAGE,1
SA,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
SA,HAEMODYNAMIC INSTABILITY,1
SA,HEPATIC STEATOSIS,1
SA,HIGH DENSITY LIPOPROTEIN DECREASED,1
SA,HYPERCALCAEMIA,1
SA,HYPERREFLEXIA,1
SA,HYPERTHERMIA,1
SA,ILL-DEFINED DISORDER,1
SA,INTENTIONAL PRODUCT MISUSE,1
SA,LETHARGY,1
SA,LEUKOCYTOSIS,1
SA,LIPASE INCREASED,1
SA,LIVER INJURY,1
SA,MENINGIOMA,1
SA,MENTAL STATUS CHANGES,1
SA,METABOLIC ACIDOSIS,1
SA,METABOLIC ALKALOSIS,1
SA,MONONEURITIS,1
SA,MULTI-ORGAN FAILURE,1
SA,MUSCLE NECROSIS,1
SA,MUSCLE RIGIDITY,1
SA,MUSCULAR WEAKNESS,1
SA,MYALGIA,1
SA,MYOCARDIAL INFARCTION,1
SA,MYOCLONUS,1
SA,NEPHROLITHIASIS,1
SA,NEUTROPENIA,1
SA,NON-ALCOHOLIC STEATOHEPATITIS,1
SA,OSTEOARTHRITIS,1
SA,OVERDOSE,1
SA,PAIN,1
SA,PLEURAL EFFUSION,1
SA,POST PROCEDURAL BILE LEAK,1
SA,PRESYNCOPE,1
SA,PRODUCT USE IN UNAPPROVED INDICATION,1
SA,PSORIASIS,1
SA,RENAL FAILURE ACUTE,1
SA,RESPIRATORY FAILURE,1
SA,RHABDOMYOLYSIS,1
SA,SEPSIS,1
SA,SKIN NECROSIS,1
SA,TACHYCARDIA,1
SA,TOE AMPUTATION,1
SA,TOXIC EPIDERMAL NECROLYSIS,1
SA,WHITE BLOOD CELL COUNT INCREASED,1
SN,ALANINE AMINOTRANSFERASE INCREASED,1
SN,ASPARTATE AMINOTRANSFERASE INCREASED,1
SN,DISCOMFORT,1
SN,FATIGUE,1
SN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SN,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
SN,LIVER DISORDER,1
RS,CARDIAC ARREST,16
RS,INTENTIONAL OVERDOSE,16
RS,METABOLIC ACIDOSIS,16
RS,HYPERGLYCAEMIA,15
RS,SHOCK,13
RS,TOXICITY TO VARIOUS AGENTS,13
RS,POISONING DELIBERATE,11
RS,BUNDLE BRANCH BLOCK RIGHT,8
RS,CARDIOTOXICITY,6
RS,DYSPNOEA,5
RS,HYPOTENSION,5
RS,SINUS TACHYCARDIA,5
RS,ATRIOVENTRICULAR BLOCK,4
RS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,4
RS,HYPOGLYCAEMIA,4
RS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
RS,COMPLETED SUICIDE,2
RS,CONFUSIONAL STATE,2
RS,FATIGUE,2
RS,HEADACHE,2
RS,HYPERTENSION,2
RS,HYPOKINESIA,2
RS,JOINT SWELLING,2
RS,OLIGURIA,2
RS,RENAL FAILURE,2
RS,RENAL FAILURE ACUTE,2
RS,SOMNOLENCE,2
RS,SWELLING FACE,2
RS,URINE OUTPUT DECREASED,2
RS,AGEUSIA,1
RS,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
RS,ANURIA,1
RS,ARRHYTHMIA,1
RS,BLOOD GLUCOSE INCREASED,1
RS,BLOOD LACTIC ACID INCREASED,1
RS,BLOOD PRESSURE INCREASED,1
RS,CARDIAC FAILURE,1
RS,CIRCULATORY COLLAPSE,1
RS,COUGH,1
RS,DIABETES MELLITUS INADEQUATE CONTROL,1
RS,DRUG LEVEL ABOVE THERAPEUTIC,1
RS,DRUG LEVEL INCREASED,1
RS,ERECTILE DYSFUNCTION,1
RS,EXTRAPYRAMIDAL DISORDER,1
RS,HAEMATOCHEZIA,1
RS,HYPERTENSIVE CRISIS,1
RS,LIMB INJURY,1
RS,LOSS OF CONSCIOUSNESS,1
RS,MALAISE,1
RS,MUSCLE ATROPHY,1
RS,NON-HODGKIN^S LYMPHOMA,1
RS,OVERDOSE,1
RS,POISONING,1
RS,PRODUCTIVE COUGH,1
RS,PSYCHOMOTOR SKILLS IMPAIRED,1
RS,RESTLESSNESS,1
RS,RHINORRHOEA,1
RS,URINARY RETENTION,1
RS,VENOUS THROMBOSIS LIMB,1
RS,WEIGHT DECREASED,1
RS,WEIGHT INCREASED,1
SG,DYSPNOEA,7
SG,DIABETIC KETOACIDOSIS,6
SG,PANCYTOPENIA,6
SG,VITAMIN B12 DEFICIENCY,6
SG,MANIA,5
SG,WITHDRAWAL SYNDROME,5
SG,ANAEMIA MACROCYTIC,4
SG,NEPHROPATHY,4
SG,VOMITING,4
SG,DECREASED APPETITE,3
SG,FALL,3
SG,FOETAL EXPOSURE DURING PREGNANCY,3
SG,LOW BIRTH WEIGHT BABY,3
SG,NAUSEA,3
SG,PAIN IN EXTREMITY,3
SG,PERIPHERAL SWELLING,3
SG,PREMATURE BABY,3
SG,ABDOMINAL DISTENSION,2
SG,ANGINA PECTORIS,2
SG,ASTHMA,2
SG,BACK PAIN,2
SG,BLOOD CREATININE INCREASED,2
SG,CORONARY ARTERY DISEASE,2
SG,DIARRHOEA,2
SG,DIZZINESS,2
SG,FANCONI SYNDROME ACQUIRED,2
SG,FATIGUE,2
SG,GASTRITIS,2
SG,HAEMOGLOBIN DECREASED,2
SG,HYPOKALAEMIA,2
SG,LARGE INTESTINE POLYP,2
SG,LETHARGY,2
SG,PNEUMONITIS,2
SG,PREMATURE DELIVERY,2
SG,SEPSIS,2
SG,TRISOMY 21,2
SG,WEIGHT INCREASED,2
SG,ACETONAEMIA,1
SG,ACUTE KIDNEY INJURY,1
SG,ACUTE MYOCARDIAL INFARCTION,1
SG,ADENOCARCINOMA OF COLON,1
SG,ADENOCARCINOMA PANCREAS,1
SG,ANGINA UNSTABLE,1
SG,ANTICOAGULATION DRUG LEVEL INCREASED,1
SG,ARTHRALGIA,1
SG,ATRIAL FIBRILLATION,1
SG,ATYPICAL FEMUR FRACTURE,1
SG,BICYTOPENIA,1
SG,BLINDNESS,1
SG,BLOOD FOLATE DECREASED,1
SG,CARDIAC FAILURE CONGESTIVE,1
SG,CARDIOPULMONARY FAILURE,1
SG,CHEST PAIN,1
SG,COLD SWEAT,1
SG,COLITIS,1
SG,COLON CANCER,1
SG,CONDITION AGGRAVATED,1
SG,CONTUSION,1
SG,COUGH,1
SG,DERMATITIS CONTACT,1
SG,DIASTOLIC DYSFUNCTION,1
SG,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
SG,DYSPHAGIA,1
SG,DYSPNOEA EXERTIONAL,1
SG,ELECTROLYTE IMBALANCE,1
SG,EMBOLIC STROKE,1
SG,EXPOSURE DURING PREGNANCY,1
SG,FEBRILE NEUTROPENIA,1
SG,FLUID OVERLOAD,1
SG,FOOT FRACTURE,1
SG,FULL BLOOD COUNT DECREASED,1
SG,FUNGAL INFECTION,1
SG,GENERAL PHYSICAL HEALTH DETERIORATION,1
SG,GENERALISED OEDEMA,1
SG,HAEMATOMA,1
SG,HEPATIC ENZYME INCREASED,1
SG,HEPATOCELLULAR CARCINOMA,1
SG,HUNGER,1
SG,HYPERBILIRUBINAEMIA,1
SG,HYPERGLYCAEMIA,1
SG,HYPOPHAGIA,1
SG,HYPOTENSION,1
SG,IGA NEPHROPATHY,1
SG,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SG,INFLAMMATORY MARKER INCREASED,1
SG,INTERNATIONAL NORMALISED RATIO INCREASED,1
SG,JOINT RANGE OF MOTION DECREASED,1
SG,KETOACIDOSIS,1
SG,LIMB INJURY,1
SG,LOWER RESPIRATORY TRACT INFECTION,1
SG,MASS,1
SG,MATERNAL EXPOSURE DURING PREGNANCY,1
SG,MENTAL STATUS CHANGES,1
SG,MYELODYSPLASTIC SYNDROME,1
SG,MYOCARDIAL INFARCTION,1
SG,MYOCARDIAL ISCHAEMIA,1
SG,NEUTROPHIL COUNT DECREASED,1
SG,NEUTROPHIL HYPERSEGMENTED MORPHOLOGY PRESENT,1
SG,NO THERAPEUTIC RESPONSE,1
SG,NON-CARDIAC CHEST PAIN,1
SG,ODYNOPHAGIA,1
SG,OEDEMA PERIPHERAL,1
SG,OESOPHAGEAL CANDIDIASIS,1
SG,OROPHARYNGEAL PAIN,1
SG,ORTHOPNOEA,1
SG,PANCREATIC CARCINOMA,1
SG,PANCREATITIS ACUTE,1
SG,PARAESTHESIA,1
SG,PARONYCHIA,1
SG,PERITONITIS,1
SG,PLASMA CELL MYELOMA,1
SG,PLATELET COUNT DECREASED,1
SG,PNEUMONIA,1
SG,POLYDIPSIA,1
SG,PRODUCT USE ISSUE,1
SG,PULMONARY CONGESTION,1
SG,PULMONARY OEDEMA,1
SG,PYREXIA,1
SG,RALES,1
SG,RASH,1
SG,RENAL IMPAIRMENT,1
SG,RESPIRATORY TRACT INFECTION,1
SG,RETINAL HAEMORRHAGE,1
SG,RHABDOMYOLYSIS,1
SG,ROTATOR CUFF SYNDROME,1
SG,SOMNOLENCE,1
SG,SPINAL OSTEOARTHRITIS,1
SG,SUBCLAVIAN VEIN THROMBOSIS,1
SG,SUBCUTANEOUS ABSCESS,1
SG,THROMBOCYTOPENIA,1
SG,TRANSAMINASES INCREASED,1
SG,TREATMENT NONCOMPLIANCE,1
SG,TWIN PREGNANCY,1
SG,UPPER RESPIRATORY TRACT INFECTION,1
SG,URINE KETONE BODY PRESENT,1
SG,VANISHING TWIN SYNDROME,1
SG,VISION BLURRED,1
SK,LACTIC ACIDOSIS,9
SK,DIABETIC METABOLIC DECOMPENSATION,7
SK,ACUTE KIDNEY INJURY,3
SK,DIARRHOEA,3
SK,HYPOTENSION,3
SK,RHABDOMYOLYSIS,3
SK,WEIGHT DECREASED,3
SK,ATRIAL TACHYCARDIA,2
SK,BLOOD GLUCOSE ABNORMAL,2
SK,COMA,2
SK,DIABETIC NEUROPATHY,2
SK,DIABETIC RETINOPATHY,2
SK,DRUG INEFFECTIVE,2
SK,DYSPNOEA,2
SK,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
SK,HYPERGLYCAEMIA,2
SK,RENAL FAILURE,2
SK,VOMITING,2
SK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SK,ACUTE CORONARY SYNDROME,1
SK,ANXIETY,1
SK,APNOEA,1
SK,ASTHENIA,1
SK,BACTERIURIA,1
SK,BLOOD BILIRUBIN INCREASED,1
SK,BLOOD GLUCOSE INCREASED,1
SK,BLOOD PRESSURE INCREASED,1
SK,BRAIN STEM HAEMORRHAGE,1
SK,CARDIAC FAILURE,1
SK,CEREBROVASCULAR ACCIDENT,1
SK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SK,COGNITIVE DISORDER,1
SK,COMPLETED SUICIDE,1
SK,COUGH,1
SK,DEATH,1
SK,DECREASED APPETITE,1
SK,DEHYDRATION,1
SK,DIABETES MELLITUS,1
SK,DYSPEPSIA,1
SK,DYSPHONIA,1
SK,EMPHYSEMA,1
SK,FALL,1
SK,FIBRIN D DIMER INCREASED,1
SK,HAEMATURIA,1
SK,HYPOGLYCAEMIA,1
SK,LEUKOCYTURIA,1
SK,LOSS OF CONSCIOUSNESS,1
SK,LUNG DISORDER,1
SK,MALAISE,1
SK,MYOCARDIAL INFARCTION,1
SK,NAUSEA,1
SK,NON-CARDIOGENIC PULMONARY OEDEMA,1
SK,PAIN,1
SK,PAIN IN EXTREMITY,1
SK,PNEUMONIA,1
SK,PNEUMONIA MYCOPLASMAL,1
SK,PRODUCT USE ISSUE,1
SK,PRODUCTIVE COUGH,1
SK,PULMONARY EMBOLISM,1
SK,RENAL INJURY,1
SK,SECRETION DISCHARGE,1
SK,THROMBOSIS,1
SK,URINE KETONE BODY PRESENT,1
SK,VERTIGO,1
SK,WEIGHT INCREASED,1
SI,CHEST PAIN,6
SI,DYSPNOEA,6
SI,GAIT DISTURBANCE,5
SI,OEDEMA PERIPHERAL,5
SI,HYPOTENSION,3
SI,ASTHENIA,2
SI,ATRIAL FIBRILLATION,2
SI,BLOOD UREA INCREASED,2
SI,DECREASED APPETITE,2
SI,DIARRHOEA,2
SI,GASTROINTESTINAL HAEMORRHAGE,2
SI,HYPOGLYCAEMIA,2
SI,MALAISE,2
SI,SYNCOPE,2
SI,VOMITING,2
SI,ACUTE KIDNEY INJURY,1
SI,ANGINA PECTORIS,1
SI,ANURIA,1
SI,ASCITES,1
SI,ASPHYXIA,1
SI,BASAL GANGLIA HAEMATOMA,1
SI,BLADDER CANCER RECURRENT,1
SI,BLOOD CREATININE INCREASED,1
SI,BLOOD POTASSIUM INCREASED,1
SI,BLOOD PRESSURE INCREASED,1
SI,BLOOD SODIUM DECREASED,1
SI,BRAIN OEDEMA,1
SI,CARDIAC FAILURE,1
SI,CARDIAC FAILURE ACUTE,1
SI,CEREBRAL HAEMORRHAGE,1
SI,CHEST DISCOMFORT,1
SI,CONDITION AGGRAVATED,1
SI,CONFUSIONAL STATE,1
SI,CORONARY ARTERY DISEASE,1
SI,CORONARY ARTERY RESTENOSIS,1
SI,CYTOKINE RELEASE SYNDROME,1
SI,DEHYDRATION,1
SI,DISTURBANCE IN ATTENTION,1
SI,DIZZINESS,1
SI,DRUG EFFECT DECREASED,1
SI,DYSSTASIA,1
SI,EJECTION FRACTION DECREASED,1
SI,EMBOLIC STROKE,1
SI,EROSIVE DUODENITIS,1
SI,FALL,1
SI,FATIGUE,1
SI,GASTRITIS EROSIVE,1
SI,HAEMATEMESIS,1
SI,HAEMATOCHEZIA,1
SI,HAEMATOMA,1
SI,HAEMORRHAGE,1
SI,HAEMORRHAGIC ANAEMIA,1
SI,HEART RATE INCREASED,1
SI,HEMIPARESIS,1
SI,HEMIPLEGIA,1
SI,HEPATIC ENCEPHALOPATHY,1
SI,HEPATIC ENZYME INCREASED,1
SI,HEPATIC FAILURE,1
SI,HEPATIC STEATOSIS,1
SI,HEPATITIS A,1
SI,HIP FRACTURE,1
SI,HOSPITALISATION,1
SI,HYPERAMMONAEMIA,1
SI,HYPERBILIRUBINAEMIA,1
SI,HYPERKALAEMIA,1
SI,HYPERTENSIVE CARDIOMYOPATHY,1
SI,HYPERTROPHIC CARDIOMYOPATHY,1
SI,HYPOVOLAEMIA,1
SI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SI,INJECTION SITE HAEMATOMA,1
SI,INJURY,1
SI,JOINT SWELLING,1
SI,LACTIC ACIDOSIS,1
SI,LEFT ATRIAL ENLARGEMENT,1
SI,LEFT VENTRICULAR DYSFUNCTION,1
SI,LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED,1
SI,LIVER DISORDER,1
SI,MELAENA,1
SI,MENTAL DISORDER,1
SI,METABOLIC ACIDOSIS,1
SI,MITRAL VALVE INCOMPETENCE,1
SI,MOVEMENT DISORDER,1
SI,MUSCULAR WEAKNESS,1
SI,NAUSEA,1
SI,NIGHT SWEATS,1
SI,OLIGURIA,1
SI,OVARIAN ADENOMA,1
SI,OXYGEN SATURATION DECREASED,1
SI,PALPITATIONS,1
SI,PLEURAL EFFUSION,1
SI,PRODUCT USE IN UNAPPROVED INDICATION,1
SI,PULMONARY OEDEMA,1
SI,PYREXIA,1
SI,RENAL FAILURE ACUTE,1
SI,RENAL IMPAIRMENT,1
SI,RENAL TUBULAR NECROSIS,1
SI,RESPIRATORY DISTRESS,1
SI,SHOCK HAEMORRHAGIC,1
SI,SPEECH DISORDER,1
SI,SUFFOCATION FEELING,1
SI,TACHYPNOEA,1
SI,TOXICITY TO VARIOUS AGENTS,1
SI,URINE OUTPUT DECREASED,1
SI,WOUND HAEMORRHAGE,1
ZA,HYPOGLYCAEMIA,28
ZA,METABOLIC ACIDOSIS,17
ZA,CARDIAC ARREST,16
ZA,INTENTIONAL OVERDOSE,16
ZA,ELECTROCARDIOGRAM QT PROLONGED,15
ZA,HYPOTENSION,13
ZA,TACHYPNOEA,13
ZA,BLOOD CREATININE INCREASED,12
ZA,COMA SCALE ABNORMAL,10
ZA,DEATH,9
ZA,DIABETES MELLITUS INADEQUATE CONTROL,8
ZA,VOMITING,7
ZA,ABDOMINAL PAIN,6
ZA,BLOOD GLUCOSE INCREASED,6
ZA,FALL,6
ZA,RENAL FAILURE,6
ZA,ASTHENIA,4
ZA,FATIGUE,4
ZA,HAEMATEMESIS,4
ZA,HOSPITALISATION,4
ZA,HYPERTENSION,4
ZA,MATERNAL EXPOSURE DURING PREGNANCY,4
ZA,MYOCARDIAL INFARCTION,4
ZA,PNEUMONIA,4
ZA,RESTLESSNESS,4
ZA,ARTHRITIS,3
ZA,BACK PAIN,3
ZA,DIABETES MELLITUS,3
ZA,HYPERGLYCAEMIA,3
ZA,MALAISE,3
ZA,NAUSEA,3
ZA,PANCREATIC CARCINOMA,3
ZA,PERIPHERAL VASCULAR DISORDER,3
ZA,PRURITUS,3
ZA,RENAL IMPAIRMENT,3
ZA,SEPSIS,3
ZA,URINARY TRACT INFECTION,3
ZA,ABDOMINAL DISTENSION,2
ZA,ANAEMIA,2
ZA,ANION GAP INCREASED,2
ZA,ARTHRALGIA,2
ZA,BLOOD GLUCOSE ABNORMAL,2
ZA,CARDIAC FAILURE,2
ZA,CEREBROVASCULAR ACCIDENT,2
ZA,CONDITION AGGRAVATED,2
ZA,DECREASED APPETITE,2
ZA,DIARRHOEA,2
ZA,DRUG INEFFECTIVE,2
ZA,FOETAL EXPOSURE DURING PREGNANCY,2
ZA,GASTROINTESTINAL HAEMORRHAGE,2
ZA,GENERALISED OEDEMA,2
ZA,HAEMOGLOBIN DECREASED,2
ZA,HEPATIC FAILURE,2
ZA,HYPOKALAEMIA,2
ZA,JAUNDICE,2
ZA,LACTIC ACIDOSIS,2
ZA,MALIGNANT MELANOMA,2
ZA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
ZA,MYOCARDIAL ISCHAEMIA,2
ZA,NEUROPATHY PERIPHERAL,2
ZA,OVERDOSE,2
ZA,PERIPHERAL SWELLING,2
ZA,RENAL DISORDER,2
ZA,WEIGHT DECREASED,2
ZA,ABASIA,1
ZA,ABORTION SPONTANEOUS,1
ZA,ACUTE KIDNEY INJURY,1
ZA,AMPUTATION,1
ZA,ANGINA PECTORIS,1
ZA,ARRHYTHMIA,1
ZA,ARTERIAL OCCLUSIVE DISEASE,1
ZA,ARTERIOGRAM CORONARY,1
ZA,ARTHROPOD BITE,1
ZA,ASTHMA,1
ZA,ATRIAL FIBRILLATION,1
ZA,BLISTER,1
ZA,BLOOD ALBUMIN DECREASED,1
ZA,BLOOD CALCIUM DECREASED,1
ZA,BLOOD CREATINE INCREASED,1
ZA,BLOOD GLUCOSE DECREASED,1
ZA,BLOOD IRON DECREASED,1
ZA,BLOOD MAGNESIUM DECREASED,1
ZA,BLOOD PHOSPHORUS DECREASED,1
ZA,BLOOD PRESSURE DECREASED,1
ZA,BLOOD PRESSURE INCREASED,1
ZA,BLOOD PRESSURE MANAGEMENT,1
ZA,BLOOD SODIUM DECREASED,1
ZA,BLOOD THYROID STIMULATING HORMONE DECREASED,1
ZA,BLOOD UREA INCREASED,1
ZA,BRAIN STEM HAEMORRHAGE,1
ZA,BURNING SENSATION,1
ZA,CARDIAC DISORDER,1
ZA,CARDIAC MURMUR,1
ZA,CARDIOGENIC SHOCK,1
ZA,CELLULITIS,1
ZA,CHEST PAIN,1
ZA,CHOLELITHIASIS,1
ZA,COMA,1
ZA,CONTUSION,1
ZA,CREATININE RENAL CLEARANCE ABNORMAL,1
ZA,DEAFNESS TRANSITORY,1
ZA,DEEP VEIN THROMBOSIS POSTOPERATIVE,1
ZA,DEHYDRATION,1
ZA,DEMENTIA,1
ZA,DEPRESSION,1
ZA,DIABETIC KETOACIDOSIS,1
ZA,DIABETIC ULCER,1
ZA,DIALYSIS,1
ZA,DRUG-INDUCED LIVER INJURY,1
ZA,DRY MOUTH,1
ZA,DYSACUSIS,1
ZA,DYSPHAGIA,1
ZA,DYSPNOEA,1
ZA,EAR PAIN,1
ZA,EAR PRURITUS,1
ZA,EATING DISORDER,1
ZA,EXPOSURE DURING PREGNANCY,1
ZA,EYE DISORDER,1
ZA,GASTRIC CANCER,1
ZA,GASTRIC HAEMORRHAGE,1
ZA,GASTRODUODENITIS,1
ZA,GASTROENTERITIS,1
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,1
ZA,GLOMERULAR FILTRATION RATE DECREASED,1
ZA,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
ZA,HEADACHE,1
ZA,HOT FLUSH,1
ZA,HYPERHIDROSIS,1
ZA,HYPERKALAEMIA,1
ZA,HYPERTRIGLYCERIDAEMIA,1
ZA,HYPERURICAEMIA,1
ZA,HYPOMAGNESAEMIA,1
ZA,HYPONATRAEMIA,1
ZA,IMMUNE THROMBOCYTOPENIC PURPURA,1
ZA,INFECTION,1
ZA,INFLUENZA,1
ZA,INJURY,1
ZA,INTRACARDIAC THROMBUS,1
ZA,IRRITABLE BOWEL SYNDROME,1
ZA,LAPAROTOMY,1
ZA,LIVER INJURY,1
ZA,LOWER LIMB FRACTURE,1
ZA,LUNG DISORDER,1
ZA,MASS,1
ZA,MELAENA,1
ZA,METASTASES TO LIVER,1
ZA,MOOD ALTERED,1
ZA,MUSCULAR WEAKNESS,1
ZA,MUSCULOSKELETAL DISCOMFORT,1
ZA,NECROTISING COLITIS,1
ZA,OESOPHAGITIS,1
ZA,OPTIC NEURITIS,1
ZA,OSTEOARTHRITIS,1
ZA,PAIN IN EXTREMITY,1
ZA,PANIC ATTACK,1
ZA,PLEURAL EFFUSION,1
ZA,PNEUMONITIS,1
ZA,POLYCYTHAEMIA,1
ZA,PRE-ECLAMPSIA,1
ZA,PREMATURE BABY,1
ZA,PSEUDOMEMBRANOUS COLITIS,1
ZA,PSEUDOMONAL SEPSIS,1
ZA,PULMONARY ARTERY ANEURYSM,1
ZA,RASH GENERALISED,1
ZA,RESPIRATORY DISTRESS,1
ZA,ROTATOR CUFF SYNDROME,1
ZA,SCAB,1
ZA,SEIZURE,1
ZA,SEPTIC SHOCK,1
ZA,SHOULDER OPERATION,1
ZA,SPINAL FUSION SURGERY,1
ZA,STEVENS-JOHNSON SYNDROME,1
ZA,STRESS,1
ZA,SUBARACHNOID HAEMORRHAGE,1
ZA,SUBDURAL HAEMORRHAGE,1
ZA,THROMBOSIS,1
ZA,TINNITUS,1
ZA,TONSILLITIS,1
ZA,TUBERCULOSIS,1
ZA,UNEVALUABLE EVENT,1
ZA,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ZA,VENTRICULAR SEPTAL DEFECT,1
ZA,VISUAL ACUITY REDUCED,1
ZA,VITAMIN D DEFICIENCY,1
ZA,WOUND,1
ES,LACTIC ACIDOSIS,90
ES,ACUTE KIDNEY INJURY,69
ES,DIARRHOEA,52
ES,METABOLIC ACIDOSIS,44
ES,ASTHENIA,42
ES,HYPOGLYCAEMIA,38
ES,VOMITING,36
ES,HYPOMAGNESAEMIA,33
ES,NAUSEA,33
ES,ANAEMIA,32
ES,CARDIO-RESPIRATORY ARREST,32
ES,RENAL FAILURE,31
ES,HYPERKALAEMIA,30
ES,RENAL FAILURE ACUTE,28
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,25
ES,PYREXIA,25
ES,TOXICITY TO VARIOUS AGENTS,25
ES,DECREASED APPETITE,23
ES,DYSPNOEA,23
ES,HYPOKALAEMIA,23
ES,PNEUMONIA,22
ES,FALL,21
ES,FATIGUE,21
ES,HYPONATRAEMIA,21
ES,HYPERGLYCAEMIA,20
ES,SEPTIC SHOCK,20
ES,ABDOMINAL PAIN,19
ES,HYPOTENSION,19
ES,INTENTIONAL OVERDOSE,19
ES,CONFUSIONAL STATE,18
ES,RENAL IMPAIRMENT,18
ES,RHABDOMYOLYSIS,18
ES,TORSADE DE POINTES,18
ES,DRUG INEFFECTIVE,17
ES,MUSCULAR WEAKNESS,17
ES,SYNCOPE,17
ES,CARDIAC FAILURE,15
ES,NEUTROPENIA,15
ES,RESPIRATORY TRACT INFECTION,15
ES,URINARY TRACT INFECTION,15
ES,DIZZINESS,14
ES,ELECTROCARDIOGRAM QT PROLONGED,14
ES,HEPATITIS,14
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,14
ES,MALAISE,14
ES,MUSCLE SPASMS,14
ES,PEMPHIGOID,14
ES,RESPIRATORY FAILURE,14
ES,WEIGHT DECREASED,14
ES,DEATH,13
ES,DISCOMFORT,13
ES,PAIN IN EXTREMITY,13
ES,SEDATION,13
ES,ANURIA,12
ES,BUNDLE BRANCH BLOCK LEFT,12
ES,CARDIAC ARREST,12
ES,DEHYDRATION,12
ES,HIP FRACTURE,12
ES,OSTEONECROSIS OF JAW,12
ES,OVERDOSE,12
ES,PULMONARY EMBOLISM,12
ES,TENDON RUPTURE,12
ES,BLOOD CREATININE INCREASED,11
ES,DIABETES MELLITUS INADEQUATE CONTROL,11
ES,FEBRILE NEUTROPENIA,11
ES,FIXED ERUPTION,11
ES,GASTROENTERITIS,11
ES,HAEMODYNAMIC INSTABILITY,11
ES,HISTIOCYTOSIS HAEMATOPHAGIC,11
ES,PANCYTOPENIA,11
ES,SHOCK,11
ES,TREMOR,11
ES,ARTHRALGIA,10
ES,BLOOD UREA INCREASED,10
ES,CEREBROVASCULAR ACCIDENT,10
ES,DISORIENTATION,10
ES,GAIT DISTURBANCE,10
ES,HEPATIC ENCEPHALOPATHY,10
ES,HYPOCALCAEMIA,10
ES,HYPONATRAEMIC ENCEPHALOPATHY,10
ES,HYPOVOLAEMIC SHOCK,10
ES,LOSS OF CONSCIOUSNESS,10
ES,OEDEMA PERIPHERAL,10
ES,PAIN,10
ES,PANCREATITIS ACUTE,10
ES,BLOOD PH DECREASED,9
ES,BLOOD PRESSURE DECREASED,9
ES,CONSTIPATION,9
ES,DIABETIC KETOACIDOSIS,9
ES,GASTROINTESTINAL HAEMORRHAGE,9
ES,HYPERHIDROSIS,9
ES,HYPERTENSION,9
ES,KETOACIDOSIS,9
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
ES,SOMNOLENCE,9
ES,ARRHYTHMIA,8
ES,ATRIOVENTRICULAR BLOCK,8
ES,BLOOD LACTIC ACID INCREASED,8
ES,HEPATIC FAILURE,8
ES,INJECTION SITE PAIN,8
ES,PNEUMONITIS,8
ES,RASH,8
ES,SEPSIS,8
ES,SUICIDE ATTEMPT,8
ES,THROMBOCYTOPENIA,8
ES,ABDOMINAL PAIN UPPER,7
ES,ACUTE MYOCARDIAL INFARCTION,7
ES,APLASTIC ANAEMIA,7
ES,ATRIOVENTRICULAR BLOCK COMPLETE,7
ES,BLOOD BICARBONATE DECREASED,7
ES,BRADYCARDIA,7
ES,CHEST PAIN,7
ES,DRUG ADMINISTRATION ERROR,7
ES,DRUG-INDUCED LIVER INJURY,7
ES,FEMUR FRACTURE,7
ES,FISTULA,7
ES,GENERAL PHYSICAL HEALTH DETERIORATION,7
ES,HEPATOTOXICITY,7
ES,HYPERREFLEXIA,7
ES,HYPERTENSIVE CRISIS,7
ES,HYPOCOAGULABLE STATE,7
ES,HYPOXIA,7
ES,LEUKOCYTOSIS,7
ES,LIVIDITY,7
ES,METABOLIC SYNDROME,7
ES,OEDEMA,7
ES,PRURITUS,7
ES,STUPOR,7
ES,TENDONITIS,7
ES,TETANY,7
ES,VENTRICULAR EXTRASYSTOLES,7
ES,VISION BLURRED,7
ES,ANGINA PECTORIS,6
ES,ANION GAP INCREASED,6
ES,ATRIAL FIBRILLATION,6
ES,BLOOD GLUCOSE INCREASED,6
ES,CELLULITIS,6
ES,CEREBRAL HAEMORRHAGE,6
ES,CHOLELITHIASIS,6
ES,CONDITION AGGRAVATED,6
ES,CONTRAINDICATED PRODUCT ADMINISTERED,6
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
ES,DYSARTHRIA,6
ES,DYSPHAGIA,6
ES,ERECTILE DYSFUNCTION,6
ES,HEADACHE,6
ES,INCORRECT DOSE ADMINISTERED,6
ES,JAUNDICE,6
ES,MALIGNANT NEOPLASM PROGRESSION,6
ES,MUCOSAL INFLAMMATION,6
ES,MYALGIA,6
ES,PANCREATITIS,6
ES,PLEURAL EFFUSION,6
ES,RECTAL HAEMORRHAGE,6
ES,SPRUE-LIKE ENTEROPATHY,6
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,6
ES,WEIGHT INCREASED,6
ES,ACUTE CORONARY SYNDROME,5
ES,ACUTE HEPATIC FAILURE,5
ES,ACUTE RESPIRATORY FAILURE,5
ES,AMNESIA,5
ES,ASCITES,5
ES,BILIARY COLIC,5
ES,BLINDNESS,5
ES,BUNDLE BRANCH BLOCK RIGHT,5
ES,CHRONIC KIDNEY DISEASE,5
ES,EXTRAPYRAMIDAL DISORDER,5
ES,FIXED DRUG ERUPTION,5
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
ES,HAEMATURIA,5
ES,HAEMOGLOBIN DECREASED,5
ES,HEART RATE INCREASED,5
ES,HYPOGLYCAEMIC COMA,5
ES,INJECTION SITE HAEMATOMA,5
ES,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,5
ES,LETHARGY,5
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,5
ES,LUNG INFILTRATION,5
ES,OLIGURIA,5
ES,PANCREATIC CARCINOMA,5
ES,PNEUMOTHORAX,5
ES,PULMONARY OEDEMA,5
ES,SALIVARY HYPERSECRETION,5
ES,ASPARTATE AMINOTRANSFERASE INCREASED,4
ES,BACK PAIN,4
ES,BALANCE DISORDER,4
ES,CARDIOMEGALY,4
ES,CHILLS,4
ES,CHOLESTASIS,4
ES,COMA,4
ES,COUGH,4
ES,CYANOSIS,4
ES,DEEP VEIN THROMBOSIS,4
ES,DRUG LEVEL INCREASED,4
ES,DYSLIPIDAEMIA,4
ES,GASTROINTESTINAL DISORDER,4
ES,HAEMATOMA,4
ES,HAEMOFILTRATION,4
ES,HYPERTHYROIDISM,4
ES,HYPOAESTHESIA,4
ES,INSOMNIA,4
ES,ISCHAEMIC STROKE,4
ES,MUSCULOSKELETAL STIFFNESS,4
ES,MYOPATHY,4
ES,NERVOUSNESS,4
ES,NEUROTOXICITY,4
ES,PLATELET COUNT DECREASED,4
ES,RENAL FAILURE CHRONIC,4
ES,STOMATITIS,4
ES,STRESS CARDIOMYOPATHY,4
ES,SUBDURAL HAEMATOMA,4
ES,TACHYCARDIA,4
ES,TOXIC SKIN ERUPTION,4
ES,VENTRICULAR TACHYCARDIA,4
ES,ABDOMINAL DISCOMFORT,3
ES,ACIDOSIS,3
ES,AGITATION,3
ES,ALANINE AMINOTRANSFERASE INCREASED,3
ES,ALOPECIA,3
ES,ANXIETY,3
ES,APHASIA,3
ES,ARTHRITIS,3
ES,BLOOD GLUCOSE DECREASED,3
ES,BLOOD PRESSURE INCREASED,3
ES,CARDIAC FAILURE CONGESTIVE,3
ES,CARDIAC PACEMAKER INSERTION,3
ES,CHOLANGITIS,3
ES,COCCYDYNIA,3
ES,COMA SCALE ABNORMAL,3
ES,CRANIOCEREBRAL INJURY,3
ES,DEPRESSION,3
ES,DIABETES MELLITUS,3
ES,DRUG ERUPTION,3
ES,DYSGEUSIA,3
ES,EOSINOPHILIA,3
ES,EPISTAXIS,3
ES,FLATULENCE,3
ES,GASTROINTESTINAL TOXICITY,3
ES,GENERALISED OEDEMA,3
ES,GENERALISED TONIC-CLONIC SEIZURE,3
ES,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
ES,HAEMORRHAGE INTRACRANIAL,3
ES,HEMIPARESIS,3
ES,HEPATIC CANCER,3
ES,HEPATITIS C,3
ES,HEPATITIS TOXIC,3
ES,HEPATOCELLULAR CARCINOMA,3
ES,HIATUS HERNIA,3
ES,HOT FLUSH,3
ES,HYPERCALCAEMIA,3
ES,HYPERSENSITIVITY,3
ES,HYPERSENSITIVITY VASCULITIS,3
ES,HYPOPHAGIA,3
ES,INFECTION,3
ES,INJECTION SITE PRURITUS,3
ES,INJURY,3
ES,INTERCEPTED DRUG ADMINISTRATION ERROR,3
ES,KOUNIS SYNDROME,3
ES,MATERNAL EXPOSURE DURING PREGNANCY,3
ES,MIXED LIVER INJURY,3
ES,MULTI-ORGAN FAILURE,3
ES,MUSCULOSKELETAL PAIN,3
ES,ORTHOSTATIC HYPOTENSION,3
ES,PALPITATIONS,3
ES,PANCREATITIS NECROTISING,3
ES,PARAESTHESIA,3
ES,PRODUCT USE ISSUE,3
ES,PSORIASIS,3
ES,PULSELESS ELECTRICAL ACTIVITY,3
ES,PUSTULAR PSORIASIS,3
ES,RENAL CYST,3
ES,RENAL TUBULAR NECROSIS,3
ES,SHOCK HAEMORRHAGIC,3
ES,SINUS TACHYCARDIA,3
ES,SKIN ULCER,3
ES,SPEECH DISORDER,3
ES,STATUS EPILEPTICUS,3
ES,TRANSIENT ISCHAEMIC ATTACK,3
ES,UNRESPONSIVE TO STIMULI,3
ES,URTICARIA,3
ES,VENTRICULAR FIBRILLATION,3
ES,VISUAL IMPAIRMENT,3
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
ES,ABDOMINAL DISTENSION,2
ES,ABDOMINAL PAIN LOWER,2
ES,ABNORMAL BEHAVIOUR,2
ES,ABORTION SPONTANEOUS,2
ES,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
ES,ACUTE MYELOID LEUKAEMIA,2
ES,ADRENAL SUPPRESSION,2
ES,AMENORRHOEA,2
ES,AMPUTATION,2
ES,ANGINA UNSTABLE,2
ES,ANGIOEDEMA,2
ES,ANGIOPATHY,2
ES,ANKLE FRACTURE,2
ES,APATHY,2
ES,ARTERIOSCLEROSIS,2
ES,ARTHROPATHY,2
ES,ASPIRATION BRONCHIAL,2
ES,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
ES,AUTOIMMUNE COLITIS,2
ES,BILE DUCT STENOSIS,2
ES,BILIARY ANASTOMOSIS,2
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,2
ES,BLOOD CORTISOL DECREASED,2
ES,BLOOD GLUCOSE FLUCTUATION,2
ES,BLOOD TRIGLYCERIDES INCREASED,2
ES,BLOOD URINE PRESENT,2
ES,BONE MARROW FAILURE,2
ES,BRADYPHRENIA,2
ES,BREAST CANCER,2
ES,BREAST NEOPLASM,2
ES,BRONCHIOLITIS,2
ES,BRONCHOSPASM,2
ES,BURNING SENSATION,2
ES,CACHEXIA,2
ES,CANCER PAIN,2
ES,CARDIOGENIC SHOCK,2
ES,CARDIOVASCULAR DISORDER,2
ES,CAROTID ARTERIOSCLEROSIS,2
ES,CENTRAL NERVOUS SYSTEM LESION,2
ES,CENTRAL OBESITY,2
ES,CHEST INJURY,2
ES,CHOLECYSTITIS ACUTE,2
ES,CHOLURIA,2
ES,CHRONIC GASTRITIS,2
ES,COAGULOPATHY,2
ES,COGNITIVE DISORDER,2
ES,COLD SWEAT,2
ES,COLON CANCER STAGE IV,2
ES,COMPLETED SUICIDE,2
ES,CONCOMITANT DISEASE PROGRESSION,2
ES,CUSHINGOID,2
ES,CUSHING^S SYNDROME,2
ES,CYST,2
ES,DEMENTIA,2
ES,DISEASE PROGRESSION,2
ES,DISEASE RECURRENCE,2
ES,DRUG HYPERSENSITIVITY,2
ES,DRUG INTOLERANCE,2
ES,DRUG PRESCRIBING ERROR,2
ES,DRUG WITHDRAWAL SYNDROME,2
ES,DYSAESTHESIA,2
ES,DYSKINESIA,2
ES,DYSPNOEA EXERTIONAL,2
ES,DYSTONIA,2
ES,ENCEPHALOPATHY,2
ES,ENTERITIS,2
ES,ERYTHEMA,2
ES,ERYTHEMA MULTIFORME,2
ES,ERYTHEMA NODOSUM,2
ES,EYE MOVEMENT DISORDER,2
ES,FACIAL PARALYSIS,2
ES,FEELING ABNORMAL,2
ES,FEELING HOT,2
ES,FEMORAL NECK FRACTURE,2
ES,FOETAL EXPOSURE DURING PREGNANCY,2
ES,FOLLICULITIS,2
ES,FOOD CRAVING,2
ES,GASTRIC ULCER,2
ES,GENITAL CANDIDIASIS,2
ES,GENOTYPE DRUG RESISTANCE TEST POSITIVE,2
ES,HAEMOPTYSIS,2
ES,HAEMORRHAGE,2
ES,HAEMORRHAGIC ANAEMIA,2
ES,HAEMORRHOIDS,2
ES,HAEMOTHORAX,2
ES,HALLUCINATION_ VISUAL,2
ES,HAND FRACTURE,2
ES,HEPATIC CIRRHOSIS,2
ES,HEPATIC FUNCTION ABNORMAL,2
ES,HERPES ZOSTER,2
ES,HYPERTRANSAMINASAEMIA,2
ES,HYPERTRIGLYCERIDAEMIA,2
ES,HYPOVENTILATION,2
ES,ILEUS PARALYTIC,2
ES,INCREASED APPETITE,2
ES,INFECTED SKIN ULCER,2
ES,INFLAMMATION,2
ES,INFLUENZA,2
ES,INJECTION SITE ERYTHEMA,2
ES,INJECTION SITE IRRITATION,2
ES,INJECTION SITE NODULE,2
ES,INTERNATIONAL NORMALISED RATIO INCREASED,2
ES,ISCHAEMIC HEPATITIS,2
ES,JOINT SWELLING,2
ES,LACUNAR INFARCTION,2
ES,LEG AMPUTATION,2
ES,LIMB DISCOMFORT,2
ES,LIPASE INCREASED,2
ES,LISTLESS,2
ES,LIVER INJURY,2
ES,LUNG NEOPLASM,2
ES,LYMPHADENOPATHY,2
ES,LYMPHOCYTOSIS,2
ES,MEDICATION ERROR,2
ES,MEMORY IMPAIRMENT,2
ES,MENINGITIS ASEPTIC,2
ES,METABOLIC ENCEPHALOPATHY,2
ES,METASTASES TO LIVER,2
ES,MUCORMYCOSIS,2
ES,MUSCLE CONTRACTIONS INVOLUNTARY,2
ES,NECROTISING COLITIS,2
ES,NEPHROLITHIASIS,2
ES,NEURALGIA,2
ES,NEUROPATHY PERIPHERAL,2
ES,ODYNOPHAGIA,2
ES,ORTHOPNOEA,2
ES,OXYGEN SATURATION DECREASED,2
ES,PALLOR,2
ES,PARALYSIS,2
ES,PARKINSONIAN GAIT,2
ES,PENILE ABSCESS,2
ES,PENILE PROSTHESIS INSERTION,2
ES,PERICARDIAL HAEMORRHAGE,2
ES,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
ES,PERIPHERAL ISCHAEMIA,2
ES,PERIPHERAL MOTOR NEUROPATHY,2
ES,PERIPHERAL SWELLING,2
ES,PERITONITIS,2
ES,PETECHIAE,2
ES,PHARYNGITIS,2
ES,PNEUMONIA ASPIRATION,2
ES,POOR PERIPHERAL CIRCULATION,2
ES,PORTAL HYPERTENSION,2
ES,PRODUCT STORAGE ERROR,2
ES,PROSTATE CANCER,2
ES,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
ES,PULMONARY TOXICITY,2
ES,PUPILS UNEQUAL,2
ES,RASH ERYTHEMATOUS,2
ES,RASH PRURITIC,2
ES,RED BLOOD CELL COUNT DECREASED,2
ES,RENAL COLIC,2
ES,RESPIRATORY ACIDOSIS,2
ES,RESPIRATORY DISORDER,2
ES,RETINAL DETACHMENT,2
ES,RHEUMATOID ARTHRITIS,2
ES,SCLERODERMA,2
ES,SKIN LESION,2
ES,SKIN STRIAE,2
ES,SPINAL FRACTURE,2
ES,SPLEEN DISORDER,2
ES,SUBARACHNOID HAEMORRHAGE,2
ES,SUDDEN DEATH,2
ES,SUICIDAL IDEATION,2
ES,SUPRAVENTRICULAR EXTRASYSTOLES,2
ES,TACHYPNOEA,2
ES,THINKING ABNORMAL,2
ES,THIRST,2
ES,THROMBOSIS,2
ES,TRANSAMINASES INCREASED,2
ES,TRANSPLANT DYSFUNCTION,2
ES,TUMOUR ASSOCIATED FEVER,2
ES,TYPE 2 DIABETES MELLITUS,2
ES,UNEVALUABLE EVENT,2
ES,URINE KETONE BODY PRESENT,2
ES,VASCULAR PSEUDOANEURYSM,2
ES,VASCULITIS,2
ES,WAIST CIRCUMFERENCE INCREASED,2
ES,WRONG DRUG ADMINISTERED,2
ES,ZYGOMYCOSIS,2
ES,ABASIA,1
ES,ABDOMINAL ABSCESS,1
ES,ABDOMINAL INFECTION,1
ES,ABDOMINAL MASS,1
ES,ABDOMINAL WALL ABSCESS,1
ES,ABSCESS JAW,1
ES,ACUTE ABDOMEN,1
ES,ACUTE PRERENAL FAILURE,1
ES,ADENOCARCINOMA OF COLON,1
ES,ADENOCARCINOMA PANCREAS,1
ES,ADRENAL INSUFFICIENCY,1
ES,ADVERSE DRUG REACTION,1
ES,AFFECTIVE DISORDER,1
ES,ALCOHOL POISONING,1
ES,ALKALOSIS HYPOKALAEMIC,1
ES,ALTERED STATE OF CONSCIOUSNESS,1
ES,AMYLASE INCREASED,1
ES,ANAL FISSURE,1
ES,ANAL PRURITUS,1
ES,ANGIOMYOLIPOMA,1
ES,ANORECTAL DISCOMFORT,1
ES,AORTIC ANEURYSM,1
ES,AORTIC ANEURYSM RUPTURE,1
ES,AORTIC ARTERIOSCLEROSIS,1
ES,AORTIC VALVE STENOSIS,1
ES,APLASIA,1
ES,APPENDICITIS PERFORATED,1
ES,APRAXIA,1
ES,ARRHYTHMIA SUPRAVENTRICULAR,1
ES,ARTERIAL DISORDER,1
ES,ASPHYXIA,1
ES,ASTERIXIS,1
ES,ATAXIA,1
ES,ATELECTASIS,1
ES,ATROPHY,1
ES,ATYPICAL FIBROXANTHOMA,1
ES,BACTERAEMIA,1
ES,BASAL CELL CARCINOMA,1
ES,BASAL GANGLIA HAEMORRHAGE,1
ES,BASE EXCESS DECREASED,1
ES,BENIGN HYDATIDIFORM MOLE,1
ES,BENIGN PANCREATIC NEOPLASM,1
ES,BENIGN PROSTATIC HYPERPLASIA,1
ES,BILE DUCT CANCER,1
ES,BILE DUCT STONE,1
ES,BLADDER DIVERTICULUM,1
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE IV,1
ES,BLINDNESS TRANSIENT,1
ES,BLINDNESS UNILATERAL,1
ES,BLISTER,1
ES,BLOOD BICARBONATE INCREASED,1
ES,BLOOD CALCIUM DECREASED,1
ES,BLOOD CHOLESTEROL INCREASED,1
ES,BLOOD CORTICOTROPHIN ABNORMAL,1
ES,BLOOD CORTICOTROPHIN DECREASED,1
ES,BLOOD CREATINE INCREASED,1
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
ES,BLOOD FIBRINOGEN INCREASED,1
ES,BLOOD INSULIN ABNORMAL,1
ES,BLOOD LACTATE DEHYDROGENASE INCREASED,1
ES,BLOOD OSMOLARITY DECREASED,1
ES,BLOOD POTASSIUM DECREASED,1
ES,BLOOD POTASSIUM INCREASED,1
ES,BLOOD PRESSURE IMMEASURABLE,1
ES,BLOOD SODIUM DECREASED,1
ES,BLOOD TRIGLYCERIDES ABNORMAL,1
ES,BLOOD URIC ACID DECREASED,1
ES,BODY TEMPERATURE DECREASED,1
ES,BODY TEMPERATURE INCREASED,1
ES,BONE LOSS,1
ES,BONE MARROW INFILTRATION,1
ES,BRAIN INJURY,1
ES,BRAIN OEDEMA,1
ES,BREAST ABSCESS,1
ES,BRONCHIAL DISORDER,1
ES,BRONCHIECTASIS,1
ES,BRONCHITIS,1
ES,BRONCHOPULMONARY ASPERGILLOSIS,1
ES,BRUGADA SYNDROME,1
ES,C-REACTIVE PROTEIN ABNORMAL,1
ES,C-REACTIVE PROTEIN DECREASED,1
ES,CAESAREAN SECTION,1
ES,CALCULUS URINARY,1
ES,CANDIDA INFECTION,1
ES,CAPILLARY LEAK SYNDROME,1
ES,CARDIAC DISORDER,1
ES,CARDIAC FAILURE ACUTE,1
ES,CARDIAC FAILURE CHRONIC,1
ES,CARDIAC MURMUR,1
ES,CARDIOACTIVE DRUG LEVEL INCREASED,1
ES,CARDIOMYOPATHY,1
ES,CAROTID ARTERY STENOSIS,1
ES,CAROTID ARTERY THROMBOSIS,1
ES,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
ES,CEREBRAL ARTERY OCCLUSION,1
ES,CEREBRAL ATROPHY,1
ES,CEREBRAL INFARCTION,1
ES,CERVICAL INCOMPETENCE,1
ES,CERVICAL VERTEBRAL FRACTURE,1
ES,CHOLANGITIS ACUTE,1
ES,CHOLECYSTITIS,1
ES,CHROMATURIA,1
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ES,CIRCUMORAL OEDEMA,1
ES,COLITIS,1
ES,COLITIS ISCHAEMIC,1
ES,COMPLEX PARTIAL SEIZURES,1
ES,COMPLICATION OF DEVICE INSERTION,1
ES,CONGESTIVE CARDIOMYOPATHY,1
ES,CONJUNCTIVAL HAEMORRHAGE,1
ES,CONSCIOUSNESS FLUCTUATING,1
ES,CONTRAINDICATED DRUG ADMINISTERED,1
ES,CONTUSION,1
ES,COORDINATION ABNORMAL,1
ES,CORONARY ARTERY DISEASE,1
ES,CORONARY ARTERY OCCLUSION,1
ES,COSTOCHONDRITIS,1
ES,CROHN^S DISEASE,1
ES,CYSTATIN C INCREASED,1
ES,CYTOMEGALOVIRUS COLITIS,1
ES,CYTOMEGALOVIRUS INFECTION,1
ES,CYTOPENIA,1
ES,DACRYOCYSTITIS,1
ES,DECUBITUS ULCER,1
ES,DELIRIUM,1
ES,DELUSION,1
ES,DEMENTIA ALZHEIMER^S TYPE,1
ES,DEMYELINATION,1
ES,DERMATITIS EXFOLIATIVE,1
ES,DERMATITIS PSORIASIFORM,1
ES,DEVICE FAILURE,1
ES,DEXAMETHASONE SUPPRESSION TEST POSITIVE,1
ES,DIABETIC HYPEROSMOLAR COMA,1
ES,DIABETIC METABOLIC DECOMPENSATION,1
ES,DIABETIC NEPHROPATHY,1
ES,DIABETIC NEUROPATHY,1
ES,DIABETIC RETINOPATHY,1
ES,DIALYSIS,1
ES,DIARRHOEA HAEMORRHAGIC,1
ES,DIFFUSE ALOPECIA,1
ES,DIPLOPIA,1
ES,DISEASE COMPLICATION,1
ES,DISTURBANCE IN ATTENTION,1
ES,DIVERTICULUM,1
ES,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
ES,DRUG ABUSE,1
ES,DRUG DOSE OMISSION,1
ES,DRUG EFFECT INCOMPLETE,1
ES,DRUG LEVEL ABOVE THERAPEUTIC,1
ES,DRUG LEVEL DECREASED,1
ES,DRUG RESISTANCE,1
ES,DRUG TOLERANCE DECREASED,1
ES,DRY SKIN,1
ES,DUODENAL PERFORATION,1
ES,DYSMETRIA,1
ES,DYSPEPSIA,1
ES,DYSSTASIA,1
ES,DYSURIA,1
ES,EAR INFECTION,1
ES,EARLY SATIETY,1
ES,ECTHYMA,1
ES,EJECTION FRACTION DECREASED,1
ES,ELECTROCARDIOGRAM CHANGE,1
ES,ELECTROCARDIOGRAM P WAVE ABNORMAL,1
ES,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
ES,ELECTROCARDIOGRAM T WAVE PEAKED,1
ES,EMBOLIC STROKE,1
ES,EMBOLISM,1
ES,EMOTIONAL DISORDER,1
ES,EMPHYSEMA,1
ES,ENDOMETRIAL CANCER,1
ES,EPILEPSY,1
ES,ESCHERICHIA INFECTION,1
ES,EXCESSIVE CERUMEN PRODUCTION,1
ES,EXTREMITY NECROSIS,1
ES,EYE DISORDER,1
ES,EYE HAEMORRHAGE,1
ES,EYELID OEDEMA,1
ES,EYELID PTOSIS,1
ES,FAECALOMA,1
ES,FLUID INTAKE REDUCED,1
ES,FLUID OVERLOAD,1
ES,FLUSHING,1
ES,FOETAL HEART RATE ABNORMAL,1
ES,GAIT INABILITY,1
ES,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
ES,GASTRIC DILATATION,1
ES,GASTRIC DISORDER,1
ES,GASTRIC HAEMORRHAGE,1
ES,GASTRIC INFECTION,1
ES,GASTRIC POLYPS,1
ES,GASTRITIS,1
ES,GASTRITIS EROSIVE,1
ES,GASTROINTESTINAL FUNGAL INFECTION,1
ES,GASTROINTESTINAL MOTILITY DISORDER,1
ES,GASTROOESOPHAGEAL REFLUX DISEASE,1
ES,GENERALISED ANXIETY DISORDER,1
ES,GENERALISED ERYTHEMA,1
ES,GENITAL INFECTION FUNGAL,1
ES,GINGIVAL PAIN,1
ES,GINGIVITIS,1
ES,GLAUCOMA,1
ES,GLOMERULAR FILTRATION RATE ABNORMAL,1
ES,GLOMERULAR FILTRATION RATE DECREASED,1
ES,GOUT,1
ES,GUILLAIN-BARRE SYNDROME,1
ES,H1N1 INFLUENZA,1
ES,HAEMANGIOMA OF LIVER,1
ES,HAEMATEMESIS,1
ES,HAEMATOCRIT DECREASED,1
ES,HAEMATOTOXICITY,1
ES,HAEMOPHILUS INFECTION,1
ES,HAEMORRHAGIC STROKE,1
ES,HAEMORRHAGIC TRANSFORMATION STROKE,1
ES,HALLUCINATIONS_ MIXED,1
ES,HEART VALVE INCOMPETENCE,1
ES,HEMIANAESTHESIA,1
ES,HEMIPLEGIA,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATITIS B,1
ES,HEPATITIS CHOLESTATIC,1
ES,HEPATOCELLULAR INJURY,1
ES,HEPATOSPLENOMEGALY,1
ES,HERNIA,1
ES,HIDRADENITIS,1
ES,HUNGER,1
ES,HYPERADRENALISM,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERCAPNIA,1
ES,HYPERCHOLESTEROLAEMIA,1
ES,HYPERFERRITINAEMIA,1
ES,HYPERKERATOSIS,1
ES,HYPERLACTACIDAEMIA,1
ES,HYPERNATRAEMIA,1
ES,HYPERTENSIVE HEART DISEASE,1
ES,HYPERVENTILATION,1
ES,HYPERVOLAEMIA,1
ES,HYPOCHROMIC ANAEMIA,1
ES,HYPOGAMMAGLOBULINAEMIA,1
ES,HYPOGEUSIA,1
ES,HYPOPERFUSION,1
ES,HYPOPHOSPHATAEMIA,1
ES,HYPOTHERMIA,1
ES,HYPOTHYROIDISM,1
ES,HYPOVOLAEMIA,1
ES,IIIRD NERVE PARESIS,1
ES,IMPAIRED GASTRIC EMPTYING,1
ES,IMPAIRED WORK ABILITY,1
ES,IMPETIGO,1
ES,IMPULSE-CONTROL DISORDER,1
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
ES,INCARCERATED HERNIA,1
ES,INCISIONAL HERNIA,1
ES,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
ES,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
ES,INJECTION SITE BRUISING,1
ES,INJECTION SITE DISCOMFORT,1
ES,INJECTION SITE HAEMORRHAGE,1
ES,INJECTION SITE URTICARIA,1
ES,INTENTIONAL PRODUCT USE ISSUE,1
ES,INTERNAL HAEMORRHAGE,1
ES,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
ES,INTERSTITIAL LUNG DISEASE,1
ES,INTERVERTEBRAL DISC PROTRUSION,1
ES,INTERVERTEBRAL DISCITIS,1
ES,INTESTINAL OBSTRUCTION,1
ES,INTESTINAL POLYP,1
ES,INTRA-ABDOMINAL HAEMATOMA,1
ES,INTRA-ABDOMINAL HAEMORRHAGE,1
ES,IRON DEFICIENCY ANAEMIA,1
ES,ISCHAEMIC CARDIOMYOPATHY,1
ES,ISCHAEMIC CEREBRAL INFARCTION,1
ES,JOINT STIFFNESS,1
ES,KAPOSI^S SARCOMA,1
ES,LARGE INTESTINE PERFORATION,1
ES,LEFT ATRIAL ENLARGEMENT,1
ES,LEFT VENTRICULAR FAILURE,1
ES,LEFT VENTRICULAR HYPERTROPHY,1
ES,LEUKOPENIA,1
ES,LICHEN PLANUS,1
ES,LICHENOID KERATOSIS,1
ES,LIMB INJURY,1
ES,LIP OEDEMA,1
ES,LIPOHYPERTROPHY,1
ES,LIPOMA,1
ES,LIVE BIRTH,1
ES,LIVER DISORDER,1
ES,LIVER FUNCTION TEST ABNORMAL,1
ES,LOCAL SWELLING,1
ES,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
ES,LONG QT SYNDROME,1
ES,LOWER RESPIRATORY TRACT INFECTION,1
ES,LUNG ADENOCARCINOMA,1
ES,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,1
ES,LUNG DISORDER,1
ES,LUNG INFECTION,1
ES,LUNG NEOPLASM MALIGNANT,1
ES,LYMPHANGIOSIS CARCINOMATOSA,1
ES,LYMPHOCYTE COUNT DECREASED,1
ES,MACULAR OEDEMA,1
ES,MACULE,1
ES,MALE SEXUAL DYSFUNCTION,1
ES,MALIGNANT MELANOMA,1
ES,MEDULLARY THYROID CANCER,1
ES,MELAENA,1
ES,MENTAL DISORDER,1
ES,MENTAL IMPAIRMENT,1
ES,METABOLIC ALKALOSIS,1
ES,METABOLIC DISORDER,1
ES,METASTASES TO BONE,1
ES,METASTASES TO CENTRAL NERVOUS SYSTEM,1
ES,METASTASES TO LUNG,1
ES,METASTASES TO MENINGES,1
ES,METASTATIC MALIGNANT MELANOMA,1
ES,MICTURITION DISORDER,1
ES,MITRAL VALVE INCOMPETENCE,1
ES,MONOCYTE COUNT DECREASED,1
ES,MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
ES,MOUTH ULCERATION,1
ES,MUCOSAL DRYNESS,1
ES,MULTIPLE PREGNANCY,1
ES,MULTIPLE SCLEROSIS RELAPSE,1
ES,MUSCULOSKELETAL DISORDER,1
ES,MUTISM,1
ES,MYELODYSPLASTIC SYNDROME,1
ES,MYOCARDIAL INFARCTION,1
ES,MYOCARDIAL ISCHAEMIA,1
ES,MYOCARDIAL NECROSIS MARKER INCREASED,1
ES,MYOCARDITIS,1
ES,NAIL DISCOLOURATION,1
ES,NAIL DISORDER,1
ES,NAIL DYSTROPHY,1
ES,NASOPHARYNGITIS,1
ES,NEOPLASM,1
ES,NEPHROPATHY TOXIC,1
ES,NERVOUS SYSTEM DISORDER,1
ES,NEUROGENIC BLADDER,1
ES,NEUROLEPTIC MALIGNANT SYNDROME,1
ES,NEUROLOGICAL DECOMPENSATION,1
ES,NEUROLOGICAL SYMPTOM,1
ES,NEUROPATHIC ARTHROPATHY,1
ES,NEUTROPENIC SEPSIS,1
ES,NEUTROPHIL COUNT DECREASED,1
ES,NEUTROPHIL PERCENTAGE INCREASED,1
ES,NODULE,1
ES,NON-SMALL CELL LUNG CANCER,1
ES,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
ES,NYSTAGMUS,1
ES,OESOPHAGEAL ATRESIA,1
ES,OESOPHAGEAL CANDIDIASIS,1
ES,OESOPHAGEAL VARICES HAEMORRHAGE,1
ES,OPTIC NEURITIS,1
ES,ORAL DISORDER,1
ES,ORAL HERPES,1
ES,ORAL MUCOSA EROSION,1
ES,OROPHARYNGEAL DISCOMFORT,1
ES,OROPHARYNGEAL PAIN,1
ES,PALATAL OEDEMA,1
ES,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
ES,PANCREAS INFECTION,1
ES,PANCREATIC CARCINOMA METASTATIC,1
ES,PANCREATIC DISORDER,1
ES,PANCREATIC PSEUDOCYST,1
ES,PANCREATIC STEATOSIS,1
ES,PARADOXICAL DRUG REACTION,1
ES,PARANEOPLASTIC SYNDROME,1
ES,PARESIS,1
ES,PARKINSON^S DISEASE,1
ES,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
ES,PATHOGEN RESISTANCE,1
ES,PCO2 DECREASED,1
ES,PCO2 INCREASED,1
ES,PEMPHIGUS,1
ES,PEPTOSTREPTOCOCCUS INFECTION,1
ES,PERIANAL STREPTOCOCCAL INFECTION,1
ES,PERICARDIAL EFFUSION,1
ES,PERINEPHRIC ABSCESS,1
ES,PERIPHERAL SENSORY NEUROPATHY,1
ES,PERITONEAL HAEMORRHAGE,1
ES,PERSONALITY DISORDER,1
ES,PHOTOPSIA,1
ES,PLASMA CELL MYELOMA,1
ES,PNEUMONIA BACTERIAL,1
ES,PNEUMONIA INFLUENZAL,1
ES,POLYMYALGIA RHEUMATICA,1
ES,PREMATURE RUPTURE OF MEMBRANES,1
ES,PRERENAL FAILURE,1
ES,PRIMARY HYPERALDOSTERONISM,1
ES,PROCTALGIA,1
ES,PRODUCT QUALITY ISSUE,1
ES,PRODUCTIVE COUGH,1
ES,PRURITUS GENERALISED,1
ES,PSEUDOMONAL BACTERAEMIA,1
ES,PSEUDOMONAS INFECTION,1
ES,PSORIATIC ARTHROPATHY,1
ES,PSYCHOMOTOR HYPERACTIVITY,1
ES,PSYCHOTIC DISORDER,1
ES,PULMONARY FIBROSIS,1
ES,PULMONARY FUNCTION TEST DECREASED,1
ES,PULMONARY HAEMORRHAGE,1
ES,PULMONARY HYPERTENSION,1
ES,PULMONARY INFARCTION,1
ES,PULMONARY MASS,1
ES,PUNCTURE SITE ABSCESS,1
ES,PURULENCE,1
ES,QUADRIPLEGIA,1
ES,QUALITY OF LIFE DECREASED,1
ES,RADIATION SKIN INJURY,1
ES,RASH GENERALISED,1
ES,RASH MACULO-PAPULAR,1
ES,RASH PAPULAR,1
ES,RAYNAUD^S PHENOMENON,1
ES,RECTAL ADENOMA,1
ES,RED BLOOD CELL SEDIMENTATION RATE DECREASED,1
ES,RENAL CELL CARCINOMA,1
ES,RENAL DISORDER,1
ES,RENAL ONCOCYTOMA,1
ES,RESPIRATORY DEPRESSION,1
ES,RESPIRATORY DISTRESS,1
ES,RESTLESSNESS,1
ES,RETROGRADE EJACULATION,1
ES,ROTAVIRUS INFECTION,1
ES,SCIATICA,1
ES,SCROTAL ANGIOKERATOMA,1
ES,SEIZURE,1
ES,SENSE OF OPPRESSION,1
ES,SENSORY LOSS,1
ES,SINUS BRADYCARDIA,1
ES,SINUS RHYTHM,1
ES,SKIN HAEMORRHAGE,1
ES,SKIN INJURY,1
ES,SKIN LESION EXCISION,1
ES,SKIN PAPILLOMA,1
ES,SKIN REACTION,1
ES,SKIN TEST POSITIVE,1
ES,SKIN TOXICITY,1
ES,SLEEP APNOEA SYNDROME,1
ES,SLUGGISHNESS,1
ES,SMALL INTESTINAL OBSTRUCTION,1
ES,SPINAL CORD COMPRESSION,1
ES,SPINAL OSTEOARTHRITIS,1
ES,SPLENIC INFARCTION,1
ES,SPLENIC LESION,1
ES,SQUAMOUS CELL CARCINOMA,1
ES,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
ES,SQUAMOUS CELL CARCINOMA OF THE VAGINA,1
ES,STAPHYLOCOCCAL SEPSIS,1
ES,STAPHYLOCOCCUS TEST POSITIVE,1
ES,STRESS,1
ES,SUBILEUS,1
ES,SUPERINFECTION,1
ES,SUPERIOR VENA CAVA SYNDROME,1
ES,SUPRAPUBIC PAIN,1
ES,SUPRAVENTRICULAR TACHYCARDIA,1
ES,SURGERY,1
ES,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
ES,SYSTEMIC MYCOSIS,1
ES,TACHYARRHYTHMIA,1
ES,TENDON DISORDER,1
ES,THERAPEUTIC PROCEDURE,1
ES,THROAT IRRITATION,1
ES,THROMBOANGIITIS OBLITERANS,1
ES,THROMBOCYTOPENIC PURPURA,1
ES,THROMBOTIC STROKE,1
ES,THYROID CANCER,1
ES,THYROID FUNCTION TEST ABNORMAL,1
ES,TONGUE DISCOMFORT,1
ES,TOOTH ABSCESS,1
ES,TOOTH EXTRACTION,1
ES,TOOTH LOSS,1
ES,TRANSFUSION,1
ES,TRANSITIONAL CELL CARCINOMA,1
ES,TRICUSPID VALVE INCOMPETENCE,1
ES,TUBULOINTERSTITIAL NEPHRITIS,1
ES,TUMOUR COMPRESSION,1
ES,TYMPANIC MEMBRANE PERFORATION,1
ES,URINARY TRACT INFECTION PSEUDOMONAL,1
ES,UROSEPSIS,1
ES,VARICELLA,1
ES,VARICES OESOPHAGEAL,1
ES,VASCULAR ENCEPHALOPATHY,1
ES,VEIN DISORDER,1
ES,VENTRICULAR ASYSTOLE,1
ES,VENTRICULAR HYPERTROPHY,1
ES,VENTRICULAR HYPOKINESIA,1
ES,VERTEBRAL ARTERY STENOSIS,1
ES,VESTIBULAR NYSTAGMUS,1
ES,VIRAL MUTATION IDENTIFIED,1
ES,VITAMIN D DEFICIENCY,1
ES,VITREOUS HAEMORRHAGE,1
ES,WHITE BLOOD CELL COUNT DECREASED,1
ES,WHITE BLOOD CELL COUNT INCREASED,1
ES,WITHDRAWAL SYNDROME,1
ES,WOUND COMPLICATION,1
ES,WRIST FRACTURE,1
ES,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
LK,HYPERKALAEMIA,1
LK,NEUTROPENIA,1
SD,CHEST PAIN,1
SD,HYPERGLYCAEMIA,1
SE,ACUTE KIDNEY INJURY,45
SE,LACTIC ACIDOSIS,41
SE,DIARRHOEA,40
SE,NAUSEA,29
SE,TOXICITY TO VARIOUS AGENTS,22
SE,DYSPNOEA,21
SE,VOMITING,21
SE,FATIGUE,19
SE,RENAL FAILURE,19
SE,BLOOD CREATININE INCREASED,14
SE,DEHYDRATION,14
SE,ABDOMINAL PAIN,11
SE,DIZZINESS,11
SE,PRURITUS,11
SE,RENAL FAILURE ACUTE,10
SE,SEPSIS,10
SE,SHOCK,10
SE,HEPATIC ENZYME INCREASED,9
SE,HEPATIC FAILURE,9
SE,HYPOTENSION,9
SE,CARDIAC FAILURE,8
SE,CONFUSIONAL STATE,8
SE,PNEUMONIA,8
SE,BACK PAIN,7
SE,GAIT DISTURBANCE,7
SE,HEPATIC CIRRHOSIS,7
SE,KETOACIDOSIS,7
SE,OVERDOSE,7
SE,ABDOMINAL PAIN UPPER,6
SE,ARRHYTHMIA,6
SE,CEREBRAL HAEMORRHAGE,6
SE,CHEST PAIN,6
SE,COORDINATION ABNORMAL,6
SE,DRUG INEFFECTIVE,6
SE,HEADACHE,6
SE,HYPONATRAEMIA,6
SE,METABOLIC ACIDOSIS,6
SE,MUSCLE SPASMS,6
SE,PALPITATIONS,6
SE,PERIPHERAL SWELLING,6
SE,TUBULOINTERSTITIAL NEPHRITIS,6
SE,URINARY TRACT INFECTION,6
SE,ACIDOSIS,5
SE,ARTHRALGIA,5
SE,BLOOD PRESSURE INCREASED,5
SE,CELLULITIS,5
SE,COMA,5
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,5
SE,EOSINOPHILIA,5
SE,FALL,5
SE,GASTROOESOPHAGEAL REFLUX DISEASE,5
SE,HYPERTENSION,5
SE,HYPERTENSIVE HEART DISEASE,5
SE,HYPOGLYCAEMIA,5
SE,KLEBSIELLA INFECTION,5
SE,LOSS OF CONSCIOUSNESS,5
SE,MALAISE,5
SE,MEMORY IMPAIRMENT,5
SE,MUSCULOSKELETAL PAIN,5
SE,OSTEOMYELITIS,5
SE,PAIN IN EXTREMITY,5
SE,PRODUCT SUBSTITUTION ISSUE,5
SE,PYREXIA,5
SE,SOMNOLENCE,5
SE,WEIGHT DECREASED,5
SE,ANXIETY,4
SE,BALANCE DISORDER,4
SE,BURNING SENSATION,4
SE,CARDIAC ARREST,4
SE,CEREBRAL INFARCTION,4
SE,CONSTIPATION,4
SE,EPISTAXIS,4
SE,LIVER DISORDER,4
SE,MUSCLE RIGIDITY,4
SE,MUSCLE TIGHTNESS,4
SE,MYOCARDIAL INFARCTION,4
SE,OLIGURIA,4
SE,TACHYCARDIA,4
SE,URTICARIA,4
SE,AGGRESSION,3
SE,AMNESIA,3
SE,ASTHENIA,3
SE,BLOOD GLUCOSE DECREASED,3
SE,BLOOD GLUCOSE INCREASED,3
SE,CEREBROVASCULAR ACCIDENT,3
SE,CHEST DISCOMFORT,3
SE,CHILLS,3
SE,COUGH,3
SE,DIABETES MELLITUS,3
SE,DIABETIC KETOACIDOSIS,3
SE,DISTURBANCE IN ATTENTION,3
SE,DYSPHAGIA,3
SE,ERYTHEMA,3
SE,FEELING HOT,3
SE,GENERAL PHYSICAL HEALTH DETERIORATION,3
SE,HAEMATURIA,3
SE,HEART RATE INCREASED,3
SE,HEPATITIS,3
SE,HYPERCALCAEMIA,3
SE,HYPERHIDROSIS,3
SE,HYPERKALAEMIA,3
SE,HYPOKALAEMIA,3
SE,ISCHAEMIC STROKE,3
SE,JAUNDICE,3
SE,MUSCULAR WEAKNESS,3
SE,PAIN,3
SE,PALLOR,3
SE,PANCREATIC CARCINOMA,3
SE,PANCYTOPENIA,3
SE,PARAESTHESIA,3
SE,PULMONARY EMBOLISM,3
SE,RENAL IMPAIRMENT,3
SE,RESPIRATORY DISORDER,3
SE,SUBDURAL HAEMATOMA,3
SE,SUDDEN CARDIAC DEATH,3
SE,SYNCOPE,3
SE,THROMBOCYTOPENIA,3
SE,TRANSAMINASES INCREASED,3
SE,URINARY RETENTION,3
SE,VISUAL IMPAIRMENT,3
SE,ABDOMINAL DISCOMFORT,2
SE,ABDOMINAL DISTENSION,2
SE,ALTERED STATE OF CONSCIOUSNESS,2
SE,ANAEMIA,2
SE,ANGIOEDEMA,2
SE,ANOSMIA,2
SE,ARTHROPATHY,2
SE,ASCITES,2
SE,ATAXIA,2
SE,BLADDER CANCER,2
SE,BLISTER,2
SE,BLOOD LACTIC ACID INCREASED,2
SE,BLOOD PRESSURE DECREASED,2
SE,BRADYCARDIA,2
SE,BRAIN INJURY,2
SE,CARDIAC DISORDER,2
SE,CHOLESTASIS,2
SE,CIRCULATORY COLLAPSE,2
SE,COLD SWEAT,2
SE,COLON CANCER,2
SE,CONTUSION,2
SE,CONVULSION,2
SE,DEATH,2
SE,DECREASED APPETITE,2
SE,DEPRESSED MOOD,2
SE,DEPRESSION,2
SE,DISSOCIATION,2
SE,DIVERTICULITIS,2
SE,DRUG LEVEL INCREASED,2
SE,DUODENAL ULCER,2
SE,DYSGEUSIA,2
SE,DYSPEPSIA,2
SE,ELEVATED MOOD,2
SE,EMOTIONAL DISORDER,2
SE,EXPOSURE DURING PREGNANCY,2
SE,FLUSHING,2
SE,GASTRIC DISORDER,2
SE,GASTRIC ULCER,2
SE,GASTROENTERITIS,2
SE,GENITAL INFECTION FUNGAL,2
SE,GYNAECOMASTIA,2
SE,HAEMORRHAGE,2
SE,HALLUCINATION,2
SE,HYPERGLYCAEMIA,2
SE,HYPERSENSITIVITY,2
SE,HYPOTHERMIA,2
SE,HYPOXIA,2
SE,INCONTINENCE,2
SE,INFECTION,2
SE,INGUINAL HERNIA,2
SE,LARYNGOSPASM,2
SE,MALIGNANT NEOPLASM PROGRESSION,2
SE,MUSCLE ATROPHY,2
SE,MYALGIA,2
SE,NEPHROLITHIASIS,2
SE,NEPHROPATHY TOXIC,2
SE,NIGHTMARE,2
SE,ORAL DISCOMFORT,2
SE,OSTEONECROSIS OF JAW,2
SE,PANCREATITIS,2
SE,PERIPHERAL COLDNESS,2
SE,PNEUMONIA PNEUMOCOCCAL,2
SE,POISONING,2
SE,POLLAKIURIA,2
SE,PORTAL VEIN THROMBOSIS,2
SE,PRESYNCOPE,2
SE,PRURITUS GENERALISED,2
SE,RASH,2
SE,RASH GENERALISED,2
SE,RENAL TUBULAR NECROSIS,2
SE,RHABDOMYOLYSIS,2
SE,SPEECH DISORDER,2
SE,SUDDEN DEATH,2
SE,SUPRAVENTRICULAR TACHYCARDIA,2
SE,TACHYPNOEA,2
SE,TIC,2
SE,VASCULAR RESISTANCE SYSTEMIC DECREASED,2
SE,ABDOMINAL PAIN LOWER,1
SE,ABNORMAL BEHAVIOUR,1
SE,ABSCESS,1
SE,ACCIDENTAL OVERDOSE,1
SE,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
SE,ACUTE HEPATIC FAILURE,1
SE,ACUTE POLYNEUROPATHY,1
SE,AGRANULOCYTOSIS,1
SE,ALCOHOL INTERACTION,1
SE,ALOPECIA,1
SE,ANAPHYLACTIC REACTION,1
SE,ANGINA UNSTABLE,1
SE,ANOSOGNOSIA,1
SE,ANURIA,1
SE,APATHY,1
SE,APPENDICITIS PERFORATED,1
SE,APPETITE DISORDER,1
SE,ARRHYTHMIA SUPRAVENTRICULAR,1
SE,ATRIAL FIBRILLATION,1
SE,ATRIAL FLUTTER,1
SE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
SE,AZOTAEMIA,1
SE,BACTERAEMIA,1
SE,BACTERIAL SEPSIS,1
SE,BALANOPOSTHITIS,1
SE,BENIGN PROSTATIC HYPERPLASIA,1
SE,BLINDNESS,1
SE,BLINDNESS TRANSIENT,1
SE,BLOOD BILIRUBIN INCREASED,1
SE,BLOOD COUNT ABNORMAL,1
SE,BLOOD CREATININE DECREASED,1
SE,BLOOD GLUCOSE ABNORMAL,1
SE,BLOOD GLUCOSE FLUCTUATION,1
SE,BLOOD INSULIN DECREASED,1
SE,BLOOD KETONE BODY INCREASED,1
SE,BLOOD URINE PRESENT,1
SE,BRAIN NEOPLASM,1
SE,BREAST MASS,1
SE,BREAST SWELLING,1
SE,BRONCHOPNEUMONIA,1
SE,BRONCHOSPASM,1
SE,BUNDLE BRANCH BLOCK LEFT,1
SE,CARDIAC FAILURE CONGESTIVE,1
SE,CARDIAC PACEMAKER INSERTION,1
SE,CARDIAC VALVE DISEASE,1
SE,CARDIOVASCULAR INSUFFICIENCY,1
SE,CARDIOVERSION,1
SE,CATARACT,1
SE,CATARRH,1
SE,CEREBELLAR ATAXIA,1
SE,CHOLECYSTITIS,1
SE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
SE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SE,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
SE,COGNITIVE DISORDER,1
SE,COLITIS ISCHAEMIC,1
SE,COLITIS ULCERATIVE,1
SE,CONGESTIVE CARDIOMYOPATHY,1
SE,CONTINUOUS HAEMODIAFILTRATION,1
SE,CONTRAINDICATED DRUG ADMINISTERED,1
SE,CORNEAL EROSION,1
SE,CORONARY ARTERY STENOSIS,1
SE,DECREASED ACTIVITY,1
SE,DEEP VEIN THROMBOSIS,1
SE,DEMENTIA,1
SE,DEVICE ISSUE,1
SE,DIABETES MELLITUS INADEQUATE CONTROL,1
SE,DIARRHOEA HAEMORRHAGIC,1
SE,DILATATION VENTRICULAR,1
SE,DISEASE PROGRESSION,1
SE,DRUG-DISEASE INTERACTION,1
SE,DRY EYE,1
SE,DRY MOUTH,1
SE,DRY SKIN,1
SE,DUODENITIS,1
SE,DYSPHONIA,1
SE,EAR PAIN,1
SE,EAR SWELLING,1
SE,ECZEMA,1
SE,ELECTROLYTE IMBALANCE,1
SE,EMBOLIC STROKE,1
SE,ENTEROCOCCAL SEPSIS,1
SE,ERECTILE DYSFUNCTION,1
SE,ERYSIPELAS,1
SE,ERYTHEMA MULTIFORME,1
SE,EXTRADURAL ABSCESS,1
SE,EXTRAPYRAMIDAL DISORDER,1
SE,EYE DISORDER,1
SE,EYE OEDEMA,1
SE,FACE OEDEMA,1
SE,FAECAL INCONTINENCE,1
SE,FEAR OF DEATH,1
SE,FEELING COLD,1
SE,FLUID RETENTION,1
SE,FOOT DEFORMITY,1
SE,GALLBLADDER PAIN,1
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SE,GASTRIC ULCER HAEMORRHAGE,1
SE,GASTROINTESTINAL DISORDER,1
SE,GASTROINTESTINAL STROMAL TUMOUR,1
SE,GENERAL SYMPTOM,1
SE,GENERALISED ERYTHEMA,1
SE,GENERALISED OEDEMA,1
SE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
SE,HAEMATOMA,1
SE,HAEMORRHAGIC EROSIVE GASTRITIS,1
SE,HEART RATE IRREGULAR,1
SE,HEPATIC CANCER,1
SE,HEPATIC FUNCTION ABNORMAL,1
SE,HEPATOCELLULAR CARCINOMA,1
SE,HEPATOTOXICITY,1
SE,HICCUPS,1
SE,HYPERKINESIA,1
SE,HYPERSENSITIVITY VASCULITIS,1
SE,HYPERSOMNIA,1
SE,HYPERVENTILATION,1
SE,HYPERVOLAEMIA,1
SE,HYPOCALCAEMIA,1
SE,IDIOSYNCRATIC DRUG REACTION,1
SE,IMMUNE THROMBOCYTOPENIC PURPURA,1
SE,IMPAIRED DRIVING ABILITY,1
SE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SE,INCORRECT DOSE ADMINISTERED,1
SE,INCORRECT DOSE ADMINISTERED BY DEVICE,1
SE,INCORRECT DRUG ADMINISTRATION DURATION,1
SE,INFLUENZA,1
SE,INFLUENZA LIKE ILLNESS,1
SE,INJECTION SITE ATROPHY,1
SE,INJECTION SITE BRUISING,1
SE,INJECTION SITE EXTRAVASATION,1
SE,INJECTION SITE MASS,1
SE,INJECTION SITE PRURITUS,1
SE,INJECTION SITE SWELLING,1
SE,INJURY,1
SE,INTENTIONAL OVERDOSE,1
SE,INTERVERTEBRAL DISC PROTRUSION,1
SE,INTERVERTEBRAL DISCITIS,1
SE,INTESTINAL GANGRENE,1
SE,INTESTINAL OBSTRUCTION,1
SE,IRON DEFICIENCY ANAEMIA,1
SE,JOINT SWELLING,1
SE,LEFT VENTRICULAR DYSFUNCTION,1
SE,LIBIDO INCREASED,1
SE,LIP SWELLING,1
SE,LIVER FUNCTION TEST ABNORMAL,1
SE,LOCAL SWELLING,1
SE,LOSS OF CONTROL OF LEGS,1
SE,LUNG CANCER METASTATIC,1
SE,MACULAR HOLE,1
SE,MAJOR DEPRESSION,1
SE,MALIGNANT MELANOMA IN SITU,1
SE,MEAN ARTERIAL PRESSURE DECREASED,1
SE,MEDICATION ERROR,1
SE,MENTAL DISORDER,1
SE,MENTAL IMPAIRMENT,1
SE,MENTAL STATUS CHANGES,1
SE,MUSCLE CONTRACTURE,1
SE,MYOCARDITIS,1
SE,NASOPHARYNGITIS,1
SE,NECK MASS,1
SE,NECK PAIN,1
SE,NECROTISING MYOSITIS,1
SE,NEOPLASM MALIGNANT,1
SE,NEUROGENIC BLADDER,1
SE,NEUTROPHIL COUNT DECREASED,1
SE,NO THERAPEUTIC RESPONSE,1
SE,NON-INFECTIOUS ENDOPHTHALMITIS,1
SE,OCULAR HYPERAEMIA,1
SE,OEDEMA PERIPHERAL,1
SE,OESOPHAGEAL OBSTRUCTION,1
SE,ORAL MUCOSAL BLISTERING,1
SE,ORAL MUCOSAL EXFOLIATION,1
SE,OROPHARYNGEAL PAIN,1
SE,OSTEONECROSIS,1
SE,OVARIAN CANCER,1
SE,OXYGEN SATURATION DECREASED,1
SE,PANCREATIC CARCINOMA METASTATIC,1
SE,PARKINSONISM,1
SE,PAROSMIA,1
SE,PENILE ULCERATION,1
SE,PENIS DISORDER,1
SE,PHARYNGEAL HAEMORRHAGE,1
SE,PHARYNGEAL OEDEMA,1
SE,PHOTOPHOBIA,1
SE,PHOTOSENSITIVITY REACTION,1
SE,POLYNEUROPATHY,1
SE,POLYP,1
SE,POOR QUALITY SLEEP,1
SE,PORTAL HYPERTENSION,1
SE,PRESCRIBED OVERDOSE,1
SE,PRESCRIBED UNDERDOSE,1
SE,PRODUCT USE ISSUE,1
SE,PSORIASIS,1
SE,PSYCHIATRIC SYMPTOM,1
SE,PSYCHOMOTOR HYPERACTIVITY,1
SE,RASH ERYTHEMATOUS,1
SE,RASH MACULAR,1
SE,RASH MACULO-PAPULAR,1
SE,REFLEXES ABNORMAL,1
SE,RENAL CANCER,1
SE,RENAL COLIC,1
SE,RENAL INJURY,1
SE,RESPIRATORY ALKALOSIS,1
SE,RESPIRATORY FAILURE,1
SE,RHEUMATOID ARTHRITIS,1
SE,RIGHT VENTRICULAR FAILURE,1
SE,ROAD TRAFFIC ACCIDENT,1
SE,SEIZURE,1
SE,SENSORY LOSS,1
SE,SINUS ARREST,1
SE,SINUS BRADYCARDIA,1
SE,SINUS NODE DYSFUNCTION,1
SE,SKIN DISORDER,1
SE,SKIN EXFOLIATION,1
SE,SLEEP DISORDER,1
SE,SOCIAL AVOIDANT BEHAVIOUR,1
SE,STAPHYLOCOCCUS TEST POSITIVE,1
SE,STRESS,1
SE,SUBARACHNOID HAEMORRHAGE,1
SE,SUBCUTANEOUS ABSCESS,1
SE,SUDDEN VISUAL LOSS,1
SE,SUICIDAL IDEATION,1
SE,SUICIDE ATTEMPT,1
SE,SWELLING FACE,1
SE,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,1
SE,TENDERNESS,1
SE,THROAT IRRITATION,1
SE,THROAT TIGHTNESS,1
SE,TOE AMPUTATION,1
SE,TONGUE OEDEMA,1
SE,TOOTH INFECTION,1
SE,TORSADE DE POINTES,1
SE,TOXIC EPIDERMAL NECROLYSIS,1
SE,TRANSIENT ISCHAEMIC ATTACK,1
SE,TREATMENT NONCOMPLIANCE,1
SE,TREMOR,1
SE,TROPONIN INCREASED,1
SE,TYPE 2 DIABETES MELLITUS,1
SE,URETHRITIS NONINFECTIVE,1
SE,URINARY INCONTINENCE,1
SE,VASODILATATION,1
SE,VENTRICULAR TACHYCARDIA,1
SE,VERTIGO,1
SE,VIITH NERVE PARALYSIS,1
SE,VISUAL ACUITY REDUCED,1
SE,WEIGHT INCREASED,1
SE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CH,LACTIC ACIDOSIS,59
CH,ACUTE KIDNEY INJURY,55
CH,HEAT STROKE,16
CH,DIARRHOEA,15
CH,MEDICATION ERROR,12
CH,NAUSEA,12
CH,SHOCK,12
CH,RENAL FAILURE,11
CH,TOXICITY TO VARIOUS AGENTS,11
CH,VOMITING,11
CH,CONFUSIONAL STATE,10
CH,DYSPNOEA,10
CH,INCORRECT DOSE ADMINISTERED,10
CH,RENAL FAILURE ACUTE,10
CH,DECREASED APPETITE,9
CH,METABOLIC ACIDOSIS,9
CH,OVERDOSE,9
CH,DIABETIC KETOACIDOSIS,8
CH,MANIA,8
CH,ANHIDROSIS,7
CH,ASTHENIA,7
CH,FATIGUE,7
CH,FOETAL EXPOSURE DURING PREGNANCY,7
CH,GLOMERULAR FILTRATION RATE DECREASED,7
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
CH,SEPTIC SHOCK,7
CH,SOMNOLENCE,7
CH,SYNCOPE,7
CH,ANAEMIA,6
CH,FALL,6
CH,GENERAL PHYSICAL HEALTH DETERIORATION,6
CH,HYPERKALAEMIA,6
CH,HYPOGLYCAEMIA,6
CH,HYPONATRAEMIA,6
CH,KETOACIDOSIS,6
CH,THROMBOCYTOPENIA,6
CH,ABDOMINAL PAIN,5
CH,ALTERED STATE OF CONSCIOUSNESS,5
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
CH,CARDIAC FAILURE,5
CH,DELIRIUM,5
CH,GASTROINTESTINAL HAEMORRHAGE,5
CH,HEPATIC FAILURE,5
CH,HYPERTENSION,5
CH,HYPOKALAEMIA,5
CH,HYPOTHERMIA,5
CH,HYPOVOLAEMIA,5
CH,LIVER DISORDER,5
CH,PYREXIA,5
CH,TACHYCARDIA,5
CH,TACHYPNOEA,5
CH,ACCIDENTAL OVERDOSE,4
CH,ACUTE MYOCARDIAL INFARCTION,4
CH,AGITATION,4
CH,CHOLECYSTITIS,4
CH,DRUG LEVEL INCREASED,4
CH,DRUG PRESCRIBING ERROR,4
CH,DUODENAL ULCER,4
CH,EXPOSURE DURING PREGNANCY,4
CH,HEPATIC ENZYME INCREASED,4
CH,HEPATOCELLULAR INJURY,4
CH,HEPATOMEGALY,4
CH,HYPERTONIA,4
CH,HYPOCHROMIC ANAEMIA,4
CH,HYPOTENSION,4
CH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
CH,JAUNDICE CHOLESTATIC,4
CH,MYALGIA,4
CH,NIGHT SWEATS,4
CH,RESPIRATORY FAILURE,4
CH,RHABDOMYOLYSIS,4
CH,TRISOMY 21,4
CH,TUBULOINTERSTITIAL NEPHRITIS,4
CH,COMA,3
CH,DEATH,3
CH,DIZZINESS,3
CH,DRUG ABUSE,3
CH,DRUG ERUPTION,3
CH,ELECTROLYTE IMBALANCE,3
CH,EPISTAXIS,3
CH,EXTRAPYRAMIDAL DISORDER,3
CH,HAEMOFILTRATION,3
CH,HAEMORRHAGIC STROKE,3
CH,HALLUCINATION_ AUDITORY,3
CH,HEADACHE,3
CH,HEPATITIS,3
CH,HYPOCALCAEMIA,3
CH,HYPOGLYCAEMIA NEONATAL,3
CH,HYPOHIDROSIS,3
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
CH,PNEUMONIA,3
CH,RENAL IMPAIRMENT,3
CH,SHOCK HAEMORRHAGIC,3
CH,SINUS BRADYCARDIA,3
CH,URINARY TRACT INFECTION,3
CH,WEIGHT DECREASED,3
CH,ABNORMAL BEHAVIOUR,2
CH,ACUTE HEPATIC FAILURE,2
CH,AFFECT LABILITY,2
CH,AGRANULOCYTOSIS,2
CH,ARRHYTHMIA,2
CH,ASCITES,2
CH,BLOOD CREATININE INCREASED,2
CH,BLOOD GLUCOSE INCREASED,2
CH,BLOOD MAGNESIUM DECREASED,2
CH,BRADYCARDIA,2
CH,C-REACTIVE PROTEIN INCREASED,2
CH,CARDIAC ARREST,2
CH,CARDIAC FAILURE CONGESTIVE,2
CH,CARDIOGENIC SHOCK,2
CH,CEREBRAL HAEMORRHAGE,2
CH,CIRCULATORY COLLAPSE,2
CH,COGNITIVE DISORDER,2
CH,DEHYDRATION,2
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CH,DRUG ADMINISTRATION ERROR,2
CH,DRUG EFFECT INCREASED,2
CH,DRUG HYPERSENSITIVITY,2
CH,DRUG INEFFECTIVE,2
CH,DRY MOUTH,2
CH,DYSURIA,2
CH,ELECTROCARDIOGRAM QT PROLONGED,2
CH,ERYSIPELAS,2
CH,FEBRILE NEUTROPENIA,2
CH,GAIT DISTURBANCE,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GASTROINTESTINAL DISORDER,2
CH,GRANULOCYTOPENIA,2
CH,HAEMATOCHEZIA,2
CH,HAEMORRHAGIC ANAEMIA,2
CH,HENOCH-SCHONLEIN PURPURA,2
CH,HEPATIC FIBROSIS,2
CH,HYPERPHOSPHATAEMIA,2
CH,HYPOPARATHYROIDISM,2
CH,IMMUNE-MEDIATED NECROTISING MYOPATHY,2
CH,INFECTION,2
CH,INTENTIONAL OVERDOSE,2
CH,LEUKOCYTOCLASTIC VASCULITIS,2
CH,LOSS OF CONSCIOUSNESS,2
CH,MATERNAL EXPOSURE DURING PREGNANCY,2
CH,MUCOSAL INFLAMMATION,2
CH,MYOCARDIAL INFARCTION,2
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
CH,ORTHOSTATIC HYPOTENSION,2
CH,PHALANGEAL AGENESIS,2
CH,POTENTIATING DRUG INTERACTION,2
CH,PRESYNCOPE,2
CH,PROTEINURIA,2
CH,RASH MACULO-PAPULAR,2
CH,SEROTONIN SYNDROME,2
CH,SPEECH DISORDER,2
CH,SUBDURAL HAEMATOMA,2
CH,TORSADE DE POINTES,2
CH,TOXIC SKIN ERUPTION,2
CH,TYPE 2 DIABETES MELLITUS,2
CH,TYPE I HYPERSENSITIVITY,2
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CH,UROSEPSIS,2
CH,VENTRICULAR EXTRASYSTOLES,2
CH,WHITE BLOOD CELL COUNT DECREASED,2
CH,ABDOMINAL PAIN UPPER,1
CH,ACID BASE BALANCE ABNORMAL,1
CH,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CH,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
CH,ADENOCARCINOMA PANCREAS,1
CH,AGGRESSION,1
CH,ALANINE AMINOTRANSFERASE INCREASED,1
CH,ALOPECIA AREATA,1
CH,ANGIOEDEMA,1
CH,ANION GAP INCREASED,1
CH,ANTI-THYROID ANTIBODY POSITIVE,1
CH,ANURIA,1
CH,ASPARTATE AMINOTRANSFERASE INCREASED,1
CH,ATRIAL FIBRILLATION,1
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
CH,BACK PAIN,1
CH,BACTERAEMIA,1
CH,BALANCE DISORDER,1
CH,BASAL GANGLIA HAEMORRHAGE,1
CH,BASEDOW^S DISEASE,1
CH,BICYTOPENIA,1
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CH,BLOOD CALCIUM INCREASED,1
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CH,BLOOD PRESSURE FLUCTUATION,1
CH,BLOOD PROLACTIN DECREASED,1
CH,BLOOD THYROID STIMULATING HORMONE DECREASED,1
CH,BRONCHIAL SECRETION RETENTION,1
CH,BUNDLE BRANCH BLOCK RIGHT,1
CH,CARDIAC DISORDER,1
CH,CARDIO-RESPIRATORY ARREST,1
CH,CARDIOTOXICITY,1
CH,CATARACT,1
CH,CATATONIA,1
CH,CELLULITIS,1
CH,CEREBELLAR SYNDROME,1
CH,CEREBROVASCULAR ACCIDENT,1
CH,CHOLELITHIASIS,1
CH,CHOLESTASIS,1
CH,CHONDROCALCINOSIS PYROPHOSPHATE,1
CH,CHROMATURIA,1
CH,CHRONIC GRANULOMATOUS DISEASE,1
CH,CHRONIC HEPATITIS,1
CH,COARCTATION OF THE AORTA,1
CH,COMA SCALE ABNORMAL,1
CH,CONGENITAL HAND MALFORMATION,1
CH,CONTRAINDICATED PRODUCT ADMINISTERED,1
CH,CORONARY ARTERY DISEASE,1
CH,CORONARY ARTERY THROMBOSIS,1
CH,CORONARY BYPASS THROMBOSIS,1
CH,CRYSTALLURIA,1
CH,CSF GLUCOSE INCREASED,1
CH,DELUSION,1
CH,DEPRESSION,1
CH,DIABETES MELLITUS,1
CH,DISEASE PROGRESSION,1
CH,DISINHIBITION,1
CH,DISTURBANCE IN ATTENTION,1
CH,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
CH,DRUG INTOLERANCE,1
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
CH,DRUG SCREEN POSITIVE,1
CH,DRUG-INDUCED LIVER INJURY,1
CH,DYSPEPSIA,1
CH,DYSPHAGIA,1
CH,DYSPNOEA EXERTIONAL,1
CH,EAR INFECTION,1
CH,EATING DISORDER,1
CH,ELECTROCARDIOGRAM T WAVE INVERSION,1
CH,ELEVATED MOOD,1
CH,ENCEPHALOPATHY,1
CH,ENDOCARDITIS,1
CH,ENERGY INCREASED,1
CH,EPILEPSY,1
CH,ERECTILE DYSFUNCTION,1
CH,ERYTHEMA,1
CH,ERYTHEMA NODOSUM,1
CH,ESCHERICHIA SEPSIS,1
CH,EUPHORIC MOOD,1
CH,EYE MOVEMENT DISORDER,1
CH,FAECALOMA,1
CH,FAECES DISCOLOURED,1
CH,FASCIITIS,1
CH,FIBRIN D DIMER INCREASED,1
CH,FINGER DEFORMITY,1
CH,FLIGHT OF IDEAS,1
CH,FOETAL DEATH,1
CH,FOETAL MONITORING ABNORMAL,1
CH,FOLATE DEFICIENCY,1
CH,FORMICATION,1
CH,GASTROINTESTINAL NECROSIS,1
CH,GASTROINTESTINAL OEDEMA,1
CH,GENERAL PHYSICAL CONDITION ABNORMAL,1
CH,GENERALISED TONIC-CLONIC SEIZURE,1
CH,GESTATIONAL DIABETES,1
CH,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CH,GRANDIOSITY,1
CH,GUILLAIN-BARRE SYNDROME,1
CH,HAEMATURIA,1
CH,HAEMODYNAMIC INSTABILITY,1
CH,HAEMOGLOBIN DECREASED,1
CH,HAEMOLYSIS,1
CH,HAEMOLYTIC ANAEMIA,1
CH,HAEMOPTYSIS,1
CH,HAEMORRHOIDS,1
CH,HEART RATE INCREASED,1
CH,HEMIPLEGIA,1
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,1
CH,HEPATIC CANCER,1
CH,HEPATIC STEATOSIS,1
CH,HEPATITIS TOXIC,1
CH,HEPATOTOXICITY,1
CH,HERPES ZOSTER,1
CH,HISTIOCYTOSIS HAEMATOPHAGIC,1
CH,HYPERBILIRUBINAEMIA,1
CH,HYPERGLYCAEMIA,1
CH,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
CH,HYPERHIDROSIS,1
CH,HYPERLACTACIDAEMIA,1
CH,HYPERNATRAEMIA,1
CH,HYPERSENSITIVITY,1
CH,HYPERSOMNIA,1
CH,HYPERTENSIVE CRISIS,1
CH,HYPERVENTILATION,1
CH,HYPOGLYCAEMIC COMA,1
CH,HYPOTHYROIDISM,1
CH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CH,IDIOPATHIC PULMONARY FIBROSIS,1
CH,IMMUNISATION,1
CH,IMPAIRED HEALING,1
CH,IMPRISONMENT,1
CH,IMPULSIVE BEHAVIOUR,1
CH,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
CH,INFLAMMATION,1
CH,INJECTION SITE ERYTHEMA,1
CH,INJECTION SITE PAIN,1
CH,INJECTION SITE PRURITUS,1
CH,INJECTION SITE WARMTH,1
CH,INTENTIONAL DRUG MISUSE,1
CH,INTERNATIONAL NORMALISED RATIO INCREASED,1
CH,INTERSTITIAL LUNG DISEASE,1
CH,INTRACARDIAC MASS,1
CH,INTRACRANIAL PRESSURE INCREASED,1
CH,INTRAVENTRICULAR HAEMORRHAGE,1
CH,IRRITABILITY,1
CH,ISCHAEMIC STROKE,1
CH,JAUNDICE,1
CH,JOINT EFFUSION,1
CH,KETONURIA,1
CH,KLEBSIELLA SEPSIS,1
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CH,LARYNGITIS,1
CH,LEUKOPENIA,1
CH,LIPODYSTROPHY ACQUIRED,1
CH,LOCALISED INFECTION,1
CH,LOGORRHOEA,1
CH,LUNG INFECTION,1
CH,LYMPHADENOPATHY,1
CH,MACULAR OEDEMA,1
CH,MALAISE,1
CH,MATERNAL DRUGS AFFECTING FOETUS,1
CH,MENTAL DISORDER,1
CH,METABOLIC DISORDER,1
CH,MITOCHONDRIAL MYOPATHY,1
CH,MUSCLE RIGIDITY,1
CH,MUSCULAR WEAKNESS,1
CH,MUSCULOSKELETAL PAIN,1
CH,MYDRIASIS,1
CH,MYOCARDIAL NECROSIS MARKER INCREASED,1
CH,MYOPATHY,1
CH,NEPHROPATHY TOXIC,1
CH,NERVOUS SYSTEM DISORDER,1
CH,NEUROLEPTIC MALIGNANT SYNDROME,1
CH,NEUROPATHY PERIPHERAL,1
CH,NEUTROPENIA,1
CH,NODULE,1
CH,NORMAL NEWBORN,1
CH,ODYNOPHAGIA,1
CH,OESOPHAGEAL ULCER,1
CH,OESOPHAGEAL VARICES HAEMORRHAGE,1
CH,OLIGURIA,1
CH,ORAL DISCOMFORT,1
CH,OROPHARYNGEAL PAIN,1
CH,PAIN IN EXTREMITY,1
CH,PALPITATIONS,1
CH,PANCYTOPENIA,1
CH,PARTIAL SEIZURES,1
CH,PERICARDIAL EFFUSION,1
CH,PERIPHERAL ARTERY THROMBOSIS,1
CH,PERIPHERAL SENSORY NEUROPATHY,1
CH,PERIPHERAL SWELLING,1
CH,PERITONITIS BACTERIAL,1
CH,PNEUMONIA ASPIRATION,1
CH,PNEUMONITIS,1
CH,PO2 DECREASED,1
CH,POISONING,1
CH,POLYDIPSIA,1
CH,POLYURIA,1
CH,POST PROCEDURAL HAEMORRHAGE,1
CH,PREGNANCY,1
CH,PRERENAL FAILURE,1
CH,PRODUCT USE ISSUE,1
CH,PROSTATE CANCER,1
CH,PROTHROMBIN TIME SHORTENED,1
CH,PRURITUS,1
CH,PSEUDOMONAL SEPSIS,1
CH,PSYCHOMOTOR HYPERACTIVITY,1
CH,PSYCHOMOTOR RETARDATION,1
CH,PULMONARY OEDEMA,1
CH,PULMONARY SEPSIS,1
CH,PURPURA,1
CH,PYELONEPHRITIS,1
CH,PYOGENIC GRANULOMA,1
CH,RASH,1
CH,RENAL TUBULAR NECROSIS,1
CH,RETINAL VEIN THROMBOSIS,1
CH,SECOND PRIMARY MALIGNANCY,1
CH,SKIN BURNING SENSATION,1
CH,SKIN EXFOLIATION,1
CH,SKIN LESION,1
CH,SKIN TOXICITY,1
CH,SLEEP DISORDER,1
CH,SOFT TISSUE INFECTION,1
CH,SOFT TISSUE NECROSIS,1
CH,SPLENOMEGALY,1
CH,SPONTANEOUS HAEMATOMA,1
CH,STENOTROPHOMONAS INFECTION,1
CH,SUBCUTANEOUS HAEMATOMA,1
CH,SUDDEN CARDIAC DEATH,1
CH,SUDDEN DEATH,1
CH,SUPRAVENTRICULAR TACHYCARDIA,1
CH,SYSTOLIC HYPERTENSION,1
CH,TACHYPHRENIA,1
CH,TENDON RUPTURE,1
CH,THERAPEUTIC RESPONSE CHANGED,1
CH,THIRST,1
CH,THROAT IRRITATION,1
CH,THROMBOTIC MICROANGIOPATHY,1
CH,TORTICOLLIS,1
CH,TOXIC EPIDERMAL NECROLYSIS,1
CH,TRANSAMINASES INCREASED,1
CH,TRANSIENT ISCHAEMIC ATTACK,1
CH,TREMOR,1
CH,URINARY BLADDER RUPTURE,1
CH,URINARY RETENTION,1
CH,URTICARIA,1
CH,VASCULITIS CEREBRAL,1
CH,VENOUS THROMBOSIS,1
CH,VENTRICULAR FIBRILLATION,1
CH,VENTRICULAR SEPTAL DEFECT,1
CH,VERTIGO,1
CH,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
CH,VISUAL ACUITY REDUCED,1
CH,VITAMIN B12 DECREASED,1
CH,VITAMIN D DECREASED,1
CH,VULVOVAGINAL MYCOTIC INFECTION,1
CH,WRONG DRUG ADMINISTERED,1
CH,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CH,XERODERMA,1
SY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
SY,CONSTIPATION,1
SY,METABOLIC ACIDOSIS,1
SY,RENAL CORTICAL NECROSIS,1
TW,LACTIC ACIDOSIS,13
TW,SUICIDE ATTEMPT,10
TW,RENAL FAILURE ACUTE,9
TW,ACUTE KIDNEY INJURY,8
TW,COUGH,7
TW,INTENTIONAL OVERDOSE,7
TW,CEREBRAL INFARCTION,6
TW,DYSTONIA,6
TW,DIABETIC KETOACIDOSIS,5
TW,DIZZINESS,5
TW,EOSINOPHILIA,5
TW,PNEUMONIA,5
TW,TOXICITY TO VARIOUS AGENTS,5
TW,DRUG LEVEL INCREASED,4
TW,HYPOTENSION,4
TW,METABOLIC SYNDROME,4
TW,PYREXIA,4
TW,SHOCK,4
TW,ALANINE AMINOTRANSFERASE INCREASED,3
TW,BRUCELLOSIS,3
TW,HYPOGLYCAEMIA,3
TW,NEUTROPENIC SEPSIS,3
TW,RENAL IMPAIRMENT,3
TW,SEPSIS,3
TW,ACUTE RESPIRATORY FAILURE,2
TW,ALTERED STATE OF CONSCIOUSNESS,2
TW,BLOOD CREATININE INCREASED,2
TW,BLOOD GLUCOSE INCREASED,2
TW,CARDIAC FAILURE CONGESTIVE,2
TW,CEREBROVASCULAR ACCIDENT,2
TW,COMA SCALE ABNORMAL,2
TW,DEATH,2
TW,DYSPNOEA,2
TW,HYPERLIPIDAEMIA,2
TW,METABOLIC ACIDOSIS,2
TW,MYOCARDIAL INFARCTION,2
TW,PAIN,2
TW,PANCREATITIS ACUTE,2
TW,PRURITUS,2
TW,RHINORRHOEA,2
TW,URINARY TRACT INFECTION,2
TW,ABDOMINAL PAIN,1
TW,ABDOMINAL PAIN UPPER,1
TW,ACUTE HEPATITIS B,1
TW,ACUTE MYELOID LEUKAEMIA,1
TW,ACUTE MYOCARDIAL INFARCTION,1
TW,ADENOCARCINOMA OF COLON,1
TW,ADRENAL INSUFFICIENCY,1
TW,ANAEMIA,1
TW,ANAPHYLACTIC SHOCK,1
TW,ANION GAP INCREASED,1
TW,ANURIA,1
TW,ASPARTATE AMINOTRANSFERASE INCREASED,1
TW,ASTHENIA,1
TW,ATRIOVENTRICULAR BLOCK COMPLETE,1
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,1
TW,BLOOD BICARBONATE DECREASED,1
TW,BLOOD BILIRUBIN INCREASED,1
TW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TW,BLOOD GLUCOSE ABNORMAL,1
TW,BLOOD PH DECREASED,1
TW,BLOOD POTASSIUM INCREASED,1
TW,BLOOD PRESSURE DECREASED,1
TW,BLOOD PRESSURE DIASTOLIC DECREASED,1
TW,BLOOD UREA INCREASED,1
TW,BODY TEMPERATURE DECREASED,1
TW,BOWEN^S DISEASE,1
TW,CARDIOGENIC SHOCK,1
TW,CARDIOMEGALY,1
TW,CATARACT,1
TW,CELLULITIS,1
TW,CEREBRAL ATROPHY,1
TW,CEREBRAL ISCHAEMIA,1
TW,CHEST DISCOMFORT,1
TW,CHEST PAIN,1
TW,CHILLS,1
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TW,COLITIS,1
TW,COMA,1
TW,CONCOMITANT DISEASE AGGRAVATED,1
TW,CYSTITIS,1
TW,DECREASED APPETITE,1
TW,DERMATITIS ALLERGIC,1
TW,DIABETES MELLITUS INADEQUATE CONTROL,1
TW,DIABETIC RETINOPATHY,1
TW,DIARRHOEA,1
TW,DIFFUSE LARGE B-CELL LYMPHOMA,1
TW,DIPLOPIA,1
TW,DISCOMFORT,1
TW,DISEASE PROGRESSION,1
TW,DRUG ERUPTION,1
TW,DRUG HYPERSENSITIVITY,1
TW,DRY GANGRENE,1
TW,DYSARTHRIA,1
TW,DYSPHAGIA,1
TW,EMBOLIC STROKE,1
TW,ERYTHEMA,1
TW,EYE DISORDER,1
TW,FATIGUE,1
TW,FEBRILE NEUTROPENIA,1
TW,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
TW,GASTROENTERITIS,1
TW,GASTROINTESTINAL HAEMORRHAGE,1
TW,GENERAL PHYSICAL CONDITION ABNORMAL,1
TW,GENERALISED TONIC-CLONIC SEIZURE,1
TW,HAEMOLYTIC ANAEMIA,1
TW,HEADACHE,1
TW,HEART INJURY,1
TW,HEART RATE INCREASED,1
TW,HEPATIC FUNCTION ABNORMAL,1
TW,HEPATOCELLULAR CARCINOMA,1
TW,HYPEREOSINOPHILIC SYNDROME,1
TW,HYPERGLYCAEMIA,1
TW,HYPERHIDROSIS,1
TW,HYPERNATRAEMIA,1
TW,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
TW,HYPERTENSION,1
TW,HYPOGLYCAEMIC COMA,1
TW,HYPOKALAEMIA,1
TW,HYPONATRAEMIA,1
TW,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
TW,INGUINAL HERNIA_ OBSTRUCTIVE,1
TW,JAUNDICE,1
TW,LARGE INTESTINE PERFORATION,1
TW,LEUKOPENIA,1
TW,LIPASE INCREASED,1
TW,LIPOSARCOMA,1
TW,LIVER DISORDER,1
TW,LIVER FUNCTION TEST ABNORMAL,1
TW,LYMPHOCYTE COUNT DECREASED,1
TW,MALAISE,1
TW,MALIGNANT NEOPLASM PROGRESSION,1
TW,MATERNAL EXPOSURE DURING PREGNANCY,1
TW,MONOCYTE COUNT INCREASED,1
TW,MULTI-ORGAN FAILURE,1
TW,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TW,MUSCLE SPASMS,1
TW,MUSCULAR WEAKNESS,1
TW,NAUSEA,1
TW,NEUTROPHIL COUNT INCREASED,1
TW,NORMAL NEWBORN,1
TW,NUCHAL RIGIDITY,1
TW,OEDEMA PERIPHERAL,1
TW,OESOPHAGITIS,1
TW,ORTHOPNOEA,1
TW,OSTEONECROSIS OF JAW,1
TW,OVERDOSE,1
TW,PANCREATIC MASS,1
TW,PANCYTOPENIA,1
TW,PCO2 DECREASED,1
TW,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
TW,PERIPHERAL ARTERY OCCLUSION,1
TW,PHARYNGITIS,1
TW,PLEURAL EFFUSION,1
TW,POSTURE ABNORMAL,1
TW,PROSTATIC OPERATION,1
TW,PULMONARY CONGESTION,1
TW,PULMONARY OEDEMA,1
TW,QUADRIPARESIS,1
TW,RALES,1
TW,RENAL FAILURE CHRONIC,1
TW,RENAL INJURY,1
TW,RESPIRATORY RATE INCREASED,1
TW,SCHIZOPHRENIA,1
TW,SKIN BURNING SENSATION,1
TW,SKIN EXFOLIATION,1
TW,SKIN PAPILLOMA,1
TW,SPLENOMEGALY,1
TW,SUDDEN DEATH,1
TW,SWELLING,1
TW,T-CELL LYMPHOMA,1
TW,THROMBOCYTOPENIA,1
TW,TINEA CRURIS,1
TW,TROPONIN I INCREASED,1
TW,UPPER RESPIRATORY TRACT INFECTION,1
TW,URINARY RETENTION,1
TW,URTICARIA,1
TW,VERTIGO,1
TW,VISION BLURRED,1
TW,VITREOUS HAEMORRHAGE,1
TW,VOMITING,1
TW,WHITE MATTER LESION,1
TH,ACUTE KIDNEY INJURY,7
TH,PNEUMONIA,6
TH,SEPSIS,5
TH,SEPTIC SHOCK,4
TH,CHOLESTASIS,3
TH,FATIGUE,3
TH,HYPOGLYCAEMIA,3
TH,LICHEN PLANUS,3
TH,PEMPHIGOID,3
TH,ABASIA,2
TH,ANGINA UNSTABLE,2
TH,BLOOD CREATININE INCREASED,2
TH,CARDIAC ARREST,2
TH,CARDIAC FAILURE CONGESTIVE,2
TH,CHEST PAIN,2
TH,DEHYDRATION,2
TH,DIABETES MELLITUS,2
TH,DIARRHOEA,2
TH,DYSPNOEA,2
TH,HYPERGLYCAEMIA,2
TH,HYPERINSULINAEMIC HYPOGLYCAEMIA,2
TH,HYPOKALAEMIA,2
TH,LEUKOCYTOCLASTIC VASCULITIS,2
TH,MUSCULAR WEAKNESS,2
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,2
TH,VASCULITIS,2
TH,ACUTE CORONARY SYNDROME,1
TH,ALTERED STATE OF CONSCIOUSNESS,1
TH,ANAEMIA,1
TH,AORTIC ANEURYSM,1
TH,AORTIC STENOSIS,1
TH,ATAXIA,1
TH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
TH,BLISTER,1
TH,BLOOD CHOLESTEROL INCREASED,1
TH,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
TH,BLOOD KETONE BODY INCREASED,1
TH,BLOOD PRESSURE FLUCTUATION,1
TH,CARDIOMEGALY,1
TH,CEREBRAL INFARCTION,1
TH,CEREBROVASCULAR ACCIDENT,1
TH,CHEST DISCOMFORT,1
TH,CHOLECYSTITIS,1
TH,CORONARY ARTERY STENOSIS,1
TH,COUGH,1
TH,CUTANEOUS VASCULITIS,1
TH,CYTOMEGALOVIRUS INFECTION,1
TH,DECREASED APPETITE,1
TH,DIABETIC KETOACIDOSIS,1
TH,DIARRHOEA INFECTIOUS,1
TH,DIZZINESS,1
TH,DYSPHONIA,1
TH,EMBOLIC STROKE,1
TH,EMPYEMA,1
TH,EPISTAXIS,1
TH,FEBRILE NEUTROPENIA,1
TH,FOOD INTERACTION,1
TH,GASTRIC POLYPS,1
TH,GASTRITIS HAEMORRHAGIC,1
TH,GENERALISED ERYTHEMA,1
TH,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
TH,HAEMORRHAGIC STROKE,1
TH,HAEMORRHOIDS,1
TH,HEART RATE INCREASED,1
TH,HEPATITIS,1
TH,HYPERCALCAEMIA,1
TH,HYPERKALAEMIA,1
TH,HYPERPHOSPHATAEMIA,1
TH,HYPERSENSITIVITY VASCULITIS,1
TH,HYPERTENSION,1
TH,HYPOAESTHESIA,1
TH,HYPOKINESIA,1
TH,HYPOPHAGIA,1
TH,HYPOPHOSPHATAEMIA,1
TH,HYPOVOLAEMIC SHOCK,1
TH,INFECTION,1
TH,INFLUENZA,1
TH,INSOMNIA,1
TH,IRON DEFICIENCY ANAEMIA,1
TH,KIDNEY RUPTURE,1
TH,LACTIC ACIDOSIS,1
TH,LOSS OF CONSCIOUSNESS,1
TH,MACULE,1
TH,METABOLIC ACIDOSIS,1
TH,MUCOSAL INFLAMMATION,1
TH,MUSCLE SPASMS,1
TH,MUSCLE TIGHTNESS,1
TH,MYOCARDIAL INFARCTION,1
TH,MYOCARDIAL ISCHAEMIA,1
TH,MYOPATHY,1
TH,NEUTROPENIA,1
TH,OEDEMA PERIPHERAL,1
TH,OSTEOMALACIA,1
TH,PAIN,1
TH,PALPABLE PURPURA,1
TH,PALPITATIONS,1
TH,PANCREATIC CARCINOMA,1
TH,PAPULE,1
TH,PERIPHERAL SENSORY NEUROPATHY,1
TH,PLASMA CELL MYELOMA,1
TH,PLEURAL EFFUSION,1
TH,PROTHROMBIN TIME PROLONGED,1
TH,PYREXIA,1
TH,RASH GENERALISED,1
TH,RASH MACULO-PAPULAR,1
TH,RENAL FAILURE,1
TH,RESPIRATORY FAILURE,1
TH,SINUS TACHYCARDIA,1
TH,SKIN HYPERPIGMENTATION,1
TH,SKIN LESION,1
TH,SOMNOLENCE,1
TH,STOMATITIS,1
TH,SYNCOPE,1
TH,THROMBOCYTOPENIA,1
TH,UNRESPONSIVE TO STIMULI,1
TH,URETERIC STENOSIS,1
TH,URINARY TRACT INFECTION,1
TH,VERTIGO,1
TT,ANGINA PECTORIS,1
TT,ARRHYTHMIA,1
TT,BLOOD GLUCOSE DECREASED,1
TT,BLOOD GLUCOSE INCREASED,1
TT,BLOOD PRESSURE INCREASED,1
TT,CARDIAC FAILURE,1
TT,CARDIAC FAILURE CONGESTIVE,1
TT,CATARACT,1
TT,CHEST DISCOMFORT,1
TT,CONGESTIVE CARDIOMYOPATHY,1
TT,DRUG DOSE OMISSION,1
TT,DYSPNOEA,1
TT,HILAR LYMPHADENOPATHY,1
TT,LYMPHADENOPATHY MEDIASTINAL,1
TT,NAUSEA,1
TT,RENAL IMPAIRMENT,1
TT,SUPRAVENTRICULAR TACHYCARDIA,1
TT,THERAPEUTIC RESPONSE DECREASED,1
TT,WEIGHT DECREASED,1
TN,LICHEN PLANUS,7
TN,PANCREATITIS ACUTE,3
TN,ANAL ULCER,2
TN,DYSPAREUNIA,2
TN,DYSURIA,2
TN,LYMPHOCYTIC INFILTRATION,2
TN,PENILE ULCERATION,2
TN,TONGUE ULCERATION,2
TN,ACANTHOSIS,1
TN,AXIAL SPONDYLOARTHRITIS,1
TN,BURNING SENSATION,1
TN,CARDIAC ARREST,1
TN,CHOLESTASIS,1
TN,DEPRESSION SUICIDAL,1
TN,DERMATITIS,1
TN,ERYTHEMA,1
TN,HEPATIC CIRRHOSIS,1
TN,HEPATIC STEATOSIS,1
TN,HEPATOCELLULAR INJURY,1
TN,LICHENOID KERATOSIS,1
TN,LIVER FUNCTION TEST ABNORMAL,1
TN,LIVER INJURY,1
TN,MUCOSAL EROSION,1
TN,MUSCULOSKELETAL STIFFNESS,1
TN,OBESITY,1
TN,ODYNOPHAGIA,1
TN,ORAL DISCOMFORT,1
TN,ORAL DISORDER,1
TN,ORAL LICHEN PLANUS,1
TN,ORAL MUCOSAL ERYTHEMA,1
TN,PAIN,1
TN,PAIN IN EXTREMITY,1
TN,RASH GENERALISED,1
TN,SKIN HYPERTROPHY,1
TR,SUICIDE ATTEMPT,50
TR,LACTIC ACIDOSIS,43
TR,INTENTIONAL OVERDOSE,32
TR,ACUTE KIDNEY INJURY,25
TR,VOMITING,17
TR,NAUSEA,15
TR,OVERDOSE,14
TR,RENAL INJURY,12
TR,MYOCARDIAL ISCHAEMIA,11
TR,TOXICITY TO VARIOUS AGENTS,11
TR,HYPOGLYCAEMIA,10
TR,HAEMOLYTIC ANAEMIA,9
TR,AUTOIMMUNE HEPATITIS,8
TR,DEHYDRATION,8
TR,DIABETIC KETOACIDOSIS,8
TR,DYSPNOEA,8
TR,FLOPPY IRIS SYNDROME,8
TR,GASTROINTESTINAL HAEMORRHAGE,8
TR,ANGIOEDEMA,7
TR,HYPOTENSION,7
TR,METABOLIC ACIDOSIS,7
TR,ACIDOSIS,6
TR,BLOOD GLUCOSE INCREASED,6
TR,CONFUSIONAL STATE,6
TR,HYPERTRIGLYCERIDAEMIA,6
TR,ALANINE AMINOTRANSFERASE INCREASED,5
TR,ASPARTATE AMINOTRANSFERASE INCREASED,5
TR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,5
TR,BLOOD LACTIC ACID INCREASED,5
TR,DRUG INEFFECTIVE,5
TR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
TR,HAEMOGLOBIN DECREASED,5
TR,HYPERNATRAEMIA,5
TR,HYPEROSMOLAR HYPERGLYCAEMIC STATE,5
TR,LOSS OF CONSCIOUSNESS,5
TR,PNEUMONIA CYTOMEGALOVIRAL,5
TR,VENTRICULAR TACHYCARDIA,5
TR,CLUSTER HEADACHE,4
TR,COMPLETED SUICIDE,4
TR,FOETAL EXPOSURE DURING PREGNANCY,4
TR,HAEMOTHORAX,4
TR,HYPERGLYCAEMIA,4
TR,HYPERTENSION,4
TR,HYPOTHERMIA,4
TR,LETHARGY,4
TR,OLIGURIA,4
TR,PEMPHIGOID,4
TR,PYREXIA,4
TR,RESPIRATORY DISTRESS,4
TR,SINUS TACHYCARDIA,4
TR,ABDOMINAL PAIN,3
TR,ABDOMINAL PAIN UPPER,3
TR,AMYLASE INCREASED,3
TR,ASTHENIA,3
TR,BLOOD GLUCOSE DECREASED,3
TR,CARDIAC ARREST,3
TR,CARPAL TUNNEL SYNDROME,3
TR,DIABETES MELLITUS INADEQUATE CONTROL,3
TR,EXOSTOSIS,3
TR,GASTROINTESTINAL ULCER,3
TR,LIPASE INCREASED,3
TR,MYALGIA,3
TR,PERIARTHRITIS,3
TR,SOMNOLENCE,3
TR,THROMBOCYTOPENIA,3
TR,URTICARIA,3
TR,WEIGHT DECREASED,3
TR,WEIGHT INCREASED,3
TR,ABDOMINAL DISTENSION,2
TR,ABDOMINAL WALL HAEMATOMA,2
TR,AKATHISIA,2
TR,ALANINE AMINOTRANSFERASE ABNORMAL,2
TR,ALTERED STATE OF CONSCIOUSNESS,2
TR,ANAPHYLACTIC SHOCK,2
TR,APATHY,2
TR,ATRIOVENTRICULAR BLOCK,2
TR,BLOOD BILIRUBIN INCREASED,2
TR,BLOOD CREATININE INCREASED,2
TR,BLOOD UREA INCREASED,2
TR,BLOOD URIC ACID INCREASED,2
TR,CARDIAC DISORDER,2
TR,CARDIOPULMONARY FAILURE,2
TR,CYTOMEGALOVIRUS INFECTION,2
TR,DEATH,2
TR,DECREASED APPETITE,2
TR,DIABETES MELLITUS,2
TR,DRUG-INDUCED LIVER INJURY,2
TR,DYSURIA,2
TR,EPISTAXIS,2
TR,FATIGUE,2
TR,FEBRILE NEUTROPENIA,2
TR,FEMUR FRACTURE,2
TR,GENERAL PHYSICAL HEALTH DETERIORATION,2
TR,HAEMODIALYSIS,2
TR,HEART RATE INCREASED,2
TR,HEPATIC ENZYME INCREASED,2
TR,HEPATIC FUNCTION ABNORMAL,2
TR,HYPERHIDROSIS,2
TR,HYPERKALAEMIA,2
TR,HYPERSENSITIVITY,2
TR,HYPOAESTHESIA,2
TR,HYPONATRAEMIA,2
TR,HYPOPHAGIA,2
TR,INTERNATIONAL NORMALISED RATIO INCREASED,2
TR,JAUNDICE,2
TR,MICROCEPHALY,2
TR,MUCOSAL DRYNESS,2
TR,MULTI-ORGAN FAILURE,2
TR,NEPHROTIC SYNDROME,2
TR,OEDEMA PERIPHERAL,2
TR,PAIN,2
TR,PANCREATITIS,2
TR,PANCREATITIS ACUTE,2
TR,POISONING,2
TR,PRIAPISM,2
TR,PRODUCT QUALITY ISSUE,2
TR,PRURITUS,2
TR,PULMONARY OEDEMA,2
TR,RENAL FAILURE,2
TR,SKIN TURGOR DECREASED,2
TR,STREPTOCOCCUS TEST POSITIVE,2
TR,SYNCOPE,2
TR,TACHYCARDIA,2
TR,TONGUE DRY,2
TR,URINARY TRACT INFECTION,2
TR,URTICARIAL VASCULITIS,2
TR,VITAMIN D DECREASED,2
TR,VITAMIN D DEFICIENCY,2
TR,ABORTION SPONTANEOUS,1
TR,ACCIDENTAL OVERDOSE,1
TR,ACINETOBACTER INFECTION,1
TR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
TR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
TR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
TR,ACUTE MYOCARDIAL INFARCTION,1
TR,ADRENAL INSUFFICIENCY,1
TR,ADRENAL NEOPLASM,1
TR,AGITATION,1
TR,ALCOHOL INTERACTION,1
TR,ALCOHOL USE,1
TR,ANAL ABSCESS,1
TR,ANAL FISTULA,1
TR,ANGINA PECTORIS,1
TR,AORTIC ELONGATION,1
TR,APHASIA,1
TR,ARRHYTHMIA,1
TR,ARTHRALGIA,1
TR,ARTHROPATHY,1
TR,ASCITES,1
TR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
TR,ATRIAL FIBRILLATION,1
TR,ATRIOVENTRICULAR BLOCK COMPLETE,1
TR,AZOTAEMIA,1
TR,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
TR,BLOOD CHROMOGRANIN A INCREASED,1
TR,BLOOD ETHANOL INCREASED,1
TR,BLOOD GASES ABNORMAL,1
TR,BLOOD GLUCOSE ABNORMAL,1
TR,BLOOD INSULIN DECREASED,1
TR,BLOOD IRON DECREASED,1
TR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TR,BLOOD PH DECREASED,1
TR,BLOOD POTASSIUM DECREASED,1
TR,BLOOD POTASSIUM INCREASED,1
TR,BLOOD PRESSURE DECREASED,1
TR,BLOOD TRIGLYCERIDES INCREASED,1
TR,BRADYARRHYTHMIA,1
TR,BRAIN INJURY,1
TR,BRONCHIAL OBSTRUCTION,1
TR,BRONCHITIS,1
TR,CARDIAC FAILURE,1
TR,CARDIO-RESPIRATORY DISTRESS,1
TR,CATARACT,1
TR,CEREBRAL HAEMORRHAGE,1
TR,CEREBROVASCULAR DISORDER,1
TR,CHILLS,1
TR,CHOLECYSTITIS ACUTE,1
TR,COMA SCALE ABNORMAL,1
TR,CORTISOL FREE URINE DECREASED,1
TR,CRANIOSYNOSTOSIS,1
TR,CUSHING^S SYNDROME,1
TR,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,1
TR,DEPRESSION,1
TR,DEREALISATION,1
TR,DERMATITIS BULLOUS,1
TR,DEVICE RELATED INFECTION,1
TR,DIABETIC CHEIROARTHROPATHY,1
TR,DIABETIC CHEIROPATHY,1
TR,DIARRHOEA,1
TR,DISCOMFORT,1
TR,DIVERTICULITIS,1
TR,DIZZINESS,1
TR,DRUG ADMINISTRATION ERROR,1
TR,DRUG DOSE OMISSION,1
TR,DRUG LEVEL INCREASED,1
TR,DRY MOUTH,1
TR,DUODENITIS,1
TR,DYSPNOEA EXERTIONAL,1
TR,EJECTION FRACTION DECREASED,1
TR,EOSINOPHILIA,1
TR,ERYTHEMA,1
TR,ESCHERICHIA TEST POSITIVE,1
TR,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
TR,EXCORIATION,1
TR,FACE OEDEMA,1
TR,FALL,1
TR,GASTRIC HAEMORRHAGE,1
TR,GASTROENTERITIS,1
TR,GENITALIA EXTERNAL AMBIGUOUS,1
TR,GROIN PAIN,1
TR,GYNAECOMASTIA,1
TR,HALLUCINATION_ TACTILE,1
TR,HALLUCINATION_ VISUAL,1
TR,HEADACHE,1
TR,HEMIANAESTHESIA,1
TR,HEPATITIS C,1
TR,HEPATITIS TOXIC,1
TR,HYPERACUSIS,1
TR,HYPEROSMOLAR STATE,1
TR,HYPERTHYROIDISM,1
TR,HYPERVENTILATION,1
TR,HYPOAESTHESIA ORAL,1
TR,HYPOTHYROIDISM,1
TR,HYPOTONIA,1
TR,IMMOBILE,1
TR,IMMUNE SYSTEM DISORDER,1
TR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
TR,INCORRECT DRUG ADMINISTRATION DURATION,1
TR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
TR,INJECTION SITE EXTRAVASATION,1
TR,INJECTION SITE HAEMORRHAGE,1
TR,INJECTION SITE PAIN,1
TR,INTENTIONAL PRODUCT MISUSE,1
TR,INTERVERTEBRAL DISC PROTRUSION,1
TR,LEFT VENTRICULAR HYPERTROPHY,1
TR,LEG AMPUTATION,1
TR,LIPIDOSIS,1
TR,LOWER LIMB FRACTURE,1
TR,MALIGNANT NEOPLASM PROGRESSION,1
TR,MATERNAL EXPOSURE DURING PREGNANCY,1
TR,MEMORY IMPAIRMENT,1
TR,MICROPHTHALMOS,1
TR,MUSCLE NECROSIS,1
TR,MUSCULAR WEAKNESS,1
TR,NEPHROPATHY TOXIC,1
TR,NERVOUS SYSTEM DISORDER,1
TR,NEUTROPENIA,1
TR,NEUTROPHIL COUNT DECREASED,1
TR,NIPPLE EXUDATE BLOODY,1
TR,NIPPLE PAIN,1
TR,OEDEMA,1
TR,ORTHOPNOEA,1
TR,OVERWEIGHT,1
TR,PALATAL OEDEMA,1
TR,PANIC ATTACK,1
TR,PCO2 DECREASED,1
TR,PERIPHERAL ARTERY THROMBOSIS,1
TR,PERIPHERAL EMBOLISM,1
TR,PLATELET COUNT DECREASED,1
TR,PLATELET COUNT INCREASED,1
TR,PLEURAL EFFUSION,1
TR,PNEUMONIA,1
TR,POSTOPERATIVE WOUND INFECTION,1
TR,PROCEDURAL COMPLICATION,1
TR,PRODUCT USE ISSUE,1
TR,PROLONGED EXPIRATION,1
TR,PSEUDOMONAS INFECTION,1
TR,PULMONARY NECROSIS,1
TR,PYELONEPHRITIS,1
TR,PYURIA,1
TR,RASH,1
TR,RASH ERYTHEMATOUS,1
TR,RASH MACULO-PAPULAR,1
TR,RENAL TUBULAR ACIDOSIS,1
TR,RESPIRATORY ARREST,1
TR,RESPIRATORY DISORDER,1
TR,RESPIRATORY RATE INCREASED,1
TR,RESTLESS LEGS SYNDROME,1
TR,RHONCHI,1
TR,SENSORY LOSS,1
TR,SEPSIS,1
TR,SEPTIC SHOCK,1
TR,SINUS ARREST,1
TR,SKIN EXFOLIATION,1
TR,SKIN LESION,1
TR,SOFT TISSUE INFECTION,1
TR,SQUAMOUS CELL CARCINOMA,1
TR,STRESS,1
TR,TACHYPNOEA,1
TR,THERAPEUTIC RESPONSE UNEXPECTED,1
TR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
TR,THYROIDITIS,1
TR,TONGUE OEDEMA,1
TR,TRANSAMINASES INCREASED,1
TR,TRANSIENT ISCHAEMIC ATTACK,1
TR,TROPONIN INCREASED,1
TR,TUBERCULOSIS,1
TR,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,1
TR,UNRESPONSIVE TO STIMULI,1
TR,UPPER RESPIRATORY TRACT INFECTION,1
TR,URINARY INCONTINENCE,1
TR,VITAMIN B12 DECREASED,1
TR,WHITE BLOOD CELL COUNT DECREASED,1
TR,WHITE BLOOD CELL COUNT INCREASED,1
UG,DIABETIC KETOACIDOSIS,2
UG,HYPERGLYCAEMIA,2
UG,URINARY TRACT INFECTION,2
UG,ASTHENIA,1
UG,DIABETES MELLITUS,1
UG,MALARIA,1
UG,PELVIC INFLAMMATORY DISEASE,1
UA,KETOACIDOSIS,4
UA,DRUG INEFFECTIVE,3
UA,ASTHENIA,2
UA,DIABETIC RETINOPATHY,2
UA,DRUG-INDUCED LIVER INJURY,2
UA,HEPATITIS TOXIC,2
UA,PNEUMONIA,2
UA,TOE AMPUTATION,2
UA,ABDOMINAL PAIN,1
UA,BLOOD GLUCOSE INCREASED,1
UA,BODY TEMPERATURE INCREASED,1
UA,CATARACT,1
UA,CHRONIC KIDNEY DISEASE,1
UA,CONDITION AGGRAVATED,1
UA,DECREASED APPETITE,1
UA,DIABETES MELLITUS,1
UA,DIABETIC FOOT,1
UA,DIABETIC MACROANGIOPATHY,1
UA,DIABETIC NEUROPATHY,1
UA,ENCEPHALOPATHY,1
UA,FATIGUE,1
UA,HEPATOMEGALY,1
UA,HYPERGLYCAEMIA,1
UA,HYPERSENSITIVITY,1
UA,HYPERSENSITIVITY VASCULITIS,1
UA,HYPERURICAEMIA,1
UA,KETONURIA,1
UA,MALAISE,1
UA,MITRAL VALVE INCOMPETENCE,1
UA,MULTI-ORGAN FAILURE,1
UA,NAUSEA,1
UA,NEUTROPENIA,1
UA,ORAL CANDIDIASIS,1
UA,OSTEOMYELITIS,1
UA,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
UA,POLYURIA,1
UA,PROSTATE CANCER,1
UA,PULMONARY ARTERY THROMBOSIS,1
UA,PYELONEPHRITIS CHRONIC,1
UA,RASH,1
UA,THERAPY CESSATION,1
UA,THIRST,1
UA,THROMBOCYTOPENIA,1
UA,TREATMENT NONCOMPLIANCE,1
UA,TREMOR,1
UA,URTICARIA,1
UA,VENOUS THROMBOSIS LIMB,1
UA,VENTRICULAR DYSFUNCTION,1
UA,VISUAL IMPAIRMENT,1
UA,WEIGHT DECREASED,1
AE,LACTIC ACIDOSIS,6
AE,ACUTE KIDNEY INJURY,5
AE,ASTHENIA,4
AE,DEHYDRATION,3
AE,HYPERBILIRUBINAEMIA,3
AE,NAUSEA,3
AE,PANCREATITIS,3
AE,DECREASED APPETITE,2
AE,DYSURIA,2
AE,FATIGUE,2
AE,URINARY TRACT INFECTION,2
AE,VOMITING,2
AE,ARTHROPOD BITE,1
AE,CHEST DISCOMFORT,1
AE,CHEST PAIN,1
AE,CONSTIPATION,1
AE,CUSHING^S SYNDROME,1
AE,DIABETIC KETOACIDOSIS,1
AE,DIARRHOEA,1
AE,DRUG DEPENDENCE,1
AE,DRUG INTOLERANCE,1
AE,DRY SKIN,1
AE,FAECALOMA,1
AE,FEAR OF INJECTION,1
AE,HYPERSENSITIVITY,1
AE,HYPOGLYCAEMIA,1
AE,MALAISE,1
AE,PALPITATIONS,1
AE,PNEUMONIA,1
AE,PROCTALGIA,1
AE,PYREXIA,1
AE,RASH,1
AE,RECTAL HAEMORRHAGE,1
AE,RENAL FAILURE ACUTE,1
AE,SKIN DISCOLOURATION,1
AE,SKIN HYPERPIGMENTATION,1
AE,SKIN ULCER,1
AE,SUBCUTANEOUS ABSCESS,1
AE,SYNCOPE,1
AE,TYPE 2 DIABETES MELLITUS,1
AE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GB,MALAISE,563
GB,ACUTE KIDNEY INJURY,485
GB,DYSPNOEA,419
GB,VOMITING,417
GB,DIARRHOEA,403
GB,NAUSEA,360
GB,FATIGUE,327
GB,DIZZINESS,313
GB,DIABETIC KETOACIDOSIS,259
GB,CONFUSIONAL STATE,258
GB,HYPOTENSION,226
GB,MYALGIA,226
GB,ABDOMINAL PAIN,215
GB,HEADACHE,200
GB,ARTHRALGIA,195
GB,FALL,190
GB,HYPONATRAEMIA,174
GB,HYPOGLYCAEMIA,165
GB,RASH,164
GB,PAIN,154
GB,PAIN IN EXTREMITY,149
GB,BLOOD GLUCOSE INCREASED,147
GB,RENAL FAILURE ACUTE,147
GB,HYPERKALAEMIA,139
GB,RENAL IMPAIRMENT,138
GB,LACTIC ACIDOSIS,136
GB,PYREXIA,126
GB,DECREASED APPETITE,125
GB,ABDOMINAL PAIN UPPER,123
GB,SYNCOPE,123
GB,PALPITATIONS,122
GB,DEHYDRATION,121
GB,CONDITION AGGRAVATED,120
GB,LIVER FUNCTION TEST ABNORMAL,120
GB,DEATH,119
GB,LETHARGY,119
GB,OVERDOSE,117
GB,PARAESTHESIA,117
GB,HYPERHIDROSIS,116
GB,PNEUMONIA,114
GB,COUGH,113
GB,TREMOR,113
GB,FEELING ABNORMAL,112
GB,PRURITUS,111
GB,MUSCLE SPASMS,110
GB,SOMNOLENCE,110
GB,CHEST PAIN,107
GB,MYOCARDIAL INFARCTION,107
GB,CONSTIPATION,106
GB,AGITATION,105
GB,LOWER RESPIRATORY TRACT INFECTION,105
GB,SEPSIS,103
GB,SWELLING FACE,101
GB,ELECTROCARDIOGRAM QT PROLONGED,98
GB,INSOMNIA,96
GB,METABOLIC ACIDOSIS,96
GB,CARDIAC ARREST,94
GB,WHITE BLOOD CELL COUNT INCREASED,94
GB,INTERNATIONAL NORMALISED RATIO INCREASED,89
GB,MUSCULAR WEAKNESS,89
GB,BACK PAIN,88
GB,HYPOAESTHESIA,87
GB,ASTHENIA,85
GB,UNRESPONSIVE TO STIMULI,83
GB,HAEMOGLOBIN DECREASED,82
GB,DEPRESSION,80
GB,BALANCE DISORDER,79
GB,WEIGHT DECREASED,79
GB,LIP SWELLING,78
GB,FOETAL EXPOSURE DURING PREGNANCY,77
GB,NEUTROPHIL COUNT INCREASED,77
GB,PANCREATITIS ACUTE,77
GB,DIABETES MELLITUS,76
GB,AMNESIA,75
GB,CEREBROVASCULAR ACCIDENT,75
GB,HYPERGLYCAEMIA,75
GB,URINARY TRACT INFECTION,75
GB,ATRIAL FIBRILLATION,74
GB,ANXIETY,73
GB,JOINT SWELLING,73
GB,PERIPHERAL SWELLING,73
GB,VISION BLURRED,71
GB,ANGIOEDEMA,70
GB,BRADYCARDIA,70
GB,SWOLLEN TONGUE,70
GB,TACHYCARDIA,70
GB,ANAEMIA,69
GB,LOSS OF CONSCIOUSNESS,69
GB,HYPERTENSION,68
GB,ABDOMINAL DISTENSION,67
GB,RENAL FAILURE,66
GB,DISTURBANCE IN ATTENTION,65
GB,HAEMATEMESIS,65
GB,AGGRESSION,64
GB,SUICIDAL IDEATION,64
GB,BLOOD CREATININE INCREASED,60
GB,DRY MOUTH,60
GB,DIABETES MELLITUS INADEQUATE CONTROL,59
GB,HALLUCINATION,59
GB,OEDEMA,59
GB,VISUAL IMPAIRMENT,59
GB,GASTROINTESTINAL HAEMORRHAGE,57
GB,MOBILITY DECREASED,56
GB,SEIZURE,56
GB,TOXICITY TO VARIOUS AGENTS,55
GB,URTICARIA,55
GB,ABDOMINAL DISCOMFORT,54
GB,ERYTHEMA,54
GB,LOCAL SWELLING,53
GB,RASH GENERALISED,53
GB,INFECTION,52
GB,SLEEP DISORDER,52
GB,WHEEZING,52
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,51
GB,DRUG INEFFECTIVE,51
GB,ANAPHYLACTIC REACTION,50
GB,OEDEMA PERIPHERAL,50
GB,OXYGEN SATURATION DECREASED,50
GB,TUBULOINTERSTITIAL NEPHRITIS,50
GB,HAEMATURIA,49
GB,ALANINE AMINOTRANSFERASE INCREASED,48
GB,ALOPECIA,48
GB,GAIT DISTURBANCE,47
GB,DYSPHAGIA,46
GB,HOT FLUSH,46
GB,JAUNDICE,46
GB,MENTAL IMPAIRMENT,46
GB,BLOOD PRESSURE INCREASED,45
GB,CARDIAC FAILURE CONGESTIVE,44
GB,NEUROPATHY PERIPHERAL,44
GB,ABNORMAL LOSS OF WEIGHT,43
GB,ACUTE MYOCARDIAL INFARCTION,43
GB,KETOACIDOSIS,43
GB,POLYURIA,43
GB,TRANSIENT ISCHAEMIC ATTACK,43
GB,TYPE 2 DIABETES MELLITUS,43
GB,DYSPEPSIA,42
GB,NIGHTMARE,42
GB,ARRHYTHMIA,41
GB,HYPERSENSITIVITY,41
GB,HYPOMAGNESAEMIA,41
GB,PANCREATITIS,41
GB,PRURITUS GENERALISED,41
GB,CARDIAC FAILURE,40
GB,CIRCULATORY COLLAPSE,40
GB,EXPOSURE DURING PREGNANCY,40
GB,OROPHARYNGEAL PAIN,40
GB,WEIGHT INCREASED,40
GB,HEART RATE INCREASED,39
GB,RESPIRATORY FAILURE,39
GB,THROMBOCYTOPENIA,39
GB,GLOMERULAR FILTRATION RATE DECREASED,38
GB,MELAENA,38
GB,INFLUENZA LIKE ILLNESS,37
GB,POLLAKIURIA,37
GB,PULMONARY EMBOLISM,37
GB,PULMONARY OEDEMA,37
GB,RASH ERYTHEMATOUS,37
GB,VERTIGO,37
GB,CHOLELITHIASIS,36
GB,MOOD ALTERED,36
GB,NEUTROPENIA,36
GB,ORTHOSTATIC HYPOTENSION,36
GB,PLATELET COUNT DECREASED,36
GB,BLISTER,35
GB,HYPOCALCAEMIA,35
GB,MATERNAL EXPOSURE DURING PREGNANCY,35
GB,MEMORY IMPAIRMENT,35
GB,PRODUCT SUBSTITUTION ISSUE,35
GB,ASTHMA,34
GB,CELLULITIS,34
GB,GASTRITIS,34
GB,GENERAL PHYSICAL HEALTH DETERIORATION,34
GB,HYPOPHAGIA,34
GB,MUSCULOSKELETAL PAIN,34
GB,URINARY RETENTION,34
GB,C-REACTIVE PROTEIN INCREASED,33
GB,HEPATIC STEATOSIS,33
GB,SWELLING,33
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,33
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,32
GB,BURNING SENSATION,32
GB,CHEST DISCOMFORT,32
GB,CHILLS,32
GB,ERECTILE DYSFUNCTION,32
GB,PANCYTOPENIA,32
GB,PSORIASIS,32
GB,THIRST,32
GB,TINNITUS,32
GB,ANGINA PECTORIS,31
GB,APHASIA,31
GB,DYSARTHRIA,31
GB,PRODUCT USE ISSUE,31
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,30
GB,DEPRESSED MOOD,30
GB,MYOPATHY,30
GB,MYOSITIS,30
GB,NEUTROPENIC SEPSIS,30
GB,RHINORRHOEA,30
GB,CANDIDA INFECTION,29
GB,CONTUSION,29
GB,DYSKINESIA,29
GB,EOSINOPHIL COUNT INCREASED,29
GB,NEUROLEPTIC MALIGNANT SYNDROME,29
GB,PLEURAL EFFUSION,29
GB,PSYCHOTIC DISORDER,29
GB,DRUG DOSE OMISSION,28
GB,DRUG PRESCRIBING ERROR,28
GB,DYSPNOEA EXERTIONAL,28
GB,EPISTAXIS,28
GB,FAECES DISCOLOURED,28
GB,FEELING HOT,28
GB,FLUSHING,28
GB,INTENTIONAL OVERDOSE,28
GB,POOR QUALITY SLEEP,28
GB,RASH PRURITIC,28
GB,SCHIZOPHRENIA,28
GB,TREATMENT NONCOMPLIANCE,28
GB,WITHDRAWAL SYNDROME,28
GB,DRUG INTOLERANCE,27
GB,GLYCOSYLATED HAEMOGLOBIN INCREASED,27
GB,PLATELET COUNT INCREASED,27
GB,RED BLOOD CELL COUNT DECREASED,27
GB,BLOOD GLUCOSE ABNORMAL,26
GB,BLOOD GLUCOSE DECREASED,26
GB,BLOOD LACTIC ACID INCREASED,26
GB,LEFT VENTRICULAR HYPERTROPHY,26
GB,PHARYNGEAL OEDEMA,26
GB,VISUAL ACUITY REDUCED,26
GB,DYSGEUSIA,25
GB,GASTROOESOPHAGEAL REFLUX DISEASE,25
GB,HEPATIC FUNCTION ABNORMAL,25
GB,IRRITABILITY,25
GB,LIMB DISCOMFORT,25
GB,MULTI-ORGAN FAILURE,25
GB,PALLOR,25
GB,PARAESTHESIA ORAL,25
GB,SKIN EXFOLIATION,25
GB,ABNORMAL DREAMS,24
GB,BLOOD URINE PRESENT,24
GB,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,24
GB,DISCOMFORT,24
GB,MYOCARDIAL ISCHAEMIA,24
GB,RECTAL HAEMORRHAGE,24
GB,SINUS BRADYCARDIA,24
GB,URINE OUTPUT DECREASED,24
GB,WHITE BLOOD CELL COUNT DECREASED,24
GB,ABNORMAL BEHAVIOUR,23
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,23
GB,CHRONIC KIDNEY DISEASE,23
GB,COGNITIVE DISORDER,23
GB,DRUG-INDUCED LIVER INJURY,23
GB,EMOTIONAL DISTRESS,23
GB,FLUID RETENTION,23
GB,GASTROINTESTINAL DISORDER,23
GB,HYPOKALAEMIA,23
GB,PREMATURE BABY,23
GB,ACCIDENTAL OVERDOSE,22
GB,HAEMORRHAGE INTRACRANIAL,22
GB,PERSONALITY CHANGE,22
GB,RHABDOMYOLYSIS,22
GB,SKIN DISCOLOURATION,22
GB,SKIN ULCER,22
GB,ABNORMAL WEIGHT GAIN,21
GB,BLADDER CANCER,21
GB,DRUG HYPERSENSITIVITY,21
GB,DUODENAL ULCER HAEMORRHAGE,21
GB,HAEMORRHAGE,21
GB,HEMIPARESIS,21
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,21
GB,NEPHROPATHY TOXIC,21
GB,PULMONARY FIBROSIS,21
GB,SEDATION,21
GB,SPUTUM DISCOLOURED,21
GB,CARDIAC DISORDER,20
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,20
GB,DUODENAL ULCER,20
GB,FEMORAL NECK FRACTURE,20
GB,GASTROENTERITIS,20
GB,NECK PAIN,20
GB,NIGHT SWEATS,20
GB,OESOPHAGITIS,20
GB,PHOTOPHOBIA,20
GB,PULSELESS ELECTRICAL ACTIVITY,20
GB,SHOCK,20
GB,STEVENS-JOHNSON SYNDROME,20
GB,STRESS,20
GB,ARTHROPATHY,19
GB,BLOOD ELECTROLYTES ABNORMAL,19
GB,CHROMATURIA,19
GB,DEEP VEIN THROMBOSIS,19
GB,DELIRIUM,19
GB,HYPOXIA,19
GB,INTERNATIONAL NORMALISED RATIO ABNORMAL,19
GB,IRRITABLE BOWEL SYNDROME,19
GB,MASS,19
GB,MOUTH ULCERATION,19
GB,PANCREATIC CARCINOMA,19
GB,PARALYSIS,19
GB,POLYDIPSIA,19
GB,RASH MACULAR,19
GB,ADVERSE EVENT,18
GB,ANGER,18
GB,BLOOD PRESSURE DECREASED,18
GB,CEREBRAL HAEMORRHAGE,18
GB,CHRONIC LYMPHOCYTIC LEUKAEMIA,18
GB,COMA SCALE ABNORMAL,18
GB,CONTRAINDICATED PRODUCT ADMINISTERED,18
GB,DIPLOPIA,18
GB,DYSSTASIA,18
GB,EYE SWELLING,18
GB,HALLUCINATIONS_ MIXED,18
GB,MUSCLE ATROPHY,18
GB,MUSCLE TWITCHING,18
GB,PNEUMONIA ASPIRATION,18
GB,RASH MACULO-PAPULAR,18
GB,RESPIRATORY RATE INCREASED,18
GB,SEPTIC SHOCK,18
GB,SINUS ARREST,18
GB,SPEECH DISORDER,18
GB,THERAPEUTIC RESPONSE UNEXPECTED,18
GB,WOUND INFECTION,18
GB,ACUTE CORONARY SYNDROME,17
GB,ANORGASMIA,17
GB,CAESAREAN SECTION,17
GB,CARDIOMYOPATHY,17
GB,CONVULSION,17
GB,DISORIENTATION,17
GB,ELECTROCARDIOGRAM ABNORMAL,17
GB,HAEMOPTYSIS,17
GB,INTERSTITIAL LUNG DISEASE,17
GB,MANIA,17
GB,MONOCLONAL B-CELL LYMPHOCYTOSIS,17
GB,PANIC ATTACK,17
GB,PULMONARY HYPERTENSION,17
GB,SUBDURAL HAEMATOMA,17
GB,SUICIDE ATTEMPT,17
GB,ADVERSE DRUG REACTION,16
GB,AFFECT LABILITY,16
GB,BLOOD BILIRUBIN INCREASED,16
GB,BLOOD CHOLESTEROL INCREASED,16
GB,BLOOD POTASSIUM INCREASED,16
GB,DRUG DEPENDENCE,16
GB,DRUG WITHDRAWAL SYNDROME,16
GB,FEELING OF BODY TEMPERATURE CHANGE,16
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,16
GB,GINGIVITIS,16
GB,HAEMATOCRIT DECREASED,16
GB,HALLUCINATION_ VISUAL,16
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,16
GB,LEUKOPENIA,16
GB,NEPHROLITHIASIS,16
GB,ORAL PAIN,16
GB,RESPIRATORY DISTRESS,16
GB,SALIVARY HYPERSECRETION,16
GB,THROAT TIGHTNESS,16
GB,URINARY INCONTINENCE,16
GB,WEIGHT BEARING DIFFICULTY,16
GB,ANAPHYLACTIC SHOCK,15
GB,ANURIA,15
GB,ARTHRITIS,15
GB,ATRIAL FLUTTER,15
GB,BLOOD MAGNESIUM DECREASED,15
GB,BLOOD SODIUM DECREASED,15
GB,CARDIOMEGALY,15
GB,CREATININE RENAL CLEARANCE ABNORMAL,15
GB,DYSPHONIA,15
GB,DYSURIA,15
GB,EAR PAIN,15
GB,EPILEPSY,15
GB,FLUID OVERLOAD,15
GB,HEPATIC ENZYME INCREASED,15
GB,INFLUENZA,15
GB,LUMBAR VERTEBRAL FRACTURE,15
GB,MEDICATION ERROR,15
GB,MUCOSAL INFLAMMATION,15
GB,NEUTROPHIL COUNT DECREASED,15
GB,OBESITY,15
GB,ORAL CANDIDIASIS,15
GB,PAIN IN JAW,15
GB,PRODUCT USE IN UNAPPROVED INDICATION,15
GB,PRODUCTIVE COUGH,15
GB,SINUS NODE DYSFUNCTION,15
GB,SKIN LESION,15
GB,TEARFULNESS,15
GB,THROMBOCYTOSIS,15
GB,UROSEPSIS,15
GB,ABSCESS,14
GB,ANTIPSYCHOTIC DRUG LEVEL DECREASED,14
GB,BONE PAIN,14
GB,CARPAL TUNNEL SYNDROME,14
GB,CEREBRAL INFARCTION,14
GB,CHANGE OF BOWEL HABIT,14
GB,CYANOSIS,14
GB,DRY SKIN,14
GB,EYE PAIN,14
GB,FEELING COLD,14
GB,FIBROMYALGIA,14
GB,GINGIVAL HYPERTROPHY,14
GB,GYNAECOMASTIA,14
GB,INTERNATIONAL NORMALISED RATIO DECREASED,14
GB,LIVER INJURY,14
GB,LOSS OF LIBIDO,14
GB,MIGRAINE,14
GB,MUSCLE TIGHTNESS,14
GB,OESOPHAGEAL PERFORATION,14
GB,PERITONITIS,14
GB,RESTLESSNESS,14
GB,SENSORY DISTURBANCE,14
GB,SUDDEN DEATH,14
GB,ULCER,14
GB,ARTERIOSCLEROSIS CORONARY ARTERY,13
GB,DEFAECATION URGENCY,13
GB,DRY EYE,13
GB,LYMPHOCYTE COUNT DECREASED,13
GB,LYMPHOCYTE COUNT INCREASED,13
GB,PRODUCT QUALITY ISSUE,13
GB,RALES,13
GB,RENAL CANCER,13
GB,RENAL CYST,13
GB,SEXUAL DYSFUNCTION,13
GB,SLEEP APNOEA SYNDROME,13
GB,UPPER RESPIRATORY TRACT INFECTION,13
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,12
GB,ACUTE HEPATIC FAILURE,12
GB,AGEUSIA,12
GB,ASPARTATE AMINOTRANSFERASE INCREASED,12
GB,BLINDNESS,12
GB,BLOOD UREA INCREASED,12
GB,BODY TEMPERATURE INCREASED,12
GB,COAGULATION TIME PROLONGED,12
GB,CONGESTIVE CARDIOMYOPATHY,12
GB,EOSINOPHILIA,12
GB,EXTRAPYRAMIDAL DISORDER,12
GB,FAECAL INCONTINENCE,12
GB,FLATULENCE,12
GB,HEPATITIS,12
GB,HYPERCHLORHYDRIA,12
GB,INCREASED APPETITE,12
GB,INFLAMMATORY MARKER INCREASED,12
GB,LIVE BIRTH,12
GB,LYMPHADENOPATHY,12
GB,MENTAL DISORDER,12
GB,MOUTH SWELLING,12
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,12
GB,MYELODYSPLASTIC SYNDROME,12
GB,NEUROPATHY_ ATAXIA_ RETINITIS PIGMENTOSA SYNDROME,12
GB,NYSTAGMUS,12
GB,OESOPHAGEAL ULCER,12
GB,RETCHING,12
GB,TACHYPNOEA,12
GB,ATAXIA,11
GB,BLOOD CALCIUM DECREASED,11
GB,BRONCHIECTASIS,11
GB,BUNDLE BRANCH BLOCK LEFT,11
GB,CARDIO-RESPIRATORY ARREST,11
GB,CARDIOVASCULAR DISORDER,11
GB,CLOSTRIDIUM DIFFICILE INFECTION,11
GB,COAGULOPATHY,11
GB,COLITIS,11
GB,CONGENITAL HYDROCEPHALUS,11
GB,CONTRAINDICATED DRUG ADMINISTERED,11
GB,DERMATITIS ALLERGIC,11
GB,DEXTROCARDIA,11
GB,DIVERTICULITIS,11
GB,EATING DISORDER,11
GB,ECZEMA,11
GB,ERYTHEMA MULTIFORME,11
GB,GASTRIC DISORDER,11
GB,GASTRIC ULCER,11
GB,HYDROCEPHALUS,11
GB,INCONTINENCE,11
GB,INJURY,11
GB,INTENTIONAL SELF-INJURY,11
GB,IRON DEFICIENCY ANAEMIA,11
GB,MEDICATION MONITORING ERROR,11
GB,MUSCULOSKELETAL STIFFNESS,11
GB,NEPHROPATHY,11
GB,PARKINSONISM,11
GB,PERIORBITAL OEDEMA,11
GB,TENDONITIS,11
GB,THINKING ABNORMAL,11
GB,TOE AMPUTATION,11
GB,TRIGGER FINGER,11
GB,ABNORMAL FAECES,10
GB,AMYLASE INCREASED,10
GB,AORTIC STENOSIS,10
GB,APNOEA,10
GB,ASCITES,10
GB,BLOOD PRESSURE ABNORMAL,10
GB,BODY TEMPERATURE DECREASED,10
GB,BRAIN HERNIATION,10
GB,CARDIOACTIVE DRUG LEVEL INCREASED,10
GB,COLITIS MICROSCOPIC,10
GB,CRYING,10
GB,DEMENTIA,10
GB,DUODENITIS,10
GB,ENCEPHALITIS,10
GB,EXTRAOCULAR MUSCLE DISORDER,10
GB,EYE MOVEMENT DISORDER,10
GB,EYELID PTOSIS,10
GB,FOETAL GROWTH RESTRICTION,10
GB,GASTRIC DILATATION,10
GB,GLOSSODYNIA,10
GB,HEART RATE IRREGULAR,10
GB,HYPOTHERMIA,10
GB,HYPOVENTILATION,10
GB,IDIOPATHIC PULMONARY FIBROSIS,10
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,10
GB,INJECTION SITE PAIN,10
GB,LISTLESS,10
GB,MALIGNANT NEOPLASM PROGRESSION,10
GB,MEAN CELL VOLUME INCREASED,10
GB,MUSCLE DISORDER,10
GB,NASOPHARYNGITIS,10
GB,PEMPHIGOID,10
GB,PERIPHERAL COLDNESS,10
GB,PERIPHERAL ISCHAEMIA,10
GB,PHARYNGITIS,10
GB,PNEUMONITIS,10
GB,POTENTIATING DRUG INTERACTION,10
GB,PROSTATE CANCER,10
GB,SEROTONIN SYNDROME,10
GB,SKIN OEDEMA,10
GB,SMALL INTESTINAL HAEMORRHAGE,10
GB,SNEEZING,10
GB,SQUAMOUS CELL CARCINOMA,10
GB,SUBARACHNOID HAEMORRHAGE,10
GB,VENTRICULAR FIBRILLATION,10
GB,ABASIA,9
GB,ACANTHOSIS,9
GB,ACIDOSIS,9
GB,ANAL INCONTINENCE,9
GB,ARTERIOSPASM CORONARY,9
GB,ATELECTASIS,9
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,9
GB,B-CELL LYMPHOMA,9
GB,BLOOD CHOLESTEROL DECREASED,9
GB,BLOOD GLUCOSE FLUCTUATION,9
GB,BLOOD POTASSIUM DECREASED,9
GB,BRAIN INJURY,9
GB,BREAST CANCER,9
GB,CARDIOGENIC SHOCK,9
GB,DRUG DISPENSING ERROR,9
GB,DRUG ERUPTION,9
GB,DYSPAREUNIA,9
GB,ENCEPHALOCELE,9
GB,EXTRAVASATION BLOOD,9
GB,FEAR OF DEATH,9
GB,FEAR OF DISEASE,9
GB,FEBRILE NEUTROPENIA,9
GB,FURUNCLE,9
GB,GESTATIONAL DIABETES,9
GB,GINGIVAL BLEEDING,9
GB,HAEMODYNAMIC INSTABILITY,9
GB,HIATUS HERNIA,9
GB,HYPOCHONDRIASIS,9
GB,INSULIN RESISTANCE,9
GB,INTESTINAL OBSTRUCTION,9
GB,ISCHAEMIA,9
GB,KETONURIA,9
GB,LYMPHOMA,9
GB,METASTATIC MALIGNANT MELANOMA,9
GB,MIDDLE INSOMNIA,9
GB,MOVEMENT DISORDER,9
GB,MUCOUS MEMBRANE DISORDER,9
GB,NECROTISING FASCIITIS,9
GB,NERVOUS SYSTEM DISORDER,9
GB,NEUTROPHILIC DERMATOSIS,9
GB,NOCTURIA,9
GB,NODULE,9
GB,OBSESSIVE THOUGHTS,9
GB,OVERWEIGHT,9
GB,PANIC DISORDER,9
GB,PARANOIA,9
GB,PERICARDIAL EFFUSION,9
GB,PREMATURE DELIVERY,9
GB,PROTEINURIA,9
GB,PYELONEPHRITIS,9
GB,RASH PUSTULAR,9
GB,RENAL FAILURE CHRONIC,9
GB,RHEUMATOID ARTHRITIS,9
GB,THROMBOTIC THROMBOCYTOPENIC PURPURA,9
GB,TROPONIN INCREASED,9
GB,VAGINAL HAEMORRHAGE,9
GB,VIRAL INFECTION,9
GB,VOLVULUS,9
GB,VULVOVAGINAL DRYNESS,9
GB,WRONG DRUG ADMINISTERED,9
GB,WRONG PATIENT RECEIVED MEDICATION,9
GB,ADAMTS13 ACTIVITY DECREASED,8
GB,ARTHROPOD STING,8
GB,ATYPICAL PNEUMONIA,8
GB,BLADDER PAIN,8
GB,BLADDER SPASM,8
GB,BLADDER TRANSITIONAL CELL CARCINOMA,8
GB,BLINDNESS CORTICAL,8
GB,BLOOD PHOSPHORUS DECREASED,8
GB,CAMPYLOBACTER INFECTION,8
GB,CHOKING,8
GB,COLITIS ULCERATIVE,8
GB,DIABETIC FOOT,8
GB,DRUG LEVEL INCREASED,8
GB,ENCEPHALOPATHY,8
GB,ENDOCARDITIS,8
GB,FEAR,8
GB,FEMUR FRACTURE,8
GB,FOETAL HYPOKINESIA,8
GB,GENITAL INFECTION FUNGAL,8
GB,GINGIVAL HYPERPLASIA,8
GB,HAEMOLYSIS,8
GB,HEPATIC FAILURE,8
GB,HYPERTENSIVE HEART DISEASE,8
GB,ILL-DEFINED DISORDER,8
GB,IRON DEFICIENCY,8
GB,ISCHAEMIC STROKE,8
GB,KIDNEY INFECTION,8
GB,LIVER FUNCTION TEST INCREASED,8
GB,LUPUS-LIKE SYNDROME,8
GB,MOOD SWINGS,8
GB,MUSCLE RIGIDITY,8
GB,NAEVUS FLAMMEUS,8
GB,OBSTRUCTIVE AIRWAYS DISORDER,8
GB,PANIC REACTION,8
GB,PERICARDITIS,8
GB,PNEUMOPERITONEUM,8
GB,POLYARTHRITIS,8
GB,POLYHYDRAMNIOS,8
GB,POLYMYOSITIS,8
GB,PROSTATITIS,8
GB,PYROGLUTAMATE INCREASED,8
GB,RASH PAPULAR,8
GB,SINUSITIS,8
GB,SKIN DISORDER,8
GB,SLUGGISHNESS,8
GB,SPLENOMEGALY,8
GB,SURGERY,8
GB,THROAT IRRITATION,8
GB,TRANSAMINASES INCREASED,8
GB,VULVOVAGINAL DISCOMFORT,8
GB,WOUND,8
GB,ABDOMINAL PAIN LOWER,7
GB,ACUTE MYELOID LEUKAEMIA,7
GB,APPETITE DISORDER,7
GB,ARTERITIS,7
GB,BLADDER ADENOCARCINOMA STAGE UNSPECIFIED,7
GB,BLOOD CREATININE ABNORMAL,7
GB,BRAIN OEDEMA,7
GB,CHOLECYSTITIS,7
GB,COMPLETED SUICIDE,7
GB,CONJUNCTIVAL DISORDER,7
GB,CSF PROTEIN INCREASED,7
GB,DEMYELINATION,7
GB,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,7
GB,DIALYSIS,7
GB,DRUG DOSE TITRATION NOT PERFORMED,7
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,7
GB,DYSHIDROTIC ECZEMA,7
GB,EPIGLOTTITIS,7
GB,FAECES SOFT,7
GB,FASCIITIS,7
GB,FOETAL DISTRESS SYNDROME,7
GB,FREQUENT BOWEL MOVEMENTS,7
GB,GASTRIC HAEMORRHAGE,7
GB,GASTROINTESTINAL CARCINOMA,7
GB,GUILLAIN-BARRE SYNDROME,7
GB,HALLUCINATION_ AUDITORY,7
GB,HEPATIC CONGESTION,7
GB,HYPOALBUMINAEMIA,7
GB,HYPOVOLAEMIC SHOCK,7
GB,IIIRD NERVE PARESIS,7
GB,INCREASED UPPER AIRWAY SECRETION,7
GB,INJECTION SITE HAEMORRHAGE,7
GB,INTESTINAL ISCHAEMIA,7
GB,LIVEDO RETICULARIS,7
GB,LIVER DISORDER,7
GB,LOCALISED OEDEMA,7
GB,LOW BIRTH WEIGHT BABY,7
GB,LOWER LIMB FRACTURE,7
GB,LUNG DISORDER,7
GB,MAST CELL DEGRANULATION PRESENT,7
GB,MICROCYTIC ANAEMIA,7
GB,NASAL CONGESTION,7
GB,NEUROLOGICAL SYMPTOM,7
GB,OSTEOMYELITIS,7
GB,PANCREATIC MASS,7
GB,PERONEAL NERVE PALSY,7
GB,POLYNEUROPATHY,7
GB,PRODUCT COATING ISSUE,7
GB,PRODUCT PACKAGING ISSUE,7
GB,RESPIRATORY ARREST,7
GB,RESPIRATORY TRACT INFECTION,7
GB,SINUS TACHYCARDIA,7
GB,STARING,7
GB,STREPTOCOCCAL INFECTION,7
GB,SUICIDAL BEHAVIOUR,7
GB,TEMPORAL ARTERITIS,7
GB,THERAPEUTIC RESPONSE DECREASED,7
GB,TONGUE ULCERATION,7
GB,TRANSPOSITION OF THE GREAT VESSELS,7
GB,TREATMENT FAILURE,7
GB,TROPONIN I INCREASED,7
GB,VASCULITIS,7
GB,VENTRICULAR HYPERTROPHY,7
GB,VENTRICULAR SEPTAL DEFECT,7
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,7
GB,XANTHOPSIA,7
GB,ABDOMINAL TENDERNESS,6
GB,ABDOMINAL WALL HAEMATOMA,6
GB,ACCIDENT,6
GB,AFFECTIVE DISORDER,6
GB,AGITATED DEPRESSION,6
GB,AGRANULOCYTOSIS,6
GB,ALVEOLITIS ALLERGIC,6
GB,ATRIOVENTRICULAR BLOCK,6
GB,AUTOIMMUNE HAEMOLYTIC ANAEMIA,6
GB,BASAL CELL CARCINOMA,6
GB,BLOOD CORTICOSTERONE DECREASED,6
GB,BODY MASS INDEX INCREASED,6
GB,CANDIDA ENDOPHTHALMITIS,6
GB,CARDIAC DISCOMFORT,6
GB,CIRCUMORAL OEDEMA,6
GB,CONCOMITANT DISEASE PROGRESSION,6
GB,CREPITATIONS,6
GB,DERMATITIS,6
GB,DERMATITIS EXFOLIATIVE,6
GB,ELECTROLYTE IMBALANCE,6
GB,ERUCTATION,6
GB,ESCHERICHIA INFECTION,6
GB,ESSENTIAL HYPERTENSION,6
GB,EYE CONTUSION,6
GB,FACIAL PARALYSIS,6
GB,FOETAL MACROSOMIA,6
GB,FRACTURE,6
GB,GAMBLING DISORDER,6
GB,GASTROINTESTINAL MOTILITY DISORDER,6
GB,GENERALISED TONIC-CLONIC SEIZURE,6
GB,GENITAL PAIN,6
GB,GINGIVAL RECESSION,6
GB,HAEMORRHAGIC STROKE,6
GB,HAND-ARM VIBRATION SYNDROME,6
GB,HEAD DISCOMFORT,6
GB,HEPATOTOXICITY,6
GB,HYPERSENSITIVITY VASCULITIS,6
GB,HYPONATRAEMIC SEIZURE,6
GB,HYPOPHOSPHATAEMIA,6
GB,INAPPROPRIATE AFFECT,6
GB,INCORRECT DOSE ADMINISTERED,6
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,6
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,6
GB,INFUSION RELATED REACTION,6
GB,INJECTION SITE MASS,6
GB,INJECTION SITE PRURITUS,6
GB,JOINT STIFFNESS,6
GB,KETOSIS,6
GB,LEFT VENTRICULAR DYSFUNCTION,6
GB,LICHEN SCLEROSUS,6
GB,LOOSE TOOTH,6
GB,LUNG NEOPLASM MALIGNANT,6
GB,LYMPHOCYTOSIS,6
GB,LYMPHOEDEMA,6
GB,MACROGLOSSIA,6
GB,MACULAR OEDEMA,6
GB,METAMORPHOPSIA,6
GB,MUSCLE FATIGUE,6
GB,PAIN OF SKIN,6
GB,PANCREATIC CARCINOMA METASTATIC,6
GB,PELVIC FLOOR MUSCLE WEAKNESS,6
GB,PERIPHERAL CIRCULATORY FAILURE,6
GB,PERITONITIS BACTERIAL,6
GB,PERSONALITY DISORDER,6
GB,PLANTAR FASCIITIS,6
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,6
GB,PNEUMONIA BACTERIAL,6
GB,POST PROCEDURAL HAEMATOMA,6
GB,PRESYNCOPE,6
GB,PULSE ABSENT,6
GB,SCIATICA,6
GB,SENSORY LOSS,6
GB,SINGLE FUNCTIONAL KIDNEY,6
GB,SKIN REACTION,6
GB,SKIN WARM,6
GB,SPLEEN CONGESTION,6
GB,STILLBIRTH,6
GB,STOMATITIS,6
GB,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,6
GB,THERMAL BURN,6
GB,TOOTH LOSS,6
GB,TRISMUS,6
GB,TROPONIN T INCREASED,6
GB,TUMOUR LYSIS SYNDROME,6
GB,URETHRAL CANCER,6
GB,VASCULITIC RASH,6
GB,VITREOUS HAEMORRHAGE,6
GB,ACTINIC ELASTOSIS,5
GB,ALCOHOLIC LIVER DISEASE,5
GB,ANGULAR CHEILITIS,5
GB,AUTOIMMUNE HEPATITIS,5
GB,AZOTAEMIA,5
GB,BILIARY SEPSIS,5
GB,BONE MARROW FAILURE,5
GB,CARDIOPULMONARY FAILURE,5
GB,CATARRH,5
GB,CHEST X-RAY ABNORMAL,5
GB,COMA,5
GB,CONDUCTION DISORDER,5
GB,COORDINATION ABNORMAL,5
GB,CORONARY ARTERY DISEASE,5
GB,DELUSION,5
GB,DEMENTIA ALZHEIMER^S TYPE,5
GB,DEVICE RELATED INFECTION,5
GB,DIABETIC NEUROPATHY,5
GB,DIABETIC RETINOPATHY,5
GB,DISEASE PROGRESSION,5
GB,DIVERTICULAR PERFORATION,5
GB,DIZZINESS POSTURAL,5
GB,DYSLIPIDAEMIA,5
GB,ELECTROCARDIOGRAM CHANGE,5
GB,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,5
GB,EMOTIONAL POVERTY,5
GB,ESCHERICHIA SEPSIS,5
GB,EXOMPHALOS,5
GB,EXTRASYSTOLES,5
GB,EYE OEDEMA,5
GB,EYELID OEDEMA,5
GB,FACIAL PARESIS,5
GB,FAECALOMA,5
GB,FEEDING DISORDER,5
GB,FLAT AFFECT,5
GB,FLUID IMBALANCE,5
GB,GASTRIC ULCER PERFORATION,5
GB,GASTROINTESTINAL STOMA COMPLICATION,5
GB,GENITAL RASH,5
GB,GLUCOSE URINE PRESENT,5
GB,HEARING IMPAIRED,5
GB,HEART DISEASE CONGENITAL,5
GB,HEPATIC CIRRHOSIS,5
GB,HYPERCALCAEMIA,5
GB,HYPERTHYROIDISM,5
GB,HYPOACUSIS,5
GB,IMMUNOSUPPRESSION,5
GB,INCREASED BRONCHIAL SECRETION,5
GB,INFLAMMATORY BOWEL DISEASE,5
GB,INJECTION SITE ERYTHEMA,5
GB,INTRACRANIAL PRESSURE INCREASED,5
GB,KIDNEY FIBROSIS,5
GB,LIBIDO DECREASED,5
GB,LICHENOID KERATOSIS,5
GB,LUNG ADENOCARCINOMA,5
GB,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,5
GB,MICTURITION DISORDER,5
GB,NECROSIS,5
GB,NEPHROTIC SYNDROME,5
GB,OBSESSIVE-COMPULSIVE DISORDER,5
GB,OCCULT BLOOD POSITIVE,5
GB,OESOPHAGITIS HAEMORRHAGIC,5
GB,ONYCHOCLASIS,5
GB,ORAL PRURITUS,5
GB,PALINDROMIC RHEUMATISM,5
GB,PANIC DISORDER WITH AGORAPHOBIA,5
GB,PAPILLOEDEMA,5
GB,PAROSMIA,5
GB,PENILE PAIN,5
GB,PERINEAL PAIN,5
GB,PETECHIAE,5
GB,PHOTOPSIA,5
GB,PHOTOSENSITIVITY REACTION,5
GB,POST PROCEDURAL INFECTION,5
GB,PROSTATOMEGALY,5
GB,PRURITUS GENITAL,5
GB,RENAL DISORDER,5
GB,RENAL INJURY,5
GB,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,5
GB,SELF-INJURIOUS IDEATION,5
GB,SENSATION OF FOREIGN BODY,5
GB,SNORING,5
GB,SPINAL COLUMN STENOSIS,5
GB,SUBSTANCE ABUSE,5
GB,TENDERNESS,5
GB,TESTICULAR PAIN,5
GB,THYROIDITIS,5
GB,TONGUE DISCOLOURATION,5
GB,TONGUE OEDEMA,5
GB,TOOTH ABSCESS,5
GB,TOOTH DISORDER,5
GB,TOOTHACHE,5
GB,URINE KETONE BODY PRESENT,5
GB,VENOUS PRESSURE JUGULAR INCREASED,5
GB,VENTRICULAR DYSFUNCTION,5
GB,VITAMIN B12 ABSORPTION TEST ABNORMAL,5
GB,VULVOVAGINAL BURNING SENSATION,5
GB,VULVOVAGINAL CANDIDIASIS,5
GB,ACTINIC KERATOSIS,4
GB,ACUTE PULMONARY OEDEMA,4
GB,ADENOMA BENIGN,4
GB,AIRWAY COMPLICATION OF ANAESTHESIA,4
GB,ANKLE FRACTURE,4
GB,ANXIETY DISORDER,4
GB,ARTHRITIS BACTERIAL,4
GB,ATRIOVENTRICULAR BLOCK COMPLETE,4
GB,ATRIOVENTRICULAR BLOCK SECOND DEGREE,4
GB,AUTOIMMUNE DISORDER,4
GB,BLADDER NEOPLASM,4
GB,BLINDNESS UNILATERAL,4
GB,BLOOD KETONE BODY INCREASED,4
GB,BLOOD PH DECREASED,4
GB,BONE MARROW DISORDER,4
GB,BRONCHITIS,4
GB,BRONCHOPNEUMONIA,4
GB,BRONCHOSPASM,4
GB,CEREBROVASCULAR DISORDER,4
GB,CHAPPED LIPS,4
GB,CHRONIC SINUSITIS,4
GB,CLONUS,4
GB,COLON CANCER STAGE III,4
GB,CORONARY ARTERY BYPASS,4
GB,CYSTITIS INTERSTITIAL,4
GB,DECUBITUS ULCER,4
GB,DEVICE DIFFICULT TO USE,4
GB,DIABETIC FOOT INFECTION,4
GB,DIABETIC KETOSIS,4
GB,DIABETIC MICROANGIOPATHY,4
GB,DILATATION VENTRICULAR,4
GB,DIVERTICULUM,4
GB,DRUG USE DISORDER,4
GB,DYSPLASIA,4
GB,DYSPNOEA AT REST,4
GB,EAR INFECTION,4
GB,ENDOPHTHALMITIS,4
GB,EPILEPTIC AURA,4
GB,EXCORIATION,4
GB,FACE OEDEMA,4
GB,FOOD AVERSION,4
GB,FUNGAL INFECTION,4
GB,GANGRENE,4
GB,GASTRIC PH DECREASED,4
GB,GASTROINTESTINAL INFLAMMATION,4
GB,GINGIVAL SWELLING,4
GB,HAEMATOCHEZIA,4
GB,HAEMATOMA,4
GB,HEMIANOPIA HOMONYMOUS,4
GB,HEPATITIS CHOLESTATIC,4
GB,HOSPITALISATION,4
GB,HYPEROSMOLAR HYPERGLYCAEMIC STATE,4
GB,HYPERTONIA,4
GB,HYPOTHYROIDISM,4
GB,ILEUS,4
GB,IMPAIRED HEALING,4
GB,INFECTED SKIN ULCER,4
GB,INFLAMMATION,4
GB,INJECTION SITE BRUISING,4
GB,INJECTION SITE RASH,4
GB,INTENTIONAL PRODUCT MISUSE,4
GB,INTRACRANIAL ANEURYSM,4
GB,LACERATION,4
GB,LIP PAIN,4
GB,LIVER TRANSPLANT REJECTION,4
GB,LOCALISED INFECTION,4
GB,LUNG CONSOLIDATION,4
GB,METASTASES TO LIVER,4
GB,METASTASES TO LUNG,4
GB,METASTASIS,4
GB,MUCOSAL DRYNESS,4
GB,MUSCULOSKELETAL CHEST PAIN,4
GB,MUSCULOSKELETAL DISCOMFORT,4
GB,NEOPLASM MALIGNANT,4
GB,OCULAR HYPERAEMIA,4
GB,ODYNOPHAGIA,4
GB,ORBITAL OEDEMA,4
GB,OSTEOARTHRITIS,4
GB,PELVIC PAIN,4
GB,PEPTIC ULCER,4
GB,PLICATED TONGUE,4
GB,PORTAL VENOUS GAS,4
GB,POSTOPERATIVE WOUND INFECTION,4
GB,PREGNANCY,4
GB,PRESCRIBED OVERDOSE,4
GB,PROCEDURAL HYPOTENSION,4
GB,PRODUCT SIZE ISSUE,4
GB,PULMONARY CONGESTION,4
GB,PULMONARY FUNCTION TEST DECREASED,4
GB,PULMONARY MASS,4
GB,QUALITY OF LIFE DECREASED,4
GB,RASH MORBILLIFORM,4
GB,REACTION TO DRUG EXCIPIENTS,4
GB,REACTION TO EXCIPIENT,4
GB,RENAL FUNCTION TEST ABNORMAL,4
GB,RENAL PAIN,4
GB,RENAL TUBULAR ACIDOSIS,4
GB,RESPIRATION ABNORMAL,4
GB,RESTLESS LEGS SYNDROME,4
GB,RETINAL VEIN OCCLUSION,4
GB,RIB FRACTURE,4
GB,SECRETION DISCHARGE,4
GB,SKIN FISSURES,4
GB,SMALL FOR DATES BABY,4
GB,SQUAMOUS CELL CARCINOMA OF SKIN,4
GB,STRESS FRACTURE,4
US,BLOOD GLUCOSE INCREASED,5742
US,DRUG INEFFECTIVE,5229
US,NAUSEA,4798
US,DIARRHOEA,4209
US,FATIGUE,3701
US,DRUG DOSE OMISSION,3163
US,WEIGHT DECREASED,2972
US,DIZZINESS,2779
US,PAIN,2653
US,HEADACHE,2646
US,DYSPNOEA,2608
US,VOMITING,2406
US,INJECTION SITE PAIN,2250
US,MALAISE,2103
US,ASTHENIA,1890
US,PAIN IN EXTREMITY,1830
US,FALL,1779
US,DECREASED APPETITE,1737
US,BLADDER CANCER,1691
US,ARTHRALGIA,1659
US,DEATH,1650
US,RASH,1523
US,BLOOD GLUCOSE DECREASED,1442
US,PRURITUS,1421
US,FEELING ABNORMAL,1419
US,PRODUCT QUALITY ISSUE,1407
US,INSOMNIA,1372
US,INCORRECT DOSE ADMINISTERED,1332
US,WEIGHT INCREASED,1320
US,BACK PAIN,1306
US,COUGH,1274
US,PNEUMONIA,1250
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,1202
US,INJECTION SITE HAEMORRHAGE,1202
US,ABDOMINAL PAIN UPPER,1179
US,UNDERDOSE,1179
US,CONSTIPATION,1149
US,ABDOMINAL DISCOMFORT,1139
US,GAIT DISTURBANCE,1103
US,COMPLETED SUICIDE,1096
US,ANXIETY,1058
US,HYPERTENSION,1053
US,ACUTE KIDNEY INJURY,1044
US,ABDOMINAL PAIN,1040
US,MYOCARDIAL INFARCTION,1038
US,MUSCLE SPASMS,1023
US,DEPRESSION,1006
US,PRODUCT USE ISSUE,1002
US,URINARY TRACT INFECTION,1002
US,DIABETES MELLITUS,998
US,GASTROINTESTINAL HAEMORRHAGE,992
US,CHEST PAIN,982
US,PERIPHERAL SWELLING,969
US,CEREBROVASCULAR ACCIDENT,929
US,DRUG HYPERSENSITIVITY,918
US,ANAEMIA,914
US,SOMNOLENCE,900
US,DEHYDRATION,893
US,INTENTIONAL PRODUCT MISUSE,880
US,DIABETIC KETOACIDOSIS,863
US,ALOPECIA,859
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,843
US,PANCREATITIS,835
US,CONDITION AGGRAVATED,830
US,PYREXIA,813
US,TREMOR,808
US,VISION BLURRED,808
US,MEMORY IMPAIRMENT,803
US,NASOPHARYNGITIS,790
US,HYPOTENSION,787
US,MYALGIA,773
US,HYPOAESTHESIA,750
US,PSORIASIS,724
US,INJECTION SITE NODULE,709
US,PARAESTHESIA,705
US,HYPERHIDROSIS,694
US,VISUAL IMPAIRMENT,694
US,INJECTION SITE MASS,686
US,DYSPEPSIA,681
US,BLOOD PRESSURE INCREASED,676
US,CONFUSIONAL STATE,656
US,TOXICITY TO VARIOUS AGENTS,655
US,LACTIC ACIDOSIS,653
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,651
US,INJECTION SITE PRURITUS,640
US,INJECTION SITE BRUISING,634
US,CARDIAC FAILURE CONGESTIVE,627
US,HYPERSENSITIVITY,618
US,GASTROOESOPHAGEAL REFLUX DISEASE,609
US,DYSGEUSIA,603
US,INJECTION SITE ERYTHEMA,602
US,MUSCULAR WEAKNESS,600
US,HYPOGLYCAEMIA,581
US,ATRIAL FIBRILLATION,573
US,URTICARIA,565
US,ABDOMINAL DISTENSION,561
US,BLOOD GLUCOSE ABNORMAL,560
US,BRONCHITIS,556
US,NEUROPATHY PERIPHERAL,549
US,SINUSITIS,548
US,RENAL FAILURE,543
US,OEDEMA PERIPHERAL,535
US,CONTUSION,521
US,ERYTHEMA,519
US,ARTHRITIS,503
US,OVERDOSE,493
US,DRY MOUTH,492
US,BALANCE DISORDER,486
US,FLUSHING,486
US,CATARACT,473
US,POLLAKIURIA,459
US,FUNGAL INFECTION,455
US,INFLUENZA,455
US,LOSS OF CONSCIOUSNESS,454
US,JOINT SWELLING,452
US,HEART RATE INCREASED,450
US,SEPSIS,447
US,OROPHARYNGEAL PAIN,437
US,PALPITATIONS,437
US,BURNING SENSATION,433
US,PULMONARY EMBOLISM,430
US,CHEST DISCOMFORT,421
US,FLATULENCE,414
US,CHILLS,411
US,DRUG EFFECT INCOMPLETE,406
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,393
US,INJECTION SITE SWELLING,391
US,MUSCULOSKELETAL PAIN,383
US,DEEP VEIN THROMBOSIS,381
US,EPISTAXIS,380
US,CARDIAC DISORDER,379
US,CELLULITIS,373
US,INFECTION,373
US,BLOOD CHOLESTEROL INCREASED,365
US,DYSPHAGIA,362
US,DEVICE MALFUNCTION,361
US,STRESS,361
US,SYNCOPE,361
US,DRUG EFFECT DECREASED,357
US,DIABETES MELLITUS INADEQUATE CONTROL,356
US,HOT FLUSH,353
US,SWELLING,352
US,DYSPHONIA,351
US,HAEMOGLOBIN DECREASED,348
US,BLOOD GLUCOSE FLUCTUATION,345
US,TYPE 2 DIABETES MELLITUS,345
US,INJECTION SITE EXTRAVASATION,342
US,ADVERSE EVENT,340
US,VISUAL ACUITY REDUCED,333
US,RESPIRATORY FAILURE,332
US,ASTHMA,329
US,NERVOUSNESS,326
US,DRY SKIN,324
US,DISEASE PROGRESSION,322
US,INJURY,322
US,AMNESIA,321
US,THROMBOSIS,321
US,INFLUENZA LIKE ILLNESS,320
US,DRUG ADMINISTRATION ERROR,316
US,NEPHROLITHIASIS,315
US,GASTROINTESTINAL DISORDER,311
US,PRODUCT USE IN UNAPPROVED INDICATION,311
US,MUSCULOSKELETAL STIFFNESS,309
US,INCORRECT PRODUCT STORAGE,306
US,NECK PAIN,304
US,OSTEOARTHRITIS,304
US,THERAPEUTIC RESPONSE UNEXPECTED,303
US,RHINORRHOEA,302
US,BLOOD CREATININE INCREASED,299
US,HYPERGLYCAEMIA,298
US,INCORRECT DRUG ADMINISTRATION DURATION,296
US,HAEMORRHAGE,292
US,CORONARY ARTERY DISEASE,290
US,PLATELET COUNT DECREASED,287
US,BLISTER,286
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,285
US,FEELING HOT,283
US,SEIZURE,282
US,DEVICE ISSUE,280
US,CARDIAC ARREST,279
US,RASH PRURITIC,279
US,WHITE BLOOD CELL COUNT DECREASED,279
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,277
US,RENAL DISORDER,277
US,RHEUMATOID ARTHRITIS,276
US,IRRITABILITY,275
US,NASAL CONGESTION,273
US,INJECTION SITE REACTION,263
US,SWELLING FACE,263
US,FLUID RETENTION,260
US,RECTAL HAEMORRHAGE,260
US,PANCREATITIS ACUTE,259
US,ERUCTATION,258
US,HEPATIC ENZYME INCREASED,257
US,UNEVALUABLE EVENT,257
US,METABOLIC ACIDOSIS,256
US,SLEEP DISORDER,256
US,HAEMATURIA,254
US,UPPER RESPIRATORY TRACT INFECTION,254
US,ARTHROPATHY,253
US,MIGRAINE,253
US,RENAL IMPAIRMENT,252
US,TREATMENT NONCOMPLIANCE,250
US,SUICIDAL IDEATION,248
US,LETHARGY,246
US,MOBILITY DECREASED,244
US,MEDICATION ERROR,243
US,AGITATION,241
US,EMOTIONAL DISTRESS,241
US,DYSURIA,240
US,INTENTIONAL PRODUCT USE ISSUE,240
US,TRANSIENT ISCHAEMIC ATTACK,240
US,WHEEZING,240
US,RENAL FAILURE ACUTE,236
US,CHOLELITHIASIS,235
US,BLOOD PRESSURE DECREASED,234
US,STOMATITIS,232
US,EXPIRED PRODUCT ADMINISTERED,229
US,PLEURAL EFFUSION,227
US,SKIN DISCOLOURATION,227
US,VERTIGO,225
US,EYE PAIN,220
US,LOCAL SWELLING,219
US,SLEEP APNOEA SYNDROME,219
US,BONE PAIN,218
US,DISCOMFORT,218
US,PRODUCTIVE COUGH,216
US,OEDEMA,215
US,PANCREATIC CARCINOMA,215
US,ADVERSE DRUG REACTION,214
US,DRUG WITHDRAWAL SYNDROME,214
US,THERAPY CESSATION,214
US,SKIN EXFOLIATION,213
US,THROAT IRRITATION,213
US,HALLUCINATION,211
US,HERPES ZOSTER,211
US,INTENTIONAL OVERDOSE,211
US,CYSTITIS,209
US,DRUG INTOLERANCE,209
US,DRUG DISPENSING ERROR,204
US,SPEECH DISORDER,204
US,DEPRESSED MOOD,202
US,HAEMORRHAGIC ANAEMIA,201
US,THROMBOCYTOPENIA,200
US,BLOOD URINE PRESENT,199
US,MENTAL STATUS CHANGES,198
US,NO ADVERSE EVENT,198
US,ACUTE MYOCARDIAL INFARCTION,196
US,MALIGNANT NEOPLASM PROGRESSION,195
US,LIMB DISCOMFORT,194
US,CRYING,193
US,ROAD TRAFFIC ACCIDENT,193
US,UPPER GASTROINTESTINAL HAEMORRHAGE,193
US,ABASIA,192
US,MEDICATION RESIDUE PRESENT,192
US,BLOOD POTASSIUM DECREASED,190
US,HOSPITALISATION,190
US,PRURITUS GENERALISED,190
US,GASTRIC DISORDER,189
US,URINARY INCONTINENCE,188
US,GENERAL PHYSICAL HEALTH DETERIORATION,187
US,INTERVERTEBRAL DISC PROTRUSION,186
US,STAPHYLOCOCCAL INFECTION,186
US,WHITE BLOOD CELL COUNT INCREASED,186
US,TACHYCARDIA,184
US,DRUG PRESCRIBING ERROR,183
US,DYSPNOEA EXERTIONAL,182
US,ACTIVITIES OF DAILY LIVING IMPAIRED,181
US,MULTIPLE SCLEROSIS RELAPSE,178
US,EXTRA DOSE ADMINISTERED,177
US,DIABETIC NEUROPATHY,176
US,HEAD INJURY,174
US,OSTEOMYELITIS,174
US,DISTURBANCE IN ATTENTION,173
US,HYPERSOMNIA,173
US,HAEMATOCHEZIA,171
US,LOCALISED INFECTION,170
US,THIRST,168
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,165
US,DYSARTHRIA,165
US,THERAPEUTIC RESPONSE DECREASED,165
US,HYPOPHAGIA,164
US,SWOLLEN TONGUE,164
US,EYE SWELLING,163
US,ORAL PAIN,163
US,RASH GENERALISED,161
US,SKIN ULCER,161
US,HUNGER,160
US,INJECTION SITE RASH,160
US,HYPOACUSIS,159
US,PRODUCT SUBSTITUTION ISSUE,159
US,BLOOD TRIGLYCERIDES INCREASED,157
US,VAGINAL HAEMORRHAGE,157
US,ANGIOEDEMA,156
US,DISORIENTATION,156
US,CORONARY ARTERY OCCLUSION,155
US,DYSSTASIA,154
US,HYPERKALAEMIA,154
US,HYPOTHYROIDISM,154
US,ARRHYTHMIA,152
US,EYE DISORDER,152
US,EYE IRRITATION,152
US,OSTEOPOROSIS,152
US,OXYGEN SATURATION DECREASED,152
US,LIP SWELLING,151
US,TINNITUS,150
US,INTERNAL HAEMORRHAGE,149
US,NEUTROPENIA,149
US,JOINT INJURY,148
US,ABNORMAL LOSS OF WEIGHT,147
US,CARDIO-RESPIRATORY ARREST,147
US,IMPAIRED HEALING,147
US,LUNG DISORDER,146
US,PSORIATIC ARTHROPATHY,145
US,FIBROMYALGIA,144
US,LIMB INJURY,144
US,PULMONARY OEDEMA,144
US,BREAST CANCER,143
US,DIVERTICULITIS,143
US,BLINDNESS,142
US,CHRONIC KIDNEY DISEASE,142
US,HYPOKALAEMIA,141
US,RETCHING,141
US,NEURALGIA,140
US,RED BLOOD CELL COUNT DECREASED,139
US,GASTRITIS,138
US,DRY EYE,137
US,HEPATIC STEATOSIS,137
US,INCREASED APPETITE,137
US,NIGHT SWEATS,137
US,RASH ERYTHEMATOUS,137
US,SURGERY,137
US,EATING DISORDER,136
US,MALABSORPTION,136
US,WITHDRAWAL SYNDROME,136
US,FEELING COLD,135
US,CARDIAC FAILURE,134
US,HIP FRACTURE,134
US,LOWER GASTROINTESTINAL HAEMORRHAGE,134
US,PANIC ATTACK,134
US,NEOPLASM MALIGNANT,133
US,APPLICATION SITE PAIN,132
US,FEELING JITTERY,132
US,ANGER,131
US,PAIN IN JAW,131
US,ACCIDENTAL EXPOSURE TO PRODUCT,130
US,GALLBLADDER DISORDER,130
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,129
US,SUICIDE ATTEMPT,129
US,AGEUSIA,127
US,HAEMOPTYSIS,127
US,HAEMORRHOIDS,127
US,MENTAL DISORDER,127
US,RHABDOMYOLYSIS,127
US,CHROMATURIA,126
US,HAIR COLOUR CHANGES,126
US,HYPERLIPIDAEMIA,126
US,LYMPHADENOPATHY,126
US,ABNORMAL BEHAVIOUR,125
US,BLADDER TRANSITIONAL CELL CARCINOMA,125
US,BACK DISORDER,124
US,INJURY ASSOCIATED WITH DEVICE,124
US,CEREBRAL HAEMORRHAGE,123
US,COAGULOPATHY,123
US,GOUT,123
US,BODY HEIGHT DECREASED,122
US,HEART RATE DECREASED,122
US,MOOD SWINGS,122
US,NIGHTMARE,122
US,RASH MACULAR,122
US,ACUTE RESPIRATORY FAILURE,121
US,BRADYCARDIA,121
US,SKIN DISORDER,121
US,HYPONATRAEMIA,120
US,PULMONARY MASS,120
US,BLOOD TESTOSTERONE DECREASED,119
US,INJECTION SITE URTICARIA,119
US,COGNITIVE DISORDER,118
US,EAR INFECTION,118
US,HYPOXIA,118
US,INTENTIONAL DRUG MISUSE,118
US,JOINT STIFFNESS,118
US,OCULAR HYPERAEMIA,118
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,118
US,UPPER LIMB FRACTURE,118
US,LACRIMATION INCREASED,117
US,ABNORMAL DREAMS,115
US,FAECES DISCOLOURED,115
US,HERNIA,115
US,WRONG DRUG ADMINISTERED,115
US,FEAR,114
US,LACERATION,114
US,PANCREATIC CARCINOMA METASTATIC,114
US,ACNE,113
US,CARPAL TUNNEL SYNDROME,113
US,COMA,113
US,DYSKINESIA,112
US,GLAUCOMA,112
US,HAIR TEXTURE ABNORMAL,112
US,LUNG NEOPLASM MALIGNANT,111
US,PLASMA CELL MYELOMA,111
US,PRESYNCOPE,111
US,ROTATOR CUFF SYNDROME,111
US,SEPTIC SHOCK,111
US,SINUS DISORDER,111
US,URINARY RETENTION,111
US,HEPATIC CIRRHOSIS,110
US,NODULE,110
US,PRODUCT ADHESION ISSUE,110
US,PROSTATE CANCER,110
US,SKIN BURNING SENSATION,110
US,ALANINE AMINOTRANSFERASE INCREASED,109
US,ANGINA PECTORIS,109
US,APHASIA,109
US,FOOT FRACTURE,109
US,MOVEMENT DISORDER,109
US,RIB FRACTURE,109
US,SKIN LESION,109
US,HAEMATOMA,108
US,LIVER DISORDER,108
US,METASTASES TO LIVER,108
US,MOOD ALTERED,108
US,POOR QUALITY SLEEP,108
US,ANKLE FRACTURE,107
US,CONVULSION,107
US,IRRITABLE BOWEL SYNDROME,107
US,RESTLESS LEGS SYNDROME,107
US,CROHN^S DISEASE,106
US,PANCYTOPENIA,106
US,BLOOD POTASSIUM INCREASED,105
US,DEVICE USE ERROR,105
US,PHARYNGEAL OEDEMA,105
US,RESTLESSNESS,105
US,SHOCK,105
US,ERECTILE DYSFUNCTION,104
US,SPINAL OSTEOARTHRITIS,104
US,ASPARTATE AMINOTRANSFERASE INCREASED,103
US,EYE HAEMORRHAGE,103
US,GLOSSODYNIA,103
US,HYPOMAGNESAEMIA,103
US,ILL-DEFINED DISORDER,103
US,VIRAL INFECTION,103
US,APPLICATION SITE ERYTHEMA,102
US,BLOOD COUNT ABNORMAL,102
US,MICTURITION URGENCY,102
US,PRODUCT PHYSICAL ISSUE,102
US,RASH PAPULAR,102
US,FREQUENT BOWEL MOVEMENTS,101
US,MENTAL IMPAIRMENT,101
US,NEEDLE ISSUE,101
US,DRUG-INDUCED LIVER INJURY,100
US,OBESITY,100
US,THINKING ABNORMAL,100
US,WOUND,100
US,HIATUS HERNIA,99
US,INTERVERTEBRAL DISC DEGENERATION,99
US,ACCIDENTAL OVERDOSE,98
US,COLITIS,98
US,EAR PAIN,98
US,FEEDING DISORDER,98
US,INJECTION SITE DISCOLOURATION,98
US,NOCTURIA,98
US,GASTROENTERITIS VIRAL,97
US,LEUKOCYTOSIS,97
US,PERICARDIAL EFFUSION,97
US,BLOOD PRESSURE ABNORMAL,96
US,GLOMERULAR FILTRATION RATE DECREASED,96
US,PRESCRIBED OVERDOSE,95
US,SCIATICA,95
US,THYROID DISORDER,95
US,COLD SWEAT,94
US,MATERNAL EXPOSURE DURING PREGNANCY,94
US,ABDOMINAL PAIN LOWER,93
US,HEART RATE IRREGULAR,93
US,SNEEZING,93
US,LOWER LIMB FRACTURE,92
US,TOE AMPUTATION,92
US,APPLICATION SITE PRURITUS,91
US,LABORATORY TEST ABNORMAL,91
US,MASS,91
US,THROAT TIGHTNESS,91
US,TOOTHACHE,91
US,DEAFNESS,90
US,DIPLOPIA,90
US,EXPOSURE DURING PREGNANCY,90
US,HAEMATEMESIS,90
US,IMPAIRED GASTRIC EMPTYING,90
US,LIPASE INCREASED,90
US,LIVER FUNCTION TEST ABNORMAL,90
US,PRE-EXISTING CONDITION IMPROVED,90
US,PRODUCT ODOUR ABNORMAL,90
US,PRODUCT STORAGE ERROR,90
US,PSYCHOLOGICAL TRAUMA,90
US,FEMUR FRACTURE,89
US,RESPIRATORY DISORDER,89
US,RESPIRATORY TRACT CONGESTION,89
US,CARDIOVASCULAR DISORDER,88
US,HAIR DISORDER,88
US,INJECTION SITE WARMTH,88
US,DEMENTIA,87
US,DIVERTICULUM,87
US,EMOTIONAL DISORDER,87
US,GASTRIC ULCER,87
US,PULMONARY HYPERTENSION,87
US,UNRESPONSIVE TO STIMULI,87
US,GLYCOSYLATED HAEMOGLOBIN DECREASED,86
US,IRON DEFICIENCY ANAEMIA,86
US,MUSCULOSKELETAL DISCOMFORT,86
US,AGGRESSION,85
US,BLOOD MAGNESIUM DECREASED,85
US,EYE PRURITUS,85
US,HAEMATOCRIT DECREASED,85
US,INFLAMMATION,85
US,INTESTINAL OBSTRUCTION,85
US,MUSCLE TWITCHING,85
US,SINUS CONGESTION,85
US,SKIN IRRITATION,85
US,BONE DISORDER,84
US,EXOSTOSIS,84
US,VITAMIN D DEFICIENCY,84
US,WRONG TECHNIQUE IN DEVICE USAGE PROCESS,84
US,EXPOSURE VIA INGESTION,83
US,KIDNEY INFECTION,83
US,MACULAR DEGENERATION,83
US,TOOTH DISORDER,82
US,INTENTIONAL DEVICE MISUSE,81
US,ANAPHYLACTIC REACTION,80
US,BLOOD UREA INCREASED,80
US,CHOLECYSTITIS CHRONIC,80
US,LUNG INFECTION,80
US,URINE OUTPUT INCREASED,80
US,HEAD DISCOMFORT,79
US,INTERNATIONAL NORMALISED RATIO INCREASED,79
US,MADAROSIS,79
US,PNEUMONIA ASPIRATION,79
US,SPINAL COLUMN STENOSIS,79
US,VITAMIN D DECREASED,79
US,DEVICE LEAKAGE,78
US,HAEMORRHAGIC STROKE,78
US,KNEE ARTHROPLASTY,78
US,NERVE INJURY,78
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,78
US,ATELECTASIS,77
US,CHOKING,77
US,FLANK PAIN,77
US,NERVE COMPRESSION,77
US,ASCITES,76
US,IMPAIRED WORK ABILITY,76
US,ISCHAEMIC STROKE,76
US,MIDDLE INSOMNIA,76
US,MUSCULOSKELETAL CHEST PAIN,76
US,POOR QUALITY DRUG ADMINISTERED,76
US,SENSORY DISTURBANCE,76
US,SUBDURAL HAEMATOMA,76
US,WEIGHT FLUCTUATION,76
US,BLOOD SODIUM DECREASED,75
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,75
US,RESPIRATORY TRACT INFECTION,75
US,DELIRIUM,74
US,DEPRESSED LEVEL OF CONSCIOUSNESS,74
US,RENAL INJURY,74
US,IMPAIRED DRIVING ABILITY,73
US,MUSCLE TIGHTNESS,73
US,SCAR,73
US,TOOTH INFECTION,73
US,WOUND COMPLICATION,73
US,CYST,72
US,INFUSION RELATED REACTION,72
US,VITREOUS FLOATERS,72
US,BLINDNESS UNILATERAL,71
US,GLUCOSE TOLERANCE IMPAIRED,71
US,HEMIPARESIS,71
US,LARGE INTESTINE POLYP,71
US,RENAL CYST,71
US,RESPIRATORY DISTRESS,71
US,BACK INJURY,70
US,BLOOD PRESSURE FLUCTUATION,70
US,DISABILITY,70
US,LARYNGITIS,70
US,MUSCULOSKELETAL DISORDER,70
US,PAPILLARY THYROID CANCER,70
US,RENAL PAIN,70
US,DEVICE FAILURE,69
US,INJECTION SITE DISCOMFORT,69
US,KETOACIDOSIS,69
US,PELVIC PAIN,69
US,PHOTOPHOBIA,69
US,DEVICE DISLOCATION,68
US,LIGAMENT SPRAIN,68
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,68
US,TENDERNESS,68
US,ULCER,68
US,HAEMORRHAGE INTRACRANIAL,67
US,INJECTION SITE INDURATION,67
US,MENISCUS INJURY,67
US,MULTIPLE SCLEROSIS,67
US,STENT PLACEMENT,67
US,ARTERIAL OCCLUSIVE DISEASE,66
US,HYPOAESTHESIA ORAL,66
US,PERIPHERAL COLDNESS,66
US,POLYP,66
US,VULVOVAGINAL MYCOTIC INFECTION,66
US,BLOOD BILIRUBIN INCREASED,65
US,CANDIDA INFECTION,65
US,CHOLECYSTECTOMY,65
US,MUCOSAL INFLAMMATION,65
US,ORAL DISCOMFORT,65
US,PARAESTHESIA ORAL,65
US,POLYURIA,65
US,SLUGGISHNESS,65
US,FULL BLOOD COUNT DECREASED,64
US,PAIN OF SKIN,64
US,PROCEDURAL PAIN,64
US,PRODUCT TASTE ABNORMAL,64
US,SPINAL FRACTURE,64
US,TREATMENT FAILURE,64
US,UROSEPSIS,64
US,BLOOD IRON DECREASED,63
US,FEBRILE NEUTROPENIA,63
US,INCONTINENCE,63
US,PARKINSON^S DISEASE,63
US,SEASONAL ALLERGY,63
US,BLADDER CANCER RECURRENT,62
US,CARDIOMEGALY,62
US,GAIT INABILITY,62
US,HEPATIC FAILURE,62
US,NEUTROPHIL COUNT DECREASED,62
US,OSTEOPENIA,62
US,SKIN CANCER,62
US,ANHEDONIA,61
US,ARTERIOSCLEROSIS,61
US,DIZZINESS POSTURAL,61
US,OSTEONECROSIS OF JAW,61
US,SINUS TACHYCARDIA,61
US,ADENOCARCINOMA PANCREAS,60
US,LEUKOPENIA,60
US,NERVOUS SYSTEM DISORDER,60
US,RESPIRATORY ARREST,60
US,BLADDER DISORDER,59
US,DIABETIC RETINOPATHY,59
US,EYE INFECTION,59
US,FLUID OVERLOAD,59
US,JAUNDICE,59
US,DEVICE EXPULSION,58
US,DRY THROAT,58
US,NEOPLASM PROGRESSION,58
US,SPLENOMEGALY,58
US,VULVOVAGINAL PRURITUS,58
US,WALKING AID USER,58
US,ABDOMINAL HERNIA,57
US,CARDIOMYOPATHY,57
US,COLON CANCER,57
US,HYPERKERATOSIS,57
US,HYPOKINESIA,57
US,DERMATITIS,56
US,GOITRE,56
US,INTRAOCULAR PRESSURE INCREASED,56
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,56
US,BURSITIS,55
US,CLOSTRIDIUM DIFFICILE INFECTION,55
US,MUSCLE ATROPHY,55
US,PARANOIA,55
US,RENAL CANCER,55
US,TENDONITIS,55
US,ACIDOSIS,54
US,ACUTE RESPIRATORY DISTRESS SYNDROME,54
US,BASAL CELL CARCINOMA,54
US,DIABETIC FOOT,54
US,ENCEPHALOPATHY,54
US,HIP ARTHROPLASTY,54
US,JOINT DISLOCATION,54
US,ORAL CANDIDIASIS,54
US,ORTHOSTATIC HYPOTENSION,54
US,SEDATION,54
US,DENTAL CARIES,53
US,GASTROENTERITIS,53
US,MULTIPLE FRACTURES,53
US,WOUND INFECTION,53
US,APHONIA,52
US,ATRIAL FLUTTER,52
US,BEDRIDDEN,52
US,CHOLECYSTITIS,52
US,CHOLECYSTITIS ACUTE,52
US,EJECTION FRACTION DECREASED,52
US,HYPOCALCAEMIA,52
US,METASTASES TO BONE,52
US,METASTASES TO LUNG,52
US,MUSCLE STRAIN,52
US,SCAB,52
US,SENSORY LOSS,52
US,SKIN FISSURES,52
US,SMALL INTESTINAL OBSTRUCTION,52
US,THYROID CANCER,52
US,URINE ODOUR ABNORMAL,52
US,WRIST FRACTURE,52
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,51
US,BLOOD TEST ABNORMAL,51
US,ELECTROCARDIOGRAM QT PROLONGED,51
US,HYPOTHERMIA,51
US,LOWER RESPIRATORY TRACT INFECTION,51
US,MELAENA,51
US,PULMONARY CONGESTION,51
US,ACCIDENTAL UNDERDOSE,50
US,ARTERIOSCLEROSIS CORONARY ARTERY,50
US,BACTERIAL INFECTION,50
US,CONCUSSION,50
US,EMPHYSEMA,50
US,FRACTURE,50
US,GROIN PAIN,50
US,METASTASES TO LYMPH NODES,50
US,PALLOR,50
US,PAROSMIA,50
US,SKIN HAEMORRHAGE,50
US,TOOTH FRACTURE,50
US,DRUG DEPENDENCE,49
US,ENERGY INCREASED,49
US,GASTROINTESTINAL PAIN,49
US,INCREASED TENDENCY TO BRUISE,49
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,49
US,PULMONARY FIBROSIS,49
US,RETINAL DETACHMENT,49
US,SECRETION DISCHARGE,49
US,TOOTH ABSCESS,49
US,ABSCESS,48
US,ARTHROPOD BITE,48
US,CATARACT OPERATION,48
US,COLITIS ULCERATIVE,48
US,EAR DISCOMFORT,48
US,FACIAL PARALYSIS,48
US,HYPERCHLORHYDRIA,48
US,MANIA,48
US,MENORRHAGIA,48
US,MYOCARDIAL ISCHAEMIA,48
US,PRESCRIBED UNDERDOSE,48
US,RASH MACULO-PAPULAR,48
US,RETINAL HAEMORRHAGE,48
US,SCRATCH,48
US,ULCER HAEMORRHAGE,48
US,UPPER-AIRWAY COUGH SYNDROME,48
US,APHAGIA,47
US,BODY TEMPERATURE INCREASED,47
US,CARDIAC MURMUR,47
US,DECREASED INTEREST,47
US,GASTRIC HAEMORRHAGE,47
US,IMMUNE SYSTEM DISORDER,47
US,IMPAIRED QUALITY OF LIFE,47
US,INJECTION SITE INJURY,47
US,JOINT RANGE OF MOTION DECREASED,47
US,PERIPHERAL VASCULAR DISORDER,47
US,PSYCHOTIC DISORDER,47
US,SUPRAVENTRICULAR TACHYCARDIA,47
US,ACUTE CORONARY SYNDROME,46
US,FACIAL PAIN,46
US,FOOD CRAVING,46
US,HAIR GROWTH ABNORMAL,46
US,HEPATOTOXICITY,46
US,OVERWEIGHT,46
US,PRODUCT PACKAGING ISSUE,46
US,PROSTATOMEGALY,46
US,TOOTH EXTRACTION,46
US,TRANSFUSION,46
US,BOWEL MOVEMENT IRREGULARITY,45
US,COORDINATION ABNORMAL,45
US,HEREDITARY ANGIOEDEMA,45
US,HYPERCALCAEMIA,45
US,OESOPHAGITIS,45
US,PNEUMOTHORAX,45
US,SPINAL DISORDER,45
US,SPINAL PAIN,45
US,TEMPERATURE INTOLERANCE,45
US,APPETITE DISORDER,44
US,CORONARY ARTERY BYPASS,44
US,DECREASED ACTIVITY,44
US,ECZEMA,44
US,FOETAL EXPOSURE DURING PREGNANCY,44
US,FURUNCLE,44
US,HEPATOMEGALY,44
US,HYPERCHOLESTEROLAEMIA,44
US,PYELONEPHRITIS,44
US,THYROID NEOPLASM,44
US,ABORTION SPONTANEOUS,43
US,AORTIC ANEURYSM,43
US,BLOOD CHOLESTEROL ABNORMAL,43
US,DRUG EFFECT DELAYED,43
US,DRUG LEVEL INCREASED,43
US,FEELING DRUNK,43
US,GANGRENE,43
US,HICCUPS,43
US,MACULAR OEDEMA,43
US,MITRAL VALVE INCOMPETENCE,43
US,MUSCLE DISORDER,43
US,PHOTOPSIA,43
US,PHOTOSENSITIVITY REACTION,43
US,TOOTH LOSS,43
US,URINE OUTPUT DECREASED,43
US,ANORECTAL DISCOMFORT,42
US,CARDIOGENIC SHOCK,42
US,CAROTID ARTERY OCCLUSION,42
US,DIVERTICULUM INTESTINAL,42
US,ESSENTIAL HYPERTENSION,42
US,GINGIVAL BLEEDING,42
US,HALLUCINATION_ AUDITORY,42
US,LIBIDO DECREASED,42
US,MOUTH ULCERATION,42
US,THROMBOPHLEBITIS SUPERFICIAL,42
US,ANGINA UNSTABLE,41
US,CENTRAL NERVOUS SYSTEM LESION,41
US,CLOSTRIDIUM DIFFICILE COLITIS,41
US,DERMATITIS CONTACT,41
US,FOOT DEFORMITY,41
US,GENERALISED OEDEMA,41
US,GINGIVAL PAIN,41
US,GRANULOCYTOPENIA,41
US,LIVER FUNCTION TEST INCREASED,41
US,MALIGNANT MELANOMA,41
US,MULTIPLE ALLERGIES,41
US,PHARYNGITIS,41
US,PNEUMONITIS,41
US,POST PROCEDURAL COMPLICATION,41
US,PRODUCT PACKAGING QUANTITY ISSUE,41
US,SKIN MASS,41
US,SYSTEMIC LUPUS ERYTHEMATOSUS,41
US,TENDON RUPTURE,41
US,ABNORMAL FAECES,40
US,AMYLASE INCREASED,40
US,APPLICATION SITE RASH,40
US,BLOOD ALKALINE PHOSPHATASE INCREASED,40
US,CEREBRAL DISORDER,40
US,CEREBRAL INFARCTION,40
US,COELIAC DISEASE,40
US,DELUSION,40
US,GASTRIC ULCER HAEMORRHAGE,40
US,HEARING IMPAIRED,40
US,HEPATITIS C,40
US,HYPOVOLAEMIA,40
US,LUNG INFILTRATION,40
US,ORAL MUCOSAL BLISTERING,40
US,PLATELET COUNT INCREASED,40
US,PROTEINURIA,40
US,PULMONARY THROMBOSIS,40
US,TONGUE DISORDER,40
US,TRICUSPID VALVE INCOMPETENCE,40
US,VENTRICULAR TACHYCARDIA,40
US,ACCIDENT,39
US,BIPOLAR DISORDER,39
US,BLINDNESS TRANSIENT,39
US,DEMENTIA ALZHEIMER^S TYPE,39
US,EXPIRED DRUG ADMINISTERED,39
US,FUNGAL SKIN INFECTION,39
US,GENITAL INFECTION FUNGAL,39
US,LYMPHOMA,39
US,NICOTINE DEPENDENCE,39
US,THERAPY NON-RESPONDER,39
US,AMMONIA INCREASED,38
US,BREAST MASS,38
US,CARDIOPULMONARY FAILURE,38
US,DISEASE RECURRENCE,38
US,END STAGE RENAL DISEASE,38
US,EYE DISCHARGE,38
US,JOINT EFFUSION,38
US,KNEE OPERATION,38
US,POST-TRAUMATIC STRESS DISORDER,38
US,PRODUCT SOLUBILITY ABNORMAL,38
US,ANAL INCONTINENCE,37
US,BLOOD CALCIUM INCREASED,37
US,BLOOD PRESSURE SYSTOLIC INCREASED,37
US,DEVICE DIFFICULT TO USE,37
US,DEVICE OCCLUSION,37
US,EYELID OEDEMA,37
US,FACIAL BONES FRACTURE,37
US,LOW DENSITY LIPOPROTEIN INCREASED,37
US,NEOPLASM,37
US,OVARIAN CYST,37
US,PANCREATIC DISORDER,37
US,PURULENT DISCHARGE,37
US,SPUTUM DISCOLOURED,37
US,WOUND HAEMORRHAGE,37
US,BLOOD LACTIC ACID INCREASED,36
US,BRAIN INJURY,36
US,DIARRHOEA HAEMORRHAGIC,36
US,ECCHYMOSIS,36
US,HYPERAESTHESIA,36
US,INCOHERENT,36
US,INCORRECT DOSE ADMINISTERED BY DEVICE,36
US,ISCHAEMIC CARDIOMYOPATHY,36
US,MYELODYSPLASTIC SYNDROME,36
US,ORAL HERPES,36
US,POST PROCEDURAL HAEMORRHAGE,36
US,PRODUCT LABEL ISSUE,36
US,SKIN ABRASION,36
US,TRIGGER FINGER,36
US,TUBULOINTERSTITIAL NEPHRITIS,36
US,VENTRICULAR EXTRASYSTOLES,36
US,ANOSMIA,35
US,BARRETT^S OESOPHAGUS,35
US,BREAST PAIN,35
US,CARDIAC FLUTTER,35
US,DYSLIPIDAEMIA,35
US,ELECTROCARDIOGRAM ABNORMAL,35
US,FOREIGN BODY SENSATION IN EYES,35
US,HAND FRACTURE,35
US,HYPOGLYCAEMIC UNCONSCIOUSNESS,35
US,INITIAL INSOMNIA,35
US,INTERSTITIAL LUNG DISEASE,35
US,MALNUTRITION,35
US,MULTI-ORGAN FAILURE,35
US,NAIL DISORDER,35
US,NON-CARDIAC CHEST PAIN,35
US,PARANASAL SINUS HYPERSECRETION,35
US,PREMATURE DELIVERY,35
US,PULMONARY ARTERIAL HYPERTENSION,35
US,RENAL FAILURE CHRONIC,35
US,TARDIVE DYSKINESIA,35
US,TRANSAMINASES INCREASED,35
US,TYPE 1 DIABETES MELLITUS,35
US,VULVOVAGINAL BURNING SENSATION,35
US,WOUND SECRETION,35
US,ADVERSE REACTION,34
US,AFFECT LABILITY,34
US,BREAST CANCER FEMALE,34
US,CONTRAINDICATED PRODUCT ADMINISTERED,34
US,HYSTERECTOMY,34
US,INJECTION SITE INFLAMMATION,34
US,INTENTIONAL UNDERDOSE,34
US,INTERVERTEBRAL DISC DISORDER,34
US,LEG AMPUTATION,34
US,MOUTH HAEMORRHAGE,34
US,NEPHROPATHY,34
US,PARALYSIS,34
US,PHARYNGITIS STREPTOCOCCAL,34
US,SEROTONIN SYNDROME,34
US,SKIN INFECTION,34
US,THERAPY CHANGE,34
US,TONGUE DISCOLOURATION,34
US,BENIGN PROSTATIC HYPERPLASIA,33
US,BREAST CANCER METASTATIC,33
US,CARDIAC OPERATION,33
US,DEFORMITY,33
US,DEVICE USE ISSUE,33
US,EYELID PTOSIS,33
US,FORMICATION,33
US,LIVER INJURY,33
US,MENSTRUATION IRREGULAR,33
US,VISUAL FIELD DEFECT,33
US,VULVOVAGINAL DISCOMFORT,33
US,ABDOMINAL TENDERNESS,32
US,APPARENT DEATH,32
US,EARLY SATIETY,32
US,EUPHORIC MOOD,32
US,HALLUCINATION_ VISUAL,32
US,HEPATIC CANCER,32
US,INSULIN RESISTANCE,32
US,LUMBAR SPINAL STENOSIS,32
US,LYMPHOEDEMA,32
US,METRORRHAGIA,32
US,POST PROCEDURAL INFECTION,32
US,RENAL TUBULAR NECROSIS,32
US,SCOLIOSIS,32
US,SKIN WARM,32
US,VITAMIN B12 DEFICIENCY,32
US,WEIGHT LOSS POOR,32
US,APATHY,31
US,APPLICATION SITE DISCOLOURATION,31
US,ATRIOVENTRICULAR BLOCK,31
US,BACTERAEMIA,31
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,31
US,BONE LESION,31
US,DECUBITUS ULCER,31
US,DEVICE BREAKAGE,31
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,31
US,ELECTROLYTE IMBALANCE,31
US,FEELING OF BODY TEMPERATURE CHANGE,31
US,HAEMOLYTIC ANAEMIA,31
US,INCREASED UPPER AIRWAY SECRETION,31
US,INJECTION SITE IRRITATION,31
US,INTERCEPTED DRUG DISPENSING ERROR,31
US,MOTOR DYSFUNCTION,31
US,ONYCHOMYCOSIS,31
US,PANCREATITIS CHRONIC,31
US,PSYCHOMOTOR HYPERACTIVITY,31
US,QUALITY OF LIFE DECREASED,31
US,SENSATION OF FOREIGN BODY,31
US,SEXUAL DYSFUNCTION,31
US,SQUAMOUS CELL CARCINOMA,31
US,SUBARACHNOID HAEMORRHAGE,31
US,SUBCUTANEOUS ABSCESS,31
US,UMBILICAL HERNIA,31
US,VIITH NERVE PARALYSIS,31
US,BONE CANCER,30
US,DRUG ABUSE,30
US,FRUSTRATION TOLERANCE DECREASED,30
US,GASTROINTESTINAL SOUNDS ABNORMAL,30
US,HYDRONEPHROSIS,30
US,ILEUS,30
US,POLYDIPSIA,30
US,RHINITIS ALLERGIC,30
US,SINUS HEADACHE,30
US,SKIN ODOUR ABNORMAL,30
UM,DEHYDRATION,1
UM,RETINOPATHY,1
UM,VISUAL ACUITY REDUCED,1
UY,RENAL FAILURE,2
UY,ANURIA,1
UY,ARTHRALGIA,1
UY,BLOOD THYROID STIMULATING HORMONE INCREASED,1
UY,BONE PAIN,1
UY,CARDIAC ARREST,1
UY,CONGENITAL ANOMALY,1
UY,DRY EYE,1
UY,FOETAL DISTRESS SYNDROME,1
UY,FOETAL EXPOSURE DURING PREGNANCY,1
UY,GASTRITIS EROSIVE,1
UY,GENERALISED OEDEMA,1
UY,HAEMOGLOBIN DECREASED,1
UY,HAEMORRHOIDS,1
UY,HEADACHE,1
UY,HYPERHIDROSIS,1
UY,HYPOAESTHESIA,1
UY,HYPOTENSION,1
UY,MONOPLEGIA,1
UY,PRODUCT USE ISSUE,1
UY,PULSE ABSENT,1
UY,RIGHT VENTRICULAR FAILURE,1
UY,ULCER,1
VE,COLITIS,2
VE,DIARRHOEA,2
VE,FATIGUE,2
VE,HEADACHE,2
VE,MYOCARDIAL INFARCTION,2
VE,PAIN,2
VE,PNEUMONIA,2
VE,SEPSIS,2
VE,ABDOMINAL PAIN UPPER,1
VE,AMOEBIC DYSENTERY,1
VE,ARTHRALGIA,1
VE,ASTHMATIC CRISIS,1
VE,BALANCE DISORDER,1
VE,BLOOD CHOLESTEROL INCREASED,1
VE,BLOOD GLUCOSE DECREASED,1
VE,BLOOD GLUCOSE INCREASED,1
VE,BLOOD TRIGLYCERIDES INCREASED,1
VE,CARDIAC DISORDER,1
VE,CARDIOMEGALY,1
VE,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,1
VE,CHIKUNGUNYA VIRUS INFECTION,1
VE,CHOLECYSTECTOMY,1
VE,CONFUSIONAL STATE,1
VE,DEATH,1
VE,DENGUE FEVER,1
VE,DISORIENTATION,1
VE,DYSPHONIA,1
VE,EXPOSURE DURING PREGNANCY,1
VE,FEAR,1
VE,FEBRILE NEUTROPENIA,1
VE,FEELING OF DESPAIR,1
VE,FLATULENCE,1
VE,FOETAL EXPOSURE DURING PREGNANCY,1
VE,GAIT DISTURBANCE,1
VE,HEART RATE DECREASED,1
VE,HIATUS HERNIA,1
VE,HIP FRACTURE,1
VE,HYPERLIPIDAEMIA,1
VE,HYPERSENSITIVITY,1
VE,HYPERTENSION,1
VE,HYPOACUSIS,1
VE,HYSTERECTOMY,1
VE,INFARCTION,1
VE,INFLUENZA,1
VE,LOW BIRTH WEIGHT BABY,1
VE,MATERNAL EXPOSURE DURING PREGNANCY,1
VE,NASAL TURBINATE HYPERTROPHY,1
VE,NEPHROLITHIASIS,1
VE,NERVOUSNESS,1
VE,NEUROPATHY PERIPHERAL,1
VE,OBESITY,1
VE,PAIN IN EXTREMITY,1
VE,PELVIC FRACTURE,1
VE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
VE,POLLAKIURIA,1
VE,POLYURIA,1
VE,POST PROCEDURAL COMPLICATION,1
VE,PREMATURE BABY,1
VE,PREMATURE DELIVERY,1
VE,PREMATURE LABOUR,1
VE,PRURITUS,1
VE,PYELONEPHRITIS,1
VE,PYREXIA,1
VE,RENAL FAILURE,1
VE,ROAD TRAFFIC ACCIDENT,1
VE,SUPPRESSED LACTATION,1
VE,THYROID DISORDER,1
VE,VASCULAR OCCLUSION,1
VN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
VN,ABSCESS LIMB,1
VN,ACNE,1
VN,ALOPECIA,1
VN,CEREBRAL VENTRICLE DILATATION,1
VN,FATIGUE,1
VN,GASTRIC ULCER,1
VN,PNEUMONIA,1
VN,POLLAKIURIA,1
VN,PRURITUS,1
VN,TACHYCARDIA,1
VN,THIRST,1
VI,DRY SKIN,1
VI,MALIGNANT NEOPLASM PROGRESSION,1
VI,RASH PAPULAR,1
